Citrus Sinensis ID: 040952

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-
Protein Sequence
MDRSATPIISLLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR
Secondary Structure (PSIPRED)
cccccccEEEEEHHHHHHHHHHHHHHHHHHHEEccccccccccHHHHHHcccccHHHHcccccHHHHHHcccccccccccccHHHHHHHHccccccccccccccccccEEccccccEEEEEEccccccccHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccHHHEEEEEEcccccccccccccccHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEEEccccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHccccccccccccccccccccccEEcHHHHHHHHHcccHHccccccccccEEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEEcccccccEEHccccccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEcccccEEccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHccccEEHccHHHccccccHHHHHHHHHHHHHEEcccHcccccHHHEEEEccccccccccccccEEEEEccccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
MDRSATPIISLLLLSIVPAAVAILGLIFYCvrrkprsrgedlmMFDLDlnlkadnviielpannkqakrskkkevdqlplfsfssvstatnkfsdanklgeggfgpvykgvlkkgdEIAVKRlsgrsgqglrEMKNEASVIAKVQHKNLVRLLGccidkdekiliyeympnksldfflfdptkrmlLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASnilldkdmnpkisdfgmaricggnelqantsrivgtygymspeyaLEGIFSIKSDVFSFGVLLLEIVSgkkntglyrtdslNLLGYAWdlwtsnrtlelidpiledeysSKHMLLRYVNIALLCVqesaddrptmNDVVSMLTNEaaallppkqpafsfvrntvtstsstgktedcsvnQVTISILEAR
Flexible Loop (DISEMBL)
MDRSATPIISLLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELpannkqakrskkkevdqlplfsfssvstatnkfsdanklgeggfgpVYKGVLKKGDEIAVkrlsgrsgqglreMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVsgkkntglyRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAllppkqpafSFVRNTVtstsstgktedcsvnqvtisilear
Low Complexity Region (SEG)
MDRSATpiisllllsivpaavailGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR
Disordered region (IsUnstruct)
******PIISLLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIEL**************************************LGEGGFGPVYKGVLKKGDEIAV******************SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQE***********V**L***********************************************
Disordered Region (DISOPRED)
******P**SLLLLSIVPAAVAILGLIFYCVRRKPR***************************************DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS**********************VTISILEAR
Disordered Region (DISEMBL)
MDRSATPIISLLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPAN************DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNT***********DCSVNQVTISILEAR
Disordered Region (DISPRO)
****ATPIISLLLLSIVPAAVAILGLIFYCVRRKPRSRG***********************************VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRN*************CSVNQVTISILEA*
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDRSATPIISLLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	411	2.2.26 [Sep-21-2011]
Q9LW83	850	G-type lectin S-receptor-	yes	no	0.817	0.395	0.604	1e-116
O81906	849	G-type lectin S-receptor-	no	no	0.827	0.400	0.593	1e-116
Q9S972	847	Receptor-like serine/thre	no	no	0.965	0.468	0.542	1e-114
Q39086	843	Receptor-like serine/thre	no	no	0.951	0.463	0.549	1e-113
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.951	0.464	0.511	1e-113
O64793	818	G-type lectin S-receptor-	no	no	0.836	0.420	0.583	1e-113
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.987	0.476	0.521	1e-112
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.934	0.460	0.504	1e-112
O81905	850	Receptor-like serine/thre	no	no	0.987	0.477	0.519	1e-110
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.936	0.455	0.504	1e-109

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  419 bits (1076), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 206/341 (60%), Positives = 262/341 (76%), Gaps = 5/341 (1%)

Query: 76  DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK 135
           ++L +FSF SV+ AT+ FSDANKLGEGGFGPVYKG L  G+E+A+KRLS  SGQGL E K
Sbjct: 510 NELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569

Query: 136 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
           NEA +IAK+QH NLV+LLGCC++KDEK+LIYEYMPNKSLD+FLFDP ++++LDW  R +I
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
           +EGI QGLLYLH+YSR+++IHRD+KA NILLD+DMNPKISDFGMARI G  E +ANT R+
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYAWDLW 313
            GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN   +      LNL+ + W+L+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLF 749

Query: 314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA-AALL 372
             NR  E+IDP L D       +LR V +ALLCVQ++ADDRP+M DVVSM+  +   AL 
Sbjct: 750 KENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALS 809

Query: 373 PPKQPAF--SFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
            PK+PAF     R++        + E+ S N+VTI+++EAR
Sbjct: 810 LPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  418 bits (1074), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 204/344 (59%), Positives = 264/344 (76%), Gaps = 4/344 (1%)

Query: 71  KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 130
           K     +LP+FS ++++ ATN F   N+LG GGFGPVYKGVL+ G EIAVKRLSG+SGQG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566

Query: 131 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV 190
           + E KNE  +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLFD TK+ L+DW 
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626

Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
            R  IIEGIA+GLLYLH+ SR+RIIHRDLK SN+LLD +MNPKISDFGMARI GGN+ +A
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686

Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW 310
           NT R+VGTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT L  ++  +L+GYAW
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746

Query: 311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 370
            L+T  R+ EL+DP +     SK   LR +++A+LCVQ+SA +RP M  V+ ML ++ A 
Sbjct: 747 YLYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTAT 805

Query: 371 LLPPKQPAF-SFVRNTVTSTSSTGKTED--CSVNQVTISILEAR 411
           L  P+QP F S  RN++    +   ++    S N++T +++  R
Sbjct: 806 LAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  412 bits (1058), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 219/404 (54%), Positives = 282/404 (69%), Gaps = 7/404 (1%)

Query: 15  SIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIEL-PANNKQAKRSKKK 73
           SI  + + +L  I +   ++ + R   +    +DL    D+++ EL  A+     +  K 
Sbjct: 444 SIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKT 503

Query: 74  EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE 133
           +  +LPL  + +++ ATN FS  NKLG+GGFG VYKG+L  G EIAVKRLS  S QG  E
Sbjct: 504 DYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDE 563

Query: 134 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 193
             NE  +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD  LFD T+   L+W  R 
Sbjct: 564 FMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRF 623

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
            II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E +ANT 
Sbjct: 624 DIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTR 683

Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYAWDL 312
           R+VGTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG+ W  
Sbjct: 684 RVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRH 743

Query: 313 WTSNRTLELIDPILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 369
           W   + LE++DPI  D  SS+   H +LR + I LLCVQE A+DRP M+ V+ ML +E  
Sbjct: 744 WKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETT 803

Query: 370 ALLPPKQPAFSFVR--NTVTSTSSTGKTEDCSVNQVTISILEAR 411
           A+  PK+P F   R    V S+SST + ++C+VNQVT+S+++AR
Sbjct: 804 AIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  409 bits (1051), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 224/408 (54%), Positives = 285/408 (69%), Gaps = 17/408 (4%)

Query: 11  LLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNK-QAKR 69
           LLLLS V         IF+  +RK + R   +   ++D     D++I ++  + +    +
Sbjct: 446 LLLLSFV---------IFHFWKRKQK-RSITIQTPNVDQVRSQDSLINDVVVSRRGYTSK 495

Query: 70  SKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ 129
            KK E  +LPL    +++TATN FS+ NKLG+GGFG VYKG L  G EIAVKRLS  S Q
Sbjct: 496 EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQ 555

Query: 130 GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW 189
           G  E  NE  +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD  LFD T+   L+W
Sbjct: 556 GTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNW 615

Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
             R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E +
Sbjct: 616 QKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETE 675

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGY 308
           ANT R+VGTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG+
Sbjct: 676 ANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGF 735

Query: 309 AWDLWTSNRTLELIDPILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
            W  W     LE++DPI  D  SSK   H +LR + I LLCVQE A+DRP M+ V+ ML 
Sbjct: 736 VWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLG 795

Query: 366 NEAAALLPPKQPAFSFVRNTVT--STSSTGKTEDCSVNQVTISILEAR 411
           +E  A+  PK+P F   R+ +   S+SST + ++C+VNQ+T+S+++AR
Sbjct: 796 SETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  408 bits (1049), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 209/409 (51%), Positives = 286/409 (69%), Gaps = 18/409 (4%)

Query: 5   ATPIISLLLLSIVPAAVAILGLIFYCVRRKP-RSRGEDLMMFDLDLNLKADNVIIELPAN 63
           A P+I ++L++   A   +L    Y  R  P + R  +LM   ++           L ++
Sbjct: 450 AAPVIGVMLIA---AVCVLLACRKYKKRPAPAKDRSAELMFKRME----------ALTSD 496

Query: 64  NKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL 123
           N+ A  S + ++ +LPLF F  ++T+T+ FS  NKLG+GGFGPVYKG L +G EIAVKRL
Sbjct: 497 NESA--SNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRL 554

Query: 124 SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK 183
           S +SGQGL E+ NE  VI+K+QH+NLV+LLGCCI+ +E++L+YEYMP KSLD +LFDP K
Sbjct: 555 SRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMK 614

Query: 184 RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 243
           + +LDW TR  I+EGI +GLLYLH+ SR++IIHRDLKASNILLD+++NPKISDFG+ARI 
Sbjct: 615 QKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIF 674

Query: 244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-S 302
             NE +ANT R+VGTYGYMSPEYA+EG FS KSDVFS GV+ LEI+SG++N+  ++ + +
Sbjct: 675 RANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENN 734

Query: 303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
           LNLL YAW LW       L DP + D+   K  + + V+I LLCVQE A+DRP +++V+ 
Sbjct: 735 LNLLAYAWKLWNDGEAASLADPAVFDKCFEKE-IEKCVHIGLLCVQEVANDRPNVSNVIW 793

Query: 363 MLTNEAAALLPPKQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
           MLT E  +L  PKQPAF   R    + SS   ++  S+N V+++ +  R
Sbjct: 794 MLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  407 bits (1047), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 203/348 (58%), Positives = 260/348 (74%), Gaps = 4/348 (1%)

Query: 68  KRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS 127
           KR+++K  ++L +FSF SV +AT+ FSD NKLGEGGFGPVYKG L  G+E+A+KRLS  S
Sbjct: 471 KRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLAS 530

Query: 128 GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLL 187
           GQGL E KNEA +IAK+QH NLV++LGCCI+KDEK+LIYEYM NKSLD+FLFDP ++ +L
Sbjct: 531 GQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVL 590

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
           DW  R +I+EGI QGLLYLH+YSR+++IHRD+KASNILLD+DMNPKISDFG+ARI G  E
Sbjct: 591 DWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEE 650

Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR--TDSLNL 305
            +ANT R+ GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN   +      LNL
Sbjct: 651 TRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNL 710

Query: 306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + + W+L+  N+  E+ID  L D       +LR V +ALLCVQE+A+DRP+M DVVSM+ 
Sbjct: 711 IVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVVSMIY 770

Query: 366 NEA-AALLPPKQPAF-SFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
            E   AL  PK+PAF    R +        +  +     +TI++LEAR
Sbjct: 771 GEGNNALSLPKEPAFYDGPRRSFPEMKVEPQEPENVSASITITVLEAR 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  406 bits (1044), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 215/412 (52%), Positives = 292/412 (70%), Gaps = 6/412 (1%)

Query: 4   SATPIISLLLLSIVPAAV-AILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPA 62
           + TP++ +++++   AA+  +L      V  + R   ++L      ++L      I+   
Sbjct: 443 AKTPVVLIIVVTFTSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKELI 502

Query: 63  NNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKR 122
            + + K+   + +D +P F   ++  AT+ FS+ANKLG+GGFGPVYKG+     EIAVKR
Sbjct: 503 ESGRFKQDDSQGID-VPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKR 561

Query: 123 LSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT 182
           LS  SGQGL E KNE  +IAK+QH+NLVRLLG C+  +EK+L+YEYMP+KSLDFF+FD  
Sbjct: 562 LSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRK 621

Query: 183 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
               LDW  R  II GIA+GLLYLHQ SR+RIIHRDLK SNILLD++MNPKISDFG+ARI
Sbjct: 622 LCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARI 681

Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD- 301
            GG+E  ANT+R+VGTYGYMSPEYALEG+FS KSDVFSFGV+++E +SGK+NTG +  + 
Sbjct: 682 FGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEK 741

Query: 302 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
           SL+LLG+AWDLW + R +EL+D  L++   ++   L+ +N+ LLCVQE  +DRPTM++VV
Sbjct: 742 SLSLLGHAWDLWKAERGIELLDQALQESCETEG-FLKCLNVGLLCVQEDPNDRPTMSNVV 800

Query: 362 SMLTNEAAALLP-PKQPAFSFVRN-TVTSTSSTGKTEDCSVNQVTISILEAR 411
            ML +  AA LP PKQPAF   R  + +  SS+ K E CS N++TI++ + R
Sbjct: 801 FMLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  404 bits (1039), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 207/410 (50%), Positives = 283/410 (69%), Gaps = 26/410 (6%)

Query: 11  LLLLSIVPAAVAILGLIFYCV----RRKPRSRGEDL----MMFDLDLNLKADNVIIELPA 62
           L+L+S++ AAV +L +I +CV    R+  R R        + FD D + +          
Sbjct: 441 LILISLI-AAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRF--------- 490

Query: 63  NNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKR 122
              +  +++ +E   LPLF  +++  ATN FS  NKLG GGFGPVYKGVL+   EIAVKR
Sbjct: 491 ---EQDKARNRE---LPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKR 544

Query: 123 LSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT 182
           LS  SGQG+ E KNE  +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F   
Sbjct: 545 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 604

Query: 183 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           +R  LDW  R++I+ GIA+G+LYLHQ SR+RIIHRDLKASNILLD +M PKISDFGMARI
Sbjct: 605 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 664

Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
            GGN+++  TSR+VGT+GYM+PEYA+EG FSIKSDV+SFGVL+LEI++GKKN+  +  +S
Sbjct: 665 FGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE-ES 723

Query: 303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
            NL+G+ WDLW +    E+ID +++ E   +  +++ + I LLCVQE+A DR  M+ VV 
Sbjct: 724 SNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVI 783

Query: 363 MLTNEAAALLPPKQPAFSFVRNTVTSTSSTGKTE-DCSVNQVTISILEAR 411
           ML + A  L  PK PAF+  R       +  K +   SVN VT S ++ R
Sbjct: 784 MLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  399 bits (1026), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 217/418 (51%), Positives = 286/418 (68%), Gaps = 12/418 (2%)

Query: 2   DRSATPIISLLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELP 61
           +RSA  I S    SI  + + +L  I + + ++ + R   +    +D  L++ ++++   
Sbjct: 437 NRSAKIIGS----SIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEV 492

Query: 62  ANNKQAKRSKKKEVD--QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIA 119
             + +   S++   D  +LPL  F  V+ ATN FS+ANKLG+GGFG VYKG L  G E+A
Sbjct: 493 VISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552

Query: 120 VKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF 179
           VKRLS  S QG  E KNE  +IA++QH NLVRLL CC+D  EK+LIYEY+ N SLD  LF
Sbjct: 553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612

Query: 180 DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 239
           D ++   L+W  R  II GIA+GLLYLHQ SR RIIHRDLKASNILLDK M PKISDFGM
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672

Query: 240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 299
           ARI G +E +ANT ++VGTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+S K+N G Y 
Sbjct: 673 ARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYN 732

Query: 300 TD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSS--KHMLLRYVNIALLCVQESADDRPT 356
           +D  LNLLG  W  W   + LE+IDPI+ D  S+  +H +LR + I LLCVQE A+DRPT
Sbjct: 733 SDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPT 792

Query: 357 MNDVVSMLTNEAAALLPPKQPAFSFVRNTVTSTSSTGKTED---CSVNQVTISILEAR 411
           M+ V+ ML +E+  +  PK P +   R+ + + SS+ K  D    +VNQ+T+S+L+AR
Sbjct: 793 MSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  394 bits (1013), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 211/418 (50%), Positives = 297/418 (71%), Gaps = 33/418 (7%)

Query: 11  LLLLSIVPAAVAILGLIFYCVRRKPRSRGEDLMM-----------FDLDLNLKADNVIIE 59
           L+L+S++ A V +L + F+C  RK R R +   +           FDL+     D+ I+E
Sbjct: 444 LILISLI-AVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLE-----DSFILE 497

Query: 60  LPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIA 119
                +   +S+ +E   LPLF  S+++TATN F+  NKLG GGFGPVYKGVL+ G EIA
Sbjct: 498 -----ELEDKSRSRE---LPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIA 549

Query: 120 VKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF 179
           VKRLS  SGQG+ E KNE  +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F
Sbjct: 550 VKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIF 609

Query: 180 DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 239
              +R  LDW  R+ II GI +G+LYLHQ SR+RIIHRDLKASN+LLD +M PKI+DFG+
Sbjct: 610 HEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGL 669

Query: 240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 299
           ARI GGN+++ +T+R+VGTYGYMSPEYA++G FSIKSDV+SFGVL+LEI++GK+N+  Y 
Sbjct: 670 ARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYE 729

Query: 300 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMND 359
            +SLNL+ + WD W +   +E+ID ++ +E   +  +++ ++I LLCVQE++ DRP M+ 
Sbjct: 730 -ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSS 788

Query: 360 VVSMLTNEAAALLPPKQPAFSF--VRNTVTSTSS----TGKTEDCSVNQVTISILEAR 411
           VV ML + A  L  PK PAF+    RNT T  SS    +G+T   ++N VT++ ++ R
Sbjct: 789 VVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSS-TINDVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	411
297742753	637	unnamed protein product [Vitis vinifera]	0.948	0.612	0.682	1e-148
359484155	865	PREDICTED: receptor-like serine/threonin	0.948	0.450	0.682	1e-148
356514857	834	PREDICTED: G-type lectin S-receptor-like	0.919	0.453	0.683	1e-146
359493705	830	PREDICTED: receptor-like serine/threonin	0.948	0.469	0.659	1e-144
302143120	674	unnamed protein product [Vitis vinifera]	0.948	0.578	0.659	1e-143
296090091	674	unnamed protein product [Vitis vinifera]	0.951	0.580	0.662	1e-143
302143125	585	unnamed protein product [Vitis vinifera]	0.948	0.666	0.652	1e-140
359493703	1658	PREDICTED: uncharacterized protein LOC10	0.948	0.235	0.652	1e-139
302143128	692	unnamed protein product [Vitis vinifera]	0.909	0.540	0.651	1e-139
359493709	894	PREDICTED: receptor-like serine/threonin	0.905	0.416	0.671	1e-139

>gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera]

 Score =  530 bits (1365), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 271/397 (68%), Positives = 319/397 (80%), Gaps = 7/397 (1%)

Query: 16  IVPAAVAIL-GLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
           IV  A+++    + + +RR+ R +GE+L++FDL  N   D    EL   +K     +KKE
Sbjct: 247 IVTLAISVTSAFVIWGIRRRLRRKGENLLLFDLS-NSSVD-TNYELSETSKLWS-GEKKE 303

Query: 75  VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           VD LP+FSF+SVS ATN FS  NKLGEGGFGPVYKG  +KG E+AVKRLS RSGQG  E+
Sbjct: 304 VD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEEL 362

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           KNE  +IAK+QHKNLV+L G CI+KDEKILIYEYMPNKSLDFFLFDPTK  +L+W TRV 
Sbjct: 363 KNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRVH 422

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           II+G+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNP+ISDFGMARI GGNE +A T+ 
Sbjct: 423 IIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA-TNH 481

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGYAWDLW 
Sbjct: 482 IVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWK 541

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            +R  EL+DP LE+   + H+LLRY+NI LLCVQESADDRPTM+DVVSML NE+  L  P
Sbjct: 542 DSRGQELMDPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPSP 600

Query: 375 KQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
           KQPAFS +R+ V    S  K + CS+N VT+S++EAR
Sbjct: 601 KQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  530 bits (1365), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 271/397 (68%), Positives = 319/397 (80%), Gaps = 7/397 (1%)

Query: 16  IVPAAVAIL-GLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
           IV  A+++    + + +RR+ R +GE+L++FDL  N   D    EL   +K     +KKE
Sbjct: 475 IVTLAISVTSAFVIWGIRRRLRRKGENLLLFDLS-NSSVD-TNYELSETSKLWS-GEKKE 531

Query: 75  VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           VD LP+FSF+SVS ATN FS  NKLGEGGFGPVYKG  +KG E+AVKRLS RSGQG  E+
Sbjct: 532 VD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEEL 590

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           KNE  +IAK+QHKNLV+L G CI+KDEKILIYEYMPNKSLDFFLFDPTK  +L+W TRV 
Sbjct: 591 KNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRVH 650

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           II+G+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNP+ISDFGMARI GGNE +A T+ 
Sbjct: 651 IIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA-TNH 709

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGYAWDLW 
Sbjct: 710 IVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWK 769

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            +R  EL+DP LE+   + H+LLRY+NI LLCVQESADDRPTM+DVVSML NE+  L  P
Sbjct: 770 DSRGQELMDPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPSP 828

Query: 375 KQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
           KQPAFS +R+ V    S  K + CS+N VT+S++EAR
Sbjct: 829 KQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 865

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max]

 Score =  525 bits (1351), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 264/386 (68%), Positives = 310/386 (80%), Gaps = 8/386 (2%)

Query: 29  YCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVST 88
           Y  RR+ R +GEDL+ F + +++K ++   EL   ++ AK  KKKEV +LPLFSF SV+ 
Sbjct: 454 YWTRRQ-RRKGEDLLRFHVSMSMKVEDS--ELAEAHRGAK-VKKKEV-KLPLFSFVSVAA 508

Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           ATN FSDANKLGEGGFGPVYKG+L  GDE+AVKRLS RSGQG  E++NEA +IAK+QH N
Sbjct: 509 ATNNFSDANKLGEGGFGPVYKGILLNGDEVAVKRLSRRSGQGWEELRNEALLIAKLQHNN 568

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           LVRLLGCCID+DEK+LIYE MPNKSLD FLFD TKR +LDW TRV+II+GIAQG+LYLHQ
Sbjct: 569 LVRLLGCCIDRDEKMLIYELMPNKSLDVFLFDATKRRMLDWGTRVRIIDGIAQGILYLHQ 628

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           YSR RIIHRDLKASNILLD +MNPKISDFGMARI G NELQANT+RIVGTYGYMSPEYA+
Sbjct: 629 YSRFRIIHRDLKASNILLDTNMNPKISDFGMARIFGDNELQANTNRIVGTYGYMSPEYAM 688

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
           EG+FSIKSDVFSFGVLLLEI+SGKKNTG Y+T+S NLLGYAWDLWT+N  ++L+DP L+D
Sbjct: 689 EGLFSIKSDVFSFGVLLLEILSGKKNTGFYQTNSFNLLGYAWDLWTNNSGMDLMDPALDD 748

Query: 329 E---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNT 385
                SS H + RYVNI LLCVQES  DRPTM+DVVSM+ N+  AL  PK PAF  VR  
Sbjct: 749 SDTTSSSMHTVPRYVNIGLLCVQESPADRPTMSDVVSMIGNDTVALPSPKPPAFLNVRGN 808

Query: 386 VTSTSSTGKTEDCSVNQVTISILEAR 411
             S       E  S+N +T +++EAR
Sbjct: 809 QNSILPASMPESFSLNLITDTMVEAR 834

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  517 bits (1332), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 262/397 (65%), Positives = 316/397 (79%), Gaps = 7/397 (1%)

Query: 16  IVPAAVAIL-GLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
           I+  A+++    + Y +  + R +GEDL++FD      +++   EL   N+   R +K+E
Sbjct: 440 IITLAISLTSAFVIYGIWGRFRRKGEDLLVFDF--GNSSEDTSYELDETNR-LWRGEKRE 496

Query: 75  VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           VD LP+FSF+SVS +TN FS  NKLGEGGFG VYKG  ++  E+AVKRLS RS QG  E+
Sbjct: 497 VD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEEL 555

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDPTK  +L+W TRV 
Sbjct: 556 KNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRVH 615

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           IIEG+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNPKISDFGMARI GGNE +  T+ 
Sbjct: 616 IIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKV-TNH 674

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGYAWDLW 
Sbjct: 675 IVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWK 734

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            +R LEL+DP LE+   + H+LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  P
Sbjct: 735 DSRGLELMDPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSP 793

Query: 375 KQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
           KQPAFS +R+ V    S  + E CS+N VT+S++EAR
Sbjct: 794 KQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 830

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera]

 Score =  515 bits (1327), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 262/397 (65%), Positives = 316/397 (79%), Gaps = 7/397 (1%)

Query: 16  IVPAAVAIL-GLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
           I+  A+++    + Y +  + R +GEDL++FD      +++   EL   N+   R +K+E
Sbjct: 284 IITLAISLTSAFVIYGIWGRFRRKGEDLLVFDF--GNSSEDTSYELDETNR-LWRGEKRE 340

Query: 75  VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           VD LP+FSF+SVS +TN FS  NKLGEGGFG VYKG  ++  E+AVKRLS RS QG  E+
Sbjct: 341 VD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEEL 399

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDPTK  +L+W TRV 
Sbjct: 400 KNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRVH 459

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           IIEG+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNPKISDFGMARI GGNE +  T+ 
Sbjct: 460 IIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKV-TNH 518

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGYAWDLW 
Sbjct: 519 IVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWK 578

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            +R LEL+DP LE+   + H+LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  P
Sbjct: 579 DSRGLELMDPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSP 637

Query: 375 KQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
           KQPAFS +R+ V    S  + E CS+N VT+S++EAR
Sbjct: 638 KQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera]

 Score =  513 bits (1320), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 263/397 (66%), Positives = 312/397 (78%), Gaps = 6/397 (1%)

Query: 16  IVPAAVAIL-GLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
           IV  A+++    + Y +  + R +GEDL++FD   N   D    EL   N+   R +KKE
Sbjct: 283 IVTLAISLTSAFVIYGIWGRFRRKGEDLLLFDFG-NSSEDTSCYELGETNR-LWRGEKKE 340

Query: 75  VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           VD LP+FSF+SVS +TN F + NKLGEGGFG VYKG  ++  E+AVKRLS RS QG  E+
Sbjct: 341 VD-LPMFSFASVSASTNNFCNENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEEL 399

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDPTK  +L+W T V 
Sbjct: 400 KNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTWVH 459

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           IIEG+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNPKISDFGMARI GGNE +A T+ 
Sbjct: 460 IIEGVAQGLLYLHQYSRMRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNEPKA-TNH 518

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           IVGTYGYMSPEYALEG+FS KSDVFSFGVLL+EI+SGKKNTG Y+TDSLNLLGYAWDLW 
Sbjct: 519 IVGTYGYMSPEYALEGLFSTKSDVFSFGVLLMEILSGKKNTGFYQTDSLNLLGYAWDLWK 578

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            +R  EL+DP LE E S  H+LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  P
Sbjct: 579 DSRGQELMDPGLE-ETSPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSP 637

Query: 375 KQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
           KQPAFS +R+ V    S  +    S+N VT+S++EAR
Sbjct: 638 KQPAFSNLRSGVEPHISQNRPGIYSLNGVTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143125|emb|CBI20420.3| unnamed protein product [Vitis vinifera]

 Score =  504 bits (1297), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 259/397 (65%), Positives = 309/397 (77%), Gaps = 7/397 (1%)

Query: 16  IVPAAVAIL-GLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
           I+  A+++    + Y +  K R +GEDL++FD   N   D    EL   N+   R +KKE
Sbjct: 195 IITLAISLTSAFVIYGIWGKFRRKGEDLLVFDFG-NSSEDTSCYELGETNR-LWRGEKKE 252

Query: 75  VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           VD LP+FSF SVS +TN F   NKLGEGGFG VYKG  ++G E+AVKRLS RS QG  E+
Sbjct: 253 VD-LPMFSFVSVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEEL 311

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDP KR +L+W TRV+
Sbjct: 312 KNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVR 371

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           IIEG+AQGLLYLHQYSR+R+IHRDLKASNILLDKDMNPKISDFGMARI GGNE +A T  
Sbjct: 372 IIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKH 430

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           IVGTYGYMSPEY L G+FS KSDVFSFGVLLLEI+SGKK T  Y +DSLNLLGYAWDLW 
Sbjct: 431 IVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSDSLNLLGYAWDLWK 490

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
           +NR  ELIDP+  +E SS+H+LLRY+N+ALLCVQE+ADDRPTM+DVVSML  E   L  P
Sbjct: 491 NNRGQELIDPV-PNEISSRHILLRYINVALLCVQENADDRPTMSDVVSMLGRENVLLSSP 549

Query: 375 KQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
            +PAFS++R  V   +S  + E CS+N VT+S + AR
Sbjct: 550 NEPAFSYLRG-VKPHASQERPEICSLNDVTLSSMGAR 585

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493703|ref|XP_002281224.2| PREDICTED: uncharacterized protein LOC100245158 [Vitis vinifera]

 Score =  500 bits (1288), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 259/397 (65%), Positives = 308/397 (77%), Gaps = 7/397 (1%)

Query: 16   IVPAAVAILG-LIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
            IV  A+++    + Y + R+ R +GEDL++FD   N   D    EL   N+   R +KKE
Sbjct: 1268 IVTLAISLTSVFVNYGIWRRFRRKGEDLLVFDFG-NSSEDTNCYELGETNR-LWRDEKKE 1325

Query: 75   VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
            VD LP+FSF+SVS +TN F   NKLGEGGFG VYKG  ++G E+AVKRLS RS QG  E+
Sbjct: 1326 VD-LPMFSFASVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEEL 1384

Query: 135  KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
            KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDP KR +L+W TRV 
Sbjct: 1385 KNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVH 1444

Query: 195  IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
            IIEG+AQGLLYLHQYSR+R+IHRDLKASNILLDKDMNPKISDFGMARI GGNE +A T  
Sbjct: 1445 IIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKH 1503

Query: 255  IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
            IVGTYGYMSPEY L G+FS KSDVFSFGVLLLEI+SGKK T  Y +DSLNLLGYAWDLW 
Sbjct: 1504 IVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSDSLNLLGYAWDLWK 1563

Query: 315  SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            SNR  ELIDP+L +E S +H+LLRY+N+ALLCVQESADDRPTM+DVVSML  E   L  P
Sbjct: 1564 SNRGQELIDPVL-NEISLRHILLRYINVALLCVQESADDRPTMSDVVSMLVKENVLLSSP 1622

Query: 375  KQPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
             +PAF    +++   +S  + E CS+N VT+S + AR
Sbjct: 1623 NEPAF-LNLSSMKPHASQDRLEICSLNDVTLSSMGAR 1658

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera]

 Score =  500 bits (1288), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 247/379 (65%), Positives = 297/379 (78%), Gaps = 5/379 (1%)

Query: 33  RKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNK 92
           R+  +  +D+++++  +  KA     EL   N+  K   K     LPLFSF+SVS AT  
Sbjct: 319 REEMTTSQDILLYEFGMGSKATEN--ELNEGNRVGKDKNKDA--WLPLFSFASVSAATEH 374

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           FS  NKLG+GGFGPVYKG L  G EIAVKRLS  SGQGL E+KNE  ++A++QH+NLVRL
Sbjct: 375 FSTENKLGQGGFGPVYKGELFNGQEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRL 434

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           LGCCI++ EKILIYEYMPNKSLD FLFDP KR  LDW  RV IIEGIAQGLLYLH+YSR+
Sbjct: 435 LGCCIEQGEKILIYEYMPNKSLDSFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRL 494

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           RIIHRDLKASNILLD DMNPKISDFGMAR+ GGNE  ANT+RIVGTYGYMSPEYALEG+F
Sbjct: 495 RIIHRDLKASNILLDNDMNPKISDFGMARMFGGNESYANTNRIVGTYGYMSPEYALEGLF 554

Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 332
           S KSDVFSFGVL+LEI+SGKKNTG Y +D+LNL+GYAW+LW S+  + L+DP+LE + SS
Sbjct: 555 STKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSDMAINLMDPMLEGQ-SS 613

Query: 333 KHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTVTSTSST 392
           ++MLLRY+N+ LLCV+E A DRPT+++VVSMLTNE A L  PK PAFS VR+     SS 
Sbjct: 614 QYMLLRYINVGLLCVEEIAADRPTLSEVVSMLTNELAVLPSPKHPAFSTVRSMENPRSSM 673

Query: 393 GKTEDCSVNQVTISILEAR 411
            + E  S N ++IS++EAR
Sbjct: 674 SRPEIYSANGLSISVMEAR 692

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  500 bits (1287), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 254/378 (67%), Positives = 300/378 (79%), Gaps = 6/378 (1%)

Query: 16  IVPAAVAIL-GLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKE 74
           I+  A+++    + Y +  K R +GEDL++FD   N   D    EL   N+   R +KKE
Sbjct: 443 IITLAISLTSAFVIYGIWGKFRRKGEDLLVFDFG-NSSEDTSCYELGETNR-LWRGEKKE 500

Query: 75  VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           VD LP+FSF SVS +TN F   NKLGEGGFG VYKG  ++G E+AVKRLS RS QG  E+
Sbjct: 501 VD-LPMFSFVSVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEEL 559

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDP KR +L+W TRV+
Sbjct: 560 KNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVR 619

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           IIEG+AQGLLYLHQYSR+R+IHRDLKASNILLDKDMNPKISDFGMARI GGNE +A T  
Sbjct: 620 IIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKH 678

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGYAWDLW 
Sbjct: 679 IVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWK 738

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            +R  EL+DP LE+   + H+LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  P
Sbjct: 739 DSRGQELMDPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSP 797

Query: 375 KQPAFSFVRNTVTSTSST 392
           KQPAFS +R+    + S+
Sbjct: 798 KQPAFSNLRSGTHKSLSS 815

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	411
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.866	0.418	0.582	3e-108
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.936	0.456	0.554	8.1e-108
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.936	0.454	0.557	1e-107
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.827	0.400	0.590	5.1e-106
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.812	0.393	0.577	3.7e-103
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.936	0.452	0.538	4.7e-103
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.817	0.399	0.575	1.5e-99
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.885	0.464	0.535	7.4e-98
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.812	0.499	0.555	3.2e-97
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.771	0.468	0.577	4.1e-97

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
 Identities = 211/362 (58%), Positives = 273/362 (75%)

Query:    56 VIIELPANNKQ-AKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK 114
             +++EL    ++  KRS +   ++L +FSF SV+ AT+ FSDANKLGEGGFGPVYKG L  
Sbjct:   489 LLLELGIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLID 548

Query:   115 GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 174
             G+E+A+KRLS  SGQGL E KNEA +IAK+QH NLV+LLGCC++KDEK+LIYEYMPNKSL
Sbjct:   549 GEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSL 608

Query:   175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI 234
             D+FLFDP ++++LDW  R +I+EGI QGLLYLH+YSR+++IHRD+KA NILLD+DMNPKI
Sbjct:   609 DYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKI 668

Query:   235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 294
             SDFGMARI G  E +ANT R+ GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN
Sbjct:   669 SDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKN 728

Query:   295 TGLYRTDS--LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESAD 352
                +      LNL+ + W+L+  NR  E+IDP L D       +LR V +ALLCVQ++AD
Sbjct:   729 NSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNAD 788

Query:   353 DRPTMNDVVSMLTNEAA-ALLPPKQPAF--SFVRNTVTSTSSTGKTEDCSVNQVTISILE 409
             DRP+M DVVSM+  +   AL  PK+PAF     R++        + E+ S N+VTI+++E
Sbjct:   789 DRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVME 848

Query:   410 AR 411
             AR
Sbjct:   849 AR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
 Identities = 218/393 (55%), Positives = 280/393 (71%)

Query:    26 LIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNK-QAKRSKKKEVDQLPLFSFS 84
             +IF+  +RK + R   +   ++D     D++I ++  + +    + KK E  +LPL    
Sbjct:   452 VIFHFWKRKQK-RSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELE 510

Query:    85 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV 144
             +++TATN FS+ NKLG+GGFG VYKG L  G EIAVKRLS  S QG  E  NE  +IAK+
Sbjct:   511 ALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKL 570

Query:   145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
             QH NLVRLLGCC+DK EK+LIYEY+ N SLD  LFD T+   L+W  R  II GIA+GLL
Sbjct:   571 QHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLL 630

Query:   205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
             YLHQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E +ANT R+VGTYGYMSP
Sbjct:   631 YLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSP 690

Query:   265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELID 323
             EYA++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG+ W  W     LE++D
Sbjct:   691 EYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVD 750

Query:   324 PILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS 380
             PI  D  SSK   H +LR + I LLCVQE A+DRP M+ V+ ML +E  A+  PK+P F 
Sbjct:   751 PINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFC 810

Query:   381 FVRNTVT--STSSTGKTEDCSVNQVTISILEAR 411
               R+ +   S+SST + ++C+VNQ+T+S+++AR
Sbjct:   811 IGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
 Identities = 219/393 (55%), Positives = 281/393 (71%)

Query:    26 LIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIEL-PANNKQAKRSKKKEVDQLPLFSFS 84
             +IF+  +RK + R   +    +DL    D+++ EL  A+     +  K +  +LPL  + 
Sbjct:   456 IIFHFWKRKQK-RSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWK 514

Query:    85 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV 144
             +++ ATN FS  NKLG+GGFG VYKG+L  G EIAVKRLS  S QG  E  NE  +IAK+
Sbjct:   515 ALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKL 574

Query:   145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
             QH NLVRLLGCC+DK EK+LIYEY+ N SLD  LFD T+   L+W  R  II GIA+GLL
Sbjct:   575 QHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLL 634

Query:   205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
             YLHQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E +ANT R+VGTYGYMSP
Sbjct:   635 YLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSP 694

Query:   265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELID 323
             EYA++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG+ W  W   + LE++D
Sbjct:   695 EYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVD 754

Query:   324 PILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS 380
             PI  D  SS+   H +LR + I LLCVQE A+DRP M+ V+ ML +E  A+  PK+P F 
Sbjct:   755 PINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFC 814

Query:   381 FVRNT--VTSTSSTGKTEDCSVNQVTISILEAR 411
               R++  V S+SST + ++C+VNQVT+S+++AR
Sbjct:   815 VGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1049 (374.3 bits), Expect = 5.1e-106, P = 5.1e-106
 Identities = 203/344 (59%), Positives = 264/344 (76%)

Query:    71 KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 130
             K     +LP+FS ++++ ATN F   N+LG GGFGPVYKGVL+ G EIAVKRLSG+SGQG
Sbjct:   507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566

Query:   131 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV 190
             + E KNE  +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLFD TK+ L+DW 
Sbjct:   567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626

Query:   191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
              R  IIEGIA+GLLYLH+ SR+RIIHRDLK SN+LLD +MNPKISDFGMARI GGN+ +A
Sbjct:   627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686

Query:   251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW 310
             NT R+VGTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT L  ++  +L+GYAW
Sbjct:   687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746

Query:   311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 370
              L+T  R+ EL+DP +     SK   LR +++A+LCVQ+SA +RP M  V+ ML ++ A 
Sbjct:   747 YLYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTAT 805

Query:   371 LLPPKQPAFSFVR-NTVTSTSSTGKTED--CSVNQVTISILEAR 411
             L  P+QP F+  R N++    +   ++    S N++T +++  R
Sbjct:   806 LAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1022 (364.8 bits), Expect = 3.7e-103, P = 3.7e-103
 Identities = 194/336 (57%), Positives = 253/336 (75%)

Query:    77 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKN 136
             +L ++S   + TAT+ FSD+NKLGEGGFGPVY G L  G+E+AVKRL   SGQGL E KN
Sbjct:   514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573

Query:   137 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
             E  +IAK+QH+NLVRLLGCCI ++EKIL+YEYMPNKSLD FLF+P K+ LLDW  R  II
Sbjct:   574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633

Query:   197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
             EGIA+GLLYLH+ SR+R++HRDLKASNILLD DM PKISDFGMAR+ GG++ Q NT+R+V
Sbjct:   634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693

Query:   257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY-RTDSLNLLGYAWDLWTS 315
             GT+GYMSPEYA+EGIFS+KSDV+ FGVL+LEI++GK+    +   DSLN+ GYAW  W  
Sbjct:   694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNE 753

Query:   316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPK 375
             +   ELIDP++    S + +L R ++IALLCVQ+ AD+RP +  V+ ML+N++++L  P+
Sbjct:   754 DNAAELIDPVIRASCSVRQVL-RCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPR 812

Query:   376 QPAFSFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
              P        + S+ S+ K    S+  VT++ L  R
Sbjct:   813 PPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1021 (364.5 bits), Expect = 4.7e-103, P = 4.7e-103
 Identities = 212/394 (53%), Positives = 276/394 (70%)

Query:    26 LIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKEVD--QLPLFSF 83
             +IF+  +RK + R   +    +D  L++ ++++     + +   S++   D  +LPL  F
Sbjct:   458 IIFFLWKRKQK-RSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEF 516

Query:    84 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK 143
               V+ ATN FS+ANKLG+GGFG VYKG L  G E+AVKRLS  S QG  E KNE  +IA+
Sbjct:   517 EEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIAR 576

Query:   144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
             +QH NLVRLL CC+D  EK+LIYEY+ N SLD  LFD ++   L+W  R  II GIA+GL
Sbjct:   577 LQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGL 636

Query:   204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
             LYLHQ SR RIIHRDLKASNILLDK M PKISDFGMARI G +E +ANT ++VGTYGYMS
Sbjct:   637 LYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMS 696

Query:   264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELI 322
             PEYA++GIFS+KSDVFSFGVLLLEI+S K+N G Y +D  LNLLG  W  W   + LE+I
Sbjct:   697 PEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEII 756

Query:   323 DPILEDEYSS--KHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS 380
             DPI+ D  S+  +H +LR + I LLCVQE A+DRPTM+ V+ ML +E+  +  PK P + 
Sbjct:   757 DPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYC 816

Query:   381 FVRNTVTSTSSTGKTED---CSVNQVTISILEAR 411
               R+ + + SS+ K  D    +VNQ+T+S+L+AR
Sbjct:   817 LERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 195/339 (57%), Positives = 251/339 (74%)

Query:    74 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE 133
             +   LP+FSF SV++AT  F++ NKLG+GGFG VYKG   +G EIAVKRLSG+S QGL E
Sbjct:   506 DTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEE 565

Query:   134 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 193
              KNE  +IAK+QH+NLVRLLGCCI+ +EK+L+YEYMPNKSLD FLFD +K+  LDW  R 
Sbjct:   566 FKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRW 625

Query:   194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
             ++I GIA+GLLYLH+ SR++IIHRDLKASNILLD +MNPKISDFGMARI    +  ANT 
Sbjct:   626 EVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTI 685

Query:   254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW 313
             R+VGTYGYM+PEYA+EGIFS KSDV+SFGVL+LEIVSG+KN     TD  +L+GYAW LW
Sbjct:   686 RVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLW 745

Query:   314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 373
             +  +T E+IDPI++D       + R +++ +LC Q+S   RP M  V+ ML ++ + L P
Sbjct:   746 SQGKTKEMIDPIVKDTRDVTEAM-RCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPP 804

Query:   374 PKQPAF-SFVRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
             P+QP F SF+ +     +  G  +  SVN VT + +  R
Sbjct:   805 PRQPTFHSFLNSGDIELNFDGH-DVASVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
 Identities = 197/368 (53%), Positives = 263/368 (71%)

Query:    46 DLDLNLKADNVIIELPANNKQAKRSKKKEVD-QLPLFSFSSVSTATNKFSDANKLGEGGF 104
             DL + L A + I  L   + +    K++E D +LP     +VS AT+ FS  NKLG+GGF
Sbjct:   418 DLYVRL-ASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGF 476

Query:   105 GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 164
             GPVYKG L  G E+AVKRLS  S QG+ E KNE  +IAK+QH+NLV++LG C+D++E++L
Sbjct:   477 GPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERML 536

Query:   165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI 224
             IYEY PNKSLD F+FD  +R  LDW  RV+II+GIA+G+LYLH+ SR+RIIHRDLKASN+
Sbjct:   537 IYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNV 596

Query:   225 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVL 284
             LLD DMN KISDFG+AR  GG+E +ANT+R+VGTYGYMSPEY ++G FS+KSDVFSFGVL
Sbjct:   597 LLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVL 656

Query:   285 LLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIA 343
             +LEIVSG++N G    +  LNLLG+AW  +  ++  E+ID  + +  +    +LR ++I 
Sbjct:   657 VLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIG 716

Query:   344 LLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTVTSTSSTGKTEDCSVNQV 403
             LLCVQ+   DRP M+ VV ML++E   LL P+QP F   RN + S + +   E  S N  
Sbjct:   717 LLCVQQDPKDRPNMSVVVLMLSSEML-LLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQ 775

Query:   404 TISILEAR 411
             T+S+++ R
Sbjct:   776 TMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
 Identities = 189/340 (55%), Positives = 251/340 (73%)

Query:    76 DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK 135
             D L L  + ++ TAT+ F ++NK+G+GGFG VYKG L  G E+AVKRLS  SGQG  E K
Sbjct:   332 DSLQL-DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFK 390

Query:   136 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
             NE  ++AK+QH+NLVRLLG C+D +E++L+YEY+PNKSLD+FLFDP K+  LDW  R +I
Sbjct:   391 NEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKI 450

Query:   196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
             I G+A+G+LYLHQ SR+ IIHRDLKASNILLD DMNPKI+DFGMARI G ++ + NTSRI
Sbjct:   451 IGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRI 510

Query:   256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN-LLGYAWDLWT 314
             VGTYGYMSPEYA+ G +S+KSDV+SFGVL+LEI+SGKKN+  Y+TD  + L+ YAW LW+
Sbjct:   511 VGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWS 570

Query:   315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
             + R LEL+DP +  E   ++ ++R V+I LLCVQE   +RPT++ +V MLT+    L  P
Sbjct:   571 NGRPLELVDPAIV-ENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVP 629

Query:   375 KQPAFSF---VRNTVTSTSSTGKTEDCSVNQVTISILEAR 411
             +QP   F   +      T +T K+   SV+  +I+ +  R
Sbjct:   630 RQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
 Identities = 187/324 (57%), Positives = 240/324 (74%)

Query:    81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 140
             F F ++  ATNKF + NKLG+GGFG VYKG+   G ++AVKRLS  SGQG RE  NE  V
Sbjct:   339 FDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIV 398

Query:   141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 200
             +AK+QH+NLVRLLG C+++DE+IL+YE++PNKSLD+F+FD T + LLDW  R +II GIA
Sbjct:   399 VAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIA 458

Query:   201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
             +G+LYLHQ SR+ IIHRDLKA NILL  DMN KI+DFGMARI G ++ +ANT RIVGTYG
Sbjct:   459 RGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYG 518

Query:   261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---NLLGYAWDLWTSNR 317
             YMSPEYA+ G FS+KSDV+SFGVL+LEI+SGKKN+ +Y+ D     NL+ Y W LW++  
Sbjct:   519 YMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGS 578

Query:   318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 377
              LEL+DP   D Y    +  R ++IALLCVQE A+DRPTM+ +V MLT  + AL  P++P
Sbjct:   579 PLELVDPSFRDNYRINEVS-RCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRP 637

Query:   378 AFSFVRNTVTSTSSTGKTEDCSVN 401
              F F R++       G  +  S+N
Sbjct:   638 GF-FFRSS--KHEQVGLVDRLSIN 658

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	411
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-57
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-56
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-55
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-36
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-35
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-32
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-30
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-28
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-22
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-22
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-21
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-20
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-19
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-09
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-09
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  187 bits (478), Expect = 4e-57
 Identities = 95/292 (32%), Positives = 137/292 (46%), Gaps = 53/292 (18%)

Query: 97  NKLGEGGFGPVYKGVLKKGD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 151
            KLGEG FG VYKG LK  D    E+AVK L    S +  ++   EA V+ K+ H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           LLG C +++   L+ EYM    L  +L      F   ++  L     +     IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 260
           L      + +HRDL A N L+ +D+  KISDFG++R     ++  +      T G     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTDSLNLLGYAWDLW 313
           +M+PE   +GIF+ KSDV+SFGVLL EI +       G  N  +     L  L       
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-----LEYL------- 220

Query: 314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
                L   +   ++ Y           + L C Q   +DRPT +++V  L 
Sbjct: 221 RKGYRLPKPEYCPDELY----------ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  185 bits (471), Expect = 4e-56
 Identities = 90/280 (32%), Positives = 129/280 (46%), Gaps = 41/280 (14%)

Query: 98  KLGEGGFGPVYKGVLKKGD-----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           KLGEG FG VYKG LK        E+AVK L    S Q + E   EA ++ K+ H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           LLG C +++   ++ EYM    L  +L     R  L     +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
              IHRDL A N L+ +++  KISDFG++R    ++        +    +M+PE   EG 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGK 179

Query: 272 FSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP 324
           F+ KSDV+SFGVLL EI +       G  N  +              L    R L     
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE-----------YLKNGYR-LPQP-- 225

Query: 325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                     +     ++ L C  E  +DRPT +++V +L
Sbjct: 226 ----PNCPPEL----YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  182 bits (465), Expect = 3e-55
 Identities = 90/281 (32%), Positives = 133/281 (47%), Gaps = 42/281 (14%)

Query: 98  KLGEGGFGPVYKGVLKKGD-----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           KLGEG FG VYKG LK        E+AVK L    S Q + E   EA ++ K+ H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           LLG C +++  +++ EYMP   L  +L    +   L     +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
              IHRDL A N L+ +++  KISDFG++R    ++        +    +M+PE   EG 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEGK 180

Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELID------- 323
           F+ KSDV+SFGVLL EI +               LG   +   ++   LE +        
Sbjct: 181 FTSKSDVWSFGVLLWEIFT---------------LGEEPYPGMSNAEVLEYLKKGYRLPK 225

Query: 324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           P          +      + L C  E  +DRPT +++V +L
Sbjct: 226 P----PNCPPEL----YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (455), Expect = 9e-54
 Identities = 95/282 (33%), Positives = 135/282 (47%), Gaps = 44/282 (15%)

Query: 98  KLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           KLGEG FG VYKG LK   E     +AVK L  G S +   E   EAS++ K+ H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           LLG C   +   ++ EYMP   L  FL        L     +Q+   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEG 270
              +HRDL A N L+ +++  KISDFG++R I   +  +      +    +M+PE   +G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179

Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELIDPILEDE 329
            F+ KSDV+SFGVLL EI +               LG   +   ++   LEL++      
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELLE------ 218

Query: 330 YSSKHMLLRYVN-------IALLCVQESADDRPTMNDVVSML 364
               + L R  N       + L C     +DRPT +++V  L
Sbjct: 219 --DGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (439), Expect = 7e-52
 Identities = 75/194 (38%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREM-KNEASVIAKVQHKNLVRLLGCC 156
           LGEGGFG VY    KK G ++A+K +       L E    E  ++ K+ H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            D++   L+ EY    SL   L +   +  L     ++I+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 217 RDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSI 274
           RDLK  NILLD D    K++DFG++++   ++    T  IVGT  YM+PE  L +G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 275 KSDVFSFGVLLLEI 288
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (417), Expect = 5e-48
 Identities = 74/199 (37%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           KLG G FG VYK   K  G  +AVK L       +  +  + E  ++ ++ H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              DKD   L+ EY     L  +L        L      +I   I +GL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN---GI 119

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS 273
           IHRDLK  NILLD++   KI+DFG+A+    +   ++ +  VGT  YM+PE  L G  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 274 IKSDVFSFGVLLLEIVSGK 292
            K DV+S GV+L E+++GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (414), Expect = 1e-47
 Identities = 73/204 (35%), Positives = 106/204 (51%), Gaps = 15/204 (7%)

Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 150
           +    KLGEG FG VY    KK G  +A+K +  +  +  RE +  E  ++ K++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQ 208
           RL     D+D+  L+ EY     L F L     R+  D       QI+  +     YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDL-FDLLKKRGRLSEDEARFYLRQILSALE----YLHS 115

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
                I+HRDLK  NILLD+D + K++DFG+AR     E     +  VGT  YM+PE  L
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLL 169

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGK 292
              +    D++S GV+L E+++GK
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (376), Expect = 4e-42
 Identities = 71/203 (34%), Positives = 110/203 (54%), Gaps = 15/203 (7%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             LG G FG VY  + K  G+ +AVK   LSG S + L  ++ E  +++ +QH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 154 GCCIDKDEK-ILIY-EYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           G   D+++  + I+ EY+   SL   L  F      ++   TR QI+EG+A    YLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILEGLA----YLH-- 118

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
               I+HRD+K +NIL+D D   K++DFG A+  G  E    T  + GT  +M+PE    
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +   +D++S G  ++E+ +GK
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (335), Expect = 3e-36
 Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 15/205 (7%)

Query: 92  KFSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
            F    K+G+GGFG VYK    + G E+A+K +   S +   ++ NE  ++ K +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLH 207
           +  G  + KDE  ++ E+    SL   L   T + L    T  QI    + + +GL YLH
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTL----TESQIAYVCKELLKGLEYLH 115

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
                 IIHRD+KA+NILL  D   K+ DFG++     +    NT  +VGT  +M+PE  
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNT--MVGTPYWMAPEVI 169

Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGK 292
               +  K+D++S G+  +E+  GK
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  131 bits (331), Expect = 1e-35
 Identities = 74/201 (36%), Positives = 105/201 (52%), Gaps = 22/201 (10%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQHKNLVRL 152
           KLG G FG V+ G      ++AVK L  + G     M       EA ++ K++H  LV+L
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL--KPGT----MSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
              C +++   ++ EYM   SL  FL     + L      V +   IA+G+ YL      
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 269
             IHRDL A NIL+ +++  KI+DFG+AR+   +E  A       I  T    +PE A  
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANY 178

Query: 270 GIFSIKSDVFSFGVLLLEIVS 290
           G F+IKSDV+SFG+LL EIV+
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  131 bits (331), Expect = 2e-35
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 33/290 (11%)

Query: 97  NKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLV 150
            +LGEG FG V            G+++AVK L+     Q   + + E  ++  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 151 RLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +  G C     +   LI EY+P+ SL  +L     R  ++    +     I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEY 266
               R IHRDL A NIL++ +   KISDFG+A++     +            + Y +PE 
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID--- 323
                FS  SDV+SFGV L E+ +    +     + L ++G A       R LEL+    
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243

Query: 324 -----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 368
                P   DE    + L++      LC +    DRP+  D++ ++    
Sbjct: 244 RLPRPPSCPDEV---YDLMK------LCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  125 bits (316), Expect = 2e-33
 Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 16/203 (7%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           F+   KLG G FG V++G+ K    +A+K L        ++ + E   + +++HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM-----LLDWVTRVQIIEGIAQGLLYLH 207
              C   +   +I E M   SL  FL  P  ++     L+D   +V      A+G+ YL 
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV------AEGMAYLE 121

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
           +      IHRDL A NIL+ +D+  K++DFG+AR+   +   ++  +I   Y + +PE A
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAA 176

Query: 268 LEGIFSIKSDVFSFGVLLLEIVS 290
             G FS KSDV+SFG+LL E+ +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  124 bits (314), Expect = 4e-33
 Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 35/268 (13%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
            LG+G  G VYK   K  G   A+K++      +  +++  E   +   +   +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRM---LLDWVTRVQIIEGIAQGLLYLHQYSRV 212
              + E  ++ EYM   SL   L     ++   +L ++ R QI+    +GL YLH     
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIAR-QIL----KGLDYLHTKRH- 120

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            IIHRD+K SN+L++     KI+DFG++++      Q NT   VGT  YMSPE      +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESY 177

Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI----DPILED 328
           S  +D++S G+ LLE   GK     +         + ++L      ++ I     P L  
Sbjct: 178 SYAADIWSLGLTLLECALGK-----FPFLPPGQPSF-FEL------MQAICDGPPPSLPA 225

Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPT 356
           E  S        +    C+Q+    RP+
Sbjct: 226 EEFSPEF----RDFISACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 2e-32
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 15/206 (7%)

Query: 92  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKN 148
            +   + +G G FG VYKG+ L+ GD +A+K++S      + L+ +  E  ++  ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           +V+ +G     D   +I EY  N SL   +  F P    L   V     +  + QGL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAV--YVYQVLQGLAYL 115

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H+     +IHRD+KA+NIL  KD   K++DFG+A           +  +VGT  +M+PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 S  SD++S G  ++E+++G 
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (307), Expect = 3e-32
 Identities = 65/194 (33%), Positives = 103/194 (53%), Gaps = 15/194 (7%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G+G FG V  G  + G ++AVK L        +    EASV+  ++H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 159 KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD 218
            +   ++ EYM   SL  +L     R ++    ++     + +G+ YL +      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 219 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGIFSIKS 276
           L A N+L+ +D+  K+SDFG+A+       +A+  +  G     + +PE   E  FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 277 DVFSFGVLLLEIVS 290
           DV+SFG+LL EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  120 bits (303), Expect = 1e-31
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L       + E   EA+V+ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 185

Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 186 SDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  120 bits (303), Expect = 2e-31
 Identities = 72/212 (33%), Positives = 107/212 (50%), Gaps = 23/212 (10%)

Query: 99  LGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVR 151
           LGEG FG VYKG L           +A+K L   +   ++ E + EA +++ +QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLF-------------DPTKRMLLDWVTRVQIIEG 198
           LLG C  +    +++EY+ +  L  FL              D T +  LD    + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           IA G+ YL   S    +HRDL A N L+ + +  KISDFG++R     +     S+ +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M PE  L G F+ +SD++SFGV+L EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  120 bits (302), Expect = 3e-31
 Identities = 72/218 (33%), Positives = 110/218 (50%), Gaps = 30/218 (13%)

Query: 99  LGEGGFGPVYKG---VLKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVR 151
           LGEG FG V+ G    L+  ++   +AVK L   +    R+  + EA ++   QH+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML---------LDWVTRVQIIEGIA 200
             G C + D  I+++EYM +  L+ FL    P    L         L     +QI   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-- 258
            G++YL   +    +HRDL   N L+  D+  KI DFGM+R    +    +  R+ G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 259 --YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 293
               +M PE  +   F+ +SDV+SFGV+L EI + GK+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (301), Expect = 3e-31
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 23/208 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEI-AVKR--LSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
            ++G+G FG VY    K   ++  +K   LS  S +   +  NE  ++ K+ H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------MLLDWVTRVQIIEGIAQGLLYL 206
               +K +  ++ EY     L   +    K         +LDW   VQ+       L YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL----CLALKYL 119

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H  SR +I+HRD+K  NI L  +   K+ DFG++++       A T  +VGT  Y+SPE 
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE- 173

Query: 267 ALEGI-FSIKSDVFSFGVLLLEIVSGKK 293
             +   ++ KSD++S G +L E+ + K 
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 4e-31
 Identities = 69/206 (33%), Positives = 115/206 (55%), Gaps = 21/206 (10%)

Query: 99  LGEGGFGPVYKGVLK-KGD----EIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG VYKGV   +G+     +A+K L   +  +  +E+ +EA V+A V H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQ 208
           LG C+   +  LI + MP   L  ++ +    +    LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               R++HRDL A N+L+    + KI+DFG+A++   +E + +         +M+ E  L
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 269 EGIFSIKSDVFSFGVLLLEIVS-GKK 293
             I++ KSDV+S+GV + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  118 bits (297), Expect = 8e-31
 Identities = 74/206 (35%), Positives = 111/206 (53%), Gaps = 15/206 (7%)

Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL 149
           F   NK+G+G FG V+K V K      A+K+  LS  + +   E  +EA V+AK+    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD---WVTRVQIIEGIAQGLLYL 206
           +R     +DK +  ++ EY  N  L   L     R L +   W   +QI+ G+A    +L
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HL 117

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H     +I+HRD+K+ N+ LD   N KI D G+A++   N   ANT  IVGT  Y+SPE 
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPEL 172

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  ++ KSDV++ GV+L E  +GK
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 1e-30
 Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG G FG V++G+      +AVK L   +    ++   EA ++ K++H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
            ++   ++ E M   SL  +L     R L      + +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFSI 274
           DL A N+L+ ++   K++DFG+AR+   +  +A      G      + +PE AL   FSI
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183

Query: 275 KSDVFSFGVLLLEIVS 290
           KSDV+SFG+LL EIV+
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 2e-30
 Identities = 80/276 (28%), Positives = 125/276 (45%), Gaps = 35/276 (12%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           K+G+G FG VYKGVLK   E+AVK         L+     EA ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           + K    ++ E +P  SL  FL     R+ +     +Q+    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---CIH 116

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL A N L+ ++   KISDFGM+R   G     +         + +PE    G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 277 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-------PILEDE 329
           DV+S+G+LL E  S       Y               ++ +T E I+       P L  E
Sbjct: 177 DVWSYGILLWETFSL--GDTPYPG------------MSNQQTRERIESGYRMPAPQLCPE 222

Query: 330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
              + M        L C     ++RP+ +++ + L 
Sbjct: 223 EIYRLM--------LQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (297), Expect = 2e-30
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 25/211 (11%)

Query: 90  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
              + +  K+GEG  G VYK      G E+A+K++  R  Q    + NE  ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG-IA------- 200
           +V      +  DE  ++ EYM   SL       T   ++     V++ E  IA       
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSL-------TD--IITQ-NFVRMNEPQIAYVCREVL 126

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           QGL YLH      +IHRD+K+ NILL KD + K++DFG A      + + N+  +VGT  
Sbjct: 127 QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPY 181

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +M+PE      +  K D++S G++ +E+  G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 3e-30
 Identities = 89/284 (31%), Positives = 128/284 (45%), Gaps = 44/284 (15%)

Query: 97  NKLGEGGFGPVYKGV--LKKGDEI--AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG G FG V KGV  +K G E+  AVK L       G +E   EASV+A++ H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           L+G C   +  +L+ E  P   L  +L          L +   +V      A G+ YL  
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTY--GYMSP 264
                 +HRDL A N+LL      KISDFGM+R    G +  +A T+   G +   + +P
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAP 167

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 322
           E    G FS KSDV+S+GV L E  S   K    +   + + +L        S   L   
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-------ESGERLPRP 220

Query: 323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
           +   ++ YS          I L C +   +DRPT +++ S    
Sbjct: 221 EECPQEIYS----------IMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 4e-30
 Identities = 84/279 (30%), Positives = 139/279 (49%), Gaps = 41/279 (14%)

Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V +G LK   +    +A+K L +G S +   +   EAS++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        ++I EYM N SLD FL +            V ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS--RIVGTYGYMSPEYALEGI 271
            +HRDL A NIL++ ++  K+SDFG++R    +E    T   +I     + +PE      
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184

Query: 272 FSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PI 325
           F+  SDV+SFG+++ E++S G++    Y           WD  ++   ++ ++     P 
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP---Y-----------WD-MSNQDVIKAVEDGYRLPP 229

Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             D  S+ + L+      L C Q+  ++RPT + +VS L
Sbjct: 230 PMDCPSALYQLM------LDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  113 bits (284), Expect = 8e-29
 Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 97  NKLGEGGFGPVYKGVL--KKGD----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 149
             LG G FG VY+G+   + GD    ++AVK L    S Q   +   EA +++K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------PTKRMLLDWVTRVQIIEGIAQG 202
           VRL+G   ++  + ++ E M    L  FL +       P+   + D +        +A+G
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL---FCARDVAKG 128

Query: 203 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 259
             YL +      IHRD+ A N LL         KI+DFGMAR            R +   
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +M PE  L+GIF+ K+DV+SFGVLL EI S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  113 bits (284), Expect = 1e-28
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 33/219 (15%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK-----NEASVIAKV-QHKNLVR 151
           +GEG F  V     K+   E A+K L  R  Q ++E K      E  V+ ++  H  +++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L     D++    + EY PN  L  ++    K   LD          I   L YLH    
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHS--- 120

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------------------QANTS 253
             IIHRDLK  NILLDKDM+ KI+DFG A++   N                    +   +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             VGT  Y+SPE   E      SD+++ G ++ ++++GK
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  111 bits (280), Expect = 2e-28
 Identities = 70/197 (35%), Positives = 108/197 (54%), Gaps = 15/197 (7%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQHKNLVRLLG 154
           KLG G FG V+ G      ++A+K L     QG    +    EA+++ ++QH  LVRL  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 155 CCIDKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
             + ++   +I EYM N SL DF       ++ ++    + +   IA+G+ ++    R  
Sbjct: 69  V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
            IHRDL+A+NIL+ + +  KI+DFG+AR+   NE  A          + +PE    G F+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFT 181

Query: 274 IKSDVFSFGVLLLEIVS 290
           IKSDV+SFG+LL EIV+
Sbjct: 182 IKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-28
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDE--IAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLL 153
           LG+G FG V   V KK      A+K L  +     + +     E ++++++ H  +V+L 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 154 GCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 +EK+ L+ EY P   L   L    +    +   R    E I   L YLH    +
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAE-IVLALEYLH---SL 112

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            II+RDLK  NILLD D + K++DFG+A+       + NT    GT  Y++PE  L   +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170

Query: 273 SIKSDVFSFGVLLLEIVSGK 292
               D +S GVLL E+++GK
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  111 bits (280), Expect = 3e-28
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 99  LGEGGFGPVYKGVLKKGD-------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 150
           LG G FG VY+G              +AVK L  G + Q  +E   EA +++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYL 206
           +LLG C+  + + +I E M    L  +L D         LL     + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 207 HQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            Q   +  IHRDL A N L+     D D   KI DFG+AR    ++        +    +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           M+PE  L+G F+ +SDV+SFGVL+ EI++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  110 bits (278), Expect = 5e-28
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 18/200 (9%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           KLGEG +G VYK + K+ G  +A+K +     + L+E+  E S++ +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 157 IDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLHQYSRV 212
               +  ++ EY    S  D  +   T + L    T  +I   +    +GL YLH     
Sbjct: 68  FKNTDLWIVMEYCGAGSVSD--IMKITNKTL----TEEEIAAILYQTLKGLEYLHS---N 118

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           + IHRD+KA NILL+++   K++DFG++        + NT  ++GT  +M+PE   E  +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGY 176

Query: 273 SIKSDVFSFGVLLLEIVSGK 292
           + K+D++S G+  +E+  GK
Sbjct: 177 NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  111 bits (278), Expect = 5e-28
 Identities = 82/283 (28%), Positives = 125/283 (44%), Gaps = 35/283 (12%)

Query: 99  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVR 151
           LG G FG V+    K  +E      + VK L     +    E + E  +  K+ HKN+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           LLG C + +   +I EY     L  FL       +  K   L    +V +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           L   S  R +HRDL A N L+      K+S   +++    +E     + ++    +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
              E  FS KSDV+SFGVL+ E+ +  +    GL   + LN L            LEL  
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------AGKLEL-- 238

Query: 324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
           P+ E   S  + L+        C   +  DRP+ +++VS L  
Sbjct: 239 PVPEGCPSRLYKLM------TRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  110 bits (275), Expect = 1e-27
 Identities = 88/271 (32%), Positives = 134/271 (49%), Gaps = 29/271 (10%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   +I EYM   SL DF   D   ++LL     +     IA+G+ Y+    R   IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185

Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDL-WTSNRTLELIDPILEDEYSSK 333
           DV+SFG+LL EIV+  K    G+  +D ++ L   + +    N   EL D          
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD---------- 235

Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                   I   C +E A++RPT + + S+L
Sbjct: 236 --------IMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  109 bits (274), Expect = 1e-27
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCC 156
           ++G G FG V+ G   +  ++A+K +  R G     +   EA V+ K+ H  LV+L G C
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++    L++E+M +  L  +L    +R      T + +   + +G+ YL   +   +IH
Sbjct: 69  TERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 273
           RDL A N L+ ++   K+SDFGM R    ++  ++T    GT     + SPE      +S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYS 179

Query: 274 IKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
            KSDV+SFGVL+ E+ S  K     R++S
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNS 208

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 1e-27
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)

Query: 99  LGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVR 151
           LG+G FG VY+G+ K   KG+    +A+K ++  +    R E  NEASV+ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 152 LLGCCIDKDEKILIYEYM-------------PNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
           LLG        +++ E M             P    +  L  PT +  +           
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           IA G+ YL      + +HRDL A N ++ +D+  KI DFGM R     +      + +  
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M+PE   +G+F+ KSDV+SFGV+L E+ +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 3e-27
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 29/210 (13%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRL---SGRSG---QGLREMKNEASVIAKVQHKNL 149
            ++GEG +G VYK   KK G+ +A+K++   + + G     +RE+K    ++ K++H N+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60

Query: 150 VRLLGCCIDKDEK--ILIYEYMPNKSLDF--FLFDPTKRMLLDWVTRV--QIIEGIAQGL 203
           VRL      K +    +++EYM +   D    L  P  +     +     Q++EG+    
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ--- 114

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            YLH      I+HRD+K SNIL++ D   K++DFG+AR          T+R++ T  Y  
Sbjct: 115 -YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 264 PEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           PE  L    +  + D++S G +L E+  GK
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  108 bits (271), Expect = 4e-27
 Identities = 82/268 (30%), Positives = 138/268 (51%), Gaps = 37/268 (13%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLS----GRSGQG-LREMKNEASVIAKVQHKNLVRL 152
           LG G FG VY+G+ L  GD  AVK +S    G++GQ  +++++ E ++++K+QH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 153 LGCCIDKDEKILIY-EYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           LG   + ++ + I+ E +P  SL   L  +      ++   TR QI+ G+     YLH  
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLH-- 119

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 268
            R   +HRD+K +NIL+D +   K++DFGMA+        +      G+  +M+PE    
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
           +G + + +D++S G  +LE+ +GK            L G A  ++   R+ EL  P + D
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWS-------QLEGVAA-VFKIGRSKEL--PPIPD 225

Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPT 356
             S +       +  L C+Q     RPT
Sbjct: 226 HLSDEAK-----DFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 6e-27
 Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 27/215 (12%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 150
           KLGEG +G VYK   KK  EI A+K++       G     LRE+    S++ +++H N+V
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI----SLLKELKHPNIV 61

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQ 208
           +LL     + +  L++EY  +  L  +L      +  + +  +  Q++ G+A    Y H 
Sbjct: 62  KLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCHS 116

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               RI+HRDLK  NIL+++D   K++DFG+AR   G  L+  T  +V T  Y +PE  L
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILL 171

Query: 269 -EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
               +S   D++S G +  E+++GK    L+  DS
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK---PLFPGDS 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (275), Expect = 7e-27
 Identities = 76/324 (23%), Positives = 130/324 (40%), Gaps = 21/324 (6%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQH-KNLVRLL 153
           KLGEG FG VY    +K   +A+K L+ +     + +     E  ++A + H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
               D+    L+ EY+   SL+  L    ++  L     + I+  I   L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 214 IIHRDLKASNILLDKDMN-PKISDFGMARICGGN----ELQANTSRIVGTYGYMSPEYAL 268
           IIHRD+K  NILLD+D    K+ DFG+A++         + A  S  VGT GYM+PE  L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 269 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
                  S  SD++S G+ L E+++G          + +       +     T  L  P+
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPSLASPL 239

Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNT 385
                          ++    + +   +R + +  +S        L            ++
Sbjct: 240 SPSNPELISKAAS--DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 386 VTSTSSTGKTEDCSVNQVTISILE 409
                S   + +  ++ +    + 
Sbjct: 298 APLRLSLPPSLEALISSLNSLAIS 321

Length = 384

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (268), Expect = 1e-26
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEI-AVK--RLSGRSG---QGLREMKNEASVIAKVQHKNLV 150
            +LG G  G V K + +   +I AVK  RL        Q LRE+     ++ K     +V
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD----ILHKCNSPYIV 62

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
              G   +  +  +  EYM   SLD  L +   R+    + +  I   + +GL YLH   
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYMSPEYA 267
           + +IIHRD+K SNIL++     K+ DFG++      +L    A T   VGT  YM+PE  
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-----QLVNSLAKTF--VGTSSYMAPERI 171

Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGK 292
               +S+KSD++S G+ L+E+ +G+
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (262), Expect = 6e-26
 Identities = 73/196 (37%), Positives = 109/196 (55%), Gaps = 13/196 (6%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           KLG G FG V+ G      ++AVK L  + G    E    EA ++ K++H  LV+L    
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV- 69

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           + ++   ++ EYM   SL  FL D   R L      V +   +A G+ Y+    R+  IH
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGIFSI 274
           RDL+++NIL+   +  KI+DFG+AR+   NE    T+R    +   + +PE AL G F+I
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 275 KSDVFSFGVLLLEIVS 290
           KSDV+SFG+LL E+V+
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  104 bits (260), Expect = 1e-25
 Identities = 69/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           KLG+G FG V+ G       +A+K L  + G    E    EA V+ K++H+ LV+L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 69

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           + ++   ++ EYM   SL  FL     + L      V +   IA G+ Y+    R+  +H
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL-RLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184

Query: 277 DVFSFGVLLLEIVS 290
           DV+SFG+LL E+ +
Sbjct: 185 DVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  104 bits (260), Expect = 1e-25
 Identities = 81/280 (28%), Positives = 118/280 (42%), Gaps = 39/280 (13%)

Query: 98  KLGEGGFGPVYKGVLKK--GDEI--AVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           KLG+G FG V +G      G  I  AVK L S +    + +   EA+++  + H+NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV-QIIEGIAQGLLYLHQYSR 211
            G  +      ++ E  P  SL   L        L  ++ +      IA G+ YL     
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFL--ISTLCDYAVQIANGMRYLESK-- 116

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYA 267
            R IHRDL A NILL  D   KI DFG+ R    NE    ++ +    V  + + +PE  
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH--LKV-PFAWCAPESL 172

Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 324
               FS  SDV+ FGV L E+ +                 Y  + W   + ++ L+ ID 
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT-----------------YGEEPWAGLSGSQILKKIDK 215

Query: 325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             E     +       N+ L C   +  DRPT   +   L
Sbjct: 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 38/275 (13%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           LG G FG V+ G  +   ++A+K +  R G     +   EA V+ K+ H NLV+L G C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKR----MLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            +    ++ EYM N  L  +L +   +     LLD  + V       + + YL       
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV------CEAMEYLESNG--- 120

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEG 270
            IHRDL A N L+ +D   K+SDFG+AR    ++  ++     GT     +  PE     
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYS 176

Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
            FS KSDV+SFGVL+ E+ S  K                ++ ++++  +E +       Y
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGK--------------MPYERFSNSEVVESVSAGYR-LY 221

Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
             K        I   C  E  +DRP    ++S LT
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (259), Expect = 2e-25
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 30/213 (14%)

Query: 97  NKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNLVRLL 153
           NK+G G FG VY  V L  G+ +AVK +  +      ++E+ +E  V+  ++H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV---QIIEGIAQGLLYLHQYS 210
           G  + +++  +  EY    +L+  L     R+L + V RV   Q++EG+A    YLH + 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLA----YLHSH- 118

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-------VGTYGYMS 263
              I+HRD+K +NI LD +   K+ DFG A       L+ NT+ +        GT  YM+
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPAYMA 171

Query: 264 PEYALEGIFSIK---SDVFSFGVLLLEIVSGKK 293
           PE    G        +D++S G ++LE+ +GK+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (256), Expect = 3e-25
 Identities = 70/194 (36%), Positives = 106/194 (54%), Gaps = 15/194 (7%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +GEG FG V +G    G ++AVK +    + Q   E   E +V+ K+ HKNLVRLLG  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +     I++ E M   +L  FL     R L+  +  +Q    +A+G+ YL      +++H
Sbjct: 69  LHNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL A NIL+ +D   K+SDFG+AR+     +  + S++     + +PE      FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKS 178

Query: 277 DVFSFGVLLLEIVS 290
           DV+S+GVLL E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  103 bits (258), Expect = 5e-25
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 30/216 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSG-----QGLREMKNEASVIAKV 144
            K  + ++LGEG  G V K  LK    I A+K ++         Q LRE++    +    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56

Query: 145 QHKNLVRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRV------QII 196
           +   +V+  G  +D+    +    EY    SLD       K++      R+      +I 
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVK-KRGGRIGEKVLGKIA 111

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
           E + +GL YLH     +IIHRD+K SNILL +    K+ DFG++    G  + +      
Sbjct: 112 ESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFT 164

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           GT  YM+PE      +SI SDV+S G+ LLE+   +
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  102 bits (254), Expect = 8e-25
 Identities = 81/273 (29%), Positives = 131/273 (47%), Gaps = 30/273 (10%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70

Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            K+   +I E+M   SL DF   D   +  L  +  +     IA+G+ ++ Q +    IH
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAFIEQRN---YIH 125

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184

Query: 277 DVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYAWDLW-TSNRTLELIDPILEDEYSSK 333
           DV+SFG+LL+EIV+  +    G+   + +  L   + +    N   EL + ++       
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR------ 238

Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
                       C +   ++RPT   + S+L +
Sbjct: 239 ------------CWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  102 bits (254), Expect = 8e-25
 Identities = 85/273 (31%), Positives = 137/273 (50%), Gaps = 30/273 (10%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           KLG+G FG V+ G      ++A+K L  + G  + E    EA ++ K++H  LV L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69

Query: 157 IDKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           + ++   ++ E+M   SL DF      K + L  +  V +   IA G+ Y+    R+  I
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL--VDMAAQIADGMAYIE---RMNYI 124

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL+A+NIL+  ++  KI+DFG+AR+   NE  A          + +PE AL G F+IK
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 276 SDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK 333
           SDV+SFG+LL E+V+  +    G+   + L  +   + +           P  +    S 
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-----------PCPQGCPESL 232

Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
           H L++      LC ++  D+RPT   + S L +
Sbjct: 233 HELMK------LCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  102 bits (256), Expect = 9e-25
 Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 39/286 (13%)

Query: 99  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 149
           LGEG FG        P   G    G+ +AVK L    GQ      K E +++  + H+N+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 150 VRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII---EGIAQGLL 204
           V+  GCC ++  K   LI EY+P  SL  +L  P  ++ L      Q++   + I +G+ 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL-----AQLLLFAQQICEGMA 121

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 263
           YLH       IHRDL A N+LLD D   KI DFG+A+ +  G+E             + +
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
            E   E  FS  SDV+SFGV L E+++   +          ++G      T  R +EL++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238

Query: 324 -----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                P  ++     ++L++       C +  A  RPT   ++ +L
Sbjct: 239 RGMRLPCPKNCPQEVYILMKN------CWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  102 bits (255), Expect = 9e-25
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 22/215 (10%)

Query: 98  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 199
             G C +    ++++EYM +  L+ FL    P  ++L          L     + I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 293
            +M PE  L   F+ +SD++SFGV+L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (252), Expect = 2e-24
 Identities = 82/283 (28%), Positives = 142/283 (50%), Gaps = 48/283 (16%)

Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V++G+LK    K   +A+K L  G + +  ++  +EAS++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        ++I EYM N +LD +L D            V ++ GIA G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 267
            +HRDL A NIL++ ++  K+SDFG++R+     L+ +      T G      + +PE  
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 268 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID--- 323
               F+  SDV+SFG+++ E++S G++                WD+ +++  ++ I+   
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY--------------WDM-SNHEVMKAINDGF 227

Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             P   D  S+ + L+      L C Q+    RP   D+V++L
Sbjct: 228 RLPAPMDCPSAVYQLM------LQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 2e-24
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 27/208 (12%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLS-GRSGQGLRE----MKNEASVIAKVQHKNLVRL 152
           LG+G FG VY    +  G E+AVK++         ++    ++ E  ++  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 153 LGCCIDKDEKILIY-EYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYLHQ 208
            GC  D DE + I+ EYMP  S+   L       L + VTR    QI+EG+     YLH 
Sbjct: 70  YGCLRD-DETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVE----YLH- 121

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----ICGGNELQANTSRIVGTYGYMSP 264
                I+HRD+K +NIL D   N K+ DFG ++    IC           + GT  +MSP
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS---GTGMKSVTGTPYWMSP 176

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +  K+DV+S G  ++E+++ K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (252), Expect = 2e-24
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 58/289 (20%)

Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V +G LK    +   +A+K L SG + +  R+  +EAS++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        ++I E+M N +LD FL     +  +  +  V ++ GIA G+ YL + + V 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSEMNYV- 128

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--------YMSPE 265
             HRDL A NIL++ ++  K+SDFG++R      L+ +TS    T          + +PE
Sbjct: 129 --HRDLAARNILVNSNLVCKVSDFGLSRF-----LEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP 324
                 F+  SDV+S+G+++ E++S G++                WD+  SN+  ++I+ 
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPY--------------WDM--SNQ--DVINA 223

Query: 325 ILEDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           I E +Y         ++ H L+      L C Q+  + RP    +VS L
Sbjct: 224 I-EQDYRLPPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  100 bits (251), Expect = 4e-24
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)

Query: 99  LGEGGFGPVYK----GVLKKGDE--IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +G+G FG V++    G+L       +AVK L    S     + + EA+++A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-------------------LDWVTR 192
           LLG C       L++EYM    L+ FL   + R                     L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR------ICGGN 246
           + I + +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R          +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           E  A   R      +M PE      ++ +SDV+++GV+L EI S
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  100 bits (250), Expect = 4e-24
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 48/283 (16%)

Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    +   +A+K L +G + +  R+  +EAS++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL     V 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLSDMGYV- 128

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 267
             HRDL A NIL++ ++  K+SDFG++R+   +   A T+R     G      + +PE  
Sbjct: 129 --HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181

Query: 268 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID--- 323
               F+  SDV+S+G+++ E++S G++                W++ ++   ++ I+   
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPY--------------WEM-SNQDVIKAIEEGY 226

Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             P   D  ++ H L+      L C Q+  ++RP    +VS+L
Sbjct: 227 RLPAPMDCPAALHQLM------LDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 99.6 bits (248), Expect = 8e-24
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 20/208 (9%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGL------REMKNEASVIAKVQHKNLV 150
             LG+G +G VY G+  +G  IAVK++   +   L       +++ E  ++  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           + LG C+D +   +  E++P  S+   L  F P    +    T+ QI++G+A    YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RIC--GGNELQANTSRIV-GTYGYMSP 264
                ++HRD+K +N++L  +   K+ DFG A R+   G +   +N  + + GT  +M+P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E   E  +  KSD++S G  + E+ +GK
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 72/229 (31%), Positives = 118/229 (51%), Gaps = 33/229 (14%)

Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLRE-MKNEA 138
           ++ +T +F +  +LGE  FG VYKG L      ++   +A+K L  ++   LRE  K+EA
Sbjct: 2   INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-------------DPTKRM 185
            + +++QH N+V LLG    +    +I+ Y  +  L  FL              D T + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
            L+    V I+  IA G+ +L  +    ++H+DL   N+L+   +N KISD G+ R    
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR---- 172

Query: 246 NELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               A+  +++G       +MSPE  + G FSI SD++S+GV+L E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.4 bits (245), Expect = 1e-23
 Identities = 83/281 (29%), Positives = 128/281 (45%), Gaps = 54/281 (19%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V  G  +   ++A+K +   S     E   EA V+ K+ H+ LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE---GIAQGLLYL--HQYSRV 212
            +    ++ EYM N  L  +L +  KR         Q++E    + +G+ YL   Q+   
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRF-----QPSQLLEMCKDVCEGMAYLESKQF--- 121

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALE 269
             IHRDL A N L+D     K+SDFG++R    +E  ++    VG+     +  PE  L 
Sbjct: 122 --IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLY 175

Query: 270 GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
             FS KSDV++FGVL+ E+ S GK                 ++ + ++ T+E +      
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKM---------------PYERFNNSETVEKV------ 214

Query: 329 EYSSKHMLLR-------YVNIALLCVQESADDRPTMNDVVS 362
             S    L R          I   C  E A++RPT   ++S
Sbjct: 215 --SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.1 bits (242), Expect = 4e-23
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 39/276 (14%)

Query: 99  LGEGGFGP--VYKGVLKKGD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           LG+G FG   +Y+   +  D       E+ + RLS +     R+  NE  +++ +QH N+
Sbjct: 8   LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNI 61

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +      +D +  ++  EY    +L +      K  L +    +  +  I   + Y+H+ 
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
               I+HRD+K  NI L K    K+ DFG+++I G     A T  +VGT  YMSPE    
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQG 175

Query: 270 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
             ++ KSD+++ G +L E+++ K+       D+ N L     +   N T  +        
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRT-----FDATNPLNLVVKIVQGNYTPVV------SV 224

Query: 330 YSSK-HMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           YSS+   L+         +Q+  + RPT ++V+   
Sbjct: 225 YSSELISLVHS------LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 7e-23
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 40/282 (14%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVK------RLSGRSGQGLREM----KNEASVIAKVQHK 147
           +G+G +G VY  + +  G+ +AVK       ++GR     ++M    ++E   +  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 148 NLVRLLGCCIDKDEKILIY-EYMPNKSLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLL 204
           N+V+ LG     +E + I+ EY+P  S+   L    +    L+ + T  Q++EG+A    
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVLEGLA---- 122

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YLH      I+HRDLKA N+L+D D   KISDFG+++             + G+  +M+P
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 265 E--YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 322
           E  ++    +S K D++S G ++LE+ +G++            +   + L          
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-----DEEAIAAMFKLGNKRSA---- 230

Query: 323 DPILEDEYSSKHMLLRYVNIALL--CVQESADDRPTMNDVVS 362
            PI  D      M L  V +  L  C   + D+RPT  +++ 
Sbjct: 231 PPIPPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 97.4 bits (242), Expect = 7e-23
 Identities = 71/220 (32%), Positives = 124/220 (56%), Gaps = 22/220 (10%)

Query: 99  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG VYKG+ + +G+ +    A+K L+  +G +   E  +EA ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           LG C+    + L+ + MP+  L  ++ +       ++LL+W  +      IA+G++YL +
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 269 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 306
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.5 bits (241), Expect = 8e-23
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 97  NKLGEGGFGPVYKGVLKKGD--EIAVKRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRL 152
             +G+G FG V K V +K D   +  K +  G   +  ++   +E +++ +++H N+VR 
Sbjct: 6   ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 153 LGCCIDKD-EKILIY-EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--- 207
               ID+  + + I  EY     L   +     +    ++    I   + Q LL L+   
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 208 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
                   ++HRDLK +NI LD + N K+ DFG+A+I G +   A T   VGT  YMSPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 +  KSD++S G L+ E+ +  
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 34/271 (12%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQ-GLREMKNEASVIAKVQHKN 148
           F+D  ++G G FG VY     + +E+ A+K++  SG+      +++  E   + +++H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
            +   GC + +    L+ EY    + D  + +  K+ L + V    I  G  QGL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHS 133

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           + R   IHRD+KA NILL +    K++DFG A +       AN+   VGT  +M+PE  L
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184

Query: 269 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
              EG +  K DV+S G+  +E+   K    L+  ++++ L +       N +     P 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHI----AQNDS-----PT 233

Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPT 356
           L    SS      + N    C+Q+   DRP+
Sbjct: 234 L----SSNDWSDYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 23/213 (10%)

Query: 98  KLGEGGFGPVYKGVL-----KKGDEIAVKRLSG-RSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGE  FG +YKG L          +A+K L    + Q   E + EAS++A++ H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLF--------------DPTKRMLLDWVTRVQIIE 197
           LLG    +    +++EY+    L  FL               D T +  LD    + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL  +     +H+DL A NIL+ + ++ KISD G++R     +      + + 
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
              +M PE  + G FS  SD++SFGV+L EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 23/216 (10%)

Query: 98  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+      +    D+  +AVK L   +    ++ + EA ++  +QH+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTR-----------VQIIEG 198
             G C D D  I+++EYM +  L+ FL    P   +L+D   R           + I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +        +  
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 293
             +M PE  +   F+ +SDV+SFGV+L EI + GK+
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 96.7 bits (240), Expect = 2e-22
 Identities = 80/271 (29%), Positives = 135/271 (49%), Gaps = 34/271 (12%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKN 148
           FSD  ++G G FG VY     +  E+ A+K++S    +S +  +++  E   + K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
            ++  GC + +    L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 269 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PA 233

Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPT 356
           L+  + S++    + N    C+Q+   DRPT
Sbjct: 234 LQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 26/214 (12%)

Query: 99  LGEGGFGPVYKGVLKKGDE------IAVKRLSG-RSGQGLREMKNEASVIAKV-QHKNLV 150
           LGEG FG V K      D       +AVK L    + + L ++ +E  ++  + +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTRVQIIE-- 197
            LLG C  +    ++ EY  + +L  FL            D   R   + +T+  ++   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP-RPPEETLTQKDLVSFA 138

Query: 198 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
             +A+G+ +L      + IHRDL A N+L+ +D   KI+DFG+AR     +    T+   
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 22/209 (10%)

Query: 99  LGEGGFGPVYKGVLKKGD----EIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V +G L + D    ++AVK  +L   +   + E  +EA+ +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 153 LGCCIDKDEK------ILIYEYMPNKSLDFFLFDPTKRMLLDWV---TRVQIIEGIAQGL 203
           +G C +          ++I  +M +  L  FL       L + +   T ++ +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANTSRIVGTYGY 261
            YL   S    IHRDL A N +L +DM   ++DFG+++ I  G+   Q   +++     +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           ++ E   + +++ KSDV++FGV + EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 67/208 (32%), Positives = 111/208 (53%), Gaps = 20/208 (9%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKR--LSGRSGQG-------LREMKNEASVIAKVQHKN 148
           +G G FG VY G+    G+ +AVK+  L   S          L  +  E +++ ++QH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +V+ LG  +D D   +  EY+P  S+   L         +       +  I +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSR--IVGTYGYMSP 264
            +R  IIHRD+K +NIL+D     KISDFG+++    N L    N +R  + G+  +M+P
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E   +  ++ K+D++S G L++E+++GK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.4 bits (237), Expect = 3e-22
 Identities = 87/304 (28%), Positives = 135/304 (44%), Gaps = 66/304 (21%)

Query: 99  LGEGGFGPVYKGVLK--KG----DEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           LGEG FG V K      KG      +AVK L    S   LR++ +E +++ +V H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL----------------------FDPTKR----- 184
           L G C      +LI EY    SL  FL                       +P +R     
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
            L+ +  +      I++G+ YL   + ++++HRDL A N+L+ +    KISDFG++R   
Sbjct: 128 DLISFAWQ------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDS 302
             +     S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+     
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238

Query: 303 LNLL--GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
            NLL  GY  +                 E  S+ M     N+ L C ++  D RPT  D+
Sbjct: 239 FNLLKTGYRME---------------RPENCSEEMY----NLMLTCWKQEPDKRPTFADI 279

Query: 361 VSML 364
              L
Sbjct: 280 SKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           LG+G FG V            G+ +AVK+L   + + LR+ + E  ++  +QH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 154 GCCID--KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           G C    +    L+ EY+P  SL  +L    +R  LD    +     I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPEY 266
            R +HRDL   NIL++ +   KI DFG+ ++   ++      +   S I     + +PE 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPES 182

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
             E  FS+ SDV+SFGV+L E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.7 bits (235), Expect = 5e-22
 Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 20/213 (9%)

Query: 98  KLGEGGFGPVY----KGVLKKGDEI--AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+      +  + D+I  AVK L   S    ++   EA ++  +QH+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML--------LDWVTRVQIIEGIAQ 201
             G C++ D  I+++EYM +  L+ FL    P   ++        L     + I + IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
           G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +        +    +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 293
           M PE  +   F+ +SDV+S GV+L EI + GK+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 95.5 bits (237), Expect = 5e-22
 Identities = 80/276 (28%), Positives = 138/276 (50%), Gaps = 34/276 (12%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKN 148
           F+D  ++G G FG VY     + +E+ A+K++S    +S +  +++  E   + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
            +   GC + +    L+ EY    + D  L +  K+ L + V    I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHS 143

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           ++   +IHRD+KA NILL +    K++DFG A I       AN+   VGT  +M+PE  L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVIL 194

Query: 269 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PT 243

Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
           L+    S +    + N    C+Q+   DRPT  +++
Sbjct: 244 LQSNEWSDY----FRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 94.2 bits (234), Expect = 9e-22
 Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 64/308 (20%)

Query: 98  KLGEGGFGPVY----KGVLKKGDE-------------IAVKRLSGRSGQGLR-EMKNEAS 139
           KLGEG FG V+    +G+ K  D+             +AVK L   + +  R +   E  
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRMLLDWVT 191
           ++++++  N++RLL  CI  D   +I EYM N  L+ FL         +    + + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 192 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 251
            + +   IA G+ YL   S +  +HRDL   N L+ K+   KI+DFGM+R     +    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK--------------NTGL 297
             R V    +MS E  L G F+  SDV++FGV L EI++  K              NTG 
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248

Query: 298 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTM 357
           +  D               R + L  P L  +   K M        L C + +A +RP+ 
Sbjct: 249 FFRD-------------QGRQVYLPKPALCPDSLYKLM--------LSCWRRNAKERPSF 287

Query: 358 NDVVSMLT 365
            ++ + L 
Sbjct: 288 QEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 67/211 (31%), Positives = 118/211 (55%), Gaps = 24/211 (11%)

Query: 92  KFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKVQ 145
           +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQ 201
           + ++ RLLG C+    + LI + MP   L  ++ +    +    LL+W  +      IA+
Sbjct: 68  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 120

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTY 259
           G+ YL +    R++HRDL A N+L+    + KI+DFG+A++ G +E    A   ++    
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PI 175

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 86/303 (28%), Positives = 136/303 (44%), Gaps = 46/303 (15%)

Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLF-------DPTKRMLLDWVTRVQIIEGIAQGL 203
           RLLG        +++ E M +  L  +L        +   R        +Q+   IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLL---GYAWDLWTSNRT 318
           PE   +G+F+  SD++SFGV+L EI S  +    GL     L  +   GY          
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---------- 239

Query: 319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
             L  P  ++       L+R      +C Q +   RPT  ++V++L ++    L P  P 
Sbjct: 240 --LDQP--DNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLKDD----LHPSFPE 285

Query: 379 FSF 381
            SF
Sbjct: 286 VSF 288

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKN 148
             F+    +G+G FG VYK + K+    +A+K +     +  + +++ E   +++ +   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           + +  G  +   +  +I EY    S      D  K   LD      I+  +  GL YLH+
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 265
                 IHRD+KA+NILL ++ + K++DFG++      +L +  S+    VGT  +M+PE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
              +  +  K+D++S G+  +E+  G+
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.0 bits (228), Expect = 2e-21
 Identities = 64/193 (33%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGCCI 157
           LG+G FG V+KG LK    +AVK       Q L+ +  +EA ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
            +    ++ E +P    DF  F   K+  L     V+     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 277
           DL A N L+ ++   KISDFGM+R        ++  + +    + +PE    G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176

Query: 278 VFSFGVLLLEIVS 290
           V+S+G+LL E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)

Query: 98  KLGEGGFGPVY----KGVLKKGDEI-------------AVKRL-SGRSGQGLREMKNEAS 139
           KLGEG FG V+     G+    ++              AVK L    S     +   E  
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTR-- 192
           +++++   N+ RLLG C       +I EYM N  L+ FL                ++   
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 193 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 251
            + +   IA G+ YL     +  +HRDL   N L+ K+   KI+DFGM+R    N   ++
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184

Query: 252 TSRIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             R+ G       +M+ E  L G F+ KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 26/209 (12%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLS------GRSGQGLREMKNEASVIAKVQHKNLVR 151
           LG G F   Y+   +K G  +AVK+++          + +  ++ E  ++A++ H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +LG   +     L  E+M   S+   L  +   K  ++     +   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 210 SRVRIIHRDLKASNILLDKD-MNPKISDFGMA-----RICGGNELQANTSRIVGTYGYMS 263
              +IIHRD+K +N+L+D      +I+DFG A     +  G  E Q    +++GT  +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE      +    DV+S G +++E+ + K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 92.0 bits (228), Expect = 5e-21
 Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 31/223 (13%)

Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASVI 141
           A  K + + +LG+G FG VY+G+ K    DE    +A+K ++  +    R E  NEASV+
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------------PTKRMLL 187
            +    ++VRLLG        ++I E M    L  +L                  K+M  
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM-- 121

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                +Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +
Sbjct: 122 -----IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                 + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 99  LGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG+GGFG V        G +    ++  KRL  R G+ +    NE  ++ KV  + +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQM--ALNEKKILEKVSSRFIVSL 58

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 KD+  L+   M    L + +++  +    +        + I  GL +LHQ    
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---R 114

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           RI++RDLK  N+LLD   N +ISD G+A        +    R  GT GYM+PE     ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVY 171

Query: 273 SIKSDVFSFGVLLLEIVSGK 292
               D F+ G  L E+++G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           LG+G +G VY    L     IA+K +  R  + ++ +  E ++ + ++H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
           +     +  E +P  SL   L      +  +  T +   + I +GL YLH     +I+HR
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132

Query: 218 DLKASNILLDKDMNP-KISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGI--FS 273
           D+K  N+L++      KISDFG + R+ G N     T    GT  YM+PE   +G   + 
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYG 189

Query: 274 IKSDVFSFGVLLLEIVSGK 292
             +D++S G  ++E+ +GK
Sbjct: 190 APADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 13/203 (6%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 150
           F+   ++G+G FG VYKG+  +  E+ A+K +     +  + +++ E +V+++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           R  G  +   +  +I EY+   S LD     P +   +       I+  I +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
              R IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 34/221 (15%)

Query: 98  KLGEGGFGPVY----KGVLK-----------KGDEIAVKRLSGRSGQGLR-EMKNEASVI 141
           KLGEG FG V+    +G+ +           +   +AVK L     +  R +   E  ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG--- 198
           +++++ N++RLLG C+  D   +I EYM N  L+ FL   ++R +    T    I     
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128

Query: 199 ---------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                    IA G+ YL   + +  +HRDL   N L+      KI+DFGM+R     +  
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               R V    +M+ E  L G F+  SDV++FGV L E+ +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 8/201 (3%)

Query: 97  NKLGEGGFGPVYKGV-LKKGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
             +G G    VY  + L   +++A+KR+   +    + E++ E   +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
             +  DE  L+  Y+   SL   +     R  LD      +++ + +GL YLH   +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 215 IHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR-IVGTYGYMSPEYALEGI- 271
           IHRD+KA NILL +D + KI+DFG+ A +  G +      +  VGT  +M+PE   +   
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +  K+D++SFG+  +E+ +G 
Sbjct: 184 YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 67/204 (32%), Positives = 110/204 (53%), Gaps = 24/204 (11%)

Query: 99  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG V+KG+ + +GD I    A+K +  RSG Q  +E+ +    +  + H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           LG C     + L+ +  P  SL   +       DP  + LL+W  +      IA+G+ YL
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQ------IAKGMYYL 125

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
            ++   R++HR+L A NILL  D   +I+DFG+A +   ++ +   S       +M+ E 
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
            L G ++ +SDV+S+GV + E++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 13/193 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI- 157
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
           +K    ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 277
           DL A N+L+ +D   K+SDFG+ +     +   +T ++     + +PE   E  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSD 181

Query: 278 VFSFGVLLLEIVS 290
           V+SFG+LL EI S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 76/241 (31%), Positives = 110/241 (45%), Gaps = 52/241 (21%)

Query: 84  SSVSTATNKFSD---ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLR-EMKNEA 138
            S  +A    S+    N++G G  G VYK + +  G   A+K + G     +R ++  E 
Sbjct: 64  GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREI 123

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD-------FFLFDPTKRMLLDWVT 191
            ++  V H N+V+         E  ++ E+M   SL+        FL D         V 
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD---------VA 174

Query: 192 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 251
           R QI+ GIA    YLH   R  I+HRD+K SN+L++   N KI+DFG++RI        N
Sbjct: 175 R-QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226

Query: 252 TSRIVGTYGYMSPE-------------YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY 298
           +S  VGT  YMSPE             YA         D++S GV +LE   G+   G+ 
Sbjct: 227 SS--VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGRFPFGVG 276

Query: 299 R 299
           R
Sbjct: 277 R 277

Length = 353

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 36/275 (13%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           +LG G FG V+ G  +   ++A+K +    G    E    EA V+ K+ H  LV+L G C
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
             +    ++ E+M N  L  +L       +K MLL       + + + +G+ YL + S  
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYLERNS-- 120

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL A N L+      K+SDFGM R    +E   ++S       +  PE      +
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKY 178

Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE-DEYS 331
           S KSDV+SFGVL+ E+ +  K                   +      E+++ I       
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMP-----------------FEKKSNYEVVEMISRGFRLY 221

Query: 332 SKHMLLRYV-NIALLCVQESADDRPTMNDVVSMLT 365
              +    V  +   C  E  + RPT  +++  +T
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 23/206 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
            ++G G +G VYK       E+ A+K +    G     ++ E S++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 156 CIDKDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            + +D+  ++ EY    SL         P   + + +V R  +     +GL YLH+  + 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHETGK- 122

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 269
             IHRD+K +NILL +D + K++DFG++      +L A  ++    +GT  +M+PE A  
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 270 ---GIFSIKSDVFSFGVLLLEIVSGK 292
              G +  K D+++ G+  +E+   +
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 66/202 (32%), Positives = 109/202 (53%), Gaps = 20/202 (9%)

Query: 99  LGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQ 208
           LG C+    + L+ + MP   L  ++ +   R+    LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
              VR++HRDL A N+L+    + KI+DFG+AR+   +E + +         +M+ E  L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
              F+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 89.2 bits (221), Expect = 6e-20
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 30/224 (13%)

Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMK-NE 137
           L +  SV     K++   K+G+G  G VY  + +  G E+A+K+++    Q  +E+  NE
Sbjct: 8   LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66

Query: 138 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
             V+ + +H N+V  L   +  DE  ++ EY+   SL             D VT   + E
Sbjct: 67  ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT------------DVVTETCMDE 114

Query: 198 GIA--------QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNEL 248
           G          Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      
Sbjct: 115 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPE 168

Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           Q+  S +VGT  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 88.8 bits (221), Expect = 6e-20
 Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 46/218 (21%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEI-AVKRL---SGRSG---QGLREMKNEASVIAKVQHKNL 149
           N++ EG +G VY+   KK  EI A+K+L     + G     LRE+    +++ K+QH N+
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQHPNI 66

Query: 150 VRL----LGCCIDKDEKILIY---EYMPN--KSL-----DFFLFDPTKRMLLDWVTRVQI 195
           V +    +G  +DK     IY   EY+ +  KSL       FL    K ++L      Q+
Sbjct: 67  VTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML------QL 115

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
           + G+A    +LH      I+HRDLK SN+LL+     KI DFG+AR  G   L+  T  +
Sbjct: 116 LSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLV 167

Query: 256 VGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           V T  Y +PE  L    +S   D++S G +  E+++ K
Sbjct: 168 V-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 102 GGFGPVYKGVLKK--GDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCC 156
           G +G V+    KK  GD  A+K +          + ++  E  ++++ Q   +V+L    
Sbjct: 4   GAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRML--LDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
             K    L+ EY+P   L   L       +  LD       I  I   L YLH      I
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLL-----ENVGSLDEDVARIYIAEIVLALEYLHSNG---I 114

Query: 215 IHRDLKASNILLDKDMNPKISDFG------MARICGGNELQANTSRIVGTYGYMSPEYAL 268
           IHRDLK  NIL+D + + K++DFG      + R    N+ +    RIVGT  Y++PE  L
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 269 EGIFSIKSDVFSFGVLLLEIVSG 291
               S   D +S G +L E + G
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 53/182 (29%), Positives = 91/182 (50%), Gaps = 32/182 (17%)

Query: 98  KLGEGGFGPVYK-GVLKKGDEIAVKRLSGRSGQG------LREMKNEASVIAKVQHKNLV 150
           ++GEG  G V+K    + G+ +A+K+++ R  +G      LRE+K     +   QH  +V
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62

Query: 151 RLLGCCIDKDEKILIYEYMPN------KSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGL 203
           +LL         +L+ EYMP+      +  +  L +   K  +        +++G+A   
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMR------MLLKGVA--- 113

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            Y+H      I+HRDLK +N+L+  D   KI+DFG+AR+    E +  + + V T  Y +
Sbjct: 114 -YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRA 168

Query: 264 PE 265
           PE
Sbjct: 169 PE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEASVIAKVQHKNLV 150
           K+GEG +G VYK   K   EI A+K++       G     LRE+K    ++ ++ H N++
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           +LL     K +  L++E+M     D +     ++  L        +  + QGL + H + 
Sbjct: 62  KLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-E 269
              I+HRDLK  N+L++ +   K++DFG+AR  G        +  V T  Y +PE  L +
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD 173

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +S   D++S G +  E++S +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 13/196 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           LG+G FG VYK   K+     A K +   S + L +   E  ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
            +++  ++ E+    +LD  +    +R L +   R  +   + + L +LH +   ++IHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127

Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS---- 273
           DLKA NILL  D + K++DFG++     + LQ   +  +GT  +M+PE      F     
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPY 185

Query: 274 -IKSDVFSFGVLLLEI 288
             K+D++S G+ L+E+
Sbjct: 186 DYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 74/223 (33%), Positives = 113/223 (50%), Gaps = 38/223 (17%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEI--AVKRLSGRSGQG-LREMKNEASVIAKV-QH 146
           KF D   +GEG FG V + ++KK G ++  A+K L   + +   R+   E  V+ K+  H
Sbjct: 5   KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------------TKRMLL 187
            N++ LLG C ++    +  EY P  +L  FL        DP            T + LL
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
            + + V      A G+ YL   S  + IHRDL A N+L+ +++  KI+DFG++R   G E
Sbjct: 123 QFASDV------ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEE 170

Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +    +       +M+ E     +++ KSDV+SFGVLL EIVS
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 21/208 (10%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE----MKNEASVIAKVQHK 147
           F   +++G G FG VY       +E+ AVK++S  SG+   E    +  E   + +++H 
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHP 81

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           N +   GC + +    L+ EY    + D  L +  K+ L + V    I  G  QGL YLH
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLH 138

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
            ++   +IHRD+KA NILL +    K++DFG A         AN+   VGT  +M+PE  
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVI 189

Query: 268 L---EGIFSIKSDVFSFGVLLLEIVSGK 292
           L   EG +  K DV+S G+  +E+   K
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 69/230 (30%), Positives = 109/230 (47%), Gaps = 43/230 (18%)

Query: 98  KLGEGGFGPV---------------YKGVLKKGDE--IAVKRLSGRSGQGLR-EMKNEAS 139
           KLGEG FG V               +   ++KG    +AVK L   + +  R +   E  
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD----------- 188
           ++++++  N++RLLG C+D+D   +I EYM N  L+ FL   +   L D           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 189 --------WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
                   + + + +   IA G+ YL   S +  +HRDL   N L+ +++  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           R     +      R V    +M+ E  L G F+  SDV++FGV L EI+ 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 98  KLGEGGFGPVYKGVLKKGD---------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           +LG+G FG VY    KK           EI V  L+        +   EA +++K+ H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +V+     +++D   +I EY   + LD  L +         ++  Q+ E   Q LL +H 
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG--KTLSENQVCEWFIQLLLGVHY 121

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
             + RI+HRDLKA NI L  ++  KI DFG++R+  G+   A T    GT  YMSPE   
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178

Query: 269 EGIFSIKSDVFSFGVLLLEI 288
              +  KSD++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 25/206 (12%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 150
           K+GEG +G VYK   K   EI A+K++       G     +RE+    S++ ++ H N+V
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI----SLLKELNHPNIV 61

Query: 151 RLLGCCIDKDEKILIYEYMP---NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           RLL     +++  L++E++     K +D          L+      Q+++GIA    Y H
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY-QLLQGIA----YCH 116

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
            +   R++HRDLK  N+L+D++   K++DFG+AR   G  ++  T  +V T  Y +PE  
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171

Query: 268 LEG-IFSIKSDVFSFGVLLLEIVSGK 292
           L    +S   D++S G +  E+V+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.5 bits (214), Expect = 3e-19
 Identities = 63/203 (31%), Positives = 109/203 (53%), Gaps = 14/203 (6%)

Query: 98  KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 153
           +LG G FG V KGV K   K  ++A+K L   + + +R EM  EA ++ ++ +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C + +  +L+ E      L+ FL    K+  +     V+++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGI 271
            +HRDL A N+LL      KISDFG+++  G ++     +R  G +   + +PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174

Query: 272 FSIKSDVFSFGVLLLEIVS-GKK 293
           FS +SDV+S+G+ + E  S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LREMKNEASVIAKV-QH 146
           KF D   +GEG FG V K  +KK     + A+KR+   + +   R+   E  V+ K+  H
Sbjct: 10  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------TKRMLLDWVTRV 193
            N++ LLG C  +    L  EY P+ +L  FL        DP      +    L     +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
                +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    +
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 181

Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                  +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 51/221 (23%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQG-------LREMKNEASVIAKVQH 146
            KLGEG +  VYK   K+ G  +A+K  +L  R           LRE+K    ++ +++H
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK----LLQELKH 61

Query: 147 KNLVRLLGCCIDKDEKILIYEYMP--------NKSLDFFLFDPTK---RMLLDWVTRVQI 195
            N++ LL     K    L++E+M         +KS+     D  K    M L        
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTL-------- 112

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTS 253
                +GL YLH      I+HRDLK +N+L+  D   K++DFG+AR  G    ++   T 
Sbjct: 113 -----RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---TH 161

Query: 254 RIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGK 292
           ++V T  Y +PE  L G   + +  D++S G +  E++   
Sbjct: 162 QVV-TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 4e-19
 Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 17/200 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRS--GQGLREM-KNEASVIAKVQHKNLVRLLG 154
           LG GGFG V    +K  +   A+K +  R     G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 155 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
               KD+K +  + EY     L   L D   R L D  T    I  +     YLH     
Sbjct: 60  -RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG-- 113

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            II+RDLK  N+LLD +   K+ DFG A+     +    T    GT  Y++PE  L   +
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169

Query: 273 SIKSDVFSFGVLLLEIVSGK 292
               D +S G+LL E+++G+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.7 bits (214), Expect = 5e-19
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 12/215 (5%)

Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           L S  SV     K++   K+G+G  G VY  + +  G E+A+K+++ +       + NE 
Sbjct: 8   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 257
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 32/213 (15%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
              +  K+GEG  G V     K  G ++AVK++  R  Q    + NE  ++   QH N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE--------GIAQG 202
            +    +  DE  ++ E++   +L             D VT  ++ E         + + 
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT------------DIVTHTRMNEEQIATVCLAVLKA 127

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTY 259
           L +LH      +IHRD+K+ +ILL  D   K+SDFG    C   ++     R   +VGT 
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF---CA--QVSKEVPRRKSLVGTP 179

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            +M+PE      +  + D++S G++++E+V G+
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 19/208 (9%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-----LREMKNEASVIAKVQH 146
           F    KLGEG +  VYKG  +   EI A+K +   + +G     +RE+    S++ +++H
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI----SLMKELKH 57

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           +N+VRL      +++ +L++EYM +K L  ++     R  LD  T       + +G+ + 
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPE 265
           H+    R++HRDLK  N+L++K    K++DFG+AR  G   +  NT S  V T  Y +P+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPD 170

Query: 266 YALEG-IFSIKSDVFSFGVLLLEIVSGK 292
             L    +S   D++S G ++ E+++G+
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 22/219 (10%)

Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHK 147
            T  F     +GEG +G VYK   KK  ++   ++         E+K E +++ K   H 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 148 NLVRLLGCCIDKDEKI------LIYEYMPNKS---LDFFLFDPTKRMLLDWVTRVQIIEG 198
           N+    G  I K+         L+ E     S   L   L    KR+  +W+    I+  
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRE 121

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
             +GL YLH+    ++IHRD+K  NILL K+   K+ DFG++        + NT   +GT
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGT 176

Query: 259 YGYMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +M+PE        +  +  +SDV+S G+  +E+  GK
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 49/227 (21%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSG---QGLREMKNEASVIAKVQHKNLV 150
           KLGEG FG VYK   +K G  +A+K++   + + G     LRE+K    ++ K++H N+V
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----ILKKLKHPNVV 70

Query: 151 RLLGCCIDKDEKIL-----IYEYMPNKSLDF--FLFDPT--------KRMLLDWVTRVQI 195
            L+   +++ +K       +Y   P    D    L +P+        K  +L      Q+
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML------QL 124

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---------CGGN 246
           +EGI     YLH+     I+HRD+KA+NIL+D     KI+DFG+AR           GG 
Sbjct: 125 LEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 247 ELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
                 + +V T  Y  PE  L E  ++   D++  G +  E+ + +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 67/230 (29%), Positives = 118/230 (51%), Gaps = 42/230 (18%)

Query: 99  LGEGGFGPVYKGVLKKGDEI---AVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           LGEG FG V +G L + D I   AVK  +++  +   + +  +EA  + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 154 GCCIDKDEK------ILIYEYMPNKSLDFFL----------FDPTKRMLLDWVTRVQIIE 197
           G C+   E       ++I  +M +  L  FL          + PT+ +       V+ + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML-------VKFMT 119

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNEL-QANTSRI 255
            IA G+ YL   S    IHRDL A N +L+++MN  ++DFG++ +I  G+   Q   +++
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLY 298
                +++ E   + +++ KSDV+SFGV + EI +       G +N+ +Y
Sbjct: 177 --PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 85.5 bits (211), Expect = 9e-19
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)

Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 257
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 178

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGL---REMKNEASVIAKVQH 146
             F    ++G+GG+G V+    K   EI A+KR+       L   R +  E  ++   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           + LV+LL    D +   L  EY+P    DF        +L +   R  + E     +  L
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDAL 117

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H+      IHRDLK  N L+D   + K++DFG+++  G     AN+  +VG+  YM+PE 
Sbjct: 118 HELG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY-ANS--VVGSPDYMAPEV 169

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
                +    D +S G +L E + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 25/221 (11%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
            ++   K+GEG +G VYKG  KK G  +A+K++       G     +RE+    S++ ++
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKEL 56

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF--FLFDPTKRMLLDWVTRVQIIEGIAQG 202
           QH N+V L    + +    LI+E++   S+D   +L    K   +D       +  I QG
Sbjct: 57  QHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           +L+ H     R++HRDLK  N+L+D     K++DFG+AR   G  ++  T  +V T  Y 
Sbjct: 114 ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV-TLWYR 168

Query: 263 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
           +PE  L    +S   D++S G +  E+ + K    L+  DS
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKP---LFHGDS 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 39/213 (18%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK-------------NEASVIAKV 144
           KLG+G +G VYK          VKRLS      L+E+              NE  ++A V
Sbjct: 7   KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML---LDWVTRVQIIEGI 199
            H N++      +D ++  ++ EY P   L   +      ++++     W   +Q++ G 
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG- 115

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
              L  LH+    +I+HRDLK++NILL  +   KI D G++++   N   A T   +GT 
Sbjct: 116 ---LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQ--IGTP 165

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            YM+PE      +S KSD++S G LL E+ +  
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 92  KFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK 143
           K+     +G G FG V+        K V+ K  +I V++++          +NE  V+  
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIK--QIPVEQMTKDERLA---AQNECQVLKL 55

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           + H N++      ++    +++ EY P  +L  ++       LLD  T   I+    Q L
Sbjct: 56  LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQIL 111

Query: 204 LYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           L LH      I+HRDLK  NILLDK  M  KI DFG+++I      ++    +VGT  Y+
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYI 168

Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 293
           SPE      ++ KSD+++ G +L E+ S K+
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 71/215 (33%), Positives = 110/215 (51%), Gaps = 26/215 (12%)

Query: 99  LGEGGFGPVYK----GVLKKGDE----IAVKRLSGR-SGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V +    G+ K   +    +AVK L    + + L ++ +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTK--RMLLDWVTRVQI 195
           ++ LLG C  +    +I EY    +L  FL           FD TK     L +   V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   SR R IHRDL A N+L+ +D   KI+DFG+AR     +    TS  
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + +++ +SDV+SFG+L+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 68/203 (33%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 151
           LG+G FG V    LK  DE+ AVK L  +    L++        E  V+A   +H  L +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L  C   KD    + EY+    L F +         +   R    E I  GL +LH+   
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALE 269
             II+RDLK  N+LLD + + KI+DFGM +  I GG      TS   GT  Y++PE    
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSY 170

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +    D ++ GVLL E+++G+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 36/216 (16%)

Query: 99  LGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LREMKNEASVIAKV-QHKNLVRLL 153
           +GEG FG V K  +KK     + A+KR+   + +   R+   E  V+ K+  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFL-------FDP------------TKRMLLDWVTRVQ 194
           G C  +    L  EY P+ +L  FL        DP            + + LL +   V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV- 121

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
                A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    + 
Sbjct: 122 -----ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 170

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                 +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 21/237 (8%)

Query: 129 QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML 186
           Q LRE++    ++ + +   +V   G  ++++   +  E+M   SLD       P    +
Sbjct: 49  QILRELQ----IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI 104

Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           L      +I   + +GL YL  Y+  RI+HRD+K SNIL++     K+ DFG++    G 
Sbjct: 105 LG-----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GE 153

Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 306
            + +     VGT  YMSPE    G +++KSDV+S G+ ++E+  GK        D     
Sbjct: 154 LINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213

Query: 307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM 363
                L    + ++   P L      + +   +V+    C+ +   +RPT   + +M
Sbjct: 214 DPMGILDLLQQIVQEPPPRLPSSDFPEDL-RDFVDA---CLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 84.4 bits (208), Expect = 3e-18
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 12/215 (5%)

Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           L +  S+     K++   K+G+G  G V+  + +  G E+A+K+++ +       + NE 
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            V+ ++++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 257
             Q L +LH     ++IHRD+K+ N+LL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 3e-18
 Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 19/272 (6%)

Query: 95  DANKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           + N +  G  G  YKG   K   +  VK +       +     E + + K+QH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPSS--EIADMGKLQHPNIVKLI 749

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C  +    LI+EY+  K+L   L +      L W  R +I  GIA+ L +LH      
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           ++  +L    I++D    P +             L    ++   +  Y++PE       +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDIT 856

Query: 274 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS- 332
            KSD++ FG++L+E+++GK           +++ +A   ++       IDP +  + S  
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916

Query: 333 KHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           ++ ++  +N+AL C       RP  NDV+  L
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 83.6 bits (206), Expect = 3e-18
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 27/209 (12%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG+G FG VY    +  G E+A K++     S  + + +  ++ E  ++  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 153 LGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR--MLLDWVTRVQIIEGIAQGLLYLHQ 208
            GC  D+ EK L    EYMP  S+     D  K    L + VTR +    I +G+ YLH 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTR-KYTRQILEGMSYLHS 124

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 263
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----VTGTPYWMS 177

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE      +  K+DV+S G  ++E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 21/202 (10%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQH---KNLVRLL 153
           +G G +G VY+G  +  G  +A+K ++  +    + +++ E +++++++     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  +      +I EY    S+   +    K   +       II  +   L Y+H   +V 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH---KVG 121

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEG 270
           +IHRD+KA+NIL+    N K+ DFG+A       L  N+S+    VGT  +M+PE   EG
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 271 I-FSIKSDVFSFGVLLLEIVSG 291
             +  K+D++S G+ + E+ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 99  LGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAKV-QHKNLV 150
           LG G FG V +     L K D   ++AVK L   +    RE + +E  +++ +  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
            LLG C      ++I EY     L  FL    +   L     +     +A+G+ +L   +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAL 268
               IHRDL A N+LL      KI DFG+AR  +   N +    +R+     +M+PE   
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIF 216

Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
             +++ +SDV+S+G+LL EI S
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 55/203 (27%), Positives = 108/203 (53%), Gaps = 13/203 (6%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 150
           F+   ++G+G FG V+KG+  +  ++ A+K +     +  + +++ E +V+++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  G  +   +  +I EY+   S LD     P      D      +++ I +GL YLH  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 120

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +   IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 74/287 (25%), Positives = 131/287 (45%), Gaps = 41/287 (14%)

Query: 90  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---------EAS 139
              F    K+G+G F  VYK + L  G  +A+K++       + EM +         E  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIE 197
           ++ ++ H N+++ L   I+ +E  ++ E      L   +  F   KR L+   T  +   
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFV 113

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            +   L ++H     RI+HRD+K +N+ +      K+ D G+ R        A++  +VG
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 168

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR 317
           T  YMSPE   E  ++ KSD++S G LL E+ + +     +  D +NL    + L    +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL----YSLC---K 218

Query: 318 TLELID--PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
            +E  D  P+  D YS +   LR  ++   C+    + RP ++ V+ 
Sbjct: 219 KIEKCDYPPLPADHYSEE---LR--DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 7/195 (3%)

Query: 98  KLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGC 155
           ++G G FG V+ G L+  +  +AVK         L+ +   EA ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  K    ++ E +  +  DF  F  T+   L     +Q++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ +    KISDFGM+R        +          + +PE    G +S +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 276 SDVFSFGVLLLEIVS 290
           SDV+SFG+LL E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)

Query: 95  DANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH-KNL 149
           D  ++G G FG V K + K  G  +AVKR+  RS    +E K    +  V+ +      +
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI--------AQ 201
           V+  G    + +  +  E M + SLD F         +  V +  I E I         +
Sbjct: 66  VKFYGALFREGDCWICMELM-DISLDKFY------KYVYEVLKSVIPEEILGKIAVATVK 118

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YL +   ++IIHRD+K SNILLD++ N K+ DFG   I G        +R  G   Y
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPY 173

Query: 262 MSPE----YALEGIFSIKSDVFSFGVLLLEIVSGK 292
           M+PE     A +G + ++SDV+S G+ L E+ +GK
Sbjct: 174 MAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.8 bits (204), Expect = 7e-18
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 150
           F+   K+G+G FG V+KG+  +  ++ A+K +     +  + +++ E +V+++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 120

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQ 175

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 41/215 (19%)

Query: 101 EGGFGPVYKGVLKKGD-----EIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           EG FG ++ G+L         E+ VK +    S   +  +  E+ ++  + H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 155 CCI-DKDEKILIYEYMPNKSLDFFLFDP-----------TKRMLLDWVTRVQIIEGIAQG 202
            CI D +   ++Y YM   +L  FL              + + L+    +      IA G
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ------IACG 129

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI-------CGGNELQANTSRI 255
           + YLH+     +IH+D+ A N ++D+++  KI+D  ++R        C G+    N +R 
Sbjct: 130 MSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----NENRP 182

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           V    +M+ E  +   +S  SDV+SFGVLL E+++
Sbjct: 183 VK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 32/209 (15%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVR 151
           +LG+G FG VY    K+  E+ A+K++  +         LRE+K   S+    +H N+V+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK---SLRKLNEHPNIVK 62

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ--Y 209
           L     + DE   ++EYM   +L   + D   +   + V R  II  I QGL ++H+  +
Sbjct: 63  LKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGF 120

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-----IVGTYGYMSP 264
                 HRDLK  N+L+      KI+DFG+AR     E++   SR      V T  Y +P
Sbjct: 121 -----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAP 167

Query: 265 EYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
           E  L    +S   D+++ G ++ E+ + +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 98  KLGEGGFGPVYKGV--LKKGDEI--AVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRL 152
            +GEG FG VY+GV    + ++I  AVK     +   +RE    EA ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G   + +   ++ E  P   L  +L     +  LD  + +     ++  L YL      
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEGI 271
           R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE      
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184

Query: 272 FSIKSDVFSFGVLLLEIVS-GKK 293
           F+  SDV+ FGV + EI+  G K
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 13/197 (6%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
               +  ++ E+ P  ++D  + +   R L +   +V I   + + L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGI 271
           RDLKA N+LL  D + K++DFG++       LQ   S  +GT  +M+PE  +     +  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCETMKDTP 191

Query: 272 FSIKSDVFSFGVLLLEI 288
           +  K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 27/203 (13%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSG----RSGQGLREMKNEASVIAKVQHKNLVRLL 153
           LG G FG V     K   +  A+K LS     +  Q +  + NE  ++  ++H  LV L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G   D     L+ EY+P   L F     + R     V R    + +   L YLH      
Sbjct: 68  GSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEP-VARFYAAQ-VVLALEYLHSLD--- 121

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           I++RDLK  N+LLD D   KI+DFG A+      ++  T  + GT  Y++PE     I  
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE-----IIL 171

Query: 274 IK-----SDVFSFGVLLLEIVSG 291
            K      D ++ G+L+ E+++G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 27/211 (12%)

Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG------LREMKNEASVIAKVQ 145
           + +  ++GEG +G VYK   L  G  +A+K++     +       LRE+    +++ +++
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI----ALLKQLE 56

Query: 146 ---HKNLVRLLGCC--IDKDEKI---LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
              H N+VRLL  C     D ++   L++E++ ++ L  +L    K  L     +  ++ 
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMR 114

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            + +G+ +LH +   RI+HRDLK  NIL+  D   KI+DFG+ARI       A TS +V 
Sbjct: 115 QLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTS-VVV 168

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 288
           T  Y +PE  L+  ++   D++S G +  E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 70/219 (31%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 99  LGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG+GGFG V        G L    ++  KRL  R  +G      E  ++AKV  + +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFD--------PTKRMLLDWVTRVQIIEGIAQGLL 204
                 K +  L+   M    L + +++        P  R         QII     GL 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF---YTAQII----SGLE 111

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGY 261
           +LHQ    RII+RDLK  N+LLD D N +ISD G+A      EL   Q+ T    GT G+
Sbjct: 112 HLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV-----ELKDGQSKTKGYAGTPGF 163

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 300
           M+PE      +    D F+ GV L E+++ +   G +R 
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR---GPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)

Query: 99  LGEGGFGPVY------KGVLKKGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVR 151
           LGEG FG V       +G    G+++AVK L     G  + ++K E  ++  + H+N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 152 LLGCCI-DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--H 207
             G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL   
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 266
           QY     +HRDL A N+L++ +   KI DFG+ + I    E       +     + +PE 
Sbjct: 129 QY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
            ++  F I SDV+SFGV L E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 26/215 (12%)

Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTK--RMLLDWVTRVQI 195
           ++ LLG C       +I EY    +L  +L           ++PT+     L +   V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 68/228 (29%), Positives = 119/228 (52%), Gaps = 24/228 (10%)

Query: 98  KLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--IAKVQHKNLV 150
           ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 151 RLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           RL   C     D++ K+ L++E++ ++ L  +L D      +   T   ++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 179

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 312
             L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 27/209 (12%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG+G FG VY       G E+AVK++     S  + + +  ++ E  ++  + H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 153 LGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR--MLLDWVTRVQIIEGIAQGLLYLHQ 208
            GC  D  E+ L    E+MP  S+     D  K    L + VTR +    I +G+ YLH 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTR-KYTRQILEGVSYLHS 124

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 263
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWMS 177

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE      +  K+D++S G  ++E+++ K
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 27/209 (12%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG VY       G E+AVK++     S  + + +  ++ E  ++  ++H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 153 LGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR--MLLDWVTRVQIIEGIAQGLLYLHQ 208
            GC  D +EK L    EYMP  S+     D  K    L + VTR +    I QG+ YLH 
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTR-RYTRQILQGVSYLHS 124

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 263
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----VTGTPYWMS 177

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE      +  K+DV+S    ++E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.9 bits (197), Expect = 9e-17
 Identities = 67/216 (31%), Positives = 117/216 (54%), Gaps = 30/216 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRL------SGRSGQGLREMKNEASVIAK 143
           +++    K+GEG +G VYK   +  +E IA+K++       G     +RE+    S++ +
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREI----SLLKE 57

Query: 144 VQHKNLVRLLGCCIDKDEKI-LIYEYMP---NKSLDFF-LFDPTKRMLLDWVTRVQIIEG 198
           +QH N+VRL    +  ++++ L++EY+     K +D    F    R++  ++   QI+ G
Sbjct: 58  MQHGNIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL--YQILRG 114

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 257
           IA    Y H +   R++HRDLK  N+L+D+  N  K++DFG+AR   G  ++  T  +V 
Sbjct: 115 IA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV- 165

Query: 258 TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 292
           T  Y +PE  L    +S   D++S G +  E+V+ K
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 20/206 (9%)

Query: 98  KLGEGGFGPVYKGVL--KKGDE-IAVKRLSGRSG-QGLR-EMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG+   KK ++ +AVK L   +    L+ E+  EA+V+ ++ +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ FL    K +    +T  +++  ++ G+ YL + +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNIT--ELVHQVSMGMKYLEETN-- 115

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 271
             +HRDL A N+LL      KISDFG+++  G +E   N  +      +    YA E + 
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171

Query: 272 ---FSIKSDVFSFGVLLLEIVS-GKK 293
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 29/196 (14%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKR-LSGRSGQG-----LREMKNEASVIAK 143
           +K+    K+G+G FG V+K   KK  +I A+K+ L     +G     LRE+K    ++  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQL 67

Query: 144 VQHKNLVRLLGCCIDKDEK--------ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
           ++H+N+V L+  C  K            L++E+  +  L   L +   +  L  + +V  
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV-- 124

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN---T 252
           ++ +  GL Y+H   R +I+HRD+KA+NIL+ KD   K++DFG+AR    ++       T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 253 SRIVGTYGYMSPEYAL 268
           +R+V T  Y  PE  L
Sbjct: 182 NRVV-TLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 35/282 (12%)

Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 148
           F    K+G G F  VY+   L  G  +A+K++        +   +   E  ++ ++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WVTRVQIIEGIAQGL 203
           +++     I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE--- 120

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE   E  ++ KSD++S G LL E+ + +     +  D +N       L++  + +E  D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN-------LYSLCKKIEQCD 224

Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM 363
             P+  D YS +  L + VN   +C+    + RP +  V  +
Sbjct: 225 YPPLPSDHYSEE--LRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 50/194 (25%), Positives = 90/194 (46%), Gaps = 29/194 (14%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-------LREMKNEASVI 141
           K+     +G G +G VYK   K G    E A+K+  G   Q         RE+    +++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI----ALL 56

Query: 142 AKVQHKNLVRLLGCCIDKDEKI--LIYEYMPNKSLDFFLF--DPTKRMLLDWVTRVQIIE 197
            +++H+N+V L+   ++  +K   L+++Y  +       F     +  +   + +  ++ 
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLW 115

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQ--AN 251
            I  G+ YLH      ++HRDLK +NIL+  +       KI D G+AR+     L+  A+
Sbjct: 116 QILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLAD 171

Query: 252 TSRIVGTYGYMSPE 265
              +V T  Y +PE
Sbjct: 172 LDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ------GLREMKNEASVIAK 143
           NK+     +GEG +G V K   K   EI A+K+              LRE+K    V+ +
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK----VLRQ 56

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           ++H+N+V L      K    L++EY+    L+  L + +   L     R   I  + Q +
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-SYIWQLLQAI 113

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            Y H      IIHRD+K  NIL+ +    K+ DFG AR          T   V T  Y +
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRA 169

Query: 264 PEYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           PE  +      K  DV++ G ++ E++ G
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 98  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V     K  G ++AVK +  R  Q    + NE  ++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  +E  ++ E++   +L     D   +  L+      + E + Q L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 217 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG  A+I   ++       +VGT  +M+PE      +  +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 33/226 (14%)

Query: 87  STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEAS 139
               +KF    ++GEG +G VYK   K  G+ +A+K++       G     +RE+K    
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK---- 58

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKI----------LIYEYMPNKSLDFFLFDPTKRMLLDW 189
           ++ ++ H+N+V L     DK + +          L++EYM     D  L    +  L+ +
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHF 113

Query: 190 VTR--VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                   ++ + +GL Y H+ +    +HRD+K SNILL+     K++DFG+AR+    E
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 248 LQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
            +  T++++ T  Y  PE  L E  +    DV+S G +L E+ + K
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 67/240 (27%), Positives = 115/240 (47%), Gaps = 31/240 (12%)

Query: 74  EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 125
           E+ + P + FS      +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 3   ELPEDPRWEFSR-----DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57

Query: 126 RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL----- 178
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 58  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117

Query: 179 ------FDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 230
                 +D  +     + +   V     +A+G+ YL   +  + IHRDL A N+L+ ++ 
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENN 174

Query: 231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)

Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 57

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 170

Query: 266 YAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 13/197 (6%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             ++   ++ E+    ++D  + +  +R L +   RV + +   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGI 271
           RDLKA NIL   D + K++DFG++       +Q   S  +GT  +M+PE  +     +  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 184

Query: 272 FSIKSDVFSFGVLLLEI 288
           +  K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 71/279 (25%), Positives = 126/279 (45%), Gaps = 35/279 (12%)

Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 148
           F    K+G G F  VY+   L     +A+K++        +  ++   E  ++ ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WVTRVQIIEGIAQGL 203
           +++ L   I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE   E  ++ KSD++S G LL E+ + +     +  D +NL           + +E  D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLFSLC-------QKIEQCD 224

Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
             P+  + YS K   LR   +  +C+    D RP +  V
Sbjct: 225 YPPLPTEHYSEK---LR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    K   +AVK L    + + L ++ +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTK--RMLLDWVTRVQI 195
           ++ LLG C       ++ EY    +L  +L           FD  K     L +   V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 28/218 (12%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGD----EIAVKRLSGR--SGQGLREMKNEASVIAKVQH 146
           F+    LG+G FG V +  LK  D    ++AVK L     S   + E   EA+ + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 147 KNLVRLLGCCIDKDEK------ILIYEYMPNKSLDFFLF------DPTKRMLLDWVTRVQ 194
            N+++L+G  +    K      ++I  +M +  L  FL       +P     L   T V+
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP---FTLPLQTLVR 117

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANT 252
            +  IA G+ YL   S    IHRDL A N +L+++M   ++DFG+++ I  G+   Q   
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           S++     +++ E   + +++  SDV++FGV + EI++
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 100 GEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           G+G FG V     +   ++ A+K ++ +       +R + NE  ++ ++ H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
             D++   L+ + +    L + L    K    +   +  I E I   L YLH      II
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHSK---GII 122

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRD+K  NILLD+  +  I+DF +A     + L  +TS   GT GYM+PE      +S+ 
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQGYSVA 179

Query: 276 SDVFSFGVLLLEIVSGKK 293
            D +S GV   E + GK+
Sbjct: 180 VDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 93  FSDANKLGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 146
           F     LG+GGFG V        G +    ++  KR+  R G+ +    NE  ++ KV  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--ALNEKQILEKVNS 59

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRMLLDWVTRVQIIEGIA 200
           + +V L      KD   L+   M    L F ++          R +            I 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEIC 112

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTY 259
            GL  LHQ    RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT 
Sbjct: 113 CGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTV 165

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           GYM+PE      ++   D ++ G LL E+++G+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.7 bits (188), Expect = 9e-16
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 20/206 (9%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 157
           +G G +G VYKG   K  ++A  ++   +G    E+K E +++ K   H+N+    G  I
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 158 DK------DEKILIYEYMPNKSLDFFLFDPTKRMLLD-WVTRVQIIEGIAQGLLYLHQYS 210
            K      D+  L+ E+    S+   + +     L + W+    I   I +GL +LHQ+ 
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQH- 130

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-- 268
             ++IHRD+K  N+LL ++   K+ DFG++        + NT   +GT  +M+PE     
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 186

Query: 269 ---EGIFSIKSDVFSFGVLLLEIVSG 291
              +  +  KSD++S G+  +E+  G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLL 153
           +G+G FG VY G L   D      AVK L+  +  + + +   E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+      PT + L+ +  +V      A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
               + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
                F+ KSDV+SFGVLL E+++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKKG---------DEIAVKRLSGRSGQGLREMKNEASVIA 142
           K+    K+GEG FG   K +L K           EI + ++S +  +   E + E +V++
Sbjct: 1   KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLS 54

Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
            ++H N+V+      +     ++ +Y     L +   +  + +L       QI++   Q 
Sbjct: 55  NMKHPNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLF---PEDQILDWFVQI 110

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
            L L      +I+HRD+K+ NI L KD   K+ DFG+AR+       A T   +GT  Y+
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYL 168

Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           SPE      ++ KSD+++ G +L E+ + K
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG+GGFG V        G +    ++  KRL  +SG+ +  ++ E  ++ KV    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 K    L+   M    L + +++  +R L +    +     I  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGI 271
            I++RD+K  N+LLD   N ++SD G+A  +  G       ++  GT GYM+PE   E  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEP 170

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +S   D F+ G  + E+V+G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V    +K  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL--AVLKALSVLHAQG---VIH 139

Query: 217 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG  A++    E+    S +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKS-LVGTPYWMAPELISRLPYGPE 196

Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 29/207 (14%)

Query: 99  LGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG+GGFG V        G +    ++  KR+  R G+ +    NE  ++ KV  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQILEKVNSRFVVSL 65

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRMLLDWVTRVQIIEGIAQGLLYL 206
                 KD   L+   M    L F +++        +R +            I  GL  L
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-------YAAEITCGLEDL 118

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 265
           H   R RI++RDLK  NILLD   + +ISD G+A  I  G  ++      VGT GYM+PE
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPE 171

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 ++   D +  G L+ E++ GK
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)

Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           +G G FG V+    +  +   A+K ++      L++   + NE  V+ +V H  ++RL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 155 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
              + D++ L  + EY+P   L  F +        +        E I   L YLH     
Sbjct: 68  -WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYLHSKE-- 121

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            I++RDLK  NILLDK+ + K++DFG A+     +L+  T  + GT  Y++PE       
Sbjct: 122 -IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE------- 168

Query: 273 SIKS-------DVFSFGVLLLEIVSGK 292
            I+S       D ++ G+L+ E++ G 
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 93  FSDANKLGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 146
           F     LG+GGFG V        G +     +  KR+  R G+ +    NE  ++ KV  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM--ALNEKQILEKVNS 59

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           + +V L      KD   L+   M    L F +++       +        E I  GL  L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDL 118

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 265
           H+ +    ++RDLK  NILLD   + +ISD G+A +I  G  ++      VGT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPE 171

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 +++  D +  G L+ E++ G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 75/288 (26%), Positives = 134/288 (46%), Gaps = 46/288 (15%)

Query: 99  LGEGGFGPVYKGVLKK---GDEIAVKRLSGRS---GQGLRE-------MKNEASVIAK-V 144
           LG G FG VYK V KK    + +A+K ++  +   G+  RE       + +E ++I + +
Sbjct: 8   LGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDPTKRMLLD----WVTRVQIIEGI 199
           +H N+VR     ++ D   ++ + +    L + F     K+        W   VQ++   
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV--- 123

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
              L YLH+  R  I+HRDL  +NI+L +D    I+DFG+A+           + +VGT 
Sbjct: 124 -LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTI 177

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL 319
            Y  PE      +  K+DV++FG +L ++ +       Y T+ L+L         + + +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSL---------ATKIV 226

Query: 320 E-LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
           E + +P+ E  YS     +        C+   A+ RP +  V +M+++
Sbjct: 227 EAVYEPLPEGMYSEDVTDV-----ITSCLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 25/204 (12%)

Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           LG G FG + +G LK   +    +A+  L +G S +  R    EA  + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G     +  +++ EYM N +LD FL     +++   +  + ++ G+A G+ YL   S + 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL--MGMLPGLASGMKYL---SEMG 127

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYG------YMSPEY 266
            +H+ L A  +L++ D+  KIS F          LQ + S  I  T        + +PE 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
                FS  SDV+SFG+++ E++S
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKR---LSGRSGQGLREMKNEASVIAKVQHKN 148
           ++    K+GEG FG +Y    K   E  V +   L+    +     K E  ++AK++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           +V       +     ++ EY     L          LF   +  +L W  +      I+ 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQ------ISL 112

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYG 260
           GL ++H     +I+HRD+K+ NI L K+ M  K+ DFG+AR    +   A T   VGT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPY 167

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           Y+SPE      ++ K+D++S G +L E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 98  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V     K  G ++AVK++  R  Q    + NE  ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + + L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCL--SVLRALSYLHNQG---VIH 141

Query: 217 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG  A++    E+    S +VGT  +M+PE      +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKS-LVGTPYWMAPEVISRLPYGTE 198

Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E++ G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 23/202 (11%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRL-------SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           LG G  G V K + +    I  ++L       + R+ Q +RE+K    V+ +     +V 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-QIIRELK----VLHECNSPYIVG 63

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
             G      E  +  E+M   SLD  L     R+  + + ++ I   + +GL YL +  +
Sbjct: 64  FYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--K 118

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
            +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSPE  L+G 
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQGT 173

Query: 272 -FSIKSDVFSFGVLLLEIVSGK 292
            ++++SD++S G+ L+E+  G+
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKV------QHKNLVR 151
           LG+G FG V+   LK  ++  A+K L  +    L +   E +++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L      K+    + EY+    L F +    K    D          I  GL +LH    
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG- 116

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 270
             I++RDLK  NILLD D + KI+DFGM   C  N L  A T    GT  Y++PE  L  
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            ++   D +SFGVLL E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 44/221 (19%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F   N++GEG +G VY+       EI A+K++       G     LRE+    +++  ++
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI----TLLLNLR 64

Query: 146 HKNLVRLLGCCIDK--DEKILIYEY-----------MPNKSLDFFLFDPTKRMLLDWVTR 192
           H N+V L    + K  D   L+ EY           MP      F     K ++L     
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP----FSESQVKCLML----- 115

Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 252
            Q++ G+     YLH+     IIHRDLK SN+LL      KI+DFG+AR   G   +  T
Sbjct: 116 -QLLRGLQ----YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMT 166

Query: 253 SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
            ++V T  Y +PE  L       + D+++ G +L E+++ K
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           F    ++G G +G VYK   +  G+  A+K +    G+    ++ E  ++   +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 152 LLGCCIDKDEKILIYEYMPNKSLD--FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G  + +D+  +  E+    SL   + +  P     + +V+R  +     QGL YLH  
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK 125

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAL 268
            +   +HRD+K +NILL  + + K++DFG+ A+I       A     +GT  +M+PE A 
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAA 179

Query: 269 ---EGIFSIKSDVFSFGVLLLEI 288
              +G ++   D+++ G+  +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 31/207 (14%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 151
           LG+G FG V    LK+   + AVK L  +    L++   E ++  K        H  L +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           L  C    D    + E++    L F +     FD  +        R    E I   L++L
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-------ARFYAAE-ITSALMFL 112

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 264
           H      II+RDLK  N+LLD + + K++DFGM +  I  G      TS   GT  Y++P
Sbjct: 113 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAP 165

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSG 291
           E   E ++    D ++ GVLL E++ G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG+GGFG V        G +    ++  KR+  R G+ +    NE  ++ KV  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKRILEKVNSRFVVSL 65

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 KD   L+   M    L F +++       D    +     +  GL  L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGI 271
           RI++RDLK  NILLD   + +ISD G+A +I  G  ++      VGT GYM+PE      
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           ++   D +  G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 32/222 (14%)

Query: 83  FSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL------SGRSGQGLREMK 135
           F +V   TN++ D   +G G FG V        G  +A+K++         + +  RE+K
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 136 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
               ++  ++H+N++ L    I   E I     +    L   L   T R L       Q 
Sbjct: 62  ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEK-----QF 109

Query: 196 IE----GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 251
           I+     I +GL Y+H      ++HRDLK SNIL++++ + KI DFG+ARI         
Sbjct: 110 IQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQ 161

Query: 252 TSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
            +  V T  Y +PE  L    + ++ D++S G +  E++ GK
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 16/197 (8%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           ++G G +G VYK   L  G+  AVK +    G     ++ E  ++ + +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 157 IDKDEKILIYEYMPNKSLD--FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
           + +++  +  EY    SL   + +  P   + + +V R  +     QGL YLH   +   
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--- 127

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 271
           +HRD+K +NILL  + + K++DFG+A         A     +GT  +M+PE A     G 
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 272 FSIKSDVFSFGVLLLEI 288
           ++   D+++ G+  +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 20/208 (9%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEASVIAKV 144
           K+    K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ ++
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKEL 56

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +HKN+VRL        +  L++EY  ++ L  + FD +    +D       +  + +GL 
Sbjct: 57  KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FD-SCNGDIDPEIVKSFMFQLLKGLA 113

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           + H +    ++HRDLK  N+L++K+   K++DFG+AR   G  ++  ++ +V T  Y  P
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWYRPP 168

Query: 265 EYALEG-IFSIKSDVFSFGVLLLEIVSG 291
           +      ++S   D++S G +  E+ + 
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 47/224 (20%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGL-------REMKNEASVIA 142
           +++ + + +G G +G V      K    +A+K+LS R  Q         RE++    ++ 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELR----LLK 69

Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ---- 194
            + H+N++ LL              + P  SL    D +L        L+ + + Q    
Sbjct: 70  HMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117

Query: 195 -----IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  I +GL Y+H      IIHRDLK SNI +++D   KI DFG+AR        
Sbjct: 118 DHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----D 169

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
              +  V T  Y +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 55/234 (23%)

Query: 97  NKLGEGGFGPVYKGV-LKKGDEIAVKRL------SGRSGQG------------LREMKNE 137
             LGEG +G V K      G  +A+K++      +  +               LRE+K  
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-- 72

Query: 138 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPTKRMLLDWVTR 192
             ++ +++H+N++ L+   ++ D   L+ + M +   K +D    L +   + +L     
Sbjct: 73  --IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL----- 125

Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN- 251
           +QI+ G+      LH++     +HRDL  +NI ++     KI+DFG+AR  G        
Sbjct: 126 LQILNGLNV----LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 252 ------------TSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
                       TS++V T  Y +PE  +    +    D++S G +  E+++GK
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 9e-14
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMK---NEASVIAKVQH-KNLVRLL 153
           LG G +G V K        I AVKR+  R+    +E K    +  +  +       V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 154 GCCIDKDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           G    + +  +  E M + SLD F   ++D    +  D + ++ +   I + L YLH  S
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKALEYLH--S 121

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV--GTYGYMSPE--- 265
           ++ +IHRD+K SN+L++++   K+ DFG   I G   L  + ++ +  G   YM+PE   
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFG---ISG--YLVDSVAKTIDAGCKPYMAPERIN 176

Query: 266 --YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                +G + +KSDV+S G+ ++E+ +G+
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 11/207 (5%)

Query: 89  ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQH 146
           A   + +  KLGEG +  VYKG+ +  G  +A+K +S ++ +G+      EAS++  ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
            N+V L      K+    ++EYM      + +  P    L  +  R+ + + + +GL Y+
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQ-LLRGLAYI 119

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      I+HRDLK  N+L+      K++DFG+AR       Q  +S +V T  Y  P+ 
Sbjct: 120 H---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPDV 174

Query: 267 ALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            L    +S   D++  G + +E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 66/282 (23%), Positives = 113/282 (40%), Gaps = 27/282 (9%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIA---VKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           +++G G FG V  G   +G   A   VK L   +          E     ++ H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ--IIEGIAQGLLYLHQYS 210
           LG CI+    +L+ E+ P   L  +L      +       V   +   +A GLL+LHQ  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
               IH DL   N  L  D++ KI D+G+A      +             +++PE     
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 271 IFSI-------KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
              +       KS+++S GV + E+ +         +D   +L          + ++L  
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV----VREQDIKLPK 232

Query: 324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           P L+ +YS      R+  +   C  +  + RPT  +V  +LT
Sbjct: 233 PQLDLKYSD-----RWYEVMQFCWLDP-ETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 31/208 (14%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 151
           LG+G FG V    LK  DE+ A+K L  +    L++   + ++  K       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVL--KKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           L  C   KD    + EY+    L F +     FD  +       +R    E +   L++L
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR-------SRFYAAE-VTLALMFL 112

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 264
           H++    +I+RDLK  NILLD + + K++DFGM +  I  G      T+   GT  Y++P
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAP 165

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E   E  +    D ++ GVL+ E+++G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 38/211 (18%)

Query: 99  LGEGGFGPV----YKG--------VLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 146
           LG G FG V    YK          LKKGD IA   +     + L   K         +H
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-----ESLMCEKRIFETANSERH 61

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSL------DFFLFDPTKRMLLDWVTRVQIIEGIA 200
             LV L  C   +D    + EY     L      D F      R +  +   V +     
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVF-YAACVVL----- 112

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
            GL YLH+    +I++RDLK  N+LLD +   KI+DFG+ +   G      TS   GT  
Sbjct: 113 -GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPE 166

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE   E  ++   D +  GVL+ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 31/202 (15%)

Query: 102 GGFGPVYKGVLKK---GDEIAVKRLSGRSGQGLREMKN----EASVIAKVQHKNLVRLLG 154
           G FG VY  + KK   GD  A+K L         ++ N     A ++ + +   + +L  
Sbjct: 7   GAFGSVY--LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRML----LDWVTRVQIIEGIAQGLLYLHQYS 210
               KD   L+ EY+        +     + L     DW    Q I  +  G+  LHQ  
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG 117

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
              IIHRD+K  N+L+D+  + K++DFG++R    N+      + VGT  Y++PE  + G
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILG 167

Query: 271 IFSIK-SDVFSFGVLLLEIVSG 291
           +   K SD +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASVIAKVQ---HKNLV 150
           ++G G +G VYK      G  +A+K +   +   G  L  ++ E +++ +++   H N+V
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65

Query: 151 RLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           RL+  C     D++ K+ L++E++      +    P   +  + +    ++    +GL +
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V T  Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPE 177

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
             L+  ++   D++S G +  E+   K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQH 146
           F   ++LG G  G V K   K    I  ++L           Q +RE++    V+ +   
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECNS 62

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             +V   G      E  +  E+M   SLD  L +  KR+  + + +V I   + +GL YL
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI--AVLRGLAYL 119

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
            +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSPE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
                +S++SD++S G+ L+E+  G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 27/206 (13%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 151
           LG+G FG V    LK  +E  A+K L  +    L +   E +++ +       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKAL--KKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           L      K+    + EY+    L F +     FD  +        R    E I  GL +L
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAE-IICGLQFL 112

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H+     II+RDLK  N+LLDKD + KI+DFGM +     E +A+T    GT  Y++PE 
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEI 167

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
                ++   D +SFGVLL E++ G+
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 257
           IA GL +LH      II+RDLK  N++LD + + KI+DFGM   C  N     T+R   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCG 163

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKR-LSGRSGQGLREMK-NEASVIAKVQHK 147
            K+ +   +GEG +G V K   K+  +I A+K+ L     + ++++   E  ++ +++H+
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           NLV L+     K    L++E++ +  LD     P     LD     + +  I +G+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 266
            ++   IIHRD+K  NIL+ +    K+ DFG AR +    E+  +    V T  Y +PE 
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPEL 171

Query: 267 ALEGI-FSIKSDVFSFGVLLLEIVSG 291
            +    +    D+++ G L+ E+++G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 16/196 (8%)

Query: 99  LGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGL-REMKNEASVIAKVQHKNLVRLLGCC 156
           LG G  G VYK   L     +AVK +       L +++ +E  ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             ++   +  E+M   SLD +     +++    + R+ +   + +GL YL     ++I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLWS---LKILH 118

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K SN+L++     K+ DFG++       + +     VGT  YM+PE      + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 277 DVFSFGVLLLEIVSGK 292
           DV+S G+  +E+  G+
Sbjct: 175 DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)

Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  V   G  +A+K+LS R  Q +   K    E 
Sbjct: 10  STFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-RPFQNVTHAKRAYREL 66

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK----RML 186
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 67  VLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMD 114

Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171

Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 172 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 157
           +G G +G VYKG   K  ++A  ++   +     E+K E +++ K   H+N+    G  I
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 158 DK------DEKILIYEYMPNKSLDFFLFDPTKRMLL--DWVTRVQIIEGIAQGLLYLHQY 209
            K      D+  L+ E+    S+   L   TK   L  DW+    I   I +GL +LH +
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 268
              ++IHRD+K  N+LL ++   K+ DFG++        + NT   +GT  +M+PE    
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIAC 195

Query: 269 ----EGIFSIKSDVFSFGVLLLEIVSG 291
               +  +  +SD++S G+  +E+  G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    I  ++L           Q +RE++    V+ + 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 117

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ------GLREMKNEASVIAKV 144
           K+   +K+GEG +G V+K   ++ G  +A+K+              LRE++    ++ ++
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQL 57

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H NLV L+     K +  L++EY  +  L+    +P     +      +II    Q + 
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVN 114

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           + H+++    IHRD+K  NIL+ K    K+ DFG ARI  G     + +  V T  Y +P
Sbjct: 115 FCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAP 169

Query: 265 EYALEG--IFSIKSDVFSFGVLLLEIVSG 291
           E  L G   +    DV++ G +  E+++G
Sbjct: 170 EL-LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE-IAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +KLGEG +  VYKG  K  D  +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                +    L++EY+ +K L  +L D    + +  V     +  + +GL Y H   R +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLNYCH---RRK 124

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGI- 271
           ++HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L    
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +S + D++  G +  E+ +G+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.4 bits (167), Expect = 8e-13
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 99  LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 151
           LG+G FG V    LK KG+  AVK L  +    L +   E +++ K       ++  L  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKAL--KKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L      K+    + E++    L F + D  +    D          I  GL +LH    
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYALEG 270
             II+RDLK  N++LD+D + KI+DFGM   C  N    N  S   GT  Y++PE     
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            ++   D +SFGVLL E++ G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 44/276 (15%)

Query: 99  LGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH-KNLVRLL 153
           +G G  G VYK    K G  +AVK++  R+G    E K    +  V+ K      +V+  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNK-EENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYL---HQ 208
           G  I   +  +  E M +  LD  L    KR+       +  ++   I + L YL   H 
Sbjct: 81  GYFITDSDVFICMELM-STCLDKLL----KRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY- 266
                +IHRD+K SNILLD   N K+ DFG++ R+    + +A T R  G   YM+PE  
Sbjct: 136 -----VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERI 186

Query: 267 ---ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
                   + I++DV+S G+ L+E+      TG +   +        +     + L+   
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELA-----TGQFPYKNCKT-----EFEVLTKILQEEP 236

Query: 324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMND 359
           P L            +V+   LC+ +    RP   +
Sbjct: 237 PSLPPNEGFSPDFCSFVD---LCLTKDHRKRPKYRE 269

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 35/225 (15%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK----------------NEASVIA 142
           LG+G FG V+           V++++G     L  MK                 E  ++A
Sbjct: 4   LGQGSFGKVF----------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA 53

Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           +V H  +V+L      + +  LI +++  +  D F     + M  +   +  + E +A  
Sbjct: 54  EVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALA 110

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           L +LH    + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165

Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLL 306
           +PE       +  +D +SFGVL+ E+++G     G  R +++ ++
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE-IAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
            KLGEG +  V+KG  K  +  +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                     L++EY+ +K L  ++ D    M +  V     +  I +GL Y H   R +
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVK--IFLYQILRGLAYCH---RRK 124

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAL-EGI 271
           ++HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L    
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +S + D++  G +  E+ SG+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 84/312 (26%), Positives = 136/312 (43%), Gaps = 46/312 (14%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 147
           + +    KLGEG +  VYKG  K  G  +A+K  RL    G     ++ EAS++  ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFF------LFDPTKRMLLDWVTRVQIIEGIAQ 201
           N+V L      K+   L++EY+      +       L     ++ L  + R         
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR--------- 114

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYG 260
           GL Y+HQ     I+HRDLK  N+L+      K++DFG+AR      + ++T S  V T  
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLW 168

Query: 261 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYR--TDSLN----LLGYA-WDL 312
           Y  P+  L    +S   D++  G + +E++ G       +   D L     +LG    D 
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228

Query: 313 WTSNRTLELIDPILEDEYSSKHML-----LRYVN----IALLCVQESADDRPTMNDVVSM 363
           W    +L    P     YS K++      L YVN    +A   +Q    +R +     + 
Sbjct: 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ---AA 285

Query: 364 LTNEAAALLPPK 375
           L++E  + LPP+
Sbjct: 286 LSHEYFSDLPPR 297

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ------GLREMKNEASVIAK 143
           NKF     +GEG +G V K   K+  EI A+K+              LRE+K    ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           ++ +N+V L      + +  L++EY+    L+     P        V   ++   I Q +
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG------VPPEKVRSYIYQLI 110

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYM 262
             +H   +  I+HRD+K  N+L+  +   K+ DFG AR +  G+   AN +  V T  Y 
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYR 168

Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           SPE  L   +    D++S G +L E+  G+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 51/226 (22%)

Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQH 146
           + + + +GEG +G V     K  G ++A+K++S    Q      LRE+K    ++ + +H
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKH 62

Query: 147 KNLVRLLGCCIDKD-----EKILIYEYMP-------------NKSLDFFLFDPTKRMLLD 188
           +N++ +L            +  ++ E M              N  + +FL+         
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY--------- 113

Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
                QI+    +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+ARI      
Sbjct: 114 -----QIL----RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161

Query: 249 QANT-SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L      K+ D++S G +L E++S +
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 92  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHK 147
           +++   ++G G +G V   +  + G+++A+K+LS R  Q     +    E +++  +QH+
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVT-------RVQ-IIEGI 199
           N++ LL    D     +  +       DF+L  P  +  L  +        +VQ ++  +
Sbjct: 75  NVIGLL----DVFTSAVSGDEFQ----DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
             GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR        A  +  V T 
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTR 178

Query: 260 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
            Y +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 21/147 (14%)

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166

Query: 267 ALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
             +G+ +   +D FS G +L +++ G      ++T   +           +R    +   
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------EIDRMTLTMAVE 217

Query: 326 LEDEYSS------KHMLLRYVNIALLC 346
           L D +S       + +L R VN  L C
Sbjct: 218 LPDSFSPELRSLLEGLLQRDVNRRLGC 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLS-------RPFQNQTH-- 66

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK----RMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125

Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)

Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEA 138
           +    S+   T+ +     +G+G +G VYK   KK G   AVK L   S     E++ E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 139 SVIAKV-QHKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKR-MLLDWVT 191
           +++  +  H N+V+  G     D+ +     L+ E     S+   +         LD   
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 192 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 251
              I+ G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++       L+ N
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186

Query: 252 TSRIVGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSG 291
           TS  VGT  +M+PE        +  +  + DV+S G+  +E+  G
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++     +G G  G V   +  VL  G  +AVK+LS       R  +N+    
Sbjct: 15  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-------RPFQNQTH-- 63

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK----RMLLDW 189
           AK  ++ LV LL C   K+   L+  + P KSL+ F        L D        M LD 
Sbjct: 64  AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH 122

Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N + 
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E+V G
Sbjct: 180 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 36/211 (17%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVR---- 151
           +G+G +G V     +  G +  +K+L+ R  S +  +  + EA ++++++H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 152 ----------LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
                     ++G C   D    +Y  +  +          +  +++W  +      IA 
Sbjct: 68  WEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP----ENQVVEWFVQ------IAM 113

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH+     I+HRDLK  N+ L +    K+ D G+AR+       A+T  ++GT  Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           MSPE      ++ KSDV++ G  + E+ + K
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.0 bits (162), Expect = 6e-12
 Identities = 61/234 (26%), Positives = 106/234 (45%), Gaps = 63/234 (26%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS--------GRSGQGLREMKNEASVIA 142
           ++     +G G +G V   V K+ G ++A+K++S         +  + LRE+K    ++ 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK--RILREIK----LLR 54

Query: 143 KVQHKNLVRLLGCCIDKDEK-----ILIYEYMP---------NKSLD-----FFLFDPTK 183
            ++H+N++ LL        +      ++ E M           + L      +FL+    
Sbjct: 55  HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY---- 110

Query: 184 RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 243
                     QI+    +GL YLH      +IHRDLK SNIL++ + + KI DFG+AR  
Sbjct: 111 ----------QIL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153

Query: 244 GGNELQAN--TSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGK 292
             +E +    T  +V T  Y +PE  L       +I  D++S G +  E+++ K
Sbjct: 154 DPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 38/94 (40%), Positives = 59/94 (62%), Gaps = 7/94 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIV 256
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR    +   ++   +R+ 
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               +M+PE   + +++ +SDV+SFGVLL EI S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 65.7 bits (161), Expect = 8e-12
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 46/220 (20%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEI-AVKRLSG------------RSGQGLREMKNEASVIAK 143
            KLG+G +G V+K + ++  E+ A+K++              R    L+E+ +       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65

Query: 144 VQHKNLVRLLGCC-IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
             H N+V+LL     + D+ I L++EYM     +  L    +  +L+ V +  I+  + +
Sbjct: 66  --HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLK 118

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANT--SRIVGT 258
            L Y+H  S   +IHRDLK SNILL+ D   K++DFG+AR +    E   N   +  V T
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 259 YGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGK 292
             Y +PE  L      +G+     D++S G +L E++ GK
Sbjct: 176 RWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 41/233 (17%)

Query: 92  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHK 147
           ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  ++  ++H+
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ--------- 194
           N++ LL              + P +SL    D +L        L+ + + Q         
Sbjct: 77  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 125 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176

Query: 255 IVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 306
            V T  Y +PE  L  + ++   D++S G ++ E+++G+  T    TD ++ L
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.5 bits (157), Expect = 8e-12
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 99  LGEGGFGPVYKGVLKK-GD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           LG+G F  ++KG+ ++ GD       E+ +K L              AS+++++ HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
              G C+  DE I++ EY+   SLD +L      + + W  ++++ + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 211 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 262
              + H ++ A N+LL      K  NP   K+SD G++      E+     RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171

Query: 263 SPEYALEG-IFSIKSDVFSFGVLLLEIVSG 291
            PE        S+ +D +SFG  L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 51/231 (22%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKR----LSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
            +G+GG G VY          +A+K+    LS       R ++ EA + A + H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADLIHPGIVPV 67

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-----------------TRVQI 195
              C D D    +Y  MP      ++   T + LL  V                   + I
Sbjct: 68  YSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQA 250
              I   + Y+H  S+  ++HRDLK  NILL       I D+G A      E     +  
Sbjct: 119 FHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 251 NTS-----------RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +             +IVGT  YM+PE  L    S  +D+++ GV+L ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 137 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           EA ++  V H +++R+    +      ++   +P+ S D + +   +   L     + I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
           + I +GL YLH     RIIHRD+K  NI ++      I D G A+      +      + 
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           GT    +PE      ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)

Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLS-------RPFQNQTH-- 59

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK----RMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 60  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH 118

Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 176 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 31/214 (14%)

Query: 99  LGEGGFGPVYKGVLK---------KGDEIAVKR-LSGRSGQGLREMKNEASVIAKVQHKN 148
           LG+G F  +YKGVL+          G E++V   + G   +        AS+++++ HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           LV+L G C+ +DE I++ EY+    LD FL      + L W  ++ + + +A  L YL  
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 209 YSRVRIIHRDLKASNILLDK-DMNP------KISDFGMARICGGNELQANTSRIVGTYGY 261
               +++H ++   NIL+ +  +N       K+SD G+       E +    RI     +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER--VERI----PW 170

Query: 262 MSPEYALEGIFSIKS--DVFSFGVLLLEIVSGKK 293
           ++PE    G  S+    D +SFG  LLEI S  +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +GEG FG          D+  A+K +   +S   + + + EA ++AK++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
                  ++ EY     L   +         +  +L W  +      +  G+ ++H+   
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
            R++HRD+K+ NI L ++   K+ DFG AR+       A T   VGT  Y+ PE      
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           ++ KSD++S G +L E+ + K
Sbjct: 177 YNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 13/198 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 153
           +G+G FG V     K   +  AVK L  ++    +E K+   E +V+ K V+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                 D+   + +Y+    L F L    +R   +   R    E IA  L YLH    + 
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---LN 116

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           II+RDLK  NILLD   +  ++DFG+ +   G E    TS   GT  Y++PE   +  + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 274 IKSDVFSFGVLLLEIVSG 291
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLL 153
           +G G +  V    LKK + I     VK+      + +  ++ E  V  +   H  LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            C   +     + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 116

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 274 IKSDVFSFGVLLLEIVSGK 292
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 92  KFSDAN---KLGEGGFGPVYKGVLKKGD--EIAVKRLSG----RSGQGLREMKNEASVIA 142
           K+ D N    LG G FG V     K  D   +A+KR       +  Q +  + +E  ++ 
Sbjct: 28  KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-VDHVFSERKILN 86

Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
            + H   V L G   D+    L+ E++     +FF F    +   + V         AQ 
Sbjct: 87  YINHPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFYA----AQI 140

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           +L       + I++RDLK  N+LLDKD   K++DFG A++     +   T  + GT  Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYI 195

Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +PE  L       +D ++ G+ + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G G +  V    LKK D+I     VK+      + +  ++ E  V  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 155 CCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            C     ++ L+ EY+    L F +    +R L +   R    E I   L +LH+     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           II+RDLK  N+LLD D + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 274 IKSDVFSFGVLLLEIVSGK 292
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 42/227 (18%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           ++ D   LG G  G V+  V    D+ +AVK++     Q ++    E  +I ++ H N+V
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 151 RLLGCCIDKDEKILIYEYMPNKS--LDFFLFDPTK-------RMLLDWVTRVQIIEG--- 198
           +             +YE +      L   +   T+       +  ++      + +G   
Sbjct: 66  K-------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLS 112

Query: 199 ----------IAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGN- 246
                     + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   + 
Sbjct: 113 EEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
             +   S  + T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 36/95 (37%), Positives = 57/95 (60%), Gaps = 7/95 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 257
           I+ GL +LH   R  II+RDLK  N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCG 163

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y++PE      +    D +++GVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 39/94 (41%), Positives = 60/94 (63%), Gaps = 7/94 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 256
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR      + ++   +R+ 
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVK--RLS----GRSGQGLREMKNEASVIAKVQHKN-L 149
           K+GEG +G VYK      G  +A+K  RL     G     LRE+    S++  +     +
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI----SLLQMLSESIYI 63

Query: 150 VRLLGC--CIDKDEKILIY---EYMPN---KSLDFFLFDPTKRMLLDWVTRV--QIIEGI 199
           VRLL      +K+ K  +Y   EY+ +   K +D     P + +    +     Q+++G+
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGT 258
           A    + H++    ++HRDLK  N+L+DK     KI+D G+ R      +++ T  IV T
Sbjct: 124 A----HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV-T 174

Query: 259 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 291
             Y +PE  L    +S   D++S G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 97  NKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMKNEASVIA--KVQ-HKNLVRL 152
            K+GEG F  V K    K G   A+K +     + L ++ N   + A  ++  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 153 LGCCIDKDEKIL----------IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           +    D+    L          +YE +  +        P KR+   ++   Q++    + 
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPL----PEKRVKS-YMY--QLL----KS 112

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           L ++H   R  I HRD+K  NIL+  D   K++DFG  R  G       T  I  T  Y 
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYR 165

Query: 263 SPEYAL-EGIFSIKSDVFSFGVLLLEIVS 290
           +PE  L +G +  K D+++ G +  EI+S
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 97  NKLGEGGFGPVYKGVLK-KGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +KLGEG +  V+KG  K   + +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                +    L++EY+ +  L  +L +    M +  V ++ + + + +GL Y H   + +
Sbjct: 70  DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNV-KIFMFQ-LLRGLSYCH---KRK 123

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGI- 271
           I+HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L    
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +S   D++  G +L E+ +G+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 257
           IA GL +LH      II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCG 163

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 27/226 (11%)

Query: 83  FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVI 141
           F S    ++ +     +G+G +G V+K + KK G + AVK L         E++ E +++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68

Query: 142 -AKVQHKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKRML-----LDWV 190
            A   H N+V+  G    KD K      L+ E     S+     D  K  L     ++  
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEP 124

Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
               I+     GL +LH     + IHRD+K +NILL  +   K+ DFG++       L+ 
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 251 NTSRIVGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSG 291
           NTS  VGT  +M+PE       L+  +  + DV+S G+  +E+  G
Sbjct: 182 NTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 51/225 (22%)

Query: 92  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---------SGRSGQGLREMKNEASVI 141
           ++ D  ++G G +G V   +  + G ++A+K+L         + R+ + LR +K+     
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----- 70

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD----FFLFDP------TKRMLLDWVT 191
             ++H+N++ LL              + P+ SLD    F+L  P       K M  + ++
Sbjct: 71  --MKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS 116

Query: 192 --RVQ-IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
             R+Q ++  + +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     + 
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QT 168

Query: 249 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            +  +  V T  Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 9/149 (6%)

Query: 98  KLGEGGFGPVYKGVLKKG---DEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLL 153
           ++G G FG V  G +  G    ++ VK L   +  Q   +   EA     +QH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLL--DWVTRVQIIEGIAQGLLYLHQYSR 211
           G C +    +L+ E+ P   L  +L    K  L+  D  T  ++   IA GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMA 240
              IH DL   N LL  D+  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 38/94 (40%), Positives = 60/94 (63%), Gaps = 7/94 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 256
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR      + ++  ++R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               +M+PE   + +++ +SDV+SFGVLL EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)

Query: 83  FSSVSTATNKFSD---ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN-- 136
           F+   T++ K SD      LG G FG V     K  G+  A+K L  R    ++++++  
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66

Query: 137 -EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
            E S++ ++ H  +V ++    D++    + E++    L F       R   D V +   
Sbjct: 67  QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPND-VAKFYH 124

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
            E +     YLH      II+RDLK  N+LLD   + K++DFG A+     ++   T  +
Sbjct: 125 AE-LVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTL 175

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            GT  Y++PE           D ++ GVLL E ++G
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 7/98 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 256
           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 294
               +M+PE   + +++++SDV+S+G+LL EI S  K+
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 98  KLGEGGFGPVYKGVLK-KGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           KLGEG +  VYKG  K  G  +A+K  RL    G     ++ EAS++  ++H N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVT--RVQIIEGIAQGLLYLHQYSRV 212
               K    L++EY+ +  L  ++ D    + +  V     Q++ G+A    Y HQ    
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA----YCHQR--- 122

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGI 271
           R++HRDLK  N+L+ +    K++DFG+AR      + + T S  V T  Y  P+  L   
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 272 -FSIKSDVFSFGVLLLEIVSG 291
            +S   D++  G +  E+ +G
Sbjct: 180 EYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 99  LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 153
           +G+G FG V     K  G   AVK L  ++    +E  +   E +V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                 ++   + +Y+    L F L    +R  L+   R    E +A  + YLH    + 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---LN 116

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           II+RDLK  NILLD   +  ++DFG+ +   G E +  TS   GT  Y++PE   +  + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 274 IKSDVFSFGVLLLEIVSG 291
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 97  NKLGEGGFGPVYKGVLKK--GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           ++LG+G +G VYK VL +  G  +A+K  RL     +   ++  E  ++ K     +V  
Sbjct: 7   DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDF 64

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            G    +    +  EYM   SLD           +      +I   + +GL +L +    
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYALEG- 270
            IIHRD+K +N+L++ +   K+ DFG++    GN L A+ ++  +G   YM+PE    G 
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GN-LVASLAKTNIGCQSYMAPERIKSGG 177

Query: 271 -----IFSIKSDVFSFGVLLLEIVSGK 292
                 ++++SDV+S G+ +LE+  G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 33/86 (38%), Positives = 56/86 (65%), Gaps = 6/86 (6%)

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166

Query: 267 ALEGI-FSIKSDVFSFGVLLLEIVSG 291
             +G  +   +D FS G +L +++ G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 8/156 (5%)

Query: 137 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           E+ V+   +H  L  L      KD    + EY+    L F L    +R+  +  TR    
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGA 102

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
           E I   L YLH     +I++RDLK  N++LDKD + KI+DFG+ +   G    A      
Sbjct: 103 E-IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFC 156

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           GT  Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 13/97 (13%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274

Query: 259 YG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                  +M+PE     +++ +SDV+S+G+LL EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 39/219 (17%)

Query: 92  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHK 147
           ++ +   +G G +G V      +   ++AVK+LS R  Q L   R    E  ++  ++H+
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHE 74

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFF--LFDPTKRMLLDWVTRVQ----------- 194
           N++ LL              + P  S++ F  ++  T  M  D    V+           
Sbjct: 75  NVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           +I  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     + 
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174

Query: 255 IVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 7/102 (6%)

Query: 192 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 251
           RV I E I   L +LHQ   + II+RD+K  NILLD + +  ++DFG+++     E +  
Sbjct: 108 RVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 252 TSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 291
            S   GT  YM+PE    G        D +S GVL  E+++G
Sbjct: 164 YS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           I +GL YLH      I+HRD+K  N+L++ +   KI DFG+AR+   +E +  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 259 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 292
           Y Y +PE  L G   ++   D++S G +  E++  +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 99  LGEGGFGPVYKGVLK-----KGDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNL 149
           LG+GG+G V++ V K      G   A+K L      R+ +     K E +++  V+H  +
Sbjct: 4   LGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           V L+       +  LI EY+    L  F+    + + ++      + E I+  L +LHQ 
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE-ISLALEHLHQQ 119

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYA 267
               II+RDLK  NILLD   + K++DFG+ +  I  G      T    GT  YM+PE  
Sbjct: 120 G---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEIL 172

Query: 268 LEGIFSIKSDVFSFGVLLLEIVSG 291
           +        D +S G L+ ++++G
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMK---NEASVIAK-VQHKNLVRL 152
           +G+G FG V      K +E   AVK L  ++    +E K   +E +V+ K V+H  LV L
Sbjct: 3   IGKGSFGKVLLA-RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                  D+   + +Y+    L + L    +R  L+   R    E IA  L YLH    +
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 115

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 271
            I++RDLK  NILLD   +  ++DFG+   C  N E    TS   GT  Y++PE   +  
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 272 FSIKSDVFSFGVLLLEIVSG 291
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 34/198 (17%)

Query: 115 GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLL--GCCIDKDEKILIYEYM 169
           G E+A+K L   + +   +      E ++ A++ H N+V LL  G          ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61

Query: 170 PNKSLDFFLFD-------PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 222
           P ++L   L          T R++L      Q+++ +A        +++  I+HRDLK  
Sbjct: 62  PGRTLREVLAADGALPAGETGRLML------QVLDALA------CAHNQ-GIVHRDLKPQ 108

Query: 223 NILL---DKDMNPKISDFGMARICGG----NELQAN-TSRIVGTYGYMSPEYALEGIFSI 274
           NI++       + K+ DFG+  +  G    +      T+ ++GT  Y +PE       + 
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 275 KSDVFSFGVLLLEIVSGK 292
            SD++++G++ LE ++G+
Sbjct: 169 NSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 52.7 bits (127), Expect = 2e-09
 Identities = 20/48 (41%), Positives = 30/48 (62%), Gaps = 2/48 (4%)

Query: 366 NEAAALLPPKQPAFSFVRNTV--TSTSSTGKTEDCSVNQVTISILEAR 411
           +E   +  PKQP F   R+     S+SST + E  +VNQVT+S+++AR
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 2/94 (2%)

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTY 259
           Q LL +H      +IHRD+K++NILL  +   K+ DFG +++     +  +  R   GT 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGTP 209

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 293
            Y++PE      +S K+D+FS GVLL E+++ K+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 31/208 (14%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQ-----------H 146
           +G G +  V    LKK   I A+K +        +E+ N+   I  VQ           H
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIK-------KELVNDDEDIDWVQTEKHVFETASNH 55

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV L  C   +     + E++    L F +    +R L +   R    E I+  L +L
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNFL 112

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 264
           H+     II+RDLK  N+LLD + + K++D+GM +  I  G+     TS   GT  Y++P
Sbjct: 113 HERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAP 165

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +    D ++ GVL+ E+++G+
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 58.6 bits (141), Expect = 3e-09
 Identities = 67/239 (28%), Positives = 113/239 (47%), Gaps = 48/239 (20%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKN-----EASVIAKV 144
           N++    K+G G FG V+    K+  E    K +S R   GL+E +      E +V+ ++
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR---GLKEREKSQLVIEVNVMREL 69

Query: 145 QHKNLVRLLGCCIDK-DEKILI-YEYMPNKSLD------FFLFDPTKRMLLDWVTRVQII 196
           +HKN+VR +   ++K ++K+ I  E+     L       + +F   +   +  +TR Q++
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLL 128

Query: 197 EGIAQGLLYLHQY----SRVRIIHRDLKASNILLD-------------KDMN----PKIS 235
             +A    Y H      +  R++HRDLK  NI L               ++N     KI 
Sbjct: 129 HALA----YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI--KSDVFSFGVLLLEIVSGK 292
           DFG+++  G   +++     VGT  Y SPE  L    S   KSD+++ G ++ E+ SGK
Sbjct: 185 DFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 32/229 (13%)

Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ 145
           +  +T +F   + LGEG FG V +   +K  E    ++     +  R+ K E   + KV+
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTR---------VQI 195
             +         D+   + I  Y  N++    +  P     LLDW+ +          QI
Sbjct: 184 QADPA-------DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI 236

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKIS-----DFGMARIC--GG 245
           I      L Y H  + + ++H DLK  NIL+   D  ++P  +     D    RIC  GG
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 246 --NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +E  + T+ IV T  Y SPE  L   +   +D++S G ++ E+ +GK
Sbjct: 295 CCDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 17/194 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           L  G  G V+  V  K  +   K++  ++  G +    E  ++  + H+ ++ L+     
Sbjct: 100 LTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW 157

Query: 159 KDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
           K    ++   MP    D F + D +  + L+    +Q    + + L YLH      IIHR
Sbjct: 158 KSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQ--RRLLEALAYLHGRG---IIHR 209

Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM---SPEYALEGIFSI 274
           D+K  NI LD+  N  + DFG A  C  +    +T +  G  G +   SPE      +  
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAA--CKLDA-HPDTPQCYGWSGTLETNSPELLALDPYCA 266

Query: 275 KSDVFSFGVLLLEI 288
           K+D++S G++L E+
Sbjct: 267 KTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 57/234 (24%)

Query: 99  LGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKNEASVIA----KVQHKN--LV 150
           +G G FG V+  V  K      A+K L       + +    A V A         +  +V
Sbjct: 9   IGRGAFGEVWL-VRDKDTGQVYAMKVLRKSD---MIKRNQIAHVRAERDILADADSPWIV 64

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG------IAQGLL 204
           +L     D++   L+ EYMP   L            ++ + R  +         IA+ +L
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVL 112

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA------------------RICGGN 246
            L    ++  IHRD+K  NIL+D D + K++DFG+                    +   N
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 247 ELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            L                VGT  Y++PE      + ++ D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 13/198 (6%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 153
           +G+G FG V     K  G   AVK L  +     +E K+   E +V+ K V+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                 ++   + +++    L F L    +R   +   R    E IA  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---IN 116

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           I++RDLK  NILLD   +  ++DFG+ +   G      T+   GT  Y++PE   +  + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 274 IKSDVFSFGVLLLEIVSG 291
              D +  G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQAN-TSRIV 256
           + +GL Y+H      +IHRDLK SN+L+++D   +I DFGMAR +           +  V
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 257 GTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV 289
            T  Y +PE  L    ++   D++S G +  E++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           I   L YLH      +++RDLK  N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN--ELQANTSRIV 256
           I  GL Y+H      ++HRDLK  N+L++ D   KI DFG+AR    N  E     +  V
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 257 GTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
            T  Y +PE  L      K+ DV+S G +L E++  K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN--TSRIV 256
           IA+ +L L    +  I++RDLK  NILLD   +  + DFG+++      L  N  T+   
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFC 157

Query: 257 GTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 291
           GT  Y++PE  L E  ++   D +S GVL+ E+  G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 2/93 (2%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++   ++ + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             Y++PE  L   ++   D ++ GVLL E+++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 12/169 (7%)

Query: 137 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           EA ++  + H ++++L G         LI   +P    D + +   KR +      + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI-AICDILAIE 188

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-I 255
             + + + YLH+    RIIHRD+KA NI ++   +  + DFG A  C   ++ AN     
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYYGW 243

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 304
            GT    +PE      +    D++S G++L E+ +   +  L+  D L+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS--LFEKDGLD 290

Length = 391

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 36/151 (23%), Positives = 56/151 (37%), Gaps = 15/151 (9%)

Query: 94  SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV--R 151
           S    L  G    VY    K  D   +K    R     RE   E +++  +  K L   +
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPK 57

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           +L          L+ E++  ++LD           +    +  I E +A+ L  LHQ   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPL 107

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           + + H DL   NIL+D      I D+  A  
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 61/244 (25%), Positives = 114/244 (46%), Gaps = 35/244 (14%)

Query: 98  KLGEGGFGPVYKGVLKKGDE---IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           K+G G +G VYK   K G +    A+K++ G +G  +   + E +++ +++H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-TGISMSACR-EIALLRELKHPNVISLQK 65

Query: 155 CCIDK-DEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY-----LH 207
             +   D K+ L+++Y  +       F    +        VQ+  G+ + LLY     +H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 122

Query: 208 QYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYM 262
                 ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ Y 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 263 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSL----NLLG 307
           +PE  L      K+ D+++ G +  E+++ +          K +  Y  D L    N++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242

Query: 308 YAWD 311
           +  D
Sbjct: 243 FPAD 246

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 8/156 (5%)

Query: 137 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           E+ V+   +H  L  L       D    + EY     L F L    +R+  +   R    
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGA 102

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
           E I   L YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      
Sbjct: 103 E-IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           GT  Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 28/184 (15%)

Query: 121 KRLSGRSGQGLR---EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE---YMPNKSL 174
           + ++ R   G R   +++NE   + ++ H+N++++        E+IL  E   YM  +  
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKY 245

Query: 175 DFFL--------FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL 226
           DF L        FD   R LL   TR  I++ +   + Y+H     ++IHRD+K  NI L
Sbjct: 246 DFDLYSFMYDEAFDWKDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300

Query: 227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 286
           + D    + DFG A +    E +A     VGT    SPE      +   +D++S G++LL
Sbjct: 301 NCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359

Query: 287 EIVS 290
           +++S
Sbjct: 360 DMLS 363

Length = 501

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 22/171 (12%)

Query: 131 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEK----ILIYEYMPNKSLDFFLFDPTKRML 186
           +   +NE   + ++   N++++ G  ID  +      LI EY     L   L    K   
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKD 118

Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           L + T++ +     +GL  L++Y+     +++L + + L+ ++   KI       IC G 
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKI-------ICHGL 169

Query: 247 E--LQANTSRIVGTYGYMSPEYALEGIFS---IKSDVFSFGVLLLEIVSGK 292
           E  L +   + V    Y S +  L  IFS   IK D++S GV+L EI +GK
Sbjct: 170 EKILSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           I   L YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 257
           +A+G+ +L   +    +HRDL A N+LL +    KI DFG+AR I   +   +  S  + 
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
              +M+PE   + +++  SDV+S+G+LL EI S
Sbjct: 303 V-KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE----MKNEASVIAKVQ 145
             F   + +G G FG V     K  GD  A+K +  +S    +E     + E  +++   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSISN 59

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQG 202
              + +L     DKD   L+ EY P   L   L    D     +  +         +A+ 
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--------LAEL 111

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           +L +H   ++  +HRD+K  N+L+D+  + K++DFG A     N+   N+   VGT  Y+
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYI 170

Query: 263 SPEY------ALEGIFSIKSDVFSFGVLLLEIVSGK 292
           +PE         +G + ++ D +S GV+  E++ G+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 50/235 (21%)

Query: 99  LGEGGFGPVYKGVLKK--GDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG V + V KK  G   A+K+L         Q +  ++ E  ++A+  +  +V+L
Sbjct: 9   IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKL 66

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                D++   LI EY+P   +   L    K    +  TR  I E I    L +    ++
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI----LAIDSIHKL 120

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGM------------ARICGGNELQANTSRI----- 255
             IHRD+K  N+LLD   + K+SDFG+             RI            I     
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 256 -------------------VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
                              VGT  Y++PE  L+  ++ + D +S GV++ E++ G
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 33/100 (33%), Positives = 60/100 (60%), Gaps = 8/100 (8%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 257
           +A+ +L +    ++  +HRD+K  N+LLDK+ + +++DFG   R+     +Q+N +  VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165

Query: 258 TYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 30/208 (14%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG V     K   ++ A+K LS      RS         E  ++A    + +V+L
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQL 108

Query: 153 LGCCIDKDEKIL--IYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
                 +D+K L  + EYMP   L   + +   P K     W  R    E +   L  +H
Sbjct: 109 --HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----W-ARFYTAE-VVLALDAIH 159

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
                  IHRD+K  N+LLDK  + K++DFG       N +       VGT  Y+SPE  
Sbjct: 160 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVL 215

Query: 268 L----EGIFSIKSDVFSFGVLLLEIVSG 291
                +G +  + D +S GV L E++ G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 10/97 (10%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           + +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+AR    +E     +  V T
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171

Query: 259 YGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 292
             Y +PE  L   E   +I  DV+S G +  E++  K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 46/218 (21%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--NEASVIAK---VQHKNLVRLL 153
           LG G +G V+           V+++SG     L  MK   +A+++ K    +H    R +
Sbjct: 8   LGTGAYGKVF----------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVT-----------------RVQII 196
              I +   ++   Y        F  D    ++LD++                   VQI 
Sbjct: 58  LEHIRQSPFLVTLHYA-------FQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110

Query: 197 EG-IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
            G I   L +LH   ++ II+RD+K  NILLD + +  ++DFG+++    +E++   S  
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-F 166

Query: 256 VGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSG 291
            GT  YM+P+     +G      D +S GVL+ E+++G
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 98  KLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           K+G G +G VYK   K G    E A+K++ G +G  +   + E +++ +++H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-TGISMSACR-EIALLRELKHPNVIALQK 65

Query: 155 CCID-KDEKI-LIYEYMPNKSLDFFLFDPT-----KRMLLDWVTRVQIIEGIAQGLLYLH 207
             +   D K+ L+++Y  +       F        K M L       ++  I  G+ YLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 208 QYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYM 262
                 ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ Y 
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 263 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
           +PE  L      K+ D+++ G +  E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 61/258 (23%), Positives = 101/258 (39%), Gaps = 77/258 (29%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDE---IAVKRLSGRSGQGLRE-----MKNEASVIAKV 144
           F     +G G FG V   +++K D     A+K L  R    L       +K E  ++A+ 
Sbjct: 3   FVKIKTIGIGAFGEVC--LVRKVDTNALYAMKTL--RKADVLMRNQAAHVKAERDILAEA 58

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG------ 198
            ++ +V+L     DKD    + +Y+P   +          M L  + R+ I E       
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDM----------MSL--LIRLGIFEEDLARFY 106

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG------------- 245
           IA+    +    ++  IHRD+K  NIL+D+D + K++DFG+   C G             
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQKG 163

Query: 246 -----------NELQANTSR--------------------IVGTYGYMSPEYALEGIFSI 274
                       E                           +VGT  Y++PE  L   ++ 
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223

Query: 275 KSDVFSFGVLLLEIVSGK 292
             D +S GV+L E++ G+
Sbjct: 224 LCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 63/289 (21%), Positives = 120/289 (41%), Gaps = 44/289 (15%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIA---VKRLSGRSGQGLREMKN---EASVIAKVQHKNLVR 151
           ++G G FG V    +     +A   VK L  ++    +E      +      +QH N+++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLY 205
            LG C++    +L++EY     L  +L         ++ +LL      ++   IA G+ +
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTH 114

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           +H+++    +H DL   N  L  D+  K+ D+G+       +             +++PE
Sbjct: 115 MHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 266 YALE---GIFSIK----SDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYAWDLWTSN 316
              E   G+ + +    S+V++ GV L E+        + L   + LN +         +
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-------IKD 224

Query: 317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + ++L  P LE  YS      R+  +   C   S + R T  +V  +LT
Sbjct: 225 QQVKLFKPQLELPYSE-----RWYEVLQFC-WLSPEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 32/211 (15%)

Query: 99  LGEGGFGPVYKGVLKK---------GDEIAVKRLSGRSGQGLREMK----NEASVIAKVQ 145
           LG G    +Y G+L             E  +K +        R++       AS++ +V 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           HK++V L G C+   E I++ E++    LD F+   +  +   W  + ++ + +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 206 LHQYSRVRIIHRDLKASNILL-----DKDMNP--KISDFGMARICGGNELQANTSRIVGT 258
           L       ++H ++   NILL     D +  P  K+SD G+         Q    RI   
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECVERI--- 172

Query: 259 YGYMSPEYALEG-IFSIKSDVFSFGVLLLEI 288
             +++PE   +    SI +D +SFG  L EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 32/100 (32%), Positives = 60/100 (60%), Gaps = 8/100 (8%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 257
           IA+ +L +H   ++  +HRD+K  N+LLD + + +++DFG   ++     +Q++ +  VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165

Query: 258 TYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 16/203 (7%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
             +     + K        +AVK+  L   S + L+ ++ E     ++QH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           I   E  ++   M   S +  L       L +      I++ +   L Y+H       IH
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-FILKDVLNALDYIHSKG---FIH 124

Query: 217 RDLKASNILLDKDMNPKISDFGMAR--ICGGNELQA---NTSRIVGTYGYMSPEY---AL 268
           R +KAS+ILL  D    +S    +   I  G   +         V    ++SPE     L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 269 EGIFSIKSDVFSFGVLLLEIVSG 291
           +G ++ KSD++S G+   E+ +G
Sbjct: 185 QG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 108

Query: 153 LGCCIDKDEKIL--IYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
              C  +D+K L  + EYMP   L   + +   P K     W          A+ +L L 
Sbjct: 109 F--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT-----AEVVLALD 156

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY 266
               + +IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT  Y+SPE 
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEV 214

Query: 267 ----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
                 +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A G+ +L   +    +HRDL A N+L+ +    KI DFG+AR    +    +       
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M+PE     +++  SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 58/246 (23%), Positives = 112/246 (45%), Gaps = 39/246 (15%)

Query: 63  NNKQAKRSKKKEVDQLPLFSFSSVSTATNK-FSDANKLGEGGFGPVYKGV-LKKGDEIAV 120
           NN      ++K +D       + ++ + NK +   N +G G FG VY+ + +   +++A+
Sbjct: 44  NNAGEDEDEEKMID-------NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAI 96

Query: 121 KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC----CIDKDEKIL----IYEYMPNK 172
           K++     Q  +    E  ++  + H N++ L       C  K+EK +    + E++P  
Sbjct: 97  KKVL----QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152

Query: 173 SLDFFLF----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 228
              +       +    + L  +   Q+   +A    Y+H      I HRDLK  N+L+D 
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALA----YIHSKF---ICHRDLKPQNLLIDP 205

Query: 229 DMNP-KISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLL 285
           + +  K+ DFG A+ +  G   Q + S I   + Y +PE  L    ++   D++S G ++
Sbjct: 206 NTHTLKLCDFGSAKNLLAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCII 261

Query: 286 LEIVSG 291
            E++ G
Sbjct: 262 AEMILG 267

Length = 440

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 62/254 (24%), Positives = 103/254 (40%), Gaps = 65/254 (25%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDE---IAVKRLSGRS---GQGLREMKNEASVIAKVQH 146
           F     LG G FG V   + +K D     A+K L  +       +  +K E  ++A+  +
Sbjct: 3   FVKIKTLGIGAFGEVC--LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           + +VRL     DKD    + +Y+P   +   L     RM +      +    IA+    +
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFY--IAELTCAV 114

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG--------------------- 245
               ++  IHRD+K  NIL+D+D + K++DFG+   C G                     
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQSGDHVRQDSM 171

Query: 246 ---NE---------------LQANTSR---------IVGTYGYMSPEYALEGIFSIKSDV 278
              NE               L+   +R         +VGT  Y++PE  L   ++   D 
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231

Query: 279 FSFGVLLLEIVSGK 292
           +S GV+L E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 26/162 (16%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSG----RSGQGLREMKNEASVIAKV 144
             F     +G+G FG V + V KK  G   A+K L      +  Q L  +K E  V+A+ 
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQ-LAHVKAERDVLAES 58

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW------VTRVQIIEG 198
               +V L     D     LI E++P   L          ML+ +      VTR  + E 
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSEDVTRFYMAEC 110

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
           +    L +    ++  IHRD+K  NIL+D+  + K+SDFG++
Sbjct: 111 V----LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 12/95 (12%)

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           +L L    ++ I++RD+K  NILLD + +  ++DFG+++     E +  T    GT  YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173

Query: 263 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 291
           +PE     I   K       D +S G+L+ E+++G
Sbjct: 174 APE-----IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 21/160 (13%)

Query: 138 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
           AS++++V H +L  + G C+   E I++ E++ +  LD  L     R+ + W  ++ + +
Sbjct: 67  ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQ 124

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNP--KISDFGMARICGGNELQA 250
            +A  L YL   +   ++H ++ A NILL +       +P  K+SD G++      E   
Sbjct: 125 QLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE--E 179

Query: 251 NTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEI 288
              RI     +++PE  + G    S  +D +SFG  LLEI
Sbjct: 180 RVERI----PWIAPE-CVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTY 259
           + L Y+H  +   + HRDLK  NIL + D   KI DFG+AR+   +   A   +  V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 260 GYMSPEYALEGIFSIKS----DVFSFGVLLLEIVSGK 292
            Y +PE  L G F  K     D++S G +  E+++GK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 17/204 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE----MKNEASVIAKVQHKNLVRLLG 154
           +G G FG V    LK  D++   ++  +     R      + E  V+    ++ +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D++   L+ +Y     L   L     R+  D + R  +    A+ ++ +    ++  
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYL----AEMVIAIDSVHQLHY 123

Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--ALE-- 269
           +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VGT  Y+SPE   A+E  
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDG 181

Query: 270 -GIFSIKSDVFSFGVLLLEIVSGK 292
            G +  + D +S GV + E++ G+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 29/90 (32%), Positives = 50/90 (55%)

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           Q +L L +    +++HRDLK++NI L      K+ DFG ++    +      S   GT  
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           Y++PE      +S K+D++S GV+L E+++
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 60/242 (24%), Positives = 102/242 (42%), Gaps = 55/242 (22%)

Query: 93  FSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRSGQGLRE-----MKNEASVIAKVQ 145
           F     +G G FG V + V KK  G   A+K L  R    L +     ++ E  ++ +  
Sbjct: 3   FESLKVIGRGAFGEV-RLVQKKDTGHVYAMKIL--RKADMLEKEQVGHIRAERDILVEAD 59

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
              +V++     DK    LI E++P   +   L      M  D +T  +    IA+ +L 
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL------MKKDTLTEEETQFYIAETVLA 113

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------------------- 245
           +    ++  IHRD+K  N+LLD   + K+SDFG+   C G                    
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL---CTGLKKAHRTEFYRNLNHSLPSD 170

Query: 246 -------NELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 289
                  ++ +A T +          VGT  Y++PE  ++  ++   D +S GV++ E++
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 290 SG 291
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 38/109 (34%), Positives = 60/109 (55%), Gaps = 10/109 (9%)

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGT 258
           A+ +L L     +  IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGT 206

Query: 259 YGYMSPEY----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
             Y+SPE       +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 18/103 (17%)

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT---------- 252
           L YLH Y    I+HRDLK  N+L+    + K++DFG+++I G   L  N           
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTR 169

Query: 253 ----SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
                ++ GT  Y++PE  L   +    D ++ G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 59/222 (26%), Positives = 85/222 (38%), Gaps = 68/222 (30%)

Query: 98  KLGEGGFGPVYKGVLKK------------------GDEIAVKRLSGRSGQGLREMKNEAS 139
           KL +G FG V   VLK                     E  V +L          MK+   
Sbjct: 23  KLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL----------MKD--- 67

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-MLLDWVTRVQIIEG 198
                 + N ++L          +LI +Y+     D  LFD  K+   L      +II  
Sbjct: 68  ------NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQ 117

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 257
           + + L  LH++    IIH D+K  N+L D+  +   + D+G+ +I G        S   G
Sbjct: 118 LVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDG 168

Query: 258 TYGYMSPEYALEGIFSIKSDV--FSF-----GVLLLEIVSGK 292
           T  Y SPE        IK      SF     GVL  E+++GK
Sbjct: 169 TLDYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 58/254 (22%), Positives = 99/254 (38%), Gaps = 65/254 (25%)

Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKN 148
           F     LG G FG V     +      A+K L  +   +   +  +K E  ++A+  ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLL--DWVTRVQIIEGIAQGLLYL 206
           +V+L     DKD    + +Y+P   +   L     RM +  + + R  I    A+  L +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYI----AELTLAI 114

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS------------- 253
               ++  IHRD+K  NIL+D D + K++DFG+   C G     N+              
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL---CTGFRWTHNSKYYQKGSHIRQDSM 171

Query: 254 -----------------------------------RIVGTYGYMSPEYALEGIFSIKSDV 278
                                               +VGT  Y++PE  L   ++   D 
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231

Query: 279 FSFGVLLLEIVSGK 292
           +S GV+L E++ G+
Sbjct: 232 WSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 51/242 (21%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ 145
           + F     +G G FG V + V KK  G   A+K L        + +  ++ E  ++ +  
Sbjct: 1   DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
              +V++     DK    LI E++P   +   L      M  D ++       IA+ +L 
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL------MKKDTLSEEATQFYIAETVLA 113

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------------------- 245
           +    ++  IHRD+K  N+LLD   + K+SDFG+   C G                    
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL---CTGLKKAHRTEFYRNLTHNPPSD 170

Query: 246 -------NELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 289
                  ++ +A T +          VGT  Y++PE  ++  ++   D +S GV++ E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 290 SG 291
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
             V+ I  +A  L YLH++    IIHRDLK  N+L+  + + K++DFG++++
Sbjct: 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 26/113 (23%)

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA---N 251
           I+ G  +GL YLHQ      IHR++KAS+IL        IS  G+  + G + L +   N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154

Query: 252 TSRIVGTYGY----------MSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 292
             +    Y +          +SPE   + +  +++KSD++S G+   E+ +G+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 26/172 (15%)

Query: 93  FSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGL----REMKNEASVIAK 143
           F    KLGEG FG VYK  L     KK  +  +K+ +      +    R  +   +  A 
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVT------- 191
             +  L  +      +DE  L++ Y    +L   +         +  LL  V        
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251

Query: 192 -RVQIIEGIAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMA 240
              +II+ I + +L+ L       I+HRD+K  NI+  +     KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 9/77 (11%)

Query: 193 VQIIEGIA-QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQA 250
           + +I+G+  Q L  L +  R+ I+HRD+K  N+L+  D   KI DFG A  +C G     
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP 367

Query: 251 NTSRIVGTYGYMSPEYA 267
                   YG + P Y+
Sbjct: 368 -------LYGMLDPRYS 377

Length = 507

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.001
 Identities = 28/117 (23%), Positives = 44/117 (37%), Gaps = 26/117 (22%)

Query: 132 REMKNEASVIAKVQHKNLVRLLGCC------IDKDEKILIYEYMPNKSLDFFLFDPTKRM 185
              + EA ++AK       R  G        +D D  +++ EY+  + L   L +     
Sbjct: 44  ERTRREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---- 93

Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
             D +  V    G   G L+     +  I+H DL  SNI+L         DFG+   
Sbjct: 94  RPDLLREV----GRLVGKLH-----KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.002
 Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 51/233 (21%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLL 153
            LG+G  G V+   LK   ++ A+K L  +      ++K    E  ++A + H  L  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 154 GCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 +  + L+ +Y P   L   L     + L + V R    E +   L YLH     
Sbjct: 68  -ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG-- 123

Query: 213 RIIHRDLKASNILLDKDMNPKISDFG-----------MARICGGNELQANTSRI------ 255
            I++RDLK  NILL +  +  +SDF            +++       +++ + I      
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 256 ----------VGTYGYMSPEYALEGIFSIKS-------DVFSFGVLLLEIVSG 291
                     VGT  Y++PE        I         D ++ G+LL E++ G
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEV-------ISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	411
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10345	210	hypothetical protein; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
smart00090	237	RIO RIO-like kinase.	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.09
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
PRK09902	216	hypothetical protein; Provisional	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.75
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.67
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.62
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.62
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.48
PF01636	239	APH: Phosphotransferase enzyme family This family	98.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.44
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.43
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.36
PLN02876	822	acyl-CoA dehydrogenase	98.31
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.31
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.24
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.18
PRK10593	297	hypothetical protein; Provisional	98.14
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.1
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.05
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.03
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.97
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.96
PRK05231	319	homoserine kinase; Provisional	97.94
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.87
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.73
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.62
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.61
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.52
PLN02236	344	choline kinase	97.47
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.45
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.39
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.28
KOG2270	520	consensus Serine/threonine protein kinase involved	97.28
PLN02756	418	S-methyl-5-thioribose kinase	97.15
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.97
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.88
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.86
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.85
COG2334	331	Putative homoserine kinase type II (protein kinase	96.82
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.75
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.69
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.67
PRK12396	409	5-methylribose kinase; Reviewed	96.35
PRK11768	325	serine/threonine protein kinase; Provisional	96.33
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.29
PRK06148	1013	hypothetical protein; Provisional	95.94
PTZ00384	383	choline kinase; Provisional	95.84
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	95.66

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-56  Score=421.61  Aligned_cols=290  Identities=45%  Similarity=0.790  Sum_probs=253.5

Q ss_pred             CCCCcchhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeee
Q 040952           77 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC  156 (411)
Q Consensus        77 ~l~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  156 (411)
                      ....|++.++..+|++|...+.||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999998899999988765443145699999999999999999999999


Q ss_pred             ecCC-ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          157 IDKD-EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       157 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                      .+.+ +.+|||||+++|+|.++|+..... +++|..+++|+.++|+||+|||....++|+||||||+|||+|+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 499999999999999999876554 78999999999999999999999888889999999999999999999999


Q ss_pred             ecCCccccCCCCcccccccc-cccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc-ccccchhHHHHHHh
Q 040952          236 DFGMARICGGNELQANTSRI-VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYAWDLW  313 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~  313 (411)
                      |||+++.....  ....... .||.+|+|||+...+..+.|+|||||||+|+||+||+++..... .....+..|++...
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999665431  1111122 79999999999999999999999999999999999998876544 34445889999999


Q ss_pred             hcCccccccccccc-cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          314 TSNRTLELIDPILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       314 ~~~~~~~~~~~~l~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ......+++|+.+. +.+........+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999987 444443557889999999999999999999999999965544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-51  Score=390.46  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=211.9

Q ss_pred             cCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .+|...+.||+|||+.||.+++ ..|+.||+|++.+.   .....+.+.+|+++.++|+|||||+++++|++.++.|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999997 67999999999864   3445677899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |+|.+++|..++.   .+.++++..+..++.||+.||.|||+++   |+|||||..|+|++++.++||+|||||..+...
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999985   4567999999999999999999999998   999999999999999999999999999988644


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      ..  ...+.||||.|.|||++....++..+||||+||++|.||.|++||....                  +.+....+.
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------------vkety~~Ik  231 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------------VKETYNKIK  231 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------------HHHHHHHHH
Confidence            32  3455799999999999999999999999999999999999999986422                  111111111


Q ss_pred             cccc-chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          327 EDEY-SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       327 ~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..++ .+...+.+..+||.++|++||.+|||+.+|+.
T Consensus       232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111 12244677899999999999999999999995

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-51  Score=365.81  Aligned_cols=253  Identities=27%  Similarity=0.386  Sum_probs=210.9

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc-eEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-KILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e  167 (411)
                      .+.+..+.||+|..|+||++.++. ++.+|+|.+... ++...+++.+|++++++++|||||.++|.|..... ..++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            356677899999999999999875 888999999544 44556789999999999999999999999999984 999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||++|+|+.++...   ..+++...-+++.++++||.|||. .+   |+||||||+|||++..|.+||||||.+..+.+.
T Consensus       159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999998654   338899999999999999999996 55   999999999999999999999999999877543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                          ....++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...........+....+..++.      +.+
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp------P~l  302 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP------PRL  302 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC------CCC
Confidence                3355799999999999999999999999999999999999999987653333333333333222211      111


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          +...++.++..++..||++||.+|||+.|+++.
T Consensus       303 ----P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  303 ----PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ----CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                111357789999999999999999999999864

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-50  Score=376.52  Aligned_cols=259  Identities=31%  Similarity=0.513  Sum_probs=211.4

Q ss_pred             CCCccCcccccCcccEEEEEecCCCE-EEEEEccCCCcc--cHHHHHHHHHHHHhcCCcccceeeeeeecCC-ceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~g~~-vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  167 (411)
                      .+...+.||+|+||+||+|.++ |+. ||||++......  ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            3445566999999999999998 555 999999865322  2568999999999999999999999999988 7999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCccccCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGN  246 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~  246 (411)
                      |+++|+|..+++.. .+..+++..++.++.||++||.|||+++.  ||||||||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999999774 34569999999999999999999999873  99999999999999998 9999999999876543


Q ss_pred             CcccccccccccccccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      .  ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....     ...+.....     ....+
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~-----~~~Rp  265 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVV-----GGLRP  265 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh-----cCCCC
Confidence            2  1222358999999999999  56899999999999999999999999875432     112222211     11122


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      .+...     ++..+..++.+||+.||++||++.+++..|+.+....
T Consensus       266 ~~p~~-----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  266 PIPKE-----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCcc-----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            22211     3667899999999999999999999999998776543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-50  Score=363.32  Aligned_cols=199  Identities=32%  Similarity=0.526  Sum_probs=180.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .++|...+.||+|+||+||+|+++. +..||||.+...  .....+.+..|+++|+.++|||||.++++++.++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4678888999999999999999764 899999999876  5566778899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC------CCeEEeecCCc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD------MNPKISDFGMA  240 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------~~~kl~Dfgl~  240 (411)
                      |||.||+|..|++..+   .+++.....++.||+.|+++||+++   ||||||||+|||++..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999996654   4899999999999999999999998   9999999999999765      45899999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  297 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~  297 (411)
                      +.+....   .....+|++.|||||++..+.|+.|+|+||+|+|+|++++|+.||..
T Consensus       163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            9987433   34557999999999999999999999999999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-50  Score=362.47  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=203.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc-------cHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-------GLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||+++.....       ....+.+|+++|++++|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567888999999999999999855 5999999999765211       2234679999999999999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CCeEEeec
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDF  237 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Df  237 (411)
                      ..||||||++||+|.+.+...   ..+.+.....++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999988543   34777777899999999999999999   9999999999999766   78999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      |+|+..+..   ....+.|||+.|.|||++.+..   +..++|+||+||+||-+++|.+||.....+..     ..+.+.
T Consensus       324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQIL  395 (475)
T ss_pred             chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHh
Confidence            999987633   3345679999999999998654   34578999999999999999999975433221     011111


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+....       ....-...+++..+||.+||..||+.|||+.|+++.
T Consensus       396 ~G~y~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  396 KGRYAF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cCcccc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            111100       001123357889999999999999999999999865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-50  Score=348.61  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=209.5

Q ss_pred             cCCCccCcccccCcccEEEEE-ecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeee-eeecCCc-eEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG-CCIDKDE-KILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  165 (411)
                      ..|.+.+.||+|.||+||++. ..+|..+|.|.+.-.  +....+.+..|+.+|++++|||||++++ .+.+++. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468889999999999999998 456999999988633  4455677899999999999999999999 4445555 7899


Q ss_pred             EeeCCCCCchhhhcC-CCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          166 YEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-RVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ||||.+|+|..++.. ...+..+++..+|+++.|++.||+.+|+.- +..|+||||||.||+++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999988854 234456899999999999999999999832 124999999999999999999999999999988


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      .....  .....+|||.||+||.+.+..|+.+|||||+||++|||..-++||...     ++...-..+ ...+.     
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI-~qgd~-----  245 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKI-EQGDY-----  245 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHH-HcCCC-----
Confidence            65432  234579999999999999999999999999999999999999998532     222222221 11111     


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                          ...+....+..+..+|..|+..||+.||+...++..+...
T Consensus       246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence                0112345688899999999999999999977777666553

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.2e-49  Score=386.44  Aligned_cols=261  Identities=30%  Similarity=0.452  Sum_probs=219.1

Q ss_pred             cCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .+....+.||+|.||+||+|....      ...||||.++..... ..++|++|++++..++|||||+|+|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            445566889999999999998432      457999999877554 7789999999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCC-----------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          164 LIYEYMPNKSLDFFLFDPTK-----------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                      ||+|||..|+|.+||.....           +.+++..+.+.|+.|||.|++||-+++   +|||||..+|+||.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            99999999999999953211           334888999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  311 (411)
                      ||+|||+++.....++........-..+|||||.++.++||.+||||||||+|||+++ |+.||.....+      .+..
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------EVIe  716 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------EVIE  716 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------HHHH
Confidence            9999999999887776665545556789999999999999999999999999999999 88886533211      1222


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .+..+++.          ..++.++.+++.|+..||+.+|++||+++||-..|+.....
T Consensus       717 ~i~~g~lL----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 CIRAGQLL----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHcCCcc----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            23333332          23445688999999999999999999999999999876653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-49  Score=368.60  Aligned_cols=257  Identities=32%  Similarity=0.461  Sum_probs=210.5

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      ..++..+.||+|-||.||.|.++....||+|.+.... ...+.|.+|+++|++|+|+|||+++++|..++..++|||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3455678999999999999999977799999998653 334678899999999999999999999999889999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      .|+|.++|... .+..+.....+.++.|||+|++||++++   +|||||..+||||+++..+||+||||++.........
T Consensus       285 ~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999773 3455888899999999999999999998   9999999999999999999999999999655444332


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      . ....-...|.|||.+..+.|+.|||||||||+||||+| |+.|++...     ..+.+          +.++... .-
T Consensus       361 ~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~----------~~le~Gy-Rl  423 (468)
T KOG0197|consen  361 S-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVL----------ELLERGY-RL  423 (468)
T ss_pred             c-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHH----------HHHhccC-cC
Confidence            2 22234678999999999999999999999999999999 777764322     11111          1111111 01


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      +.+..++..+.+++..||+.+|++|||+..+...|+.+-.
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            2234457889999999999999999999999999887654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-49  Score=352.51  Aligned_cols=242  Identities=24%  Similarity=0.339  Sum_probs=201.2

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .+.|++.+.||+|+||+||.++.++ ++.+|+|.+++.   ...+.+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            5789999999999999999999654 899999999865   234567789999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +||+.||.|..+|.+..   .+++..+.-++..|+.||.|||+++   |+||||||+|||+|.+|.++|+|||+++..-.
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999995443   3888888888999999999999999   99999999999999999999999999985432


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .  ...+..++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.     ..+....... ..       
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~-k~-------  242 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKG-KL-------  242 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcC-cC-------
Confidence            2  2334558999999999999999999999999999999999999999853321     1111111111 10       


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCC
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRP  355 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RP  355 (411)
                         ...+...+.+..+++.+.|+.||++|.
T Consensus       243 ---~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence               011222366789999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.2e-47  Score=329.85  Aligned_cols=262  Identities=23%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|+.+..+|+|+||.||+++.++ |+.||||++.....  .-.+-..+|+++|++++|+|+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            467888899999999999999775 99999999986643  223456899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      ||+..-|+++-+....   ++.....++++|+++|+.|+|+++   ++||||||+|||++.+|.+||||||+|+.+....
T Consensus        82 ~~dhTvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9999888776543332   788889999999999999999998   9999999999999999999999999999886422


Q ss_pred             cccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc---------chhHHHHHHhhcCc
Q 040952          248 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---------NLLGYAWDLWTSNR  317 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~  317 (411)
                        ...+..+.|.+|.|||.+.+ -.|+..+||||+||++.||++|.+-|...++-..         ++...-...+....
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              23345688999999999987 6799999999999999999999998865432211         11111122233322


Q ss_pred             cccccc-cc------cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 TLELID-PI------LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 ~~~~~~-~~------l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ....+. |.      +...++  ..+..+.+++..||+.||.+|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p--~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYP--KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcc--cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            222111 11      111121  12457899999999999999999999984

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-47  Score=352.72  Aligned_cols=254  Identities=28%  Similarity=0.374  Sum_probs=208.6

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCce
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (411)
                      ...++|...+.||.|+|++|++|+.. .++.||||++.+.   .+.-.+.+..|-..|.+| .||.|++|+..|++...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34578999999999999999999965 4999999998754   223345567888899999 899999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      |+|+||+++|+|.+++...+   .+++.....++.+|+.||+|||++|   ||||||||+|||+|+|+.++|+|||.++.
T Consensus       150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999996654   3899899999999999999999999   99999999999999999999999999988


Q ss_pred             cCCCCcc---------ccc--ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH
Q 040952          243 CGGNELQ---------ANT--SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       243 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  311 (411)
                      +......         ...  ..++||..|.+||++..+..+..+|+|+||||||+|+.|.+||......    ..+.. 
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----liFqk-  298 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LIFQK-  298 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HHHHH-
Confidence            7542211         111  4489999999999999999999999999999999999999998643311    11100 


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      +       ..++..+...     .+..+.+|+.+.|..||++|+|..++.+..
T Consensus       299 I-------~~l~y~fp~~-----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  299 I-------QALDYEFPEG-----FPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             H-------HHhcccCCCC-----CCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            0       0111112222     246788999999999999999999998764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=340.85  Aligned_cols=258  Identities=25%  Similarity=0.409  Sum_probs=204.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCC--ceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  166 (411)
                      ..+|...+.||+|+||.||++...+ |...|||.....+....+.+.+|+.+|.+++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3557778999999999999999765 8999999987664333677899999999999999999999855555  588999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+++|+|.+++.....  .+++..+..+..|+++||+|||+++   |+||||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999976543  4899999999999999999999998   999999999999999 79999999999987664


Q ss_pred             -CCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          246 -NELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       246 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                       ...........||+.|||||++..+ ....++|||||||++.||+||++||...    .....+..........     
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~-----  241 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSL-----  241 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCC-----
Confidence             1112223346899999999999863 3345999999999999999999998643    1111111111111111     


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      |.+     +...+.+..+++.+|++.+|++|||+.++++..--
T Consensus       242 P~i-----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  242 PEI-----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             CCC-----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            111     22236678999999999999999999999987643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=351.66  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=211.0

Q ss_pred             hcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ...|...++||+|+.|.||.|.. ..++.||||++........+.+.+|+.+|+..+|+|||++++.|...+.+|.||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45688889999999999999984 45889999999887766677889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      ++||+|.+.+..    ..+++.+...|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+.... 
T Consensus       352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-  423 (550)
T KOG0578|consen  352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-  423 (550)
T ss_pred             cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence            999999998843    33889999999999999999999999   9999999999999999999999999998775433 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       ......+||+.|||||+.....|+.+.||||||++++||+-|.+||-....     +.-.+-....+...         
T Consensus       424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAlyLIa~ng~P~---------  488 (550)
T KOG0578|consen  424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTPK---------  488 (550)
T ss_pred             -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHHHHhhcCCCC---------
Confidence             244567999999999999999999999999999999999999999743111     11111111111111         


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      -..+...+..+.+++.+||+.|+++||++.|+|+.
T Consensus       489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            11233347789999999999999999999999974

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=378.64  Aligned_cols=277  Identities=30%  Similarity=0.456  Sum_probs=226.5

Q ss_pred             cCCCccCcccccCcccEEEEEecC--CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK--GD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .+.+..+.||+|.||.||.|...+  |.    .||+|.+... +.+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345667889999999999999654  43    4899998765 5567788999999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCC----CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          164 LIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      +++|||++|+|..+|++.+    ....+.....+.++.|||+|+.||++++   +|||||..+|+||+....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999997652    2345888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      |+.+...++........-...|||||.+..+.||.|+|||||||+|||++| |..||+..+.     .+........++ 
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----~~v~~~~~~ggR-  922 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----FEVLLDVLEGGR-  922 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----HHHHHHHHhCCc-
Confidence            997666555554444344568999999999999999999999999999999 8888763221     111112222221 


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeeecccc
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTV  386 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~  386 (411)
                             +   ..+..++..+.+++..||+.+|++||++..+++++..+.....+..-+.....+.+.
T Consensus       923 -------L---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~~~~  980 (1025)
T KOG1095|consen  923 -------L---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADYESV  980 (1025)
T ss_pred             -------c---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccccccCcc
Confidence                   1   123445778999999999999999999999999999888877766666666555544

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-45  Score=347.30  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=204.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecCC-
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD-  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  160 (411)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++.... ......+.+|+.++..+ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467999999999999999999742      25689999987543 23346788999999999 8999999999887654 


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC---------------------------------------------------------
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK---------------------------------------------------------  183 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  183 (411)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999988864211                                                         


Q ss_pred             --CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccc
Q 040952          184 --RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY  261 (411)
Q Consensus       184 --~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y  261 (411)
                        ...+++.....++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134777888899999999999999988   999999999999999999999999999765432222222233567889


Q ss_pred             cChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHH
Q 040952          262 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYV  340 (411)
Q Consensus       262 ~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~  340 (411)
                      +|||.+.+..++.++|||||||++|||++ |..||....... .   . ......+....          .+...+..+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~---~-~~~~~~~~~~~----------~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E---F-CQRLKDGTRMR----------APENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H---H-HHHHhcCCCCC----------CCCCCCHHHH
Confidence            99999999999999999999999999997 999986432211 0   1 11111111000          0112245789


Q ss_pred             HHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          341 NIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       341 ~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      +++.+||+.||++|||+.|+++.|+++..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=335.44  Aligned_cols=264  Identities=24%  Similarity=0.354  Sum_probs=209.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..+.|++.+.||.|..++||+|... .+..||||++.... ..+.+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            3578999999999999999999954 48999999997653 334688999999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      +||.+|++.+++...-.. .+++.....|.+++++||.|||++|   .||||||+.||||+.+|.+||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999998664332 3888999999999999999999999   999999999999999999999999988655432


Q ss_pred             Cccc--ccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          247 ELQA--NTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       247 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ....  ....++||++|||||+++.  ..|+.|+||||||++.+||.+|..||..+.+-...+..    .-.......  
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t----Lqn~pp~~~--  253 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT----LQNDPPTLL--  253 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH----hcCCCCCcc--
Confidence            2111  1245689999999999654  46999999999999999999999999866543322211    111110000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...+.. .........+.+++..||+.||.+|||+.++++.
T Consensus       254 t~~~~~-d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 TSGLDK-DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccCCh-HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            111111 1112235689999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-45  Score=341.18  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=204.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC--Cce
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  162 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (411)
                      ...+.|+.+++||+|+||.||+|++ .+|+.||+|++....  +.......+|+.+|++++||||+++.+...+.  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            3456788999999999999999995 469999999987654  44566778999999999999999999998876  689


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      |||+|||++ +|.-++....  ..++..++..++.|++.||+|+|+.+   |+|||||.+|||||.+|.+||+|||||++
T Consensus       194 YlVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence            999999987 6777765432  34888999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc---c
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR---T  318 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~  318 (411)
                      +........ +..+-|.+|.|||++.+. .|+.+.|+||.||||.||++|++.|.....-.  .+..+....-.+.   +
T Consensus       268 y~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  268 YTPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             ccCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HHHHHHHHhCCCChhcc
Confidence            765544333 334679999999999875 69999999999999999999999876443211  1111111111100   0


Q ss_pred             -------cccccc------ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          319 -------LELIDP------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       319 -------~~~~~~------~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                             ...+.+      .+...  -...+....+|+..+|..||.+|.|+.++++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~--~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRET--FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHH--hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                   011111      11111  1123567789999999999999999999985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.2e-46  Score=348.64  Aligned_cols=270  Identities=26%  Similarity=0.353  Sum_probs=223.1

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|.+.+.||+|+||+||+|+-+ +.+.||+|.+.+..  ..+.+.+.+|++++++++||||+.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999965 48899999997653  4457789999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+.| +|..+|.+...   +++..+..++.++..||.|||+++   |+|||+||.|||++.++.+|+||||+++....+.
T Consensus        82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9988 99999966554   899999999999999999999998   9999999999999999999999999999876533


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                        ...+...|||.|||||+..++.|+..+|+||+||++||+++|++||-..     .....+..+..++           
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~-----------  216 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDP-----------  216 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCC-----------
Confidence              3345568999999999999999999999999999999999999997321     1111222211111           


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhhcccccCCCCCCceeeecccc
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALLPPKQPAFSFVRNTV  386 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~~~~~~~~~~~~~~~~~  386 (411)
                       ..++...+..+.+++...|++||.+|.|-.+++..  .++.......|..+++..+-.+.
T Consensus       217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~  276 (808)
T KOG0597|consen  217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNN  276 (808)
T ss_pred             -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccC
Confidence             11233457889999999999999999999999954  56666666666666666544443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=349.80  Aligned_cols=267  Identities=28%  Similarity=0.454  Sum_probs=213.2

Q ss_pred             hhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           84 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      .+.+...+.+.+.+.||+|.||+||+|.+. | .||||++...  +.+..+.|++|+..+++-+|.||+-+.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            444555666778899999999999999986 3 5999999765  34567889999999999999999999999998877


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                       .+|..+|+|.+|..+++....  .++....+.|++|+++|+.|||.++   |||||||+.|||+.+++.+||+|||++.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             999999999999999987653  3888999999999999999999998   9999999999999999999999999986


Q ss_pred             ccCCCCcccccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      .-..-.-........|...|||||++..   .+|+..+||||||+++|||++|..||.....+..-        +.-++-
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--------fmVGrG  608 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--------FMVGRG  608 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------EEeccc
Confidence            5432111122233467889999999874   46999999999999999999999998632222111        111111


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .-..|..    .....++.++.+|+..||..++++||.+.+|+..|+.+.+.
T Consensus       609 ~l~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  609 YLMPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ccCccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            0111111    11223467899999999999999999999999999988775

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=347.75  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=207.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC----Cc-ccHHHHHHHHHHHHhcC-CcccceeeeeeecCC
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR----SG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  160 (411)
                      ...++|.+.+.||+|+||+|+.|... +|..||+|++...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34578999999999999999999854 5899999977653    12 23456778999999998 999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGM  239 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl  239 (411)
                      ..++||||+.||+|.+++.+   ...+.+.....+++|++.|++|+|+++   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999966   234788899999999999999999998   9999999999999999 9999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....     .......      
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~k------  234 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRK------  234 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHH------
Confidence            98874  1223345579999999999999877 85 78999999999999999999986421     1111111      


Q ss_pred             cccccccccccccc-hHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          318 TLELIDPILEDEYS-SKHM-LLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       318 ~~~~~~~~l~~~~~-~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                             ...+.+. +... +.++..++.+||..+|.+|+|+.+++ .-.....
T Consensus       235 -------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  235 -------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             -------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence                   1111111 1112 56789999999999999999999999 4444443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=341.71  Aligned_cols=264  Identities=27%  Similarity=0.416  Sum_probs=215.2

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      ....+.+.||+|-||.|.++....+..||||.++..... ...+|.+|+++|.+++||||+.++|+|..++.+++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            345677899999999999999987899999999876544 3578999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|..++....... ++.....+|+.||+.|++||.+.+   +|||||.++|+|+++++++||+|||+++-+...+..
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999997653322 455566789999999999999988   999999999999999999999999999988777776


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhC--CCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG--KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      ....+.+-..+|||||.+..++++.++|||+||+++||+++-  ..||+....  .+..+.....+..+.....+     
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~~~~~l-----  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQGRQVVL-----  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCCcceec-----
Confidence            666677778999999999999999999999999999999774  456543222  12222222222222211111     


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        ..+.-++..+.+++.+||..+.++||+++++...|...
T Consensus       767 --~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 --SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             --cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence              11333467899999999999999999999999988754

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.7e-44  Score=335.20  Aligned_cols=265  Identities=27%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-----------------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVR  151 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  151 (411)
                      .++|.+.+.||+|+||.||+|.+++                 +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999998532                 3369999987643 334567889999999999999999


Q ss_pred             eeeeeecCCceEEEEeeCCCCCchhhhcCCC----------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 040952          152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII  215 (411)
Q Consensus       152 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  215 (411)
                      +++++.+.+..++||||+++|+|.+++....                ....+++....+++.|++.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999998875321                1134677888999999999999999998   99


Q ss_pred             ecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhC--CC
Q 040952          216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG--KK  293 (411)
Q Consensus       216 H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg--~~  293 (411)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999765433322223334567889999999988999999999999999999975  45


Q ss_pred             CCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          294 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       294 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      ||....  ....................  ..     .+..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       241 p~~~~~--~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELT--DEQVIENAGEFFRDQGRQVY--LF-----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCC--HHHHHHHHHHHhhhcccccc--cc-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            554322  11111111111111100000  00     011224678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=339.48  Aligned_cols=265  Identities=24%  Similarity=0.312  Sum_probs=205.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHH--HHHHHHHHHhcC-CcccceeeeeeecCC-ce
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLRE--MKNEASVIAKVQ-HKNLVRLLGCCIDKD-EK  162 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~  162 (411)
                      ...++|.+.++||.|+||.||+|+.. +|..||||+++..-. .+++  -.+|++.|+++. ||||+++.+++.+.+ .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            34578999999999999999999954 599999999986532 2333  357999999998 999999999999988 99


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++|||||+. +|.+++.++  +..+++.....|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            999999976 777777665  567999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc--
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL--  319 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  319 (411)
                      ......   .+..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++-|...+.-.  ..--+..+.-.+...  
T Consensus       160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICEVLGTPDKDSW  234 (538)
T ss_pred             cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHHHhCCCccccc
Confidence            764432   34457899999999886 5679999999999999999999998886433211  000001111111100  


Q ss_pred             ----------ccccccccccc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          320 ----------ELIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       320 ----------~~~~~~l~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                                ..--+...+..   -....+.+..+++.+||..||++|||+.|.++.-
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence                      00001111100   0111467899999999999999999999999863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=318.11  Aligned_cols=236  Identities=28%  Similarity=0.383  Sum_probs=201.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|+..+.||.|+||.|.+++.+. |..+|+|++.+..   -...+...+|-.+|+.+.||+++++++.|.+.+..+||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            4678999999999999999999764 8899999998653   23456678999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||.+||.|..+|+..++   +++..+.-++.||+.||+|||+++   |++|||||+|||+|.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999965443   888888999999999999999998   99999999999999999999999999988653


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                           .+.+.||||.|+|||++....|+.++|.|||||++|||+.|.+||.....                  ..+...+
T Consensus       197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------------~~iY~KI  253 (355)
T KOG0616|consen  197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------------IQIYEKI  253 (355)
T ss_pred             -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------------HHHHHHH
Confidence                 24567999999999999999999999999999999999999999864433                  1111122


Q ss_pred             ccccc-chHHHHHHHHHHHHHccccCCCCC
Q 040952          326 LEDEY-SSKHMLLRYVNIALLCVQESADDR  354 (411)
Q Consensus       326 l~~~~-~~~~~~~~l~~li~~cl~~~p~~R  354 (411)
                      +.+.. .+...+..+.+|+.+.|+.|-.+|
T Consensus       254 ~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 LEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            22211 122335678999999999999999

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.6e-44  Score=307.00  Aligned_cols=278  Identities=23%  Similarity=0.318  Sum_probs=209.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc--cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .+|...+.||+|.||.||+|++. +|+.||||++...+..  ......+|++.|+.++|+||+.++++|...+..-+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999954 5999999999765322  23457899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |++. +|...+.+.  ...+.......++.++++|++|||++.   |+||||||.|+|++.+|.+||+|||+++.++...
T Consensus        82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9964 888888654  346888899999999999999999998   9999999999999999999999999999987554


Q ss_pred             cccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc------Ccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS------NRTLE  320 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~  320 (411)
                      .....  .+-|..|.|||++.|. .|+...|+||.|||+.||+.|.+-|... .+..++ .......-.      ++...
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL-~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQL-SKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHH-HHHHHHcCCCCcccCccccc
Confidence            33322  2678999999999875 5999999999999999999988655432 222111 111111111      11111


Q ss_pred             ccccccc-------cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCcee
Q 040952          321 LIDPILE-------DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS  380 (411)
Q Consensus       321 ~~~~~l~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~  380 (411)
                      +.|..--       ...--...+....+|+.+++..||.+|+|+.|++++=  .-...++|..|...
T Consensus       232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~l  296 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKL  296 (318)
T ss_pred             cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhC
Confidence            1111100       0001111256679999999999999999999998752  22234455444444

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=329.70  Aligned_cols=269  Identities=26%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             CCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHH--hcCCcccceeeeeeecCC----ceEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIA--KVQHKNLVRLLGCCIDKD----EKILI  165 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lv  165 (411)
                      ..+..++||+|+||.||+|++. ++.||||+++....   +.|.+|-++.+  .++|+||+++++.-....    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3455678999999999999998 69999999986543   45666666665  469999999999877655    88999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY------SRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ++|.+.|+|.+||..    ..++|....+++..+++||+|||+-      ..++|+|||||++||||..|+++.|+|||+
T Consensus       287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999944    4589999999999999999999963      356799999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCC-CC-----cchhhHHHHHHHHHHHhCCCCCCC--Cccc---------c
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS-----IKSDVFSFGVLLLEIVSGKKNTGL--YRTD---------S  302 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~elltg~~p~~~--~~~~---------~  302 (411)
                      |..+............+||.+|||||++.+.. +.     .+.||||+|.+||||++...-...  ....         .
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            98887555555555579999999999987643 22     358999999999999997654321  1111         1


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                      ....+-.+..+..+    ..+|.+............+.+.+..||..||+.|.|+.=|-+.+.++.-..+
T Consensus       443 hPt~e~mq~~VV~k----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  443 HPTLEEMQELVVRK----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCHHHHHHHHHhh----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            11122222322222    2223333222222336789999999999999999999999999988766444

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.2e-44  Score=334.75  Aligned_cols=255  Identities=22%  Similarity=0.302  Sum_probs=202.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ...++|+.+++||+|+||.||+|+-+ +|..+|+|++++..   ...++.++.|-.+|...++|+||+++..|++.+++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35688999999999999999999965 49999999998763   445677889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      |||||++||++..+|...   ..+++..+..++.+++.||+.||+.|   +|||||||+|+|||..|++||+||||+.-+
T Consensus       218 LiMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999999543   45888888899999999999999999   999999999999999999999999998532


Q ss_pred             CC----------------------CCcc------cc-----------------cccccccccccChhhhccCCCCcchhh
Q 040952          244 GG----------------------NELQ------AN-----------------TSRIVGTYGYMSPEYALEGIFSIKSDV  278 (411)
Q Consensus       244 ~~----------------------~~~~------~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv  278 (411)
                      ..                      .+..      ..                 ....+|||.|+|||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                      0000      00                 011479999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCC--
Q 040952          279 FSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT--  356 (411)
Q Consensus       279 wslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt--  356 (411)
                      ||||||+||||.|.+||....+...-     ..+.+........        .....+.+..+||.+||. ||++|..  
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~-----rkI~nwr~~l~fP--------~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETY-----RKIVNWRETLKFP--------EEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHHhhhccCC--------CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            99999999999999999654432211     1111111111111        111124678999999999 9999976  


Q ss_pred             -HHHHHH
Q 040952          357 -MNDVVS  362 (411)
Q Consensus       357 -~~evl~  362 (411)
                       +.||.+
T Consensus       438 G~~EIK~  444 (550)
T KOG0605|consen  438 GAEEIKK  444 (550)
T ss_pred             cHHHHhc
Confidence             556554

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=334.14  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..|+..+.||+|.||.||+|.+. .++.||+|++... .....+.++.|+.+|.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777789999999999999965 4889999999765 445678899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      |.||++.+.|...   ..+++....-++++++.|+.|||.++   .+|||||+.|||+..+|.+||+|||++-.......
T Consensus        93 ~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999998432   23466677788999999999999998   99999999999999999999999999987765443


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .  ...++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+.               +..-++...-+.
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIpk~~PP  229 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIPKSAPP  229 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEeccCCCCC
Confidence            3  25679999999999999889999999999999999999999997644331               112222221111


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .... +++..+.+++..||+.||+.||++.++++.
T Consensus       230 ~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1111 346779999999999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-45  Score=345.83  Aligned_cols=248  Identities=25%  Similarity=0.349  Sum_probs=207.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .+-|+..+.||.|+.|.|-+|++. +|+.+|||++.+..   ......+.+|+-+|+.+.|||++.+++++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            356889999999999999999964 59999999998762   22345688999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      .||+++|-|.+++...   .++.+....+++.||+.|+.|+|..+   |+||||||+|+|+|..+++||+|||+|..-..
T Consensus        91 lEyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            9999999999998543   45889999999999999999999998   99999999999999999999999999976443


Q ss_pred             CCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...   ..+-||++.|.|||++++.+| +.++||||+|||||.||||+.||+..                  ++..++..
T Consensus       165 gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------------------Nir~LLlK  223 (786)
T KOG0588|consen  165 GKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------------------NIRVLLLK  223 (786)
T ss_pred             Ccc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------------------cHHHHHHH
Confidence            322   334599999999999999988 57899999999999999999998621                  11111111


Q ss_pred             ccccccc-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          325 ILEDEYS-SKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       325 ~l~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      ...+.+. +..++.+..+|+.+|+..||+.|.|+.||++.-
T Consensus       224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            1122221 223467889999999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-43  Score=329.08  Aligned_cols=245  Identities=21%  Similarity=0.300  Sum_probs=197.5

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCccc---HHHHHHHHHHHHhcCCcccceeeeeeec----CCceEEEEeeC
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIYEYM  169 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  169 (411)
                      ..||+|++|.||+|.++ |+.||||.+.......   .+.+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            57999999999999985 8999999997653332   4678899999999999999999999877    34678999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      ++|+|.+++...   ..+++.....++.|++.|+.|||+. +   ++||||||+||++++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999998653   3478889999999999999999985 5   8899999999999999999999999987654221 


Q ss_pred             ccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                          ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......     ...........     ...+
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~~i~~~~~-----~~~~  243 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYDLIINKNN-----SLKL  243 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcCC-----CCCC
Confidence                22467899999999876  67999999999999999999999998643211     11111111110     0001


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                           +...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       244 -----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        244 -----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                 1123567999999999999999999999999998753

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=322.92  Aligned_cols=277  Identities=23%  Similarity=0.333  Sum_probs=215.8

Q ss_pred             CcchhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHh--cCCcccceeeeeee
Q 040952           80 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCI  157 (411)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~  157 (411)
                      ..++--..+...+..+.+.||+|.||.||+|.++ |+.||||+|...++.   .+.+|.++.+.  |+|+||+.+++.-.
T Consensus       200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             CchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccc
Confidence            3444555677788999999999999999999998 999999999876554   45777777775  59999999999865


Q ss_pred             cCC----ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeecCCCCCCEEEcC
Q 040952          158 DKD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-----YSRVRIIHRDLKASNILLDK  228 (411)
Q Consensus       158 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~dlkp~Nill~~  228 (411)
                      .++    +++||.+|.++|||.+||..    ..++....++++..+|.||++||.     +|.+.|.|||||+.||||.+
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk  351 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  351 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence            543    67899999999999999943    458889999999999999999994     67888999999999999999


Q ss_pred             CCCeEEeecCCccccCCC--CcccccccccccccccChhhhccCC----C-C-cchhhHHHHHHHHHHHhCC--------
Q 040952          229 DMNPKISDFGMARICGGN--ELQANTSRIVGTYGYMSPEYALEGI----F-S-IKSDVFSFGVLLLEIVSGK--------  292 (411)
Q Consensus       229 ~~~~kl~Dfgl~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DvwslG~il~elltg~--------  292 (411)
                      ++.+.|+|+|||-.....  .........+||.+|||||++.+.-    | + ..+||||||.++||+.-..        
T Consensus       352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            999999999999765432  3334445568999999999987542    2 1 3589999999999997643        


Q ss_pred             --CCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          293 --KNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       293 --~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                        .||-..-+...+.. -..+.    --.+.+.|.+++.....+....+.+++..||..+|..|.|+--+.+.|.++..
T Consensus       432 y~~Pyyd~Vp~DPs~e-eMrkV----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  432 YQLPYYDVVPSDPSFE-EMRKV----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             hcCCcccCCCCCCCHH-HHhcc----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence              23321111111111 11111    12344556666666677778999999999999999999999999999988764

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-45  Score=327.90  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=211.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ...+|++.+.||+|+||.|-+|.. ..|+.||||.+.+.   ++++.-.+.+|+++|..++||||+.++.+|++.+...+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            356899999999999999999985 56999999998765   44556668899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||..+|.|.+|+.+.   ..+++.....+++||..|+.|+|.++   ++|||||.+|||+|.|+++||+|||++.++.
T Consensus       131 vMEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            99999999999999554   44899999999999999999999998   9999999999999999999999999998875


Q ss_pred             CCCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ...   ....+||++.|.+||++.+.+| ++.+|.|||||+||.|+.|..||...+.                  ..++.
T Consensus       205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------------------k~lvr  263 (668)
T KOG0611|consen  205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------------------KRLVR  263 (668)
T ss_pred             ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------------------HHHHH
Confidence            433   2456799999999999999988 5789999999999999999999864321                  12222


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      .+-.+.+.....+....-||++||..||++|.|+.+|....
T Consensus       264 QIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  264 QISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            22233333333356677899999999999999999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=337.57  Aligned_cols=248  Identities=27%  Similarity=0.433  Sum_probs=204.5

Q ss_pred             ccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           95 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      .++-||.|+.|.||+|++. ++.||||++....       ..+++-|++|+||||+.+.|+|.....+|+|||||..|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            3578999999999999998 8899999987533       3568889999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      ...|...   ..+.......|..+||.|+.|||.+.   |||||||+-||||+.+..+||+|||-++.....   ...-.
T Consensus       200 ~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  200 YEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             HHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            9999553   34777788899999999999999998   999999999999999999999999998775432   22334


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      ++||..|||||++.+.+.+.|+|||||||+|||||||..||...+....     +|.+  ..+...+        ..+..
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGV--GsNsL~L--------pvPst  335 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGV--GSNSLHL--------PVPST  335 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEec--cCCcccc--------cCccc
Confidence            7899999999999999999999999999999999999999764332110     1100  0011111        12334


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCC
Q 040952          335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP  374 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  374 (411)
                      ++.-+.-|+.+||+..|..||++++++..|.-..+++...
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~  375 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLST  375 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcc
Confidence            4677889999999999999999999999998887765443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=341.88  Aligned_cols=244  Identities=26%  Similarity=0.381  Sum_probs=206.8

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      ....++|...++||+|.||+|+++..+. ++.+|||.+++.   ..++++..+.|-+++... +||++++++.+|+..++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3445789999999999999999999774 889999999876   356678888999999887 59999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      +|+||||+.||++..+.+    ...+++..+.-++..++.||.|||+++   ||+||||.+|||+|.+|.+||+|||+++
T Consensus       444 l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            999999999999554442    234888899999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      .--..  ...++++|||+.|+|||++.+..|+.++|.|||||+||||+.|..||...+.                  .++
T Consensus       517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------------ee~  576 (694)
T KOG0694|consen  517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------------EEV  576 (694)
T ss_pred             ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------------------HHH
Confidence            64322  2356778999999999999999999999999999999999999999864332                  233


Q ss_pred             cccccccc-cchHHHHHHHHHHHHHccccCCCCCCCH
Q 040952          322 IDPILEDE-YSSKHMLLRYVNIALLCVQESADDRPTM  357 (411)
Q Consensus       322 ~~~~l~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~  357 (411)
                      ++.++..+ ..+..++.+..+++.++|..+|++|..+
T Consensus       577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            33333332 2344457889999999999999999877

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-43  Score=338.60  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             hcCCCccCcccccCcccEEEEEe------cCCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      .++|++.+.||+|+||.||+|..      .++..||||++.... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999973      235689999997543 23445688999999999 89999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCC----------------------------------------------------------
Q 040952          162 KILIYEYMPNKSLDFFLFDPTK----------------------------------------------------------  183 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  183 (411)
                      .++||||+++|+|..++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988854221                                                          


Q ss_pred             --------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          184 --------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       184 --------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                                    ...+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124778888999999999999999988   999999999999999999999999999866433222


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....+. ..    ......+..     ...  
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~----~~~~~~~~~-----~~~--  338 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF----YKMIKEGYR-----MLS--  338 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH----HHHHHhCcc-----CCC--
Confidence            22222345678999999999999999999999999999998 888875432211 11    111111110     000  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                         +...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus       339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               011145789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-44  Score=338.07  Aligned_cols=263  Identities=30%  Similarity=0.424  Sum_probs=209.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecC--C--CE-EEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK--G--DE-IAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      .++....++||+|+||.||+|.+..  +  .. ||||.....   ......++.+|+++|++++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3455666899999999999999653  2  23 899998852   45667889999999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      +++|||+|.||+|+++|.....  .++...+..++.+.|.||+|||+++   ++||||..+|+|++.++.+||+|||+++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999976543  4889999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ....-.  .......-...|+|||.+....|+.++|||||||++||+++ |..||......     +........+-.. 
T Consensus       311 ~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~~~~~r~-  382 (474)
T KOG0194|consen  311 AGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIVKNGYRM-  382 (474)
T ss_pred             CCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHHhcCccC-
Confidence            643111  11101124578999999999999999999999999999999 78786533211     1111111111100 


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCC
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP  374 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  374 (411)
                          .     .+...+..+..++.+||..+|++||||.++.+.|+.+.....++
T Consensus       383 ----~-----~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  383 ----P-----IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             ----C-----CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence                0     01123667889999999999999999999999999988876654

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=304.08  Aligned_cols=267  Identities=23%  Similarity=0.253  Sum_probs=211.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEE-ecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----c
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----E  161 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  161 (411)
                      ...++|++.+.||+|||+-||.++ ..+++.+|+|++...+.++.+..++|++..++++|||+++++++...+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            346789999999999999999998 5568999999999888788889999999999999999999999876544     4


Q ss_pred             eEEEEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          162 KILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      .|++++|+..|+|.+.+... .++..+++...++|+.++++||.+||+.. +++.||||||.|||+++++.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence            89999999999998888653 33447999999999999999999999986 46999999999999999999999999998


Q ss_pred             cccCCCCccc-------ccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH
Q 040952          241 RICGGNELQA-------NTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       241 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  310 (411)
                      +...-.....       .......|..|.|||.+.-   ...+.++|||||||+||+|+.|..||........++.    
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----  252 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----  252 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE----
Confidence            7643111100       0112346889999998864   4578999999999999999999999874332221111    


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                              .....+.+.- +.....++.+.+++.+|++.||.+||++.+++..+.++.
T Consensus       253 --------LAv~n~q~s~-P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 --------LAVQNAQISI-PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------Eeeecccccc-CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                    0011101100 011114788999999999999999999999999998764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-43  Score=340.24  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=203.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      .++|++.+.||+|+||.||+|...      ++..||+|++.... ......+.+|+.+++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            467999999999999999998742      24579999997543 23345688999999999 89999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCC-----------------------------------------------------------
Q 040952          162 KILIYEYMPNKSLDFFLFDPT-----------------------------------------------------------  182 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  182 (411)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998875321                                                           


Q ss_pred             --------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          183 --------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       183 --------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                              ....+++....+++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124678888999999999999999988   99999999999999999999999999876543222111222


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK  333 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  333 (411)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..    .......     ......     .
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~----~~~~~~~-----~~~~~~-----~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KF----YKMVKRG-----YQMSRP-----D  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HH----HHHHHcc-----cCccCC-----C
Confidence            345678999999998899999999999999999997 999986432211 11    1111111     000000     0


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          334 HMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       334 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      ..+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11457899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=370.30  Aligned_cols=265  Identities=25%  Similarity=0.432  Sum_probs=211.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ...|...+.||+|+||.||+|... +|..||||.+.......    ..|++.+++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            456777889999999999999974 68999999987543221    3568899999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++|+|.++++.      ++|..+.+++.|+++|++|||....++++||||||+||+++.++..++. ||.......   
T Consensus       765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---  834 (968)
T PLN00113        765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---  834 (968)
T ss_pred             CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence            999999999842      7899999999999999999996655569999999999999999888876 665433211   


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||............|+............+++.+..
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               11236789999999999999999999999999999999999998654444445555555444444444455555533


Q ss_pred             cc-chHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          329 EY-SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       329 ~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      .. .......++.+++.+||+.+|++||||.|+++.|+......
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            22 22344678899999999999999999999999999876633

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=324.75  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=201.3

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--------------cccHHHHHHHHHHHHhcCCcccce
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--------------GQGLREMKNEASVIAKVQHKNLVR  151 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~  151 (411)
                      ....++|++.+.||+|.||.|-+|+.. +++.||||++.+..              ....+.+.+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            344678999999999999999999965 58999999996531              112457899999999999999999


Q ss_pred             eeeeeecC--CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 040952          152 LLGCCIDK--DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  229 (411)
Q Consensus       152 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  229 (411)
                      |+.+..+.  +.+|||+|||..|.+...-   .....++..+++++++++..||+|||.++   |+||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            99998764  5889999999998885442   22222889999999999999999999999   9999999999999999


Q ss_pred             CCeEEeecCCccccCCC---CcccccccccccccccChhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 040952          230 MNPKISDFGMARICGGN---ELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  302 (411)
Q Consensus       230 ~~~kl~Dfgl~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~  302 (411)
                      |++||+|||.+..+...   .........+|||.|+|||.+.++.    .+.+.||||+||+||-|+.|+.||....   
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---  323 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---  323 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence            99999999999866322   1122234468999999999988632    3567899999999999999999975211   


Q ss_pred             cchhHHHHHHhhcCccccccccccccc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                                     ..++.+.++...   ....++...+.+||.++|++||++|.+..+|....-
T Consensus       324 ---------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  324 ---------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             ---------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence                           112222222111   011133677899999999999999999999987763

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-43  Score=334.87  Aligned_cols=246  Identities=23%  Similarity=0.302  Sum_probs=200.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367889999999999999999976 48899999986532   23346688999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999999988543   34788888899999999999999998   99999999999999999999999999976543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ... ......... .     
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~-~~~i~~~~~-~-----  233 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRI-YEKILAGRL-K-----  233 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHH-HHHHhcCCc-C-----
Confidence            21     235789999999999999999999999999999999999999853221     011 111111110 0     


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                      +..     ..+..+.+++.+||+.||++||+     +.++++.
T Consensus       234 ~p~-----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 FPN-----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCC-----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            011     12456889999999999999997     6787754

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-44  Score=333.68  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=210.5

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc-eEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-KILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  166 (411)
                      ++|..++++|+|+||.++..+.+ +++.+++|.+....  ....+....|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999999866 47889999886543  3334467899999999999999999999999988 89999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      +||+||++.+.+.+.. ...+++.....|+.|++.|+.|||++.   |+|||||+.|||++.++.++|+|||+|+..+..
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999987654 466899999999999999999999887   999999999999999999999999999998754


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .  .......||+.|+.||++.+.+|+.|+|+|||||++|||++-+++|...+..     ..+.......     ..   
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~ki~~~~-----~~---  224 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELILKINRGL-----YS---  224 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHHHHhhcc-----CC---
Confidence            4  2345578999999999999999999999999999999999999998644322     1122211110     11   


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         ..+...+.++..++..||+.+|+.||++.+++..
T Consensus       225 ---Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 ---PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               1222337789999999999999999999999976

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=329.15  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=199.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 58899999986432   223456889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..+++.....++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999998543   34788888999999999999999998   999999999999999999999999998765421


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ...... .....      .+
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i-~~~~~------~~  217 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKI-LAGKL------EF  217 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-HhCCc------CC
Confidence                 22347899999999999888999999999999999999999998643211     111111 11110      00


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                           +...+..+.+++.+||+.||.+||+     +.++++.
T Consensus       218 -----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 -----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 1112456889999999999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=348.93  Aligned_cols=262  Identities=28%  Similarity=0.403  Sum_probs=215.0

Q ss_pred             cCCCccCcccccCcccEEEEEecC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ....+.++||.|.||.|++|+++.    ...||||.++.. .+....+|..|+.||.+++||||++|.|+.......++|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            345678999999999999999763    346999999865 455567899999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      .|||++|+|+.||+.....  +.+.+...+.++|+.|+.||-..+   +|||||..+|||++.+..+|++|||+++.+.+
T Consensus       709 TEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999999876543  788889999999999999999998   99999999999999999999999999998865


Q ss_pred             CCcccc-cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          246 NELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       246 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ...... +....-..+|.|||.+.-.++|.+|||||||+++||.++ |.+||-...  ..   +....          +.
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQ---dVIka----------Ie  848 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQ---DVIKA----------IE  848 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hH---HHHHH----------HH
Confidence            442222 222223578999999999999999999999999999888 888863211  11   11111          11


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCC
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP  373 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  373 (411)
                      ... .-+++.+++..+.+|++.||++|-.+||.+.+++..|.+++....+
T Consensus       849 ~gy-RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  849 QGY-RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             hcc-CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            111 1234566789999999999999999999999999999988775433

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-42  Score=320.60  Aligned_cols=257  Identities=31%  Similarity=0.500  Sum_probs=205.5

Q ss_pred             cCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643      2579999987543 233456889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          164 LIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                      ++|||+++++|.+++.....             ...+++.....++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998854321             144788889999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHH
Q 040952          231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  309 (411)
                      .++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......  +    .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~----~  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--E----V  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--H----H
Confidence            999999999976543332222334466888999999988899999999999999999998 99887543211  1    1


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      ...+.......          .+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       236 ~~~i~~~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 IEMIRSRQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11111111110          112235779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.4e-42  Score=326.42  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=204.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+++.. +|..+|+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999976 48889999987542 3345678999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|.+++...   ..+++.....++.|++.||.|||+.+  +|+||||||+|||++.++.++|+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            99999999998543   34788889999999999999999853  3999999999999999999999999998765322 


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH-HhhcCc---------
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD-LWTSNR---------  317 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~---------  317 (411)
                         ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......  +...... ......         
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcc
Confidence               1233468999999999999899999999999999999999999986433211  0000000 000000         


Q ss_pred             --------------------cccccccccc---cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          318 --------------------TLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       318 --------------------~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                                          ..+..+....   ........+.++.+++.+||+.||++|||+.|+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                0000000000   0001112356789999999999999999999998763

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-42  Score=322.37  Aligned_cols=264  Identities=22%  Similarity=0.275  Sum_probs=201.2

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999976 48899999987542  2334667899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |++++++..+...   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9999887765432   234788889999999999999999988   9999999999999999999999999998754322


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH----------HHHh-hcC
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA----------WDLW-TSN  316 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~----------~~~~-~~~  316 (411)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .....          ...+ ...
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccc
Confidence            1 122335689999999999988899999999999999999999999865332110 00000          0000 000


Q ss_pred             cccccccccccccc-----chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 RTLELIDPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ~~~~~~~~~l~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .......+......     .....+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000001000000     01123567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=345.44  Aligned_cols=265  Identities=25%  Similarity=0.300  Sum_probs=211.8

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecCC-CEEEEEEccCCCcccHHHHHHHHHHHHhcC-Ccccceeeee-eec----
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKKG-DEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC-CID----  158 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~----  158 (411)
                      +.....++++.+.|.+|||+.||.|++..+ ..||+|++-..++...+.+.+|+++|++|+ |+|||.+++. ...    
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            344557788999999999999999998765 999999998888888999999999999996 9999999993 222    


Q ss_pred             --CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEee
Q 040952          159 --KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  236 (411)
Q Consensus       159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D  236 (411)
                        .-+++|.||||.||.|-+++..+.... +.+..+++|+.|+++|+++||... ++|||||||-+||||+.++..||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence              125689999999999999987655544 899999999999999999999985 6799999999999999999999999


Q ss_pred             cCCccccCCCCcccc-------cccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 040952          237 FGMARICGGNELQAN-------TSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  306 (411)
Q Consensus       237 fgl~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  306 (411)
                      ||.+.-.........       .-...-|+.|+|||++.   +...+.|+|||+|||+||-|+....||+....      
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------  263 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------  263 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence            999864321110000       00123589999999874   77899999999999999999999999864311      


Q ss_pred             HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                                  ..++.....- ++....+..|.+||..||+.||++||++.+|++.+..+....
T Consensus       264 ------------laIlng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 ------------LAILNGNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ------------eeEEeccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                        1111111110 111334889999999999999999999999999998776543

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.8e-42  Score=320.27  Aligned_cols=261  Identities=28%  Similarity=0.431  Sum_probs=209.8

Q ss_pred             cCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999843      245689999876665556778999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC
Q 040952          165 IYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  231 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  231 (411)
                      ||||+++++|.+++....             ....+++..++.++.|++.|++|||+++   ++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986432             1234788999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHH
Q 040952          232 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       232 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  310 (411)
                      ++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |+.||.......      ..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VI  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence            99999999976543332222233456788999999999999999999999999999999 999975432211      11


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .....+.....          ....+..+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus       236 ~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 ECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            11111111111          011245689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-42  Score=321.31  Aligned_cols=252  Identities=25%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .|+..+.||+|+||.||+|... +|+.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677889999999999999964 58999999986432   2233457889999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|..++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999988775432 234788899999999999999999998   9999999999999999999999999997654222


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                         ......||..|+|||++.+..++.++|||||||++|||++|+.||........  ............ .        
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~-~--------  222 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKEDQ-E--------  222 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhccc-c--------
Confidence               12234789999999999999999999999999999999999999864332110  000111110000 0        


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                        ..+...+..+.+|+.+||+.||++||+     +.++++.
T Consensus       223 --~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         223 --EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             --cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence              001122567889999999999999997     7888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.3e-43  Score=330.27  Aligned_cols=242  Identities=22%  Similarity=0.298  Sum_probs=195.2

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.||+|+||.||++..+ +|+.||+|++...   .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 5899999998753   2233456788999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccc
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  252 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  252 (411)
                      +|..++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            998888543   34788899999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccch
Q 040952          253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS  332 (411)
Q Consensus       253 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  332 (411)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...      ..........      .+     +
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~------~~-----p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEEI------RF-----P  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCCC------CC-----C
Confidence            34579999999999999999999999999999999999999985432110      0111111110      00     1


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          333 KHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       333 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            12256788999999999999999     79998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-42  Score=319.43  Aligned_cols=257  Identities=29%  Similarity=0.467  Sum_probs=205.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+...... ..+.+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999998643      478999999765443 456889999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC
Q 040952          163 ILIYEYMPNKSLDFFLFDPT-----------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  231 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  231 (411)
                      ++||||+++++|.+++....           ....+++.....++.|++.|+.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999986432           2244788889999999999999999998   999999999999999999


Q ss_pred             eEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHH
Q 040952          232 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       232 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  310 (411)
                      ++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......  ...    
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~----  234 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVI----  234 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----
Confidence            99999999876543322222223345788999999999999999999999999999998 99997533211  111    


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      .....+....          .+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus       235 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1111111100          01122567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-43  Score=331.76  Aligned_cols=253  Identities=22%  Similarity=0.331  Sum_probs=203.1

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|.+.. |+.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            468899999999999999999764 8899999987542   234556889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            999999999998543   34788889999999999999999998   99999999999999999999999999876542 


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||.......     .............  .+..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~~~~~--~~~~  222 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-----TWENLKYWKETLQ--RPVY  222 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-----HHHHHHhcccccc--CCCC
Confidence                2234578999999999999999999999999999999999999986432211     0011111000000  0000


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .  ......+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~--~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 D--DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             C--ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0  0011235678999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.1e-42  Score=332.29  Aligned_cols=262  Identities=25%  Similarity=0.359  Sum_probs=205.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcC-CcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  161 (411)
                      .++|.+.+.||+|+||.||+|.+..      +..||||++..... ...+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            5688999999999999999998531      34699999975432 33467889999999996 9999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCC----------------------------------------------------------
Q 040952          162 KILIYEYMPNKSLDFFLFDPTK----------------------------------------------------------  183 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  183 (411)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988754210                                                          


Q ss_pred             -----------------------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 040952          184 -----------------------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  228 (411)
Q Consensus       184 -----------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~  228 (411)
                                                         ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               123677788899999999999999988   999999999999999


Q ss_pred             CCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhH
Q 040952          229 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLG  307 (411)
Q Consensus       229 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  307 (411)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+..    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999986543322222233456788999999998899999999999999999997 8888753321110    


Q ss_pred             HHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          308 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                       .......+.     ...     .+...+..+.+++.+||+.+|++|||+.+|.+.|+.+.+
T Consensus       349 -~~~~~~~~~-----~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 -FYNKIKSGY-----RMA-----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHHHHhcCC-----CCC-----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             111111110     000     011235678999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.1e-43  Score=345.71  Aligned_cols=253  Identities=18%  Similarity=0.210  Sum_probs=203.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-C-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-K-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            34888999999999999999854 3 678899987655555556778899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++|+|.+++.+. ..+.++++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999887543 23346888899999999999999999988   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......... +..    .+   
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~-~~~----~~---  290 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLY-GKY----DP---  290 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-CCC----CC---
Confidence            22223445799999999999999999999999999999999999999853221     111111111 110    00   


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                         .+...+..+.+++.+||+.+|++||++.+++.
T Consensus       291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               01122457899999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.6e-42  Score=318.20  Aligned_cols=261  Identities=28%  Similarity=0.448  Sum_probs=208.6

Q ss_pred             cCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888999999999999999842      245689999887655556778999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCC----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          165 IYEYMPNKSLDFFLFDPT----------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                      ||||+++++|.+++....          ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999885432          2234899999999999999999999988   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHh
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      +|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......     .. ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~~-~~i  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----VI-ECI  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH-HHH
Confidence            99999976543322222223345778999999998889999999999999999999 888875332111     11 111


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .......     ..     ...+..+.+++.+||+.+|.+|||+.++++.|+++...
T Consensus       236 ~~~~~~~-----~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         236 TQGRVLQ-----RP-----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HcCCcCC-----CC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1111111     00     11245689999999999999999999999999888754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.8e-43  Score=319.73  Aligned_cols=250  Identities=34%  Similarity=0.520  Sum_probs=193.3

Q ss_pred             ccCcccccCcccEEEEEec-----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           95 DANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999977     25689999996543 33477899999999999999999999999988889999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++|+|.+++... ....+++..+..|+.|+++||.|||+.+   ++|+||+++||+++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999765 2245899999999999999999999988   99999999999999999999999999987633322


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      ........+...|+|||.+.+..++.++||||||+++|||++ |+.|+.....     ....... .......       
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~-~~~~~~~-------  225 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKL-KQGQRLP-------  225 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHH-HTTEETT-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccc-cccccce-------
Confidence            222233456788999999999889999999999999999999 6788653321     1111111 1111111       


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                         .+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               0111255688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-42  Score=318.11  Aligned_cols=256  Identities=25%  Similarity=0.349  Sum_probs=202.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.+.... ......+.+|+..+++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999854    35689999987653 2334568899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||+++   ++||||||+||+++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999986532  34789999999999999999999998   9999999999999999999999999876532


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      .... .......++..|+|||.+.+..++.++|||||||++||+++ |..||......     ..... .....     .
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~-~~~~~-----~  226 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKA-VEDGF-----R  226 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHH-HHCCC-----C
Confidence            2111 11112245678999999999999999999999999999875 99998543211     11111 11110     0


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ..     .+..++..+.+++.+||+.+|++||++.++++.|++.
T Consensus       227 ~~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LP-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            00     1122356789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-42  Score=323.93  Aligned_cols=264  Identities=24%  Similarity=0.311  Sum_probs=196.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 588999999875432 223456789999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+. ++|..++...  ...++...+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 5666666432  234778888999999999999999998   9999999999999999999999999987543221


Q ss_pred             cccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc------c-
Q 040952          248 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT------L-  319 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~-  319 (411)
                        .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+. ...........      . 
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhCCCChhhccchhh
Confidence              11233468899999998865 4588999999999999999999999975432111111 00000000000      0 


Q ss_pred             -ccccc---------ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          320 -ELIDP---------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       320 -~~~~~---------~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                       ...++         .+.........+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000         00000000011346789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.8e-42  Score=319.82  Aligned_cols=262  Identities=22%  Similarity=0.310  Sum_probs=197.3

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999965 58899999987543 22345678999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++ +|..++....  ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            985 8887775432  34678888999999999999999998   99999999999999999999999999876532221


Q ss_pred             ccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh------------c
Q 040952          249 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT------------S  315 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~  315 (411)
                        ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.......  ..........            .
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhccccc
Confidence              1223467899999998865 568999999999999999999999986433211  0100000000            0


Q ss_pred             Ccccccccccccccc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          316 NRTLELIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ........+......   .....+.++.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000011101000000   00112456889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.4e-42  Score=315.62  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=202.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999998753      25679999986432 2334568899999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCC-------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          162 KILIYEYMPNKSLDFFLFDPTK-------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                      .++||||+++++|.+++.....       ....++.....++.|++.||.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       133577888899999999999999988   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHh
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  .   .. ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~---~~-~~~  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--Q---VL-RFV  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--H---HH-HHH
Confidence            99999876543322222222345778999999998889999999999999999999 67887533211  1   11 111


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      ........          +...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       235 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 MEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11111110          11124568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.8e-42  Score=312.54  Aligned_cols=256  Identities=30%  Similarity=0.463  Sum_probs=209.2

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      ..+|++.+.||.|+||.||+|...+++.+|+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45688899999999999999998889999999998766555677899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999997643 245788999999999999999999988   999999999999999999999999999765432211


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......  ....    .....     ....   
T Consensus       161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~----~~~~~-----~~~~---  224 (261)
T cd05148         161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYD----QITAG-----YRMP---  224 (261)
T ss_pred             --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHH----HHHhC-----CcCC---
Confidence              112345678999999988899999999999999999998 88887533211  1111    11110     0000   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        .+...+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         225 --CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              1112256788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-42  Score=314.21  Aligned_cols=252  Identities=28%  Similarity=0.399  Sum_probs=201.5

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      ++|++.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4578889999999999999998878899999886432 334678899999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +|+|.+++....  ..+++.....++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||.++.........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999886432  24788899999999999999999998   9999999999999999999999999987654322211


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ............   ...      
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~~~~~---~~~------  222 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMISRGFR---LYR------  222 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCC---CCC------
Confidence             122235568999999988889999999999999999999 8888753221     111111111100   000      


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                        +...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1111456899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-42  Score=314.37  Aligned_cols=256  Identities=29%  Similarity=0.406  Sum_probs=205.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|++|.||+|.+++++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46688899999999999999998778899999987543 33567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++.....++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999986543 235789999999999999999999988   999999999999999999999999999876532211


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       .......+..|+|||.+.+..++.++||||||+++|||++ |+.||......      ..........     ...   
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~-----~~~---  224 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------EVLQQVDQGY-----RMP---  224 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-----CCC---
Confidence             1111223457999999998899999999999999999999 88887533211      0111111100     000   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        .+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       225 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         225 --CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              0112246789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-41  Score=311.28  Aligned_cols=256  Identities=30%  Similarity=0.437  Sum_probs=205.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46788999999999999999998888899999987543 23567899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999986532 234788888999999999999999988   999999999999999999999999999876432221


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      . .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||......  ..   ... .....     ...   
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~---~~~-~~~~~-----~~~---  224 (261)
T cd05072         160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DV---MSA-LQRGY-----RMP---  224 (261)
T ss_pred             c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HH---HHH-HHcCC-----CCC---
Confidence            1 122345678999999988889999999999999999998 89888532211  11   111 11110     000   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        .....+..+.+++.+||+.+|++||++.++.+.|++.
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 --RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              0011245688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=327.23  Aligned_cols=239  Identities=21%  Similarity=0.260  Sum_probs=192.1

Q ss_pred             ccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           99 LGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ||+|+||.||+|... +++.||+|.+...   .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 4889999998643   233456678899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      .+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||+++......  .....
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            9988543   34788899999999999999999998   9999999999999999999999999987543221  12234


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........       ..+     +..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~-------~~~-----~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP-------LRF-----PDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC-------CCC-----CCc
Confidence            5789999999999999999999999999999999999999863221     11111111110       000     112


Q ss_pred             HHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 040952          335 MLLRYVNIALLCVQESADDRPT---MNDVVS  362 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt---~~evl~  362 (411)
                      .+..+.+++.+||+.||++||+   +.+++.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            2467889999999999999985   566654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-41  Score=321.45  Aligned_cols=200  Identities=28%  Similarity=0.361  Sum_probs=173.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||++.+. +|..+|+|.+... .......+.+|+++++.++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999976 4888999988754 22334668899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|.+++...   ..+++.....++.|++.||.|||+.+  +++||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            99999999998543   34788888999999999999999753  3999999999999999999999999998755321 


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY  298 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  298 (411)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence               122346899999999999888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-41  Score=323.56  Aligned_cols=262  Identities=27%  Similarity=0.393  Sum_probs=204.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC-C
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK-D  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  160 (411)
                      .++|++.+.||+|+||.||+|...      .++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999632      25789999987543 23345678899999999 899999999988654 5


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC---------------------------------------------------------
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK---------------------------------------------------------  183 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  183 (411)
                      ..++++||+++++|..++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999988753211                                                         


Q ss_pred             -CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccccccccccc
Q 040952          184 -RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM  262 (411)
Q Consensus       184 -~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~  262 (411)
                       ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125788999999999999999999988   9999999999999999999999999998764332222223345677899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHH
Q 040952          263 SPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVN  341 (411)
Q Consensus       263 aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~  341 (411)
                      |||.+.+..++.++|||||||++|||++ |..||....... .    ..........     ..     .+...+..+.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~----~~~~~~~~~~-----~~-----~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E----FCRRLKEGTR-----MR-----APEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H----HHHHHhccCC-----CC-----CCccCCHHHHH
Confidence            9999999999999999999999999998 998875322111 0    1111111110     00     01122457899


Q ss_pred             HHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          342 IALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       342 li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ++.+||+.+|++||++.|+++.|+++..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.5e-42  Score=324.30  Aligned_cols=258  Identities=28%  Similarity=0.438  Sum_probs=202.5

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCC----EEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .+|+..+.||+|+||.||+|.+. +|.    .||+|.+.... ....+.+.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56899999999999999999864 233    48999987543 34456788999999999999999999998764 5789


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ++||+++|+|.+++....  ..+++...+.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999986533  34788888999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||......     .. ..........  . 
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----~~-~~~~~~~~~~--~-  231 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EI-SSILEKGERL--P-  231 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HH-HHHHhCCCCC--C-
Confidence            4332222222334678999999999999999999999999999998 99987532211     11 1111111000  0 


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                             .+..++..+.+++.+||+.+|++||++.+++..|......
T Consensus       232 -------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         232 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                   0011245688999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.2e-42  Score=324.84  Aligned_cols=245  Identities=24%  Similarity=0.352  Sum_probs=193.2

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHH---HhcCCcccceeeeeeecCCceEEE
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVI---AKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      |++.+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|..++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999999965 48999999987432   23345566666655   466899999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++++|..++..    ..+++.....++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888743    34889999999999999999999998   99999999999999999999999999865322


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......     ........ ...      .
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~-~~~------~  219 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVN-DEV------R  219 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-CCC------C
Confidence            11  2223457899999999999999999999999999999999999998643211     11111111 100      0


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      .     +...+..+.+++.+||+.||++||     ++.++++.
T Consensus       220 ~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         220 Y-----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             C-----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            0     111245688999999999999999     56777654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.1e-42  Score=303.08  Aligned_cols=266  Identities=23%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc-c-HHHHHHHHHHHHhcCCcccceeeeeeecC--Cce
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-G-LREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  162 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (411)
                      ...+.|+.++.|++|+||.||+|+++ +++.||+|+++...+. . --.-.+|+.+|.+++|||||.+..+....  +..
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            34567999999999999999999976 4889999999765321 1 12347899999999999999999887754  478


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      |+|||||+. +|..++..-.  .++...++..++.|+++|++|||.+.   |+|||||++|+|++..|.+||+|||+|+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence            999999976 7888776544  35788888999999999999999998   99999999999999999999999999999


Q ss_pred             cCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH-----------
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-----------  310 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-----------  310 (411)
                      ++...  ...+..+-|..|.|||++.+. .|+...|+||+|||+.||+++++.|.......  ..+...           
T Consensus       227 ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iw  302 (419)
T KOG0663|consen  227 YGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccC
Confidence            87653  233445779999999999875 59999999999999999999998876433211  111111           


Q ss_pred             HHhhcCcc------ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          311 DLWTSNRT------LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       311 ~~~~~~~~------~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+..-..      ....-..+...+.....+..-.+|+..+|..||.+|.|+.|.++.
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            11110000      001111111111111134667899999999999999999999864

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-42  Score=342.64  Aligned_cols=257  Identities=22%  Similarity=0.272  Sum_probs=203.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC----
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  160 (411)
                      ...++|.+.+.||+|+||+||+|... +|+.||||.+...  .......+.+|+..+..++|+|++++.+.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34579999999999999999999854 5899999998654  3344566889999999999999999988765432    


Q ss_pred             ----ceEEEEeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          161 ----EKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       161 ----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                          ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence                3579999999999999886432 2345888899999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ........ .
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~~-~  259 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKTL-A  259 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHh-c
Confidence            99999876533222223446799999999999999999999999999999999999999864321     11111111 1


Q ss_pred             CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...    .+ +     +...+..+.+++.+||+.+|++||++.++++.
T Consensus       260 ~~~----~~-~-----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRY----DP-L-----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCC----CC-C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            110    11 1     11225678999999999999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-41  Score=327.27  Aligned_cols=259  Identities=17%  Similarity=0.199  Sum_probs=195.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||++.+. .++.||+|....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999965 488999997542      3467899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +. ++|..++...   ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....... 
T Consensus       165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            85 6777776443   34788899999999999999999998   9999999999999999999999999987543211 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-----cchhHHHHHHhhc---C----
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-----LNLLGYAWDLWTS---N----  316 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~---~----  316 (411)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......     .............   .    
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            112234579999999999999999999999999999999999998764322100     0000000000000   0    


Q ss_pred             ---cccccc---------ccc-cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 ---RTLELI---------DPI-LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ---~~~~~~---------~~~-l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                         ......         .+. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               000000         000 0000011123567899999999999999999999995

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-41  Score=313.35  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=202.4

Q ss_pred             cCCCccCcccccCcccEEEEEe-----cCCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      +.|++.+.||+|+||.||+|..     ..+..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     236789999997543 3345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCC--------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          165 IYEYMPNKSLDFFLFDPT--------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                      +|||+++++|.+++....              ....+++.....++.|++.||+|||+++   ++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999885321              1234788888999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHH
Q 040952          231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  309 (411)
                      .+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......  .    .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~----~  235 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--E----V  235 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H----H
Confidence            999999999976543322222233445778999999988889999999999999999998 88887432210  1    1


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      ...........     .     +...+..+.+++.+||+.+|++||++.++++.|..
T Consensus       236 ~~~~~~~~~~~-----~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKRQLLP-----C-----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC-----C-----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111111110     0     11124568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-41  Score=312.79  Aligned_cols=260  Identities=20%  Similarity=0.351  Sum_probs=207.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|... +++.||||.+...   .......+.+|+.+++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999965 5899999987643   2233456889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+++++|..++.... ....++......++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988875422 2345788888999999999999999988   99999999999999999999999999877543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ...  ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........   .+.... ....     .+ 
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~-~~~~-----~~-  226 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKI-EQCD-----YP-  226 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHH-hcCC-----CC-
Confidence            221  11234678899999999988899999999999999999999999753322111   111111 1000     00 


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                         .......+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               0111223567899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.6e-42  Score=326.59  Aligned_cols=242  Identities=23%  Similarity=0.274  Sum_probs=195.1

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.||+|+||.||++... +|+.||+|++...   .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 4899999998753   2334567788999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccc
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  252 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  252 (411)
                      +|..++...   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            998887543   34788899999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccch
Q 040952          253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS  332 (411)
Q Consensus       253 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  332 (411)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||......     .... ......      ..+.     
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~-~~~~~~------~~~p-----  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFE-LILMED------IKFP-----  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHH-HhccCC------ccCC-----
Confidence            3457899999999999889999999999999999999999998643211     1111 110000      0011     


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          333 KHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       333 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            11245688999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.6e-41  Score=309.00  Aligned_cols=255  Identities=29%  Similarity=0.439  Sum_probs=204.2

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      ..|.+.+.||+|+||.||+|.++. ++.||+|.+... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            457788999999999999999654 889999998754 334567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999985433 244788899999999999999999988   999999999999999999999999998776433221


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      . .....++..|+|||.+.+..++.++|||||||++|||++ |..||......     . .+......     .....  
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~-~~~~~~~~-----~~~~~--  226 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q-VYELLEKG-----YRMER--  226 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----H-HHHHHHCC-----CCCCC--
Confidence            1 112234668999999998899999999999999999998 88887533211     1 11111111     00011  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                         +...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               111246789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-42  Score=329.48  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=200.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC--CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.++.  +..||+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4679999999999999999998653  368999998643   22345668899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999998543   34788889999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......      ...........  .+  
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~--~~--  247 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGII--YF--  247 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCC--CC--
Confidence            22     23357899999999999888999999999999999999999998643211      11111111110  00  


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                             +...+..+.+++.+||+.+|++|+     ++.++++.
T Consensus       248 -------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        248 -------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   111245678999999999999995     89998875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-41  Score=324.07  Aligned_cols=263  Identities=19%  Similarity=0.299  Sum_probs=194.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----ceE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI  163 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  163 (411)
                      +|++.+.||+|+||.||+|... +|+.||||++...  .......+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5788899999999999999965 5899999998743  2233456889999999999999999999886432     479


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+. ++|..++...   ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 5788777433   34889999999999999999999998   999999999999999999999999999764


Q ss_pred             CCCCc-ccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH--------
Q 040952          244 GGNEL-QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL--------  312 (411)
Q Consensus       244 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------  312 (411)
                      ..... ........||+.|+|||++.+  ..++.++|||||||++|||++|++||.......  ........        
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~  231 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHH
Confidence            32211 111233578999999999875  678999999999999999999999986433110  00011000        


Q ss_pred             ---hhcCccccccccccccccch-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 ---WTSNRTLELIDPILEDEYSS-----KHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ---~~~~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         .........+..........     ...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence               00000000000000000000     0123567899999999999999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.9e-42  Score=316.45  Aligned_cols=268  Identities=29%  Similarity=0.401  Sum_probs=201.0

Q ss_pred             CCccCcccccCcccEEEEEe-----cCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceEE
Q 040952           93 FSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKIL  164 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  164 (411)
                      |+..+.||+|+||.||++..     .+++.||+|.+..... .....+.+|+++++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     3478899999875432 3456788999999999999999999988754  35789


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      +|||+++++|.+++..    ..+++..+..++.|++.|+.|||+++   ++||||||+||++++++.++|+|||++....
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999853    23899999999999999999999998   9999999999999999999999999988664


Q ss_pred             CCCcccc-cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........................+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            3221111 112235667999999988889999999999999999999999975433211111100000000001111111


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      ...... .+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       239 ~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111100 11223567999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-41  Score=327.44  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=195.9

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .|+..+.||+|+||+||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888899999999999999865 48899999997532   2345678899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999998543   34788888899999999999999998   9999999999999999999999999975431100


Q ss_pred             c---------------------------------------------ccccccccccccccChhhhccCCCCcchhhHHHH
Q 040952          248 L---------------------------------------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG  282 (411)
Q Consensus       248 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  282 (411)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001234799999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHH--ccccCCCCCCCHHHH
Q 040952          283 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALL--CVQESADDRPTMNDV  360 (411)
Q Consensus       283 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~ev  360 (411)
                      |++|||++|+.||........     .............     ..   ....+.++.+++.+  |+..++..||++.++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~-----~~~i~~~~~~~~~-----~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET-----QLKVINWENTLHI-----PP---QVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH-----HHHHHccccccCC-----CC---CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999864332111     0111110000000     00   01124567788887  556666679999999


Q ss_pred             HHH
Q 040952          361 VSM  363 (411)
Q Consensus       361 l~~  363 (411)
                      +..
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-42  Score=326.33  Aligned_cols=242  Identities=22%  Similarity=0.289  Sum_probs=194.3

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.||+|+||.||++... +|+.||+|.+...   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 5899999998753   2234456778999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccc
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  252 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  252 (411)
                      +|..++...   ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            998887543   34788999999999999999999998   9999999999999999999999999987532211  112


Q ss_pred             ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccch
Q 040952          253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS  332 (411)
Q Consensus       253 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  332 (411)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...     .. ........      .+.     
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~-~~~~~~~~------~~p-----  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LF-ELILMEEI------RFP-----  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----HH-HHHhcCCC------CCC-----
Confidence            33578999999999999999999999999999999999999986432211     00 11111100      011     


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          333 KHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       333 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            11245688999999999999998     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.7e-41  Score=324.56  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=194.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|+..+.||+|+||.||+|.+. +|+.||||.+..... .....+.+|+++++.++|+||+++++++...+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            356778899999999999999965 589999999865432 334678899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|....       ..++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            99999986432       2456677889999999999999998   9999999999999999999999999997654321


Q ss_pred             cccccccccccccccChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                        .......||..|+|||.+..     ...+.++|||||||++|||++|+.||......  +............      
T Consensus       223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~------  292 (353)
T PLN00034        223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQ------  292 (353)
T ss_pred             --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccC------
Confidence              11233478999999998743     23456899999999999999999998732211  1111111110000      


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...     .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       293 ~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 PPE-----APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCC-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000     011225678999999999999999999999975

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-43  Score=295.11  Aligned_cols=249  Identities=25%  Similarity=0.320  Sum_probs=206.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   ......+.+|+++-+.++||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467999999999999999999965 47789999987642   23346788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +||..+|.+...|.+.. ...+++.....++.|+|.|+.|+|..+   ++||||||+|+|++..+.+||+|||.+.... 
T Consensus       101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999886433 244788888999999999999999988   9999999999999999999999999987654 


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                         .......|||..|.+||...+..++..+|+|++|++.||++.|.+||.....+ . .    +..+..   .+..   
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-e-t----YkrI~k---~~~~---  240 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-E-T----YKRIRK---VDLK---  240 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-H-H----HHHHHH---cccc---
Confidence               22345579999999999999999999999999999999999999998643311 0 0    011110   1111   


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           .+...+....++|.+|+..+|.+|.+..|++..
T Consensus       241 -----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  241 -----FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                 122336678999999999999999999999864

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-41  Score=309.78  Aligned_cols=248  Identities=27%  Similarity=0.371  Sum_probs=195.1

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      +.||+|+||.||+|.+. +|+.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999975 58899999886543 33456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      .+++....  ..+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99985432  34788899999999999999999988   99999999999999999999999999875432211111111


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK  333 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  333 (411)
                      ..++..|+|||.+.++.++.++|||||||++|||++ |..||.......      ........     ....     .+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~~-----~~~~-----~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQG-----VRLP-----CPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHcC-----CCCC-----Ccc
Confidence            123457999999998889999999999999999998 888875322110      01111110     0000     011


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          334 HMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       334 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            22567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.7e-42  Score=311.57  Aligned_cols=252  Identities=29%  Similarity=0.419  Sum_probs=201.5

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      ++|++.+.||+|+||.||.|...++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999998777789999987543 234678999999999999999999999999889999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|.+++.....  .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||.++........ 
T Consensus        83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            9999999865332  4789999999999999999999998   999999999999999999999999998765432211 


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......     ..... ......     ...   
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~-~~~~~~-----~~~---  222 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEK-VSQGLR-----LYR---  222 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHH-HhcCCC-----CCC---
Confidence            1112235678999999988889999999999999999999 99887543311     01111 111100     000   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                        +...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              0112467899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=312.56  Aligned_cols=257  Identities=30%  Similarity=0.441  Sum_probs=204.8

Q ss_pred             hcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999998742    3579999987543 3345578899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      +|||+++++|.+++....  ..+++.....++.|++.|++|||+.+   |+||||||+||++++++.++|+|||+++...
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999986533  25789999999999999999999988   9999999999999999999999999998775


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||......  .    ...........    
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~----~~~~~~~~~~~----  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--D----VIKAVEDGYRL----  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--H----HHHHHHcCCCC----
Confidence            2222222222345678999999998899999999999999999998 98887533211  1    11111111000    


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      +      .+...+..+.+++.+||+.+|++||++.++++.|.++
T Consensus       228 ~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 P------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0      0111245689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=307.40  Aligned_cols=268  Identities=22%  Similarity=0.313  Sum_probs=203.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccC--CCcccHHHHHHHHHHHHhcCCcccceeeeeeec-----CC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSG--RSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-----KD  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~  160 (411)
                      ....|...+.||+|+||.|..+.++ +|+.||||++..  .+....++..+|+++|+.++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456776899999999999999966 589999999973  355567788999999999999999999999865     34


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..|+|+|+| +.+|...+...   ..++......++.|+++||.|+|+.+   ++||||||+|++++.+..+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            679999999 66888888443   33788888899999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-cccchh--------HHHH
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-DSLNLL--------GYAW  310 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~-~~~~~~--------~~~~  310 (411)
                      +...........+..+.|..|.|||++. ...||...||||.|||+.||++|++-|...+. ++..+.        ....
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            9876442223335567899999999876 56799999999999999999999998865431 111100        0001


Q ss_pred             HHhhcCccccccccccc--ccc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          311 DLWTSNRTLELIDPILE--DEY---SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~--~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+.++.....+.....  ...   .-........+|+.+||..||.+|+|+.|.++.
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11111111111111100  000   001224568899999999999999999999975

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=326.50  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=199.1

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999976 48999999987532   233456788999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999998543   34888999999999999999999998   999999999999999999999999998754321


Q ss_pred             Cccc------------------------------------ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh
Q 040952          247 ELQA------------------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  290 (411)
Q Consensus       247 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  290 (411)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0012469999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 040952          291 GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNDVVSM  363 (411)
Q Consensus       291 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~  363 (411)
                      |..||......     ................     ..   ...+..+.+++.+|+. +|.+|++   +.++++.
T Consensus       235 G~~Pf~~~~~~-----~~~~~i~~~~~~~~~~-----~~---~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQ-----ETYRKIINWKETLQFP-----DE---VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHH-----HHHHHHHcCCCccCCC-----CC---CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99998643211     1111111111100000     00   0124567889999996 9999998   8888874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.9e-41  Score=314.08  Aligned_cols=265  Identities=27%  Similarity=0.404  Sum_probs=205.1

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-----------------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVR  151 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  151 (411)
                      .++|++.+.||+|+||.||+|.+..                 +..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3678999999999999999988542                 2458999987653 334567889999999999999999


Q ss_pred             eeeeeecCCceEEEEeeCCCCCchhhhcCCC--------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 040952          152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  223 (411)
Q Consensus       152 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N  223 (411)
                      +++++...+..++++||+++++|..++....        ....+++...+.++.|++.||+|||+++   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986533        1125789999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccc
Q 040952          224 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTD  301 (411)
Q Consensus       224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~  301 (411)
                      |+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++  |..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999876544333233334456788999999988889999999999999999998  5566643221 


Q ss_pred             ccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          302 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                       ..........+..........       .+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 -QQVIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -HHHHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence             111111111111111100000       011124679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-41  Score=310.18  Aligned_cols=257  Identities=28%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CC----EEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ++|++.+.||+|+||.||+|.+.. |+    .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            568888999999999999999643 44    47888876432 2334567788889999999999999998754 56789


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ++||+++|+|.+++....  ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999986432  34889999999999999999999988   9999999999999999999999999998664


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ............++..|+|||.+.++.++.++|||||||++|||++ |..||.......      ..+.........  .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~--~  232 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE------VPDLLEKGERLA--Q  232 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCC--C
Confidence            3332222333456788999999998899999999999999999998 998875332111      111111111110  0


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      +.        .....+.+++.+||..+|++|||+.|+++.|.....
T Consensus       233 ~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         233 PQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            00        113457889999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=314.56  Aligned_cols=264  Identities=26%  Similarity=0.405  Sum_probs=200.5

Q ss_pred             cCCCccCcccccCcccEEEEEecC---------------CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK---------------GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLG  154 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~  154 (411)
                      ++|++.+.||+|+||.||++....               ...||+|.+... .......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987542               225899998754 2334457889999999999999999999


Q ss_pred             eeecCCceEEEEeeCCCCCchhhhcCCCC---------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 040952          155 CCIDKDEKILIYEYMPNKSLDFFLFDPTK---------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  225 (411)
Q Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil  225 (411)
                      ++...+..++||||+++++|.+++.....         ...+++...+.++.|++.||+|||+++   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999998854321         123678888999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccccc
Q 040952          226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSL  303 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~  303 (411)
                      ++.++.+||+|||++................++..|+|||.+.++.++.++|||||||++|+|++  |..||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            99999999999999876543322222233345778999999998899999999999999999998  45565432211  


Q ss_pred             chhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          304 NLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      .........+.........  .     .+...+..+.+++.+||+.+|++|||+.+|++.|..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~--~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYL--S-----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHhhhhccccccC--C-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1111111111110000000  0     011124579999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.4e-41  Score=308.73  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=197.7

Q ss_pred             CCccCcccccCcccEEEEEecC-CC--EEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC------Cc
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DE  161 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  161 (411)
                      |.+.+.||+|+||.||+|++.. +.  .+|+|.+...  .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3466889999999999999764 33  6899988754  234456788999999999999999999987532      24


Q ss_pred             eEEEEeeCCCCCchhhhcCC---CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          162 KILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                      .++++||+++|+|..++...   .....+++.....++.|++.||+|||+++   |+||||||+|||++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998887421   12345789999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      +++...............+++.|+|||...+..++.++|||||||++|||++ |+.||......  .    .......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~----~~~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--E----IYDYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H----HHHHHHcCC
Confidence            9987643322111222345678999999998899999999999999999999 78887542211  1    111122111


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ....          ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       232 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1110          111245689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=315.12  Aligned_cols=261  Identities=28%  Similarity=0.422  Sum_probs=206.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  160 (411)
                      ..++|++.+.||+|+||.||++....      ...+|+|.+... .......+.+|+.++.++ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34678889999999999999998642      367999998754 233445688999999999 8999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCC-------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          161 EKILIYEYMPNKSLDFFLFDP-------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                      ..+++|||+++|+|..++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998542             12345888999999999999999999988   99999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchh
Q 040952          228 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLL  306 (411)
Q Consensus       228 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  306 (411)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......    
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  242 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence            999999999999987654332222223345678999999988899999999999999999998 888875322110    


Q ss_pred             HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                        ............          .+...+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       243 --~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 --LFKLLKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              111111111000          01112457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.3e-41  Score=311.45  Aligned_cols=259  Identities=29%  Similarity=0.426  Sum_probs=203.7

Q ss_pred             CCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      23578999887543 2345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCC---------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 040952          165 IYEYMPNKSLDFFLFDPT---------------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  223 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N  223 (411)
                      ++||+.+++|.+++....                     ....+++...+.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1234788899999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 040952          224 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  302 (411)
Q Consensus       224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  302 (411)
                      |++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999876543222222223345678999999988889999999999999999998 98887533211 


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                           ..+.......     ....     +...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       237 -----~~~~~~~~~~-----~~~~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 -----RLFNLLKTGY-----RMER-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -----HHHHHHhCCC-----CCCC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                 1111111110     0000     11124578899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.3e-42  Score=323.38  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=200.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||++... +|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999965 58899999987542   234556889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++....  ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999986542  34888889999999999999999998   999999999999999999999999999876433


Q ss_pred             CcccccccccccccccChhhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ... ......||+.|+|||++.      +..++.++|||||||++|||++|+.||......     ..............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~  229 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRFLK  229 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCccC
Confidence            221 222346899999999986      456789999999999999999999998643211     11111111111111


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+        ....+..+.+++.+||+ +|++|||+.++++.
T Consensus       230 ~~~--------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 FPE--------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCC--------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            000        01124568899999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.3e-42  Score=316.99  Aligned_cols=257  Identities=30%  Similarity=0.441  Sum_probs=202.1

Q ss_pred             cCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .+|.+.+.||+|+||.||+|...+      +..||+|++...... ..+.+.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            347778899999999999998532      478999999755332 2456889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCC-------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          164 LIYEYMPNKSLDFFLFDP-------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                      +++||+.+++|..++...             ..+..+++.....++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999887421             11234788888999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHH
Q 040952          231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  309 (411)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......     ...
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~  236 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVI  236 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence            999999999876543332222233456789999999988889999999999999999998 77777533211     111


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                       ..........          .+..++..+.+++.+||+.+|++||++.+++..|++
T Consensus       237 -~~i~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 -EMIRNRQVLP----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHcCCcCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             1111111110          111235668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.3e-41  Score=314.83  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=192.9

Q ss_pred             cCCCccCcccccCcccEEEEEec--CCCEEEEEEccCCC--cccHHHHHHHHHHHHhc---CCcccceeeeeeec-----
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCID-----  158 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  158 (411)
                      ++|++.+.||+|+||.||+|...  +|+.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  36789999886542  22234456677777665   69999999998852     


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                      ....++||||+. ++|..++..... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            446899999997 588888754332 34788899999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc---
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS---  315 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  315 (411)
                      ++......   .......||+.|+|||.+.+..++.++|||||||++|||++|++||.......  ...........   
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~  230 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE  230 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence            99765432   22234568999999999988899999999999999999999999986433211  11011000000   


Q ss_pred             Ccc---cccccccccc--ccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          316 NRT---LELIDPILED--EYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       316 ~~~---~~~~~~~l~~--~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ...   .......+..  ...    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000   0000000000  000    0112456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=327.14  Aligned_cols=253  Identities=23%  Similarity=0.297  Sum_probs=196.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||++... +|+.||||.+...   .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999865 5889999998643   2234566888999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999988543   34788888899999999999999998   999999999999999999999999998633210


Q ss_pred             Ccc------------c---------------------------------ccccccccccccChhhhccCCCCcchhhHHH
Q 040952          247 ELQ------------A---------------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSF  281 (411)
Q Consensus       247 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  281 (411)
                      ...            .                                 .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCC---CCHH
Q 040952          282 GVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR---PTMN  358 (411)
Q Consensus       282 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~  358 (411)
                      ||++|||++|..||......     ...............     ..   ....+..+.+++.+||+ +|.+|   +++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~~-----p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH-----ETYRKIINWRETLYF-----PD---DIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH-----HHHHHHHccCCccCC-----CC---CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999998543221     111111111111110     00   01124568899999997 66665   5999


Q ss_pred             HHHHH
Q 040952          359 DVVSM  363 (411)
Q Consensus       359 evl~~  363 (411)
                      |++..
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-40  Score=316.69  Aligned_cols=265  Identities=26%  Similarity=0.382  Sum_probs=206.5

Q ss_pred             hcCCCccCcccccCcccEEEEEecC--------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (411)
                      ..+|++.+.||+|+||.||+|....        +..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3568899999999999999997421        2368999887542 33456788999999999 899999999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                      +..++++||+++|+|.+++....             ....+++..+..++.|++.||+|||+++   ++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999986432             1234788888999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 040952          227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  305 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  305 (411)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....     
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  242 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----  242 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence            9999999999999876543322222222344567999999999999999999999999999998 7888753221     


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCC
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP  373 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  373 (411)
                      .... ...........          +...+..+.+++.+||+.+|++|||+.|+++.|.++......
T Consensus       243 ~~~~-~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~  299 (334)
T cd05100         243 EELF-KLLKEGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST  299 (334)
T ss_pred             HHHH-HHHHcCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence            1111 11111111110          111245788999999999999999999999999988754443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-41  Score=312.26  Aligned_cols=256  Identities=29%  Similarity=0.413  Sum_probs=203.3

Q ss_pred             cCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .+|...+.||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999742      356799999887666666789999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCC------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          165 IYEYMPNKSLDFFLFDPTK------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                      +|||+++++|.+++.....            ...+++..+..++.|++.|++|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            134788899999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  311 (411)
                      +|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||......     .....
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----EAIEC  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----HHHHH
Confidence            9999999876543222222223345678999999998999999999999999999998 88887432211     01111


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                       .........          +...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       237 -~~~~~~~~~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 -ITQGRELER----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHcCccCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             111100000          1112456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-41  Score=319.21  Aligned_cols=241  Identities=27%  Similarity=0.361  Sum_probs=189.4

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|... +++.||+|.+...   .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 4789999998753   223344556677777654 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            9999888543   34788888999999999999999988   9999999999999999999999999987643222  22


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......     .........       .+.+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~-------~~~~~----  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSILND-------RPHFP----  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcC-------CCCCC----
Confidence            33457899999999999989999999999999999999999998643221     111111110       01111    


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMN-DVVS  362 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  362 (411)
                       ...+..+.+++.+||+.+|++||++. ++++
T Consensus       217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 -RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             11245678999999999999999976 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=326.66  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=202.9

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 58999999987532   234567889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998654   34888899999999999999999988   999999999999999999999999999765432


Q ss_pred             C---------------------------cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 040952          247 E---------------------------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  299 (411)
Q Consensus       247 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  299 (411)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011233568999999999999999999999999999999999999986443


Q ss_pred             ccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 040952          300 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT-MNDVVSM  363 (411)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~  363 (411)
                      ..     ..............     +...   ...+..+.+++.+|++ +|.+||+ +.++++.
T Consensus       235 ~~-----~~~~~i~~~~~~~~-----~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQ-----ETYNKIINWKESLR-----FPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-----HHHHHHhccCCccc-----CCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11     11111111000000     0000   0025678899999997 9999999 9999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-41  Score=321.74  Aligned_cols=242  Identities=24%  Similarity=0.311  Sum_probs=192.8

Q ss_pred             CcccccCcccEEEEEec----CCCEEEEEEccCC----CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +.||+|+||.||++...    .++.||+|.+...    .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999852    4789999998643    222345577899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++...   ..+.+.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            9999999888543   34677788889999999999999998   9999999999999999999999999987543221 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ........ ... .     +. 
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~-~~~-~-----~~-  220 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILK-GKL-N-----LP-  220 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc-CCC-C-----CC-
Confidence             1123357899999999999888999999999999999999999998643211     11111111 100 0     11 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                          ...+..+.+++.+||+.+|++||     ++.++++.
T Consensus       221 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         221 ----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                11245688999999999999999     78888763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5e-41  Score=308.41  Aligned_cols=260  Identities=22%  Similarity=0.355  Sum_probs=208.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+...   .....+.+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999976 6899999988643   2233567889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+++++|..++... .....+++..+..++.+++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999888543 22345788999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ...  ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......   ....... .....    .   
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~----~---  225 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK-IEKCD----Y---  225 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhh-hhcCC----C---
Confidence            221  122346788999999999888999999999999999999999997533211   1111111 11100    0   


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                        ...+....+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence              01111233567899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.1e-41  Score=314.15  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=206.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (411)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            567888999999999999999741        24579999987542 34456788999999999 899999999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                      ...+++|||+++|+|.+++.....             ...+++..+..++.|++.||.|||+++   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999865321             234778888999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 040952          227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  305 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  305 (411)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....     .
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence            9999999999999987654332222233345678999999998889999999999999999998 777764322     1


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      .... ..........          .+...+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       246 ~~~~-~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 EELF-KLLKEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHH-HHHHcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            1111 1111111000          011235678999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=309.17  Aligned_cols=252  Identities=29%  Similarity=0.404  Sum_probs=200.7

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4578889999999999999998777789999986543 234567889999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|.+++....  ..+++.....++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            999999986433  24789999999999999999999998   9999999999999999999999999987654322111


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......     .... ....     .....   
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~-~~~~-----~~~~~---  222 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----VVES-VSAG-----YRLYR---  222 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHH-HHcC-----CcCCC---
Confidence             111233457999999998899999999999999999999 788876432211     1111 1110     00000   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                        +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       223 --~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 --PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence              0112567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.2e-41  Score=311.41  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=207.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeec-CCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  162 (411)
                      .++|.+.+.||+|+||.||+|.+..     +..|++|.+... .......+.+|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            5778899999999999999999765     678999988754 23345678899999999999999999998776 4678


Q ss_pred             EEEEeeCCCCCchhhhcCCCCC-----cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                      +++++|+++++|..++......     ..+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653222     45889999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcC
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      |+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||.....  ....    ......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~----~~~~~~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMA----AYLKDG  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHH----HHHHcC
Confidence            99976543322222222345678999999988889999999999999999999 9999854321  1111    111111


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .     ....     ....+..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       236 ~-----~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         236 Y-----RLAQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             C-----CCCC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            0     0000     011245689999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=311.03  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=199.8

Q ss_pred             CCccCcccccCcccEEEEEecC----CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc-----
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-----  161 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  161 (411)
                      |.+.+.||+|+||.||+|....    +..||+|++....  ......+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999998642    3679999987542  2345678999999999999999999998876554     


Q ss_pred             -eEEEEeeCCCCCchhhhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          162 -KILIYEYMPNKSLDFFLFDPT---KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       162 -~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                       .++++||+++++|..++....   ....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998875421   2245888899999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcC
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      |+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  ...    .....+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~----~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIY----DYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcC
Confidence            99986643332222222335678999999988889999999999999999999 88887532211  111    111111


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ....          .+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       232 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111          0112356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.6e-41  Score=314.83  Aligned_cols=262  Identities=27%  Similarity=0.400  Sum_probs=205.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (411)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999753        13569999997542 33456788899999999 799999999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                      +..++||||+++|+|.+++.....             ...+++.....++.|++.||+|||+++   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999865321             134788899999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 040952          227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  305 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  305 (411)
                      +.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            9999999999999876543222111222234568999999998889999999999999999998 8888743221     


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ... ..........+          .+...+..+.+++.+||+.+|++|||+.++++.|..+.+.
T Consensus       249 ~~~-~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         249 EEL-FKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHH-HHHHHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            111 11111111000          0112256788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.2e-41  Score=320.47  Aligned_cols=248  Identities=22%  Similarity=0.347  Sum_probs=194.1

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|... +++.||+|++...   .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 4789999998754   223345677888888877 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            9998887543   34888999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc---ccchhHHHHHHhhcCcccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD---SLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......+..........      .+  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~--  224 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI--  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC--
Confidence            23457899999999999999999999999999999999999998532211   11112222222221111      01  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPT------MNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~~  363 (411)
                         +...+..+.+++.+||+.||++||+      +.++++.
T Consensus       225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         225 ---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               1122456889999999999999998      4666544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.5e-41  Score=309.69  Aligned_cols=255  Identities=23%  Similarity=0.359  Sum_probs=201.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++...+..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999999964 5889999999765555556788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++...   ..+++.....++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            9999999988543   34788899999999999999999988   9999999999999999999999999997654221 


Q ss_pred             ccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                       .......|+..|+|||.+.   ...++.++|||||||++|||++|+.||......... .    . ....   ....+.
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~----~-~~~~---~~~~~~  230 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-F----L-MSKS---NFQPPK  230 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-e----e-eecC---CCCCCC
Confidence             1122346888999999874   445788999999999999999999997432211000 0    0 0000   000000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      ..   .....+..+.+++.+||+.+|++|||+.++++.|
T Consensus       231 ~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 LK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             Cc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00   0112246789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.6e-41  Score=322.67  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=195.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||+||++... +++.||+|++....   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999865 48899999987532   233456788999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999998543   34888999999999999999999998   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------------cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 040952          247 ELQ---------------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  293 (411)
Q Consensus       247 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~  293 (411)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123479999999999999999999999999999999999999


Q ss_pred             CCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 040952          294 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQ--ESADDRPTMNDVVSM  363 (411)
Q Consensus       294 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~evl~~  363 (411)
                      ||......     ..............     +....   ..+..+.+++.+++.  .++..||++.|+++.
T Consensus       235 Pf~~~~~~-----~~~~~i~~~~~~~~-----~p~~~---~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQ-----ETYKKVMNWKETLI-----FPPEV---PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHH-----HHHHHHHcCcCccc-----CCCcC---CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            98643211     11111111100000     01110   123456777777543  233456899999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-41  Score=320.63  Aligned_cols=252  Identities=22%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             CCCccCcccccCcccEEEEEec----CCCEEEEEEccCC----CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCce
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR----SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (411)
                      +|++.+.||+|+||.||+++..    +|+.||+|++...    .....+.+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999998752    4789999998643    222345678899999999 599999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||+++|+|..++...   ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999988543   34788899999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..........       
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~-------  225 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK-------  225 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-------
Confidence            5332211 22335799999999998865 478899999999999999999999864332111 1111111111       


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      .++.+.     ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       226 ~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 CDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            011111     11245688999999999999999     77788754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-40  Score=311.21  Aligned_cols=264  Identities=27%  Similarity=0.435  Sum_probs=201.3

Q ss_pred             cCCCccCcccccCcccEEEEEec-----------------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCccccee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-----------------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRL  152 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  152 (411)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+.... ......+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999998532                 23468999987543 3345678899999999999999999


Q ss_pred             eeeeecCCceEEEEeeCCCCCchhhhcCCCC--------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 040952          153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTK--------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  224 (411)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni  224 (411)
                      ++++...+..+++|||+++++|..++.....        ...+++.....++.|++.||+|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999998865321        124677889999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcccc
Q 040952          225 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDS  302 (411)
Q Consensus       225 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~  302 (411)
                      +++.++.++|+|||++..+.............++..|++||...++.++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999876543322222223344678999999888889999999999999999998  66676432211 


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                       .........+........+ +      .+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       241 -~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 -QVIENTGEFFRDQGRQVYL-P------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -HHHHHHHHHHhhccccccC-C------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             1111111111111000000 0      011124678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-40  Score=309.98  Aligned_cols=261  Identities=28%  Similarity=0.421  Sum_probs=203.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ..++|++.+.||+|+||.||+|..++      +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45789999999999999999997542      4579999886543 2233467889999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCC-------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          162 KILIYEYMPNKSLDFFLFDPTK-------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                      .++||||+++|+|.+++.....       .....+.....++.|++.||.|||+++   ++||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999864221       233566778899999999999999998   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHh
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......     +... ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~-~~  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLK-FV  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-HH
Confidence            99999876543322222222345678999999998899999999999999999999 67787532211     1111 11


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      ........          +...+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus       235 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 MDGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11111110          1112457999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-41  Score=309.30  Aligned_cols=259  Identities=21%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|... +|+.+|||.+...   .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999964 6899999987643   2233457889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+++++|.+++... .....+++...+.++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988542 22345889999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ...  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........   .....      .....+ 
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~------~~~~~~-  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKI------EQCDYP-  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH---Hhhhh------hcCCCC-
Confidence            221  112346888999999998888999999999999999999999997532211111   11100      000011 


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                         .......+..+.+++.+||+.+|++|||+.+|++.++..
T Consensus       227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence               111122356799999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-41  Score=308.87  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=204.5

Q ss_pred             hcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678889999999999999998653      3689999987543 23345688999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCC-------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          163 ILIYEYMPNKSLDFFLFDPTK-------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                      ++||||+++++|..++.....       ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999864321       224678889999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhh
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      |||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......  ..    .....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~----~~~~~  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EV----LKFVI  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HH----HHHHh
Confidence            9999876544332222233456788999999988889999999999999999998 88887532211  11    11111


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      .......     .     ...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       236 ~~~~~~~-----~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 DGGHLDL-----P-----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             cCCCCCC-----C-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1111111     1     1115678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-41  Score=318.50  Aligned_cols=248  Identities=22%  Similarity=0.338  Sum_probs=195.4

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|... +++.||+|++...   .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999975 4889999999753   223345678899999988 799999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            9998887543   34899999999999999999999998   999999999999999999999999998642211  112


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc---cchhHHHHHHhhcCcccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|+.||.......   .....+.......... .     +. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~p-  225 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-----IP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----CC-
Confidence            234578999999999999999999999999999999999999986432111   1111222222221111 0     11 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPT------MNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~~  363 (411)
                          ...+..+.+++.+||+.||.+||+      +.++++.
T Consensus       226 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         226 ----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                112456889999999999999997      6777653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.3e-41  Score=309.89  Aligned_cols=247  Identities=24%  Similarity=0.331  Sum_probs=194.8

Q ss_pred             ccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           99 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ||+|+||+||++... +|+.||+|.+....   ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999865 58899999986532   22345677899999999999999999999999999999999999999


Q ss_pred             hhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccc
Q 040952          175 DFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS  253 (411)
Q Consensus       175 ~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  253 (411)
                      ..++... .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8877542 23345889999999999999999999998   99999999999999999999999999876543221  123


Q ss_pred             cccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchH
Q 040952          254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK  333 (411)
Q Consensus       254 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  333 (411)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ........         ....   ..+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~---------~~~~---~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRIL---------NDSV---TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhc---------ccCC---CCcc
Confidence            357899999999999999999999999999999999999998643321110 00000000         0000   0011


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          334 HMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       334 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      ..+..+.+++.+||+.||++||     ++.++++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            2356789999999999999999     77778764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-40  Score=322.08  Aligned_cols=262  Identities=24%  Similarity=0.363  Sum_probs=204.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcC-CcccceeeeeeecCC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  160 (411)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||+|++..... ...+.+.+|+.++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888899999999999999854      245799999976432 33456889999999997 999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC---------------------------------------------------------
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK---------------------------------------------------------  183 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  183 (411)
                      ..++||||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999998854211                                                         


Q ss_pred             --------------------------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 040952          184 --------------------------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  225 (411)
Q Consensus       184 --------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil  225 (411)
                                                            ...+++.....++.|++.||+|||+.+   ++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                  123667778899999999999999987   999999999999


Q ss_pred             EcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 040952          226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  304 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  304 (411)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......  
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--  349 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--  349 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence            99999999999999976532221111223356788999999998889999999999999999998 888875332111  


Q ss_pred             hhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          305 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                         ........+.     ...     .+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       350 ---~~~~~~~~~~-----~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 ---QFYNAIKRGY-----RMA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ---HHHHHHHcCC-----CCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               1111111110     000     01112567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.6e-41  Score=311.43  Aligned_cols=257  Identities=30%  Similarity=0.450  Sum_probs=201.5

Q ss_pred             hcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|.+.+.||+|+||.||+|.+..      +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998753      5678999887543 33345688999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCC----CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---CeEEe
Q 040952          163 ILIYEYMPNKSLDFFLFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKIS  235 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~  235 (411)
                      ++||||+++++|.+++.....    ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    135888999999999999999999998   99999999999998754   59999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhh
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      |||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......  ...    ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~----~~~~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVM----EFVT  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHH
Confidence            9999987643222222222234568999999998899999999999999999997 88887533211  111    1111


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ......          .+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       236 ~~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            110000          01122457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-40  Score=308.95  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=202.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999864      36789999987543 23356688999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCC-------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 040952          163 ILIYEYMPNKSLDFFLFDPT-------------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  223 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N  223 (411)
                      ++++||+++++|.+++....                   ....+++..++.++.|++.||+|||..+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986321                   1134678888999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 040952          224 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  302 (411)
Q Consensus       224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  302 (411)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.....  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999876543322222222344667999999998899999999999999999998 7777642211  


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                         ...... ........          .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       239 ---~~~~~~-~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 ---EEVIYY-VRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HHHHHH-HhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               111111 11111110          011124678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-40  Score=307.39  Aligned_cols=262  Identities=25%  Similarity=0.390  Sum_probs=201.1

Q ss_pred             cCCCccCcccccCcccEEEEEec-----CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec--CCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  163 (411)
                      .+|++.+.||+|+||.||++..+     ++..||+|.+........+.+.+|+.+++.++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888899999999999999742     478999999987666667788999999999999999999998754  34678


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +|+||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            9999999999999985432  34788999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccc-cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc----------chhHHHHHH
Q 040952          244 GGNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL----------NLLGYAWDL  312 (411)
Q Consensus       244 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~----------~~~~~~~~~  312 (411)
                      ........ .....++..|+|||.+.+..++.++|||||||++|||++|..++........          .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            43221111 1112234569999999988899999999999999999998776532211000          000000000


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      .....          ........+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       239 ~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000          0001112246799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-41  Score=324.73  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=200.0

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|++.+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3578999999999999999999976 4889999998643   22334557789999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|..++...    .++......++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999988532    3677788889999999999999998   9999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccChhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......     ..............
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~~~~  267 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKNSLT  267 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCcCC
Confidence            3221 112345799999999998653    4789999999999999999999998643211     11111111111000


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  363 (411)
                      .     ..   ....+..+.+++.+||+.+|++  |||+.++++.
T Consensus       268 ~-----~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 F-----PD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C-----CC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0     00   0112567889999999999987  9999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.4e-41  Score=306.77  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=201.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            357888999999999999999988888999999876433 3457899999999999999999999875 45689999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999986532 234788899999999999999999998   999999999999999999999999999765432211


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....  ..   ..... ...     .....  
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~---~~~~~-~~~-----~~~~~--  224 (260)
T cd05070         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--RE---VLEQV-ERG-----YRMPC--  224 (260)
T ss_pred             c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HH---HHHHH-HcC-----CCCCC--
Confidence            1 112235667999999988889999999999999999999 8888753221  11   11111 110     00000  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                         +...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       225 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 ---PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               11224678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-41  Score=321.22  Aligned_cols=242  Identities=25%  Similarity=0.344  Sum_probs=193.3

Q ss_pred             CcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|+... ++.||+|++...   .....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999764 789999998753   233445677888888876 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            9998888543   34788888999999999999999998   9999999999999999999999999987543221  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     .......... .      ..     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~-~------~~-----  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDD-V------LY-----  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC-C------CC-----
Confidence            23457899999999999989999999999999999999999998643311     1111111111 0      00     


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRP-------TMNDVVSM  363 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~~  363 (411)
                      +...+..+.+++.+||+.||++||       ++.++++.
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            111245688999999999999999       88888755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3e-41  Score=317.79  Aligned_cols=240  Identities=28%  Similarity=0.370  Sum_probs=189.9

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|.+. +|+.||+|.+....   .........|..++... +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 48899999987531   23345567788888765 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.++|+|||+++......  ..
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            9998888543   34788888999999999999999998   9999999999999999999999999986432111  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..    .......      .+.+..   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~----~~~~~~~------~~~~~~---  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--EL----FESIRVD------TPHYPR---  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH----HHHHHhC------CCCCCC---
Confidence            23457899999999999999999999999999999999999998643211  11    1111110      011111   


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMN-DVV  361 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl  361 (411)
                        ..+..+.+++.+||+.||++||++. +++
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 --WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              1245688999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.4e-41  Score=310.57  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=202.6

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCC----EEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.+. +|+    .||+|.+.... ......+.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            357888899999999999999854 344    48999987543 3345678899999999999999999999875 4578


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +++||+++|+|.+++....  ..+++.....++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            9999999999999986532  34788899999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .............++..|+|||...+..++.++|||||||++|||++ |..||......  ...    ..........  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~~--  231 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIP----DLLEKGERLP--  231 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHCCCcCC--
Confidence            43222211222244678999999998899999999999999999998 88887533211  111    1111111000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                              .+...+..+.+++.+||+.||++||++.++++.|.......
T Consensus       232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                    01112456889999999999999999999999998775543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-41  Score=320.44  Aligned_cols=236  Identities=26%  Similarity=0.358  Sum_probs=189.5

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|..+ +++.||+|++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 4889999998743   233455677888888876 799999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            9999888543   34788899999999999999999998   9999999999999999999999999987542211  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..... ......      ..     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~-i~~~~~------~~-----  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEA-ILNDEV------VY-----  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHH-HhcCCC------CC-----
Confidence            23457899999999999989999999999999999999999998643311     11111 111110      00     


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTM  357 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~  357 (411)
                      +...+..+.+++.+||+.||++||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11124568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.9e-41  Score=306.29  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=202.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.++++..||+|++.... ...+.+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            35699999999999999999998777789999997543 23457889999999999999999999875 45679999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999986532 234688889999999999999999988   999999999999999999999999999766433221


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      . .....++..|+|||...+..++.++|||||||++|||++ |..||.......      .........     ..    
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~-----~~----  222 (262)
T cd05071         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGY-----RM----  222 (262)
T ss_pred             c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhcCC-----CC----
Confidence            1 122345678999999988889999999999999999999 777875322110      111111110     00    


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                       ......+..+.+++.+|++.+|++||++.++++.|++.
T Consensus       223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             01122356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-41  Score=302.20  Aligned_cols=265  Identities=22%  Similarity=0.292  Sum_probs=199.5

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc--cHHHHHHHHHHHHhcCCcc-cceeeeeeecCC------
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKN-LVRLLGCCIDKD------  160 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  160 (411)
                      ..|...+.||+|+||+||+|+.. +|+.||+|++......  ......+|+.++++++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45667788999999999999955 5899999999765332  2345689999999999999 999999999877      


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCC-cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKR-MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ..++|+||++ .+|..++...... ..++......++.||++||+|||+++   |+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7889999985 4888888654422 34666788999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--  316 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  316 (411)
                      |+...-...  ..+..++|..|+|||++.+. .|+...||||+|||+.||+++++-|......  +...........+  
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHHcCCCCc
Confidence            986553222  23345789999999999987 6999999999999999999998877654431  1111111111111  


Q ss_pred             ----ccccc--cccccccccch----HHH---HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 ----RTLEL--IDPILEDEYSS----KHM---LLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 ----~~~~~--~~~~l~~~~~~----~~~---~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ....+  .+........+    ...   .....+++.+||+.+|.+|.|+..++++
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                00001  11111111101    111   1478899999999999999999999986

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.2e-42  Score=323.41  Aligned_cols=242  Identities=22%  Similarity=0.290  Sum_probs=193.6

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.||+|+||.||++... +|+.||+|.+...   .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 5899999998753   2233456778999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      +|..++...   ..+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            998887543   348899999999999999999997 56   9999999999999999999999999987532211  11


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......     . .........      .+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~-~~~i~~~~~------~~p----  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----L-FELILMEEI------RFP----  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----H-HHHHhcCCC------CCC----
Confidence            233568999999999999999999999999999999999999986432111     0 011111100      011    


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                       ...+..+.+++.+||+.||++|+     ++.++++.
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 -RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             11245688999999999999996     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-41  Score=320.75  Aligned_cols=246  Identities=26%  Similarity=0.309  Sum_probs=194.7

Q ss_pred             CCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCc-ccceeeeeeecCCceEEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  166 (411)
                      +|++.+.||+|+||.||+|.... ++.||+|++...   .....+.+..|..++..++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47888999999999999999764 789999998753   233456678899999999765 5888999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|..++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            999999999888543   34788889999999999999999998   999999999999999999999999998653221


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ....... ...      ..+
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~-~~~------~~~  220 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQSIM-EHN------VSY  220 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHH-cCC------CCC
Confidence            1  1223457899999999999999999999999999999999999998643211     1111111 100      001


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTM-----NDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  362 (411)
                      .     ...+..+.+++.+||+.+|.+|++.     .++++
T Consensus       221 ~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         221 P-----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             C-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1     1124568899999999999999986     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.8e-42  Score=323.09  Aligned_cols=238  Identities=24%  Similarity=0.294  Sum_probs=190.4

Q ss_pred             CcccccCcccEEEEEe----cCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           97 NKLGEGGFGPVYKGVL----KKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      +.||+|+||.||++..    .+|+.||+|++....  ......+..|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    248899999987542  2233456789999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            99999888543   34889999999999999999999998   9999999999999999999999999987654321  1


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ......... ..      .+    
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~-~~------~~----  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKA-KL------GM----  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcC-CC------CC----
Confidence            223357899999999999888999999999999999999999998643211     111111110 00      00    


Q ss_pred             chHHHHHHHHHHHHHccccCCCCCCCHHH
Q 040952          331 SSKHMLLRYVNIALLCVQESADDRPTMND  359 (411)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~~p~~RPt~~e  359 (411)
                       +...+..+.+++.+||+.||++||++.+
T Consensus       218 -p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 -PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             1112456889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.1e-40  Score=309.53  Aligned_cols=262  Identities=27%  Similarity=0.383  Sum_probs=203.5

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CC--EEEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568889999999999999998754 33  4788888743 333456788999999999 799999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          166 YEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                      +||+++++|.+++....             ....+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1134788899999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  311 (411)
                      ||+|||++......   ........+..|+|||.+.+..++.++|||||||++|||++ |..||.......      ...
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence            99999998643211   11111223557999999988889999999999999999998 999985332111      111


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCC
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP  374 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  374 (411)
                      ....+     .....     +...+..+.+++.+||+.+|.+|||+.++++.|.+......+.
T Consensus       230 ~~~~~-----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~  282 (297)
T cd05089         230 KLPQG-----YRMEK-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY  282 (297)
T ss_pred             HHhcC-----CCCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence            11111     00000     1112457889999999999999999999999999887765443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-40  Score=307.83  Aligned_cols=247  Identities=24%  Similarity=0.342  Sum_probs=193.0

Q ss_pred             ccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           99 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ||+|+||.||++..+ +|+.||+|.+....   ......+..|++++++++||||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999865 48999999986432   12234456799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      ..++.... ...+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            88875432 234788888999999999999999988   9999999999999999999999999987654322   1223


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.||........ .......... ..    +..      ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~~----~~~------~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-DE----VKF------EHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-cc----ccc------cccc
Confidence            4689999999999988899999999999999999999999864332111 0111111110 00    000      0111


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          335 MLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      .+.++.+++.+||+.||++||++.|+++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            255689999999999999999997766444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-40  Score=310.57  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=204.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            467899999999999999999742      24579999987543 33356788999999999 79999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .+++|||+++|+|..++..... ..+++.....++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999864332 33789999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......     ..........   
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-----~~~~~~~~~~---  261 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-----KFYKLIKEGY---  261 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-----HHHHHHHcCC---
Confidence            6543221111222345778999999998899999999999999999998 898875332111     0011111110   


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        ...     .+...+..+.+++.+||+.+|++|||+.|+++.|.+.
T Consensus       262 --~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 --RMA-----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --cCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              000     0111245789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-40  Score=302.97  Aligned_cols=247  Identities=29%  Similarity=0.420  Sum_probs=194.7

Q ss_pred             cccccCcccEEEEEec---CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           98 KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      .||+|+||.||+|.++   ++..+|+|++....  ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   47889999986543  233567889999999999999999999875 45678999999999


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc-c
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA-N  251 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~  251 (411)
                      +|.+++...   ..+++.....++.|++.|++|||+++   ++||||||+||+++.++.++|+|||++.......... .
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            999998543   34788999999999999999999988   9999999999999999999999999998764332211 1


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                      .....++..|+|||.+....++.++|+|||||++|||++ |..||......  .   .. ..........     ..   
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~---~~-~~i~~~~~~~-----~~---  220 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--E---VT-QMIESGERME-----CP---  220 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H---HH-HHHHCCCCCC-----CC---
Confidence            112234578999999988889999999999999999998 99998643221  1   11 1111111111     11   


Q ss_pred             chHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        ...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus       221 --~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         221 --QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              11256788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-41  Score=320.23  Aligned_cols=237  Identities=24%  Similarity=0.294  Sum_probs=186.4

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHH-HHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 58999999986532   222334445544 56778999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            9999888543   34788888999999999999999998   9999999999999999999999999986532211  22


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......... ...      .+..   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~-~~~------~~~~---  217 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILN-KPL------RLKP---  217 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHc-CCC------CCCC---
Confidence            3345789999999999999999999999999999999999999864321     111111111 100      0011   


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMN  358 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~  358 (411)
                        ..+..+.+++.+||+.+|++||++.
T Consensus       218 --~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 --NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              1255688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.2e-41  Score=325.45  Aligned_cols=253  Identities=22%  Similarity=0.312  Sum_probs=196.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999965 48899999986432   233456789999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..++......++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999998543   34788888899999999999999998   999999999999999999999999997532100


Q ss_pred             Cc-----------------------------------------ccccccccccccccChhhhccCCCCcchhhHHHHHHH
Q 040952          247 EL-----------------------------------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL  285 (411)
Q Consensus       247 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il  285 (411)
                      ..                                         .......+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0001134799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCC---CHHHHHH
Q 040952          286 LEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP---TMNDVVS  362 (411)
Q Consensus       286 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~  362 (411)
                      |||++|+.||.......     ..............     ..   ....+..+.+++.+|+ .+|.+|+   ++.++++
T Consensus       235 yell~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~-----~~---~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTPAE-----TQLKVINWETTLHI-----PS---QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCHHH-----HHHHHhccCccccC-----CC---CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999986433211     11111111000000     00   0112456778888876 5999999   8899986


Q ss_pred             H
Q 040952          363 M  363 (411)
Q Consensus       363 ~  363 (411)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-40  Score=301.42  Aligned_cols=250  Identities=34%  Similarity=0.492  Sum_probs=202.7

Q ss_pred             CcccccCcccEEEEEecC----CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|....    +..|++|.+...... ..+.+.+|++.++.++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999764    788999999865433 367889999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCC------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          172 KSLDFFLFDPTK------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       172 g~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ++|.+++.....      ...+++..++.++.|+++||+|||+++   ++||||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999866421      256899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....     ...... .......     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~-~~~~~~~-----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEY-LRKGYRL-----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH-HHcCCCC-----
Confidence            332222334467889999999988889999999999999999999 5888764421     111111 1111100     


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      .     .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       227 ~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 P-----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C-----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0     11122567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-40  Score=316.33  Aligned_cols=262  Identities=27%  Similarity=0.393  Sum_probs=201.3

Q ss_pred             hcCCCccCcccccCcccEEEEEe------cCCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC-C
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK-D  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  160 (411)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999973      246789999997543 23356688999999999 689999999988654 4


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC---------------------------------------------------------
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK---------------------------------------------------------  183 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  183 (411)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999988754210                                                         


Q ss_pred             -------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccccc
Q 040952          184 -------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV  256 (411)
Q Consensus       184 -------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  256 (411)
                             ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123677888899999999999999998   9999999999999999999999999987653322212222234


Q ss_pred             ccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHH
Q 040952          257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM  335 (411)
Q Consensus       257 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  335 (411)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .   . ...........     ..     ...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~---~-~~~~~~~~~~~-----~~-----~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E---F-CRRLKEGTRMR-----AP-----DYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H---H-HHHHhccCCCC-----CC-----CCC
Confidence            5678999999988899999999999999999997 888875432111 0   1 11111111000     00     011


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          336 LLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       336 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      +..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3468899999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.6e-42  Score=307.43  Aligned_cols=258  Identities=23%  Similarity=0.325  Sum_probs=191.4

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----ceEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKILI  165 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  165 (411)
                      .|...+.+|.|+||.||+|... +++.||||+.-...+    .-.+|+.+|+.++|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666789999999999999965 478999998865433    2257999999999999999999887533     33589


Q ss_pred             EeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCCcccc
Q 040952          166 YEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARIC  243 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl~~~~  243 (411)
                      |||++. +|...++.. ..+..++.....-+..||++||+|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 666666431 12334666777889999999999999988   9999999999999976 99999999999987


Q ss_pred             CCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc----
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT----  318 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  318 (411)
                      ...+..   .....|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|...+. ..++. .....+-.+.-    
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~-eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLV-EIIKVLGTPTREDIK  251 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHH-HHHHHhCCCCHHHHh
Confidence            654433   223568899999998875 599999999999999999999998865322 11111 11111111100    


Q ss_pred             ------ccccccccccc----cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          319 ------LELIDPILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       319 ------~~~~~~~l~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                            .+...+.+...    ......+.+..+|+.++|+.+|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  01111111111    122234677899999999999999999999984

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.5e-41  Score=325.02  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=194.4

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .|+..+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999965 48899999987532   2334578899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999988543   34788888899999999999999998   9999999999999999999999999975321100


Q ss_pred             c---------------------------------------------ccccccccccccccChhhhccCCCCcchhhHHHH
Q 040952          248 L---------------------------------------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG  282 (411)
Q Consensus       248 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  282 (411)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 040952          283 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MND  359 (411)
Q Consensus       283 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e  359 (411)
                      |++|||++|+.||......     ...............     .   .....+..+.+++.+|+ .+|++|++   +.+
T Consensus       236 vil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~~-----p---~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPL-----ETQMKVINWQTSLHI-----P---PQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHH-----HHHHHHHccCCCcCC-----C---CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999998643211     111111111000000     0   01112456778888876 49999997   888


Q ss_pred             HHHH
Q 040952          360 VVSM  363 (411)
Q Consensus       360 vl~~  363 (411)
                      +++.
T Consensus       302 i~~h  305 (382)
T cd05625         302 IKAH  305 (382)
T ss_pred             HhcC
Confidence            7753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.6e-40  Score=311.33  Aligned_cols=261  Identities=27%  Similarity=0.422  Sum_probs=204.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (411)
                      .++|.+.+.||+|+||.||++...        .+..+|+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            367888999999999999999742        24579999987542 33456788999999999 699999999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                      +..+++|||+++|+|..++....             ....+++.....++.|++.||.|||+++   ++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999986532             1234788889999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 040952          227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  305 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  305 (411)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  . 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~-  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E-  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H-
Confidence            9999999999999976543222111222234567999999998899999999999999999999 88887432211  1 


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                         .............          +...+..+.+++.+||+.+|++|||+.++++.|.+...
T Consensus       245 ---~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ---LFKLLREGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ---HHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               1111111111000          11124568899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-40  Score=304.97  Aligned_cols=254  Identities=27%  Similarity=0.404  Sum_probs=191.9

Q ss_pred             CcccccCcccEEEEEecC---CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.||+|+||.||+|...+   +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45799998875432 33456888999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCC--CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          173 SLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       173 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +|.+++.....  ....++.....++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999864321  234566777889999999999999988   9999999999999999999999999987544332222


Q ss_pred             ccccccccccccChhhhccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEG-------IFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ......++..|+|||++.+.       .++.++|+||||+++|||++ |+.||.......  ....   ... .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~---~~~-~~~~~~~  231 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY---TVR-EQQLKLP  231 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH---Hhh-cccCCCC
Confidence            22334678889999988642       35789999999999999996 999986433211  1111   011 1111111


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ++.+...     ....+.+++..|+ .+|++|||+.||+..|+
T Consensus       232 ~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLKLP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccCCC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1211111     1345788999998 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-40  Score=340.85  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=202.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++....   ....+++.+|+.++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999976 48999999987532   223456889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCC--------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          167 EYMPNKSLDFFLFDPTK--------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                      ||++|++|.+++.....        ....++.....++.|+++||+|||+++   |+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998854211        123556677899999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCc----------------ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 040952          239 MARICGGNEL----------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  302 (411)
Q Consensus       239 l~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  302 (411)
                      ++........                ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521110                001123469999999999999999999999999999999999999986422111


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhccc
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-TMNDVVSMLTNEAA  369 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~  369 (411)
                      ..     ..    .   ....+.-  ..+....+..+.+++.+||+.||++|| ++.++++.|+....
T Consensus       239 i~-----~~----~---~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 IS-----YR----D---VILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh-----hh----h---hccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00     00    0   0000000  000112345688999999999999995 66777777776644

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-40  Score=306.63  Aligned_cols=248  Identities=23%  Similarity=0.373  Sum_probs=197.1

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      +|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5778899999999999999864 5889999998654 2334467889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|..+.       .+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......   
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            999997552       2577788899999999999999998   999999999999999999999999998765422   


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchh--HHHHHHhhcCccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL--GYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~  327 (411)
                       ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........  ..... .....     .+.+ 
T Consensus       149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~-  220 (279)
T cd06619         149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDED-----PPVL-  220 (279)
T ss_pred             -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccC-----CCCC-
Confidence             12335789999999999988999999999999999999999999864332111110  00000 00000     0001 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         .....+..+.+++.+||+.+|++||++.|+++.
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 ---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               011124568999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=307.94  Aligned_cols=252  Identities=27%  Similarity=0.328  Sum_probs=199.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      +|++.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999965 58899999986532   2223456789999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|..++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999998875432 234889999999999999999999998   9999999999999999999999999987654222


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      .   .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......  .............      .   
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~------~---  222 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVKEDQ------E---  222 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhhhcc------c---
Confidence            1   123478999999999998889999999999999999999999986432211  0000000000000      0   


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                       . .+...+..+.+++.+||+.||++||     ++.++++.
T Consensus       223 -~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         223 -E-YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -c-cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             0 1112356789999999999999999     88898664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.6e-41  Score=314.96  Aligned_cols=241  Identities=27%  Similarity=0.370  Sum_probs=190.4

Q ss_pred             CcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|.+.. ++.||+|.+....   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999764 7899999987541   23345566778888764 999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            9999988543   34788888999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..... ....      .+...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~-i~~~------~~~~~----  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----ELFQS-IRMD------NPCYP----  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HHhC------CCCCC----
Confidence            23457899999999999989999999999999999999999998643211     11111 1110      01111    


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMN-DVVS  362 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  362 (411)
                       ...+..+.+++.+||+.+|++||++. ++++
T Consensus       217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 -RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             11245688999999999999999997 5643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.2e-41  Score=316.52  Aligned_cols=242  Identities=27%  Similarity=0.340  Sum_probs=193.9

Q ss_pred             CcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|.+.. ++.||+|++...   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999764 789999998753   233455677888999888 799999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            9998887543   24889999999999999999999998   9999999999999999999999999986532111  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      ....+|++.|+|||++.+..++.++|||||||++|+|++|+.||......     ..... ......      ..     
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~-i~~~~~------~~-----  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQS-ILEDEV------RY-----  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHH-HHcCCC------CC-----
Confidence            23357899999999999999999999999999999999999998643211     11111 111110      00     


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTM-----NDVVSM  363 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~~  363 (411)
                      +...+..+.+++.+||+.||++|||+     .++++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            11124578999999999999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.4e-41  Score=312.36  Aligned_cols=253  Identities=23%  Similarity=0.383  Sum_probs=204.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ....+|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++||
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            34578999999999999999999864 58899999998765555677889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++.+    ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999998843    23788889999999999999999998   999999999999999999999999998765322


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .  .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......     ..........      +.+
T Consensus       170 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~~~~~~~------~~~  236 (296)
T cd06654         170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGT------PEL  236 (296)
T ss_pred             c--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHHHhcCCC------CCC
Confidence            2  11223468899999999998889999999999999999999999985432211     0000000000      000


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         ..+......+.+++.+||..+|++|||+.++++.
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence               0112234668899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-40  Score=300.95  Aligned_cols=250  Identities=28%  Similarity=0.376  Sum_probs=202.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|++|.||+|... +|+.|++|.+...  .......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999975 4889999998643  334456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++.... ...+++...+.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999986542 245888899999999999999999988   99999999999999999999999999876653321


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......|++.|+|||+..+..++.++|+|||||++|+|++|+.||......     ..... ......     +.+. 
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~-----~~~~-  222 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILK-IIRGVF-----PPVS-  222 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HHcCCC-----CCCc-
Confidence              122346888999999999888999999999999999999999998643311     11111 111100     0011 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ...+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 ----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                1225678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.5e-40  Score=298.20  Aligned_cols=247  Identities=27%  Similarity=0.367  Sum_probs=196.5

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCch
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD  175 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  175 (411)
                      +.||+|+||.||+|...+++.+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999876532 23346889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccc
Q 040952          176 FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  255 (411)
Q Consensus       176 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  255 (411)
                      +++....  ..+++.....++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........ ......
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  154 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK  154 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence            9885432  34788999999999999999999988   99999999999999999999999999875432221 111122


Q ss_pred             cccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       256 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      .++..|+|||.+.+..++.++||||||+++|++++ |..||......     . .........     ....     +..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~-~~~~~~~~~-----~~~~-----~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----Q-AREQVEKGY-----RMSC-----PQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----H-HHHHHHcCC-----CCCC-----CCC
Confidence            34567999999998889999999999999999998 88887533211     0 111111110     0000     111


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          335 MLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      .+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-40  Score=304.67  Aligned_cols=249  Identities=30%  Similarity=0.398  Sum_probs=198.6

Q ss_pred             CcccccCcccEEEEEecC--CC--EEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK--GD--EIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~--g~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|++|.||+|.+.+  ++  .||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998653  33  689999987655 556788999999999999999999999988 889999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc-
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA-  250 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-  250 (411)
                      ++|.+++.+... ..+++...+.++.|++.||+|||+++   ++|+||+|+||+++.++.+||+|||++.......... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999866432 45899999999999999999999998   9999999999999999999999999998765422111 


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......     ..............         
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~---------  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEGERLE---------  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcCCcCC---------
Confidence            1122456788999999998899999999999999999999 99997533211     11111111000000         


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                       .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             01112467899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.7e-40  Score=301.06  Aligned_cols=254  Identities=31%  Similarity=0.461  Sum_probs=203.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            46788999999999999999998889999999987543 33467889999999999999999999874 46789999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      .+++|.+++.... ...+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999885533 245788899999999999999999988   999999999999999999999999998765422211


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.||......  ..   ... ....     .....  
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~---~~~-~~~~-----~~~~~--  224 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EV---IQN-LERG-----YRMPR--  224 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HH---HHH-HHcC-----CCCCC--
Confidence             1122345678999999988889999999999999999999 99998533211  11   111 1110     00000  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                         +...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ---PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               11124579999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-40  Score=315.09  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=194.4

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|... +++.||+|++...   .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 4789999999754   223455678899999888 699999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            9998887433   34889999999999999999999998   9999999999999999999999999987532111  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-cchhHHHHHHhhcCcccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................ .     +    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-----~----  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-R-----I----  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-C-----C----
Confidence            234579999999999999999999999999999999999999996433211 1111222222211110 0     0    


Q ss_pred             chHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040952          331 SSKHMLLRYVNIALLCVQESADDRPTM------NDVVSM  363 (411)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~~  363 (411)
                       +...+..+.+++.+||+.||++||++      .++++.
T Consensus       223 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         223 -PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             11124567899999999999999984      466543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.6e-41  Score=321.28  Aligned_cols=255  Identities=21%  Similarity=0.263  Sum_probs=198.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ...++|++.+.||+|+||.||++... +++.+|+|.+...   .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999976 4889999998642   2233456788999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++|+|.+++...    .+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999988432    3678888899999999999999998   999999999999999999999999999875


Q ss_pred             CCCCcccccccccccccccChhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....     ..............
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~  266 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNSL  266 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCccc
Confidence            43221 122345799999999998754    378899999999999999999999864321     11111111111101


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNDVVSM  363 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  363 (411)
                      ..     .   .....+..+.+++.+||+.++..  ||++.|+++.
T Consensus       267 ~~-----p---~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NF-----P---EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CC-----C---CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            10     0   01122556788999999855543  8999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-41  Score=319.63  Aligned_cols=241  Identities=22%  Similarity=0.279  Sum_probs=187.8

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHH-HHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|... +|+.||+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 5899999998653   1223344555554 46778999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            9998887533   34788899999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.     ......... ...      .+..   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~-~~~------~~~~---  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILH-KPL------VLRP---  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHc-CCc------cCCC---
Confidence            2345789999999999999999999999999999999999999864321     111111111 100      0001   


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        ..+..+.+++.+||+.+|.+||++.+.++
T Consensus       218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         218 --GASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             --CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence              12456789999999999999998864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.3e-41  Score=318.59  Aligned_cols=246  Identities=26%  Similarity=0.326  Sum_probs=194.5

Q ss_pred             CCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      +|++.+.||+|+||.||+|.... ++.||+|.+....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47788999999999999999764 7899999987532   22344566788888777 5899999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999998888543   34788899999999999999999998   999999999999999999999999998754321


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..   .... .....      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~---~~~i-~~~~~------~~  220 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL---FQSI-MEHNV------AY  220 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HH---HHHH-HhCCC------CC
Confidence            1  1223457899999999999999999999999999999999999998643321  11   1111 11110      00


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTM-----NDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  362 (411)
                           +...+..+.+++.+||+.+|++|++.     .++++
T Consensus       221 -----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         221 -----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             -----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence                 11225678899999999999999985     56553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.5e-41  Score=306.31  Aligned_cols=252  Identities=30%  Similarity=0.450  Sum_probs=198.8

Q ss_pred             CCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHH--HHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      |++.+.||+|+||+||++.... ++.+|+|.+.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678899999999999999775 668999999877544322  3456999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.   ....+++..+..++.|+++||.+||+.+   ++|+||||+||+++.++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999986   3345899999999999999999999998   9999999999999999999999999987642  112


Q ss_pred             cccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..||.......  .......... .   ......   
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~-~---~~~~~~---  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKILK-R---PLPSSS---  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHHH-T---HHHHHT---
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhccc-c---cccccc---
Confidence            2334457899999999998 7889999999999999999999999987541100  0000000000 0   000000   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                       .........+.+++.+||+.||++|||+.++++
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000001267999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-40  Score=299.79  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=204.5

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888999999999999999876 88999999986543 4567899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++..... ..+++.....++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||.++......  
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999865432 35899999999999999999999998   9999999999999999999999999987653221  


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                         ....++..|+|||.+.+..++.++||||||+++|||++ |..||......  .    ..........     ..   
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~----~~~~~~~~~~-----~~---  219 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D----VVPHVEKGYR-----ME---  219 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHhcCCC-----CC---
Confidence               12234567999999988889999999999999999998 98887533211  1    1111111100     00   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              0112256789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=301.34  Aligned_cols=252  Identities=27%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-----ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ++|.+.+.||+|++|.||.|... +++.+|+|.+.....     .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999865 589999998864321     224568889999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ++||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999888543   34788888999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCcccc-cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......     ...........     .
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-----~  225 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIATQPT-----N  225 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHHHhccCC-----C
Confidence            3221111 12345788999999999888999999999999999999999998533211     11111111110     0


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+     +...+..+.+++.+||+.+|++|||+.++++.
T Consensus       226 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQL-----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCC-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            111     11225568899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-41  Score=309.77  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=201.2

Q ss_pred             cCCCccCcccccCcccEEEEEe-----cCCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecC--Cce
Q 040952           91 NKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  162 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (411)
                      ..|++.+.||+|+||.||.+.+     .++..||+|.+.... ......+.+|+.+++.++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3578889999999999999974     247889999987543 33456789999999999999999999998875  567


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999985432  24789999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc---------cchhHHHHHH
Q 040952          243 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---------LNLLGYAWDL  312 (411)
Q Consensus       243 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---------~~~~~~~~~~  312 (411)
                      ....... .......++..|+|||.+.+..++.++|||||||++|||++++.|........         ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6432211 11223456778999999988889999999999999999999876643211000         0000000000


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      .......          ......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       239 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1110000          00111356799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-40  Score=303.30  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=189.0

Q ss_pred             CcccccCcccEEEEEecC---CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.||+|+||.||+|....   ...+++|.+.... ......+.+|+..++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999997543   3578889876543 233456789999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCC--CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          173 SLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       173 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +|.+++.....  ....++.....++.|++.|++|||+++   |+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865432  223466777899999999999999998   9999999999999999999999999986543222212


Q ss_pred             ccccccccccccChhhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          251 NTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||.......     ....... .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~-~~~~~~~  231 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-----VLKQVVR-EQDIKLP  231 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhh-ccCccCC
Confidence            2233355778999998742       356889999999999999999 777775332110     1111111 1111122


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      .+.+..     ..+..+.+++..|+ .||++|||+.+|++.|.
T Consensus       232 ~~~~~~-----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQLDL-----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcccc-----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222211     12455677888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-40  Score=321.25  Aligned_cols=262  Identities=20%  Similarity=0.256  Sum_probs=198.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec---CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+....     ...+|+.++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   35789999886532     3468999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |++. ++|..++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++......
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9986 57777773   2345899999999999999999999998   999999999999999999999999999776543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-cchhHHHHHHhhcCcc-------
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDLWTSNRT-------  318 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~-------  318 (411)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................       
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            33333334679999999999999999999999999999999999999986443221 0000000000000000       


Q ss_pred             cc------ccccccccccc------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LE------LIDPILEDEYS------SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~------~~~~~l~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..      .........+.      .......+.+++.+||+.||++|||+.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00      00000000000      01124567899999999999999999999976

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.2e-41  Score=327.45  Aligned_cols=261  Identities=18%  Similarity=0.276  Sum_probs=189.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecC--------C
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--------D  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~  160 (411)
                      .++|++.+.||+|+||.||+|... .++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999975 48899999886432    2345799999999999999998876432        2


Q ss_pred             ceEEEEeeCCCCCchhhhcC-CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecC
Q 040952          161 EKILIYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFG  238 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg  238 (411)
                      ..++||||+++ +|..++.. ......+++.....++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999986 55555432 223345888899999999999999999998   99999999999998665 79999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC-
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN-  316 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  316 (411)
                      +++......   ......||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+... ....... 
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i-~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRI-IQVLGTPT  291 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH-HHHhCCCC
Confidence            998654322   12234689999999988764 68999999999999999999999986432110 01000 0000000 


Q ss_pred             ---------ccccccccccccc----cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 ---------RTLELIDPILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 ---------~~~~~~~~~l~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                               ...+..-+.....    ..+...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                     0000000000000    0011124678999999999999999999999843

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=303.77  Aligned_cols=255  Identities=30%  Similarity=0.456  Sum_probs=205.2

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.+++++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++......+++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46789999999999999999998878899999987543 34567899999999999999999999999989999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            9999999986543 234788999999999999999999998   999999999999999999999999998776432211


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......  ..   .... ...     ....   
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~---~~~~-~~~-----~~~~---  224 (261)
T cd05034         160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EV---LEQV-ERG-----YRMP---  224 (261)
T ss_pred             -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHH-HcC-----CCCC---
Confidence             1112234568999999998889999999999999999999 89887532211  11   1111 100     0000   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                        .+...+..+.+++.+||+.+|++||++.++.+.|++
T Consensus       225 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 --RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              011114568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-40  Score=322.39  Aligned_cols=262  Identities=17%  Similarity=0.186  Sum_probs=195.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..+|.+.+.||+|+||.||+|.+.. ++.||||....      ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999764 78999996432      2357899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +. ++|..++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 67777764432  35899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc-cc-ccchhHHHHHHhhcCcc-----ccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TD-SLNLLGYAWDLWTSNRT-----LEL  321 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~-~~-~~~~~~~~~~~~~~~~~-----~~~  321 (411)
                      ........||..|+|||++.+..++.++|||||||++|||++|..|+.... .. ...........+.....     ...
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            222234579999999999999999999999999999999999886543221 10 01111111111111000     000


Q ss_pred             c----------------cccccc--ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 I----------------DPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~----------------~~~l~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .                .+....  ..........+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0                000000  00000123468899999999999999999999974

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-40  Score=304.81  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=202.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-C---CEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-G---DEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|+..+.||+|+||.||+|.... +   ..+|+|.+.... ....+.+..|+.++++++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3568888999999999999999753 3   379999987542 3345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|..++....  ..+++.....++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999986432  34788899999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCcccc-cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          245 GNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       245 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ....... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||......     ..... .....    .
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~-i~~~~----~  228 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKA-INDGF----R  228 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHH-HhcCC----C
Confidence            3221111 111223457999999988889999999999999999998 99997533211     11111 11110    0


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      .      ......+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       229 ~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 L------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0      01112246789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-40  Score=300.49  Aligned_cols=248  Identities=30%  Similarity=0.426  Sum_probs=197.8

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCch
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD  175 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  175 (411)
                      +.||+|+||.||++.+.+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccc
Q 040952          176 FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  255 (411)
Q Consensus       176 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  255 (411)
                      +++....  ..+++.....++.+++.|++|||+++   ++||||+|+||+++.++.++|+|||++...............
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9985532  24788888999999999999999988   999999999999999999999999998765422211111222


Q ss_pred             cccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       256 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      .++..|+|||.+.++.++.++|+|||||++|||++ |..||.......  ..    .......  .        ...+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~----~~~~~~~--~--------~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TR----ERIESGY--R--------MPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HH----HHHhcCC--C--------CCCCcc
Confidence            34567999999988899999999999999999999 788875432111  00    1111100  0        001122


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          335 MLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      .+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-40  Score=309.47  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=201.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+|.... ++.+++|.+........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            3678999999999999999999764 889999999877666677889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|..++.+..  ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999988775432  34788999999999999999999988   9999999999999999999999999986543221 


Q ss_pred             ccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                       .......++..|+|||.+.     ...++.++|||||||++|||++|..||......     ..........      .
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~------~  232 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSE------P  232 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHHhcCC------C
Confidence             1123346788999999874     345788999999999999999999998643211     1111111110      0


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +..   ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus       233 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 PTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000   0111224568899999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3e-40  Score=301.93  Aligned_cols=248  Identities=27%  Similarity=0.405  Sum_probs=193.3

Q ss_pred             cccccCcccEEEEEec---CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCC
Q 040952           98 KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS  173 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (411)
                      .||+|+||.||+|.+.   .+..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   355799999876532 33456889999999999999999999885 457899999999999


Q ss_pred             chhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc-c
Q 040952          174 LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-T  252 (411)
Q Consensus       174 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~  252 (411)
                      |.+++...  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........... .
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99988543  235889999999999999999999988   99999999999999999999999999876543221111 1


Q ss_pred             ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       253 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||......     .. ...........     .     
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~-~~~~~~~~~~~-----~-----  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EV-MSFIEQGKRLD-----C-----  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HH-HHHHHCCCCCC-----C-----
Confidence            11233578999999988889999999999999999996 99998533211     11 11111111100     0     


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      +...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            111256788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.5e-40  Score=308.17  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=199.5

Q ss_pred             CCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            36778899999999999999764 77889999876665566778899999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .
T Consensus        86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            99998887542  235889999999999999999999998   9999999999999999999999999987653221  1


Q ss_pred             ccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ......++..|+|||++.     +..++.++|||||||++|||++|++||......     ...........      +.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~------~~  227 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEP------PT  227 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHHHhhcCC------CC
Confidence            123346889999999874     345788999999999999999999997643211     11111111100      00


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +.   .+...+..+.+++.+||+.+|++||++.++++.
T Consensus       228 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 LA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   011124678999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.7e-40  Score=301.80  Aligned_cols=253  Identities=30%  Similarity=0.455  Sum_probs=200.8

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      ++|.+.+.||+|+||.||+|.++.+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688889999999999999998877789999886543 23457889999999999999999999875 456889999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..........
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            999999986532 234788889999999999999999988   9999999999999999999999999997654332211


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       .....++..|+|||...+..++.++||||||+++|||++ |..||......  ...    ......     ....    
T Consensus       160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~-----~~~~----  223 (260)
T cd05069         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVL----EQVERG-----YRMP----  223 (260)
T ss_pred             -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcC-----CCCC----
Confidence             112345678999999988889999999999999999999 88887532211  010    111110     0000    


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                       .+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             111235678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.4e-41  Score=316.92  Aligned_cols=237  Identities=23%  Similarity=0.279  Sum_probs=184.9

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHH-HHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEA-SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 48899999986432   12233444554 467889999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      ++|..++...   ..+++.....++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            9998887432   34778888899999999999999988   9999999999999999999999999987532211  22


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.     ......... .. .     .+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~-~~-~-----~~~----  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILH-KP-L-----QLP----  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhc-CC-C-----CCC----
Confidence            3345789999999999988999999999999999999999999854321     111111111 10 0     000    


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMN  358 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~  358 (411)
                       ......+.+++.+||+.+|.+||++.
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 -GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             11245688999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-40  Score=305.58  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=201.1

Q ss_pred             cCCCccCcccccCcccEEEEEecC-C---CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-G---DEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ..|++.+.||+|+||.||+|.+.. +   ..||+|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457788999999999999999653 3   36999998754 334456789999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++++|..++....  ..+++.....++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999986532  34788899999999999999999988   99999999999999999999999999876543


Q ss_pred             CCccccccccc---ccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          246 NELQANTSRIV---GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       246 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...........   .+..|+|||.+.+..++.++|||||||++|||++ |..||......  ....   . .....  ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~---~-i~~~~--~~  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVIN---A-IEQDY--RL  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHH---H-HHcCC--cC
Confidence            22211111111   2457999999998899999999999999999886 99887533211  1111   1 11000  00


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                              ..+...+..+.+++.+||+.+|++||++.+++..|++.
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    00112245688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.8e-40  Score=310.43  Aligned_cols=262  Identities=22%  Similarity=0.341  Sum_probs=196.3

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57889999999999999999976 47889999987543 22334577899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++ +|..++....  ..+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            986 7777664432  34788888999999999999999998   99999999999999999999999999876432221


Q ss_pred             ccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH-----------HhhcC
Q 040952          249 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD-----------LWTSN  316 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~~  316 (411)
                        ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.......  .......           .....
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhhcch
Confidence              1223467899999998865 468999999999999999999999986443211  1000000           00000


Q ss_pred             ccccccc-cccccc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 RTLELID-PILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ~~~~~~~-~~l~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ......+ +.....   ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000 000000   000112456889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-40  Score=300.84  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=202.8

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      ++|+..+.||+|+||.||+|...+ ++.+++|.+.....  .+.+.+|++++++++||||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            678899999999999999999765 78999999875533  678999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++....  ..+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999999985432  45789999999999999999999988   99999999999999999999999999876643221 


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..........     . ...     .....+   
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~-~~~-----~~~~~~---  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----M-IPN-----KPPPTL---  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----h-hcc-----CCCCCC---
Confidence             1223457889999999998899999999999999999999999986432211000     0 000     000000   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..+......+.+++.+||+.+|++|||+.|+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            012223467899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-40  Score=303.50  Aligned_cols=240  Identities=23%  Similarity=0.358  Sum_probs=187.8

Q ss_pred             CcccccCcccEEEEEecC-------------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           97 NKLGEGGFGPVYKGVLKK-------------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      +.||+|+||.||+|....             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2258999887665555567889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC-------eEEee
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-------PKISD  236 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-------~kl~D  236 (411)
                      ++|||+++++|+.++....  ..+++.....++.|+++||+|||+.+   ++||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999998875432  34788889999999999999999988   999999999999987664       89999


Q ss_pred             cCCccccCCCCcccccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCcccccchhHHHHHHhh
Q 040952          237 FGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIV-SGKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       237 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      ||++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+.......     . .... 
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~-~~~~-  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----K-ERFY-  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----H-HHHH-
Confidence            9998654321      2235778899999886 567899999999999999998 4777764321110     0 0000 


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ... .....          .....+.+++.+||+.||++||++.++++.++
T Consensus       223 ~~~-~~~~~----------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ-CMLVT----------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC-ccCCC----------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            000 00000          01356889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-40  Score=317.54  Aligned_cols=263  Identities=24%  Similarity=0.293  Sum_probs=195.0

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  160 (411)
                      ..++|++.+.||+|+||.||++... +|+.||+|.+...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999965 4899999998643  2334566789999999999999999999986543     


Q ss_pred             -ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          161 -EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                       ..++||||++++ |...+.     ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             468999999765 444442     12677888899999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-------------chh
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-------------NLL  306 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-------------~~~  306 (411)
                      ++......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+....             ...
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            87543221   12334689999999999999999999999999999999999999975432100             000


Q ss_pred             H----HHHHHhhcCcc------cccccccc-ccc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          307 G----YAWDLWTSNRT------LELIDPIL-EDE-YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       307 ~----~~~~~~~~~~~------~~~~~~~l-~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .    ...........      .+...... ... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0    00000000000      00000000 000 0011124568999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.9e-41  Score=318.42  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=187.3

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHH-HHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEA-SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|.+. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 47889999987532   12223344444 456778999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+.......++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            9999988543   33677778889999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......... .. . +         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~-~~-~-~---------  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILNK-PL-Q-L---------  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHhC-Cc-C-C---------
Confidence            33457999999999999999999999999999999999999998633211     111111111 00 0 0         


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....+..+.+++.+||+.+|.+||++.+.+..
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            01124568899999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-40  Score=308.50  Aligned_cols=262  Identities=26%  Similarity=0.373  Sum_probs=203.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-----CCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeec--CCce
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK  162 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  162 (411)
                      ..|+..+.||+|+||.||+|.+.     .+..+|||.+...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999854     3678999999865443 46779999999999999999999999887  5578


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      +++|||+++++|.+++.....  .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999865432  4888999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCccc-ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc---------hhHHHHHH
Q 040952          243 CGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN---------LLGYAWDL  312 (411)
Q Consensus       243 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~---------~~~~~~~~  312 (411)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........         ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            65322111 111223456799999998888999999999999999999999887543221110         00000011


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ....         .. ...+..++..+.+++.+||+.+|++|||+.||+++|+++
T Consensus       239 ~~~~---------~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEG---------ER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcC---------Cc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1100         00 001112346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-40  Score=318.32  Aligned_cols=258  Identities=21%  Similarity=0.258  Sum_probs=199.5

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      .....++|++.+.||+|+||.||++..+ +++.+|+|.+...   .......+.+|..+++.++||||+++++++.+.+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3344689999999999999999999976 4889999998642   22334557889999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+++|+|..++...    .++......++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            99999999999999988532    3677888899999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      ....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....     ............
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~  264 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHKN  264 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC
Confidence            7643221 112345799999999998754    378999999999999999999999864321     111111111111


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNDVVSML  364 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L  364 (411)
                      .....        .....+..+.+++.+||+.++.+  ||++.++++..
T Consensus       265 ~~~~~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         265 SLTFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cccCC--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11110        01123567889999999844433  78999998853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=295.46  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=200.2

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .++|++-+.||+|.|+.||++... +|+.+|+|++...  +..+.+.+.+|+.+-+.++||||+++.+.+......|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            567888899999999999998855 5899999988643  3446788999999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCCcccc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARIC  243 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl~~~~  243 (411)
                      |++.|++|..-+-   .+...++..+-..++||+++|.|+|.++   |+|||+||+|+++-.   .--+||+|||++..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999965542   3355788888899999999999999998   999999999999943   345999999999887


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      +...   ......|||.|||||++...+|+..+|||+.||+||-|+.|.+||-..+  ...+.+.    +..+. .+...
T Consensus       164 ~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~----I~~g~-yd~~~  233 (355)
T KOG0033|consen  164 NDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQ----IKAGA-YDYPS  233 (355)
T ss_pred             CCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHH----Hhccc-cCCCC
Confidence            6332   2344689999999999999999999999999999999999999984321  1111111    11100 00000


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +      .-...+++..+|+.+||..||.+|.|+.|.++
T Consensus       234 ~------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 P------EWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             c------ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            0      01123567899999999999999999988764

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-39  Score=297.99  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=198.5

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeee-cCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI-DKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  169 (411)
                      .+|.+.+.||+|+||.||++... |..+|+|.+....  ..+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            56888899999999999999876 8889999986432  3467889999999999999999999765 456789999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++.....++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999986533 234788899999999999999999988   9999999999999999999999999987543221  


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                         ....++..|+|||++.+..++.++|||||||++|||++ |+.||.....     ...... ......     +..  
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~-~~~~~~-----~~~--  220 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR-VEKGYK-----MDA--  220 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HhcCCC-----CCC--
Confidence               22234568999999988889999999999999999998 8888753221     111111 111100     001  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                         ....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       221 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 ---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               112256788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=305.08  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=202.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++|+||+++.+++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999966 48899999987543 34456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++...    .+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999998543    5889999999999999999999988   9999999999999999999999999998765332 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......     .... ....     ..+.+..
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~-~~~~-----~~~~~~~  220 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFL-IPKN-----NPPSLEG  220 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHH-hhhc-----CCCCCcc
Confidence             12233467889999999998889999999999999999999999986433111     0000 0000     1111111


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .    ..+..+.+++.+||..+|++|||+.++++.
T Consensus       221 ~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         221 N----KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             c----ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1    024568899999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-40  Score=311.04  Aligned_cols=259  Identities=29%  Similarity=0.396  Sum_probs=200.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CC--EEEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.++. |.  .+++|.+... .......+.+|+.++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3578888999999999999999653 54  4578877643 233456788999999999 89999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC
Q 040952          165 IYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  231 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  231 (411)
                      ||||+++++|.+++....             ....+++..+..++.|++.|++|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999986432             1235788899999999999999999988   999999999999999999


Q ss_pred             eEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHH
Q 040952          232 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       232 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  310 (411)
                      +||+|||++......   .......++..|+|||.+.+..++.++|||||||++|||+| |..||......  ...    
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~----  233 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELY----  233 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHH----
Confidence            999999998642211   11111234567999999988889999999999999999998 99987532211  111    


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .......     ...     .+...+..+.+++.+||+.+|++||++.++++.|.++...
T Consensus       234 ~~~~~~~-----~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         234 EKLPQGY-----RLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHHhcCC-----cCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111100     000     0111245688999999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.2e-40  Score=308.17  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ....+|++.+.||+|+||.||+|... +|+.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34578999999999999999999964 58999999997665555667889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999998843    34788889999999999999999988   999999999999999999999999998765432


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      ..  ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........     ....+      .+. 
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~~~-  234 (297)
T cd06656         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------TPE-  234 (297)
T ss_pred             cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------CCC-
Confidence            21  12234688899999999988899999999999999999999999854322111000     00000      000 


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00112234668899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.3e-40  Score=303.32  Aligned_cols=257  Identities=27%  Similarity=0.430  Sum_probs=202.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-C---CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-K---GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..+|++.+.||+|+||.||+|.+. +   +..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357888999999999999999864 2   3379999987542 2345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++....  ..+++.....++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999986533  34788889999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccc-ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          245 GNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       245 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ...... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||......  ....    ......     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~----~~~~~~-----  226 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIK----AIEEGY-----  226 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHH----HHhCCC-----
Confidence            322111 1111233568999999998889999999999999999887 99997543211  1111    111110     


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ...     .+...+..+.+++.+|++.+|++||++.++++.|.++
T Consensus       227 ~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 RLP-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             cCC-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            000     0111245688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.7e-40  Score=307.65  Aligned_cols=261  Identities=24%  Similarity=0.317  Sum_probs=199.8

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||+|+||.||++... +|..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999965 47889999887542 23345688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|.+++...   ..+++.....++.|+++||.|||+. +   ++||||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998543   3478888999999999999999974 5   999999999999999999999999998654321 


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH---hhcCc-------
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL---WTSNR-------  317 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~-------  317 (411)
                         ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+...  ........   .....       
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccC
Confidence               1233478899999999988889999999999999999999999985332111  00000000   00000       


Q ss_pred             ----------cccccccccc---cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 ----------TLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ----------~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                                ..+..+....   ...+....+..+.+++.+||+.+|++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0000000000   000011134568999999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=313.11  Aligned_cols=253  Identities=25%  Similarity=0.308  Sum_probs=209.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcC-CcccceeeeeeecCCce
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  162 (411)
                      .....|++.+.||+|.||.||+++.+. |+.+|+|.+.+...   .....+.+|+.+|+++. ||||+.+.+.|++....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345779999999999999999999775 99999999976643   24568999999999998 99999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC----CCeEEeecC
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKISDFG  238 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg  238 (411)
                      ++|||++.||.|.+.+...    .+++.....++.|++.++.|||+.|   ++||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999988665    2889999999999999999999988   9999999999999543    579999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      ++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||..........      .+...+.
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~  255 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF  255 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC
Confidence            9998764   334566799999999999999999999999999999999999999986433221111      1111111


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                            ..... .-+..+..+.+++..|+..||..|+|+.++++.
T Consensus       256 ------~f~~~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ------DFTSE-PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ------CCCCC-CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                  01111 111226778999999999999999999999994

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.1e-40  Score=304.28  Aligned_cols=265  Identities=25%  Similarity=0.335  Sum_probs=197.4

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|++|.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999975 58899999986542  22346788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      ++ ++|..++........+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 578777765444456889999999999999999999988   9999999999999999999999999987654221 


Q ss_pred             ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH-------HHhhc----C
Q 040952          249 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-------DLWTS----N  316 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~----~  316 (411)
                       .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ......       ..+..    .
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence             111223568899999988654 578999999999999999999999864321100 000000       00000    0


Q ss_pred             ccccccccccccc--cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 RTLELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 ~~~~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .............  ......+.++.+++.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000000000  0001124677899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.4e-40  Score=316.98  Aligned_cols=262  Identities=22%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----ceE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI  163 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  163 (411)
                      +|++.+.||+|+||.||++... +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 5899999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +|+||+. ++|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 467666643   234888999999999999999999998   999999999999999999999999999765


Q ss_pred             CCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc----
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT----  318 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  318 (411)
                      ..... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......  ...........+..    
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHH
Confidence            43221 112234678999999998764 47999999999999999999999986433211  01001000000000    


Q ss_pred             ------cccc-----c-cccccc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 ------LELI-----D-PILEDE-YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ------~~~~-----~-~~l~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                            ...+     . +..... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                  0000     0 000000 0001124578899999999999999999999974

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=297.79  Aligned_cols=249  Identities=33%  Similarity=0.475  Sum_probs=195.9

Q ss_pred             CcccccCcccEEEEEecC----CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|.+..    +..+|+|.+..... ...+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    36899999886543 24567889999999999999999999876 4568999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc-
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA-  250 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-  250 (411)
                      ++|.+++....   .+++..+..++.|++.|++|||..+   ++|+||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999986543   4789999999999999999999988   9999999999999999999999999998664322111 


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....  ....    ..........         
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~----~~~~~~~~~~---------  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVI----AMLESGERLP---------  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHH----HHHHcCCcCC---------
Confidence            1111223567999999998899999999999999999998 9999864321  1111    1111111000         


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                       .+...+..+.+++.+||+.+|++||++.++++.|++..
T Consensus       219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             11112457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.8e-40  Score=302.78  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=200.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++++||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888899999999999999865 5889999998766555556788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++...   ..+++.....++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          88 CGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999999988543   34789999999999999999999998   9999999999999999999999999987654221 


Q ss_pred             ccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                       .......|+..|+|||.+.   ...++.++|+|||||++|+|++|..||........     ....... .   ...+.
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-----~~~~~~~-~---~~~~~  230 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----LFLMTKS-N---FQPPK  230 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----HHhhhcc-C---CCCCc
Confidence             1223457899999999874   45688999999999999999999999753221110     0000000 0   00000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...   ....+..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 LKD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000   00123568899999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.9e-40  Score=318.04  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=196.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|+..+.||+|+||.||++... +++.||+|++...   .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 4889999998643   2234567888999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999998543   34788889999999999999999998   999999999999999999999999998654221


Q ss_pred             Ccc---------------------------------cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 040952          247 ELQ---------------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  293 (411)
Q Consensus       247 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~  293 (411)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            000                                 00113479999999999999999999999999999999999999


Q ss_pred             CCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 040952          294 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNDVVSM  363 (411)
Q Consensus       294 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~  363 (411)
                      ||.......     ............. +    ...   ...+..+.+++.+|+. +|++|++   +.++++.
T Consensus       235 Pf~~~~~~~-----~~~~i~~~~~~~~-~----p~~---~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQE-----TYRKVMNWKETLV-F----PPE---VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHH-----HHHHHHcCCCcee-c----CCC---CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            986432211     1111111110000 0    000   0124567888888774 9999985   5666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-40  Score=304.76  Aligned_cols=253  Identities=26%  Similarity=0.411  Sum_probs=197.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecC------
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK------  159 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------  159 (411)
                      .+.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            34677899999999999999999965 48899999987543 3345788999999998 799999999998753      


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ...+++|||+++++|.+++.... ...+++.....++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            35789999999999999986532 245788889999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      +.......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||........    . ... .
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~-~~~-~  229 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----L-FLI-P  229 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----H-HHH-h
Confidence            87653221  1223356899999999886     34588899999999999999999999853321100    0 000 0


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ....     ...    .....+..+.+++.+||+.+|.+|||+.++++
T Consensus       230 ~~~~-----~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNPA-----PRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCCC-----CCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000     000    11112456899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-40  Score=314.00  Aligned_cols=241  Identities=25%  Similarity=0.323  Sum_probs=191.3

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  166 (411)
                      +|+..+.||+|+||.||+|... +|+.||+|++...   .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999965 4889999998753   2233456778888988885 577888999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|..++...   ..+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999999888543   34889999999999999999999998   999999999999999999999999998754322


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .   ...... ....      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~---~~~~i~-~~~~------~~  220 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--E---LFQSIM-EHNV------SY  220 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--H---HHHHHH-hCCC------CC
Confidence            1  1123356899999999999989999999999999999999999998643221  1   111111 1100      00


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTM  357 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  357 (411)
                           +...+..+.+++.+||+.+|.+|++.
T Consensus       221 -----p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 -----PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 11124568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-40  Score=303.17  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=202.9

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CC----EEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .+|++.+.||+|+||.||+|.+.+ |+    .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568888999999999999998643 33    58999887553 3345678899999999999999999999987 78899


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      |+||+++|+|.+++....  ..+++.....++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999986533  23889999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ............++..|+|||.+....++.++|+||||+++||+++ |+.||......     .+... .......    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~-~~~~~~~----  230 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----EIPDL-LEKGERL----  230 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH-HhCCCCC----
Confidence            3222111122234568999999988889999999999999999999 99997543211     11111 1111100    


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                            ..+...+..+.+++.+||..+|++||++.++++.|.....
T Consensus       231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  0011123568899999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.9e-39  Score=297.03  Aligned_cols=255  Identities=29%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+.+++.++|+||+++.+++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46788999999999999999998778889999887543 234678899999999999999999999887 7789999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999986532 234788888999999999999999988   999999999999999999999999998765432211


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       ......++..|+|||.+....++.++|+|||||++|++++ |+.||......  ...    ..........        
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~----~~~~~~~~~~--------  223 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVI----RALERGYRMP--------  223 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHhCCCCCC--------
Confidence             1122345677999999988889999999999999999999 88887532211  111    1111110000        


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        .....+..+.+++.+||+.+|++||++.++.+.|+++
T Consensus       224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence              0112246789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=320.05  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=203.1

Q ss_pred             cccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCchh
Q 040952           98 KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF  176 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  176 (411)
                      +||+|+||+||.|++.+ ...+|||-++.......+-+.+|+.+.++++|.|||+++|.+.+.+.+-+.||..+||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999999765 55789999998877777889999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeEEeecCCccccCCCCcccccccc
Q 040952          177 FLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRI  255 (411)
Q Consensus       177 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  255 (411)
                      +|...-+.-.-.+.+.--+..||++||.|||.+.   |||||||-+|||++ -.|.+||+|||-++.+.+  ....+..+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            9976443322366777788999999999999998   99999999999996 479999999999987654  33445667


Q ss_pred             cccccccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchH
Q 040952          256 VGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK  333 (411)
Q Consensus       256 ~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  333 (411)
                      .||..|||||++..+  .|+.++|||||||++.||.||++||-.........       +.-+  .-..     ....+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVG--myKv-----HP~iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVG--MYKV-----HPPIPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhc--ceec-----CCCCcH
Confidence            899999999999865  48999999999999999999999985433221110       1100  0001     112355


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          334 HMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       334 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +.+.+..++|.+|+.++|.+||++.++++.
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            678899999999999999999999999964

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=308.49  Aligned_cols=255  Identities=20%  Similarity=0.246  Sum_probs=195.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||++... +++.||+|++...   .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999965 4889999998642   2233456888999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|..++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999985422  34788888999999999999999998   999999999999999999999999998765432


Q ss_pred             CcccccccccccccccChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ... ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.....     ................
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~  229 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKEHFQF  229 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCcccC
Confidence            211 1222468999999999863     4578899999999999999999999853221     1111111111111111


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESAD--DRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~evl~~  363 (411)
                      .     ..  ....+..+.+++.+|+..+++  .||++.++++.
T Consensus       230 ~-----~~--~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 P-----PD--VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C-----Cc--cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0     00  011355678888887765433  47899999877

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.3e-40  Score=316.95  Aligned_cols=263  Identities=23%  Similarity=0.270  Sum_probs=195.7

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC-----
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----  159 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  159 (411)
                      ...++|++.+.||+|+||.||++... .++.||||.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34678999999999999999999865 4889999998754  223346678899999999999999999988643     


Q ss_pred             -CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          160 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                       ...++||||+++ ++...+.     ..+++.....++.|+++||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             346899999976 4545442     13678888899999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhH-----------
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG-----------  307 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-----------  307 (411)
                      +++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||........ ...           
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~  240 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPE  240 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence            997654322   12234689999999999998999999999999999999999999864321100 000           


Q ss_pred             -------HHHHHhhcC-cccccc------cccccc-ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          308 -------YAWDLWTSN-RTLELI------DPILED-EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       308 -------~~~~~~~~~-~~~~~~------~~~l~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                             ......... ......      +..... ..........+.+++.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   000000000 000000      000000 00011124568899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.4e-40  Score=307.09  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=203.2

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..+|++.+.||.|+||.||+|... +|+.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            356899999999999999999854 5899999999766555567788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|..++..    ..+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999998843    24789999999999999999999998   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........     ........ .     +.+. 
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----~~~~~~~~-~-----~~~~-  236 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNG-T-----PELQ-  236 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcC-C-----cccC-
Confidence              12234688899999999988899999999999999999999999864332110     00000000 0     0000 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        .+...+..+.+++.+||..+|++|||+.++++.
T Consensus       237 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 --NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             --CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence              111224568899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.1e-40  Score=299.97  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=200.9

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++|||++++++++......++++||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4678889999999999999998778899999987543 234578899999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|.+++....  ..+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++......... 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            999999885432  34788889999999999999999988   999999999999999999999999998765432211 


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |..||......     ...... ...  .....+.    
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~-~~~--~~~~~~~----  224 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI-NAG--FRLYKPR----  224 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH-hCC--CCCCCCC----
Confidence            1112234678999999998889999999999999999998 88887532211     111111 100  0111111    


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                          ..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                11467899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=297.84  Aligned_cols=250  Identities=29%  Similarity=0.416  Sum_probs=194.0

Q ss_pred             CcccccCcccEEEEEecC-CC--EEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|.+.+ |.  .+++|.+.... ....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 43  46888887532 34456788999999999 899999999999999999999999999


Q ss_pred             CCchhhhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          172 KSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       172 g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                      |+|.+++....             ....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1234788899999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      ++......   ........+..|+|||.+....++.++|||||||++|||++ |..||......     ... .......
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~-~~~~~~~  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELY-EKLPQGY  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHH-HHHhCCC
Confidence            98532211   11111233567999999988889999999999999999997 99987532211     111 1111110


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      ..+.          +...+..+.+++.+||+.+|.+|||+.+++..|.++.
T Consensus       229 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0000          0112456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=306.29  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=203.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||.|+||.||+|... ++..+|+|.+........+.+..|++++++++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999975 5889999999876656667888999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|..++....  ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            99999999985432  34888999999999999999999998   9999999999999999999999999987653221 


Q ss_pred             ccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                       .......+++.|+|||.+.     ...++.++|+||||+++|||++|+.||.......     .........      .
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~------~  225 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-----VLLKILKSE------P  225 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----HHHHHhcCC------C
Confidence             1223346889999999875     3457789999999999999999999986432111     111111100      0


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +.+.   .+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       226 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0110   011224568899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-39  Score=299.84  Aligned_cols=249  Identities=28%  Similarity=0.457  Sum_probs=198.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc---------cHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ---------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      +|.+.+.||+|+||.||+|... +++.+|+|.+......         ..+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4777889999999999999865 4889999988654221         23567889999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++++||+++++|..++...   ..+++.....++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999998543   34788888899999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCcc----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          242 ICGGNELQ----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       242 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      ........    .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......     .......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~----  225 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIG----  225 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHh----
Confidence            76432111    1112245788999999999888999999999999999999999998643211     0011100    


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        ....+.+.     ...+..+.+++.+||+.+|++||++.++++
T Consensus       226 --~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 --ENASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --ccCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              01111111     122567899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-40  Score=304.37  Aligned_cols=239  Identities=23%  Similarity=0.332  Sum_probs=185.8

Q ss_pred             cccccCcccEEEEEecC-------------------------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccccee
Q 040952           98 KLGEGGFGPVYKGVLKK-------------------------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL  152 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  152 (411)
                      .||+|+||.||+|.+..                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13589999876544445678889999999999999999


Q ss_pred             eeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC--
Q 040952          153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM--  230 (411)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--  230 (411)
                      ++++......++||||+++|+|+.++....  ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999885432  34788889999999999999999988   99999999999997644  


Q ss_pred             -----CeEEeecCCccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCccccc
Q 040952          231 -----NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV-SGKKNTGLYRTDSL  303 (411)
Q Consensus       231 -----~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~  303 (411)
                           .++++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 3899999987543211      12356788999998865 56899999999999999995 6888875332111 


Q ss_pred             chhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          304 NLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                       ..    ......       ..+...     ....+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 -~~----~~~~~~-------~~~~~~-----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 -KE----RFYEKK-------HRLPEP-----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HH----HHHHhc-------cCCCCC-----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             00    001100       000110     1246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.1e-40  Score=304.82  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=190.9

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhc---CCcccceeeeeeecC-----C
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKV---QHKNLVRLLGCCIDK-----D  160 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~  160 (411)
                      +|++.+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888899999999999999976 488999998875421  1223455677766655   799999999988652     3


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..+++|||+.+ +|..++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999985 7877775432 234788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc---
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR---  317 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  317 (411)
                      .......   ......||..|+|||++.+..++.++|||||||++|+|++|++||.......  .............   
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~  230 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDD  230 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhh
Confidence            7654322   1223467899999999998899999999999999999999999985432211  0000111000000   


Q ss_pred             c---ccccccccccc-c-----chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 T---LELIDPILEDE-Y-----SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 ~---~~~~~~~l~~~-~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .   ........... .     .....+..+.+++.+||+.||++|||+.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0   00000000000 0     00122456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4e-40  Score=300.61  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=200.7

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      +|++.+.||+|+||.||++... +++.+|+|.+... .....+.+..|+.+++.++|+||+++++.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999965 4889999988643 2334567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++.... ...++......++.|++.||.|||+++   ++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            9999988875432 234788888999999999999999998   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....     ....... .......     +   
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~~-----~---  220 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKV-CQGSYKP-----L---  220 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHH-hcCCCCC-----C---
Confidence             12234688899999999988899999999999999999999999864221     1111111 1111100     0   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        +...+..+.+++.+||+.+|++|||+.+++..
T Consensus       221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              11124568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5e-40  Score=303.34  Aligned_cols=256  Identities=27%  Similarity=0.374  Sum_probs=202.3

Q ss_pred             cCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|+.+      +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999854      2467999988765433 4567899999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCC------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          164 LIYEYMPNKSLDFFLFDPTKR------MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998654422      25899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcC
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......     ..... ....
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~~~~-~~~~  234 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNR-LQAG  234 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HHHHH-HHcC
Confidence            99865432221 12223356778999999988888999999999999999999 77787532211     11111 1111


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ....    ..     ....+..+.+++.+||+.+|++|||+.+++..|.
T Consensus       235 ~~~~----~~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLEL----PV-----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcCC----CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1100    00     1112457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.7e-39  Score=298.09  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=199.1

Q ss_pred             CCCccCcccccCcccEEEEEecCCCEEEEEEccCCC------cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      +|++.+.||+|+||.||+|...+|+.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998789999999886432      12235688999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +||+++++|.+++...   ..+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998543   24788888899999999999999988   99999999999999999999999999876532


Q ss_pred             CCc----ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          246 NEL----QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       246 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...    ........|+..|+|||.+.+..++.++|||||||++|+|++|..||...+....     ........    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~----~  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHR----G  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhcc----C
Confidence            111    1112234688999999999988899999999999999999999999864321110     00000000    0


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..+.+..     ..+..+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMPRLPD-----SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCC-----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0111111     12456899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-41  Score=289.56  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-----cc---cHHHHHHHHHHHHhc-CCcccceeeeeee
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQ---GLREMKNEASVIAKV-QHKNLVRLLGCCI  157 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~  157 (411)
                      ...++|.-.+.||+|..+.|.++..+ +|+..|+|++....     +.   -.+.-..|+.+|+++ .||+|+.+.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34567777889999999999988765 48899999885321     11   123456799999998 7999999999999


Q ss_pred             cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                      .+...++|+|.|+.|.|.++|..   ...+++....+|+.|+..|++|||..+   |+||||||+|||++++.+++|+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            99999999999999999999954   345899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  311 (411)
                      |+++.+....   .....||||+|+|||.+..      ..|+...|+|++|||+|.|+.|.+||--..  ..    ....
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Qm----lMLR  238 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QM----LMLR  238 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HH----HHHH
Confidence            9998876443   3455799999999998853      348889999999999999999999972100  00    0001


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+.++...     .  ....=.+.+....+||.+||+.||.+|.|+.|++..
T Consensus       239 ~ImeGkyq-----F--~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  239 MIMEGKYQ-----F--RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHhcccc-----c--CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            11111100     0  000112246788999999999999999999999854

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-39  Score=299.44  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=205.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|+..++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999965 58899999987543 23567789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++........+++.....++.|++.|++|||+.+   ++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433345889999999999999999999988   99999999999999999999999999876654322


Q ss_pred             cc--ccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          249 QA--NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       249 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..  ......|+..|+|||.+... .++.++|+|||||++|+|++|+.||.......     ........      ..+.
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~------~~~~  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQN------DPPS  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHHHhcC------CCCC
Confidence            21  22334688999999998876 78999999999999999999999986432211     11111111      0111


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +.........+..+.+++.+||+.||++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11111112235678999999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-39  Score=298.25  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=189.3

Q ss_pred             CcccccCcccEEEEEecCC---CEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLKKG---DEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3599999999999975433   346677766443 234567899999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCC-CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          173 SLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       173 ~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      +|..++..... ....+......++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865322 234566677889999999999999988   99999999999999999999999999764322222222


Q ss_pred             cccccccccccChhhhcc-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          252 TSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      .....++..|+|||++..       ..++.++|||||||++|||+++ ..||.....     ........ .+......+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~-~~~~~~~~~  231 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVI-KDQQVKLFK  231 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH-hhcccccCC
Confidence            234567889999998743       2457899999999999999974 556643221     11111111 112222333


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      +.+...+     ...+.+++..|| .+|++||++.+|++.|.
T Consensus       232 ~~~~~~~-----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELPY-----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCCC-----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3332222     456788999999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-40  Score=303.70  Aligned_cols=240  Identities=25%  Similarity=0.408  Sum_probs=188.6

Q ss_pred             CcccccCcccEEEEEecC--------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998642        234888888765555566788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC--------eEEeecCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------PKISDFGMA  240 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfgl~  240 (411)
                      +++|+|..++.....  .+++.....++.|++.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999865432  4788889999999999999999998   999999999999987765        699999987


Q ss_pred             cccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCcccccchhHHHHHHhhcCcc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      .....      .....++..|+|||.+.+ ..++.++|||||||++|||++|. .|+.......     .. ......  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----~~-~~~~~~--  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----KL-QFYEDR--  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----HH-HHHHcc--
Confidence            65432      223467889999999876 45799999999999999999995 4543221110     00 001100  


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ..     +.     .....++.+++.+||+.+|++|||+.++++.|+
T Consensus       222 ~~-----~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 HQ-----LP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc-----CC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00     00     011356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-42  Score=298.20  Aligned_cols=248  Identities=25%  Similarity=0.420  Sum_probs=208.1

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      -|.++.+||+|+||.||+|.++ .|+.+|+|.++..  .+.+++..|+.+|++++.|++|+++|.|.....+|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            4677889999999999999976 4999999999864  457889999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      .|+..+.++.  +++++.+.....++...++||+|||...   -+|||||..|||++.+|.+||+|||.+-.+...  ..
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA  184 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA  184 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence            9999999864  3456899999999999999999999987   799999999999999999999999998765432  22


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                      ......||+.|||||++..-.|+.++||||||++..||..|++||....+.               +..-++.-.-+..+
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RAIFMIPT~PPPTF  249 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RAIFMIPTKPPPTF  249 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------------ceeEeccCCCCCCC
Confidence            334568999999999999999999999999999999999999997532211               11111111111111


Q ss_pred             -chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          331 -SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       331 -~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       .++..+.++.+++++||-.+|++|-|+.++++.
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence             255678999999999999999999999988865

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-40  Score=300.24  Aligned_cols=263  Identities=21%  Similarity=0.262  Sum_probs=208.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..+.|+.++.||+|.-|+||++.+++ +..+|+|++.+..   .....+.+.|-+||+.++||.++.|+..|+.++..|+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            34668889999999999999999875 6889999998653   3445667889999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      +||||+||+|..+++.+.. ..+++..+.-++..++-||+|||-.|   ||.|||||+||||.++|.+-|+||.|+..+.
T Consensus       155 ~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            9999999999998866544 45888888889999999999999999   9999999999999999999999999975431


Q ss_pred             CC--------------------------------C-cc---------------------cccccccccccccChhhhccC
Q 040952          245 GN--------------------------------E-LQ---------------------ANTSRIVGTYGYMSPEYALEG  270 (411)
Q Consensus       245 ~~--------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~  270 (411)
                      ..                                . ..                     .....++||-.|+|||++.+.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            10                                0 00                     011235799999999999999


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccC
Q 040952          271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQES  350 (411)
Q Consensus       271 ~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~  350 (411)
                      ..+.++|+|+|||++|||+.|.-||........              +.+++...+.-. ...+.+..+.+||++.|.+|
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~Fp-~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKFP-EEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcCC-CCCcchhHHHHHHHHHhccC
Confidence            999999999999999999999999865432211              111111111110 01133678999999999999


Q ss_pred             CCCCCC----HHHHHHH--Hhhcccc
Q 040952          351 ADDRPT----MNDVVSM--LTNEAAA  370 (411)
Q Consensus       351 p~~RPt----~~evl~~--L~~~~~~  370 (411)
                      |.+|..    +.||-+.  +++...+
T Consensus       376 P~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hhhhhccccchHHhhcCccccCCChh
Confidence            999998    8888754  4555444

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-39  Score=299.24  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=202.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|.+.+.||+|+||.||+|.+.+    ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568888999999999999998643    2468999887654 3445678999999999999999999998875 56789


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999999986432  24789999999999999999999988   9999999999999999999999999987664


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ...... .....++..|+|||.+....++.++||||||+++|||++ |..||......     ............     
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~~~-----  227 (270)
T cd05056         159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIGRIENGERL-----  227 (270)
T ss_pred             ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHcCCcC-----
Confidence            332211 112234568999999988889999999999999999996 99998643321     111111111000     


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                       ..     +...+..+.+++.+|+..+|++|||+.++++.|.++..+
T Consensus       228 -~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 -PM-----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             01     112245789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-39  Score=298.91  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=198.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++++.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++++||
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            445555568999999999999965 4788999998876666667889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|..++.........++.....++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|||++.......
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            999999999865322212277778889999999999999988   999999999999976 6799999999987654322


Q ss_pred             cccccccccccccccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .  ......|+..|+|||.+.+..  ++.++||||||+++|+|++|+.||..........  +.....      . ..+.
T Consensus       164 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~------~-~~~~  232 (268)
T cd06624         164 P--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMF------K-IHPE  232 (268)
T ss_pred             C--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhh------c-cCCC
Confidence            1  122245789999999986543  7899999999999999999999985432211100  000000      0 0011


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +     +......+.+++.+||+.+|++|||+.++++.
T Consensus       233 ~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         233 I-----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             C-----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            1     11235678899999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.9e-40  Score=317.33  Aligned_cols=262  Identities=22%  Similarity=0.253  Sum_probs=195.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC------
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  159 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (411)
                      ..++|.+.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999965 4889999998753  233456678999999999999999999987643      


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ...|+||||+++ +|..++..     .+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            356999999976 55555521     2678888899999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH----------
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA----------  309 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~----------  309 (411)
                      ++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.... .....          
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~  248 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEF  248 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHH
Confidence            97654322   12334689999999999999999999999999999999999999864431100 00000          


Q ss_pred             --------HHHhhcCc-cc-----cccccccccc--cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          310 --------WDLWTSNR-TL-----ELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       310 --------~~~~~~~~-~~-----~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                              ........ ..     ..........  .........+.+++.+||+.||++|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    00000000 00     0000000000  0001123568899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.6e-40  Score=299.52  Aligned_cols=251  Identities=27%  Similarity=0.392  Sum_probs=190.9

Q ss_pred             CcccccCcccEEEEEecC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeec-CCceEEEEeeCC
Q 040952           97 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYMP  170 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  170 (411)
                      +.||+|+||.||+|.+.+    +..+|+|.+... .....+.+.+|+.+++.++||||+++++++.. .+..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    357999998643 23345678899999999999999999998764 556789999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc-
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-  249 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  249 (411)
                      +++|..++.....  ..++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999864332  3567777889999999999999988   999999999999999999999999998765432111 


Q ss_pred             -cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          250 -ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       250 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                       .......++..|+|||.+.+..++.++|||||||++|||++| .+||....  ....   ..... ....     ... 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~---~~~~~-~~~~-----~~~-  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDI---TVYLL-QGRR-----LLQ-  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH---HHHHh-cCCC-----CCC-
Confidence             111223457789999999888899999999999999999995 45553221  1111   11111 1100     000 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                          +...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                1112456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.2e-40  Score=302.14  Aligned_cols=251  Identities=31%  Similarity=0.482  Sum_probs=197.3

Q ss_pred             CcccccCcccEEEEEecC-------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKK-------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +.||+|+||.||+|...+       +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998643       2579999886543 23456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCC----CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-----CeEEeecCC
Q 040952          169 MPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-----NPKISDFGM  239 (411)
Q Consensus       169 ~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfgl  239 (411)
                      +++++|.+++....    ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2234788889999999999999999988   99999999999999887     899999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      +................++..|+|||.+.++.++.++|||||||++|||++ |+.||.....  ....   . .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~---~-~~~~~~~  231 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVL---Q-HVTAGGR  231 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHH---H-HHhcCCc
Confidence            876543332222223355788999999999999999999999999999998 9988753221  1111   1 1111100


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      .          ..+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       232 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         232 L----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0          0111235678999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.7e-39  Score=306.21  Aligned_cols=198  Identities=25%  Similarity=0.406  Sum_probs=159.5

Q ss_pred             cCcccccCcccEEEEEec---CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec--CCceEEEEeeCC
Q 040952           96 ANKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMP  170 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  170 (411)
                      .+.||+|+||.||+|...   +++.||+|.+.....  ...+.+|+.++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            367999999999999864   367899999875432  2456789999999999999999998864  446789999986


Q ss_pred             CCCchhhhcCC------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCCeEEeecCCc
Q 040952          171 NKSLDFFLFDP------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMA  240 (411)
Q Consensus       171 ~g~L~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfgl~  240 (411)
                      + +|..++...      .....+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 666665321      12235788889999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCCcc-cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 040952          241 RICGGNELQ-ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYR  299 (411)
Q Consensus       241 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~  299 (411)
                      +........ .......||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876432211 122345789999999998764 58999999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-39  Score=302.61  Aligned_cols=251  Identities=26%  Similarity=0.353  Sum_probs=197.9

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .|+..+.||+|+||.||++... +++.||+|.+....   ......+..|+.++++++|+|++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677788999999999999966 48899999986542   2223456789999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999998885432 234788899999999999999999988   9999999999999999999999999987653222


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                         ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........  .........      ..... 
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~------~~~~~-  224 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE------VQEEY-  224 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhh------hhhhc-
Confidence               112346899999999999999999999999999999999999998643221100  000000000      00001 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVS  362 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  362 (411)
                          +...+..+.+++.+||+.||++|||     +.|+++
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 ----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                1112456889999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.5e-40  Score=304.83  Aligned_cols=262  Identities=24%  Similarity=0.374  Sum_probs=200.7

Q ss_pred             hhhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeee---
Q 040952           83 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI---  157 (411)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~---  157 (411)
                      +..+....++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4455567789999999999999999999875 48899999886532 2235678899999999 7999999999874   


Q ss_pred             --cCCceEEEEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          158 --DKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       158 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                        ..+..++||||+++++|..++... .....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999887532 22345788888999999999999999988   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  309 (411)
                      +|||++........  ......|+..|+|||.+.     +..++.++|||||||++|||++|+.||.......     ..
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~  238 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----AL  238 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HH
Confidence            99999876543221  122346899999999875     3457889999999999999999999975432110     00


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      ... ...     ..+..   ..+...+..+.+++.+||+.+|++|||+.|+++.+
T Consensus       239 ~~~-~~~-----~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 FKI-PRN-----PPPTL---HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hhc-ccc-----CCCcc---cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            000 000     00000   00111245688999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.5e-40  Score=298.19  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=203.0

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|+..+.||.|+||.||.++.. +++.+++|.+...  +......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999854 4889999988654  334456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++.... ...+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986542 345788899999999999999999988   99999999999999999999999999876643321


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......|++.|+|||.+.+..++.++||||||+++|||++|..||.....     ........ .+....        
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~-~~~~~~--------  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIV-QGNYTP--------  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHH-cCCCCC--------
Confidence              22334689999999999888899999999999999999999999753221     11111111 111110        


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                        .....+..+.+++.+||+.+|++||++.++++.+
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              0112256788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=332.86  Aligned_cols=258  Identities=25%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC--C
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--D  160 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  160 (411)
                      .....++|.+.+.||+|+||.||+|.+.. +..+|+|.+...  .......+..|+.++++++||||++++++|...  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            34456789999999999999999999764 778999988653  233456788999999999999999999988653  5


Q ss_pred             ceEEEEeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeecCCCCCCEEEcC-------
Q 040952          161 EKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSR----VRIIHRDLKASNILLDK-------  228 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~dlkp~Nill~~-------  228 (411)
                      .+|+||||+++++|..++.... ....+++..++.|+.||+.||+|||+.+.    .+|+||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            6899999999999999886432 22458999999999999999999998541    34999999999999964       


Q ss_pred             ----------CCCeEEeecCCccccCCCCcccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 040952          229 ----------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTG  296 (411)
Q Consensus       229 ----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~  296 (411)
                                .+.+||+|||++........   .....||+.|+|||++.+  ..++.++|||||||+||||++|+.||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      33489999999976543221   233478999999999864  458999999999999999999999986


Q ss_pred             CCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          297 LYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ....    ........ ....       .+    +....+..+.+||..||+.+|.+||++.|++.
T Consensus       245 ~~~~----~~qli~~l-k~~p-------~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANN----FSQLISEL-KRGP-------DL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCc----HHHHHHHH-hcCC-------CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            4321    11111111 1110       00    00111456899999999999999999999984

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.8e-39  Score=301.43  Aligned_cols=251  Identities=25%  Similarity=0.321  Sum_probs=197.4

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      |+..+.||+|+||+||+|.+. +++.+|+|.+....   ......+.+|+.+++.++|+||+++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999965 58899999986542   22334577899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|..++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999988875432 235899999999999999999999988   9999999999999999999999999987653221 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......|+..|+|||.+.+..++.++|+|||||++|||++|..||........ .. ..........      ...  
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~-~~~~~~~~~~------~~~--  224 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-RE-EVDRRVLETE------EVY--  224 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHhhhccc------ccc--
Confidence              11234689999999999988999999999999999999999999864321110 00 0000000000      000  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                         ....+..+.+++.+||+.+|++||+     +.+++..
T Consensus       225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence               1112456789999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-40  Score=314.02  Aligned_cols=259  Identities=22%  Similarity=0.308  Sum_probs=193.5

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC------
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  159 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (411)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999865 58899999987542  22345677899999999999999999987543      


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ...+++++++ +++|..++..    ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3568999987 7788877632    34888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc---
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS---  315 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  315 (411)
                      +......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......  +...........   
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~  237 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTPSP  237 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCCH
Confidence            9765422     233468999999999876 56899999999999999999999998643211  000000000000   


Q ss_pred             --------Cccccccccccccccc------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 --------NRTLELIDPILEDEYS------SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 --------~~~~~~~~~~l~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                              ......+.. +.....      .......+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    000000000 000000      00012357899999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-39  Score=302.74  Aligned_cols=258  Identities=29%  Similarity=0.465  Sum_probs=200.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCC----EEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGD----EIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|+..+.||+|+||.||+|.+. +|.    .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999864 344    579998875432 2344688999999999999999999998754 567


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +++||+++|+|.+++....  ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            9999999999999885432  24788888999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....  ...    ...........  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~----~~~~~~~~~~~--  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REI----PDLLEKGERLP--  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHH----HHHHHCCCCCC--
Confidence            53332222223345778999999998899999999999999999998 8888753221  111    11111111000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      .        +...+..+.+++.+||..+|++||++.++++.|+.+..
T Consensus       232 ~--------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         232 Q--------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0        01124568899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=297.55  Aligned_cols=253  Identities=23%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      ++|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999975 47889999998766556778999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++....  ..+++.....++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            9999999885432  34788899999999999999999988   9999999999999999999999999987654321  


Q ss_pred             cccccccccccccChhhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .......++..|+|||.+.+.   .++.++|+|||||++|||++|+.||........     .... ...   ......+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~~-~~~---~~~~~~~  226 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFLI-SKS---NFPPPKL  226 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-Hhc---cCCCccc
Confidence            112234678899999998776   789999999999999999999999854321110     0000 000   0000000


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .   .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       227 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 K---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0   12223567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-39  Score=308.42  Aligned_cols=255  Identities=19%  Similarity=0.230  Sum_probs=196.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999976 4788999998642   2233455788999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|..++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999986532  34788888899999999999999998   999999999999999999999999998765432


Q ss_pred             CcccccccccccccccChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      .. .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||.....     ............... 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~-  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEERFQ-  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCccc-
Confidence            21 11233579999999998875     5688999999999999999999999853221     111111111110000 


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  363 (411)
                      +....      ...+..+.+++.+|+...+++  |+++.++++.
T Consensus       229 ~p~~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 FPSHI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCcc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00000      112467889999999865544  4688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-39  Score=302.59  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=197.9

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc-----cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      +|+..+.||+|+||.||+|... +|+.||+|.+......     ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999965 5899999999754322     234567899999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+ +++|..++....  ..+++..+..++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999986533  35899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--------
Q 040952          246 NELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--------  316 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  316 (411)
                      ...  ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||......  .............        
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhhhc
Confidence            321  1222356788999998864 45789999999999999999997776533211  1111110000000        


Q ss_pred             -cccccccccccccc----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 -RTLELIDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 -~~~~~~~~~l~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       ..............    .....+..+.+++.+||+.+|++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             00000000000000    011225678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=310.87  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=207.3

Q ss_pred             CCCccCcccccCcccEEEEEecC---CC--EEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK---GD--EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ..+..+.||.|-||.||+|.+.+   |.  .||||..+.. ..+..+.|..|..+|+.++||||++++|+|.+ ...|+|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            34456789999999999999643   33  4889988763 45567889999999999999999999999986 577999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||.++-|.|..||....  ..++......++.||+.||+|||+..   +|||||..+|||+....-+||+|||+++.+..
T Consensus       469 mEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            99999999999997644  34888888999999999999999998   99999999999999999999999999999876


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ....... ...-...|||||.+.-..++.+||||.|||.+||+++ |..||......               ++.-.+..
T Consensus       544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DVI~~iEn  607 (974)
T KOG4257|consen  544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DVIGHIEN  607 (974)
T ss_pred             cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ceEEEecC
Confidence            6554433 3345678999999999999999999999999999988 88998643211               11111111


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      . ..-+.++.++..+..|+.+||..+|.+||++.++...|..+..
T Consensus       608 G-eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  608 G-ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             C-CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            0 0112344567789999999999999999999999988866554

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-39  Score=307.53  Aligned_cols=255  Identities=20%  Similarity=0.238  Sum_probs=195.3

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||++..+. ++.+|+|++...   .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468889999999999999999764 788999998642   2223445788999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++....  ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999986532  34788888899999999999999998   999999999999999999999999998754322


Q ss_pred             CcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....     ................ 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~-  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKERFQ-  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCcccc-
Confidence            11 1223357999999999886     3468899999999999999999999986332     1111111111110000 


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  363 (411)
                          ...  .....+..+.+++.+|+..+++.  |+++.++++.
T Consensus       229 ----~p~--~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 ----FPA--QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----CCC--ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                000  01122556888999988654443  6899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-39  Score=298.50  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|+..+.||+|+||.||++.++ +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999976 48899999987653 34456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|.+++....  ..++......++.|++.|++|||+ .+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999986532  457888889999999999999999 77   9999999999999999999999999986553211


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                          .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....................      .+.+ 
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~-  224 (265)
T cd06605         156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PPRL-  224 (265)
T ss_pred             ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CCCC-
Confidence                11156888999999999989999999999999999999999998654322222222221111110      0111 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         .....+..+.+++.+||..+|++|||+.+++..
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         225 ---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               111135678999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-39  Score=300.34  Aligned_cols=253  Identities=22%  Similarity=0.363  Sum_probs=199.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||+|+||.||++... .|+.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888899999999999999976 5899999988754 333456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|..++........+++.....++.|++.||.|||+. +   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999886543334689999999999999999999974 5   9999999999999999999999999987653221


Q ss_pred             cccccccccccccccChhhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                          .....++..|+|||.+.+.      .++.++|+|||||++|+|++|+.||.......  ......... ...    
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~-~~~----  226 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAIV-DGD----  226 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHHh-hcC----
Confidence                2234578899999988543      35889999999999999999999985432111  111111100 000    


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       .+.+     +...+..+.+++.+||+.+|++||++.+++..
T Consensus       227 -~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 -PPTL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -CCCC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             0111     11235678899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4e-39  Score=294.13  Aligned_cols=247  Identities=28%  Similarity=0.446  Sum_probs=199.2

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-----cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777889999999999999976 68999999886543     23456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +||+++++|.+++...   ..+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999998543   34788889999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ..   ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.....     .............     +
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~-----~  221 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKEL-----P  221 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHhcccC-----C
Confidence            22   123346888999999987766 89999999999999999999999864331     1111111110000     0


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .+     +......+.+++.+||+.+|++||++.++++
T Consensus       222 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 PI-----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             Cc-----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11     1112456889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-39  Score=298.28  Aligned_cols=238  Identities=26%  Similarity=0.441  Sum_probs=188.3

Q ss_pred             CcccccCcccEEEEEecCCC-----------EEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           97 NKLGEGGFGPVYKGVLKKGD-----------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999976422           5788887654433 5778899999999999999999999988 788999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-------CeEEeecC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-------NPKISDFG  238 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg  238 (411)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+|||+++   |+||||||+||+++.++       .++|+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999865432  5788889999999999999999988   99999999999999887       79999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                      ++.....      .....++..|+|||.+.+.  .++.++|||||||++|||++ |..|+.......     +.. .+..
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-----~~~-~~~~  221 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-----KER-FYQD  221 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-----HHH-HHhc
Confidence            9876542      1223567789999998876  78999999999999999999 466665432111     000 0110


Q ss_pred             CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ...       ... ..    ...+.+++.+||+.+|.+|||+.++++.|+
T Consensus       222 ~~~-------~~~-~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QHR-------LPM-PD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCC-------CCC-CC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000       000 00    257889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=316.95  Aligned_cols=246  Identities=30%  Similarity=0.454  Sum_probs=199.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..|..++.||.|+||.||-|++. +.+.||||++.-.   +...|+++..|+.+|++++|||++.+.|||......|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            44677788999999999999965 5788999998754   3445888999999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |||-| +-.+++.-  .++++.+.....|+.+.++||+|||+++   .||||||..|||+++.|.+||+|||.+....  
T Consensus       106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--  177 (948)
T KOG0577|consen  106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--  177 (948)
T ss_pred             HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence            99965 55555532  2356888899999999999999999998   9999999999999999999999999986543  


Q ss_pred             CcccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                          ....++|||.|||||++.   .+.|+-++||||||++..||.-.++|.......     .-.+.+...+      .
T Consensus       178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----SALYHIAQNe------s  242 (948)
T KOG0577|consen  178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNE------S  242 (948)
T ss_pred             ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----HHHHHHHhcC------C
Confidence                334579999999999985   678999999999999999999999985322211     1111111111      1


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      |.+    ...+++..+.+++..||++-|.+|||..++++.
T Consensus       243 PtL----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 PTL----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCC----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            112    234568889999999999999999999987754

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.5e-40  Score=301.90  Aligned_cols=248  Identities=25%  Similarity=0.432  Sum_probs=199.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34666788999999999999865 47889999987543 33456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++..    ..+++..+..++.|+++|+.|||+++   ++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999988743    34788889999999999999999988   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......|+..|+|||.+.+..++.++|||||||++|||++|+.|+.......     .... ....     ..+.+. 
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~-~~~~-----~~~~~~-  222 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLFL-IPKN-----SPPTLE-  222 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHhh-hhcC-----CCCCCC-
Confidence              1223467889999999998889999999999999999999999975322111     0000 0000     011111 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ...+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 ----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                1124568899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.2e-39  Score=298.74  Aligned_cols=263  Identities=24%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|+..+.||+|+||.||+|.+. +|+.||+|++....  ....+.+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999976 48999999886442  2233567899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|..++...   ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99999998876432   24789999999999999999999988   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH----------HHhhcC
Q 040952          248 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW----------DLWTSN  316 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~  316 (411)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......          ..+...
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccc
Confidence            1  1223457889999998875 5688999999999999999999999864332111 000000          000000


Q ss_pred             cccc-ccccccccccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 RTLE-LIDPILEDEYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ~~~~-~~~~~l~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .... ...+.......    ....+..+.+++.+||+.+|++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000 00000000000    0112467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.2e-39  Score=298.36  Aligned_cols=248  Identities=23%  Similarity=0.413  Sum_probs=200.9

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999975 48899999987543 34456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++..    ..+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998843    24788888999999999999999988   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......++..|+|||.+.+..++.++|+|||||++|||++|..||........     ... ....     ..+.   
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~-~~~~-----~~~~---  220 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFL-IPKN-----NPPT---  220 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhh-hhcC-----CCCC---
Confidence              12234678899999999888899999999999999999999999764321110     000 0000     0011   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        .....+..+.+++.+||+.+|++||++.++++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 --LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              112236678999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-39  Score=304.98  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=196.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999875 48899999987543 22344677899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      ++ ++|..++....  ..+++.....++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            97 47877775432  34788889999999999999999988   9999999999999999999999999987643221 


Q ss_pred             ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh-----------cC
Q 040952          249 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT-----------SN  316 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~  316 (411)
                       .......+++.|+|||.+.+. .++.++|||||||++|||++|++||...+...  ..........           ..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhhhcc
Confidence             112233568899999988654 57889999999999999999999986443211  1111111000           00


Q ss_pred             -cccccccccccccc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 -RTLELIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 -~~~~~~~~~l~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                       .......+......   .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             00000000000000   00112456889999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.9e-39  Score=307.22  Aligned_cols=264  Identities=19%  Similarity=0.240  Sum_probs=192.0

Q ss_pred             ccCccccc--CcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           95 DANKLGEG--GFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        95 ~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      +.++||+|  +||+||++..+ +|+.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999865 58999999987542  233456788999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|.+++..... ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999854322 34788899999999999999999988   999999999999999999999999865433211110


Q ss_pred             -----cccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH-------------
Q 040952          250 -----ANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-------------  309 (411)
Q Consensus       250 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-------------  309 (411)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.||..............             
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                 01112346778999999876  4589999999999999999999999864321110000000             


Q ss_pred             HHHhhcCcccccccccc-------------cc---ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          310 WDLWTSNRTLELIDPIL-------------ED---EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l-------------~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .............+...             ..   .......+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00000000000000000             00   0011123467899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-39  Score=302.81  Aligned_cols=263  Identities=24%  Similarity=0.351  Sum_probs=197.8

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999976 489999999865422  234567889999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|..+....   ..+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999998876432   23789999999999999999999988   9999999999999999999999999987654322


Q ss_pred             cccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH----------HHhhcC
Q 040952          248 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW----------DLWTSN  316 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~  316 (411)
                        .......++..|+|||.+.+ ..++.++||||||+++|||++|++||....... .......          ......
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccc
Confidence              11223457889999998875 457889999999999999999998885332110 0000000          000000


Q ss_pred             ccc-ccccccccccc----chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 RTL-ELIDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ~~~-~~~~~~l~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ... ....+......    .....+..+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000 00000000000    01123567999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.8e-39  Score=296.41  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=199.4

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC-CceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  167 (411)
                      +|++.+.||+|++|.||++... +++.||+|.+....  ....+.+.+|+.++++++|+|++++.+.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999965 47899999986542  23456688999999999999999999987644 45789999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|.+++.... ...+++.....++.|++.|+++||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999886532 345789999999999999999999998   9999999999999999999999999987664322


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      .  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.     ........ ....     +.+ 
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~-~~~~-----~~~-  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRII-EGKL-----PPM-  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH-hcCC-----CCC-
Confidence            1  22335688999999999999999999999999999999999999753221     11111111 1111     001 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          +...+..+.+++.+||+.+|++|||+.++++.
T Consensus       223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                11235678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-39  Score=298.95  Aligned_cols=253  Identities=24%  Similarity=0.397  Sum_probs=199.3

Q ss_pred             CCCccCcccccCcccEEEEEecC--CCEEEEEEccCC----------CcccHHHHHHHHHHHHh-cCCcccceeeeeeec
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGR----------SGQGLREMKNEASVIAK-VQHKNLVRLLGCCID  158 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  158 (411)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+...          .......+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  688999987532          12234556778888875 799999999999999


Q ss_pred             CCceEEEEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEee
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISD  236 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~D  236 (411)
                      .+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999998887432 223458888999999999999999996 45   99999999999999999999999


Q ss_pred             cCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC
Q 040952          237 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       237 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      ||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....     ........ ..
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~-~~  228 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKIV-EA  228 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHHh-hc
Confidence            99997754332   22345688999999999988899999999999999999999999753321     11111111 11


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ..    .+..     ....+..+.+++.+||+.||++||++.|+...+.
T Consensus       229 ~~----~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY----EPLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC----CcCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            10    0110     0112456899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-39  Score=300.55  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=203.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            356888899999999999999965 48899999886543 3345678899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |+++++|..++...   ..+++.....++.+++.||.|||+. +   ++||||+|+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            99999999887542   3478899999999999999999974 5   999999999999999999999999998654221


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc------chhHHHHHHhhcCcccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL------NLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~  320 (411)
                          ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........      .............    
T Consensus       158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence                12235789999999999888899999999999999999999999874432110      0111111111110    


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                        .+    .......+..+.+++.+||+.||++|||+.|+++..
T Consensus       230 --~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 --PP----RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --CC----CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence              00    111112356789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.1e-39  Score=294.54  Aligned_cols=256  Identities=24%  Similarity=0.401  Sum_probs=197.1

Q ss_pred             CCccCcccccCcccEEEEEec----CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC------
Q 040952           93 FSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  160 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (411)
                      |.+.+.||+|+||.||+|.+.    .++.||+|.+...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999853    3678999998754  2334567889999999999999999999886542      


Q ss_pred             ceEEEEeeCCCCCchhhhcCC---CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          161 EKILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                      ..++++||+.+|+|..++...   .....+++.....++.|++.|++|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            236889999999998876432   12234788889999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcC
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      |+++...............++..|++||.+.+..++.++|||||||++|||++ |++||.....  .....    .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~----~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYN----YLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHH----HHHcC
Confidence            99886543322222222345678999999988889999999999999999999 8888753221  11111    11111


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ....     .     +...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       232 ~~~~-----~-----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRLK-----Q-----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1000     0     011245799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-39  Score=309.68  Aligned_cols=192  Identities=23%  Similarity=0.299  Sum_probs=163.1

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ...+|++.+.||+|+||.||+|.... ++.||+|.....      ....|+.++++++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            34579999999999999999999764 778999975432      23568999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      ++. ++|..++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       138 ~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        138 HYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             ccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            995 5777776543  235889999999999999999999998   999999999999999999999999998753321 


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT  295 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~  295 (411)
                        .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1223356899999999999999999999999999999999966554

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-39  Score=323.35  Aligned_cols=261  Identities=21%  Similarity=0.247  Sum_probs=189.0

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC------cccceeeeeeecC
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH------KNLVRLLGCCIDK  159 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~  159 (411)
                      ....++|++.+.||+|+||.||+|.+. .++.||||++.... .....+..|+.++..++|      ++++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            344678999999999999999999965 47889999986432 223445667777777755      4588888888765


Q ss_pred             -CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCC-------
Q 040952          160 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDM-------  230 (411)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~-------  230 (411)
                       ...|+|||++ +++|.+++...   ..+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence             4678899987 66777777433   348888999999999999999997 46   99999999999998765       


Q ss_pred             ---------CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc
Q 040952          231 ---------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  301 (411)
Q Consensus       231 ---------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  301 (411)
                               .+||+|||++....     ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     49999999875432     1223457999999999999999999999999999999999999999643321


Q ss_pred             ccchhHHHHHH-------hh----cCcccccc------cccccc---------c-cchHHHHHHHHHHHHHccccCCCCC
Q 040952          302 SLNLLGYAWDL-------WT----SNRTLELI------DPILED---------E-YSSKHMLLRYVNIALLCVQESADDR  354 (411)
Q Consensus       302 ~~~~~~~~~~~-------~~----~~~~~~~~------~~~l~~---------~-~~~~~~~~~l~~li~~cl~~~p~~R  354 (411)
                        .........       +.    .....+..      ++....         . .........+.+|+.+||+.||++|
T Consensus       352 --~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        352 --EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             --HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence              100000000       00    00000000      000000         0 0000113567899999999999999


Q ss_pred             CCHHHHHH
Q 040952          355 PTMNDVVS  362 (411)
Q Consensus       355 Pt~~evl~  362 (411)
                      ||+.|+++
T Consensus       430 ~ta~e~L~  437 (467)
T PTZ00284        430 LNARQMTT  437 (467)
T ss_pred             CCHHHHhc
Confidence            99999997

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.2e-39  Score=293.12  Aligned_cols=247  Identities=29%  Similarity=0.444  Sum_probs=197.1

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      ++|++.+.||+|+||.||++... ++.||+|.+....  ....+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC-CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            56888999999999999999764 8889999986532  335788999999999999999999998654 5799999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|.+++.... ...+++.....++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++......    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999986543 234788889999999999999999988   999999999999999999999999998754321    


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       ......+..|+|||.+.+..++.++|+|||||++|||++ |+.||......     .. .........   .+      
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~-~~~~~~~~~---~~------  217 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EV-KECVEKGYR---ME------  217 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HH-HHHHhCCCC---CC------
Confidence             112234567999999988899999999999999999998 88887543211     11 111111100   00      


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                       .....+..+.+++.+||+.+|++||++.++++.|++
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             011224678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-38  Score=291.39  Aligned_cols=251  Identities=33%  Similarity=0.499  Sum_probs=199.4

Q ss_pred             CCccCcccccCcccEEEEEecC-----CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      +++.+.||.|+||.||++....     +..||+|.+...... ..+.+..|+..+..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999764     378999999765433 5678899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++..... ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854322 11789999999999999999999998   999999999999999999999999999776543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.....     ....... ......     .
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~-~~~~~~-----~  224 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEYL-KKGYRL-----P  224 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-hcCCCC-----C
Confidence            222111 2236789999999988889999999999999999998 7777653211     1111111 111110     0


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      .     +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       225 ~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 K-----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C-----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0     111356789999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.6e-40  Score=304.89  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      +.|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            44555577999999999999865 48899999987655555667889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++..    ..+++.....++.|++.||+|||+++   ++||||||+||++++++.++|+|||++.......  
T Consensus       102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658         102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            99999998743    23788899999999999999999998   9999999999999999999999999987553222  


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......     .......      ..+.+.+.. 
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~------~~~~~~~~~-  240 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----QAMRRIR------DNLPPRVKD-  240 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH------hcCCCcccc-
Confidence            1122346889999999998888999999999999999999999998632211     0011100      011111111 


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        ....+..+.+++.+||+.+|++|||+.++++.
T Consensus       241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              11124568899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=303.30  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      +.+-|...+.||+|.|+.|-+|++ -.|..||||++.+..-  .....+..|++.|+.++|||||+++.+......+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            356688899999999999999984 3699999999987643  3345688999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeEEeecCCccccC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICG  244 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~  244 (411)
                      +|.-++|+|.+|+.....+  +.+....+++.||+.|+.|+|+.+   +|||||||+||.+- +-|-+||+|||++..+.
T Consensus        96 LELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999999765543  788889999999999999999999   99999999999875 56889999999998765


Q ss_pred             CCCcccccccccccccccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ...   .....||+..|.|||++.+..|+ +++||||||||||-|++|++||....+.                  +.+.
T Consensus       171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS------------------ETLT  229 (864)
T KOG4717|consen  171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS------------------ETLT  229 (864)
T ss_pred             Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch------------------hhhh
Confidence            332   33456999999999999999987 5689999999999999999998643221                  1111


Q ss_pred             cccccc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDE-YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .++.-. ..+...+.++.+||.+||..||.+|.+.+|++..
T Consensus       230 mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  230 MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            111111 1244557889999999999999999999998754

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=316.95  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=205.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .+-|+++..||.|+||.||+|+.++ +-..|.|.+...+....+.+.-|+++|..++||+||++++.|+..+.++++.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3457788899999999999999775 444577888887888889999999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      |.||-.+..+.+-.  ..+.+....-+++|++.||.|||++.   |||||||..|||++-+|.++|+|||.+.....  .
T Consensus       111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T  183 (1187)
T ss_pred             cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence            99999988876544  34788888899999999999999998   99999999999999999999999999865432  1


Q ss_pred             ccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....+.+.|||.|||||+.+     ..+|+.++||||||++|.||..+.+|.....+     ......+..++ .     
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MRVllKiaKSe-P-----  252 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSE-P-----  252 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HHHHHHHhhcC-C-----
Confidence            22345578999999999876     45799999999999999999999998542221     11111111111 0     


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      |.+   ..+..++..+.+++.+||..||..||++.++++.
T Consensus       253 PTL---lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 PTL---LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             Ccc---cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            111   1234557889999999999999999999998864

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.3e-39  Score=296.86  Aligned_cols=261  Identities=26%  Similarity=0.333  Sum_probs=200.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  166 (411)
                      ++|+..+.||.|++|.||++.+. +++.+|+|.+..... .....+.+|++++++++||||++++++|.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999975 488999999875432 3456788999999999999999999998654  4689999


Q ss_pred             eeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+++++|.+++... .....++......++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876432 22345788888999999999999999988   99999999999999999999999999865432


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..    .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.................. ....... ...
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~  231 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPEL-KDE  231 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhh-ccC
Confidence            21    12345788999999999889999999999999999999999998754321111111111111 1011011 000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..   .....+..+.+++.+||+.+|++|||+.|+++.
T Consensus       232 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         232 PG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             CC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00   001135678999999999999999999999973

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.8e-39  Score=296.41  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|+||.+|.+... +|+.||+|.+...  .......+.+|+.++++++||||+++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888899999999999999865 5889999998643  233446788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++.... ...+++.....++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999998885432 234688888999999999999999988   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.....     .......... ..     +.   
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~-~~-----~~---  220 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRG-SY-----PP---  220 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcC-CC-----CC---
Confidence              11234578899999999988899999999999999999999999753221     1111111111 00     00   


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        .+...+..+.+++.+||+.+|++||++.+|++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              111225678999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5e-39  Score=296.20  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=197.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc----------ccHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG----------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      +|...+.||.|+||.||+|... +|+.+|+|.+.....          ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4777899999999999999865 588999998753211          11345788999999999999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998654   34788888999999999999999988   999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      ................|+..|+|||.+....  ++.++|+||||+++|+|++|..||.....     ........... .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFKLGNKR-S  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHHhhccc-c
Confidence            7654322112223346788999999987654  88999999999999999999999753211     11111111110 0


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...+....     ....+..+.+++.+||+.+|++|||+.++++.
T Consensus       230 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            01111111     11235678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-40  Score=308.79  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=200.1

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccC--CCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSG--RSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ....|+++++||+||.+.||++...+.+.||+|++..  .+.+...-+.+|+..|.++ .|.+|+++++|-..++.+|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3457999999999999999999988778889987753  3556678899999999999 589999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||- ..+|..+|..... ...+| .+..+..||+.|+.++|.+|   |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus       439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            9975 5689999866543 22334 66788999999999999999   99999999999994 67999999999998876


Q ss_pred             CCcccccccccccccccChhhhccCC-----------CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGI-----------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      ..........+||..||+||.+....           .+.++||||||||||+|+.|+.||+.+....       .    
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~-------a----  580 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI-------A----  580 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-------H----
Confidence            65555556679999999999885322           5678999999999999999999987432111       1    


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        .+..+.++.-.-+++......++.+++..||+.||++|||+.|+|+.
T Consensus       581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              11122222111111100002238999999999999999999999864

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-39  Score=301.08  Aligned_cols=262  Identities=22%  Similarity=0.304  Sum_probs=194.2

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|+||.||+|... +|+.||+|.+....  ......+.+|+.++++++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999975 58999999986532  22234677899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++ +|..++...  ...+++.....++.||++||.|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            975 676666432  234889999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc------cccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR------TLEL  321 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~  321 (411)
                       .......++..|+|||.+.+. .++.++|||||||++|+|++|+.|+........ .............      ....
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhc
Confidence             112234578899999988764 478999999999999999999988643222111 1100000000000      0000


Q ss_pred             cc----cccccc----cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 ID----PILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~----~~l~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .+    +.....    ......+..+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    000000    001112467889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.8e-39  Score=302.46  Aligned_cols=197  Identities=26%  Similarity=0.414  Sum_probs=158.5

Q ss_pred             CcccccCcccEEEEEecC---CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec--CCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  171 (411)
                      ..||+|+||.||+|...+   +..||+|.+.....  ...+.+|+.+++.++||||+++++++..  ....++|+||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999999653   57899999875432  2457889999999999999999999854  4577899999876


Q ss_pred             CCchhhhcC------CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCCeEEeecCCcc
Q 040952          172 KSLDFFLFD------PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMAR  241 (411)
Q Consensus       172 g~L~~~l~~------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfgl~~  241 (411)
                       +|..++..      ......+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             55555431      112235788889999999999999999998   9999999999999    566789999999998


Q ss_pred             ccCCCCcc-cccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 040952          242 ICGGNELQ-ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  299 (411)
Q Consensus       242 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~  299 (411)
                      ........ .......||+.|+|||.+.+ ..++.++|||||||++|||+||++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76533211 12233568999999999876 458999999999999999999999986443

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4e-39  Score=295.98  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=193.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-----cccHHHHHHHHHHHHhcCCcccceeeeeeecC--Cce
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  162 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (411)
                      .+|+..+.||+|+||.||+|... +|..|++|.+....     ......+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999865 48899999886432     12345688899999999999999999998763  567


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++++||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999988543   23788888999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          243 CGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       243 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.....     ...........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~~~~~~-----  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFKIATQP-----  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcCC-----
Confidence            532111 1112234578899999999988899999999999999999999999864321     11111111000     


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..+.+     +......+.+++ +||..+|++||++.|+++
T Consensus       226 ~~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            01111     112244566676 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.3e-40  Score=313.87  Aligned_cols=199  Identities=26%  Similarity=0.373  Sum_probs=170.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-C-----cccceeeeeeecCCc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-H-----KNLVRLLGCCIDKDE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~  161 (411)
                      ...+|++.+.||+|+||.|.+|.+. +++.||||+++... ....+...|+.+|..++ |     -|+|+++++|...++
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            3447899999999999999999965 49999999998653 34556688999999996 4     389999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC--CCeEEeecCC
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD--MNPKISDFGM  239 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfgl  239 (411)
                      .|+|+|.+. .+|.+++....- ..++......++.||+.||.+||+.+   |||+||||+||||.+-  ..+||+|||.
T Consensus       263 lciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence            999999984 589999876543 34889999999999999999999998   9999999999999653  4799999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY  298 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  298 (411)
                      |+.......     ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|...
T Consensus       338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            988654332     335577899999999999999999999999999999998877543

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=297.88  Aligned_cols=255  Identities=26%  Similarity=0.394  Sum_probs=199.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCC-----
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD-----  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----  160 (411)
                      ...++|++.+.||+|+||.||+|..+ +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            34688999999999999999999975 478999999876543 346788999999999 7999999999997654     


Q ss_pred             -ceEEEEeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          161 -EKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999998875432 2345888999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      ++.......  .......|+..|+|||.+..     ..++.++|||||||++|+|++|+.||.......     ......
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~  231 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-----ALFKIP  231 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-----HHHHhh
Confidence            987654322  11223468899999998753     347789999999999999999999985322110     011111


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..      ..+   ....+...+..+.+++.+||..||++|||+.++++
T Consensus       232 ~~------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN------PPP---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc------CCC---CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00      000   11112223567899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-39  Score=296.57  Aligned_cols=247  Identities=24%  Similarity=0.421  Sum_probs=198.1

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcC---CcccceeeeeeecCCceEEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999964 5899999998754 3344567889999999996   999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++...    .+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999988432    5889999999999999999999998   999999999999999999999999998776543


Q ss_pred             CcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .  .......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||.......     ... ..     .....+.
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~-----~~~~~~~  221 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LI-----PKSKPPR  221 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-cc-----ccCCCCC
Confidence            3  112334688999999988754 47899999999999999999999986432110     000 00     0000111


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +..    ...+..+.+++.+||+.+|++||++.++++
T Consensus       222 ~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LED----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111    112457899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-39  Score=300.96  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=201.4

Q ss_pred             chhhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecC
Q 040952           82 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  159 (411)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (411)
                      ...++....++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34455566789999999999999999999975 58899999986543 2235677899999998 899999999998754


Q ss_pred             -----CceEEEEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeE
Q 040952          160 -----DEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  233 (411)
Q Consensus       160 -----~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  233 (411)
                           +..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 3579999999999999887532 12345788899999999999999999988   99999999999999999999


Q ss_pred             EeecCCccccCCCCcccccccccccccccChhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHH
Q 040952          234 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  308 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  308 (411)
                      |+|||++.........  .....|+..|+|||.+...     .++.++|||||||++|||++|+.||......     ..
T Consensus       169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----~~  241 (291)
T cd06639         169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----KT  241 (291)
T ss_pred             Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----HH
Confidence            9999998765432211  1234678899999987543     3688999999999999999999998643211     00


Q ss_pred             HHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....... ......        .+......+.+++.+||+.+|++||++.|+++.
T Consensus       242 ~~~~~~~-~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 LFKIPRN-PPPTLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHhcC-CCCCCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111111 000000        111224568999999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=315.68  Aligned_cols=253  Identities=30%  Similarity=0.389  Sum_probs=206.0

Q ss_pred             cCCCccCcccccCcccEEEEEecC--CC--EEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK--GD--EIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~--g~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ++....+.||+|.||.|++|.|+.  |+  .||||++...... ....|.+|+.+|.+|+|+|+++|+|+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            345566889999999999999764  54  5899999865433 56789999999999999999999999988 778899


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +|.++.|+|.+.|+. ..+..+-......++.|||.|+.||.+++   +|||||..+|+|+-....+||+||||.+.++.
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 44566777888899999999999999998   99999999999999999999999999998877


Q ss_pred             CCccccccc-ccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          246 NELQANTSR-IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       246 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ++..+.... ..-...|+|||.+....|+.++|||+|||++|||+| |..||.....               -.+.+.+|
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~iD  329 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNID  329 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhcc
Confidence            665443322 223567999999999999999999999999999999 6677643221               11222233


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                       .-..-..++.+++++++++..||..+|.+|||+..+.+.+
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence             1111123455688999999999999999999999998544

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-39  Score=299.68  Aligned_cols=258  Identities=23%  Similarity=0.374  Sum_probs=199.5

Q ss_pred             hhhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeec--
Q 040952           83 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID--  158 (411)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--  158 (411)
                      +.......+.|++.+.||.|+||.||+|.+. +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            4444456688999999999999999999975 48899999986543 2345678899999998 79999999999853  


Q ss_pred             ----CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          159 ----KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                          ....+++|||+++|+|.+++.... ...+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence                456799999999999999886432 234778888899999999999999998   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  309 (411)
                      +|||++.......  .......|+..|+|||.+.     +..++.++|||||||++|||++|+.||.........     
T Consensus       163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----  235 (282)
T cd06636         163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----  235 (282)
T ss_pred             eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence            9999987653221  1123356889999999875     346888999999999999999999998533211000     


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ...      ......    .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~------~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 FLI------PRNPPP----KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhH------hhCCCC----CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            000      000000    0111123567999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-40  Score=312.82  Aligned_cols=240  Identities=22%  Similarity=0.289  Sum_probs=184.9

Q ss_pred             ccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhc---CCcccceeeeeeecCCceEEEEeeCCC
Q 040952           99 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      ||+|+||.||+|+.. +|+.||+|++....   ......+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999975 48999999986432   12233445566676655   699999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|..++...   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            9998888543   34788899999999999999999998   9999999999999999999999999987543221  12


Q ss_pred             cccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                      .....||..|+|||.+.+. .++.++|||||||++|+|++|+.||......     ..... ...... .     +    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~-i~~~~~-~-----~----  216 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRN-IAFGKV-R-----F----  216 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHH-HHcCCC-C-----C----
Confidence            2345799999999998764 4899999999999999999999998542211     11111 111110 0     0    


Q ss_pred             chHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 040952          331 SSKHMLLRYVNIALLCVQESADDRP----TMNDVVS  362 (411)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~~p~~RP----t~~evl~  362 (411)
                      +....+..+.+++.+||+.+|++||    ++.++++
T Consensus       217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0111245678999999999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.1e-39  Score=299.55  Aligned_cols=256  Identities=18%  Similarity=0.250  Sum_probs=198.5

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||++.... ++.|++|.+....   ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368889999999999999999764 7899999887543   233456789999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|..++...   ..+++.....++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999998543   34788888999999999999999988   999999999999999999999999998642110


Q ss_pred             Cc-------------ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          247 EL-------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       247 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      ..             ........++..|+|||.+.+..++.++|+|||||++|||++|..||.....     ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVI  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence            00             0011124578899999999888899999999999999999999999853221     11111111


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                      ...    ...+..     ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       230 ~~~----~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDD----IEWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcc----cCCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            110    000000     01125568999999999999999997666665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.4e-39  Score=298.58  Aligned_cols=248  Identities=24%  Similarity=0.345  Sum_probs=198.1

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      |.....||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++|||++++++++...+..++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344557999999999999865 5899999998765545556788999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      ++|..++..    ..+++.....++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++........  .
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            999887733    34788899999999999999999988   99999999999999999999999999875543221  1


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......  .   .... ..... .    ....   .
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~---~~~~-~~~~~-~----~~~~---~  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--Q---AMKR-LRDSP-P----PKLK---N  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHH-HhccC-C----CCcc---c
Confidence            22346889999999999888999999999999999999999998633211  1   0111 11000 0    0000   0


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....+..+.+++.+||+.+|++||++.++++.
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11124568899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-38  Score=292.88  Aligned_cols=253  Identities=24%  Similarity=0.447  Sum_probs=199.5

Q ss_pred             CCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCC------cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      +|+..+.||+|++|.||+|.. .+++.||+|.+....      ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 458899999986432      1134678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCcccc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARIC  243 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~~~  243 (411)
                      |+||+++++|.+++.+.   ..+++.....++.|++.||.|||+++   ++|+||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999998543   34788899999999999999999998   99999999999998776 5999999998766


Q ss_pred             CCCCcc--cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          244 GGNELQ--ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       244 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......  .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||......  .............     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-----  227 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT-----  227 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC-----
Confidence            432111  1122346788999999998888999999999999999999999998643321  1111111110000     


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..+     ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 TAP-----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCC-----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000     112233567899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5e-39  Score=299.55  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=202.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            478999999999999999999864 5889999998765545556788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++.+    ..+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999853    23678888999999999999999998   99999999999999999999999998876543221


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        ......|++.|+|||.+.+..++.++|+||||+++|++++|+.||..........     .....+.      +   .
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~------~---~  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT------P---E  234 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCC------C---C
Confidence              1223468889999999988889999999999999999999999986432211000     0000000      0   0


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .......+..+.+++.+||+.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01122234578899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=320.04  Aligned_cols=256  Identities=28%  Similarity=0.405  Sum_probs=207.8

Q ss_pred             CCccCcccccCcccEEEEEec-CCC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ....++||+|+||+||+|.+- .|+    +||+|++... ..+...++.+|+.+|.+++|||+++++++|..+. ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            344688999999999999853 344    6899988654 3445678999999999999999999999998776 78999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      +|++.|+|.++++..  +..+.....+.|..||++|+.|||.+.   ++||||..+||||..-..+||.|||+++.....
T Consensus       777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999999764  345788889999999999999999988   999999999999999999999999999988765


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....+.      +.+.+.      .-+. 
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------I~dlle------~geR-  918 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------IPDLLE------KGER-  918 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------hhHHHh------cccc-
Confidence            55554444455678999999999999999999999999999999 888865332211      111111      1111 


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      +   ..++-++.++..++.+||..|++.||+++++...+.....+
T Consensus       919 L---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  919 L---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             C---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            1   12333477899999999999999999999999998776554

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=299.93  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=200.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|+||.||+|.++ +++.||+|.+...  .......+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999976 4889999988754  23335678899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |++++.+..+....   ..+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99998887665332   33788899999999999999999998   9999999999999999999999999987765433


Q ss_pred             cccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH-----------hhc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL-----------WTS  315 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~  315 (411)
                      . .......++..|+|||++.+. .++.++||||||+++|+|++|++||.......  ........           ...
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhhccc
Confidence            2 122335678899999999887 88999999999999999999999986432110  00000000           000


Q ss_pred             -Ccc-----ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          316 -NRT-----LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       316 -~~~-----~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                       ...     .+..+........+...+..+.+++.+||..+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             000     00000000000011122577999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=306.35  Aligned_cols=256  Identities=30%  Similarity=0.454  Sum_probs=208.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..+...-.+||-|.||.||.|.|+. .-.||||.++... -..++|..|+.+|+.++|||+|+++|+|..+..+|+|.||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            3345556789999999999999875 6689999998643 4578999999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      |.+|+|.+||++.. +..++....+.++.||..|++||...+   +|||||..+|+|+.++..+|++||||++++....+
T Consensus       345 M~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             ccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            99999999997654 345777788899999999999999998   99999999999999999999999999999876554


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      ... ....-...|.|||-+.-..++.|+|||+|||+|||+.| |..||...     ++. .++.....+--.+       
T Consensus       421 TAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlS-qVY~LLEkgyRM~-------  486 (1157)
T KOG4278|consen  421 TAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS-QVYGLLEKGYRMD-------  486 (1157)
T ss_pred             ecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHH-HHHHHHhcccccc-------
Confidence            332 22233578999999999999999999999999999998 77776432     221 2222222211111       


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                         .++.|+..+++|++.||+.+|.+||++.|+-+.++..
T Consensus       487 ---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  487 ---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence               1333577899999999999999999999987776543

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.3e-39  Score=293.64  Aligned_cols=250  Identities=25%  Similarity=0.361  Sum_probs=194.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-----cccHHHHHHHHHHHHhcCCcccceeeeeeecC--Cce
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  162 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (411)
                      ++|++.+.||+|+||.||.|... +|+.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999975 48899999875321     12345788899999999999999999998764  457


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      +++|||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999988543   23678888999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          243 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       243 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......    .. ........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~-~~~~~~~~-----  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AA-IFKIATQP-----  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HH-HHHHhcCC-----
Confidence            5322111 1122346888999999998888999999999999999999999998532111    00 01111000     


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..+.     .+......+.+++.+|+. +|++||++.++++
T Consensus       226 ~~~~-----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 TNPV-----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCC-----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0111     122335678889999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.6e-38  Score=289.78  Aligned_cols=253  Identities=26%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||+|++|.||+|.... ++.|++|++..... .....+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368888999999999999999774 89999999876543 4457789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|.+++...   ..+++.....++.|+++|++|||+ .+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998543   458899999999999999999999 88   9999999999999999999999999988764332


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ........... ....     +.+.
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~-~~~~-----~~~~  224 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAIC-DGPP-----PSLP  224 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHh-cCCC-----CCCC
Confidence            22  1234678899999999988899999999999999999999999865432  01111111111 1000     1111


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ....+..+.+++.+||+.+|++||++.++++.
T Consensus       225 ----~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         225 ----AEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                11035679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-38  Score=290.64  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=199.8

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|+..+.||+|+||.||++... +++.+|+|.+...  .......+.+|+.++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788899999999999999865 5889999998654  233456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999986532 344788899999999999999999988   9999999999999865 458999999998764332


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                         ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......     ........ ......     .
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~-----~  222 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMS-GTFAPI-----S  222 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHh-cCCCCC-----C
Confidence               122346788999999998888999999999999999999999998543221     11111111 100010     0


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           ...+..+.+++.+||+.+|++|||+.|++..
T Consensus       223 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         223 -----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -----CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                 1125568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.3e-39  Score=297.75  Aligned_cols=264  Identities=24%  Similarity=0.324  Sum_probs=193.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      +++|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.+++.++|+||+++.+++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            478999999999999999999865 588999999875432 223456789999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+. +++..++....  ..+.+.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 56655553322  23677788889999999999999998   9999999999999999999999999987543221


Q ss_pred             cccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc-----------
Q 040952          248 LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-----------  315 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------  315 (411)
                      .  ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.........+. ..+.....           
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE-KIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH-HHHHHcCCCChhhhhhhhh
Confidence            1  11223578899999988754 578899999999999999999999864432111110 01100000           


Q ss_pred             -Cccc-cccccccccc----cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          316 -NRTL-ELIDPILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       316 -~~~~-~~~~~~l~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                       .... ..........    .........+.+++.+|++.||++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             0000 0000000000    000001356789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=298.46  Aligned_cols=268  Identities=21%  Similarity=0.301  Sum_probs=195.8

Q ss_pred             CCCccCcccccCcccEEEEEecC---CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI  163 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  163 (411)
                      +|++.+.||+|+||.||+|....   ++.||+|.+....   ......+.+|+.++..++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999653   7899999998632   33345678899999999999999999999988  7899


Q ss_pred             EEEeeCCCCCchhhhcCC-C-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC----CCCeEEeec
Q 040952          164 LIYEYMPNKSLDFFLFDP-T-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK----DMNPKISDF  237 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~-~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Df  237 (411)
                      +||||+++ +|..++... . ....++......++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 455544322 1 1235788899999999999999999998   999999999999999    999999999


Q ss_pred             CCccccCCCCc-ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchh-------HH
Q 040952          238 GMARICGGNEL-QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL-------GY  308 (411)
Q Consensus       238 gl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-------~~  308 (411)
                      |++........ ........++..|+|||.+.+. .++.++|||||||++|+|++|++||...........       ..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1122334678899999988764 578999999999999999999999875443220000       00


Q ss_pred             HHHHhh------------cCccccccccccccccc--------hH--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          309 AWDLWT------------SNRTLELIDPILEDEYS--------SK--HMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       309 ~~~~~~------------~~~~~~~~~~~l~~~~~--------~~--~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ......            ........+........        ..  .....+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000            00000000000000000        00  124568999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-38  Score=294.03  Aligned_cols=263  Identities=22%  Similarity=0.292  Sum_probs=199.7

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|+||.||+|.+. +|+.||+|++....  ......+.+|+.++++++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 58999999987653  33356788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      + +++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999886433  45889999999999999999999998   99999999999999999999999999887653321


Q ss_pred             ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC-----------
Q 040952          249 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN-----------  316 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  316 (411)
                       .......|+..|+|||.+.+. .++.++||||+||++|||++|.+||......  .............           
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCc
Confidence             112234688999999988654 4689999999999999999998776532211  1111111100000           


Q ss_pred             -ccccccccccccc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 -RTLELIDPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 -~~~~~~~~~l~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       .......+.....   .........+.+++.+||+.+|++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000000000000   0001124788999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-38  Score=291.89  Aligned_cols=252  Identities=27%  Similarity=0.456  Sum_probs=200.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|.+.+.||+|+||.||+|... +++.|++|.+.....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999865 588999999876544  3567889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999998543   33678888999999999999999998   99999999999999999999999999877643322


Q ss_pred             ccc--cccccccccccChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          249 QAN--TSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       249 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ...  .....++..|+|||.+.+..   ++.++||||||+++|+|++|+.||...+...    ....... ..     ..
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~-~~-----~~  224 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVG-AG-----HK  224 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHh-cC-----CC
Confidence            111  12346788999999988766   8899999999999999999999986432111    1111110 00     01


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +.+...   ......+.+++.+||+.+|++|||+.+++.
T Consensus       225 ~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111   112456789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-39  Score=297.42  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=195.2

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67889999999999999999976 588999999865432 2234567899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +.+ +|..++....  ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 8888875433  25788899999999999999999988   99999999999999999999999999865432211


Q ss_pred             ccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc----------
Q 040952          249 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR----------  317 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  317 (411)
                      .  .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .+.....+.......          
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChhhhhhhhhc
Confidence            1  122346788999998875 45889999999999999999999998643311 111111111100000          


Q ss_pred             --ccccc-----ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 --TLELI-----DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 --~~~~~-----~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        .....     ...+............+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              00000     0000000000001256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-38  Score=287.77  Aligned_cols=251  Identities=28%  Similarity=0.444  Sum_probs=204.4

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceEEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY  166 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  166 (411)
                      +|...+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|+..+++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 588999999876542  4567889999999999999999999999988  8899999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++....   .+++..++.++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986543   5899999999999999999999988   999999999999999999999999999876544


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++|..||....    +................      
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~------  224 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSSGEPPE------  224 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccccCCCcC------
Confidence            32111233567889999999988889999999999999999999999986544    11111111111011100      


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                          .+...+..+.+++.+|++.+|++||++.+++.
T Consensus       225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                11122567999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.7e-39  Score=298.74  Aligned_cols=244  Identities=26%  Similarity=0.336  Sum_probs=198.5

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||++.+. +++.+|+|.+....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999976 48999999986532   233566889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++...   ..++......++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998543   34788899999999999999999988   999999999999999999999999998776433


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                           .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......      ..........      ..+
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~------~~~  217 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEGK------VRF  217 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC------ccC
Confidence                 23346889999999998888999999999999999999999998643310      0111111110      001


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  362 (411)
                      ..     ..+..+.+++.+||+.+|.+||     ++.|+++
T Consensus       218 ~~-----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 PS-----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             Cc-----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            11     1245788999999999999999     6777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-39  Score=301.35  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=200.5

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|+..+.||+|+||.||+|...+ ++.||+|.+.....   ...+.+.+|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999999764 89999999976532   24556889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+.+++|.+++... ....+++.....++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988643 2345888899999999999999999988   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 040952          247 ELQ---------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  299 (411)
Q Consensus       247 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  299 (411)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01122467889999999998889999999999999999999999986433


Q ss_pred             ccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 040952          300 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT----MNDVVS  362 (411)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~  362 (411)
                      ...     ......... .      ...   .....+..+.+++.+||+.+|++|||    +.+++.
T Consensus       237 ~~~-----~~~~~~~~~-~------~~~---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDE-----TFSNILKKE-V------TFP---GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHH-----HHHHHhcCC-c------cCC---CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211     001111000 0      000   01113567999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.4e-38  Score=288.90  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeec--CCceEEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIY  166 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  166 (411)
                      +|++.+.||.|+||.||++... +|+.+|+|.+...  .....+.+..|+.+++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999865 5889999998653  23345668889999999999999999998764  34578999


Q ss_pred             eeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          167 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLH-----QYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       167 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ||+++++|..++... .....+++...+.++.|++.||.|||     +.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999988543 22356889999999999999999999     555   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      .........  .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ..   .. ........  
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~---~~-~~~~~~~~--  227 (265)
T cd08217         158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQ---LA-SKIKEGKF--  227 (265)
T ss_pred             ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HH---HH-HHHhcCCC--
Confidence            876543321  2234688999999999988899999999999999999999999864331  11   11 11111111  


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         +.+     +...+..+.+++.+||+.+|++||++.+|++.
T Consensus       228 ---~~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ---RRI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---CCC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               111     11235678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.8e-39  Score=297.20  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ...+.|+..+.||+|++|.||+|.++ +++.+++|.+..... ....+.+|++.++.++|+|++++++++...+..++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34677888999999999999999977 588999999976544 4567889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999986543  35899999999999999999999988   999999999999999999999999988655432


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      ..  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........     .... ......       
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-----~~~~-~~~~~~-------  234 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-----LFLI-TTKGIP-------  234 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-HhcCCC-------
Confidence            21  12234578899999999888899999999999999999999999864322110     0000 000000       


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       ........+..+.+++.+||+.+|.+|||+.++++.
T Consensus       235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         235 -PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             000111135678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-38  Score=294.91  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=192.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHH-HHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+..|+.. ++..+||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999976 48999999987542 2233445556664 566789999999999999999999999


Q ss_pred             eCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          168 YMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       168 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |++ |+|..++... .....+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 5777766432 2335689999999999999999999986 6   99999999999999999999999999876532


Q ss_pred             CCcccccccccccccccChhhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALE----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ..   ......|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||........    ........      
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~------  223 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ----QLKQVVEE------  223 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH----HHHHHHhc------
Confidence            21   1122467889999998864    4568899999999999999999999854322111    11111110      


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..+.+    +....+..+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQL----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00111    11122567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-40  Score=312.52  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=192.8

Q ss_pred             CccCcccccCcccEEEEEecC-CCEEEEEEccC----CCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc--eEEEE
Q 040952           94 SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--KILIY  166 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  166 (411)
                      +....||+|+|-+||+|.+.. |-.||--.++.    ..+...++|.+|+.+|+.|+||||+++++++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            345679999999999999764 76776543321    234556889999999999999999999999887665  77999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~  245 (411)
                      |.+..|+|..|+.+..+   ++.....+|++||++||.|||++. ++|+|||||.+||||+.+ |.+||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999966544   778889999999999999999986 679999999999999865 8999999999988653


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..    .....|||.|||||+.. ..|+..+||||||++++||+|+..||..-.    +.. .++..+.++.....+...
T Consensus       199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~A-QIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPA-QIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHH-HHHHHHHcCCCHHHhhcc
Confidence            22    23368999999999765 789999999999999999999999974211    111 122222222211111111


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                               ...++.++|.+||.. .++|||+.|+|..
T Consensus       269 ---------~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  269 ---------KDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ---------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                     135689999999999 9999999999953

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-38  Score=295.80  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=195.2

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|+..+.||.|++|.||+|... +|+.||||.+....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999975 58899999887542  22345688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +. ++|..++.... ...+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 57887775433 245788999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc-----------C
Q 040952          249 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-----------N  316 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~  316 (411)
                        ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||....... .........-..           .
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHH
Confidence              122235688899999887644 6889999999999999999999986433211 010000000000           0


Q ss_pred             cccccccccccccc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 RTLELIDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ~~~~~~~~~l~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .....+........  ........+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000000000  00112456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-38  Score=295.46  Aligned_cols=263  Identities=22%  Similarity=0.304  Sum_probs=197.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  165 (411)
                      ++|++.+.||+|+||.||+|..+ +++.+++|.+.....  .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999976 488999999875432  2233567899999999999999999998877  889999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +||+++ +|..++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 8888775432  25889999999999999999999998   99999999999999999999999999887654


Q ss_pred             CCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHH----------HHHHhh
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY----------AWDLWT  314 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~----------~~~~~~  314 (411)
                      ..  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||........ ....          .+..+.
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhh
Confidence            32  112234578899999988754 468999999999999999999999864432110 0000          000000


Q ss_pred             c------CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          315 S------NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       315 ~------~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .      ..........+.........+..+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0      00000000011111111112566889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.4e-39  Score=293.61  Aligned_cols=247  Identities=24%  Similarity=0.294  Sum_probs=200.4

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      +|++.+.||.|+||.||+|.+. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999976 48999999987542   2346778999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+.+++|..++...   ..+++.....++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998543   35888899999999999999999988   9999999999999999999999999987654332


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ..........      ...   
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~------~~~---  219 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAKQET------ADV---  219 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHHhcc------ccc---
Confidence               1233467889999999998889999999999999999999999986543221   1111111110      000   


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTM--NDVV  361 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl  361 (411)
                        ..+...+..+.+++.+||+.+|.+||++  .|++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              0111225678999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.7e-38  Score=292.21  Aligned_cols=247  Identities=25%  Similarity=0.421  Sum_probs=198.9

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      -|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677889999999999999865 58899999886543 234567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|..++..    ..+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            99999988843    34788899999999999999999988   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......     ..... .....     .+.+.. 
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~-----~~~~~~-  223 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKNN-----PPTLEG-  223 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcCC-----CCCCCc-
Confidence             122346788999999998888999999999999999999999998543211     01111 11110     011111 


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ..+..+.+++.+||+.+|++||++.++++.
T Consensus       224 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         224 ----NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                124568899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.5e-38  Score=286.37  Aligned_cols=250  Identities=29%  Similarity=0.466  Sum_probs=203.1

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .|+..+.||+|++|.||++... +++.+++|++..........+.+|+..++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999976 588999999987655556788999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|.+++....  ..+++.....++.|++.|+.+||..+   ++||||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999885532  35899999999999999999999987   99999999999999999999999999877653321  


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......     ..... .........        
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~~~~--------  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----ALFKI-ATNGPPGLR--------  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHH-HhcCCCCcC--------
Confidence             234568899999999988889999999999999999999999976432111     00000 000000000        


Q ss_pred             chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .....+..+.+++.+||+.+|++|||+.++++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            011124568999999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-38  Score=296.86  Aligned_cols=247  Identities=28%  Similarity=0.431  Sum_probs=195.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ...|...+.||+|+||.||+|... +|+.||+|.+....   ....+.+.+|+.+++.++||||+++.+++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            456888999999999999999965 58999999886432   23345688999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +||+.+ ++.+++...  ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            999975 555555322  234889999999999999999999988   99999999999999999999999999865432


Q ss_pred             CCcccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .      ....++..|+|||.+.   ...++.++||||||+++|||++|..||......     ......... .     
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~-~-----  230 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQN-D-----  230 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcC-C-----
Confidence            1      2346788999999874   456889999999999999999999997533211     111111100 0     


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .    ........+..+.+++.+||+.+|++||++.+++..
T Consensus       231 ~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 S----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             C----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0    011122235678999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.6e-38  Score=292.27  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=198.3

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      +|++.+.||.|++|.||+|+.. +|+.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999976 488999999876532 23456778999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 78777765444456899999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc--------ccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR--------TLE  320 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~  320 (411)
                       ......++..|++||.+.+. .++.++|||||||++|+|++|+.||.......  .............        ...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhHHHHhcCc
Confidence             11223568899999988654 57899999999999999999999986433211  1000000000000        000


Q ss_pred             cccccccc------ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          321 LIDPILED------EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       321 ~~~~~l~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .+......      .......+..+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000      0001122567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-39  Score=304.73  Aligned_cols=250  Identities=23%  Similarity=0.346  Sum_probs=210.5

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ....+.|.+.+.||+|.|+.|.+|.+. +|..||+|.+.+..  ....+.+.+|+++|..++|||||+++.+......+|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            345678999999999999999999965 49999999998763  333455889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+.+|.+.+++.....   ........++.|+..|++|||+++   |+|||||.+||||+.+.++||+|||++..+
T Consensus       132 lV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence            99999999999999976544   445777889999999999999998   999999999999999999999999999887


Q ss_pred             CCCCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ....   ....++|++.|.|||++.+..| ++++|+||+|++||.|+.|..||.                  ...+..+-
T Consensus       206 ~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD------------------G~~lk~Lr  264 (596)
T KOG0586|consen  206 DYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD------------------GQNLKELR  264 (596)
T ss_pred             cccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC------------------Cccccccc
Confidence            6333   3455799999999999998876 578999999999999999999974                  22233333


Q ss_pred             ccccccccc-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYS-SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ++.+.+.+. +..++.++.++++++|-.+|.+|+++.++.+.
T Consensus       265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            444444332 22346778899999999999999999999864

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.8e-38  Score=293.36  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=198.3

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .|...+.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3455678999999999999864 588999999876554455668899999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|.+++..    ..+++.....++.|++.|++|||+++   ++||||+|+||+++.++.++|+|||.+........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999998855    23788889999999999999999998   99999999999999999999999998865533211  


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.....     ....... ...     ..+....  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~-~~~-----~~~~~~~--  237 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRI-RDN-----LPPKLKN--  237 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHH-Hhc-----CCCCCcc--
Confidence            12234688999999999888899999999999999999999999753221     1111111 110     0011110  


Q ss_pred             chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                       ....+..+.+++.+||+.+|++|||+.++++
T Consensus       238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             1112457899999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-38  Score=302.95  Aligned_cols=263  Identities=24%  Similarity=0.293  Sum_probs=196.0

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC------
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  159 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (411)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 5899999998643  233345677899999999999999999988643      


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ...++||||+.+ +|...+...     ++......++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            356999999965 676666321     678888899999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc----------chhHH-
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL----------NLLGY-  308 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~----------~~~~~-  308 (411)
                      +........   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....          ....+ 
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            987543221   2234678899999999999999999999999999999999999864331100          00000 


Q ss_pred             ------HHHHhhcCc------ccccccccccc---ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          309 ------AWDLWTSNR------TLELIDPILED---EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       309 ------~~~~~~~~~------~~~~~~~~l~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                            .........      ..+.....+..   .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  000000000      00000000000   00011235568899999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-38  Score=315.15  Aligned_cols=270  Identities=19%  Similarity=0.250  Sum_probs=186.6

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEecC--CCEEEEE------------------EccCCCcccHHHHHHHHHHHHhcCC
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVK------------------RLSGRSGQGLREMKNEASVIAKVQH  146 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h  146 (411)
                      ....++|++.+.||+|+||+||++..+.  +...+.|                  .+. ........+.+|+.++++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            3446789999999999999999987542  2222222                  111 112234567899999999999


Q ss_pred             cccceeeeeeecCCceEEEEeeCCCCCchhhhcCCCC--CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 040952          147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  224 (411)
Q Consensus       147 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni  224 (411)
                      |||+++++++...+..|++++++.+ +|..++.....  ...........++.|++.||.|||+++   |+||||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            9999999999999999999999865 55555433211  111234556789999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCC-CCCCCcccc-
Q 040952          225 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRTDS-  302 (411)
Q Consensus       225 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~-  302 (411)
                      |++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|.. |++...... 
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999999999987643221 12233579999999999999999999999999999999999875 443221111 


Q ss_pred             cchhHHH-----------------HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          303 LNLLGYA-----------------WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       303 ~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+....                 ++.+........ ...+............+.+++.+||+.||++|||+.|+++.
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111100                 000000000000 00000000001123457788999999999999999999864

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-37  Score=287.63  Aligned_cols=242  Identities=24%  Similarity=0.288  Sum_probs=185.3

Q ss_pred             cccccCcccEEEEEec-CCCEEEEEEccCCCc---ccHHHHHHHHHHHH---hcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           98 KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVIA---KVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .||+|+||.||++... +|+.+|+|.+.....   .....+.+|..+++   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 488999998865321   11222344443333   3479999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|..++...   ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            99999888543   34899999999999999999999998   9999999999999999999999999987553221   


Q ss_pred             ccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..........   ......      .....+   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~------~~~~~~---  218 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL------TVNVEL---  218 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhh------cCCcCC---
Confidence             122468999999998864 568999999999999999999999986433211110   000000      001111   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                        +...+..+.+++.+||+.||++||     |++++++.
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              112356789999999999999999     69999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.4e-38  Score=294.09  Aligned_cols=260  Identities=16%  Similarity=0.179  Sum_probs=183.1

Q ss_pred             hcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCCCcccH-----------HHHHHHHHHHHhcCCcccceeee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGL-----------REMKNEASVIAKVQHKNLVRLLG  154 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~  154 (411)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|..........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999999654    34566665433222110           11123334555678999999999


Q ss_pred             eeecCC----ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          155 CCIDKD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       155 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                      ++....    ..+++++++.. ++.+.+...   ...++.....++.|++.||+|||+.+   ++||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            766543    33677777643 454444322   22466778899999999999999988   99999999999999999


Q ss_pred             CeEEeecCCccccCCCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 040952          231 NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  305 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  305 (411)
                      .++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999866422111     11223469999999999999999999999999999999999999997543222111


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      .....+..         .....+......++..+.+++..|++.+|++||++.++++.|+
T Consensus       244 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFI---------KRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHH---------HHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            10011110         0000111111122567899999999999999999999998763

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6e-38  Score=286.33  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=199.0

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|+||.||+|..+ +|..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999976 48899999986532  23345678999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC-eEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-PKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|.+++.... ...+++..+..++.|+++|+.|||+.+   ++|+||+|+||++++++. ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999886532 234788999999999999999999988   999999999999998864 6999999987764322


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      ..  .....|++.|+|||.+.+..++.++|+||||+++|||++|..||....     ........... .    ..+.  
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~-~----~~~~--  222 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQG-Y----FAPI--  222 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcc-c----CCCC--
Confidence            11  122458889999999988889999999999999999999999975322     11111111111 1    1110  


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ....+..+.+++.+||+.+|++|||+.++++.
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                01124568999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.5e-38  Score=292.70  Aligned_cols=264  Identities=22%  Similarity=0.278  Sum_probs=193.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcC-CcccceeeeeeecCCc-----
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE-----  161 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  161 (411)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+....  ......+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999975 58999999876542  223456788999999995 6999999999887665     


Q ss_pred             eEEEEeeCCCCCchhhhcCCCC--CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecC
Q 040952          162 KILIYEYMPNKSLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFG  238 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg  238 (411)
                      .+++|||+++ +|..++.....  ...+++.....++.||+.||.|||+.+   ++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 77777654322  345799999999999999999999998   999999999999998 8999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      ++........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....... .+.... .......
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~-~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIF-KLLGTPT  232 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-HHhCCCC
Confidence            9876532211  1122356788999998865 457999999999999999999999986432111 000000 0000000


Q ss_pred             ------cccccc----cccccc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 ------TLELID----PILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 ------~~~~~~----~~l~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                            .....+    +.....   ......+..+.+++.+||+.+|.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                  000000    000000   001123567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-37  Score=284.40  Aligned_cols=242  Identities=27%  Similarity=0.375  Sum_probs=194.2

Q ss_pred             ccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           99 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ||.|+||.||++.... ++.+|+|.+....   ....+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999999764 8899999987542   23346788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      .+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            9998543   33788889999999999999999988   9999999999999999999999999988765332   1223


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      ..|+..|++||.+.+..++.++|+||||+++|+|++|..||.....+...   ..........         .... +..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~---------~~~~-~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDILKGNG---------KLEF-PNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHhccCC---------CCCC-Ccc
Confidence            46788999999998888999999999999999999999998754421111   1111110000         0001 111


Q ss_pred             HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 040952          335 MLLRYVNIALLCVQESADDRPT-----MNDVVS  362 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt-----~~evl~  362 (411)
                      .+..+.+++.+||+.+|++||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2567899999999999999999     677765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-38  Score=290.09  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=194.7

Q ss_pred             ccccCcccEEEEEecC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           99 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ||.|+||.||++.... |+.+++|.+.....   ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999774 89999999875432   3456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc------
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------  248 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~------  248 (411)
                      .+++....   .+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99986433   4889999999999999999999988   99999999999999999999999999876433211      


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      ........++..|+|||...+..++.++||||||+++|+|++|..||......     ..... ......    .  .. 
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~----~--~~-  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQN-ILNGKI----E--WP-  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HhcCCc----C--CC-
Confidence            11223346788999999998888999999999999999999999998643311     11111 111000    0  00 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                        .....+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 --EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             --ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence              00002567899999999999999999966555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-38  Score=291.88  Aligned_cols=263  Identities=22%  Similarity=0.308  Sum_probs=195.4

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      |++.+.||.|++|.||+|... +|..||+|++....  ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999965 59999999987543  223356788999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      + ++|..++..... ..+++..+..++.|+++||+|||+++   ++||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 688888754332 34789999999999999999999988   99999999999999999999999999876542211 


Q ss_pred             cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh-----------hcCc
Q 040952          250 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW-----------TSNR  317 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~  317 (411)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ..........           ....
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchh
Confidence             11223568899999987654 57899999999999999999999986443211 0000000000           0000


Q ss_pred             cccccccccccc--cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 TLELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ~~~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....+.......  ......+..+.+++.+||+.+|++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000000  0011123678899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=333.12  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=205.3

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ...+-+|.....||.|.||.||.|.. ++|.-.|+|-+....  ......+.+|+.++..++|||+|+++|+-...+..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34455677888999999999999995 458999999876542  334566889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +.||||++|+|.+++...+   ..++.....+..|++.|++|||++|   ||||||||.||+++.+|.+|++|||.|..+
T Consensus      1311 IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999985433   3566677788899999999999999   999999999999999999999999999887


Q ss_pred             CCCC--cccccccccccccccChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          244 GGNE--LQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       244 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      ..+.  .........||+.|||||++.+..   ...++||||+||++.||+||++||...+....-    .+.+ ..+. 
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI----My~V-~~gh- 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI----MYHV-AAGH- 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH----HhHH-hccC-
Confidence            6542  222234568999999999997543   567899999999999999999999765543211    1111 1111 


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          .|.+     +...+.+-.+++..||+.||++|.++.|+++.
T Consensus      1459 ----~Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ----KPQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----CCCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                1111     22257788999999999999999999988875

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=299.06  Aligned_cols=269  Identities=21%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----ce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  162 (411)
                      +++|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999865 58999999986432 233456788999999999999999999876543     57


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++++||+.+ +|..++..    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999975 67666532    34888899999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCccc-ccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc---
Q 040952          243 CGGNELQA-NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR---  317 (411)
Q Consensus       243 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  317 (411)
                      ........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..  ..............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQED  233 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHH
Confidence            54322111 1223468899999998754 56899999999999999999999998543210  00000001000000   


Q ss_pred             --------ccccccccccccc-----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhcc
Q 040952          318 --------TLELIDPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEA  368 (411)
Q Consensus       318 --------~~~~~~~~l~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~  368 (411)
                              ....+...-....     .....+..+.+++.+||+.+|++|||+.++++.  ++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                    0000000000000     001124668899999999999999999999986  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.4e-38  Score=291.80  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=192.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|...+.||+|+||.||++... +|+.+|+|.+.... ......+.+|+.++.++. ||||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4566788999999999999965 48999999987543 234556889999999996 99999999999999999999999


Q ss_pred             CCCCCchhhhcC--CCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          169 MPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       169 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      +.. ++..+...  ......+++.....++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 44433211  11224588889999999999999999975 5   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccChhhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ...   .....|+..|+|||.+.+.   .++.++|||||||++|+|++|+.||.....    ...........      .
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~------~  227 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKG------D  227 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCC------C
Confidence            221   1223578899999998765   689999999999999999999999864331    11111111100      0


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+.+.... ....+..+.+++.+||+.+|++|||+.+|++.
T Consensus       228 ~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111111 12235678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-37  Score=292.63  Aligned_cols=267  Identities=22%  Similarity=0.307  Sum_probs=193.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  160 (411)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999975 48999999886432  222335678999999999999999999987654     


Q ss_pred             ---ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          161 ---EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       161 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                         ..++||||+.+ +|..++....  ..+++.....++.|++.||.|||+++   ++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence               34999999975 6766664322  34789999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCcc--cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh-
Q 040952          238 GMARICGGNELQ--ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW-  313 (411)
Q Consensus       238 gl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-  313 (411)
                      |++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|..||.......  ......... 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~  241 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCG  241 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence            999765432211  112234578889999988764 47889999999999999999999986433211  111111100 


Q ss_pred             -------hcCcccccccc---------ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          314 -------TSNRTLELIDP---------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       314 -------~~~~~~~~~~~---------~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                             .........+.         ..............+.+++.+||+.||++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence                   00000000000         000000000013457799999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-37  Score=286.58  Aligned_cols=244  Identities=27%  Similarity=0.381  Sum_probs=191.0

Q ss_pred             ccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           99 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ||+|+||+||++... +|+.||+|.+....   ......+.+|++++++++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 48899999986532   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      .+++..... ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            998865432 35788999999999999999999998   999999999999999999999999998765431   11223


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|+.||......... ..     .... .... ...     .+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~-----~~~~-~~~~-~~~-----~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-EE-----LKRR-TLEM-AVE-----YPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-HH-----HHhc-cccc-ccc-----CCcc
Confidence            45788999999998888999999999999999999999998644321110 00     0000 0000 000     1111


Q ss_pred             HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 040952          335 MLLRYVNIALLCVQESADDRP-----TMNDVVS  362 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~  362 (411)
                      .+..+.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            256789999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.5e-38  Score=291.82  Aligned_cols=245  Identities=23%  Similarity=0.318  Sum_probs=195.4

Q ss_pred             cCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           96 ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ...||+|+||.||++..+ +|+.||+|.+..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            467999999999999875 5889999998755545556788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      .+++..    ..+++.....++.|++.|++|||+.+   ++||||+|+||+++.++.++|+|||++.......  .....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            988743    23788889999999999999999998   9999999999999999999999999887554321  11223


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      ..|+..|+|||.+.+..++.++|+||||+++|+|++|..||......  ...   .. ...     ...+.+..   ...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~---~~-~~~-----~~~~~~~~---~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAM---KM-IRD-----NLPPKLKN---LHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---HH-HHh-----hCCcccCC---ccc
Confidence            46789999999998888999999999999999999999997532211  000   00 000     00111100   011


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          335 MLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+..+.+++.+||+.+|.+||++.++++.
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            24567889999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-37  Score=292.77  Aligned_cols=251  Identities=29%  Similarity=0.444  Sum_probs=196.3

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      +.|...+.||+|+||.||+|... +|..+|+|.+....   ......+.+|+.+++.++|||++++++++.+.+..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34777889999999999999965 58899999986432   233456888999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+.+ +|.+++...  ...+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99975 666665432  234889999999999999999999998   99999999999999999999999998865432 


Q ss_pred             CcccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                           .....|+..|+|||.+.   ++.++.++|||||||++|||++|+.||......     ...........      
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~------  241 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNES------  241 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHhccC------
Confidence                 12346788999999874   456889999999999999999999997532211     00111111100      


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      +    .......+..+.+++.+||+.+|.+||++.++++.+--..
T Consensus       242 ~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 P----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             C----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            0    0111123556899999999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=292.60  Aligned_cols=272  Identities=29%  Similarity=0.364  Sum_probs=215.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..+.|..-++||+|+||.||-++.. +|+-+|.|++.+.   .........+|-.+|.++..++||.+-..|+..+.+|+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3466888899999999999999865 4999999988654   23445567889999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      |+..|.||+|.-++.+... ..+++....-++.+|+.||++||...   ||.|||||+|||+|++|+++|+|.|||..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999999987665 45899999999999999999999998   9999999999999999999999999998776


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      .....   ...+||.+|||||++.++.|+...|.|||||++|||+.|+.||.......               ..+-+|.
T Consensus       339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eEvdr  400 (591)
T KOG0986|consen  339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREEVDR  400 (591)
T ss_pred             CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHHHHH
Confidence            44332   23489999999999999999999999999999999999999986433211               0111111


Q ss_pred             c-ccc-ccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH--------hhcccccCCCCCCceeee
Q 040952          325 I-LED-EYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSML--------TNEAAALLPPKQPAFSFV  382 (411)
Q Consensus       325 ~-l~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~L--------~~~~~~~~~~~~~~~~~~  382 (411)
                      . +.. ...++..+++...+....|+.||++|..     +.+|.+.-        +-....+.||--|+-..+
T Consensus       401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aV  473 (591)
T KOG0986|consen  401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAV  473 (591)
T ss_pred             HHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcccc
Confidence            1 111 1122445778899999999999999965     44555431        122345667766665543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=9.5e-39  Score=321.77  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=186.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecC------
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  159 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (411)
                      .-..+|+..+.||+||||.||+++.+ ||+.||||++... +......+.+|+..|.+|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            44567889999999999999999976 6999999999865 334456788999999999999999987532100      


Q ss_pred             --------------------------------------------------------------------------------
Q 040952          160 --------------------------------------------------------------------------------  159 (411)
Q Consensus       160 --------------------------------------------------------------------------------  159 (411)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHH
Q 040952          160 ---------------------------------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL  206 (411)
Q Consensus       160 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L  206 (411)
                                                       ..+|+-||||+..++.+++.+.....  .....++++++|++||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01356788888888877775433211  3566789999999999999


Q ss_pred             hhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC----C------------CCcccccccccccccccChhhhccC
Q 040952          207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG----G------------NELQANTSRIVGTYGYMSPEYALEG  270 (411)
Q Consensus       207 H~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~  270 (411)
                      |++|   ||||||||.||++++++.+||+|||+++...    .            .......+..+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999   9999999999999999999999999998621    0            0111123456899999999998754


Q ss_pred             ---CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc--cchHHHHHHHHHHHHH
Q 040952          271 ---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE--YSSKHMLLRYVNIALL  345 (411)
Q Consensus       271 ---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~l~~li~~  345 (411)
                         .|+.|+|+||||+|++||+.   ||+..-...    ....         .+-+..++..  +.... ...-..+|.+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa----~iL~---------~LR~g~iP~~~~f~~~~-~~~e~slI~~  853 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA----SILT---------NLRKGSIPEPADFFDPE-HPEEASLIRW  853 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHH----HHHH---------hcccCCCCCCccccccc-chHHHHHHHH
Confidence               49999999999999999985   454322111    1111         1111111111  11111 3345689999


Q ss_pred             ccccCCCCCCCHHHHHH
Q 040952          346 CVQESADDRPTMNDVVS  362 (411)
Q Consensus       346 cl~~~p~~RPt~~evl~  362 (411)
                      +++.||++|||+.|++.
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999985

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.1e-37  Score=285.66  Aligned_cols=259  Identities=21%  Similarity=0.259  Sum_probs=191.0

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CcccceeeeeeecC--CceEEEEe
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKILIYE  167 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  167 (411)
                      |++.+.||+|+||.||+|... +++.||+|.+.... ........+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999999965 58899999987542 222234457888898885 99999999999987  88999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++ +|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 6666664422  35899999999999999999999998   999999999999999 999999999997654322


Q ss_pred             cccccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh-----------hc
Q 040952          248 LQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW-----------TS  315 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~  315 (411)
                      .   .....++..|+|||.+. ++.++.++|||||||++|||++|..||...+..  +.........           ..
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcc
Confidence            1   12245788999999765 456789999999999999999999998643321  1111111100           00


Q ss_pred             Cccccccccccccc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 NRTLELIDPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 ~~~~~~~~~~l~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ........+.....   ......+..+.+++.+||+++|++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000000000000   0011236789999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-37  Score=292.88  Aligned_cols=264  Identities=24%  Similarity=0.313  Sum_probs=194.6

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|.+.....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999975 489999999864422  2223456899999999999999999998765  46799


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+.+ +|..++....  ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 7777765432  45889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--cc---
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--RT---  318 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~---  318 (411)
                      ....  ......++..|+|||.+.+ ..++.++|||||||++|||++|++||......  .............  ..   
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchh
Confidence            3221  1122245788999998865 45899999999999999999999998643211  1111010100000  00   


Q ss_pred             ---------ccccccccccc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 ---------LELIDPILEDE-YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ---------~~~~~~~l~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                               ........... ......+..+.+++.+||+.||++|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                     00000000000 0001125667899999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.7e-37  Score=283.09  Aligned_cols=247  Identities=23%  Similarity=0.290  Sum_probs=191.0

Q ss_pred             hhHHhcCCCccCcc--cccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           86 VSTATNKFSDANKL--GEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        86 ~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      .....++|++.+.+  |+|+||.||++... ++..+|+|.+........     |+.....+ +||||+++++++...+.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34445677777776  99999999999965 488899999875422211     22222222 79999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMA  240 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~  240 (411)
                      .++||||+++++|.+++....   .+++.....++.|+++||.|||+.+   ++||||+|+||+++.++ .++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            999999999999999985432   5899999999999999999999998   99999999999999998 9999999998


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ......      ....++..|+|||++.+..++.++||||||+++|||++|+.||............+....   .....
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~  228 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLP  228 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCC
Confidence            765422      223678899999999988899999999999999999999999874332222222111111   00000


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT-MNDVVS  362 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  362 (411)
                                .....+..+.+++.+||+.+|.+||+ +.++++
T Consensus       229 ----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        229 ----------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ----------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                      11123567899999999999999996 588874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.2e-38  Score=297.26  Aligned_cols=265  Identities=19%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeec----CCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  162 (411)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999965 48999999987542  2345667889999999999999999998764    3467


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++|+||+. ++|..++...   ..+++.....++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 5888887543   33889999999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCCcc--cccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH--------
Q 040952          243 CGGNELQ--ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD--------  311 (411)
Q Consensus       243 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--------  311 (411)
                      .......  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  .......        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~~  234 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSEE  234 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChhH
Confidence            5432211  11223478899999998765 468999999999999999999999985432110  0000000        


Q ss_pred             ---HhhcCcccccccccccc-ccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          312 ---LWTSNRTLELIDPILED-EYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       312 ---~~~~~~~~~~~~~~l~~-~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         ........+..+..-.. ...    ....+..+.+++.+||+.+|++|||+.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               00000011111000000 000    01125679999999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5e-37  Score=279.92  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=203.5

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|.+.+.||.|+||.||++.+. +++.+++|++.....  .....+.+|+++++.++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999976 588999999876532  4556788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|.+++.... ....+++.....++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999886532 2356899999999999999999999998   9999999999999999999999999987764432


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                        .......|++.|+|||...+..++.++|+||+|+++|+|++|+.||.....     ........ ...    ..+ +.
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~-~~~----~~~-~~  224 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKIL-KGQ----YPP-IP  224 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHh-cCC----CCC-CC
Confidence              122334688899999999888899999999999999999999999754321     11111111 111    111 11


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .     ..+..+.+++.+||..+|++|||+.++++.
T Consensus       225 ~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         225 S-----QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             C-----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1     224678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-37  Score=296.03  Aligned_cols=265  Identities=25%  Similarity=0.341  Sum_probs=196.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCcccceeeeeeecC--Cce
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK--DEK  162 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  162 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999976 4889999988543  233345677899999999 999999999998654  367


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||++ ++|..++...    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 4888877432    5788888999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCCcc---cccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH------
Q 040952          243 CGGNELQ---ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL------  312 (411)
Q Consensus       243 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~------  312 (411)
                      .......   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~  234 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPSA  234 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCH
Confidence            5432211   12233568899999998764 457899999999999999999999986432211  00000000      


Q ss_pred             -----hhcCcccccccccccccc-----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 -----WTSNRTLELIDPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 -----~~~~~~~~~~~~~l~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           .........++.......     .....+..+.+++.+||+.+|++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 000000001110000000     001135678999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.2e-38  Score=297.20  Aligned_cols=267  Identities=20%  Similarity=0.309  Sum_probs=197.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC-----Cc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (411)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999965 4899999998753  223345677899999999999999999988654     34


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++++||+. ++|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 6787777433   34888999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh-------
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW-------  313 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------  313 (411)
                      ......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..  ..........       
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  232 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEED  232 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHH
Confidence            654322  11223457889999998765 46899999999999999999999998643211  0000000000       


Q ss_pred             ----hcCcccccccccc---cc--ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhc
Q 040952          314 ----TSNRTLELIDPIL---ED--EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNE  367 (411)
Q Consensus       314 ----~~~~~~~~~~~~l---~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~  367 (411)
                          .........+...   ..  .......+..+.+++.+||+.+|++|||+.++++.  +...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                0000000000000   00  00011235678999999999999999999999977  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=280.77  Aligned_cols=247  Identities=28%  Similarity=0.426  Sum_probs=201.3

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 488999999976543  4566789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988543   45899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .  .....++..|+|||...+..++.++||||||+++|+|++|..||.....     ....+.....  ..    +.+  
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~--~~----~~~--  219 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIVQD--DH----PPL--  219 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcc--CC----CCC--
Confidence            1  2234678899999998887889999999999999999999999864321     1111111100  00    011  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                         +...+..+.+++.+||+.+|++|||+.+++.
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               1112457889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-37  Score=284.30  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=201.5

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|++.+.||+|+||.||++... +++.+++|.+....  ......+.+|+.+++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 58899999987542  33455678899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +++++|..++.... ....+++...+.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999885522 2345788899999999999999999998   999999999999999999999999999776543 


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..     ..... ......    . .  
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~----~-~--  220 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYK-VQRGKY----P-P--  220 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HhcCCC----C-C--
Confidence               122245788999999999989999999999999999999999998643321     11111 111100    0 0  


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         .+...+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               111335679999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=287.95  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             CCccCcccccCcccEEEEEecC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceEEEEe
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIYE  167 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  167 (411)
                      |++.+.||.|+||.||+|...+ |+.+|+|.+....  ......+.+|+.+++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5677899999999999999764 8899999998653  33445688999999999999999999999988  88999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++ +|..++....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 7877775432  35889999999999999999999988   9999999999999999999999999998765432


Q ss_pred             cccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc------ccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR------TLE  320 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~  320 (411)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......  .............      ...
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhcccccc
Confidence            1 11223356788999997764 457899999999999999999999986443211  1111111100000      000


Q ss_pred             -----------ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          321 -----------LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       321 -----------~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                                 .....+.... ....+..+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHh-cccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       0000000000 0002567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=286.62  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=197.2

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      |++.+.||+|++|.||+|... +|+.+++|.+.....  .....+.+|+.++++++|+||+++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566788999999999999975 588999999875532  23567888999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++ ++..++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            76 7777765432  35889999999999999999999998   9999999999999999999999999987765432  


Q ss_pred             cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--cccccccc--
Q 040952          250 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--RTLELIDP--  324 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--  324 (411)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......  +............  ........  
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--DQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCchHhcccchhhh
Confidence            112224578889999998876 7899999999999999999999998543321  1000000000000  00000000  


Q ss_pred             ----------cc-ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          325 ----------IL-EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       325 ----------~l-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                                .. .........+..+.+++.+||+.||.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      00 000011224678999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=301.35  Aligned_cols=205  Identities=30%  Similarity=0.427  Sum_probs=177.2

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC------ce
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------EK  162 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~  162 (411)
                      ..|...+.||+|+||.||+|+.+ .|+.||||.+.... ....+...+|+++|++++|+|||++++.-+...      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            34566788999999999999955 59999999997642 334566789999999999999999999865543      55


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCC--CeEEeecC
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDM--NPKISDFG  238 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg  238 (411)
                      .+|||||.+|+|...|.++.+...+++...+.+..++..||.|||+++   |+||||||.||++-  .+|  .-||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            899999999999999999888888999999999999999999999988   99999999999994  333  37999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  301 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~  301 (411)
                      .|+-+..+.   ......||..|.+||+..+ +.|+..+|.|||||++|+..||..||-.....
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            999887554   4456799999999999985 88999999999999999999999999755433

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-37  Score=279.83  Aligned_cols=250  Identities=26%  Similarity=0.359  Sum_probs=195.5

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCcccceeeeeeecC--Cce
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  162 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (411)
                      .+|.+.+.||+|+||.||+|.+. +|+.||+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47888999999999999999965 4899999987532     123445788999999999999999999998764  457


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++++||+++++|.+++...   ..+++.....++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999888543   33788888999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCc-ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          243 CGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       243 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...... ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......     .........+     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~-----  225 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIFKIATQP-----  225 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHHHHHcCC-----
Confidence            532111 11112346889999999999888999999999999999999999998633211     0111111110     


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..+.+     +......+.+++.+||+ +|..||+..+++.
T Consensus       226 ~~~~~-----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 TKPML-----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCC-----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            00111     12235679999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-37  Score=290.36  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=192.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .++|++.+.||+|+||.||+|.++. ++.||||.+.... ......+..|+.++.+.. ||||+++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678889999999999999999875 8999999997543 223445667777777764 999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+.+ ++..++....  ..+++..+..++.|++.|++|||+. +   ++||||+|+||++++++.++|+|||++.....
T Consensus        94 e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99854 6666654322  3588889999999999999999974 5   99999999999999999999999999876542


Q ss_pred             CCcccccccccccccccChhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.......    .......... .   
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~-~---  236 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVLTKILQEE-P---  236 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHHHHHhcCC-C---
Confidence            221   12235778999999987553    7889999999999999999999985422111    1111111110 0   


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        +....   ....+..+.+++.+||+.+|++||++.++++.
T Consensus       237 --~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 --PSLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --CCCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              00000   00124568999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.9e-37  Score=289.67  Aligned_cols=262  Identities=20%  Similarity=0.228  Sum_probs=190.2

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCC
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS  173 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (411)
                      .+.+|.|+++.||++.. +|+.||||++...  .......+..|+.+++.++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34445555555555544 4899999998754  34456789999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc-----
Q 040952          174 LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-----  248 (411)
Q Consensus       174 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-----  248 (411)
                      |.+++..... ..+++.....++.|+++||+|||+++   |+||||||+||+++.++.++|+|||.+........     
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999865422 34788888899999999999999998   99999999999999999999999998865432211     


Q ss_pred             ccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH----Hhh-------c
Q 040952          249 QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD----LWT-------S  315 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~----~~~-------~  315 (411)
                      ........++..|+|||++.+  ..++.++|+|||||++|||++|+.||........ .......    ...       .
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhc
Confidence            111122356778999999875  3588999999999999999999999864321110 0000000    000       0


Q ss_pred             Ccccc----cccccc---ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 NRTLE----LIDPIL---EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 ~~~~~----~~~~~l---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .....    ..++..   ............+.+++.+||+.||++|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            00000    000000   0011122335678999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.8e-37  Score=286.99  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=192.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|++|.||+|..+ +|+.||+|.+.....  .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999976 588999999865422  234567889999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccccCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGN  246 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~  246 (411)
                      |+++ +|..++.... ....++.....++.|++.||+|||+++   ++||||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 6766664322 223577788899999999999999988   999999999999985 567999999999765432


Q ss_pred             CcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--cc----c
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--RT----L  319 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~----~  319 (411)
                      .  .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... .... .......+  ..    .
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFK-IFRILGTPNEETWPGVT  232 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCChhhccccc
Confidence            1  111223568899999988664 57899999999999999999999986432110 0000 00000000  00    0


Q ss_pred             cccc--cccc---cc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          320 ELID--PILE---DE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       320 ~~~~--~~l~---~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .+.+  ....   ..   ......+..+.+++.+|++.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  0000   00   001112456889999999999999999999986

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-37  Score=287.82  Aligned_cols=249  Identities=27%  Similarity=0.360  Sum_probs=200.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  165 (411)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999975 5899999998753   2233466888999999998 99999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++++|.+++....   .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999985432   5899999999999999999999998   99999999999999999999999999876643


Q ss_pred             CCcc------------------cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhH
Q 040952          246 NELQ------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  307 (411)
Q Consensus       246 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  307 (411)
                      ....                  .......++..|+|||...+..++.++|+||||+++|++++|..||......     .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~  229 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----L  229 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----H
Confidence            3211                  1223346788999999998888999999999999999999999998644311     0


Q ss_pred             HHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 040952          308 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTM----NDVVS  362 (411)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~  362 (411)
                      .......       ....     .+...+..+.+++.+||+.+|++|||+    .++++
T Consensus       230 ~~~~~~~-------~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 TFQKILK-------LEYS-----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHh-------cCCC-----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0011110       0000     111125568999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=283.61  Aligned_cols=243  Identities=24%  Similarity=0.277  Sum_probs=186.4

Q ss_pred             CcccccCcccEEEEEec-CCCEEEEEEccCCCc---ccHHHHHHHHHHH-HhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVI-AKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|... +|+.||+|.+.....   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999975 488999999875432   1222334454444 445899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      ++|..++...   ..+++.....++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            9999998543   34788889999999999999999988   99999999999999999999999999875432      


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||......     .. ..........  ....     .
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~~~~~--~~~~-----~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AV-FDNILSRRIN--WPEE-----V  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HH-HHHHHhcccC--CCCc-----c
Confidence            22346788999999998888999999999999999999999998643211     11 1111111000  0000     0


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      ...++..+.+++.+||+.+|++||++.++.+.|
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            112356789999999999999999776555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.2e-37  Score=290.63  Aligned_cols=262  Identities=22%  Similarity=0.265  Sum_probs=190.4

Q ss_pred             Cccccc--CcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEG--GFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      ..||+|  +||+||.+.+. +|+.||+|++....  ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  89999999975 59999999987542  23456788999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc-
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA-  250 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-  250 (411)
                      ++|.+++..... ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998865432 34788888899999999999999988   9999999999999999999999998654322111000 


Q ss_pred             ----ccccccccccccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH--------------
Q 040952          251 ----NTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW--------------  310 (411)
Q Consensus       251 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------------  310 (411)
                          ......++..|+|||++.+.  .++.++|||||||++|||++|+.||...............              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112345679999998764  4789999999999999999999998643311100000000              


Q ss_pred             -HHhhc----------------CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          311 -DLWTS----------------NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       311 -~~~~~----------------~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       .....                ..........+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             00000                000000000000 11123346789999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.5e-37  Score=287.56  Aligned_cols=265  Identities=25%  Similarity=0.340  Sum_probs=195.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCC----
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  160 (411)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.+....  ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999976 48899999986542  223356778999999999999999999987655    


Q ss_pred             ------ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          161 ------EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       161 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                            ..++|+||+++ ++..++...  ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999987 555555432  234789999999999999999999998   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      +|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||.....  ...........
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~  234 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLC  234 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence            999998765432211 1122345778999998764 4578999999999999999999999864321  11111111111


Q ss_pred             hcCcc------cc-----ccc------cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          314 TSNRT------LE-----LID------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       314 ~~~~~------~~-----~~~------~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .....      .+     ..+      ......  ....+..+.+++.+||+.+|++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE--FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhh--cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000      00     000      000000  01124678999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-37  Score=293.88  Aligned_cols=267  Identities=21%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCC----
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  160 (411)
                      ...++|++.+.||+|+||.||+|... +|..||||++....  ......+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34678999999999999999999855 58999999986432  223456789999999999999999999987654    


Q ss_pred             --ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          161 --EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       161 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                        ..++||||+ +++|..++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              358999998 6788877743    34788999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH-------
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-------  310 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------  310 (411)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... .......       
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence            98765321     223467889999998876 458899999999999999999999986432110 0000000       


Q ss_pred             ---HHhhcCcccccccc---cccccc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhhcc
Q 040952          311 ---DLWTSNRTLELIDP---ILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNDVVS--MLTNEA  368 (411)
Q Consensus       311 ---~~~~~~~~~~~~~~---~l~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~  368 (411)
                         ..............   ......  .....+..+.+++.+|++.||++|||+.+++.  .++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence               00000000000000   000000  00112456889999999999999999999993  344443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-37  Score=272.56  Aligned_cols=272  Identities=21%  Similarity=0.297  Sum_probs=198.3

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-----CCEEEEEEccCCCcc--cHHHHHHHHHHHHhcCCcccceeeeeeec-CCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCID-KDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  161 (411)
                      ...|+....||+|+||.||+|.-.+     ...+|+|+++.....  .-....+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3568889999999999999996332     236899999865221  12456789999999999999999999988 778


Q ss_pred             eEEEEeeCCCCCchhhhc--CCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC----CCeEEe
Q 040952          162 KILIYEYMPNKSLDFFLF--DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKIS  235 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~  235 (411)
                      .++++||.+. +|...++  ...+...++...+.+|+.||+.|+.|||++.   |+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            8999999987 5555543  2233356888999999999999999999998   9999999999999877    999999


Q ss_pred             ecCCccccCCCCccc-ccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-------chh
Q 040952          236 DFGMARICGGNELQA-NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-------NLL  306 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-------~~~  306 (411)
                      |||+++.+.+.-... ..+..+-|..|.|||++.+. .||.+.|||+.|||+.||+|-.+-|.....+..       +.+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999887543332 34556779999999999876 589999999999999999999887754332111       111


Q ss_pred             HHHHHHhhc------Ccccccccc------ccccccchH---------H-HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          307 GYAWDLWTS------NRTLELIDP------ILEDEYSSK---------H-MLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       307 ~~~~~~~~~------~~~~~~~~~------~l~~~~~~~---------~-~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      +......-.      +.+.+..+.      .-...+.+.         . .+....+|+.++|+.||-+|.|+.+.++..
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            111111100      000011100      000001100         0 123368899999999999999999999875


Q ss_pred             h
Q 040952          365 T  365 (411)
Q Consensus       365 ~  365 (411)
                      =
T Consensus       339 y  339 (438)
T KOG0666|consen  339 Y  339 (438)
T ss_pred             c
Confidence            3

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-37  Score=294.31  Aligned_cols=265  Identities=23%  Similarity=0.337  Sum_probs=194.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (411)
                      .++|...+.||+|+||.||+|... +|+.||+|.+...  .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999965 5899999998653  2223456789999999999999999999987543      


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..++|+||+.. +|..+..     ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999864 6665541     23788889999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH-------
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL-------  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  312 (411)
                      .....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ........       
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~  237 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPE  237 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence            75432     1223467889999998876 468999999999999999999999986432110  00000000       


Q ss_pred             ----hhcCcccccc---ccccccccc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhcccc
Q 040952          313 ----WTSNRTLELI---DPILEDEYS--SKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAA  370 (411)
Q Consensus       313 ----~~~~~~~~~~---~~~l~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~  370 (411)
                          ..........   .........  ....+..+.+++.+||+.||++||++.+++..  ++...+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                0000000000   000000000  00123568899999999999999999999954  6665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-37  Score=283.68  Aligned_cols=262  Identities=22%  Similarity=0.279  Sum_probs=194.1

Q ss_pred             CCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEeeC
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      |++.+.||+|++|.||+|...+ ++.|++|++..... .......+|+..+++++ |||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677899999999999999764 78999999875422 22234457899999998 999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             788888775433 235789999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch-----------hHHHHHHhhcCc
Q 040952          250 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-----------LGYAWDLWTSNR  317 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~~~~  317 (411)
                        .....++..|+|||.+. +..++.++|+||||+++|||++|++||..........           ..|.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              12345788999999875 4457899999999999999999999986443211000           000000000000


Q ss_pred             cccccccccc---cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 TLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....+.....   ....+. ....+.+++.+||+.+|++|||+.|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPN-ASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHccc-CCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000   000011 14678999999999999999999999763

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.6e-37  Score=295.70  Aligned_cols=264  Identities=22%  Similarity=0.280  Sum_probs=192.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecC---------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK---------  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  159 (411)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|.+........+.+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            478999999999999999999975 4889999998776656667788999999999999999999876654         


Q ss_pred             -----CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeE
Q 040952          160 -----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPK  233 (411)
Q Consensus       160 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~k  233 (411)
                           ...++|+||++ ++|..++..    ..+++.....++.|++.||.|||+.+   ++||||||+||+++. ++.++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35689999997 588777632    24788899999999999999999998   999999999999974 56789


Q ss_pred             EeecCCccccCCCCccc-ccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH
Q 040952          234 ISDFGMARICGGNELQA-NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  311 (411)
                      |+|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence            99999987654221111 1122357889999998754 5688899999999999999999999854321100 0000000


Q ss_pred             H-hh----cCcccccccc-----ccccccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          312 L-WT----SNRTLELIDP-----ILEDEYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       312 ~-~~----~~~~~~~~~~-----~l~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      . ..    .......+..     .......    .......+.+++.+||+.||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0 00    0000000000     0000000    0112467889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.1e-37  Score=284.30  Aligned_cols=255  Identities=24%  Similarity=0.294  Sum_probs=197.5

Q ss_pred             CCCccCcccccCcccEEEEEec----CCCEEEEEEccCCC----cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCce
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (411)
                      +|++.+.||+|++|.||++...    +++.||||.+....    ......+.+|+.++.++ +||||+++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4777889999999999998843    47889999986432    22345678899999999 699999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||+++++|..++...   ..+++.....++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999888542   34788888999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ....... ......|+..|+|||.+.+..  .+.++||||||+++|||++|..||....... ............     
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-----  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS-----  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-----
Confidence            5432211 122346788999999987655  7889999999999999999999986432111 111111111110     


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN  366 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  366 (411)
                        .+..     +......+.+++.+||+.+|++|||+.++.+.|+-
T Consensus       228 --~~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 --KPPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --CCCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              0001     11124568899999999999999999888877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-36  Score=280.92  Aligned_cols=242  Identities=25%  Similarity=0.306  Sum_probs=185.5

Q ss_pred             cccccCcccEEEEEec-CCCEEEEEEccCCCc---ccHHHHHHHHH---HHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           98 KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEAS---VIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .||+|+||.||+|... +|+.||+|.+.....   .....+..|..   .++...||||+.+.+++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 488999999875421   11122333433   4444579999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|..++...   ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++.......   
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            99999888532   35899999999999999999999988   9999999999999999999999999987553221   


Q ss_pred             ccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       .....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...........   .....      .....+.. 
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~------~~~~~~~~-  220 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTL------TMAVELPD-  220 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhh------ccCCCCCC-
Confidence             1234689999999998754 689999999999999999999999864422111100   00000      00111111 


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                          ..+..+.+++.+||..+|.+||     ++.++++.
T Consensus       221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                1256789999999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.2e-37  Score=288.67  Aligned_cols=248  Identities=31%  Similarity=0.446  Sum_probs=193.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      +.|+..+.||+|+||.||+|... +++.+|+|.+...   .......+.+|+.+++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44777789999999999999965 4788999988642   2233456788999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+. |++..++...  ...+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-  167 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence            9997 5676665432  234788889999999999999999988   99999999999999999999999999876432 


Q ss_pred             CcccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                           .....++..|+|||.+.   ...++.++|||||||++|+|++|+.||.......     ........ ..     
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~-~~-----  231 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQN-ES-----  231 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-----HHHHHhhc-CC-----
Confidence                 12346788999999874   3567889999999999999999999975432110     11111100 00     


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      +.    ......+..+.+++.+||+.+|++||++.++++..-
T Consensus       232 ~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         232 PA----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             CC----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            00    011123566889999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-37  Score=292.89  Aligned_cols=267  Identities=23%  Similarity=0.315  Sum_probs=201.6

Q ss_pred             CCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----ceE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI  163 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  163 (411)
                      +|++.+.||.|+||.||+|.... |+.||+|.+....  ....+.+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            57888999999999999999764 8999999987643  344567889999999999999999999988775     789


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ++|||+++ +|..++...   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 787777543   25889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCc-ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh--------
Q 040952          244 GGNEL-QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW--------  313 (411)
Q Consensus       244 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------  313 (411)
                      ..... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.......  .........        
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhHh
Confidence            54321 0112334678899999999877 78999999999999999999999986443211  000000000        


Q ss_pred             ---hcCcccccccccccccc-----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhc
Q 040952          314 ---TSNRTLELIDPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNE  367 (411)
Q Consensus       314 ---~~~~~~~~~~~~l~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~  367 (411)
                         ......+.+........     .....+..+.+++.+||+.+|++|||+.+++..  +++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence               00000000000000000     001125678999999999999999999999975  5544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-37  Score=293.50  Aligned_cols=266  Identities=22%  Similarity=0.290  Sum_probs=195.6

Q ss_pred             hhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC-
Q 040952           84 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-  159 (411)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  159 (411)
                      .++....++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            345566789999999999999999999864 58899999987532  22345678899999999999999999988643 


Q ss_pred             -----CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          160 -----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       160 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                           ...+++++++ +++|..++..    ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.++|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467788776 7788877743    23788899999999999999999998   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH---
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW---  310 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---  310 (411)
                      +|||++.....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.....   
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  235 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG  235 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            99999876432     1223467889999998866 568899999999999999999999985432111 0000000   


Q ss_pred             -------HHhhcCcccc---ccccccccccc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          311 -------DLWTSNRTLE---LIDPILEDEYS--SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       311 -------~~~~~~~~~~---~~~~~l~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                             ..........   .+.......+.  ....+..+.+++.+||+.+|.+||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                   0000000000   00000000000  00124568899999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.6e-36  Score=283.95  Aligned_cols=244  Identities=28%  Similarity=0.453  Sum_probs=190.9

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      |...+.||+|+||.||+|... +|+.|++|.+....   ......+.+|+.+++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999965 48899999987532   23345678899999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +.+ ++..++...  ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....    
T Consensus       103 ~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            964 666665432  234889999999999999999999998   9999999999999999999999999875432    


Q ss_pred             ccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                        ......|+..|+|||.+.   +..++.++|||||||++|+|++|..||.....     ........... ...     
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~-~~~-----  239 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND-SPT-----  239 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC-CCC-----
Confidence              122346888999999874   45688999999999999999999999754321     11111111110 000     


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .    .....+..+.+++.+||+.+|.+||++.+++..
T Consensus       240 ~----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 L----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0    011123468899999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=289.39  Aligned_cols=265  Identities=21%  Similarity=0.302  Sum_probs=194.6

Q ss_pred             hcCCC-ccCcccccCcccEEEEEec-CCCEEEEEEccCCCccc--------------HHHHHHHHHHHHhcCCcccceee
Q 040952           90 TNKFS-DANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--------------LREMKNEASVIAKVQHKNLVRLL  153 (411)
Q Consensus        90 ~~~y~-~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  153 (411)
                      .++|. +.+.||.|+||.||+|.+. +++.||||.+.......              ...+.+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            35665 4577999999999999965 58999999886542211              12467899999999999999999


Q ss_pred             eeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeE
Q 040952          154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  233 (411)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  233 (411)
                      +++...+..++||||+. |+|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 588888743   234788899999999999999999988   99999999999999999999


Q ss_pred             EeecCCccccCCCCc------------ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 040952          234 ISDFGMARICGGNEL------------QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  300 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~  300 (411)
                      |+|||++........            ........++..|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999876542110            1111223467889999988764 478999999999999999999999864432


Q ss_pred             cccchhHHHHHHhhcCccc---cc--------ccccccccc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          301 DSLNLLGYAWDLWTSNRTL---EL--------IDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~---~~--------~~~~l~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .  ................   ..        .........  .....+..+.+++.+||+.+|++|||+.|++..
T Consensus       240 ~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 I--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             H--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1  1111111111100000   00        000000000  001124678899999999999999999999964

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.2e-37  Score=288.71  Aligned_cols=262  Identities=23%  Similarity=0.336  Sum_probs=195.2

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeec-CCceE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKI  163 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  163 (411)
                      ..+++|++.+.||.|+||.||+|... +|+.||+|++...  .....+.+..|+.+++.++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            35788999999999999999999865 5899999988643  22334667889999999999999999999876 56788


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +++||+ +++|..++..    ..++......++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 5688877743    23677788889999999999999998   999999999999999999999999998754


Q ss_pred             CCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc--h--------hHHHHHH
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN--L--------LGYAWDL  312 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~--------~~~~~~~  312 (411)
                      ...     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........  .        ..+... 
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT-  232 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh-
Confidence            321     122356888999998765 56899999999999999999999998643321000  0        000000 


Q ss_pred             hhcCccccccccccccc-cch----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 WTSNRTLELIDPILEDE-YSS----KHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~-~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .......+.+....... .+.    ...+..+.+++.+||+.+|++|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000011110000000 000    0124678999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.2e-37  Score=287.65  Aligned_cols=263  Identities=24%  Similarity=0.348  Sum_probs=192.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCC------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (411)
                      .++|++.+.||+|+||.||+|... +++.+|+|++.....  .....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999965 488999998864422  22345678999999999999999999875543      


Q ss_pred             --ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          161 --EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       161 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                        ..++|+||+.+ ++...+...  ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45899999876 555555432  234899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccc---------ccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHH
Q 040952          239 MARICGGNELQA---------NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  308 (411)
Q Consensus       239 l~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  308 (411)
                      ++..........         ......+++.|+|||.+.+. .++.++|||||||++|||++|++||.......  ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~  238 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHL  238 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            997654322111         11223568889999987654 58899999999999999999999986433211  0000


Q ss_pred             HHHHhhcC-----------------ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          309 AWDLWTSN-----------------RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       309 ~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ........                 .......+.+...+  ......+.+++.+||+.+|++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF--GKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc--ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000000                 00000000000000  112357889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=270.54  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=197.1

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      +..+.+..||.|+.|.||+++... |..+|||.+.... ....+++...+.++... ++|+||+.+|+|......++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            445567789999999999999764 8899999997663 34456777888877766 48999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      .|. ..++.++...  ..++++...-++...+.+||.||..++  +|+|||+||+|||+|+.|++||||||++-.+....
T Consensus       172 lMs-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHH-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            873 3455555432  244788777888899999999998877  59999999999999999999999999997664333


Q ss_pred             cccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                         ..++..|-+.|||||.+.   ...|+.++||||||++++||.||..||..-+.+...+    ....++.      .+
T Consensus       247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l----tkvln~e------PP  313 (391)
T KOG0983|consen  247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL----TKVLNEE------PP  313 (391)
T ss_pred             ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH----HHHHhcC------CC
Confidence               234457889999999886   3469999999999999999999999987655443222    2222211      13


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+.+...   .+..+.+++..||+.|+.+||...++++.
T Consensus       314 ~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            3332221   46789999999999999999999999875

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-36  Score=281.97  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=194.6

Q ss_pred             CCCccCcccccCcccEEEEEe----cCCCEEEEEEccCCC----cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCce
Q 040952           92 KFSDANKLGEGGFGPVYKGVL----KKGDEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (411)
                      +|++.+.||+|+||.||.+..    .+|+.||+|++....    ....+.+.+|+.++.++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    358899999987532    12345678899999999 699999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++|+||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999998543   34788888899999999999999988   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ....... ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...... ..............    
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~----  228 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE----  228 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC----
Confidence            5432211 12234688999999988753  4688999999999999999999998632211 11111111111100    


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                         +.     .+......+.+++.+||+.+|++||     +..+++..
T Consensus       229 ---~~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 ---PP-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---CC-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence               00     1112356788999999999999997     66776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=277.24  Aligned_cols=241  Identities=24%  Similarity=0.276  Sum_probs=196.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      -++|..+++||+|.||+|.+++-+ .|+.+|+|++++.-   .+....-..|-++|+..+||.+..+...|+..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467889999999999999999865 59999999998652   33445566789999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||..||.|..+|..   ...+++....-+-..|..||.|||+++   ||.||||.+|.|+|.+|.+||+|||+++.-- 
T Consensus       247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence            999999999888844   334777777778889999999999988   9999999999999999999999999986422 


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                       .....+..+||||.|+|||++....|+.++|.|.+||++|||++|+.||-..+.+.  +...    +.-.++       
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeL----Il~ed~-------  385 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFEL----ILMEDL-------  385 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHH----HHhhhc-------
Confidence             23344567899999999999999999999999999999999999999985433221  1111    110000       


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCC
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRP  355 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RP  355 (411)
                          ..+...+.+...|+.-.|..||.+|.
T Consensus       386 ----kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 ----KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence                01222255678899999999999995

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=280.40  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=192.5

Q ss_pred             CCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcc--cHHHHHHHHHHHHhc---CCcccceeeeeeecCCc-----
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ--GLREMKNEASVIAKV---QHKNLVRLLGCCIDKDE-----  161 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  161 (411)
                      |++.+.||+|+||.||+|..+. ++.||+|.+......  ....+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999864 899999999754221  223456777777666   59999999999988776     


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .+++|||+.+ +|.+++..... ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 78777754322 34889999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc----
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR----  317 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  317 (411)
                      .......   .....++..|+|||.+.+..++.++|+|||||++|||++|++||....... ..... ........    
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~  230 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKI-FDVIGLPSEEEW  230 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHH-HHHcCCCChHhc
Confidence            7643321   122357889999999999899999999999999999999998876433110 00000 00000000    


Q ss_pred             --cc----cccccccccc--cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 --TL----ELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 --~~----~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        ..    ..........  .........+.+++.+||+.||++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              00    0000000000  001123567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=311.34  Aligned_cols=275  Identities=23%  Similarity=0.258  Sum_probs=214.1

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      +....++|.++++||+|+||.|..++.+. ++.||.|++++.   .......|.+|-.+|..-+.+-|+.++..|++..+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            44556889999999999999999999764 889999999863   34556789999999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      +|+|||||+||+|-.++....   .+++..+.-++..|.-||.-||+.|   +|||||||+|||+|.+|++||+|||.+-
T Consensus       150 LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence            999999999999999996544   4788888888899999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccccccChhhhc----c-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYAL----E-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      .+..... ......+|||.|.+||++.    + +.|+..+|.||+||++|||+.|.-||-..     .++..-..+.+-.
T Consensus       224 km~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk  297 (1317)
T KOG0612|consen  224 KMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHK  297 (1317)
T ss_pred             hcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchh
Confidence            7764332 2345568999999999985    3 57999999999999999999999998421     1211111111211


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH--hhc----ccccCCCCCCceee
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNDVVSML--TNE----AAALLPPKQPAFSF  381 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~L--~~~----~~~~~~~~~~~~~~  381 (411)
                      +.....+        ....+....+||.+.+. +|+.|..   +.++....  .++    +....||..|..+.
T Consensus       298 ~~l~FP~--------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss  362 (1317)
T KOG0612|consen  298 ESLSFPD--------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS  362 (1317)
T ss_pred             hhcCCCc--------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence            1111111        11136678889998875 7889988   88887642  232    23455666666554

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-36  Score=278.32  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=193.1

Q ss_pred             CCCccCcccccCcccEEEEEecC-CCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      +|.+.+.||+|+||.||++.+.. +..+++|.+...     .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998653 445556655431     122334567789999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          166 YEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      +||+++++|..++... .....+++.....++.|++.|+.|||+.+   ++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887542 22345899999999999999999999988   999999999999975 569999999987654


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ....  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....     .......... .     ..+
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~-~-----~~~  223 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVE-G-----PTP  223 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc-C-----CCC
Confidence            3221  1223457889999999988888999999999999999999999975321     1111111110 0     111


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..     +...+..+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 SL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            11     12235678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=278.70  Aligned_cols=260  Identities=25%  Similarity=0.335  Sum_probs=196.5

Q ss_pred             CCccCcccccCcccEEEEEecC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      |+..+.||+|++|.||+|+... ++.+|+|.+....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5567889999999999999764 8999999998653  333466788999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      + ++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58988886532  34889999999999999999999998   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc---------Ccc-
Q 040952          250 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS---------NRT-  318 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~-  318 (411)
                       ......++..|+|||.+.+. .++.++|||||||++|||++|++||.......  ...........         ... 
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHHHhhcccc
Confidence             12223457789999998766 78999999999999999999999885433110  00000000000         000 


Q ss_pred             --cccccccccccc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          319 --LELIDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       319 --~~~~~~~l~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        ............  .....+..+.+++.+||+.+|++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              000000000000  00112467999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=303.92  Aligned_cols=263  Identities=28%  Similarity=0.409  Sum_probs=206.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC--------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeec
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  158 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (411)
                      ..++..+.+.||+|.||.|++|....        ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            34455666799999999999998431        3469999998653 34567899999999999 69999999999999


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCC-------C----C--cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPT-------K----R--MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  225 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil  225 (411)
                      .+..++|.||+..|+|..+|+...       .    .  ..+.....+.++.||+.|++||++..   ++||||..+|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence            999999999999999999997654       0    0  23788899999999999999999988   999999999999


Q ss_pred             EcCCCCeEEeecCCccccCCCCccccc-ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 040952          226 LDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  303 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~  303 (411)
                      +.++..+||+|||+++........... +...-...|||||.+....|+.++||||||++|||++| |..|+.....   
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~---  527 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP---  527 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc---
Confidence            999999999999999875544333211 11112456999999999999999999999999999999 7778653110   


Q ss_pred             chhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          304 NLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                       ..+. ......+.-.          ..+..+..++.+++..||+.+|++||++.++++.+.....
T Consensus       528 -~~~l-~~~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 -TEEL-LEFLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             -HHHH-HHHHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence             1111 1122222111          1233446789999999999999999999999999998644

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-37  Score=291.04  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=195.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc----
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  161 (411)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999976 4889999998653  22334567789999999999999999998876554    


Q ss_pred             --eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          162 --KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       162 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                        .++|+||+ +++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5688888743    34889999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh-----
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW-----  313 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----  313 (411)
                      +......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......  .........     
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~  237 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLVGTPDE  237 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCH
Confidence            8765422     223467889999998865 367899999999999999999999986432210  000000000     


Q ss_pred             ------hcCcccccccccc---ccccc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          314 ------TSNRTLELIDPIL---EDEYS--SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       314 ------~~~~~~~~~~~~l---~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                            .............   .....  ....+..+.+++.+||+.+|++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                  0000000000000   00000  00125678999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4e-36  Score=285.04  Aligned_cols=261  Identities=23%  Similarity=0.259  Sum_probs=189.7

Q ss_pred             CCCccCcccccCcccEEEEEec-C--CCEEEEEEccCCC--cccHHHHHHHHHHHHhc-CCcccceeeeeeecC----Cc
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-K--GDEIAVKRLSGRS--GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK----DE  161 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  161 (411)
                      +|++.+.||+|+||.||++... .  +..||+|.+....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999965 3  6789999987432  22345678899999999 599999999875432    45


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .+++++|+. ++|..++..   ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.++|+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 578887743   234888999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCcc--cccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH-------
Q 040952          242 ICGGNELQ--ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD-------  311 (411)
Q Consensus       242 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------  311 (411)
                      ........  .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||...+...  .......       
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  231 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTPDE  231 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCCCH
Confidence            65432211  11233468999999998765 468999999999999999999999986433110  0000000       


Q ss_pred             ----HhhcCcccccc-------ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          312 ----LWTSNRTLELI-------DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       312 ----~~~~~~~~~~~-------~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ...........       ...+...  .......+.+++.+||+.+|++|||+.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESI--FPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhh--CCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                00000000000       0000000  00114578899999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=267.95  Aligned_cols=251  Identities=20%  Similarity=0.253  Sum_probs=195.2

Q ss_pred             HhcCCCcc-CcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeec----CCc
Q 040952           89 ATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID----KDE  161 (411)
Q Consensus        89 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~  161 (411)
                      .+++|.+. ++||-|-.|.|..+..+ +|+++|+|++...     ...++|++..-.. .|||||.++++|.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35666653 57999999999999866 5899999998754     2346777776655 79999999999875    346


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecC
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  238 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg  238 (411)
                      +.+|||+|+||.|...+.+.+. ..+.+..+..|+.||+.|+.|||+.+   |.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999988866543 56889999999999999999999998   999999999999964   5679999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      +++....   .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-....  ..+..-....+..+  
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g--  282 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG--  282 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc--
Confidence            9987543   2223456889999999999999999999999999999999999999842221  11111111111111  


Q ss_pred             ccccccccccccchH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LELIDPILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~---~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                              ...++.+   +.++...++|+.+|..+|.+|.|+.+++..
T Consensus       283 --------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  283 --------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             --------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                    0112222   236788999999999999999999999865

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=269.42  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             cCcccccCcccEEEEE-ecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCCCCC
Q 040952           96 ANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKS  173 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (411)
                      .+.||+|+++.|--++ +.+|.+||||++.+.......++.+|++++.++ .|+||+.++++|+++..+|+|||.|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3679999999999887 667999999999988777788899999999999 59999999999999999999999999999


Q ss_pred             chhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---CeEEeecCCccccCCCC---
Q 040952          174 LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMARICGGNE---  247 (411)
Q Consensus       174 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfgl~~~~~~~~---  247 (411)
                      |..++++   +..+++..+.++..+|+.||.|||.+|   |.||||||+|||.....   -+||+||.+..-...+.   
T Consensus       163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9888854   445889999999999999999999999   99999999999997654   38999998864332111   


Q ss_pred             --cccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc--
Q 040952          248 --LQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT--  318 (411)
Q Consensus       248 --~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  318 (411)
                        ........+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||.......   ..     ++.++.  
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CG-----WdrGe~Cr  308 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CG-----WDRGEVCR  308 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CC-----ccCCCccH
Confidence              112233468999999999864     2358999999999999999999999996433211   00     111110  


Q ss_pred             --c-cccccccccc--cch---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          319 --L-ELIDPILEDE--YSS---KHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       319 --~-~~~~~~l~~~--~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        . .++..+-.+.  ++.   .+++.+..+++...+..++.+|.++.+++.
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              0 1111111111  121   134678899999999999999999999987

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=273.41  Aligned_cols=236  Identities=26%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             ccccCcccEEEEEec-CCCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           99 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|+.++++++||||+++++.+...+..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 488999999875432   2456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  254 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  254 (411)
                      .+++....   .+++.....++.|+++|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99985432   4788999999999999999999988   9999999999999999999999999987754322  12233


Q ss_pred             ccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       255 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      ..++..|+|||...+..++.++|+||||+++|+|++|..||...+.     ......... .      ...+     +..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-~------~~~~-----~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILK-D------PLRF-----PEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc-C------CCCC-----CCC
Confidence            4678899999999888899999999999999999999999854332     111111111 0      0001     111


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHH
Q 040952          335 MLLRYVNIALLCVQESADDRPTMND  359 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt~~e  359 (411)
                      .+..+.+++.+||..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1456889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=272.00  Aligned_cols=263  Identities=23%  Similarity=0.332  Sum_probs=207.8

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeec-
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-  158 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-  158 (411)
                      .....+++....+-+|.||.||.|.+.+      .+.|-+|.++.. +.-....+..|.-.+..+.|||+.++.+++.+ 
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            3344567777889999999999996543      345777877654 34456678889999999999999999998765 


Q ss_pred             CCceEEEEeeCCCCCchhhhc-----CCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeE
Q 040952          159 KDEKILIYEYMPNKSLDFFLF-----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  233 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  233 (411)
                      ....+.+|.++.-|+|..+|.     +......+...+...++.|++.|++|||.++   ++|.||..+|++||+..++|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEE
Confidence            456788999999999999997     4555556777888899999999999999998   99999999999999999999


Q ss_pred             EeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHH
Q 040952          234 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      |+|-.+++.+-..+...-.+.......||+||.+.+..|+..+|||||||+||||+| |+.|+...++..  ...+..+.
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--m~~ylkdG  514 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--MEHYLKDG  514 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--HHHHHhcc
Confidence            999999987655554443333445678999999999999999999999999999999 888875433211  11111111


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      +           .+.   .+.+++.++..++.-||...|++||++++++.-|.+.-
T Consensus       515 y-----------Rla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  515 Y-----------RLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             c-----------eec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            1           111   23345778999999999999999999999999987653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=287.96  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=204.2

Q ss_pred             cCCCccCcccccCcccEEEEEecCCC-EEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGD-EIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .+++.+..||-|+||.|=++..+... .+|+|++++.   .....+.+..|-.+|..++.|.||+++-.|.++...|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45667778999999999999877433 4899988765   3344566889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |-|-||.+...|.+.+   .++.....-++..+.+|++|||.++   ||.|||||+|.+++.+|.+||.|||+++.+...
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999996544   4788888889999999999999999   999999999999999999999999999998754


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .   .+.++||||.|.|||++.+...+.++|.||||+++|||++|.+||...++....  ..             +-..+
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY--n~-------------ILkGi  635 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY--NL-------------ILKGI  635 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH--HH-------------HHhhh
Confidence            3   456789999999999999999999999999999999999999999765432211  11             11111


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                      .....+..+.....+++.+.+..+|.+|..     +.++-+.
T Consensus       636 d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  636 DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            111122344667789999999999999986     5666654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.3e-36  Score=305.35  Aligned_cols=146  Identities=27%  Similarity=0.405  Sum_probs=130.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++....   ......+..|+.++..++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367899999999999999999976 58899999987542   23346788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      |||+.+++|..++...   ..+++...+.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999998543   24788888999999999999999987   9999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=292.63  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=209.0

Q ss_pred             chhhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeec-
Q 040952           82 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID-  158 (411)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  158 (411)
                      .+..+...++.|++.+.||.|.+|.||+++.. +|+..|+|+..... +..+++..|.++++.. .|||++.++|+|.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34455566788999999999999999999954 58899999987653 3346778899999987 79999999999864 


Q ss_pred             ----CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          159 ----KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                          ++.+|||||||.+|+..+++.... ...+.|.....|++.++.|+.+||.+.   ++|||||-.|||++.++.+||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                568899999999999999987655 556899999999999999999999988   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  309 (411)
                      +|||++..+.....  ......||+.|||||++...     .|+..+|+||||++..||--|.+|+....          
T Consensus       165 vDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH----------  232 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH----------  232 (953)
T ss_pred             eeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc----------
Confidence            99999987754332  23446899999999998643     47889999999999999999999964211          


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          .-.-+.......-..-..+.....++.++|..||..|.++||++.++++.
T Consensus       233 ----PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  233 ----PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                11111111111111112245568999999999999999999999998854

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=277.51  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCC-------cccHHHHHHHHHHHHhcCCcccceeeeeeec
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS-------GQGLREMKNEASVIAKVQHKNLVRLLGCCID  158 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (411)
                      ....++|-.+..||+|||+.||+|.+ ...+.||||+-....       ....+...+|.++.+.++||.||+++++|.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            34456788899999999999999994 447889999764331       1223446789999999999999999999864


Q ss_pred             -CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEE
Q 040952          159 -KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKI  234 (411)
Q Consensus       159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl  234 (411)
                       .+.+|-|+|||+|.+|+-||..   ...+++..+..|+.||..||.||.... ++|||.||||.|||+..   .|.+||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence             5678899999999999999954   345889999999999999999999875 67999999999999954   578999


Q ss_pred             eecCCccccCCCCccc-----ccccccccccccChhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 040952          235 SDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  305 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  305 (411)
                      +|||+++.+.......     -++...||.+|++||++.-+    +.+.|+||||.|||+|..+.|+.||+......   
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---  691 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---  691 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence            9999999887654332     24456899999999988633    47889999999999999999999998543221   


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  361 (411)
                           ++.....+...-.-.+   +..+..+.+...+|++||++--++|....++.
T Consensus       692 -----dILqeNTIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 -----DILQENTILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -----HHHhhhchhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                 1111111111100000   11112256788999999999999998877764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-38  Score=267.64  Aligned_cols=257  Identities=26%  Similarity=0.372  Sum_probs=194.5

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++.+.+..||.|+||+|++-.++ .|+..|||++..... .+.+++..|.+...+- +.||||+++|.+..++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34455678999999999999876 499999999986643 4556778888766554 79999999999999999999999


Q ss_pred             eCCCCCchhhhcC--CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          168 YMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       168 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      .|+ .+|+.+-..  ..+...+++...-+|......||.||....  .|+|||+||+|||++..|.+||||||++-.+..
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            995 466554321  112234777777788888899999998765  599999999999999999999999999866543


Q ss_pred             CCcccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ..   ..+...|-..|||||.+..  ..|+.+|||||||++|||+.||+.|+..++.-..    ....... ++     .
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe----ql~~Vv~-gd-----p  287 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE----QLCQVVI-GD-----P  287 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH----HHHHHHc-CC-----C
Confidence            22   1233467788999998863  3599999999999999999999999875553211    1111111 11     2


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +.+.......+.+..+..++.-||.+|-++||...++.++
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2232333333446789999999999999999999998865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.4e-35  Score=266.22  Aligned_cols=220  Identities=18%  Similarity=0.127  Sum_probs=174.9

Q ss_pred             cCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCchhhhcC
Q 040952          102 GGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD  180 (411)
Q Consensus       102 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  180 (411)
                      |.+|.||++.+. +|+.||+|.+....     .+..|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999975 58899999997643     223445555566799999999999999999999999999999998854


Q ss_pred             CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccccccccc
Q 040952          181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  260 (411)
Q Consensus       181 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  260 (411)
                      .   ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.++++|||.+......     .....++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            3   23889999999999999999999988   999999999999999999999999987665422     122345678


Q ss_pred             ccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHH
Q 040952          261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYV  340 (411)
Q Consensus       261 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~  340 (411)
                      |+|||.+.+..++.++|+||+|+++|||++|..|+.......           ..     .....+     +...+..+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~-----~~~~~~-----~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NT-----HTTLNI-----PEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cc-----ccccCC-----cccCCHHHH
Confidence            999999988889999999999999999999998754221100           00     000001     111245688


Q ss_pred             HHHHHccccCCCCCCCHH
Q 040952          341 NIALLCVQESADDRPTMN  358 (411)
Q Consensus       341 ~li~~cl~~~p~~RPt~~  358 (411)
                      +++.+||+.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=286.78  Aligned_cols=241  Identities=22%  Similarity=0.242  Sum_probs=192.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .+..|+....+|.|+|+.|-.+... +++..+||++.....    +..+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3567888888999999999998865 488999999987622    234566666655 7999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-cCCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |.+.++-+.+.+....    .....+..|+.+|+.|+.|||++|   ++||||||+|||+ +..++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999998766653322    222566789999999999999998   9999999999999 6899999999999987654


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .     ....+-|..|.|||++....|+.++|+||||++||+|++|+.||.....+ ..    ....+..+         
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e----i~~~i~~~---------  529 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE----IHTRIQMP---------  529 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH----HHHhhcCC---------
Confidence            3     22346688999999999999999999999999999999999998654332 11    11111111         


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         . .....+....+|+.+||+.||.+||+|.++...
T Consensus       530 ---~-~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 ---K-FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ---c-cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence               1 113346788999999999999999999999854

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=238.32  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=193.6

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +|...++||+|+||+||+|+.. +++.||+|++....  +.--....+|+-+++.++|.|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666788999999999999955 48899999886543  22345678999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      |. .+|..+...-  +..++.....+++.|+++|+.|+|+++   +.|||+||.|.+++.+|.+||+|||+++.++-...
T Consensus        83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            95 4666665432  244788899999999999999999998   99999999999999999999999999998764321


Q ss_pred             ccccccccccccccChhhhccCC-CCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHh---hc---Ccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW---TS---NRTLE  320 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~---~~---~~~~~  320 (411)
                        ..+..+-|..|.+|.++.+.+ |+...|+||-|||+.|+.. |++.|...+.+.  .+.......   .+   +....
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCccccCCcccc
Confidence              122235688999999998765 8999999999999999988 444454333221  111111111   11   11222


Q ss_pred             ccccccccccch--------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 LIDPILEDEYSS--------KHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +.|...-..++.        +.....-.+++.+.+..+|.+|.++.+.++.
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            333222222211        1112344688999999999999999988753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=268.49  Aligned_cols=272  Identities=20%  Similarity=0.242  Sum_probs=203.3

Q ss_pred             cchhhhhHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC--Cc----ccceee
Q 040952           81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ--HK----NLVRLL  153 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~l~  153 (411)
                      +-+.......++|.+...+|+|+||.|-.+.+.. +..||||+++.... ..+..+-|+++|+++.  .|    -++.+.
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            5556666678999999999999999999998664 78999999975432 2345577999999993  23    378888


Q ss_pred             eeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc------
Q 040952          154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD------  227 (411)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~------  227 (411)
                      +||.-.++.|+|+|.+ |.|+.++|.+.. -.+++......++.|++++++|||+.+   ++|-||||+|||+.      
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence            9999999999999988 558888886543 356788889999999999999999998   99999999999993      


Q ss_pred             --------------CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 040952          228 --------------KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  293 (411)
Q Consensus       228 --------------~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~  293 (411)
                                    .+..++|+|||.++.-..     ..+..+.|..|.|||++.+-.++.++||||+||||+||.+|..
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                          134589999999987442     2355688999999999999999999999999999999999998


Q ss_pred             CCCCCcccc---------cchhHH------HHHHhhcCcc-----------cccccccc---ccccchHHHHHHHHHHHH
Q 040952          294 NTGLYRTDS---------LNLLGY------AWDLWTSNRT-----------LELIDPIL---EDEYSSKHMLLRYVNIAL  344 (411)
Q Consensus       294 p~~~~~~~~---------~~~~~~------~~~~~~~~~~-----------~~~~~~~l---~~~~~~~~~~~~l~~li~  344 (411)
                      .|..-+...         .+....      ....+..+.+           ....++..   ...........++.+|+.
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            876544110         000000      0011111100           00000000   000112233567999999


Q ss_pred             HccccCCCCCCCHHHHHHH
Q 040952          345 LCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       345 ~cl~~~p~~RPt~~evl~~  363 (411)
                      +||..||.+|+|+.|++..
T Consensus       388 ~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHccCccccccHHHHhcC
Confidence            9999999999999999853

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-36  Score=270.52  Aligned_cols=242  Identities=28%  Similarity=0.346  Sum_probs=195.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (411)
                      ...+|..+.+||+|+||.|.+|.-+. .+.+|||++++.   ..++.+.-+.|-++|... +-|.++++..+|+.-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34578889999999999999998664 678999999865   233455556777788766 6789999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+.||+|-.++++..+   +.+..+.-++..|+-||-+||+++   |+.||||.+|||+|.+|.+||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999888866544   556667788899999999999999   999999999999999999999999998643


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      -.  ....+..++||+.|+|||++.-++|+.++|.|||||+||||+.|++||...+.+.                  ++.
T Consensus       501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------------------lF~  560 (683)
T KOG0696|consen  501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------------------LFQ  560 (683)
T ss_pred             cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------------------HHH
Confidence            21  1233556899999999999999999999999999999999999999986544321                  111


Q ss_pred             cccc-cccchHHHHHHHHHHHHHccccCCCCCCC
Q 040952          324 PILE-DEYSSKHMLLRYVNIALLCVQESADDRPT  356 (411)
Q Consensus       324 ~~l~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt  356 (411)
                      .+.. .-..+...+.+...++...|...|.+|..
T Consensus       561 aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  561 AIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence            1111 11234445778889999999999999954

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-36  Score=257.87  Aligned_cols=268  Identities=22%  Similarity=0.356  Sum_probs=192.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC-------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-------  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  159 (411)
                      .+.|+....||+|.||.||+|+.++ |+.||+|+....+  ...-....+|+++|..++|+|++.++..|...       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3567778899999999999999654 8889998764322  22233457899999999999999999988642       


Q ss_pred             -CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          160 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                       ..+|+||.+|+. +|.-+|.+...  .++.....+++.++..||.|+|.+.   |+|||+|+.|+||+.+|.+||+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence             357999999976 77777755433  3777888999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCc--ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-cchh--------
Q 040952          239 MARICGGNEL--QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLL--------  306 (411)
Q Consensus       239 l~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~--------  306 (411)
                      +++.+.....  ....+..+-|..|.+||.+.+. .|+++.|||.-|||+.||+|+.+-+....... ..+.        
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            9977643221  1122334568999999998865 59999999999999999999988765332111 0000        


Q ss_pred             HHHHHHhhcCcccccc--cccccccc-------chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          307 GYAWDLWTSNRTLELI--DPILEDEY-------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       307 ~~~~~~~~~~~~~~~~--~~~l~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .-+|+....-.+.+.+  .|...+.+       .+........+|+.+++..||.+|+++.+++..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            0011111100011111  11111111       011112467899999999999999999998864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.8e-34  Score=258.91  Aligned_cols=238  Identities=29%  Similarity=0.368  Sum_probs=191.8

Q ss_pred             CcccEEEEEecC-CCEEEEEEccCCCccc-HHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCchhhhcC
Q 040952          103 GFGPVYKGVLKK-GDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD  180 (411)
Q Consensus       103 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  180 (411)
                      +||.||+|.... |+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999874 8999999998765444 67899999999999999999999999999999999999999999998854


Q ss_pred             CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccccccccc
Q 040952          181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  260 (411)
Q Consensus       181 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  260 (411)
                      ...   +++.....++.++++++.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            332   788899999999999999999998   9999999999999999999999999998765432   2233467889


Q ss_pred             ccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHH
Q 040952          261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYV  340 (411)
Q Consensus       261 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~  340 (411)
                      |++||.+.+..++.++||||||+++|+|++|..||...... ...    ..........        ........+..+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~----~~~~~~~~~~--------~~~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LEL----FKKIGKPKPP--------FPPPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHH----HHHHhccCCC--------CccccccCCHHHH
Confidence            99999998888999999999999999999999997542111 111    1111110000        0000000246789


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 040952          341 NIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       341 ~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=275.95  Aligned_cols=243  Identities=23%  Similarity=0.338  Sum_probs=193.8

Q ss_pred             cCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCC
Q 040952           96 ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      .+.||.|.||+||-|+.+ +|+.||||++.+..  ......+++|+.+|+.+.||.||.+...|+..+..+.|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999965 59999999987542  233467899999999999999999999999999999999999766


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCCccccCCCCcc
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      -|..+|....  ..+++....-++.||+.||.|||.++   |+|+||||+|||+..   --++||||||+++.++.....
T Consensus       649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            6666664433  33788888889999999999999998   999999999999964   357999999999998765433


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                         ...+||+.|+|||++.++.|+..-|+||.|||+|--++|..||+...+...+... +.              .+-..
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN-Aa--------------FMyPp  785 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN-AA--------------FMYPP  785 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc-cc--------------cccCC
Confidence               3468999999999999999999999999999999999999998754322211110 00              00011


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  361 (411)
                      .+=.+.+....+||...|+..-++|-|...-+
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            11223456778899999999888888877554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.4e-34  Score=285.58  Aligned_cols=261  Identities=19%  Similarity=0.208  Sum_probs=167.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-----CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeee------ee
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC------CI  157 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  157 (411)
                      ..++|.+.+.||+|+||.||+|.+.+     +..||+|++......  +....+  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            35789999999999999999999753     689999987643221  111111  1222223333332222      24


Q ss_pred             cCCceEEEEeeCCCCCchhhhcCCCCC-----------------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 040952          158 DKDEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  220 (411)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  220 (411)
                      .....++|+||+++++|.+++......                 ..........++.|++.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            556789999999999999888543210                 01112335579999999999999988   9999999


Q ss_pred             CCCEEEcC-CCCeEEeecCCccccCCCCcccccccccccccccChhhhccC----------------------CCCcchh
Q 040952          221 ASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG----------------------IFSIKSD  277 (411)
Q Consensus       221 p~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  277 (411)
                      |+|||++. ++.+||+|||+++....... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 68999999999976543221 222345789999999965422                      2345679


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc----ccccccccc----ccccc-hHHHHHHHHHHHHHccc
Q 040952          278 VFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR----TLELIDPIL----EDEYS-SKHMLLRYVNIALLCVQ  348 (411)
Q Consensus       278 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l----~~~~~-~~~~~~~l~~li~~cl~  348 (411)
                      ||||||++|||+++..++...      ...+.......+.    +...+.+..    ...+. .........+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            999999999999976553211      1101000000000    000000000    00000 00012235589999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 040952          349 ESADDRPTMNDVVSM  363 (411)
Q Consensus       349 ~~p~~RPt~~evl~~  363 (411)
                      .||++|||+.++++.
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=282.60  Aligned_cols=246  Identities=28%  Similarity=0.416  Sum_probs=189.9

Q ss_pred             CCccCcccccCccc-EEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeCC
Q 040952           93 FSDANKLGEGGFGP-VYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        93 y~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      |.-.+.+|.|+.|+ ||+|... |+.||||++-..   ......+|+..|+.- +|||||++++.-.+.+..|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456789999987 7999997 899999998753   234568999999988 69999999999999999999999996


Q ss_pred             CCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---C--CCeEEeecCCccccC
Q 040952          171 NKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---D--MNPKISDFGMARICG  244 (411)
Q Consensus       171 ~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~--~~~kl~Dfgl~~~~~  244 (411)
                      . +|++++... ...........+.+..|++.|+++||+.+   ||||||||.||||+.   +  ..++|+|||+++...
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            4 899998653 11111111345788899999999999988   999999999999975   2  568999999999886


Q ss_pred             CCC-cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          245 GNE-LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       245 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ... .........||.+|+|||.+.+..-+.++|||||||++|+.++| .+||+.......+.       .........+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~~~L~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGNYTLVHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCccceeee
Confidence            543 22335567899999999999998888899999999999999996 88998543322221       1111111111


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .+       ..++  +..+||.+|++++|..||++.+|+.
T Consensus       736 ~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 EP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            11       1111  6789999999999999999999974

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-34  Score=272.67  Aligned_cols=204  Identities=25%  Similarity=0.367  Sum_probs=171.9

Q ss_pred             cCCCccCcccccCcccEEEEE-ecCCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .-|..++.||-|+||.|-++. .++...||.|.+.+.+   ......++.|-.||...+.+-||+|+..|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            347778899999999999987 4447789999987653   344566788999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC-
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-  245 (411)
                      +|++||++-.+|...   ..+++..+.-++..+..|+++.|..|   +|||||||+|||||.+|.+||+||||+.-+.. 
T Consensus       709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            999999998888543   44788888888889999999999998   99999999999999999999999999753211 


Q ss_pred             --------CCccc-------------------------------ccccccccccccChhhhccCCCCcchhhHHHHHHHH
Q 040952          246 --------NELQA-------------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL  286 (411)
Q Consensus       246 --------~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  286 (411)
                              .+...                               .....+||+.|+|||++....|+..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    00000                               011247999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCcc
Q 040952          287 EIVSGKKNTGLYRT  300 (411)
Q Consensus       287 elltg~~p~~~~~~  300 (411)
                      ||+.|++||-....
T Consensus       863 em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTP  876 (1034)
T ss_pred             HHhhCCCCccCCCC
Confidence            99999999975543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.1e-33  Score=273.65  Aligned_cols=262  Identities=21%  Similarity=0.263  Sum_probs=178.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEe-----------------cCCCEEEEEEccCCCcccHHH--------------HHHH
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL-----------------KKGDEIAVKRLSGRSGQGLRE--------------MKNE  137 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~e  137 (411)
                      ..++|++.++||+|+||.||+|.+                 ..++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235679999987543222222              3346


Q ss_pred             HHHHHhcCCccc-----ceeeeeeec--------CCceEEEEeeCCCCCchhhhcCCCC---------------------
Q 040952          138 ASVIAKVQHKNL-----VRLLGCCID--------KDEKILIYEYMPNKSLDFFLFDPTK---------------------  183 (411)
Q Consensus       138 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  183 (411)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     677777653        3567999999999999998864211                     


Q ss_pred             CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccC
Q 040952          184 RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS  263 (411)
Q Consensus       184 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a  263 (411)
                      ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            122466778899999999999999988   99999999999999999999999999875432211 11112234789999


Q ss_pred             hhhhccCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCCCcccccchhH-----HHHHHhhc
Q 040952          264 PEYALEGI--------------------F--SIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLG-----YAWDLWTS  315 (411)
Q Consensus       264 PE~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~-----~~~~~~~~  315 (411)
                      ||.+....                    +  ..+.||||+||++|+|++|.. |+.....-......     ..|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875322                    1  124799999999999999875 55321110000000     00111100


Q ss_pred             CccccccccccccccchHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 040952          316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESA---DDRPTMNDVVSM  363 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~~  363 (411)
                      ..    .+..     ..........+++.++|..+|   .+|+|+.|+++.
T Consensus       459 ~~----~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QK----YDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cC----CCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00    0000     111225678899999999765   789999999864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=249.93  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (411)
                      ..++|..+++||+|+|++|..+++. +.+.+|+|++++.   ...+++-++.|-.+..+. +||.+|.+..+|+.+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3467999999999999999999965 4788999998754   334455667777777776 7999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +|.||.+||+|--++++..+   +++..+.-+...|.-||.|||+.|   |+.||||.+|+|+|..|.+||+|||+.+.-
T Consensus       328 fvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            99999999999777754433   788888888889999999999999   999999999999999999999999998643


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc--cchhHHHHHHhhcCccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  321 (411)
                      -  .....++.++|||.|.|||++.+..|+...|.|+|||+++||+.|+.||.....+.  .+..++....+.+..+.  
T Consensus       402 l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--  477 (593)
T KOG0695|consen  402 L--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--  477 (593)
T ss_pred             C--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--
Confidence            2  22334667899999999999999999999999999999999999999997654332  33344444444433221  


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCC
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRP  355 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP  355 (411)
                               .+...+.....++..-|++||.+|.
T Consensus       478 ---------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 ---------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---------ccceeehhhHHHHHHhhcCCcHHhc
Confidence                     1122244566788888999999885

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=231.82  Aligned_cols=214  Identities=26%  Similarity=0.344  Sum_probs=170.7

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCce
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (411)
                      .+...+.......||+|++|.|-+-++. +|...|+|++... +.+..++..+|+.+..+. .+|++|.++|...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344455566778999999999887754 5999999999755 344556778888887766 799999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          163 ILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ++.||.|+ .||+.+-.+. .+...+++...-+|+..+..||.|||++-  .++|||+||+|||++.+|++|+||||++-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999995 4777664331 23455788888899999999999999975  59999999999999999999999999997


Q ss_pred             ccCCCCcccccccccccccccChhhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALE----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  305 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  305 (411)
                      .+.+...   .+...|-..|||||.+..    ..|+.++||||||+++.||.+++.||..+.+....+
T Consensus       198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL  262 (282)
T KOG0984|consen  198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL  262 (282)
T ss_pred             eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence            7653321   122357778999998753    369999999999999999999999987665544333

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=235.34  Aligned_cols=280  Identities=17%  Similarity=0.273  Sum_probs=206.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeee-eecCCceEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGC-CIDKDEKILI  165 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv  165 (411)
                      ..+.|.+.++||+|.||.+-++.++. .+.+++|.++... ...++|.+|...--.+ .|.||+.-++. |+..+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            35779999999999999999999875 6789999887643 3356788888766556 58899987765 5667778899


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCCCeEEeecCCcccc
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNPKISDFGMARIC  243 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfgl~~~~  243 (411)
                      +||++.|+|..-+..    ..+.+....+++.|++.||.|+|+.+   +||||||.+||||-  +...+||||||+.+..
T Consensus       101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999877643    33778888999999999999999998   99999999999993  3457999999998876


Q ss_pred             CCCCcccccccccccccccChhhhcc---C--CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALE---G--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      +.....     ..-+..|.+||....   +  ...+.+|+|.||+++|.++||+.||.........+..|  ..+..+..
T Consensus       174 g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~--~~w~~rk~  246 (378)
T KOG1345|consen  174 GTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW--EQWLKRKN  246 (378)
T ss_pred             Cceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH--HHHhcccC
Confidence            533221     223567999997753   2  24678999999999999999999998444333333322  22332222


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc--ccccCCCCCCceeeecccccccC
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE--AAALLPPKQPAFSFVRNTVTSTS  390 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~--~~~~~~~~~~~~~~~~~~~~~~~  390 (411)
                      ..+     +..+.+  .+..+.++..+-|.++|++|--..++.+.....  ...+.+-+.|....+.|.++.++
T Consensus       247 ~~~-----P~~F~~--fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~S~  313 (378)
T KOG1345|consen  247 PAL-----PKKFNP--FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTASK  313 (378)
T ss_pred             ccC-----chhhcc--cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCcch
Confidence            222     111111  256788899999999999997777766665432  23356667777777777776665

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-33  Score=242.69  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=190.2

Q ss_pred             CccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----ceEEE
Q 040952           94 SDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKILI  165 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  165 (411)
                      +-.+.||-|+||.||...+. +|+.||+|++...  +-...+.+.+|+++|..++|.|++..++...-.+     +.|.+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            44578999999999999864 6999999998754  2334567899999999999999999988765443     45778


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      .|.|. .+|..++-..   ..++.....-+..||++||.|||+.+   |.||||||.|.|++.|..+||||||+++.-..
T Consensus       136 TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            88875 4677776433   34666777788999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc------
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT------  318 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  318 (411)
                      .+.... +..+-|..|.|||++++. .|+...||||.|||+.||+..+..|..-.+.  ..++...+....+..      
T Consensus       209 d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  209 RDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             hhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHH
Confidence            333222 233568899999999976 5899999999999999999887766543221  111122221111111      


Q ss_pred             -----cccccccc-----c---cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          319 -----LELIDPIL-----E---DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       319 -----~~~~~~~l-----~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                           ..++....     .   .-..+.....+...+..+++..||+.|.+..+.+..+
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                 11111110     0   0011122245667888999999999999999988765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=9.8e-31  Score=230.19  Aligned_cols=211  Identities=36%  Similarity=0.576  Sum_probs=183.0

Q ss_pred             ccccCcccEEEEEecC-CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCchh
Q 040952           99 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF  176 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  176 (411)
                      ||+|.+|.||++.... |+.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999765 899999999865432 34678999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccccCCCCcccccccc
Q 040952          177 FLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRI  255 (411)
Q Consensus       177 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~  255 (411)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985432  34788899999999999999999998   999999999999999 89999999999876643321  12334


Q ss_pred             cccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHH
Q 040952          256 VGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH  334 (411)
Q Consensus       256 ~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  334 (411)
                      .+...|++||..... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578889999998877 788999999999999999                                              


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          335 MLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       335 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                        ..+.+++.+|++.+|++||++.++++.+
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              3578899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.7e-32  Score=254.51  Aligned_cols=208  Identities=21%  Similarity=0.277  Sum_probs=176.3

Q ss_pred             cchhhhhHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCC------cccceee
Q 040952           81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQH------KNLVRLL  153 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~  153 (411)
                      |.+.-.+...++|.+....|+|-|++|..|.+.. |+.||||++..+. .-.+.=+.|+++|++|+.      -|.++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            4444455566789999999999999999999765 8899999998653 223445789999999953      4899999


Q ss_pred             eeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCe
Q 040952          154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNP  232 (411)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~  232 (411)
                      -.|...+++|||+|-+ ..+|.+.|...+....+....+..++.|+.-||..|-..+   |+|.||||+|||+++. ..+
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence            9999999999999987 5689999988887777888999999999999999999888   9999999999999875 568


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  297 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~  297 (411)
                      ||||||.|...+.++....    .-+..|.|||++.|..|+...|+||.||+||||.||+..|..
T Consensus       577 KLCDfGSA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  577 KLCDFGSASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             eeccCccccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            9999999988766554332    335679999999999999999999999999999999987754

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.2e-31  Score=225.54  Aligned_cols=259  Identities=18%  Similarity=0.317  Sum_probs=194.3

Q ss_pred             hcCCCccCcccccCcccEEEEE-ecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCC--ceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD--EKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv  165 (411)
                      .++|++.+.+|+|.++.||.|. ..++++++||+++...   .+.+.+|+.+|..+. ||||+++++...+..  ...+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            5789999999999999999998 4568899999998643   356789999999996 999999999988754  56799


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCCccccC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICG  244 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~  244 (411)
                      +||..+.+...+.      ..+........+.++++||.|+|+.|   |.|||+||.|+|+|.. -.++|+|+|+|.+..
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998886664      22566677789999999999999999   9999999999999864 569999999998875


Q ss_pred             CCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH--------Hh--
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD--------LW--  313 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~--  313 (411)
                      ....   ....+.+..|.-||++.. +.|+.+-|+|||||++..|+..+.||....+...+++..+.-        ..  
T Consensus       185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            4332   222356778899998865 458889999999999999999999986554443333322210        00  


Q ss_pred             ----hcCccccccccccccc------cchHHH-HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          314 ----TSNRTLELIDPILEDE------YSSKHM-LLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       314 ----~~~~~~~~~~~~l~~~------~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ..++...++.......      ..+... ..+..+++.+.|..|-.+|||+.|.+..
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                0111111111000000      001111 3678899999999999999999998753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=251.18  Aligned_cols=195  Identities=26%  Similarity=0.382  Sum_probs=166.4

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc--------ccHHHHHHHHHHHHhcC---Ccccceeeeeeec
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--------QGLREMKNEASVIAKVQ---HKNLVRLLGCCID  158 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  158 (411)
                      ..|+..+.+|.|+||.|+.|.++. ...|+||.+.+..-        ...-.+-.|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458899999999999999999875 66799998876421        11223557999999997   9999999999999


Q ss_pred             CCceEEEEeeCC-CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          159 KDEKILIYEYMP-NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       159 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                      .+.+|+++|... +-+|.+++.-   +..+++.....|+.|++-|+++||+++   |+|||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999864 4578888743   334889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCC
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNT  295 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~  295 (411)
                      |.+.+...    .....++||..|.|||++.+.+| +..-|||++|++||.++....||
T Consensus       715 gsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99877543    34567899999999999998887 45579999999999999888885

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=254.68  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=202.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|+.+..+|.|++|.||++++. .++..|+|.++......+.-++.|+-+++.++||||+.+++.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467888999999999999999965 5899999999987777788889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      |.+|+|++.-+-   ..++++.+....++..++|+.|||+++   =+|||||-.||++++.|.+|++|||.+-.+.... 
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence            999999888643   345888888999999999999999998   7899999999999999999999999987665322 


Q ss_pred             ccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                       .....+.||+.|||||+..   .+.|+..+|+|++|+...|+---++|......       ...-+.-..   ..+++.
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTk---S~~qpp  235 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTK---SGFQPP  235 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhc---cCCCCC
Confidence             2234468999999999764   56799999999999999999887777321110       000000000   011111


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      -.  .+.......+.++++.|+..+|++|||+..++.
T Consensus       236 ~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11  112223677999999999999999999987664

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-30  Score=236.11  Aligned_cols=131  Identities=24%  Similarity=0.321  Sum_probs=107.2

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----C---cccceeeeeeec---
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----H---KNLVRLLGCCID---  158 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~---  158 (411)
                      ++|.+.++||-|-|++||++.+.. .+.||+|+.+.. ....+....|+++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            789999999999999999999764 678999998753 344566789999999984     3   369999999975   


Q ss_pred             -CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          159 -KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                       +.++|||+|++.. +|..++..... .-++...+.+|++||+.||.|||...  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvLGd-nLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGD-NLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhhhh-HHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             4588999999955 55555543322 33788889999999999999999976  69999999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.3e-29  Score=226.00  Aligned_cols=198  Identities=32%  Similarity=0.456  Sum_probs=171.0

Q ss_pred             CCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           93 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      |.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999875 889999999876544 56788999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +++|..++......  +++.....++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            99999998543321  688889999999999999999997   999999999999999999999999998876543211 


Q ss_pred             ccccccccccccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 040952          251 NTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  296 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~  296 (411)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22334678889999998 66678889999999999999999999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=228.84  Aligned_cols=263  Identities=24%  Similarity=0.277  Sum_probs=193.4

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC------
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  159 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (411)
                      ...+|...+.+|.|.- .|-.+.+. .+++||+|++...  +...+++..+|...+..++|+||++++.+|.-.      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            4567888889999988 56666543 3889999987543  345677889999999999999999999998643      


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ...|+|||+|.. +|...+.     ..++-.....|+.|++.|+.|||+.+   |+||||||+||++..++.+||.|||+
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence            366999999964 6766654     22566778899999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-----------------
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-----------------  302 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-----------------  302 (411)
                      ++..+..   -..+..+.|..|.|||++.+..|...+||||+||++.||++|+.-|...+...                 
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            9875432   23344577889999999998889999999999999999999998765322100                 


Q ss_pred             cchhHHHHHHhhcCc------ccc-ccccccccccc-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          303 LNLLGYAWDLWTSNR------TLE-LIDPILEDEYS-SKHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~------~~~-~~~~~l~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                      .++...+..+.....      ..+ ..|........ +.-......+++.+||-.+|++|.++.++++.-
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence            011111111111000      000 11111111110 111245678999999999999999999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.3e-29  Score=231.06  Aligned_cols=267  Identities=24%  Similarity=0.361  Sum_probs=200.6

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec----CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCC
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  160 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  160 (411)
                      .....+.|..+++||.|.|++||++.+.    .++.||+|.+...+.  ...+.+|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4455678999999999999999999843    367899999876532  35689999999999 5899999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGM  239 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl  239 (411)
                      ...+|+||+++....++...      ++......+++.++.||.++|.+|   |+||||||+|+|.+. .+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999888733      567778889999999999999999   999999999999985 46789999999


Q ss_pred             ccccCCCC-------------cc-----------------------------cccccccccccccChhhhcc-CCCCcch
Q 040952          240 ARICGGNE-------------LQ-----------------------------ANTSRIVGTYGYMSPEYALE-GIFSIKS  276 (411)
Q Consensus       240 ~~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~  276 (411)
                      +.......             ..                             .......||++|.|||++.. ...+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            87211000             00                             00112469999999999874 5678999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH---------HhhcCc--cc---------------ccc--ccccc-
Q 040952          277 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD---------LWTSNR--TL---------------ELI--DPILE-  327 (411)
Q Consensus       277 DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~---------~~~~~~--~~---------------~~~--~~~l~-  327 (411)
                      ||||.|||++.+++++.||.....+...+...+.-         ....+.  +.               +.+  ..... 
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            99999999999999999997666554443332210         000011  00               000  00000 


Q ss_pred             ------cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 ------DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                            .....+..+..+.+++.+|++.||.+|.|+++.|+.
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                  011122234578999999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=5.4e-29  Score=261.36  Aligned_cols=195  Identities=19%  Similarity=0.242  Sum_probs=137.2

Q ss_pred             cCC-cccceeeeee-------ecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 040952          144 VQH-KNLVRLLGCC-------IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII  215 (411)
Q Consensus       144 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  215 (411)
                      ++| +||.+++++|       .....+++++||+ +++|.+++...  ...+++..+..++.||++||.|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            455 5888888877       2334667888887 56999999643  234889999999999999999999998   99


Q ss_pred             ecCCCCCCEEEcC-------------------CCCeEEeecCCccccCCCCc--------------cccccccccccccc
Q 040952          216 HRDLKASNILLDK-------------------DMNPKISDFGMARICGGNEL--------------QANTSRIVGTYGYM  262 (411)
Q Consensus       216 H~dlkp~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~gt~~y~  262 (411)
                      ||||||+||||+.                   ++.+|++|||+++.......              ........||+.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999964                   44566666666653211000              00011235788999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHH
Q 040952          263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNI  342 (411)
Q Consensus       263 aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l  342 (411)
                      |||++.+..++.++|||||||+||||++|.+|+.....       ..... ..    ....+..      .........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------~~~~~-~~----~~~~~~~------~~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------TMSSL-RH----RVLPPQI------LLNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------HHHHH-HH----hhcChhh------hhcCHHHHHH
Confidence            99999999999999999999999999998887532110       00000 00    0001100      0012345688


Q ss_pred             HHHccccCCCCCCCHHHHHH
Q 040952          343 ALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       343 i~~cl~~~p~~RPt~~evl~  362 (411)
                      +.+||+++|.+||++.|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            89999999999999999985

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.4e-27  Score=203.84  Aligned_cols=168  Identities=20%  Similarity=0.124  Sum_probs=125.4

Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      |+|.+++...  +..+++..++.++.|++.||.|||+++         ||+|||++.++.+++  ||++......     
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence            6788888543  235899999999999999999999875         999999999999999  9998765432     


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                        ...||+.|+|||++.+..++.++|||||||++|||++|+.||.................. .     . .+  .....
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~-----~-~~--~~~~~  131 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-A-----D-DP--RDRSN  131 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-c-----C-Cc--ccccc
Confidence              126789999999999999999999999999999999999998543221111111111100 0     0 00  00011


Q ss_pred             hHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          332 SKHMLL--RYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       332 ~~~~~~--~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      ......  .+.+++.+||+.+|++||++.|+++.+....
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            122233  6899999999999999999999999886553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-25  Score=210.92  Aligned_cols=278  Identities=22%  Similarity=0.250  Sum_probs=204.1

Q ss_pred             CCCccCcccccCcccEEEEEecCC--CEEEEEEccCCCcccHHHHHHHHHHHHhcCC----cccceeeeee-ecCCceEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKKG--DEIAVKRLSGRSGQGLREMKNEASVIAKVQH----KNLVRLLGCC-IDKDEKIL  164 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  164 (411)
                      +|.+.+.||+|+||.||.+.....  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999997653  4788888765433322267788899988863    6899999998 47778899


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-----CCeEEeecCC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-----MNPKISDFGM  239 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfgl  239 (411)
                      ||+.+ |.+|.++..... ...++..+...++.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99976 778988775444 455888999999999999999999999   9999999999999765     4699999999


Q ss_pred             cc--ccCCCC------cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH
Q 040952          240 AR--ICGGNE------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       240 ~~--~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  311 (411)
                      ++  ......      .........||..|+++....+...+.+.|+||++.++.|++.|..||........ .......
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~  252 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD  252 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH
Confidence            98  321111      11112345699999999999999999999999999999999999999854332111 0000000


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeeecccc
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTV  386 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~  386 (411)
                      .     ....... . ...    .+..+.++...+-..+...+|....+...|.............+++|.....
T Consensus       253 ~-----~~~~~~~-~-~~~----~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~  316 (322)
T KOG1164|consen  253 P-----RKLLTDR-F-GDL----KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR  316 (322)
T ss_pred             h-----hhhcccc-c-cCC----ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence            0     0000000 0 001    1344556666666689999999999999998887766555556666665443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3.7e-26  Score=214.86  Aligned_cols=167  Identities=18%  Similarity=0.206  Sum_probs=129.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec--CCCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      ...++|.+.+.||+|+||+||+|.+.  +++.||||++...     .......+.+|+++|++++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            44678999999999999999999865  4777899987533     12234568999999999999999853322   24


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEEEcCCCCeEEeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfgl  239 (411)
                      ..++||||++|++|....    .   ..   ...++.|+++||.|||+.+   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            679999999999996321    1   01   1467889999999999998   999999 99999999999999999999


Q ss_pred             ccccCCCCcccc------cccccccccccChhhhccC
Q 040952          240 ARICGGNELQAN------TSRIVGTYGYMSPEYALEG  270 (411)
Q Consensus       240 ~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  270 (411)
                      ++.+........      .....+++.|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            987654321111      1345688899999988643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=2.6e-23  Score=195.49  Aligned_cols=260  Identities=28%  Similarity=0.370  Sum_probs=196.9

Q ss_pred             CCccCcccccCcccEEEEEecCCCEEEEEEccCCCcc---cHHHHHHHHHHHHhcCCc-ccceeeeeeecCCceEEEEee
Q 040952           93 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ---GLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  168 (411)
                      |...+.||.|+||.||.+...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999987  78999998765332   367789999999999988 799999999777778999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~  247 (411)
                      +.++++..++........+.......++.|++.++.|+|..+   ++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643321124788888999999999999999998   99999999999999988 79999999998654433


Q ss_pred             ccc----ccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccc--ccchhHHHHHHhhcCcc
Q 040952          248 LQA----NTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD--SLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       248 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  318 (411)
                      ...    ......|+..|++||.+.+   ..++...|+||+|++++++++|..||......  .........    ....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL----ELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH----hcCC
Confidence            221    2345689999999999987   57889999999999999999999996544321  111111111    1100


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      . ........... ......+.+++..|+..+|..|.+..+....
T Consensus       233 ~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 00000000000 1123578899999999999999999987765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-23  Score=184.78  Aligned_cols=281  Identities=17%  Similarity=0.242  Sum_probs=212.1

Q ss_pred             HhcCCCccCcccccCcccEEEEE-ecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..-.|.+.++||+|+||..+.|+ +-+++.||||.-+..++.  -.+..|.+..+.| ..++|...+.+...+.+-.||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34579999999999999999998 445999999987765432  4567888888887 5789999998888888889999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-----CCeEEeecCCcc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-----MNPKISDFGMAR  241 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfgl~~  241 (411)
                      |.+ |.+|.++..-..++  ++..++.-++.|++.-++|+|+++   +|.|||||+|+||..-     ..+.++|||+++
T Consensus       104 dLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            987 66887776433332  788899999999999999999998   9999999999999643     458999999998


Q ss_pred             ccCCCCc-----ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC
Q 040952          242 ICGGNEL-----QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       242 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      .+.+...     ........||.+||+-....+...+.+.|+-|||-++.+.|-|..||.....+...   ..+..+-+.
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---~kYeKIGe~  254 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---EKYEKIGET  254 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---HHHHHhccc
Confidence            7754321     22234467999999999889999999999999999999999999999765433211   111111111


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeeecccc
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTV  386 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~  386 (411)
                      .-..-++ .+.     ...+.++..-+.-.=..+-.+-|...-+...+......+.-.....++|...+.
T Consensus       255 Kr~T~i~-~Lc-----~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~  318 (449)
T KOG1165|consen  255 KRSTPIE-VLC-----EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNN  318 (449)
T ss_pred             cccCCHH-HHH-----hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCC
Confidence            0000000 111     112445666665555677888899999888888888888888888899877663

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.6e-25  Score=190.36  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=189.0

Q ss_pred             CCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           93 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .....+|.+...|..|+|+++ |..+++|++....  ...-+.|.+|.-.|+-+.||||+++++.|....+..++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            344567889999999999998 7778888886542  2223568889999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe--ecCCccccCCCCc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS--DFGMARICGGNEL  248 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~--Dfgl~~~~~~~~~  248 (411)
                      .|+|...|++... ..++..+..+++.++++|++|||+..+. |.---|.+..+++|++.+++|.  |--++..      
T Consensus       271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfq------  342 (448)
T KOG0195|consen  271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQ------  342 (448)
T ss_pred             chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeee------
Confidence            9999999987654 4577788899999999999999998732 4445799999999999988875  3222211      


Q ss_pred             ccccccccccccccChhhhccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIF---SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                         .....-.+.|++||.++..+-   -.++|+|||++++|||.|...||........     ... +    ..+.+...
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----gmk-i----aleglrv~  409 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----GMK-I----ALEGLRVH  409 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----hhh-h----hhcccccc
Confidence               111234678999999987653   3578999999999999999999975542211     001 1    11222222


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ++.     ..+..+.+|+.-|+..||.+||.+..++-.|++.
T Consensus       410 ipp-----gis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  410 IPP-----GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCC-----CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            222     1256788999999999999999999999888764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=5e-24  Score=180.96  Aligned_cols=278  Identities=19%  Similarity=0.272  Sum_probs=204.5

Q ss_pred             HhcCCCccCcccccCcccEEEEE-ecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC-cccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..++|.+++.||.|+||.+|.|. ..+|..||||.-+.....  ..+..|.++.+.+++ ..|..+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35789999999999999999998 567999999987655333  346778888888875 66777788888888899999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCCcccc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARIC  243 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl~~~~  243 (411)
                      +.+ |.+|.++..-..++  ++..+++-++-|++.-++|+|..+   ++||||||+|+|..-   ...+.|+|||+++.+
T Consensus        91 dLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            987 67888876433332  677888899999999999999998   999999999999964   356899999999876


Q ss_pred             CCCCc-----ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          244 GGNEL-----QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       244 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      .+...     ........||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||........   ...++.+.+...
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK~  241 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKKM  241 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhhc
Confidence            54321     1223446799999998888888888999999999999999999999875442211   111222222221


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeeec
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVR  383 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~  383 (411)
                      .-.+ ..+...+     +.++.-.+.-|=..--++-|...-+-+.++-+-..+...-.=.++|+.
T Consensus       242 s~~i-e~LC~G~-----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~  300 (341)
T KOG1163|consen  242 STPI-EVLCKGF-----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM  300 (341)
T ss_pred             CCCH-HHHhCCC-----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence            1111 1111112     445666777777777788888877777776666666666666666643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=3e-25  Score=222.04  Aligned_cols=254  Identities=20%  Similarity=0.251  Sum_probs=185.4

Q ss_pred             CccCcccccCcccEEEEEec-CCCEEEEEEcc----CC-Cc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           94 SDANKLGEGGFGPVYKGVLK-KGDEIAVKRLS----GR-SG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~----~~-~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .....+|.|++|.|+..... .....+.|.+.    .. .. .....+..|+.+-..+.|||++..+..+.+....+..|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988877633 23334444332    11 11 11222567787888899999999888888777777779


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |||++ +|..++...   ..+....+-.++.|+..|+.|+|+.|   |.|||+|++|++++.+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 998888543   23677788899999999999999999   999999999999999999999999998765433


Q ss_pred             Ccc--cccccccccccccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          247 ELQ--ANTSRIVGTYGYMSPEYALEGIFSIK-SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       247 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ...  ......+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||.........+..     .......... 
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----~~~~~~~~~~-  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----NNYSDQRNIF-  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----hccccccccc-
Confidence            322  34456789999999999999999865 79999999999999999998654433222100     0000000000 


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        ..........+.....++.++|+.+|.+|.|+.+|++
T Consensus       548 --~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 --EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              0011112233567889999999999999999999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=6.3e-25  Score=220.37  Aligned_cols=249  Identities=21%  Similarity=0.248  Sum_probs=181.2

Q ss_pred             CCCccCcccccCcccEEEEEecCCCEEEEEEccCCC-cccHHHHH---HHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS-GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      +|...+.||.+.|=+|.+|+++.|. |+||++-+.. ....+.+.   +|++ ...++|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677789999999999999998776 9999987664 22333333   4444 555699999999988777778899999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |..+ +|.+.+   ..+..+...+...|+.|++.|+..+|..|   |+|||||.+||||+..+.+.|+||...+...-..
T Consensus       102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9866 566665   45566888889999999999999999998   9999999999999999999999999876543222


Q ss_pred             cc-----cccccccccccccChhhhccC-----------CCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHH
Q 040952          248 LQ-----ANTSRIVGTYGYMSPEYALEG-----------IFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       248 ~~-----~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  310 (411)
                      ..     ..+++-..-.+|.|||.+...           ..+++.||||+||++.||++ |+++|....     +..+  
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aY--  247 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAY--  247 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhH--
Confidence            11     112222234579999987531           15788999999999999999 577764211     1111  


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                         ..+. .......+..- .    ...+.+++..|++.||++|.++.+.++.-+
T Consensus       248 ---r~~~-~~~~e~~Le~I-e----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  248 ---RSGN-ADDPEQLLEKI-E----DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             ---hccC-ccCHHHHHHhC-c----CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence               1110 00011111110 0    235789999999999999999999998843

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=7e-24  Score=185.77  Aligned_cols=172  Identities=16%  Similarity=0.151  Sum_probs=133.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccH---HH------HHHHHHHHHhcCCcccceeeeeeec
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGL---RE------MKNEASVIAKVQHKNLVRLLGCCID  158 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~niv~l~~~~~~  158 (411)
                      ...++|...++||.|+||.||+... ++..+|+|.+........   ..      +.+|+..+.++.||+|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3468999999999999999999766 477899999975532222   22      5789999999999999999888664


Q ss_pred             C--------CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          159 K--------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       159 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                      .        +..+++|||++|.+|.++..       ++.    ....+++.++..+|..+   ++|||++|+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            3        35789999999999977631       222    34568999999999998   99999999999999988


Q ss_pred             CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHH
Q 040952          231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV  289 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  289 (411)
                       ++|+|||..........              ...+.....|+.++|+||||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence             99999998755421110              011345556778999999999887664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=9.8e-23  Score=176.49  Aligned_cols=139  Identities=15%  Similarity=0.140  Sum_probs=107.3

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcc--c-------H-----------------HHHHHHHHHHHhcCCccc
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ--G-------L-----------------REMKNEASVIAKVQHKNL  149 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni  149 (411)
                      ...||+|+||.||+|...+|+.||||++......  .       .                 .....|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998653211  0       0                 122359999999988876


Q ss_pred             ceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCCEEEcC
Q 040952          150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL-HQYSRVRIIHRDLKASNILLDK  228 (411)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlkp~Nill~~  228 (411)
                      .....+..  ...++||||++++++......   ...++......++.|++.+|.++ |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44332222  234899999999877654322   23478888899999999999999 6777   99999999999998 


Q ss_pred             CCCeEEeecCCcccc
Q 040952          229 DMNPKISDFGMARIC  243 (411)
Q Consensus       229 ~~~~kl~Dfgl~~~~  243 (411)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            578999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=1e-21  Score=170.75  Aligned_cols=140  Identities=19%  Similarity=0.213  Sum_probs=109.5

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcc---------------------c-----HHHHHHHHHHHHhcCCccc
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ---------------------G-----LREMKNEASVIAKVQHKNL  149 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni  149 (411)
                      ...||+|+||.||+|.+.+|+.||||++......                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754211                     0     1123578999999999987


Q ss_pred             ceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcC
Q 040952          150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDK  228 (411)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~  228 (411)
                      .....+...  ..++||||++++++......   ...++......++.|++.++.++|+ .+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  34899999998865433211   1236677888999999999999999 87   99999999999999 


Q ss_pred             CCCeEEeecCCccccC
Q 040952          229 DMNPKISDFGMARICG  244 (411)
Q Consensus       229 ~~~~kl~Dfgl~~~~~  244 (411)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=3.6e-22  Score=180.22  Aligned_cols=233  Identities=19%  Similarity=0.251  Sum_probs=150.3

Q ss_pred             CCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCC----------cccceeeeeee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQH----------KNLVRLLGCCI  157 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~  157 (411)
                      .+...+.||.|+++.||.+++.. |+.+|||.+....   ...++.+++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            44556889999999999999875 8999999885432   3346677777665555332          12222222221


Q ss_pred             ---------cCC--------ceEEEEeeCCCCCchhhhcC----CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 040952          158 ---------DKD--------EKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH  216 (411)
Q Consensus       158 ---------~~~--------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  216 (411)
                               ...        +.+++|+-+ .++|..++..    ......+....+..+..|+.+.+++||+.|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                     111        235677776 5577766431    112234556677888899999999999999   999


Q ss_pred             cCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhcc--------CCCCcchhhHHHHHHHHHH
Q 040952          217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--------GIFSIKSDVFSFGVLLLEI  288 (411)
Q Consensus       217 ~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el  288 (411)
                      +||+|+|++++.+|.++|+||+.....+....     ....+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999987765442111     0233577999997643        2478899999999999999


Q ss_pred             HhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCC
Q 040952          289 VSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR  354 (411)
Q Consensus       289 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~R  354 (411)
                      ++|..||+..........              .+.      ... +.++.+..||..+|+.+|++|
T Consensus       244 WC~~lPf~~~~~~~~~~~--------------~f~------~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW--------------DFS------RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG--------------GGT------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc--------------cch------hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999986543322111              011      112 457889999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=7.9e-22  Score=188.98  Aligned_cols=219  Identities=24%  Similarity=0.342  Sum_probs=163.8

Q ss_pred             HHhcCCcccceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 040952          141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  220 (411)
Q Consensus       141 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  220 (411)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+...  ...+++.-...+.++++.||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            35689999999999999999999999999999999999763  344889889999999999999999875  23999999


Q ss_pred             CCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccC-------CCCcchhhHHHHHHHHHHHhCCC
Q 040952          221 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-------IFSIKSDVFSFGVLLLEIVSGKK  293 (411)
Q Consensus       221 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~elltg~~  293 (411)
                      +.|+++|..+.+||+|||+.................-..-|.|||.+.+.       ..+.+.|+||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765421111111111234569999988753       14677999999999999999999


Q ss_pred             CCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          294 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       294 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ||......... .+.+.....  .....+.|.+....   +....+..++..||..+|++||++.++-..++..-.
T Consensus       157 ~~~~~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDP-DEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCCh-HHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            98764432221 112222111  11222333322111   334478999999999999999999999998877655

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=4.8e-22  Score=203.07  Aligned_cols=197  Identities=19%  Similarity=0.219  Sum_probs=161.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CcccceeeeeeecCCceEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  164 (411)
                      .....|.+.+.||+|+||.||.|...+|+.||+|.-+..+..+   |.--.+++.+|+   -+-|+.+..++.-.+..++
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            3456788999999999999999998889999999987765432   222234445555   2345666666777888999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-------CCCCeEEeec
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-------KDMNPKISDF  237 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-------~~~~~kl~Df  237 (411)
                      |+||.+.|+|.+++.   ....++|..++.+..|+++.++.||..+   |||+||||+|+||.       ++..++|+||
T Consensus       772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999996   4455899999999999999999999998   99999999999994       2456999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  293 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~  293 (411)
                      |.+..+..-.........++|..+-.+|...|..++.++|.|.|+-+++-||.|+.
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99865543333344556788999999999999999999999999999999999975

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.2e-20  Score=162.04  Aligned_cols=184  Identities=18%  Similarity=0.147  Sum_probs=137.5

Q ss_pred             CccCcccccCcccEEEEEecCCCEEEEEEccCCCcc----cHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEee
Q 040952           94 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ----GLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .+...|++|+||+||.+.. ++.+++.+.+......    ....+.+|+++|+++. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997766 5888888887755331    1235789999999995 5789999886    457999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      +.|.+|...+..          ....++.|++++|.++|.+|   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999988654311          11357789999999999998   999999 7999999999999999999998654322


Q ss_pred             cc----cc-------cccccccccccChhhhccC-CCC-cchhhHHHHHHHHHHHhCCCCC
Q 040952          248 LQ----AN-------TSRIVGTYGYMSPEYALEG-IFS-IKSDVFSFGVLLLEIVSGKKNT  295 (411)
Q Consensus       248 ~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~p~  295 (411)
                      ..    ..       ......++.|++|+-..-. ..+ ...+.++.|+-+|.++|++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            10    00       0112357778888744321 223 5678999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.1e-22  Score=195.04  Aligned_cols=224  Identities=24%  Similarity=0.312  Sum_probs=176.4

Q ss_pred             cccccCcccEEEEE----ecCCCEEEEEEccCCCcc--cHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEeeCC
Q 040952           98 KLGEGGFGPVYKGV----LKKGDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      .+|+|.||.|+++.    .+.|..+|.|.+.+.+..  .......|..++...+ ||.++++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999864    334778999988765321  1113456778888886 9999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +|.|...+....   ...+.........++-+++++|+.+   ++|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999988774433   3566666677778899999999998   99999999999999999999999999986543222  


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc-cc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE-DE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~  329 (411)
                          .|||..|||||++.  .....+|.||||++++||+||..||..                      +....++. .-
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------------~~~~~Il~~~~  204 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------------DTMKRILKAEL  204 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------------HHHHHHhhhcc
Confidence                18999999999988  567889999999999999999999864                      01111111 11


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCH
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTM  357 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~  357 (411)
                      ..+.+......+++..++..+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2345557788899999999999999766

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=4.3e-20  Score=161.45  Aligned_cols=136  Identities=21%  Similarity=0.282  Sum_probs=105.2

Q ss_pred             CccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-----CCcccceeeeeeecCC---ceE-E
Q 040952           94 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-----QHKNLVRLLGCCIDKD---EKI-L  164 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  164 (411)
                      ...+.||+|+||.||.  +......+||++........+.+.+|+.+++.+     .||||+++++++..+.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  433333479988765444567789999999999     5799999999998864   333 7


Q ss_pred             EEee--CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCCEEEcC----CCCeEEeec
Q 040952          165 IYEY--MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL-LYLHQYSRVRIIHRDLKASNILLDK----DMNPKISDF  237 (411)
Q Consensus       165 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Df  237 (411)
                      |+||  +.+++|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    ++.++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  5589999999542    14444  35677888777 9999998   999999999999974    347999995


Q ss_pred             CCc
Q 040952          238 GMA  240 (411)
Q Consensus       238 gl~  240 (411)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=165.11  Aligned_cols=198  Identities=23%  Similarity=0.295  Sum_probs=134.0

Q ss_pred             CCcccceeeeeeecC---------------------------CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHH
Q 040952          145 QHKNLVRLLGCCIDK---------------------------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE  197 (411)
Q Consensus       145 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~  197 (411)
                      +|||||++.++|.++                           ...|+||.-++. +|..++....    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            599999999887542                           235788877654 7777774432    34555667888


Q ss_pred             HHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CC--CCeEEeecCCccccCCCCcc----cccccccccccccChhhhcc
Q 040952          198 GIAQGLLYLHQYSRVRIIHRDLKASNILLD--KD--MNPKISDFGMARICGGNELQ----ANTSRIVGTYGYMSPEYALE  269 (411)
Q Consensus       198 ~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~--~~~kl~Dfgl~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~  269 (411)
                      |+++|+.|||.+|   +.|||+|++|||+.  +|  -.+.|+|||.+--......+    +.....-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999993  33  34789999976433221111    11122357888999998763


Q ss_pred             CC------CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHH
Q 040952          270 GI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIA  343 (411)
Q Consensus       270 ~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li  343 (411)
                      -+      --.|+|.|+.|.+.||++....||-.-.....+...     +.+.++     +.+.     ...+..+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qL-----Palp-----~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQL-----PALP-----SRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhC-----CCCc-----ccCChHHHHHH
Confidence            22      125899999999999999999997431111111111     111111     1111     22245688999


Q ss_pred             HHccccCCCCCCCHHHHHHHHh
Q 040952          344 LLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       344 ~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ...|+.||++|++..=....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999876655553

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=8.5e-21  Score=178.70  Aligned_cols=174  Identities=25%  Similarity=0.335  Sum_probs=130.8

Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      +.|+.|++|...+|.+|+.........++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999766555667888889999999999999   55   999999999999999999999999998


Q ss_pred             cccCCCC----cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcccccchhHHHHHHhhc
Q 040952          241 RICGGNE----LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       241 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                      .......    .....+...||..||+||.+.+..|+.++||||||++|+||+.-- -++                 ...
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~-----------------er~  466 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF-----------------ERI  466 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH-----------------HHH
Confidence            7655433    223445678999999999999999999999999999999999721 111                 111


Q ss_pred             CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 040952          316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMND  359 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  359 (411)
                      ....++-+..++..+...  ...-..|+.+++.+.|.+||++.+
T Consensus       467 ~t~~d~r~g~ip~~~~~d--~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  467 ATLTDIRDGIIPPEFLQD--YPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HhhhhhhcCCCChHHhhc--CcHHHHHHHHhcCCCcccCchHHH
Confidence            111122222222110000  122357999999999999994443

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=3.4e-19  Score=159.58  Aligned_cols=144  Identities=16%  Similarity=0.149  Sum_probs=110.3

Q ss_pred             cCCCccCcccccCcccEEEEE--ecCCCEEEEEEccCCCcc------------------------cHHHHHHHHHHHHhc
Q 040952           91 NKFSDANKLGEGGFGPVYKGV--LKKGDEIAVKRLSGRSGQ------------------------GLREMKNEASVIAKV  144 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  144 (411)
                      .-|.+.+.||+|+||.||+|.  ..+|+.||+|++......                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  457999999998743210                        012356899999999


Q ss_pred             CCcc--cceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 040952          145 QHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  222 (411)
Q Consensus       145 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~  222 (411)
                      .+.+  +.+++++    ...++||||+++++|..+...   ...........++.|++.++.+||..+  .++||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            7533  3344432    245899999999888665422   123455566789999999999999876  4999999999


Q ss_pred             CEEEcCCCCeEEeecCCccccC
Q 040952          223 NILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       223 Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||+++ ++.++|+|||.+...+
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999886543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6e-19  Score=156.14  Aligned_cols=134  Identities=20%  Similarity=0.313  Sum_probs=112.5

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcc--------cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ--------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      +.||+|++|.||+|.. .|..+++|........        ....+.+|+.++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 4788999986543211        123577899999999999988877777777888999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++|++|.+++...      .. ....++.+++.++.++|+.+   ++|||++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887432      11 67789999999999999998   99999999999999 88999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=9e-19  Score=153.56  Aligned_cols=130  Identities=23%  Similarity=0.364  Sum_probs=106.2

Q ss_pred             cccccCcccEEEEEecCCCEEEEEEccCCCc--c------cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           98 KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG--Q------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .||+|+||.||+|.+. |..+++|.......  .      ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999965 78899998654311  1      1245778999999999887665555566677789999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      +|++|.+++....          ..++.+++.+|.+||+.+   ++|||++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988873321          078899999999999998   99999999999999 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.6e-18  Score=151.85  Aligned_cols=139  Identities=19%  Similarity=0.194  Sum_probs=109.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcc----------------------cHHHHHHHHHHHHhcCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ----------------------GLREMKNEASVIAKVQHK  147 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~  147 (411)
                      ...|.+.+.||+|+||.||++...+|+.||||++......                      ....+..|..++..+.|+
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3447888999999999999999878999999987543210                      012356788899988777


Q ss_pred             c--cceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 040952          148 N--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  225 (411)
Q Consensus       148 n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil  225 (411)
                      +  +...++    ....++||||+++++|..+...         .....++.+++.++.++|+.+   ++||||+|+||+
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil  157 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL  157 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence            4  444443    2456899999999998765421         233578889999999999988   999999999999


Q ss_pred             EcCCCCeEEeecCCccccC
Q 040952          226 LDKDMNPKISDFGMARICG  244 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~  244 (411)
                      +++++.++|+|||++....
T Consensus       158 l~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EcCCCcEEEEECCccccCC
Confidence            9999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.5e-18  Score=172.75  Aligned_cols=137  Identities=20%  Similarity=0.325  Sum_probs=111.5

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEc-cCC-C------cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL-SGR-S------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~~-~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ...|...+.||+|+||.||+|.+.. ..+++|+. ... .      ....+.+.+|++++..++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            3455667899999999999998764 34444432 211 1      1123567899999999999999988888777778


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ .++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999988873           34678999999999999998   9999999999999 67899999999986


Q ss_pred             c
Q 040952          242 I  242 (411)
Q Consensus       242 ~  242 (411)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=6.6e-19  Score=177.31  Aligned_cols=213  Identities=20%  Similarity=0.247  Sum_probs=143.8

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..+|+.++.|..|++|.||..+++. .+.+|.|+ .+++     .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence            4679999999999999999998774 67788843 3221     11111  23333444444                  


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC-
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  247 (411)
                         |+-...+.....   ++.        +++.+++|||+.+   |+|||+||+|.+|+.-|.+|++|||+++...... 
T Consensus       136 ---gDc~tllk~~g~---lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP---LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcccCCC---Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               444444433222   221        2377899999998   9999999999999999999999999987532110 


Q ss_pred             ------------cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc
Q 040952          248 ------------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       248 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                                  ........+||+.|.|||++..+.|+..+|+|++|+|+||.+-|+.||....++. .+-.++.+.+..
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd~i~w  277 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIEW  277 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhhhccc
Confidence                        0011234689999999999999999999999999999999999999986433221 111111111111


Q ss_pred             CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 040952          316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMND  359 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  359 (411)
                      .   +- +.         ....+..+++.+.|+.+|..|--...
T Consensus       278 p---E~-de---------a~p~Ea~dli~~LL~qnp~~Rlgt~g  308 (1205)
T KOG0606|consen  278 P---EE-DE---------ALPPEAQDLIEQLLRQNPLCRLGTGG  308 (1205)
T ss_pred             c---cc-Cc---------CCCHHHHHHHHHHHHhChHhhcccch
Confidence            1   11 11         11456889999999999999954433

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=1.3e-16  Score=132.94  Aligned_cols=135  Identities=22%  Similarity=0.239  Sum_probs=114.0

Q ss_pred             ccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC--cccceeeeeeecCCceEEEEeeCCCC
Q 040952           95 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      +.+.||+|.++.||++... +..+++|.......  ...+..|+..+..++|  .++.++++++...+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            3567999999999999986 47899999876543  4578899999999976  58999999888888899999999988


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      .+..+          +......++.+++++++++|.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77544          4445677889999999999986545599999999999999999999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5.9e-17  Score=140.52  Aligned_cols=136  Identities=20%  Similarity=0.247  Sum_probs=97.1

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcc--cHHH----------------------HHHHHHHHHhcCCcc--c
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ--GLRE----------------------MKNEASVIAKVQHKN--L  149 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  149 (411)
                      .+.||+|+||.||+|...+|+.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988653211  1111                      134555666654432  3


Q ss_pred             ceeeeeeecCCceEEEEeeCCCCCchhh-hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEc
Q 040952          150 VRLLGCCIDKDEKILIYEYMPNKSLDFF-LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~  227 (411)
                      .+.+++    ...++||||++++.+... +....    .. .....++.+++.++.++|. .+   |+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            344433    246899999999654321 11111    11 4567899999999999999 77   99999999999999


Q ss_pred             CCCCeEEeecCCccccC
Q 040952          228 KDMNPKISDFGMARICG  244 (411)
Q Consensus       228 ~~~~~kl~Dfgl~~~~~  244 (411)
                       ++.++|+|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             9999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=2.6e-18  Score=172.28  Aligned_cols=257  Identities=19%  Similarity=0.259  Sum_probs=191.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC--CCEEEEEEccCCC--cccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  164 (411)
                      ...|.+.+.||+|+|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3467778889999999998877543  4456777665443  223344555777777776 9999999999999999999


Q ss_pred             EEeeCCCCCchhhh-cCCCCCcCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCcc
Q 040952          165 IYEYMPNKSLDFFL-FDPTKRMLLDWVTRVQIIEGIAQGLLYLH-QYSRVRIIHRDLKASNILLDKDM-NPKISDFGMAR  241 (411)
Q Consensus       165 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~  241 (411)
                      +++|..++++...+ .....  ..+.......+.|+..++.|+| ..+   +.|+||||+|.+++..+ .+++.|||++.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999998877 32221  2344456678999999999999 777   99999999999999999 99999999998


Q ss_pred             ccCC-CCcccccccccc-cccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          242 ICGG-NELQANTSRIVG-TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       242 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      .+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+............|....   .. 
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~-  249 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GR-  249 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---cc-
Confidence            7765 444444455678 9999999998874 456789999999999999999999876554333222221110   00 


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         .     .............+++.+++..+|+.|.+..++...
T Consensus       250 ---~-----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  250 ---F-----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ---c-----ccCccccCChhhhhcccccccCCchhcccccccccc
Confidence               0     000111124557789999999999999999887643

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=5.6e-16  Score=139.11  Aligned_cols=134  Identities=21%  Similarity=0.258  Sum_probs=103.6

Q ss_pred             Cccc-ccCcccEEEEEecCCCEEEEEEccCCC-------------cccHHHHHHHHHHHHhcCCccc--ceeeeeeecCC
Q 040952           97 NKLG-EGGFGPVYKGVLKKGDEIAVKRLSGRS-------------GQGLREMKNEASVIAKVQHKNL--VRLLGCCIDKD  160 (411)
Q Consensus        97 ~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~  160 (411)
                      ..|| .|+.|+||.+... +..++||++....             ......+.+|+.++.+++|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8999999999876 7789999885321             1123457889999999998875  66666644332


Q ss_pred             c----eEEEEeeCCC-CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          161 E----KILIYEYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       161 ~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                      .    .++|+|+++| .+|.+++...    .++.    ..+.+++.++.+||+.|   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 6888887432    2333    23678999999999998   9999999999999999999999


Q ss_pred             ecCCccc
Q 040952          236 DFGMARI  242 (411)
Q Consensus       236 Dfgl~~~  242 (411)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1e-14  Score=142.05  Aligned_cols=141  Identities=23%  Similarity=0.271  Sum_probs=99.3

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccH----------------------------------------HHHH
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGL----------------------------------------REMK  135 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~  135 (411)
                      .+.||.|++|.||+|++.+|+.||||+.........                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999865321100                                        0133


Q ss_pred             HHHHHHHhc----CCcccceeeeeeec-CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHH-HHHHHhhc
Q 040952          136 NEASVIAKV----QHKNLVRLLGCCID-KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ-GLLYLHQY  209 (411)
Q Consensus       136 ~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~  209 (411)
                      +|+..+.++    +|.+-+.+-..+.+ ....++||||++|++|.++.......  .   ....++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence            455555554    23333343333332 45679999999999998876422111  1   23456666665 46788888


Q ss_pred             CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       210 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      |   ++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=6.6e-15  Score=131.20  Aligned_cols=205  Identities=21%  Similarity=0.224  Sum_probs=139.5

Q ss_pred             HHHHhcCCcccceeeeeeecCC-----ceEEEEeeCCCCCchhhhcCCCC-CcCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 040952          139 SVIAKVQHKNLVRLLGCCIDKD-----EKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRV  212 (411)
Q Consensus       139 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~  212 (411)
                      .-|-++.|.|||+++.++.+..     ...++.||+..|++..+|++..+ ...+......+|+.||..||.|||+.. +
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            3455567999999998876543     56899999999999999975322 234566667799999999999999975 6


Q ss_pred             CeeecCCCCCCEEEcCCCCeEEeecCCc--cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh
Q 040952          213 RIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  290 (411)
Q Consensus       213 ~ivH~dlkp~Nill~~~~~~kl~Dfgl~--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  290 (411)
                      +|+|+++..+.|++..+|-+|++--.-.  ...-............+.++|.+||.-..-..+..+|||+||+...||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            7999999999999999999988632211  11111111122233456789999997666667789999999999999988


Q ss_pred             CCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          291 GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       291 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      |..-..........       .....+....+...+            -..++.+|++..|..||+|++++..
T Consensus       278 lEiq~tnseS~~~~-------ee~ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  278 LEIQSTNSESKVEV-------EENIANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             heeccCCCcceeeh-------hhhhhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence            76432111100000       000011111111111            1357889999999999999988754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1.8e-14  Score=138.63  Aligned_cols=250  Identities=22%  Similarity=0.251  Sum_probs=178.8

Q ss_pred             hcCCCccCcccc--cCcccEEEEEe--c-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGE--GGFGPVYKGVL--K-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~--G~~g~Vy~~~~--~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      ...|.+.+.+|.  |.+|.||.+..  . ++..+|+|.-+..  ....-..-.+|+...+.+ .|+|.++....+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345677788999  99999999986  2 4788999974332  222222234566666666 59999998888888999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEee
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ----GLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISD  236 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~D  236 (411)
                      .++-+|++. .+|..+.+...  ..++....+..+.+..+    |+.++|+.+   ++|-|+||.||+...+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            999999986 67777765433  33666777888888888    999999988   9999999999999999 8899999


Q ss_pred             cCCccccCCCCccccc---ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          237 FGMARICGGNELQANT---SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       237 fgl~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      ||+...+.........   .+..|...|++||.. ++.++..+|+|++|.++.+-.+|...........           
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----------  334 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----------  334 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------
Confidence            9999888765533322   223677889999954 5668999999999999999999876532110000           


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                          +.+.-...++.++.. ..+..+...+..+++.+|-.|++.+.+..
T Consensus       335 ----W~~~r~~~ip~e~~~-~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 ----WSQLRQGYIPLEFCE-GGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ----ccccccccCchhhhc-CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                001000011111110 11345556899999999999999887764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=2.6e-13  Score=115.60  Aligned_cols=131  Identities=22%  Similarity=0.180  Sum_probs=97.7

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccce-eeeeeecCCceEEEEeeCCCCCc
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR-LLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      .+.|+.|.++.||++... |+.+++|....... ....+..|+.+++.+.+.++++ ++.+.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            357899999999999876 78899999865432 1234578999999986655543 44433  3346899999999887


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ....        .   ....++.+++++++.||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430        0   11245678999999999886  23369999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=1.6e-13  Score=135.35  Aligned_cols=144  Identities=18%  Similarity=0.181  Sum_probs=93.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcc----------------------------------cHHH-
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ----------------------------------GLRE-  133 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~~-  133 (411)
                      ...|+. +.||.|++|.||+|++++ |+.||||+..+.-..                                  ..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999987 999999998743110                                  0111 


Q ss_pred             -----HHHHHHHHHhcC----Ccccceeeeeeec-CCceEEEEeeCCCCCchhhh--cCCC-CCcCCCHHHHHHHHHHHH
Q 040952          134 -----MKNEASVIAKVQ----HKNLVRLLGCCID-KDEKILIYEYMPNKSLDFFL--FDPT-KRMLLDWVTRVQIIEGIA  200 (411)
Q Consensus       134 -----~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~~~~~~~~~i~~~i~  200 (411)
                           +.+|+..+.+++    +.+.+.+-.++++ ....++||||++|+.+.++-  .... ....+.......++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence                 233444444432    3444444444443 45678999999999997642  1111 1111222222223333  


Q ss_pred             HHHHHHhhcCCCCeeecCCCCCCEEEcCCC----CeEEeecCCccccC
Q 040952          201 QGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDFGMARICG  244 (411)
Q Consensus       201 ~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfgl~~~~~  244 (411)
                           +...|   ++|+|+||.||+++.++    .+++.|||++..+.
T Consensus       276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 33455   99999999999999888    99999999987654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=5.9e-12  Score=122.77  Aligned_cols=167  Identities=15%  Similarity=0.201  Sum_probs=126.2

Q ss_pred             ecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHH
Q 040952          112 LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVT  191 (411)
Q Consensus       112 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  191 (411)
                      ..++.+|.|...+..+........+-++.|+.++||||+++++.++.++..|+|+|-+.  .|..++.+..      ...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHH
Confidence            33588899998887665445567888999999999999999999999999999999864  4555553322      344


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCC
Q 040952          192 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI  271 (411)
Q Consensus       192 ~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  271 (411)
                      ....++||+.||.|||..+  +++|++|.-+.|+|+..|..||++|.++..........  ....--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc
Confidence            5567889999999998655  49999999999999999999999999876544322111  1111223466777544332


Q ss_pred             CCcchhhHHHHHHHHHHHhCC
Q 040952          272 FSIKSDVFSFGVLLLEIVSGK  292 (411)
Q Consensus       272 ~~~~~DvwslG~il~elltg~  292 (411)
                        -..|.|-|||+++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3569999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=4.1e-11  Score=103.11  Aligned_cols=135  Identities=14%  Similarity=0.118  Sum_probs=96.5

Q ss_pred             CcccccCcccEEEEEecC-------CCEEEEEEccCCC------------c----------ccHHHHH----HHHHHHHh
Q 040952           97 NKLGEGGFGPVYKGVLKK-------GDEIAVKRLSGRS------------G----------QGLREMK----NEASVIAK  143 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~------------~----------~~~~~~~----~e~~~l~~  143 (411)
                      ..||.|.-+.||.|...+       +..+|||+.....            .          .....+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       4799999764210            0          0112233    79999999


Q ss_pred             cCC--cccceeeeeeecCCceEEEEeeCCCCCchh-hhcCCCCCcCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecCC
Q 040952          144 VQH--KNLVRLLGCCIDKDEKILIYEYMPNKSLDF-FLFDPTKRMLLDWVTRVQIIEGIAQGLLYL-HQYSRVRIIHRDL  219 (411)
Q Consensus       144 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl  219 (411)
                      +..  -++...+++    ...++||||+.++.+.. .+.+    ..++......+..+++.+|..| |..+   ++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            853  455566654    56789999998754422 2211    1234445567788999999999 7777   999999


Q ss_pred             CCCCEEEcCCCCeEEeecCCcccc
Q 040952          220 KASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       220 kp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ++.||+++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 578999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=3.3e-11  Score=107.18  Aligned_cols=142  Identities=18%  Similarity=0.255  Sum_probs=108.5

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCC--cccceeeeeeecCC---ceEEEEeeCC
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQH--KNLVRLLGCCIDKD---EKILIYEYMP  170 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  170 (411)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|+.++..+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887678999999765432 134567899999999976  34566777766542   5689999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS----------------------------------------  210 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  210 (411)
                      |.++...+..    ..++......++.++++++..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765521    23566667778888888888888521                                        


Q ss_pred             -------------CCCeeecCCCCCCEEEcC--CCCeEEeecCCccc
Q 040952          211 -------------RVRIIHRDLKASNILLDK--DMNPKISDFGMARI  242 (411)
Q Consensus       211 -------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfgl~~~  242 (411)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  56689999997653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=3.1e-11  Score=100.39  Aligned_cols=131  Identities=23%  Similarity=0.326  Sum_probs=101.6

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEc-cCCC--c-----ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRL-SGRS--G-----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~~~--~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..+++|+-+.+|.+.+. |.++++|.= ++.-  +     -...+..+|++++.+++--.|.-..-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 555677643 3221  1     1123467899999999776666666666778888999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++..++ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888443          2467778888899999998   99999999999997665 99999999865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=5.3e-12  Score=121.86  Aligned_cols=245  Identities=18%  Similarity=0.177  Sum_probs=170.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec--CCCEEEEEEccCCCcccHHH--HHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRSGQGLRE--MKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..+|..+..||.|.|+.|+....+  ++..|++|.+.........+  -..|+.+...+ .|.+++.....+..-...|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            456888899999999999998744  47889999887553322222  23455555555 58888887777777777789


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCCcccc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARIC  243 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl~~~~  243 (411)
                      -.|||+++++....   .....++...++.+..|++.++.++|+..   ++|+|++|+||++..+ +..+++|||....+
T Consensus       344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence            99999999886655   22234677778899999999999999888   9999999999999876 88899999987642


Q ss_pred             CCCCccccccccccccccc--ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          244 GGNELQANTSRIVGTYGYM--SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...     ........++.  +|.......+..+.|++|||..+.+.++|..-.. .                ...+..+
T Consensus       418 ~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~----------------~~~~~~i  475 (524)
T KOG0601|consen  418 AFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-S----------------GVQSLTI  475 (524)
T ss_pred             cee-----cccccccccccccchhhccccccccccccccccccccccccCcccCc-c----------------cccceee
Confidence            211     11112233344  4555556678899999999999999999875311 0                0001111


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      .......   .......+..+...+..+++..||.+.++....+
T Consensus       476 ~~~~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  476 RSGDTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ecccccC---CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            1111111   1111356777888899999999999988765543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=5.8e-11  Score=98.29  Aligned_cols=144  Identities=25%  Similarity=0.344  Sum_probs=107.1

Q ss_pred             ccCcccccCcccEEEEEecCCCEEEEEE-ccCCC-------cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           95 DANKLGEGGFGPVYKGVLKKGDEIAVKR-LSGRS-------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ....+-+|+-+.|+++.+. |+...||. +.+.-       .-...+...|++.|.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567889999999999987 88877774 33321       112345778999999987666666666677777788999


Q ss_pred             eeCCC-CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC---eEEeecCCccc
Q 040952          167 EYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARI  242 (411)
Q Consensus       167 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfgl~~~  242 (411)
                      ||++| .++.+++.........+ .....++..|-+.+.-||.++   |+|+||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46667765433322222 233678889999999999998   999999999999976543   58999999865


Q ss_pred             c
Q 040952          243 C  243 (411)
Q Consensus       243 ~  243 (411)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.25  E-value=1.9e-12  Score=131.37  Aligned_cols=251  Identities=18%  Similarity=0.196  Sum_probs=170.1

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ...+.+.+.+.+-+|.++.++.+.-. .|...+.|.....   .....+....+-.++-.-++|.++.....+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34567788888999999999987633 2433344433221   1112222233333333345677776666666677889


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ++++|+.+++|...|+....   .+..........+.++.++||...   +.|+|++|.|.+...++..++.|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999988876542   344444556667889999999876   899999999999999999999999843321


Q ss_pred             CCC-------------------------Ccc----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 040952          244 GGN-------------------------ELQ----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  294 (411)
Q Consensus       244 ~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  294 (411)
                      +..                         ...    .......||+.|.+||...+......+|.|++|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                         000    011234689999999999999999999999999999999999999


Q ss_pred             CCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHH
Q 040952          295 TGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMN  358 (411)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  358 (411)
                      |........         +     ..++.........+........+++...+..+|.+|..+.
T Consensus      1035 ~na~tpq~~---------f-----~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI---------F-----ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhh---------h-----hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            764332110         0     1111111111122334456788899999999999998877

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.17  E-value=1.4e-09  Score=103.30  Aligned_cols=169  Identities=21%  Similarity=0.344  Sum_probs=127.1

Q ss_pred             cccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec----CCceEEEEeeCCCC-Cchhh
Q 040952          104 FGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIYEYMPNK-SLDFF  177 (411)
Q Consensus       104 ~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g-~L~~~  177 (411)
                      ..+.|++..+ +|..|++|+++............-++.++++.|+|+|++.+++..    +...++||+|+++. +|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999854 699999999965544433334556889999999999999998873    44678999998864 55444


Q ss_pred             hcCC------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          178 LFDP------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       178 l~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      -...            ..+...++...|.++.|+..||.++|+.|   +.-+-|.|.+|+++++.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            3221            12234677889999999999999999999   88899999999999999999998888765542


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  294 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  294 (411)
                      ..              .+|  +.+   -.+-|.=.||.+++.|.||...
T Consensus       446 d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP--------------TEP--LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            22              011  111   2356889999999999999654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=2.8e-09  Score=98.97  Aligned_cols=272  Identities=15%  Similarity=0.102  Sum_probs=168.5

Q ss_pred             ccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeee----e--ecCCc-eEEEE
Q 040952           95 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGC----C--IDKDE-KILIY  166 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~----~--~~~~~-~~lv~  166 (411)
                      ..+.||+|+-+.+|-.-.- + ..+.|++...........   +..|... .||-+-.-+.|    .  -+.+. .-++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-h-chhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            3577999999999964211 1 235577765544332222   2223333 56644331221    1  11222 45778


Q ss_pred             eeCCCCC-chhhhcC---CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          167 EYMPNKS-LDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       167 e~~~~g~-L~~~l~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      +.+.+.- ...++.-   ...-...+|.-.++.++.++.+.+.||..|   .+-+|+.++|+|+++++.+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            8777653 2223222   122245788899999999999999999999   89999999999999999999998665443


Q ss_pred             cCCCCcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcccc--cchhHHHHHHhh
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDS--LNLLGYAWDLWT  314 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~--~~~~~~~~~~~~  314 (411)
                      ..+   .......+|...|.+||...     +..-+..+|.|.||+++++++.| ++||......+  ..-.+  . .+.
T Consensus       167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~-~Ia  240 (637)
T COG4248         167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--T-DIA  240 (637)
T ss_pred             ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--h-hhh
Confidence            321   12234467899999999765     23346779999999999999997 88986432111  11000  0 011


Q ss_pred             cCcccccccccc-----ccccchHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHHhhcccccCCCCCCcee
Q 040952          315 SNRTLELIDPIL-----EDEYSSKHMLLRYVNIALLCVQE--SADDRPTMNDVVSMLTNEAAALLPPKQPAFS  380 (411)
Q Consensus       315 ~~~~~~~~~~~l-----~~~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~  380 (411)
                      .+......+...     ....+-.-.+..+..+..+|+..  ++.-|||++-.+..|..+..++.+...+.-.
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H  313 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH  313 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence            111111111100     11222222356788899999964  3568999999999998888877776665544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.09  E-value=2.4e-09  Score=97.37  Aligned_cols=134  Identities=19%  Similarity=0.135  Sum_probs=96.0

Q ss_pred             cccEEEEEecCCCEEEEEEccCCCcc-----------cHHHHHHHHHHHHhcCCcc--cceeeeeeec-----CCceEEE
Q 040952          104 FGPVYKGVLKKGDEIAVKRLSGRSGQ-----------GLREMKNEASVIAKVQHKN--LVRLLGCCID-----KDEKILI  165 (411)
Q Consensus       104 ~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv  165 (411)
                      ...|++.... |+.+.||........           ....+.+|...+.++...+  ....+++...     ....++|
T Consensus        35 ~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            3446676664 788999977543211           1113678999998885333  3444555543     2346899


Q ss_pred             EeeCCCC-CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-------CCCeEEeec
Q 040952          166 YEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-------DMNPKISDF  237 (411)
Q Consensus       166 ~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~kl~Df  237 (411)
                      +|++++. +|.+++.+... ...+......++.+++..+.-||..|   |+|+|++++|||++.       ++.+.|+||
T Consensus       114 te~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        114 TEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            9999986 78888743221 23455666789999999999999999   999999999999975       468999999


Q ss_pred             CCccc
Q 040952          238 GMARI  242 (411)
Q Consensus       238 gl~~~  242 (411)
                      +.+..
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=2.7e-09  Score=91.49  Aligned_cols=125  Identities=24%  Similarity=0.295  Sum_probs=81.6

Q ss_pred             cEEEEEecCCCEEEEEEccCCC--------------c-------c-----cHHHHHHHHHHHHhcCCc--ccceeeeeee
Q 040952          106 PVYKGVLKKGDEIAVKRLSGRS--------------G-------Q-----GLREMKNEASVIAKVQHK--NLVRLLGCCI  157 (411)
Q Consensus       106 ~Vy~~~~~~g~~vavK~~~~~~--------------~-------~-----~~~~~~~e~~~l~~l~h~--niv~l~~~~~  157 (411)
                      .||.|...+|..+|||+.....              .       .     ......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999864320              0       0     123466899999999765  455665442 


Q ss_pred             cCCceEEEEeeCC--CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          158 DKDEKILIYEYMP--NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       158 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                         ..++||||++  |..+..+....     ++......++.+++..+.. +|..|   |+|+||++.||+++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4579999999  66665543221     1122345677778875555 56777   9999999999999887 9999


Q ss_pred             eecCCcccc
Q 040952          235 SDFGMARIC  243 (411)
Q Consensus       235 ~Dfgl~~~~  243 (411)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999987553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=1.7e-08  Score=89.23  Aligned_cols=135  Identities=21%  Similarity=0.235  Sum_probs=97.5

Q ss_pred             CCccCcccccCcccEEEEEecCCCEEEEEEccCC-----------------Cc-----ccHHHHHHHHHHHHhcCCc--c
Q 040952           93 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR-----------------SG-----QGLREMKNEASVIAKVQHK--N  148 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-----------------~~-----~~~~~~~~e~~~l~~l~h~--n  148 (411)
                      ..+..+||-|.-+.||.|....|.++|||.=...                 ..     .......+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4566889999999999999999999999953211                 00     0123467899999998655  6


Q ss_pred             cceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 040952          149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  228 (411)
Q Consensus       149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~  228 (411)
                      +.+.+++    +...+||||++|-.|...-        ++....-.++..|++-+.-+-..|   ++|+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6666654    5678999999997764432        112223345555665555555666   999999999999999


Q ss_pred             CCCeEEeecCCccc
Q 040952          229 DMNPKISDFGMARI  242 (411)
Q Consensus       229 ~~~~kl~Dfgl~~~  242 (411)
                      +|.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976543

>PRK09902 hypothetical protein; Provisional

Probab=98.82  E-value=1.3e-07  Score=81.77  Aligned_cols=139  Identities=16%  Similarity=0.141  Sum_probs=102.1

Q ss_pred             ccccCcccEEEEEecCCCEEEEEEccCC------CcccHHHHHHHHHHHHhcCCc--ccceeeeeeecCC----ceEEEE
Q 040952           99 LGEGGFGPVYKGVLKKGDEIAVKRLSGR------SGQGLREMKNEASVIAKVQHK--NLVRLLGCCIDKD----EKILIY  166 (411)
Q Consensus        99 lg~G~~g~Vy~~~~~~g~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~  166 (411)
                      -|+||.+.|+.-... |+.+-+|+-...      .+.....|.+|+..+.++...  .+.+...+.....    ..++|+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            377899999998776 667999976522      133567899999999998533  2444442222211    357999


Q ss_pred             eeCCC-CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC--eEEeecCCccc
Q 040952          167 EYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFGMARI  242 (411)
Q Consensus       167 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfgl~~~  242 (411)
                      |-+++ .+|.+++.+... ...+...+..+..++++.+.-||..|   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 478888754322 23566677899999999999999998   999999999999986667  99999986654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=4.7e-08  Score=85.89  Aligned_cols=106  Identities=25%  Similarity=0.281  Sum_probs=82.2

Q ss_pred             HHHHHHHHHHHHhcCCc--ccceeeeeeecCC----ceEEEEeeCCCC-CchhhhcCCCCCcCCCHHHHHHHHHHHHHHH
Q 040952          131 LREMKNEASVIAKVQHK--NLVRLLGCCIDKD----EKILIYEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL  203 (411)
Q Consensus       131 ~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l  203 (411)
                      .....+|...+..+..-  ...+.+++.....    ..++|+|++++. +|.+++.....   .+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            34577888888887533  3455666655532    348999999985 78888854322   45556778999999999


Q ss_pred             HHHhhcCCCCeeecCCCCCCEEEcCCC---CeEEeecCCccc
Q 040952          204 LYLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMARI  242 (411)
Q Consensus       204 ~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfgl~~~  242 (411)
                      +-||..|   |+|+|+++.|||++.++   .+.++||+.++.
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999   99999999999999887   899999997765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.75  E-value=2.2e-09  Score=105.48  Aligned_cols=151  Identities=21%  Similarity=0.342  Sum_probs=100.7

Q ss_pred             HHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc------c-cccccccccccChhhhccC
Q 040952          198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA------N-TSRIVGTYGYMSPEYALEG  270 (411)
Q Consensus       198 ~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~  270 (411)
                      +++.|+.|+|...  ++||++|.|++|.++.++..||+.|+.+..........      . .....-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4558999999865  69999999999999999999999999875543311110      0 0011235679999999998


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCC-CCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHcccc
Q 040952          271 IFSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQE  349 (411)
Q Consensus       271 ~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~  349 (411)
                      ..+.++|+||+||++|.+..|..+ +.......    .+...       ....+...  .....+.+.++.+=+.+++..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~~-------~~~~~~~~--~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSFS-------RNLLNAGA--FGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcc----hhhhh-------hccccccc--ccccccCcHHHHHHHHHHhcC
Confidence            889999999999999999965544 22111000    00000       00000000  011123366788889999999


Q ss_pred             CCCCCCCHHHHHHH
Q 040952          350 SADDRPTMNDVVSM  363 (411)
Q Consensus       350 ~p~~RPt~~evl~~  363 (411)
                      ++..||++.++...
T Consensus       252 ~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  252 DSAVRPTLDLLLSI  265 (700)
T ss_pred             CcccCcchhhhhcc
Confidence            99999988776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.67  E-value=5e-07  Score=80.42  Aligned_cols=138  Identities=18%  Similarity=0.192  Sum_probs=85.2

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc--cceeeeeeecCCceEEEEeeCCCCC-
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKS-  173 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  173 (411)
                      .+||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   25568889887533  3355788999999986433  4667777777777889999999963 


Q ss_pred             chhhh---------------------cCCCCCcCCCHHHH-HHHHHHH----------H-HHHHHHhhc-CCCCeeecCC
Q 040952          174 LDFFL---------------------FDPTKRMLLDWVTR-VQIIEGI----------A-QGLLYLHQY-SRVRIIHRDL  219 (411)
Q Consensus       174 L~~~l---------------------~~~~~~~~~~~~~~-~~i~~~i----------~-~~l~~LH~~-~~~~ivH~dl  219 (411)
                      +...+                     +..... ....... ..+..++          . ....+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            21111                     110000 0010000 0000000          0 012222211 1234799999


Q ss_pred             CCCCEEEcCCCCeEEeecCCcc
Q 040952          220 KASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       220 kp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.62  E-value=6.3e-07  Score=77.75  Aligned_cols=137  Identities=16%  Similarity=0.149  Sum_probs=90.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHH---------HHHHHHHHhcCC---cccceeeeee
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM---------KNEASVIAKVQH---KNLVRLLGCC  156 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~l~~~~  156 (411)
                      ..++|...+.+-......|.+-..+ |+.+++|.........++.|         .+.+..+.+++.   .....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            3567888888888777777766665 78999998876543222222         223333333322   2233323222


Q ss_pred             e-----cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC
Q 040952          157 I-----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  231 (411)
Q Consensus       157 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  231 (411)
                      .     .....+++|||++|..|.++..       ++.    .+...+.+++.-||..|   +.|+|..|.|+++++++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     2335578999999988866531       222    24456778899999999   99999999999998554 


Q ss_pred             eEEeecCCcc
Q 040952          232 PKISDFGMAR  241 (411)
Q Consensus       232 ~kl~Dfgl~~  241 (411)
                      +++.||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=2.9e-07  Score=90.73  Aligned_cols=140  Identities=19%  Similarity=0.256  Sum_probs=91.7

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCccc------------------------------HH----------HHHH
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG------------------------------LR----------EMKN  136 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------------~~----------~~~~  136 (411)
                      +.|+.++-|.||+|++++|+.||||+..+.-...                              .+          ++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999999999999875431100                              01          1223


Q ss_pred             HHHHHHhc----CCcccceeeeeeec-CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHH-HHHHhhcC
Q 040952          137 EASVIAKV----QHKNLVRLLGCCID-KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG-LLYLHQYS  210 (411)
Q Consensus       137 e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~  210 (411)
                      |+..+.++    ++..-+.+-.+|++ .+...++|||++|-.+.+...-...  ..+.   ..++..++++ +..+-..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~---k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDR---KELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCH---HHHHHHHHHHHHHHHHhcC
Confidence            44444444    22233344444543 5677899999999999887422111  1332   2333333332 22222344


Q ss_pred             CCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       211 ~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                         +.|.|.+|.||+++.+|.+.+.|||+...+.
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence               9999999999999999999999999986654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.48  E-value=3.4e-06  Score=74.13  Aligned_cols=151  Identities=18%  Similarity=0.184  Sum_probs=96.3

Q ss_pred             cchhhhhHHhcCCCccCc---ccccCcccEEEEEecCCCEEEEEEccCCCccc-------------------H-----HH
Q 040952           81 FSFSSVSTATNKFSDANK---LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-------------------L-----RE  133 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~---lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------~-----~~  133 (411)
                      .+...+....++..+...   |..|.-+.||+|...++..+|||++.......                   .     .-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            334444444555555444   55677778999998889999999986432110                   0     11


Q ss_pred             HHHHHHHHHhcC--CcccceeeeeeecCCceEEEEeeCCCCCc-hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-c
Q 040952          134 MKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-Y  209 (411)
Q Consensus       134 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~  209 (411)
                      ..+|+..|.++.  +-.+.+.+++.    .-.+||||+..... .-.|.+.    .+.......+..++++.+.-|-. .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc
Confidence            235666666663  33344444443    34699999865421 1122111    12222456677888888888876 4


Q ss_pred             CCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       210 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +   +||+||+.=|||+. ++.+.++|||-+...
T Consensus       187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             C---cccccchhhheEEE-CCeEEEEECcccccc
Confidence            4   99999999999999 889999999987554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.47  E-value=1.5e-06  Score=77.68  Aligned_cols=142  Identities=23%  Similarity=0.243  Sum_probs=83.2

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc--ccceeeeeeec---CCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLGCCID---KDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~  171 (411)
                      +.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+...  .+.+++.+...   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568999999999999886 69999997654  3456678888888888533  34556654322   3346899999999


Q ss_pred             CCchh----------------hh---cCC-CCCcCCCHHH---------HHHH------------HHHHHH-HHHHHhh-
Q 040952          172 KSLDF----------------FL---FDP-TKRMLLDWVT---------RVQI------------IEGIAQ-GLLYLHQ-  208 (411)
Q Consensus       172 g~L~~----------------~l---~~~-~~~~~~~~~~---------~~~i------------~~~i~~-~l~~LH~-  208 (411)
                      ..+..                .+   +.. ..........         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   111 0000011100         0000            111222 2333332 


Q ss_pred             ---cCCCCeeecCCCCCCEEEc-CCCCeEEeecCCcc
Q 040952          209 ---YSRVRIIHRDLKASNILLD-KDMNPKISDFGMAR  241 (411)
Q Consensus       209 ---~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfgl~~  241 (411)
                         .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1344599999999999999 56666899998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=3.1e-06  Score=76.49  Aligned_cols=140  Identities=16%  Similarity=0.137  Sum_probs=84.9

Q ss_pred             cccccCc-ccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEeeCCCCCch
Q 040952           98 KLGEGGF-GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLD  175 (411)
Q Consensus        98 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  175 (411)
                      .|..|.. ..||+.... +..+.||+.....   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3455555 678998765 5788899886543   335678888888883 444556777776666789999999998776


Q ss_pred             hhh-------------------cCCCC-CcCCCHH--HHHHHHH--------------------HHHHHHHHHhh----c
Q 040952          176 FFL-------------------FDPTK-RMLLDWV--TRVQIIE--------------------GIAQGLLYLHQ----Y  209 (411)
Q Consensus       176 ~~l-------------------~~~~~-~~~~~~~--~~~~i~~--------------------~i~~~l~~LH~----~  209 (411)
                      ...                   +.... ..+....  .......                    .+......|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11100 0011100  0000000                    01111222211    1


Q ss_pred             CCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       210 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ..+.++|+|+.|.|||++++....|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23459999999999999998778899998663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.44  E-value=1.3e-05  Score=69.12  Aligned_cols=104  Identities=20%  Similarity=0.232  Sum_probs=81.7

Q ss_pred             HHHHHHHHhcCC-cccceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 040952          135 KNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR  213 (411)
Q Consensus       135 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  213 (411)
                      ..|.-+++.+++ +++.+++|+|    ..+++.||...+++...-..-..-...+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457788888876 6999999999    44789999988766422100011122689999999999999999999865555


Q ss_pred             eeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          214 IIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       214 ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      +...|++++|+-+++++++|+.|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            99999999999999999999999987644

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.43  E-value=4.9e-08  Score=95.28  Aligned_cols=188  Identities=18%  Similarity=0.110  Sum_probs=135.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc-cceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  167 (411)
                      .+.-+...+-+++|+++++++.+....+...++.+...     ....-++++|.+++||| .+..++-+..+...+++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            34445556678999999999988654455556655543     34456889999999999 7777777777888899999


Q ss_pred             eCCCC--CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          168 YMPNK--SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       168 ~~~~g--~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ++..+  +.....   .....+.......+.+.-+++++++|+..   =+|+|    ||+..+ +..+.+||+....+..
T Consensus       315 i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  315 ICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence            99887  222111   11111333334455666678899999864   48998    776654 7889999998876653


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT  295 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~  295 (411)
                      ..   ......+++.++|||+..++.+..+.|+|++|+--.++--|-+|-
T Consensus       384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            32   234457899999999999999999999999998877777777664

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=4.5e-06  Score=82.20  Aligned_cols=141  Identities=17%  Similarity=0.239  Sum_probs=89.3

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCccc---------------------------HH----------HHHHHH
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG---------------------------LR----------EMKNEA  138 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---------------------------~~----------~~~~e~  138 (411)
                      .+.||..+.|.||+|++++|+.||||+-++.-...                           .+          +|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36899999999999999999999999865431100                           00          123344


Q ss_pred             HHHHhc----CCcc---cceeeeeeec-CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHH-Hhhc
Q 040952          139 SVIAKV----QHKN---LVRLLGCCID-KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY-LHQY  209 (411)
Q Consensus       139 ~~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~  209 (411)
                      +-..++    +|-+   -|.+-.++++ .....|+|||++|..+.+...-..  ..++..   .++..+.++... +=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~---~i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPH---DILNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHH---HHHHHHHHHHHHHHHhc
Confidence            433333    3445   2334444544 346789999999998876632111  113333   333334333221 1223


Q ss_pred             CCCCeeecCCCCCCEEEcC----CCCeEEeecCCccccC
Q 040952          210 SRVRIIHRDLKASNILLDK----DMNPKISDFGMARICG  244 (411)
Q Consensus       210 ~~~~ivH~dlkp~Nill~~----~~~~kl~Dfgl~~~~~  244 (411)
                      |   ++|+|-+|.||+++.    ++.+.+.|||+.....
T Consensus       321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            4   999999999999983    6789999999976553

>PLN02876 acyl-CoA dehydrogenase

Probab=98.31  E-value=1.5e-05  Score=84.54  Aligned_cols=79  Identities=16%  Similarity=0.360  Sum_probs=58.1

Q ss_pred             cCcccccCcccEEEEEecCC---CEEEEEEccCCC-cccHHHHHHHHHHHHhcC-Cccc--ceeeeeeecC---CceEEE
Q 040952           96 ANKLGEGGFGPVYKGVLKKG---DEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNL--VRLLGCCIDK---DEKILI  165 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  165 (411)
                      .+.++.|.+..+|+....++   ..+++|+.+... ......+.+|+++++.+. |.++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876653   467888765432 123356789999999995 6664  6777777664   467899


Q ss_pred             EeeCCCCCc
Q 040952          166 YEYMPNKSL  174 (411)
Q Consensus       166 ~e~~~~g~L  174 (411)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=5.7e-06  Score=68.78  Aligned_cols=130  Identities=20%  Similarity=0.255  Sum_probs=90.8

Q ss_pred             CCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccccee-eeeeecCCceEEEEeeCCC
Q 040952           93 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL-LGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~~~~  171 (411)
                      ....+.||+|++|.||+|.+. |..+|+|.-...  .....+..|+++|..++-.++.+= +.+..    -++.|||+.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence            345678999999999999998 668999987643  334678999999999987777553 33322    2455999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC-CCCEEEcCCCCeEEeecCCccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK-ASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk-p~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      -.|.++-...      +    .+-...+++.-.-|-..|   |-|+.|+ |...++.+++.+.|+||..|+.
T Consensus        97 ~~L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8886664211      1    122334555544555556   9999987 5555555556999999998864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.24  E-value=1.5e-05  Score=71.51  Aligned_cols=73  Identities=14%  Similarity=0.249  Sum_probs=46.5

Q ss_pred             CcccccCcc-cEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc---ccceeeeeeecC---CceEEEEeeC
Q 040952           97 NKLGEGGFG-PVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCIDK---DEKILIYEYM  169 (411)
Q Consensus        97 ~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  169 (411)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|.+++..+...   -+.+.++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777776 48875    345778875542  2345788999999888532   233444433322   2348899999


Q ss_pred             CCCCch
Q 040952          170 PNKSLD  175 (411)
Q Consensus       170 ~~g~L~  175 (411)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            998774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.18  E-value=2.3e-05  Score=71.35  Aligned_cols=139  Identities=14%  Similarity=0.095  Sum_probs=79.5

Q ss_pred             cccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccc-eeeeeeecCCceEEEEeeCCCCCchh
Q 040952           98 KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMPNKSLDF  176 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~~  176 (411)
                      .+..|-.+.+|+... +|+.+++|..........-....|..+++.+....+. +++..+.    -++|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356688889998874 4778889876543322111347788899888644333 3343322    368999999877643


Q ss_pred             h-----------------hcCCCC-CcCCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCCeeecCCCCCC
Q 040952          177 F-----------------LFDPTK-RMLLDWVTR-VQIIEGI---------AQGLLYLHQY-----SRVRIIHRDLKASN  223 (411)
Q Consensus       177 ~-----------------l~~~~~-~~~~~~~~~-~~i~~~i---------~~~l~~LH~~-----~~~~ivH~dlkp~N  223 (411)
                      .                 ++.... ..+++.... .....++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 111111 111221111 1111111         1112222111     12358999999999


Q ss_pred             EEEcCCCCeEEeecCCccc
Q 040952          224 ILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       224 ill~~~~~~kl~Dfgl~~~  242 (411)
                      |++++++ +.|+||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999997753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=98.14  E-value=6.6e-05  Score=69.81  Aligned_cols=78  Identities=13%  Similarity=0.121  Sum_probs=57.1

Q ss_pred             CccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC---cccceeeeeeec---CCceEEEEe
Q 040952           94 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH---KNLVRLLGCCID---KDEKILIYE  167 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e  167 (411)
                      ...+.||.|..+.||.....++ .+.+|..+...  ....+..|...|+.+.-   ..+.++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3356799999999999876655 46777754311  23578899999998843   367788887754   356899999


Q ss_pred             eCCCCCc
Q 040952          168 YMPNKSL  174 (411)
Q Consensus       168 ~~~~g~L  174 (411)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.10  E-value=5.7e-05  Score=67.76  Aligned_cols=74  Identities=19%  Similarity=0.293  Sum_probs=49.1

Q ss_pred             CcccccCcccEEEEEecC--CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccc-ceeeeeeecCCceEEEEeeCCCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPNKS  173 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  173 (411)
                      +.|..|-...+|+....+  ++.|++|+........ .....|+.++..+...++ .++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567788888999988664  6789999876543221 233578888888854343 34443332    247999999977


Q ss_pred             ch
Q 040952          174 LD  175 (411)
Q Consensus       174 L~  175 (411)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.05  E-value=9.9e-05  Score=63.94  Aligned_cols=128  Identities=17%  Similarity=0.249  Sum_probs=89.0

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCC----------------cccHHHHHHHHHHHHhcC------Ccccceee
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS----------------GQGLREMKNEASVIAKVQ------HKNLVRLL  153 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~  153 (411)
                      ...||+|+.-.||.  +.++...+||+.....                ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999999985  4445567888886554                123455667777666665      78899999


Q ss_pred             eeeecCCceEEEEeeCCC--C----CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          154 GCCIDKDEKILIYEYMPN--K----SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                      |+.+.+...-+|+|.+.+  |    +|.+++.+    ..++.    .+...+-+-..||-.++   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~----~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE----ELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH----HHHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998643  2    45666632    22443    23333445566777777   99999999999996


Q ss_pred             CC--C--CeEEee
Q 040952          228 KD--M--NPKISD  236 (411)
Q Consensus       228 ~~--~--~~kl~D  236 (411)
                      .+  +  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            43  2  466665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.03  E-value=6e-05  Score=64.82  Aligned_cols=125  Identities=22%  Similarity=0.362  Sum_probs=89.1

Q ss_pred             cCCCccCcccccCc-ccEEEEEecCCCEEEEEEccC---CCc------------------ccHHHHHHHHHHHHhcC---
Q 040952           91 NKFSDANKLGEGGF-GPVYKGVLKKGDEIAVKRLSG---RSG------------------QGLREMKNEASVIAKVQ---  145 (411)
Q Consensus        91 ~~y~~~~~lg~G~~-g~Vy~~~~~~g~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~---  145 (411)
                      ..++.++.||.|.- |.||++++. |+.+|+|.+..   ...                  ....-|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            77888999999999 999999998 88999999321   100                  11234777888887774   


Q ss_pred             Cccc--ceeeeeeecCC------------------ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHH
Q 040952          146 HKNL--VRLLGCCIDKD------------------EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY  205 (411)
Q Consensus       146 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~  205 (411)
                      +.++  |+++||..-..                  ...+|.||.+...            .+    ..+-+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence            4455  88998874221                  1246777665432            01    12345677788889


Q ss_pred             HhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       206 LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      +|..|   |+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999986     4589999854

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.97  E-value=3.3e-05  Score=80.89  Aligned_cols=199  Identities=19%  Similarity=0.194  Sum_probs=137.5

Q ss_pred             HHHHHHHHHHHhcCCcccceeeeeeecCCceE----EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh
Q 040952          132 REMKNEASVIAKVQHKNLVRLLGCCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH  207 (411)
Q Consensus       132 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH  207 (411)
                      .....|...+....|+|++.++.+.......-    +..+++..-++...+...   ..++......+..++.+|+.|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHH
Confidence            34456778888889999999999877654332    345677777777666433   34777788889999999999999


Q ss_pred             hcCCCCeeecCCCCC---CEEEcCCCCeEEe--ecCCccccCCCCcccccccccccccccChhhhccCCCCcc--hhhHH
Q 040952          208 QYSRVRIIHRDLKAS---NILLDKDMNPKIS--DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK--SDVFS  280 (411)
Q Consensus       208 ~~~~~~ivH~dlkp~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Dvws  280 (411)
                      +..   ..|.-+..+   +.-.+..+....+  ||+.+...........   ...+..+.+||......++.+  .|+|.
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHH
Confidence            985   666666555   5555667777777  9998877654332211   233556788887776655444  79999


Q ss_pred             HHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 040952          281 FGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV  360 (411)
Q Consensus       281 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  360 (411)
                      +|..+..+..|..+-...                     ......+....     ...+.+...+|+..++++|+++.++
T Consensus       378 lgll~~~~~~~~~i~~~~---------------------~~~~~~l~~~~-----~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKS---------------------AVPVSLLDVLS-----TSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHhhhhhcCcccccc---------------------cchhhhhcccc-----chhhhhhhhhhcchhhhhccchhhh
Confidence            999999999987652211                     11111111111     1146778899999999999999999


Q ss_pred             HHHHh
Q 040952          361 VSMLT  365 (411)
Q Consensus       361 l~~L~  365 (411)
                      +...-
T Consensus       432 l~~~f  436 (1351)
T KOG1035|consen  432 LTHPF  436 (1351)
T ss_pred             hhchh
Confidence            97653

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.96  E-value=0.00014  Score=69.84  Aligned_cols=75  Identities=16%  Similarity=0.259  Sum_probs=53.8

Q ss_pred             CcccccCcccEEEEEecCC-CEEEEEEccCC------C-cccHHHHHHHHHHHHhcC---CcccceeeeeeecCCceEEE
Q 040952           97 NKLGEGGFGPVYKGVLKKG-DEIAVKRLSGR------S-GQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  165 (411)
                      +.||.|.+..||++...+| +.++||.-...      . +...++...|.+.|..+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998876 48999985421      1 224556777888888762   2356666665  44667899


Q ss_pred             EeeCCCCC
Q 040952          166 YEYMPNKS  173 (411)
Q Consensus       166 ~e~~~~g~  173 (411)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PRK05231 homoserine kinase; Provisional

Probab=97.94  E-value=0.00026  Score=66.63  Aligned_cols=142  Identities=15%  Similarity=0.169  Sum_probs=76.9

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc--cceeeee------eecCCceEEEEe
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGC------CIDKDEKILIYE  167 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  167 (411)
                      .+.|+.|....+|.....+| .+++|++....   .+.+..|+.++..+...+  +.+.+..      ....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35577787789999886645 68999876212   233444556665553211  3333321      122456789999


Q ss_pred             eCCCCCchh-----h---------hcCCCCC--------cCCCH-HHHHH------------HHHH-HHHHHHHHhhc--
Q 040952          168 YMPNKSLDF-----F---------LFDPTKR--------MLLDW-VTRVQ------------IIEG-IAQGLLYLHQY--  209 (411)
Q Consensus       168 ~~~~g~L~~-----~---------l~~~~~~--------~~~~~-~~~~~------------i~~~-i~~~l~~LH~~--  209 (411)
                      |++|..+..     .         ++.....        ..+.| .....            ...+ +...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421     1         1111100        01111 11111            1111 11122333211  


Q ss_pred             --CCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          210 --SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       210 --~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                        -+.++||+|+.|.||+++++...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23459999999999999976666899999764

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=0.00018  Score=66.97  Aligned_cols=142  Identities=15%  Similarity=0.140  Sum_probs=85.2

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc--cceeeee------eecCCceEEEEe
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGC------CIDKDEKILIYE  167 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  167 (411)
                      .+.+..|....+|+.... +..+++|+....   ....+..|+.++..+.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            456788888899998765 457899988652   2345667888888774332  4444332      122345689999


Q ss_pred             eCCCCCchhh--------------hcCCC--------CCcCCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 040952          168 YMPNKSLDFF--------------LFDPT--------KRMLLDWVTRV----------QIIEGIAQGLLYLHQ----YSR  211 (411)
Q Consensus       168 ~~~~g~L~~~--------------l~~~~--------~~~~~~~~~~~----------~i~~~i~~~l~~LH~----~~~  211 (411)
                      |++|..+...              ++...        ......|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9999876431              01100        00111221110          011123334445443    112


Q ss_pred             CCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          212 VRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       212 ~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ..++|+|+.|.||++++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            359999999999999998778999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.87  E-value=0.00028  Score=66.06  Aligned_cols=143  Identities=17%  Similarity=0.170  Sum_probs=82.3

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc--cceeeeee------ecCCceEEEEe
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCC------IDKDEKILIYE  167 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~e  167 (411)
                      .+.++.|....+|+...++| .+++|+.....  ....+..|..++..+....  +.+++...      ...+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677887789999876544 67889875432  1234556777777774222  33443321      12345689999


Q ss_pred             eCCCCCchhh--------------hcCCCCC------c---CCCHHHHH------------HHHHHHHHHHHHHhh----
Q 040952          168 YMPNKSLDFF--------------LFDPTKR------M---LLDWVTRV------------QIIEGIAQGLLYLHQ----  208 (411)
Q Consensus       168 ~~~~g~L~~~--------------l~~~~~~------~---~~~~~~~~------------~i~~~i~~~l~~LH~----  208 (411)
                      |++|..+...              ++.....      .   .-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654211              1110000      0   01111100            011123344555542    


Q ss_pred             cCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       209 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ....+++|+|+.+.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123469999999999999998877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.73  E-value=0.00029  Score=65.81  Aligned_cols=140  Identities=27%  Similarity=0.329  Sum_probs=82.3

Q ss_pred             CcccccCcccEEEEEecC-------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccc-ceeeeeeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKK-------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  168 (411)
                      +.|..|-...+|+....+       ++.+++|+...... ......+|..++..+....+ .++++++..    ..|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            445667677899887654       57899999765432 22345788888888854333 345554432    368999


Q ss_pred             CCCCCchhh-----------------hcCCCCCc------CCC--HHHHHH--------------------------HHH
Q 040952          169 MPNKSLDFF-----------------LFDPTKRM------LLD--WVTRVQ--------------------------IIE  197 (411)
Q Consensus       169 ~~~g~L~~~-----------------l~~~~~~~------~~~--~~~~~~--------------------------i~~  197 (411)
                      ++|..+...                 +|......      ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431                 11111100      011  100000                          111


Q ss_pred             HHHHHHHHHhh------cCCCCeeecCCCCCCEEEcCC----CCeEEeecCCcc
Q 040952          198 GIAQGLLYLHQ------YSRVRIIHRDLKASNILLDKD----MNPKISDFGMAR  241 (411)
Q Consensus       198 ~i~~~l~~LH~------~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfgl~~  241 (411)
                      .+...+.++-.      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      134569999999999999985    889999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.62  E-value=0.00014  Score=66.44  Aligned_cols=133  Identities=15%  Similarity=0.172  Sum_probs=93.5

Q ss_pred             CCCccCcccccCcccEEEEEecCCCEEEEEEccCC-----------------CcccH-----HHHHHHHHHHHhcC-Ccc
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR-----------------SGQGL-----REMKNEASVIAKVQ-HKN  148 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-----------------~~~~~-----~~~~~e~~~l~~l~-h~n  148 (411)
                      -+.+.++||-|.-+.+|.+-+..|++.++|.-...                 ....|     -...+|...|+.+. |-.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            46778999999999999999999999999843110                 01111     12456888888774 332


Q ss_pred             -cceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          149 -LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       149 -iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                       +.+.+++    +..++|||++.+-.|...-+-      .+   ...+...+..-+--|..+|   +||+|..--||+++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------ED---PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CC---hHHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence             3344443    467899999999888554311      11   1244555555666777777   99999999999999


Q ss_pred             CCCCeEEeecCCc
Q 040952          228 KDMNPKISDFGMA  240 (411)
Q Consensus       228 ~~~~~kl~Dfgl~  240 (411)
                      +++.++++||--.
T Consensus       237 dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  237 DDDKIVVIDFPQM  249 (465)
T ss_pred             cCCCEEEeechHh
Confidence            9999999999654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.61  E-value=0.0012  Score=61.20  Aligned_cols=136  Identities=18%  Similarity=0.255  Sum_probs=84.3

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccC--CCcccHHHHHHHHHHHHhcCC--cccceeeeeeecCC--ceEEEEeeCC
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSG--RSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKD--EKILIYEYMP  170 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~  170 (411)
                      +.+..|..-.+|..... ++++++. .+.  ..........+|+.+++.+.-  --+...+++|.++.  ..+.||+|++
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            34433444445655554 7888888 332  223345566788888887743  22344566666655  6799999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHH-HHHHHHHHHHhh-----------------------------------------
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQ-----------------------------------------  208 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~-~~i~~~l~~LH~-----------------------------------------  208 (411)
                      |......+....    ..    .+++ ..++..|+-||+                                         
T Consensus       109 Ge~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         109 GEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            865433321111    00    1122 244455555552                                         


Q ss_pred             ---------c-----CCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          209 ---------Y-----SRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       209 ---------~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                               +     +...++|+|+.+.|++++.++-+-+.||+++..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                     1     134589999999999999998899999999865

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.52  E-value=0.0014  Score=60.24  Aligned_cols=31  Identities=29%  Similarity=0.587  Sum_probs=25.5

Q ss_pred             CCeeecCCCCCCEEEcCCCC-eEEeecCCccc
Q 040952          212 VRIIHRDLKASNILLDKDMN-PKISDFGMARI  242 (411)
Q Consensus       212 ~~ivH~dlkp~Nill~~~~~-~kl~Dfgl~~~  242 (411)
                      ..++|+|++|.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 56999997754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.47  E-value=0.0016  Score=61.97  Aligned_cols=141  Identities=16%  Similarity=0.210  Sum_probs=82.3

Q ss_pred             CcccccCcccEEEEEecC-----CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccc-eeeeeeecCCceEEEEeeCC
Q 040952           97 NKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  170 (411)
                      +.|-.|-.-.+|+....+     ++.|++|+.........++ ..|..++..+..-++. ++++.+...    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345557778899987532     3689999887655443333 6788888888544443 455555332    5899998


Q ss_pred             CCCchhh-----------------hcCCC---CCcCCCHHHHHHHHHH-----------------HHHHHHHH----hh-
Q 040952          171 NKSLDFF-----------------LFDPT---KRMLLDWVTRVQIIEG-----------------IAQGLLYL----HQ-  208 (411)
Q Consensus       171 ~g~L~~~-----------------l~~~~---~~~~~~~~~~~~i~~~-----------------i~~~l~~L----H~-  208 (411)
                      +.++...                 +|...   ......+....++..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421                 11111   0111112222222211                 11112222    11 


Q ss_pred             cCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccc
Q 040952          209 YSRVRIIHRDLKASNILLDK-DMNPKISDFGMARI  242 (411)
Q Consensus       209 ~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~  242 (411)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22345899999999999986 47899999987753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.45  E-value=0.00099  Score=61.35  Aligned_cols=73  Identities=16%  Similarity=0.233  Sum_probs=47.5

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CcccceeeeeeecCCceEEEEeeCCCC
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      .+.++.|....+|+.. .+++.+.||.-..   .....|..|..-|+.|.   .-.+.+.+++....+..++++||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4568888889999877 5588999998773   22346778888888883   446778888888777889999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.39  E-value=0.0003  Score=45.23  Aligned_cols=43  Identities=53%  Similarity=0.742  Sum_probs=35.7

Q ss_pred             cccCCCCCCceeeecccccccCCCCCC--CCCCcceeEEeeeccC
Q 040952          369 AALLPPKQPAFSFVRNTVTSTSSTGKT--EDCSVNQVTISILEAR  411 (411)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  411 (411)
                      ..++.|+.|.|...+......++....  .++|.|++|+|++|||
T Consensus         4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            468999999999888877555555554  8999999999999998

; GO: 0004674 protein serine/threonine kinase activity

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.28  E-value=0.00012  Score=78.84  Aligned_cols=160  Identities=13%  Similarity=-0.014  Sum_probs=113.5

Q ss_pred             HHHHHHHHHhcCCcccceeeeeeec--CCceEEEEeeCCCCCchhhhcCCCCC-cCCCHHHHHHHHHHHHHHHHHHhhc-
Q 040952          134 MKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMPNKSLDFFLFDPTKR-MLLDWVTRVQIIEGIAQGLLYLHQY-  209 (411)
Q Consensus       134 ~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~-  209 (411)
                      ...|...++...|+++.....-...  ..+.+.+++|+.+|.+...+.....+ .+++...+.....+......-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445555566789888776655443  34568899999999998887654433 3444444433333334444444433 


Q ss_pred             -CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHH
Q 040952          210 -SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI  288 (411)
Q Consensus       210 -~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  288 (411)
                       +...-+|+++|+-|.+|..+..+|++++|+.+....  .........+++.|+.|++...-.++.++|+|+.|+-+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence             234579999999999999999999999999983221  12223445778899999998888899999999999999999


Q ss_pred             HhCCCCC
Q 040952          289 VSGKKNT  295 (411)
Q Consensus       289 ltg~~p~  295 (411)
                      -.|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            9888764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.28  E-value=0.0034  Score=58.61  Aligned_cols=139  Identities=17%  Similarity=0.197  Sum_probs=92.3

Q ss_pred             ccCcccccCcccEEEEEecCCCEEEEEEccCC-----Cc-----------------cc---HH-HHHHHHHHHHhcCCcc
Q 040952           95 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR-----SG-----------------QG---LR-EMKNEASVIAKVQHKN  148 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-----~~-----------------~~---~~-~~~~e~~~l~~l~h~n  148 (411)
                      +...|..|.-+.||.|.-.+|..+|||+++..     ..                 ..   ++ -...|++-|.+++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            44567888899999999989999999987421     00                 00   01 1346788888876554


Q ss_pred             cceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 040952          149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  228 (411)
Q Consensus       149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~  228 (411)
                      |.-.--. .- ....|||+|+....   |-.-..+...++...+..+-.|++.-+.-|.+.+  ++||.||+--|+|+ .
T Consensus       228 IP~PePI-lL-k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h  299 (520)
T KOG2270|consen  228 IPCPEPI-LL-KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H  299 (520)
T ss_pred             CCCCCce-ee-ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence            3221111 11 23479999986422   2111123334566666777788888888887665  59999999999998 5


Q ss_pred             CCCeEEeecCCcc
Q 040952          229 DMNPKISDFGMAR  241 (411)
Q Consensus       229 ~~~~kl~Dfgl~~  241 (411)
                      +|.+.++|.+-+.
T Consensus       300 dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  300 DGKLYIIDVSQSV  312 (520)
T ss_pred             CCEEEEEEccccc
Confidence            6789999988664

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.15  E-value=0.008  Score=57.77  Aligned_cols=73  Identities=12%  Similarity=0.136  Sum_probs=50.9

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCC----Cc---ccHHHHHHHHHHHHhcC---CcccceeeeeeecCCceEEE
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR----SG---QGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  165 (411)
                      .+.||.|....||+.... ++.++||.-...    ..   ....+-..|+..|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998865 567999976521    11   13344455677776653   246777888776  457889


Q ss_pred             EeeCCC
Q 040952          166 YEYMPN  171 (411)
Q Consensus       166 ~e~~~~  171 (411)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.97  E-value=0.011  Score=55.25  Aligned_cols=32  Identities=25%  Similarity=0.373  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          211 RVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       211 ~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      +.+++|+|+.++|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34599999999999999999999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.88  E-value=0.03  Score=49.07  Aligned_cols=170  Identities=21%  Similarity=0.271  Sum_probs=95.1

Q ss_pred             ccEEEEE-e-cCCCEEEEEEccCCCcccHHHHHHHHHHHHhc---CCcccceeeeeeecCCceEEEEeeCCCCCchhh--
Q 040952          105 GPVYKGV-L-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--  177 (411)
Q Consensus       105 g~Vy~~~-~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~--  177 (411)
                      |.|..|. . .+..++.||+-..   .....|..|+.-|..|   +.-++.+.+.+..+..+.|+|+||++-+.++..  
T Consensus        27 G~inea~~v~dg~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d~~~~  103 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLDAHSA  103 (286)
T ss_pred             ccccceeEeecCCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCCchhH
Confidence            4444443 2 2366788887543   3345567777766666   446688888888889999999999998777511  


Q ss_pred             ---------hcCCC---------------CCcCCCHHH---------HHHHHHHHH--------------HHHHHHhhc-
Q 040952          178 ---------LFDPT---------------KRMLLDWVT---------RVQIIEGIA--------------QGLLYLHQY-  209 (411)
Q Consensus       178 ---------l~~~~---------------~~~~~~~~~---------~~~i~~~i~--------------~~l~~LH~~-  209 (411)
                               |+...               ...+-.|..         ++-+..|++              ..+.-+=.. 
T Consensus       104 ~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~elL~~h  183 (286)
T COG3001         104 FILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQELLADH  183 (286)
T ss_pred             HHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcC
Confidence                     11100               011112221         222222222              122222111 


Q ss_pred             -CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhcc--------CCCCcchhhHH
Q 040952          210 -SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--------GIFSIKSDVFS  280 (411)
Q Consensus       210 -~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws  280 (411)
                       ..+.++|+||-+.|+++..+| +.+.|  -++..+..+.........|.   .+||+..+        ..|..+-++|.
T Consensus       184 qpqPsLlHGDLW~gN~a~~~~G-Pv~fD--PA~y~GDrE~Dlam~elFgg---fp~efy~gY~sv~PL~~G~~eRk~iYq  257 (286)
T COG3001         184 QPQPSLLHGDLWSGNCAFGKDG-PVIFD--PACYWGDRECDLAMLELFGG---FPPEFYDGYQSVSPLPAGYLERKPIYQ  257 (286)
T ss_pred             CCCcceeecccccccccccCCC-Ceeec--cccccCCcccceehhhhhcC---CcHHHHHhhhccCCCCCchHHHhHHHH
Confidence             236699999999999999999 66655  34444443333333333332   45665443        22456677877


Q ss_pred             HHH
Q 040952          281 FGV  283 (411)
Q Consensus       281 lG~  283 (411)
                      |=.
T Consensus       258 LY~  260 (286)
T COG3001         258 LYH  260 (286)
T ss_pred             HHH
Confidence            433

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.86  E-value=0.011  Score=55.77  Aligned_cols=72  Identities=17%  Similarity=0.271  Sum_probs=47.8

Q ss_pred             cccccCcccEEEEEecCC-CEEEEEEccC-------CCcccHHHHHHHHHHHHhcC--Ccc-cceeeeeeecCCceEEEE
Q 040952           98 KLGEGGFGPVYKGVLKKG-DEIAVKRLSG-------RSGQGLREMKNEASVIAKVQ--HKN-LVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  166 (411)
                      .||.|...-||++...+| +.|+||.-..       .-+-...+..-|...|+...  .|. +.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999997654 5899996431       11334455667788887653  343 333433  4456667999


Q ss_pred             eeCCC
Q 040952          167 EYMPN  171 (411)
Q Consensus       167 e~~~~  171 (411)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.85  E-value=0.013  Score=55.33  Aligned_cols=141  Identities=16%  Similarity=0.238  Sum_probs=79.3

Q ss_pred             CcccccCcccEEEEEecC----CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccc-eeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.|..|-...+|+....+    +..|++|+........+ .-.+|..+++.+..-++- ++++++.  +.  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence            345556677788886543    23789998876543332 236788888888655553 4555553  22  58999987


Q ss_pred             CCchhh-----------------hcCCC---CCcCCCHHHHHHHHHHH----------------------HHHHHHHh--
Q 040952          172 KSLDFF-----------------LFDPT---KRMLLDWVTRVQIIEGI----------------------AQGLLYLH--  207 (411)
Q Consensus       172 g~L~~~-----------------l~~~~---~~~~~~~~~~~~i~~~i----------------------~~~l~~LH--  207 (411)
                      ..+..-                 +|...   ...+.-+....++..++                      ..-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321                 11111   01111122222222111                      11111111  


Q ss_pred             --h-cCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccc
Q 040952          208 --Q-YSRVRIIHRDLKASNILLDK-DMNPKISDFGMARI  242 (411)
Q Consensus       208 --~-~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~  242 (411)
                        . .....++|.|+.+.||++++ ++.++++||..+-.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              1 11234899999999999975 57899999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.82  E-value=0.029  Score=52.71  Aligned_cols=140  Identities=19%  Similarity=0.230  Sum_probs=81.1

Q ss_pred             cccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc---cce---eeee----eecCCceEEEEe
Q 040952           98 KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN---LVR---LLGC----CIDKDEKILIYE  167 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n---iv~---l~~~----~~~~~~~~lv~e  167 (411)
                      .|.+ .-..+|+....+|+. ++|+....  ....++..|...+..+.-..   .++   +-|-    .......+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 556799998886766 88888765  33456677888888873211   112   1111    111136778999


Q ss_pred             eCCCCCchh-hh--------------c----CCC--C---CcCCCHHH-------------HHHHHHHHHHHHHHHhhc-
Q 040952          168 YMPNKSLDF-FL--------------F----DPT--K---RMLLDWVT-------------RVQIIEGIAQGLLYLHQY-  209 (411)
Q Consensus       168 ~~~~g~L~~-~l--------------~----~~~--~---~~~~~~~~-------------~~~i~~~i~~~l~~LH~~-  209 (411)
                      |++|..+.. ..              +    +..  .   .....|..             ......++...+..+... 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988872 11              1    000  0   11122320             011222333334444321 


Q ss_pred             ---CCCC---eeecCCCCCCEEEcCCCC-eEEeecCCcc
Q 040952          210 ---SRVR---IIHRDLKASNILLDKDMN-PKISDFGMAR  241 (411)
Q Consensus       210 ---~~~~---ivH~dlkp~Nill~~~~~-~kl~Dfgl~~  241 (411)
                         -...   +||+|+.|.||+++.+.. +-+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               1222   899999999999999885 8999999653

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.75  E-value=0.0041  Score=54.71  Aligned_cols=30  Identities=40%  Similarity=0.560  Sum_probs=21.3

Q ss_pred             CeeecCCCCCCEEE-cCCCCeEEeecCCccc
Q 040952          213 RIIHRDLKASNILL-DKDMNPKISDFGMARI  242 (411)
Q Consensus       213 ~ivH~dlkp~Nill-~~~~~~kl~Dfgl~~~  242 (411)
                      .++|+|+.|.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999997643

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.69  E-value=0.012  Score=55.06  Aligned_cols=102  Identities=16%  Similarity=0.176  Sum_probs=69.9

Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..|++|++. |+++..       .....+.+...++.+.+..+.-+...-  ++-|||+.-.||+|+ +|++-|+||-++
T Consensus       300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence            445666654 444422       233567888899999988888888765  589999999999999 999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHH
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSF  281 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  281 (411)
                      +.-..+....       ....-.|..+. +.-+.+-|||-+
T Consensus       369 Rl~~~q~~is-------y~rldhp~lF~-G~dd~QFeIYrl  401 (488)
T COG5072         369 RLSYSQGIIS-------YNRLDHPDLFN-GVDDYQFEIYRL  401 (488)
T ss_pred             ecccCCceee-------ccccCchhhhc-CccceeeeHHHH
Confidence            8543222111       12234455555 333667788874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.67  E-value=0.031  Score=52.28  Aligned_cols=28  Identities=29%  Similarity=0.374  Sum_probs=24.6

Q ss_pred             CCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          212 VRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       212 ~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      .+++|+|+.+.||+++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            45999999999999987 67899999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.35  E-value=0.012  Score=56.37  Aligned_cols=74  Identities=12%  Similarity=0.203  Sum_probs=50.1

Q ss_pred             cCcccccCcccEEEEEecC-CCEEEEEEccC------CCcccHHHHHHHHHHHHhcC--Ccc-cceeeeeeecCCceEEE
Q 040952           96 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG------RSGQGLREMKNEASVIAKVQ--HKN-LVRLLGCCIDKDEKILI  165 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv  165 (411)
                      .+.||.|.-.-||++.+.+ ++.|+||.-..      .-+-..++..-|.+.|+...  .|. +.+++.  .+.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            4678999999999999753 56899996431      11334566777888888763  354 444443  345566789


Q ss_pred             EeeCCC
Q 040952          166 YEYMPN  171 (411)
Q Consensus       166 ~e~~~~  171 (411)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.33  E-value=0.12  Score=48.82  Aligned_cols=72  Identities=11%  Similarity=0.069  Sum_probs=45.3

Q ss_pred             cCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc--ccceee---e--eeecCCceEEEEeeCCCCCc
Q 040952          102 GGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLL---G--CCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus       102 G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~g~L  174 (411)
                      +.-..||+...++|..+++|+..... .....+..|...+..+...  .++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34467999888778889999876332 2445667788888777321  122211   1  12224567789999988654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.29  E-value=0.022  Score=49.62  Aligned_cols=152  Identities=19%  Similarity=0.152  Sum_probs=87.7

Q ss_pred             cCcccEEEEEecCCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCchhhhcC
Q 040952          102 GGFGPVYKGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD  180 (411)
Q Consensus       102 G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  180 (411)
                      |+.++.-.+..+-| +..+|++....-. ....+..+.+++.++.  .|+++..-  +....-++.|+|-....      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            33344444443323 3455655433222 3345678888888774  46666632  33345588888743111      


Q ss_pred             CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccccccccccccc
Q 040952          181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  260 (411)
Q Consensus       181 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  260 (411)
                            .   . ..++.-=+.+|.-.|+.+ .+.+|+|..|+|||-|..|.+||.|-+..-.        .      +..
T Consensus       142 ------~---~-~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------~------~V~  196 (308)
T PF07387_consen  142 ------N---F-SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------N------QVN  196 (308)
T ss_pred             ------c---h-hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------h------eee
Confidence                  0   0 122222246778888543 3599999999999999999999999874310        0      111


Q ss_pred             ccChhhhccCCCCcchhhHHHHHHHHHHHhCC
Q 040952          261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK  292 (411)
Q Consensus       261 y~aPE~~~~~~~~~~~DvwslG~il~elltg~  292 (411)
                      |.--|   -...|+++.+-+|=.-++++....
T Consensus       197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  197 MVNIE---YESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             EEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence            22211   123466777777777777776643

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.94  E-value=0.15  Score=55.64  Aligned_cols=142  Identities=20%  Similarity=0.269  Sum_probs=77.6

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-------Ccccceee-e----eeec-CC--c
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-------HKNLVRLL-G----CCID-KD--E  161 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-------h~niv~l~-~----~~~~-~~--~  161 (411)
                      +.|+ |..-.+|+....+|..+++|+......  ......|...|..+.       -|.+++-. |    .... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 456788998877788999999986432  223344555665442       23333322 1    1111 22  4


Q ss_pred             eEEEEeeCCCCCchhhh---------------------cC---CCCCcCCCHHH-----------------HHHHHHHHH
Q 040952          162 KILIYEYMPNKSLDFFL---------------------FD---PTKRMLLDWVT-----------------RVQIIEGIA  200 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l---------------------~~---~~~~~~~~~~~-----------------~~~i~~~i~  200 (411)
                      .+-+++|++|..+.+..                     .+   ......+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            56789999998775410                     00   00001122211                 112222222


Q ss_pred             HHHH-----HHhhcCCCCeeecCCCCCCEEEcCCC--CeE-EeecCCccc
Q 040952          201 QGLL-----YLHQYSRVRIIHRDLKASNILLDKDM--NPK-ISDFGMARI  242 (411)
Q Consensus       201 ~~l~-----~LH~~~~~~ivH~dlkp~Nill~~~~--~~k-l~Dfgl~~~  242 (411)
                      ..+.     .+.. -+..+||+|+.+.||+++.++  .+. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2221     1222 134599999999999999875  554 999998754

>PTZ00384 choline kinase; Provisional

Probab=95.84  E-value=0.12  Score=49.89  Aligned_cols=74  Identities=19%  Similarity=0.343  Sum_probs=45.9

Q ss_pred             CcccccCcccEEEEEecCC--C-----EEEEEEccCCCcccHHHHHHHHHHHHhcCCcccc-eeeeeeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKKG--D-----EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g--~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  168 (411)
                      +.|..|-...+|++...++  .     .|.++.......... .-..|..+++.+...++- ++++.+..    ++++||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            4555688889999875432  2     244444333222222 235788999998655554 45555532    699999


Q ss_pred             CCCCCch
Q 040952          169 MPNKSLD  175 (411)
Q Consensus       169 ~~~g~L~  175 (411)
                      ++|..|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998774

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=95.66  E-value=0.0064  Score=47.64  Aligned_cols=32  Identities=28%  Similarity=0.634  Sum_probs=15.9

Q ss_pred             CeEEeehHHHHHHHHHHHHHHHHHHhhccCCC
Q 040952            7 PIISLLLLSIVPAAVAILGLIFYCVRRKPRSR   38 (411)
Q Consensus         7 ~i~~~~~~~~~~~~~~i~~~~~~~~~r~~~~~   38 (411)
                      +.|+.+++++++++++++++++||+||++++.
T Consensus        64 ~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~   95 (122)
T PF01102_consen   64 PAIIGIIFGVMAGVIGIILLISYCIRRLRKKS   95 (122)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred             cceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence            33444455555555555566666666655544

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	411
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-50
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-40
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-25
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-23
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-22
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-21
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-21
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-21
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-20
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-20
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-20
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-20
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-20
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-20
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-20
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-20
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-20
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-20
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-20
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-20
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-20
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-20
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-19
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-19
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-19
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-19
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-19
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-19
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-19
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-19
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-19
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-19
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-19
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-18
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-11
3soa_A	444	Full-Length Human Camkii Length = 444		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  200 bits (508), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 116/309 (37%), Positives = 177/309 (57%), Gaps = 7/309 (2%)
Query: 67  AKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR 126
           A+   +  + QL  FS   +  A++ FS+ N LG GGFG VYKG L  G  +AVKRL   
Sbjct: 14  AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 73
Query: 127 SGQGLR-EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-PTKR 184
             QG   + + E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L + P  +
Sbjct: 74  RXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             LDW  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++  
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 193
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR---TD 301
             +     + + GT G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D
Sbjct: 194 YKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 302 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
            + LL +   L    +   L+D  L+  Y  +  + + + +ALLC Q S  +RP M++VV
Sbjct: 253 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 362 SMLTNEAAA 370
            ML  +  A
Sbjct: 312 RMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 114/309 (36%), Positives = 175/309 (56%), Gaps = 7/309 (2%)
Query: 67  AKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR 126
           A+   +  + QL  FS   +  A++ F + N LG GGFG VYKG L  G  +AVKRL   
Sbjct: 6   AEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEE 65
Query: 127 SGQGLR-EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-PTKR 184
             QG   + + E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L + P  +
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             LDW  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++  
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR---TD 301
             +     + + G  G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D
Sbjct: 186 YKDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 302 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
            + LL +   L    +   L+D  L+  Y  +  + + + +ALLC Q S  +RP M++VV
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 362 SMLTNEAAA 370
            ML  +  A
Sbjct: 304 RMLEGDGLA 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  177 bits (449), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 112/283 (39%), Positives = 175/283 (61%), Gaps = 16/283 (5%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           ATN F     +G G FG VYKGVL+ G ++A+KR +  S QG+ E + E   ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLY 205
           LV L+G C +++E ILIY+YM N +L   L+    PT  M + W  R++I  G A+GL Y
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARGLHY 154
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV-GTYGYMS 263
           LH  +   IIHRD+K+ NILLD++  PKI+DFG+++   G EL Q +   +V GT GY+ 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKGTLGYID 209
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYAWDLWTSNRTLEL 321
           PEY ++G  + KSDV+SFGV+L E++  +      L R + +NL  +A +   + +  ++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQI 268
Query: 322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           +DP L D+   +  L ++ + A+ C+  S++DRP+M DV+  L
Sbjct: 269 VDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 112/283 (39%), Positives = 175/283 (61%), Gaps = 16/283 (5%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           ATN F     +G G FG VYKGVL+ G ++A+KR +  S QG+ E + E   ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLY 205
           LV L+G C +++E ILIY+YM N +L   L+    PT  M + W  R++I  G A+GL Y
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARGLHY 154
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV-GTYGYMS 263
           LH  +   IIHRD+K+ NILLD++  PKI+DFG+++   G EL Q +   +V GT GY+ 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGYID 209
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYAWDLWTSNRTLEL 321
           PEY ++G  + KSDV+SFGV+L E++  +      L R + +NL  +A +   + +  ++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQI 268
Query: 322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           +DP L D+   +  L ++ + A+ C+  S++DRP+M DV+  L
Sbjct: 269 VDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 115/302 (38%), Positives = 156/302 (51%), Gaps = 21/302 (6%)
Query: 81  FSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+        E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 135 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRMLLD 188
           K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T    L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 131
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 308
               SRIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 189 TVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 368
                      + ID  + D  S+   +    ++A  C+ E  + RP +  V  +L    
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 369 AA 370
           A+
Sbjct: 306 AS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 114/302 (37%), Positives = 155/302 (51%), Gaps = 21/302 (6%)
Query: 81  FSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+        E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 135 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRMLLD 188
           K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T    L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 131
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 308
                RIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 189 TVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 368
                      + ID  + D  S+   +    ++A  C+ E  + RP +  V  +L    
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 369 AA 370
           A+
Sbjct: 306 AS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 114/302 (37%), Positives = 155/302 (51%), Gaps = 21/302 (6%)
Query: 81  FSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+        E+
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 135 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRMLLD 188
           K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T    L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 125
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 308
                RIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 241
Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 368
                      + ID  + D  S+   +    ++A  C+ E  + RP +  V  +L    
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299
Query: 369 AA 370
           A+
Sbjct: 300 AS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 113/302 (37%), Positives = 151/302 (50%), Gaps = 21/302 (6%)
Query: 81  FSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM 134
           FSF  +   TN F +       NK GEGGFG VYKG +     +AVK+L+        E+
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 135 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRMLLD 188
           K     E  V AK QH+NLV LLG   D D+  L+Y Y PN SL       D T    L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--LS 122
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 308
               SRIVGT  Y +PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 368
                      + ID    D  S+   +    ++A  C+ E  + RP +  V  +L    
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDADSTS--VEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXT 296
Query: 369 AA 370
           A+
Sbjct: 297 AS 298

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 133/273 (48%), Gaps = 29/273 (10%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   +I EYM   SL DF   D   ++LL     +     IA+G+ Y+    R   IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 192
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDL-WTSNRTLELIDPILEDEYSSK 333
           DV+SFG+LL EIV+  K    G    D +  L   + +    N   EL D          
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYD---------- 242
Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
                   I  +C +E A++RPT + + S+L +
Sbjct: 243 --------IMKMCWKEKAEERPTFDYLQSVLDD 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 136/270 (50%), Gaps = 27/270 (10%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   +I E+M   SL DF   D   ++LL     +     IA+G+ Y+    R   IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 191
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           +V+SFG+LL EIV+  K    G    D ++ L   + +           P +E+     +
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM-----------PRMENCPDELY 240
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSML 364
            +++      +C +E A++RPT + + S+L
Sbjct: 241 DIMK------MCWKEKAEERPTFDYLQSVL 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 135
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 193
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 242
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 243 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 134
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 135 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 192
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 193 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 241
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 242 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 142/287 (49%), Gaps = 36/287 (12%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 87
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 139
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 140 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 197
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 198 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 246
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 377
              + L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 247 EELYQLMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 287

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 142/287 (49%), Gaps = 36/287 (12%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 129
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 187
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 236
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 377
              + L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 237 EELYQLMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 142/287 (49%), Gaps = 36/287 (12%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 135
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 193
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 242
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 377
              + L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 243 EELYQLMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 283

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 114/211 (54%), Gaps = 31/211 (14%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G GGFG VY+     GDE+AVK           Q +  ++ EA + A ++H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQYS 210
            C+ +    L+ E+     L+  L    KR+    L++W  +      IA+G+ YLH  +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ------IARGMNYLHDEA 125
Query: 211 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTS-RIVGTYGY 261
            V IIHRDLK+SNIL+     + D++    KI+DFG+AR     E    T     G Y +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAW 180
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           M+PE     +FS  SDV+S+GVLL E+++G+
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 129
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 187
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 236
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 237 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 129
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 187
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 236
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 237 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 86
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 138
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 139 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 196
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 245
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 246 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 275

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 142/287 (49%), Gaps = 36/287 (12%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 85
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 137
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 138 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 195
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 244
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 377
              + L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 245 EELYQLMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 285

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 78
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 130
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 131 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 188
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 237
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 238 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 79
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 131
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 132 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 189
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 238
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 239 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 268

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 124
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 125 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 182
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 231
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 232 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 261

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 32/286 (11%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++A+K L   +         EA ++ K++H  LV+L    +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAV-V 73
Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
            ++   ++ EYM   SL  FL D   R L      V +   +A G+ Y+    R+  IHR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 277
           DL+++NIL+   +  KI+DFG+AR+   NE  A          + +PE AL G F+IKSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 188
Query: 278 VFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILEDEYSS 332
           V+SFG+LL E+V+     G      +N          +   LE ++     P  +D   S
Sbjct: 189 VWSFGILLTELVT----KGRVPYPGMN----------NREVLEQVERGYRMPCPQDCPIS 234
Query: 333 KHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            H L+      + C ++  ++RPT   + S L +   A  P  QP 
Sbjct: 235 LHELM------IHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/276 (31%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 158 DKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 125
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
             IHR+L+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 126 -YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 183
Query: 273 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++  
Sbjct: 184 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNCP 232
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              + L+R      LC +E  +DRPT + + S+L +
Sbjct: 233 EELYQLMR------LCWKERPEDRPTFDYLRSVLED 262

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 362
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 411
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 412 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY-AVV 331
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 386
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 494
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 495 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 362
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 411
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 412 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 362
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 411
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 412 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 72
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 186
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 235
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 236 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 273

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 75
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 130
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 189
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 238
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 239 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 276

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--VDMSAQIASGMAYVE---RMNYVH 134
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 242
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 243 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 73
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 187
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 236
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 237 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 274

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/195 (35%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    ++ EYMP  +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYL---EKKNFI 152
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNTFSIK 211
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 212 SDVWAFGVLLWEIAT 226

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 71
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 126
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 185
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 234
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 235 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 272

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--VDMSAQIASGMAYVE---RMNYVH 134
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 242
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 243 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 140/285 (49%), Gaps = 30/285 (10%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           KLG+G FG V+ G       +A+K L  + G    E    EA V+ K++H+ LV+L    
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV- 248
Query: 157 IDKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           + ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYV 303
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL+A+NIL+ +++  K++DFG+ R+   NE  A          + +PE AL G F+IK
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 362
Query: 276 SDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK 333
           SDV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S 
Sbjct: 363 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESL 411
Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
           H L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 412 HDLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 24/277 (8%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL + S   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SDV+SFGVL+ E+ S  K     R++S  +     D+ T  R   L  P L    +S H+
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---LYKPRL----ASTHV 233
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 I   C +E  +DRP  + ++  L   AA+ L
Sbjct: 234 Y----QIMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 6/201 (2%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGC 155
           K+G G FG V++     G ++AVK L  +     R  E   E +++ +++H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
                   ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDLK+ N+L+DK    K+ DFG++R+     L +  +   GT  +M+PE   +   + K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA--AGTPEWMAPEVLRDEPSNEK 219
Query: 276 SDVFSFGVLLLEIVSGKKNTG 296
           SDV+SFGV+L E+ + ++  G
Sbjct: 220 SDVYSFGVILWELATLQQPWG 240

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 6/201 (2%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGC 155
           K+G G FG V++     G ++AVK L  +     R  E   E +++ +++H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
                   ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIV 161
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HR+LK+ N+L+DK    K+ DFG++R+     L + ++   GT  +M+PE   +   + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEK 219
Query: 276 SDVFSFGVLLLEIVSGKKNTG 296
           SDV+SFGV+L E+ + ++  G
Sbjct: 220 SDVYSFGVILWELATLQQPWG 240

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG+AR+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 138/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 120/220 (54%), Gaps = 22/220 (10%)
Query: 99  LGEGGFGPVYKGVLKKGDE-----IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRL 152
           LG G FG VYKG+     E     +A+K L+  +G     E  +EA ++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           LG C+    + L+ + MP+  L  ++ +       ++LL+W  +      IA+G++YL +
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 269 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 306
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 120/220 (54%), Gaps = 22/220 (10%)
Query: 99  LGEGGFGPVYKGVLKKGDE-----IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRL 152
           LG G FG VYKG+     E     +A+K L+  +G     E  +EA ++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           LG C+    + L+ + MP+  L  ++ +       ++LL+W  +      IA+G++YL +
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 269 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 306
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 140/288 (48%), Gaps = 36/288 (12%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +LG G  G V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           + ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + + 
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN- 129
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
              IHRDL+A+NIL+   ++ KI+DFG+AR+    E  A          + +PE    G 
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI-KWTAPEAINYGT 186
Query: 272 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P  ++ 
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRP--DNC 235
Query: 330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 377
               + L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 236 PEELYQLMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 138/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM    L DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
                 ++   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 ------DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 146/304 (48%), Gaps = 45/304 (14%)
Query: 81  FSFSSVSTATNKFS---DAN------KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGR 126
           F+F   + A  +F+   DA+       +G G FG V  G LK   +    +A+K L +G 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 127 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML 186
           + +  R+  +EAS++ +  H N++ L G        ++I EYM N SLD FL     R  
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           +  +  V ++ GI  G+ YL   S V   HRDL A NIL++ ++  K+SDFGM+R+   +
Sbjct: 130 V--IQLVGMLRGIGSGMKYLSDMSAV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 247 ELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL 305
              A T+R       + +PE      F+  SDV+S+G+++ E++S  +            
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---------- 234
Query: 306 LGYAWDLWTSNRTLELID-----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
               WD+ ++   ++ I+     P   D   + H L+      L C Q+   DRP    +
Sbjct: 235 ---YWDM-SNQDVIKAIEEGYRLPPPMDCPIALHQLM------LDCWQKERSDRPKFGQI 284
Query: 361 VSML 364
           V+ML
Sbjct: 285 VNML 288

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 138/284 (48%), Gaps = 28/284 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            ++   ++ EYM    L DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 277 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           DV+SFG+LL E+ +  +    G+   + L+ +   + +           P   +   S H
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------PCPPECPESLH 245
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            L+        C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 246 DLM------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 79
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            K+   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    IH
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 134
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGSFTIKS 193
Query: 277 DVFSFGVLLLEIVS 290
           DV+SFG+LL+EIV+
Sbjct: 194 DVWSFGILLMEIVT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 137
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 196
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/195 (35%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G FG VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 146
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 205
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 138
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-YGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 199 TSASDVWSYGIVLWEVMS 216

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/217 (33%), Positives = 115/217 (52%), Gaps = 12/217 (5%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREM 134
           +  F+    ATN  S    +G G FG V  G LK    K   +A+K L  G + +  R+ 
Sbjct: 33  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
             EAS++ +  H N++RL G        +++ EYM N SLD FL     +  +  +  V 
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVG 149
Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           ++ GIA G+ YL   S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R
Sbjct: 150 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206
Query: 255 IVG-TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                  + SPE      F+  SDV+S+G++L E++S
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 136/271 (50%), Gaps = 34/271 (12%)
Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 148
           FSD  ++G G FG VY    ++  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
            ++  GC + +    L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 184
Query: 269 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PA 233
Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPT 356
           L+  + S++    + N    C+Q+   DRPT
Sbjct: 234 LQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 134
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 252
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            K+   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    IH
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 366
Query: 277 DVFSFGVLLLEIVS 290
           DV+SFG+LL+EIV+
Sbjct: 367 DVWSFGILLMEIVT 380

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 136/271 (50%), Gaps = 34/271 (12%)
Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 148
           FSD  ++G G FG VY    ++  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
            ++  GC + +    L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 172
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 223
Query: 269 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PA 272
Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPT 356
           L+  + S++    + N    C+Q+   DRPT
Sbjct: 273 LQSGHWSEY----FRNFVDSCLQKIPQDRPT 299

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 155
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-YGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 215
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 216 TSASDVWSYGIVLWEVMS 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG+ R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 138/297 (46%), Gaps = 42/297 (14%)
Query: 98  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 199
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG--LYRTDSLNLLGYAWDLWTSNR 317
            +M PE  L   F+ +SDV+SFGV+L EI +  K     L  T++++ +       T  R
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-------TQGR 254
Query: 318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            LE       + Y+          I   C Q     R ++ DV + L  +A A  PP
Sbjct: 255 ELERPRACPPEVYA----------IMRGCWQREPQQRHSIKDVHARL--QALAQAPP 299

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 135/277 (48%), Gaps = 36/277 (12%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK   +    +A+K L +G + +  R+  +EAS++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        ++I EYM N SLD FL     R  +  +  V ++ GI  G+ YL   S V 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSYV- 132
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
             HRDL A NIL++ ++  K+SDFGM+R+   +   A T+R       + +PE      F
Sbjct: 133 --HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILE 327
           +  SDV+S+G+++ E++S  +                WD+ ++   ++ I+     P   
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERP-------------YWDM-SNQDVIKAIEEGYRLPPPM 236
Query: 328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           D   + H L+      L C Q+   DRP    +V+ML
Sbjct: 237 DCPIALHQLM------LDCWQKERSDRPKFGQIVNML 267

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 138/297 (46%), Gaps = 42/297 (14%)
Query: 98  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 199
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG--LYRTDSLNLLGYAWDLWTSNR 317
            +M PE  L   F+ +SDV+SFGV+L EI +  K     L  T++++ +       T  R
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-------TQGR 248
Query: 318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
            LE       + Y+          I   C Q     R ++ DV + L  +A A  PP
Sbjct: 249 ELERPRACPPEVYA----------IMRGCWQREPQQRHSIKDVHARL--QALAQAPP 293

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 135/277 (48%), Gaps = 36/277 (12%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK   +    +A+K L +G + +  R+  +EAS++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        ++I EYM N SLD FL     R  +  +  V ++ GI  G+ YL   S V 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSYV- 138
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
             HRDL A NIL++ ++  K+SDFGM+R+   +   A T+R       + +PE      F
Sbjct: 139 --HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILE 327
           +  SDV+S+G+++ E++S  +                WD+ ++   ++ I+     P   
Sbjct: 197 TSASDVWSYGIVMWEVMSYGERP-------------YWDM-SNQDVIKAIEEGYRLPPPM 242
Query: 328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           D   + H L+      L C Q+   DRP    +V+ML
Sbjct: 243 DCPIALHQLM------LDCWQKERSDRPKFGQIVNML 273

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 182
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SDV+SFGVL+ E+ S  K     R++S  +     D+ T  R   L  P L    +S H+
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---LYKPRL----ASTHV 231
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 I   C +E  +DRP  + ++  L   A + L
Sbjct: 232 Y----QIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SDV+SFGVL+ E+ S  K     R++S  +     D+ T  R   L  P L    +S H+
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---LYKPRL----ASTHV 233
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 I   C +E  +DRP  + ++  L   A + L
Sbjct: 234 Y----QIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 38/279 (13%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V +G LK    K   +A+K L  G + +  RE  +EAS++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII---EGIAQGLLYLHQYS 210
           G   +    +++ E+M N +LD FL     R+     T +Q++    GIA G+ YL + S
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRYLAEMS 138
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYA 267
            V   HRDL A NIL++ ++  K+SDFG++R    N      +  +G      + +PE  
Sbjct: 139 YV---HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 268 LEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 325
               F+  SD +S+G+++ E++S   +    +   D +N +   + L           P 
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL-----------PP 244
Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             D  +S H L+      L C Q+  + RP    VVS L
Sbjct: 245 PPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 277

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A          + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 134
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K++DFG++R+  G+   A          + +PE      FSIK
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 38/295 (12%)
Query: 98  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 199
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL 319
            +M PE  L   F+ +SDV+SFGV+L EI +  K      +++      A D  T  R L
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-----EAIDCITQGREL 279
Query: 320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 374
           E       + Y+          I   C Q     R ++ DV + L  +A A  PP
Sbjct: 280 ERPRACPPEVYA----------IMRGCWQREPQQRHSIKDVHARL--QALAQAPP 322

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 187
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SDV+SFGVL+ E+ S  K     R++S  +     D+ T  R   L  P L    +S H+
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---LYKPRL----ASTHV 236
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 I   C +E  +DRP  + ++  L   A + L
Sbjct: 237 Y----QIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 15  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 73  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 126
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 270
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +S +SDV++FG++L E+++G+
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQ 208

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 40  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 98  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 270
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +S +SDV++FG++L E+++G+
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 99  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 270
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +S +SDV++FG++L E+++G+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 18  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 76  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 270
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +S +SDV++FG++L E+++G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 32/276 (11%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V +G LK    K   +A+K L  G + +  RE  +EAS++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G   +    +++ E+M N +LD FL     +  +  +  V ++ GIA G+ YL + S V 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLAEMSYV- 138
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 270
             HRDL A NIL++ ++  K+SDFG++R    N      +  +G      + +PE     
Sbjct: 139 --HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 271 IFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
            F+  SD +S+G+++ E++S   +    +   D +N +   + L           P   D
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL-----------PPPPD 245
Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             +S H L+      L C Q+  + RP    VVS L
Sbjct: 246 CPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 275

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 113/206 (54%), Gaps = 21/206 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 33  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 91  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 268
           IIHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 200
Query: 269 --EGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +S +SDV++FG++L E+++G+
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 71  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 270
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +S +SDV++FG++L E+++G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 113/206 (54%), Gaps = 21/206 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 99  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 268
           IIHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 208
Query: 269 --EGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +S +SDV++FG++L E+++G+
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 113/206 (54%), Gaps = 21/206 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 71  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 268
           IIHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 180
Query: 269 --EGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +S +SDV++FG++L E+++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 18  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 76  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 270
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +S +SDV++FG++L E+++G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 139/278 (50%), Gaps = 37/278 (13%)
Query: 99  LGEGGFGPVYKGVLK-----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG VYKG+LK     K   +A+K L +G + +   +   EA ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            G        ++I EYM N +LD FL +  K      +  V ++ GIA G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 271
             +HRDL A NIL++ ++  K+SDFG++R+   + E    TS       + +PE      
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PIL 326
           F+  SDV+SFG+++ E+++  +                W+L +++  ++ I+     P  
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP-------------YWEL-SNHEVMKAINDGFRLPTP 272
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            D  S+ + L+      + C Q+    RP   D+VS+L
Sbjct: 273 MDCPSAIYQLM------MQCWQQERARRPKFADIVSIL 304

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 379
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 438
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 399
Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/258 (32%), Positives = 135/258 (52%), Gaps = 47/258 (18%)
Query: 58  IELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVL----- 112
           +E+P  N Q K++K KE+      S S+V     +F +  +LGE  FG VYKG L     
Sbjct: 7   MEMPLIN-QHKQAKLKEI------SLSAV-----RFME--ELGEDRFGKVYKGHLFGPAP 52
Query: 113 -KKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYM 169
            ++   +A+K L  ++   LRE  ++EA + A++QH N+V LLG  + KD+ + +I+ Y 
Sbjct: 53  GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV-VTKDQPLSMIFSYC 111
Query: 170 PNKSLDFFLF-------------DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            +  L  FL              D T +  L+    V ++  IA G+ YL   S   ++H
Sbjct: 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVH 168
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIF 272
           +DL   N+L+   +N KISD G+ R        A+  +++G       +M+PE  + G F
Sbjct: 169 KDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKF 224
Query: 273 SIKSDVFSFGVLLLEIVS 290
           SI SD++S+GV+L E+ S
Sbjct: 225 SIDSDIWSYGVVLWEVFS 242

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 138/282 (48%), Gaps = 22/282 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           ++ +   ++G G FG V+ G     D++A+K +   S     +   EA V+ K+ H  LV
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLV 85
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           +L G C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +  
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
              +IHRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE     
Sbjct: 144 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFS 199
Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
            +S KSDV+SFGVL+ E+ S  K     R++S  +     D+ T  R   L  P L    
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---LYKPRL---- 248
Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
           +S H+      I   C +E  +DRP  + ++  L   A + L
Sbjct: 249 ASTHVY----QIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ E M N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 24/277 (8%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C+++    L+ E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 185
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SDV+SFGVL+ E+ S  K     R++S  +     D+ T  R   L  P L    +S H+
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---LYKPRL----ASTHV 234
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 I   C +E  +DRP  + ++  L   A + L
Sbjct: 235 Y----QIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ E M N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 138
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-YGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 199 TSASDVWSYGIVLWEVMS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ E M N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 107/202 (52%), Gaps = 13/202 (6%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        I + ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 71  GYSTAPQLAI-VTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 270
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +S +SDV++FG++L E+++G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 98  KLGEGGFGPVY----KGVLKKGDEI--AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+      +  + D+I  AVK L   S    ++   EA ++  +QH+++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML--------LDWVTRVQIIEGIAQ 201
             G C++ D  I+++EYM +  L+ FL    P   ++        L     + I + IA 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
           G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +        +    +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 294
           M PE  +   F+ +SDV+S GV+L EI +  K 
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 19/194 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 246
Query: 158 DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            K+   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    IH
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 301
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL+A+NIL+   +  KI+DFG+AR+     ++           + +PE    G F+IKS
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIKS 350
Query: 277 DVFSFGVLLLEIVS 290
           DV+SFG+LL+EIV+
Sbjct: 351 DVWSFGILLMEIVT 364

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 98  KLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           +LGEG FG V+          K    +AVK L   +    ++ + EA ++  +QH+++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTR-----------VQIIEG 198
             G C D D  I+++EYM +  L+ FL    P   +L+D   R           + I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +        +  
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 294
             +M PE  +   F+ +SDV+SFGV+L EI +  K 
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 125 EGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 17  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   
Sbjct: 75  GYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS--- 128
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 268
           IIHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRM 184
Query: 269 --EGIFSIKSDVFSFGVLLLEIVSGK 292
                +S +SDV++FG++L E+++G+
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 138 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 121/230 (52%), Gaps = 35/230 (15%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLRE-MKNEA 138
           +S +  +F +  +LGE  FG VYKG L      ++   +A+K L  ++   LRE  ++EA
Sbjct: 6   ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLF-------------DPTKR 184
            + A++QH N+V LLG  + KD+ + +I+ Y  +  L  FL              D T +
Sbjct: 64  MLRARLQHPNVVCLLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             L+    V ++  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R   
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR--- 176
Query: 245 GNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                A+  +++G       +M+PE  + G FSI SD++S+GV+L E+ S
Sbjct: 177 -EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 134 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G    K +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   
Sbjct: 87  GYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS--- 140
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 268
           IIHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 196
Query: 269 --EGIFSIKSDVFSFGVLLLEIVSGK 292
                +S +SDV++FG++L E+++G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 153 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 23/278 (8%)
Query: 99  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 149
           LGEG FG        P   G    G+ +AVK L    G   R   K E  ++  + H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 150 VRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           ++  GCC D+ EK L  + EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 266
                  IHR+L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 135 S---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
             E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                 K     Y ++   C +  A  RPT  +++ +L
Sbjct: 252 RLPRPDKCPCEVY-HLMKNCWETEASFRPTFENLIPIL 288

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 99  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 149
           LGEG FG        P   G    G+ +AVK L    G   R   K E  ++  + H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 150 VRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           ++  GCC D+ EK L  + EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 266
                  IHR+L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 135 A---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID--- 323
             E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             P  +      + L++       C +  A  RPT  +++ +L
Sbjct: 252 RLPRPDKCPCEVYHLMKN------CWETEASFRPTFENLIPIL 288

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 138/277 (49%), Gaps = 36/277 (12%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    +   +A+K L  G + +  R+   EAS++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL---SDMG 144
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 272
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + +PE      F
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILE 327
           +  SDV+S+G+++ E+VS  +                W++ T+   ++ ++     P   
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERP-------------YWEM-TNQDVIKAVEEGYRLPSPM 250
Query: 328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           D  ++ + L+      L C Q+  + RP  +++V+ML
Sbjct: 251 DCPAALYQLM------LDCWQKERNSRPKFDEIVNML 281

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 142/306 (46%), Gaps = 47/306 (15%)
Query: 81  FSFSSVSTATNKFSDA---------NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGR 126
           F+F   + A  +F+             +G G FG V  G LK   +    +A+K L SG 
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 127 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML 186
           + +  R+  +EAS++ +  H N++ L G        ++I E+M N SLD FL     +  
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           +  +  V ++ GIA G+ YL   + +  +HRDL A NIL++ ++  K+SDFG++R    +
Sbjct: 134 V--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 247 ELQANTSRIVG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
                 +  +G      + +PE      F+  SDV+S+G+++ E++S  +          
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 240
Query: 304 NLLGYAWDLWTSNRTLELID-----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMN 358
                 WD+ T+   +  I+     P   D  S+ H L+      L C Q+  + RP   
Sbjct: 241 -----YWDM-TNQDVINAIEQDYRLPPPMDCPSALHQLM------LDCWQKDRNHRPKFG 288
Query: 359 DVVSML 364
            +V+ L
Sbjct: 289 QIVNTL 294

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 130
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYAL 268
              R IHRDL   NIL++ +   KI DFG+ ++   ++              + +PE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
           E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 129
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 185
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 161
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 217
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 133
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 189
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     LG G FG VYKG+ + +G+++    A+  L    S +  +E+ +EA V+A V
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 162 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 128
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYAL 268
              R IHRDL   NIL++ +   KI DFG+ ++   ++              + +PE   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
           E  FS+ SDV+SFGV+L E+ +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G      +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   
Sbjct: 87  GYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS--- 140
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 268
           IIHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 196
Query: 269 --EGIFSIKSDVFSFGVLLLEIVSGK 292
                +S +SDV++FG++L E+++G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL--- 133
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYAL 268
              R IHRDL   NIL++ +   KI DFG+ ++   ++              + +PE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
           E  FS+ SDV+SFGV+L E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 130
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++   ++      +   S I     + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAP 186
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 136
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 192
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 135
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 191
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 130
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 186
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 134
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYAL 268
              R IHRDL   NIL++ +   KI DFG+ ++   ++              + +PE   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
           E  FS+ SDV+SFGV+L E+ +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 98  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 153 LGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
            G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 265
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 205
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS 290
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 137
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 264
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 193
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 128/283 (45%), Gaps = 33/283 (11%)
Query: 99  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 149
           LGEG FG        P   G    G+ +AVK L    G  LR   + E  ++  + H+++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 150 VRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           V+  GCC D+ EK   L+ EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 266
                  IHR L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 129 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID--- 323
             E  F   SDV+SFGV L E+++   +     T    L+G+     T  R  EL++   
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGE 245
Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             P  +      + L++       C +  A  RPT  ++V +L
Sbjct: 246 RLPRPDRCPCEIYHLMKN------CWETEASFRPTFQNLVPIL 282

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 128/283 (45%), Gaps = 33/283 (11%)
Query: 99  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 149
           LGEG FG        P   G    G+ +AVK L    G  LR   + E  ++  + H+++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 150 VRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           V+  GCC D+ EK   L+ EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 266
                  IHR L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 130 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID--- 323
             E  F   SDV+SFGV L E+++   +     T    L+G+     T  R  EL++   
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGE 246
Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             P  +      + L++       C +  A  RPT  ++V +L
Sbjct: 247 RLPRPDRCPCEIYHLMKN------CWETEASFRPTFQNLVPIL 283

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 144
            +F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 200
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 98  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 153 LGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
            G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 265
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 205
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS 290
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 140
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 193
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
           Q+   IA G+ YL+     + +HRDL A N  + +D   KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 129/283 (45%), Gaps = 33/283 (11%)
Query: 99  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 149
           LGEG FG        P   G    G+ +AVK L   +G   R   K E  ++  + H+++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 150 VRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           ++  GCC D     L  + EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 266
                  IHRDL A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID--- 323
             E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++   
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             P  +   +  + L++       C +  A  RPT  +++ +L
Sbjct: 269 RLPRPDKCPAEVYHLMKN------CWETEASFRPTFENLIPIL 305

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 30/263 (11%)
Query: 114 KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 172
           K +++A+KR++    Q  + E+  E   +++  H N+V      + KDE  L+ + +   
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 173 S-LDFFLF----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD 227
           S LD           K  +LD  T   I+  + +GL YLH+  +   IHRD+KA NILL 
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 155
Query: 228 KDMNPKISDFGM-ARICGGNELQANTSR--IVGTYGYMSPEYALEGI--FSIKSDVFSFG 282
           +D + +I+DFG+ A +  G ++  N  R   VGT  +M+PE  +E +  +  K+D++SFG
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFG 214
Query: 283 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY--- 339
           +  +E+ +G      Y    + +L           TL+   P LE     K ML +Y   
Sbjct: 215 ITAIELATGAAPYHKYPPMKVLML-----------TLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 340 -VNIALLCVQESADDRPTMNDVV 361
              +  LC+Q+  + RPT  +++
Sbjct: 264 FRKMISLCLQKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 30/263 (11%)
Query: 114 KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 172
           K +++A+KR++    Q  + E+  E   +++  H N+V      + KDE  L+ + +   
Sbjct: 34  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 173 S-LDFFLF----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD 227
           S LD           K  +LD  T   I+  + +GL YLH+  +   IHRD+KA NILL 
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 150
Query: 228 KDMNPKISDFGM-ARICGGNELQANTSR--IVGTYGYMSPEYALEGI--FSIKSDVFSFG 282
           +D + +I+DFG+ A +  G ++  N  R   VGT  +M+PE  +E +  +  K+D++SFG
Sbjct: 151 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFG 209
Query: 283 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY--- 339
           +  +E+ +G      Y    + +L           TL+   P LE     K ML +Y   
Sbjct: 210 ITAIELATGAAPYHKYPPMKVLML-----------TLQNDPPSLETGVQDKEMLKKYGKS 258
Query: 340 -VNIALLCVQESADDRPTMNDVV 361
              +  LC+Q+  + RPT  +++
Sbjct: 259 FRKMISLCLQKDPEKRPTAAELL 281

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 98  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 153 LGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
            G C     +   LI E++P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 265
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 190
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS 290
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G  G V  G L+   +    +A+K L +G + +  R+  +EAS++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ G+  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAL 268
            +HRDL A N+L+D ++  K+SDFG++R+   +   A T+    T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIA 227
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
              FS  SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 130/292 (44%), Gaps = 50/292 (17%)
Query: 99  LGEGGFGPVYKGVL--KKG----DEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           LGEG FG V K      KG      +AVK L    S   LR++ +E +V+ +V H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEG 198
           L G C      +LI EY    SL  FL +  K                LD      +  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 199 --------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
                   I+QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R     +   
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGY 308
             S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+      NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-- 265
Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
                 +   +E  D   E+ Y           + L C ++  D RP   D+
Sbjct: 266 -----KTGHRMERPDNCSEEMY----------RLMLQCWKQEPDKRPVFADI 302

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 133/279 (47%), Gaps = 38/279 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK   +    +A+K L SG + +  R+  +EAS++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        ++I E+M N SLD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 270
            +HR L A NIL++ ++  K+SDFG++R    +      +  +G      + +PE     
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PI 325
            F+  SDV+S+G+++ E++S  +                WD+ T+   +  I+     P 
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERP-------------YWDM-TNQDVINAIEQDYRLPP 235
Query: 326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             D  S+ H L+      L C Q+  + RP    +V+ L
Sbjct: 236 PMDCPSALHQLM------LDCWQKDRNHRPKFGQIVNTL 268

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 129/292 (44%), Gaps = 50/292 (17%)
Query: 99  LGEGGFGPVYKGVL--KKG----DEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           LGEG FG V K      KG      +AVK L    S   LR++ +E +V+ +V H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEG 198
           L G C      +LI EY    SL  FL +  K                LD      +  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 199 --------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
                   I+QG+ YL + S   ++HRDL A NIL+ +    KISDFG++R     +   
Sbjct: 151 DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGY 308
             S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+      NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-- 265
Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
                 +   +E  D   E+ Y           + L C ++  D RP   D+
Sbjct: 266 -----KTGHRMERPDNCSEEMY----------RLMLQCWKQEPDKRPVFADI 302

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G  G V  G L+   +    +A+K L +G + +  R+  +EAS++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ EYM N SLD FL     +  +  +  V ++ G+  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAL 268
            +HRDL A N+L+D ++  K+SDFG++R+   +   A T+    T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIA 227
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
              FS  SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 108/205 (52%), Gaps = 19/205 (9%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           + ++G G FG VYKG       + + ++   + +  +  +NE +V+ K +H N++  +G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG- 99
Query: 156 CIDKDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
            + KD   ++ ++    SL   L    TK  +      + I    AQG+ YLH  +   I
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDYLHAKN---I 153
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL-- 268
           IHRD+K++NI L + +  KI DFG+A    R  G  +++  T  ++    +M+PE     
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRMQ 209
Query: 269 -EGIFSIKSDVFSFGVLLLEIVSGK 292
               FS +SDV+S+G++L E+++G+
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 130/292 (44%), Gaps = 50/292 (17%)
Query: 99  LGEGGFGPVYKGVL--KKG----DEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
           LGEG FG V K      KG      +AVK L    S   LR++ +E +V+ +V H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEG 198
           L G C      +LI EY    SL  FL +  K                LD      +  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 199 --------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
                   I+QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R     +   
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGY 308
             S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+      NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-- 265
Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
                 +   +E  D   E+ Y           + L C ++  D RP   D+
Sbjct: 266 -----KTGHRMERPDNCSEEMY----------RLMLQCWKQEPDKRPVFADI 302

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 98  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 153 LGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
            G C     +   LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 132
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPE 265
             R IHR+L   NIL++ +   KI DFG+ ++   ++      +   S I     + +PE
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAPE 188
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS 290
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 250
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q + + RPT  ++V++L ++    L
Sbjct: 251 ------LDQPDNCPE----------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----L 290
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 291 HPSFPEVSFFHS 302

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 51  LKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEG 102
           L+A  + ++ P       R+     D  P +SF+  +++ +   +  +        LG G
Sbjct: 9   LQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHG 68
Query: 103 GFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 155
            FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR +G 
Sbjct: 69  AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGV 128
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
            +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL +   
Sbjct: 129 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 186
Query: 212 VRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSP 264
              IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       +M P
Sbjct: 187 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPP 241
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E  +EGIF+ K+D +SFGVLL EI S
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 117/248 (47%), Gaps = 33/248 (13%)
Query: 69  RSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 116
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 117 --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
             ++AVK L    S Q   +   EA +I+K+ H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 174 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-- 227
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 228 -KDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 282
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 283 VLLLEIVS 290
           VLL EI S
Sbjct: 234 VLLWEIFS 241

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           F    KLGEG +G VYK + K+ G  +A+K++   S   L+E+  E S++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
             G      +  ++ EY    S+   +    K +  D +    I++   +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLH---F 143
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
           +R IHRD+KA NILL+ + + K++DFG+A      +  A  + ++GT  +M+PE   E  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           ++  +D++S G+  +E+  GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 134
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 191
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 247
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q +   RPT  ++V++L ++    L
Sbjct: 248 ------LDQPDNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----L 287
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 288 HPSFPEVSFFHS 299

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 69  RSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 116
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 117 --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 174 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-- 227
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 228 -KDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 282
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 283 VLLLEIVS 290
           VLL EI S
Sbjct: 234 VLLWEIFS 241

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 250
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q +   RPT  ++V++L ++    L
Sbjct: 251 ------LDQPDNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----L 290
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 291 HPSFPEVSFFHS 302

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 69  RSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 116
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 7   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 66
Query: 117 --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 67  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 126
Query: 174 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-- 227
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 127 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 183
Query: 228 -KDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 282
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 184 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 239
Query: 283 VLLLEIVS 290
           VLL EI S
Sbjct: 240 VLLWEIFS 247

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 257
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSEMVG 178
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 135/282 (47%), Gaps = 46/282 (16%)
Query: 99  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G G FG V  G LK    +   +A+K L  G + +  R+   EAS++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G        +++ E+M N +LD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYL---ADMG 165
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 267
            +HRDL A NIL++ ++  K+SDFG++R+     ++ +   +  T G      + +PE  
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID---- 323
               F+  SDV+S+G+++ E++S  +                WD+ ++   ++ I+    
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDM-SNQDVIKAIEEGYR 266
Query: 324 -PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            P   D  +  H L+      L C Q+   +RP    +V +L
Sbjct: 267 LPAPMDCPAGLHQLM------LDCWQKERAERPKFEQIVGIL 302

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 257
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSXMVG 178
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 257
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVG 178
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 10  LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 125
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 257
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 126 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSXMVG 179
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 250
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q +   RPT  ++V++L ++    L
Sbjct: 251 ------LDQPDNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----L 290
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 291 HPSFPEVSFFHS 302

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 99  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 151
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K+ H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 260
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKN 148
           F   N LG+G F  VY+   +  G E+A+K +  ++      ++ ++NE  +  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++ L     D +   L+ E   N  ++ +L +  K    +       +  I  G+LYLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYLHS 130
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           +    I+HRDL  SN+LL ++MN KI+DFG+A        +  T  + GT  Y+SPE A 
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIAT 185
Query: 269 EGIFSIKSDVFSFGVLLLEIVSGK 292
                ++SDV+S G +   ++ G+
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 136
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 249
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q +   RPT  ++V++L ++    L
Sbjct: 250 ------LDQPDNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----L 289
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 290 HPSFPEVSFFHS 301

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 115/248 (46%), Gaps = 33/248 (13%)
Query: 69  RSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 116
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 17  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 76
Query: 117 --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 77  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 174 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-- 227
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 137 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 193
Query: 228 -KDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 282
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 194 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 249
Query: 283 VLLLEIVS 290
           VLL EI S
Sbjct: 250 VLLWEIFS 257

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 138/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R            + + 
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLL 194
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 250
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q +   RPT  ++V++L ++    L
Sbjct: 251 ------LDQPDNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----L 290
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 291 HPSFPEVSFFHS 302

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 69  RSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 116
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 117 --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 174 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-- 227
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 228 -KDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 282
                 KI DFGMA+    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAQ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 283 VLLLEIVS 290
           VLL EI S
Sbjct: 234 VLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 99  LGEGGFGPVYKGVLKKGD------EIAVKRLSG-RSGQGLREMKNEASVIAKVQHKNLVR 151
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 260
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 26/267 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
            +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLHR 144
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSIK 275
           DL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SD+++FGVL+ EI S  K      T+S      A       + L L  P L  E      
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------ 248
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVS 362
             +   I   C  E AD+RPT   ++S
Sbjct: 249 --KVYTIMYSCWHEKADERPTFKILLS 273

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 99  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 151
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 260
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             +    +I EYM N  L  +L +   R        +++ + + + + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLES---KQFLH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 274
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           KSD+++FGVL+ EI S  K      T+S      A       + L L  P L  E     
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE----- 232
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVS 362
              +   I   C  E AD+RPT   ++S
Sbjct: 233 ---KVYTIMYSCWHEKADERPTFKILLS 257

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 99  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 151
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 260
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 122/268 (45%), Gaps = 26/268 (9%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 123
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 274
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           KSD+++FGVL+ EI S  K      T+S      A       + L L  P L  E     
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE----- 228
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVS 362
              +   I   C  E AD+RPT   ++S
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLS 253

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 99  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 151
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 260
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 99  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 151
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 260
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 202
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 114/248 (45%), Gaps = 33/248 (13%)
Query: 69  RSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 116
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 18  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 77
Query: 117 --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 78  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 174 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 226
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 138 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 194
Query: 227 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 282
                 KI DFGMAR    +  +A   R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 195 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 250
Query: 283 VLLLEIVS 290
           VLL EI S
Sbjct: 251 VLLWEIFS 258

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 26/267 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
            +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLHR 144
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSIK 275
           DL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SD+++FGVL+ EI S  K      T+S      A       + L L  P L  E      
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------ 248
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVS 362
             +   I   C  E AD+RPT   ++S
Sbjct: 249 --KVYTIMYSCWHEKADERPTFKILLS 273

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 140/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +      + + 
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 250
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q + + RPT  ++V++L ++    L
Sbjct: 251 ------LDQPDNCPE----------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----L 290
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 291 HPSFPEVSFFHS 302

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 114/248 (45%), Gaps = 33/248 (13%)
Query: 69  RSKKKEVDQLPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 116
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 41  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 100
Query: 117 --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 174 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 226
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 217
Query: 227 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 282
                 KI DFGMAR    +  +A   R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 218 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273
Query: 283 VLLLEIVS 290
           VLL EI S
Sbjct: 274 VLLWEIFS 281

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 16/213 (7%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK-NEASVIAKVQ 145
           +++++F    KLG G +  VYKG+ K  G  +A+K +   S +G       E S++ +++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPN---KSLDFFLFDPTKRML-LDWVTRVQIIEGIAQ 201
           H+N+VRL      +++  L++E+M N   K +D      T R L L+ V   Q    + Q
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQ 119
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYG 260
           GL + H+    +I+HRDLK  N+L++K    K+ DFG+AR  G   +  NT S  V T  
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVVTLW 173
Query: 261 YMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 292
           Y +P+  +    +S   D++S G +L E+++GK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 121/267 (45%), Gaps = 26/267 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
            +    +I EYM N  L  +L +   R        +++ + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLES---KQFLHR 129
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSIK 275
           DL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS K
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 335
           SD+++FGVL+ EI S  K      T+S      A       + L L  P L  E      
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------ 233
Query: 336 LLRYVNIALLCVQESADDRPTMNDVVS 362
             +   I   C  E AD+RPT   ++S
Sbjct: 234 --KVYTIMYSCWHEKADERPTFKILLS 258

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 140/312 (44%), Gaps = 58/312 (18%)
Query: 98  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 150
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 197
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 138
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +      + + 
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 312
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 251
Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 372
                 L+  D   E          R  ++  +C Q + + RPT  ++V++L ++    L
Sbjct: 252 ------LDQPDNCPE----------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----L 291
Query: 373 PPKQPAFSFVRN 384
            P  P  SF  +
Sbjct: 292 HPSFPEVSFFHS 303

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             +    +I EYM N  L  +L +   R        +++ + + + + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLES---KQFLH 134
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 274
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           KSD+++FGVL+ EI S  K      T+S      A       + L L  P L  E     
Sbjct: 192 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE----- 239
Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVS 362
              +   I   C  E AD+RPT   ++S
Sbjct: 240 ---KVYTIMYSCWHEKADERPTFKILLS 264

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQ 208
           LG C+    + L+ + MP   L   + +   R+    LL+W  +      IA+G+ YL  
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
              VR++HRDL A N+L+    + KI+DFG+AR+   +E + +         +M+ E  L
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
              F+ +SDV+S+GV + E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 119/266 (44%), Gaps = 22/266 (8%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             +    +I EYM N  L  +L +   R        +++ + + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLES---KQFLH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKS 187
Query: 277 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 336
           D+++FGVL+ EI S  K      T+S      A       + L L  P L  E       
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------- 233
Query: 337 LRYVNIALLCVQESADDRPTMNDVVS 362
            +   I   C  E AD+RPT   ++S
Sbjct: 234 -KVYTIMYSCWHEKADERPTFKILLS 258

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LREMKNEASVIAKV-QH 146
           KF D   +GEG FG V K  +KK     + A+KR+   + +   R+   E  V+ K+  H
Sbjct: 18  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------TKRMLLDWVTRV 193
            N++ LLG C  +    L  EY P+ +L  FL        DP      +    L     +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
                +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    +
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 189
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                  +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LREMKNEASVIAKV-QH 146
           KF D   +GEG FG V K  +KK     + A+KR+   + +   R+   E  V+ K+  H
Sbjct: 28  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------TKRMLLDWVTRV 193
            N++ LLG C  +    L  EY P+ +L  FL        DP      +    L     +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
                +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    +
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                  +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +LG G FG V  G  K   ++AVK +   S     E   EA  + K+ H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             +    ++ EY+ N  L  +L    K   L+    +++   + +G+ +L  +   + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 273
           RDL A N L+D+D+  K+SDFGM R    ++  ++    VGT     + +PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYS 183
Query: 274 IKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 332
            KSDV++FG+L+ E+ S GK    LY    + L          ++   L  P L  +   
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL--------KVSQGHRLYRPHLASD--- 232
Query: 333 KHMLLRYVNIALLCVQESADDRPTMNDVVS 362
                    I   C  E  + RPT   ++S
Sbjct: 233 -----TIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 150
           F+  +++G+G FG VYKG+     E+ A+K +    +   + +++ E +V+++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           R  G  +   +  +I EY+   S LD     P +   +       I+  I +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHS- 134
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
              R IHRD+KA+N+LL +  + K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 135 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 190
Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 191 SAYDFKADIWSLGITAIELAKGE 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 37/275 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G G FG V K   +  D +A+K++   S +  +    E   +++V H N+V+L G C++
Sbjct: 17  VGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 159 KDEKILIYEYMPNKSLDFFLF--DP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                L+ EY    SL   L   +P    T    + W  +       +QG+ YLH     
Sbjct: 74  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 213 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
            +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 331
           +S K DVFS+G++L E+++ +K        +  ++   W +    R      P++     
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTRP-----PLI----- 227
Query: 332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
            K++     ++   C  +    RP+M ++V ++T+
Sbjct: 228 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 261

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LREMKNEASVIAKV-QH 146
           KF D   +GEG FG V K  +KK     + A+KR+   + +   R+   E  V+ K+  H
Sbjct: 25  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------TKRMLLDWVTRV 193
            N++ LLG C  +    L  EY P+ +L  FL        DP      +    L     +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
                +A+G+ YL   S+ + IHR+L A NIL+ ++   KI+DFG++R   G E+    +
Sbjct: 143 HFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 196
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                  +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 37/275 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G G FG V K   +  D +A+K++   S +  +    E   +++V H N+V+L G C++
Sbjct: 16  VGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 159 KDEKILIYEYMPNKSLDFFLF--DP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                L+ EY    SL   L   +P    T    + W  +       +QG+ YLH     
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 213 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
            +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 331
           +S K DVFS+G++L E+++ +K        +  ++   W +    R      P++     
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTRP-----PLI----- 226
Query: 332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
            K++     ++   C  +    RP+M ++V ++T+
Sbjct: 227 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAK 143
           SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE  V+ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
            ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +     Q L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 130
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYM 262
            +LH     ++IHR++K+ NILL  D + K++DFG  A+I      Q+  S +VGT  +M
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWM 184
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           +PE      +  K D++S G++ +E++ G+
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 153
             ++G G FG V+ G L+  +  +AVK         L+ +   EA ++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C  K    ++ E +  +  DF  F  T+   L   T +Q++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
            IHRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 274 IKSDVFSFGVLLLEIVS 290
            +SDV+SFG+LL E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 96  ANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 153
             ++G G FG V+ G L+  +  +AVK         L+ +   EA ++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C  K    ++ E +  +  DF  F  T+   L   T +Q++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
            IHRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 274 IKSDVFSFGVLLLEIVS 290
            +SDV+SFG+LL E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 19/209 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
            K+    K+GEG +G VYK    +G  +A+KR+       G     +RE+    S++ ++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
            H N+V L+     +    L++E+M  K L   L D  K  L D   ++ + + + +G+ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVA 133
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y +P
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAP 188
Query: 265 EYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           +  +    +S   D++S G +  E+++GK
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 19/209 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
            K+    K+GEG +G VYK    +G  +A+KR+       G     +RE+    S++ ++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
            H N+V L+     +    L++E+M  K L   L D  K  L D   ++ + + + +G+ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVA 133
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y +P
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAP 188
Query: 265 EYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           +  +    +S   D++S G +  E+++GK
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQG-------LREMKNEA 138
           + A N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            +++ + H N+V+L G   +     ++ E++P   L   L D  K   + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMN----PKISDFGMARICGGNELQANTS 253
           IA G+ Y+ Q     I+HRDL++ NI L   D N     K++DFG+++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 254 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD 311
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+     Y    +  +    +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
                   E + P + ++        R  N+  LC       RP  + +V  L+
Sbjct: 245 --------EGLRPTIPEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 108/195 (55%), Gaps = 17/195 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 159 KDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
           +   + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG--TYGYMSPEYALEGIFSIK 275
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFSTK 185
Query: 276 SDVFSFGVLLLEIVS 290
           SDV+SFG+LL EI S
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG---- 154
           +G G +G VYKG L +   +AVK  S  + Q     KN   V   ++H N+ R +     
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYRV-PLMEHDNIARFIVGDER 78
Query: 155 -CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH------ 207
                + E +L+ EY PN SL  +L   T     DWV+  ++   + +GL YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL----QANTSRI--VGTYGY 261
            + +  I HRDL + N+L+  D    ISDFG++    GN L    + + + I  VGT  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 262 MSPEYALEGIFSIKS--------DVFSFGVLLLEI 288
           M+PE  LEG  +++         D+++ G++  EI
Sbjct: 195 MAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQG-------LREMKNEA 138
           + A N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            +++ + H N+V+L G   +     ++ E++P   L   L D  K   + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMN----PKISDFGMARICGGNELQANTS 253
           IA G+ Y+ Q     I+HRDL++ NI L   D N     K++DFG ++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVS 184
Query: 254 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD 311
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+     Y    +  +    +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
                   E + P + ++        R  N+  LC       RP  + +V  L+
Sbjct: 245 --------EGLRPTIPEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 256
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 257 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 96
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L  C  D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 148
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 144
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 252
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 253 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 287

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 256
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 257 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 141
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 249
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 250 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 168
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 276
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 277 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 311

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 147
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 255
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 256 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 147
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 255
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 256 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 108/195 (55%), Gaps = 17/195 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 159 KDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
           +   + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG--TYGYMSPEYALEGIFSIK 275
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 276 SDVFSFGVLLLEIVS 290
           SDV+SFG+LL EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 167
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 275
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 276 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 310

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 146
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 254
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 255 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 289

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 108/195 (55%), Gaps = 17/195 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 159 KDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
           +   + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG--TYGYMSPEYALEGIFSIK 275
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 276 SDVFSFGVLLLEIVS 290
           SDV+SFG+LL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 108/195 (55%), Gaps = 17/195 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 159 KDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 217
           +   + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT--YGYMSPEYALEGIFSIK 275
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 276 SDVFSFGVLLLEIVS 290
           SDV+SFG+LL EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 122/237 (51%), Gaps = 24/237 (10%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--I 141
           A  ++    ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 142 AKVQHKNLVRLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
              +H N+VRL   C     D++ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 312
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 150
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 150
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 143
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 198
Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 208
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 316
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 317 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 351

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 154
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 262
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 263 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 297

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 258
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 259 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 155 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +   NT+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           F+P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 33/229 (14%)
Query: 91  NKFSDANKLGEGGFGPVYK----GVL--KKGDEIAVKRLSGRSGQGLR-EMKNEASVIAK 143
           N       +GEG FG V++    G+L  +    +AVK L   +   ++ + + EA+++A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLL-----DWVTRVQ---- 194
             + N+V+LLG C       L++EYM    L+ FL   +   +      D  TR +    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 195 ------------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR- 241
                       I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           I   +  +A+ +  +    +M PE      ++ +SDV+++GV+L EI S
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 114/241 (47%), Gaps = 29/241 (12%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGDE--IAVK 121
           D+LPL        +  S      ++ +    LG G FG V +    G+ K      +AVK
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 63
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL 178
            L  G +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 179 ------FDPTKRMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKD 229
                 F P K +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEK 180
Query: 230 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 289
              KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL EI 
Sbjct: 181 NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 290 S 290
           S
Sbjct: 241 S 241

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           LG+G FG   K   ++  E+ V K L     +  R    E  V+  ++H N+++ +G  +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-L 76
Query: 158 DKDEKI-LIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
            KD+++  I EY+   +L   +    K M     W  RV   + IA G+ YLH    + I
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR------------IVGTYGYM 262
           IHRDL + N L+ ++ N  ++DFG+AR+    + Q    R            +VG   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +PE      +  K DVFSFG++L EI+ 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 122/237 (51%), Gaps = 24/237 (10%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--I 141
           A  ++    ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 142 AKVQHKNLVRLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
              +H N+VRL   C     D++ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 312
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQG-------LREMKNEA 138
           + A N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
            +++ + H N+V+L G   +     ++ E++P   L   L D  K   + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMN----PKISDFGMARICGGNELQANTS 253
           IA G+ Y+ Q     I+HRDL++ NI L   D N     K++DF +++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVS 184
Query: 254 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD 311
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+     Y    +  +    +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
                   E + P + ++        R  N+  LC       RP  + +V  L+
Sbjct: 245 --------EGLRPTIPEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 154 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 266
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 258
Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           + EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 259 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 122/237 (51%), Gaps = 24/237 (10%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--I 141
           A  ++    ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 142 AKVQHKNLVRLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
              +H N+VRL   C     D++ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 312
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRMLLDWVTRVQI 195
           + QH+N+V LLG C      ++I EY     L  FL        D      L+    +  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTS 253
              +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           R+     +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 215 RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 150
           F+   ++G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  G  +   +  +I EY+   S LD     P      D      +++ I +GL YLH  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 139
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +   IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 194
Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 195 SAYDSKADIWSLGITAIELAKGE 217

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 35/222 (15%)
Query: 99  LGEGGFGPVYK----GVLKKGD--EIAVKRLSGRSGQGLRE-MKNEASVIAKV-QHKNLV 150
           LG G FG V      G+ K G   ++AVK L  ++    RE + +E  ++ ++  H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRM-------LLDWV 190
            LLG C       LI+EY     L  +L             ++  KR+       +L + 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNEL 248
             +     +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR  +   N +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               +R+     +M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 230 VRGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRMLLDWVTRVQI 195
           + QH+N+V LLG C      ++I EY     L  FL        D      L+    +  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTS 253
              +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           R+     +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 223 RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 114/241 (47%), Gaps = 29/241 (12%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGDE--IAVK 121
           D+LPL        +  S      ++ +    LG G FG V +    G+ K      +AVK
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 63
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL 178
            L  G +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 179 ------FDPTKRMLLDWVTRVQII---EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD 229
                 F P K +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEK 180
Query: 230 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 289
              KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL EI 
Sbjct: 181 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 290 S 290
           S
Sbjct: 241 S 241

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 35/230 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---- 198
           + QH+N+V LLG C      ++I EY     L  FL    + ML   +   Q  EG    
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 199 ----------------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR- 241
                           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 242 -ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +   N +    +R+     +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 208 IMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E   S  SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 28/223 (12%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVT 191
           + QH+N+V LLG C      ++I EY     L  FL           ++P+        +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 192 R--VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNE 247
           R  +     +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +    +R+     +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 223 IVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV---------TR- 192
           + QH+N+V LLG C      ++I EY     L  FL   ++ +  D           TR 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 193 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQ 249
            +     +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N + 
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
              +R+     +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 223 KGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 98  KLGEGGFGPVYKGVL---KKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +LG G FG V +GV    KK  ++A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C   +  +L+ E      L  FL    KR  +      +++  ++ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGI 271
            +HRDL A N+LL      KISDFG+++  G ++    T+R  G +   + +PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 189
Query: 272 FSIKSDVFSFGVLLLEIVS 290
           FS +SDV+S+GV + E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V     K  G ++AVK +  R  Q    + NE  ++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  +E  ++ E++   +L     D   ++ L+      + E + Q L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K+ +ILL  D   K+SDFG       +        +VGT  +M+PE     +++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 277 DVFSFGVLLLEIVSGK 292
           D++S G++++E+V G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 99  LGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V            G+++AVK L   SG   + ++K E  ++  + H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 153 LGCCI-DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--HQ 208
            G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL   Q
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEY 266
           Y     +HRDL A N+L++ +   KI DFG+ +    ++        R    + Y +PE 
Sbjct: 147 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
            ++  F I SDV+SFGV L E+++
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG V+KGV + +G+ I     +K +  +SG Q  + + +    I  + H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDWVTRVQIIEGIAQGLL 204
           LG C     + L+ +Y+P  SL     D  ++        +LL+W  +      IA+G+ 
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL ++    ++HR+L A N+LL      +++DFG+A +   ++ Q   S       +M+ 
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E    G ++ +SDV+S+GV + E+++
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 99  LGEGGFGPVYKGVLKKGD----EIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V +G LK+ D    ++AVK  +L   S + + E  +EA+ +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 153 LGCCIDKDEK-----ILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLL 204
           LG CI+   +     ++I  +M    L  +L      T    +   T ++ +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYM 262
           YL   S    +HRDL A N +L  DM   ++DFG+++    G    Q   +++     ++
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKWI 216
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           + E   + +++ KSDV++FGV + EI +
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV---------TR- 192
           + QH+N+V LLG C      ++I EY     L  FL   ++ +  D           TR 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 193 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQ 249
            +     +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N + 
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
              +R+     +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 223 KGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 99  LGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V            G+++AVK L   SG   + ++K E  ++  + H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 153 LGCCI-DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--HQ 208
            G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL   Q
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEY 266
           Y     +HRDL A N+L++ +   KI DFG+ +    ++        R    + Y +PE 
Sbjct: 135 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
            ++  F I SDV+SFGV L E+++
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 99  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 195
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 150
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 138
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 193
Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 152
           LG G FG V+KGV + +G+ I     +K +  +SG Q  + + +    I  + H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDWVTRVQIIEGIAQGLL 204
           LG C     + L+ +Y+P  SL     D  ++        +LL+W  +      IA+G+ 
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL ++    ++HR+L A N+LL      +++DFG+A +   ++ Q   S       +M+ 
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVS 290
           E    G ++ +SDV+S+GV + E+++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 150
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 151 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 178
Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 155 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 155 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 155 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 119/233 (51%), Gaps = 18/233 (7%)
Query: 89  ATNKFSDANK---LGEGGFGPVYK-GVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV 144
           A N F   +K   LG G FG V+K      G ++A K +  R  +   E+KNE SV+ ++
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
            H NL++L      K++ +L+ EY+    L   + D +    L  +  +  ++ I +G+ 
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIR 201
Query: 205 YLHQYSRVRIIHRDLKASNIL-LDKDMNP-KISDFGMARICGGNE-LQANTSRIVGTYGY 261
           ++HQ   + I+H DLK  NIL +++D    KI DFG+AR     E L+ N     GT  +
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTPEF 254
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSL-NLLGYAWDL 312
           ++PE       S  +D++S GV+   ++SG     G    ++L N+L   WDL
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 215
               +  ++ E+ P  ++D  + +   R L +   ++Q++   + + L +LH     RII
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE--PQIQVVCRQMLEALNFLHSK---RII 131
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL----- 268
           HRDLKA N+L+  + + +++DFG++       L+    R   +GT  +M+PE  +     
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 269 EGIFSIKSDVFSFGVLLLEI 288
           +  +  K+D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 215
               +  ++ E+ P  ++D  + +   R L +   ++Q++   + + L +LH     RII
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE--PQIQVVCRQMLEALNFLHSK---RII 139
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL----- 268
           HRDLKA N+L+  + + +++DFG++       L+    R   +GT  +M+PE  +     
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
           +  +  K+D++S G+ L+E+  
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQ 217

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKN 148
           F    K+G G F  VY+   L  G  +A+K++        +   +   E  ++ ++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WVTRVQIIEGIAQGL 203
           +++     I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE--- 150
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 151 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 204
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE   E  ++ KSD++S G LL E+ + +     +  D +N       L++  + +E  D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN-------LYSLCKKIEQCD 254
Query: 324 --PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
             P+  D YS +  L + VN   +C+    + RP +  V
Sbjct: 255 YPPLPSDHYSEE--LRQLVN---MCINPDPEKRPDVTYV 288

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG-RSGQGLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L    + + L ++ +E  ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 155 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 66
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 118
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 68
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 120
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 155 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 32/244 (13%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVK 121
           D+LPL        +  S      ++ +    LG G FG V +    G+ K      +AVK
Sbjct: 5   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 64
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY----------EYM 169
            L  G +    R + +E  ++  +  H N+V LLG C      +++            Y+
Sbjct: 65  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
Query: 170 PNKSLDFFLFDPTKRMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNILL 226
            +K  +F  +   + +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL
Sbjct: 125 RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILL 181
Query: 227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 286
            +    KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL 
Sbjct: 182 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 287 EIVS 290
           EI S
Sbjct: 242 EIFS 245

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 67
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 119
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 69
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 121
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 106/200 (53%), Gaps = 15/200 (7%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 215
             ++   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 270
           HRDLKA NIL   D + K++DFG++       +Q   S  +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDS-FIGTPYWMAPEVVMCETSKDR 215
Query: 271 IFSIKSDVFSFGVLLLEIVS 290
            +  K+DV+S G+ L+E+  
Sbjct: 216 PYDYKADVWSLGITLIEMAE 235

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 98  KLGEGGFGPVYKGVL---KKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +LG G FG V +GV    KK  ++A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C   +  +L+ E      L  FL    KR  +      +++  ++ G+ YL + +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGI 271
            +HR+L A N+LL      KISDFG+++  G ++    T+R  G +   + +PE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 272 FSIKSDVFSFGVLLLEIVS 290
           FS +SDV+S+GV + E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 215
             ++   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 270
           HRDLKA NIL   D + K++DFG++               +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 271 IFSIKSDVFSFGVLLLEI 288
            +  K+DV+S G+ L+E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 215
             ++   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 270
           HRDLKA NIL   D + K++DFG++               +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 271 IFSIKSDVFSFGVLLLEIVS 290
            +  K+DV+S G+ L+E+  
Sbjct: 216 PYDYKADVWSLGITLIEMAE 235

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMK-NEASVIAKVQHKNL 149
           K+    K+GEG +G VYK     G+  A+K++   +  +G+      E S++ +++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML------LDWVTRVQIIEGIAQGL 203
           V+L      K   +L++E++             K++L      L+ VT    +  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  IV T  Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIV-TLWYRA 168
Query: 264 PEYAL-EGIFSIKSDVFSFGVLLLEIVSG 291
           P+  +    +S   D++S G +  E+V+G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 114/238 (47%), Gaps = 23/238 (9%)
Query: 67  AKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR 126
           A  S  + +D++ L   S++      F     +G G +G VYKG   K  ++A  ++   
Sbjct: 3   ASDSPARSLDEIDL---SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV 59
Query: 127 SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK------DEKILIYEYMPNKSLDFFLF 179
           +G    E+K E +++ K   H+N+    G  I K      D+  L+ E+    S+   + 
Sbjct: 60  TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 180 DPTKRMLLD-WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 238
           +     L + W+    I   I +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG
Sbjct: 120 NTKGNTLKEEWI--AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 239 MARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG 291
           ++        + NT   +GT  +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 175 VSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 74  EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 125
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 69  ELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123
Query: 126 RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL----- 178
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 179 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 228
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 238
Query: 229 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 288
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 289 VS 290
            +
Sbjct: 299 FT 300

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 73
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 125
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 92
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 144
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 88
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 140
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 92
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 144
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 88
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 140
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 266 YAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGP-VYKGVLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F   V    L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 33/244 (13%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGDE--IAVK 121
           D+LPL        +  S      ++      LG G FG V +    G+ K      +AVK
Sbjct: 6   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 65
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY----------EYM 169
            L  G +    R + +E  ++  +  H N+V LLG C      +++            Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 170 PNKSLDFFLFDPTKRMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNILL 226
            +K  +F  + P + +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL
Sbjct: 126 RSKRNEFVPYKP-EDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILL 181
Query: 227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 286
            +    KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL 
Sbjct: 182 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 287 EIVS 290
           EI S
Sbjct: 242 EIFS 245

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 93  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 146
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 94
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 201
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 146
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 137/287 (47%), Gaps = 42/287 (14%)
Query: 99  LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNLVRLLGC 155
           LG+G FG V K   +    E AVK ++  S +      +  E  ++ K+ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
             D     ++ E      L    FD   KR         +II+ +  G+ Y+H+++   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 215 IHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGTYGYMSPEYALE 269
           +HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT  Y++PE  L 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 270 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL------GYAWDL--W--TSNRTL 319
           G +  K DV+S GV+L  ++SG      Y  +  ++L       YA+DL  W   S+   
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 320 ELIDPILEDEYSSKHMLLRYVNIALL---CVQESADDRPTMNDVVSM 363
           +LI  +L     + H  LR      L    +Q+ + + PT++D+ S+
Sbjct: 255 DLIRKML-----TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSL 296

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 142 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINN 196
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 74  EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 125
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 15  ELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 69
Query: 126 RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL----- 178
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 70  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 129
Query: 179 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 228
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 130 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 184
Query: 229 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 288
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 185 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244
Query: 289 VS 290
            +
Sbjct: 245 FT 246

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMK-NEASVIAKVQHKNL 149
           K+    K+GEG +G VYK     G+  A+K++   +  +G+      E S++ +++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML------LDWVTRVQIIEGIAQGL 203
           V+L      K   +L++E++             K++L      L+ VT    +  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  +V T  Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV-TLWYRA 168
Query: 264 PEYAL-EGIFSIKSDVFSFGVLLLEIVSG 291
           P+  +    +S   D++S G +  E+V+G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR    
Sbjct: 144 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 198
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 199 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVI 141
           +K +    LGEG FG V         K   K+   +AVK L   + +  L ++ +E  ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRM 185
             + +HKN++ LLG C       +I EY    +L  +L           +D    P ++M
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                  V     +A+G+ YL   +  + IHRDL A N+L+ ++   +I+DFG+AR    
Sbjct: 155 TFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINN 209
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMK-NEASVIAKVQHKNL 149
           K+    K+GEG +G VYK     G+  A+K++   +  +G+      E S++ +++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML------LDWVTRVQIIEGIAQGL 203
           V+L      K   +L++E++             K++L      L+ VT    +  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  +V T  Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV-TLWYRA 168
Query: 264 PEYAL-EGIFSIKSDVFSFGVLLLEIVSG 291
           P+  +    +S   D++S G +  E+V+G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 67
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 180
Query: 266 YAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 215

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 174
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 64
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 177
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 67
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 180
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++     DF        + L  +     +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 135
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 68
Query: 136 NEASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 188
           ++ S++ +VQ      H N+++L     DK    L+ E      L    FD    R    
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 124
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 245
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 125 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 179
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 180 -EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 135
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 91
Query: 136 NEASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 188
           ++ S++ +VQ      H N+++L     DK    L+ E      L    FD    R    
Sbjct: 92  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 147
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 245
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 148 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 202
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 203 -EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 135
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 92
Query: 136 NEASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 188
           ++ S++ +VQ      H N+++L     DK    L+ E      L    FD    R    
Sbjct: 93  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 148
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 245
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 149 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 203
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 204 -EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 135
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 74
Query: 136 NEASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 188
           ++ S++ +VQ      H N+++L     DK    L+ E      L    FD    R    
Sbjct: 75  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 130
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 245
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 131 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---H 184
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 185 FEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++     DF        + L  +     +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 158 DKDEKILIYEYMPNKSLDFFL---FDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +     +  E +P  SL   L   + P K     + + T+ QI+E    GL YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 141
Query: 213 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
           +I+HRD+K  N+L++      KISDFG ++   G  +   T    GT  YM+PE   +G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 199
Query: 272 --FSIKSDVFSFGVLLLEIVSGK 292
             +   +D++S G  ++E+ +GK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 35/242 (14%)
Query: 74  EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 125
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 126 RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL----- 178
            + +  L ++ +E  ++  + +HKN++ LLG C       +I  Y    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRP 137
Query: 179 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 228
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 229 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 288
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 289 VS 290
            +
Sbjct: 253 FT 254

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++     DF        + L  +     +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 92  KFSDANKLGEGGFGPVY---KGVLKKGDEIAVKRL---SGRSGQGLREMKNEASVIAKVQ 145
           ++   +KLG GG   VY     +L    ++A+K +        + L+  + E    +++ 
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H+N+V ++    + D   L+ EY+   +L  ++        L   T +     I  G+ +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H    +RI+HRD+K  NIL+D +   KI DFG+A+      L   T+ ++GT  Y SPE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPE 182
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
            A        +D++S G++L E++ G+
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 158 DKDEKILIYEYMPNKSLDFFL---FDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +     +  E +P  SL   L   + P K     + + T+ QI+E    GL YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 127
Query: 213 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
           +I+HRD+K  N+L++      KISDFG ++   G  +   T    GT  YM+PE   +G 
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 185
Query: 272 --FSIKSDVFSFGVLLLEIVSGK 292
             +   +D++S G  ++E+ +GK
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKG---------DEIAVKRLSGRSGQGLREMKNEAS 139
           +  K+    K+GEG FG   K +L K           EI + R+S +  +   E + E +
Sbjct: 22  SMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVA 75
Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
           V+A ++H N+V+      +     ++ +Y     L F   +  K +L       QI++  
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQ---EDQILDWF 131
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
            Q  L L      +I+HRD+K+ NI L KD   ++ DFG+AR+       A     +GT 
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTP 189
Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            Y+SPE      ++ KSD+++ G +L E+ + K
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 35/242 (14%)
Query: 74  EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 125
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 126 RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL----- 178
            + +  L ++ +E  ++  + +HKN++ LLG C       +I  Y    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRP 137
Query: 179 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 228
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 229 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 288
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 289 VS 290
            +
Sbjct: 253 FT 254

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+ ++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+ ++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 172
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 172
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 150
           F     LG GGFG V++   K  D   A+KR+   + +  RE +  E   +AK++H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE------------G 198
           R     ++K+    +    P   L   +    K  L DW+     IE             
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--------- 249
           IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +         
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 250 -ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 289
            A  +  VGT  YMSPE      +S K D+FS G++L E++
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 64
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 177
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 212

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASV--IA 142
           AT+++    ++G G +G VYK      G  +A+K +   +G  G  +  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 143 KVQHKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
             +H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVV 173
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  + A + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 24/219 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWVTRVQIIEGIAQGLL 204
           H N+V+LL     +++  L++E++   S+D   F D +    +        +  + QGL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAP 173
Query: 265 EYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
           E  L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 24/219 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWVTRVQIIEGIAQGLL 204
           H N+V+LL     +++  L++E++   S+D   F D +    +        +  + QGL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAP 175
Query: 265 EYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
           E  L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 86  VSTATNKFSDANK----LGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKNE 137
           V  +T  FSD  K    LG+G FG V   +L K    G E AVK +S R    +++  ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKTDK 70
Query: 138 ASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWV 190
            S++ +VQ      H N+ +L     DK    L+ E      L    FD    R     V
Sbjct: 71  ESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV 126
Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNE 247
              +II  +  G+ Y H   + +I+HRDLK  N+LL+   KD N +I DFG++      E
Sbjct: 127 DAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---E 180
Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
                   +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 181 ASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVK 121
           D+LPL        +  S      ++      LG G FG V +    G+ K      +AVK
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL 178
            L  G +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 179 ------FDPTK----RMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNIL 225
                 F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NIL
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNIL 180
Query: 226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           L +    KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL
Sbjct: 181 LSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 286 LEIVS 290
            EI S
Sbjct: 241 WEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVK 121
           D+LPL        +  S      ++      LG G FG V +    G+ K      +AVK
Sbjct: 6   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 65
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL 178
            L  G +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 179 ------FDPTKR----MLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNIL 225
                 F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NIL
Sbjct: 126 RSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNIL 182
Query: 226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           L +    KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL
Sbjct: 183 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 242
Query: 286 LEIVS 290
            EI S
Sbjct: 243 WEIFS 247

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVK 121
           D+LPL        +  S      ++      LG G FG V +    G+ K      +AVK
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL 178
            L  G +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 179 ------FDPTK----RMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNIL 225
                 F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NIL
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNIL 180
Query: 226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           L +    KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 286 LEIVS 290
            EI S
Sbjct: 241 WEIFS 245

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 111/217 (51%), Gaps = 22/217 (10%)
Query: 87  STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RLSG-RSGQGLREMKNEAS 139
           S   + +    +LG G F  V K   K  G E A K     RLS  R G    E++ E +
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
           ++ +++H N++ L     +K + +LI E +    L  FL +  + +  D  T  Q ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQI 117
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSR 254
             G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----N 170
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           I GT  +++PE        +++D++S GV+   ++SG
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 73  KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVKRL-SG 125
           +  ++LP +  S      ++      LG G FG V +    G+ K      +AVK L  G
Sbjct: 1   EHAERLP-YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 59
Query: 126 RSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL----- 178
            +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L     
Sbjct: 60  ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 119
Query: 179 -FDPTK----RMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 230
            F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL +  
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 176
Query: 231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 177 VVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASV--IA 142
           AT+++    ++G G +G VYK      G  +A+K +   +G  G  +  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 143 KVQHKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
             +H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVV 173
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 73  KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVKRL-SG 125
           +  ++LP +  S      ++      LG G FG V +    G+ K      +AVK L  G
Sbjct: 1   EHAERLP-YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 59
Query: 126 RSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL----- 178
            +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L     
Sbjct: 60  ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 179 -FDPTK----RMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 230
            F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL +  
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 176
Query: 231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 177 VVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 148
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 206 VDIWSLGIMVIEMVDGE 222

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVK 121
           D+LPL        +  S      ++      LG G FG V +    G+ K      +AVK
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL 178
            L  G +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 179 ------FDPTK----RMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNIL 225
                 F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NIL
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNIL 180
Query: 226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           L +    KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 286 LEIVS 290
            EI S
Sbjct: 241 WEIFS 245

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 29/234 (12%)
Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRL------SGRSGQGLREM 134
           S +  +T+ +++    KLGEG +G VYK +    +E +A+KR+       G  G  +RE+
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
               S++ ++QH+N++ L           LI+EY  N    +   +P   M +      Q
Sbjct: 85  ----SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNP--KISDFGMARICGGNELQ 249
           +I G+     + H  SR R +HRDLK  N+LL   D    P  KI DFG+AR   G  ++
Sbjct: 141 LINGVN----FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIR 192
Query: 250 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
             T  I+ T  Y  PE  L    +S   D++S   +  E++     T L+  DS
Sbjct: 193 QFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML---MKTPLFPGDS 242

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 139
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 150
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 208 VDIWSLGIMVIEMVDGE 224

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAV-KRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRLLGC 155
           +G G +G   K   K   +I V K L  G   +  ++M  +E +++ +++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 156 CIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSR- 211
            ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 212 -VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
              ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 271 IFSIKSDVFSFGVLLLEIVS 290
            ++ KSD++S G LL E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 111/217 (51%), Gaps = 22/217 (10%)
Query: 87  STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RL-SGRSGQGLREMKNEAS 139
           S   + +    +LG G F  V K   K  G E A K     RL S R G    E++ E +
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
           ++ +++H N++ L     +K + +LI E +    L  FL +  + +  D  T  Q ++ I
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQI 138
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSR 254
             G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----N 191
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           I GT  +++PE        +++D++S GV+   ++SG
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 270
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 328 VDIWSLGIMVIEMVDGE 344

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 143
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 201 VDIWSLGIMVIEMVDGE 217

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 76  DQLPL--------FSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVK 121
           D+LPL        +  S      ++      LG G FG V +    G+ K      +AVK
Sbjct: 41  DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 100
Query: 122 RL-SGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL 178
            L  G +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L
Sbjct: 101 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 160
Query: 179 ------FDPTK----RMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNIL 225
                 F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NIL
Sbjct: 161 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNIL 217
Query: 226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           L +    KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL
Sbjct: 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277
Query: 286 LEIVS 290
            EI S
Sbjct: 278 WEIFS 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 30/240 (12%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--LREMKNEASVIAKV 144
           T   +++    LG+G FG V K   +    E AVK ++  S +      +  E  ++ K+
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGL 203
            H N+++L     D     ++ E      L    FD   KR         +II+ +  G+
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 204 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGT 258
            Y+H+++   I+HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGT 186
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL------GYAWDL 312
             Y++PE  L G +  K DV+S GV+L  ++SG      Y  +  ++L       YA+DL
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDL 243

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASV--IA 142
           AT+++    ++G G +G VYK      G  +A+K +   +G  G  +  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 143 KVQHKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
             +H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVV 173
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 73  KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVKRL-SG 125
           +  ++LP +  S      ++      LG G FG V +    G+ K      +AVK L  G
Sbjct: 1   EHAERLP-YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 59
Query: 126 RSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL----- 178
            +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L     
Sbjct: 60  ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 179 -FDPTK----RMLLDWVTRVQII---EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 230
            F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL +  
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 176
Query: 231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 177 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 73  KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYK----GVLKKGD--EIAVKRL-SG 125
           +  ++LP +  S      ++      LG G FG V +    G+ K      +AVK L  G
Sbjct: 1   EHCERLP-YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 59
Query: 126 RSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL-IYEYMPNKSLDFFL----- 178
            +    R + +E  ++  +  H N+V LLG C      ++ I E+    +L  +L     
Sbjct: 60  ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 179 -FDPTK----RMLLDWVTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 230
            F P K     +  D++T   +I     +A+G+ +L   +  + IHRDL A NILL +  
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 176
Query: 231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             KI DFG+AR    +              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 177 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAV-KRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRLLGC 155
           +G G +G   K   K   +I V K L  G   +  ++M  +E +++ +++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 156 CIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSR- 211
            ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 212 -VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
              ++HRDLK +N+ LD   N K+ DFG+ARI   +E  A     VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM 191
Query: 271 IFSIKSDVFSFGVLLLEIVS 290
            ++ KSD++S G LL E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 30/240 (12%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--LREMKNEASVIAKV 144
           T   +++    LG+G FG V K   +    E AVK ++  S +      +  E  ++ K+
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGL 203
            H N+++L     D     ++ E      L    FD   KR         +II+ +  G+
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 204 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGT 258
            Y+H+++   I+HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGT 186
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL------GYAWDL 312
             Y++PE  L G +  K DV+S GV+L  ++SG      Y  +  ++L       YA+DL
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDL 243

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAK 143
           + +    +LG G F  V K   K  G E A K +      S R G    E++ E +++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           ++H N++ L     +K + +LI E +    L  FL +  + +  D  T  Q ++ I  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQILDGV 128
Query: 204 LYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSRIVGT 258
            YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     I GT
Sbjct: 129 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGT 181
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             +++PE        +++D++S GV+   ++SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 89  ATNKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVI 141
           A+ KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
            K+QH N+VRL     ++    L+++ +    L     D   R           I+ I +
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILE 139
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR---- 254
            + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S     
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHG 189
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 149 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 198
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 140 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 189
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 73  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 126
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 187 VDVWSCGIVLTAMLAGE 203

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   +   L   +K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 74/309 (23%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           F +   +G GGFG V+K   +  G    ++R+   + +  RE+K     +AK+ H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIVH 69
Query: 152 LLGCCIDKDEKILIYEYMP---NKSLDFFLFDPT---------------------KRMLL 187
             GC          ++Y P   + SL+   +DP                      K  L 
Sbjct: 70  YNGCWDG-------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 188 DWVTR-----------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD 236
            W+ +           +++ E I +G+ Y+H     ++IHRDLK SNI L      KI D
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 237 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG 296
           FG+      +      +R  GT  YMSPE      +  + D+++ G++L E+        
Sbjct: 180 FGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL-------- 228
Query: 297 LYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT 356
                 L++   A++  TS    +L D I+ D +  K   L         + +  +DRP 
Sbjct: 229 ------LHVCDTAFE--TSKFFTDLRDGIISDIFDKKEKTL-----LQKLLSKKPEDRPN 275
Query: 357 MNDVVSMLT 365
            ++++  LT
Sbjct: 276 TSEILRTLT 284

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 106/239 (44%), Gaps = 25/239 (10%)
Query: 61  PANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-A 119
           P NN + + + K++ ++           A   F     LG+G FG VY    K+   I A
Sbjct: 9   PENNPEEELASKQKNEE-----SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA 63
Query: 120 VKRL--SGRSGQGL-REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 176
           +K L  +     G+  +++ E  + + ++H N++RL G   D     LI EY P   L  
Sbjct: 64  LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGT 120
Query: 177 FLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD 236
              +  K    D       I  +A  L Y H     R+IHRD+K  N+LL      KI+D
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIAD 177
Query: 237 FGMARICGGNELQANTSR---IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           FG +       + A +SR   + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 178 FGWS-------VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 193
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E+V G+
Sbjct: 251 VDIWSLGIMVIEMVDGE 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNE 137
           +  S   A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 138 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
             + + ++H N++RL G   D     LI EY P   L     +  K    D       I 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYIT 118
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--- 254
            +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   
Sbjct: 119 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAA 168
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 79
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 132
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 271
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 188
Query: 272 FS-IKSDVFSFGVLL 285
           ++  + DV+S GV+L
Sbjct: 189 YAGPEVDVWSCGVIL 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 177
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGD----EIAVKRLSGR--SGQGLREMKNEASVIAKV 144
            +F+    LG+G FG V +  LK+ D    ++AVK L     +   + E   EA+ + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 145 QHKNLVRLLGCCIDKDEK------ILIYEYMPNKSLDFFLF------DPTKRMLLDWVTR 192
            H ++ +L+G  +    K      ++I  +M +  L  FL       +P     L   T 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN---LPLQTL 139
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQA 250
           V+ +  IA G+ YL   S    IHRDL A N +L +DM   ++DFG++R    G    Q 
Sbjct: 140 VRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             S++     +++ E   + ++++ SDV++FGV + EI++
Sbjct: 197 CASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 78
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 131
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 271
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 187
Query: 272 FS-IKSDVFSFGVLL 285
           ++  + DV+S GV+L
Sbjct: 188 YAGPEVDVWSCGVIL 202

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 131/276 (47%), Gaps = 26/276 (9%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 152 LLGCCID--KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G      + E  L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 128
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYA 267
           SR R +HRDL A NIL++ + + KI+DFG+A++   ++      R  G     + +PE  
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DXXVVREPGQSPIFWYAPESL 186
Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID---- 323
            + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+    R LEL++    
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 246
Query: 324 -PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMN 358
            P      +  H L++      LC   S  DRP+ +
Sbjct: 247 LPAPPACPAEVHELMK------LCWAPSPQDRPSFS 276

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 125 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 174
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 151
           LG+G FG V+    KK ++  A+K L  +    L +   E +++ K       +H  L  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           +      K+    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG- 139
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 270
             I++RDLK  NILLDKD + KI+DFGM   C  N L  A T+   GT  Y++PE  L  
Sbjct: 140 --IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            ++   D +SFGVLL E++ G+
Sbjct: 195 KYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLDY 173
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 69
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 122
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 271
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 178
Query: 272 FS-IKSDVFSFGVLL 285
           ++  + DV+S GV+L
Sbjct: 179 YAGPEVDVWSCGVIL 193

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 173
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 73
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                 KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 126
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 271
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 182
Query: 272 FS-IKSDVFSFGVLL 285
           ++  + DV+S GV+L
Sbjct: 183 YAGPEVDVWSCGVIL 197

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 32/285 (11%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 152 LLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G       + L  + EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 264
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 199
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID- 323
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +R LEL++ 
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 324 ----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
               P      +  H L++      LC   S  DRP+ + +   L
Sbjct: 260 GQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFSALGPQL 298

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 99  LGEGGFGPV-----YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           LGEG FG V     YK   K   +   ++L  +S   +R ++ E S +  ++H ++++L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                  + +++ EY   +  D+ +    KRM  D   R    + I   + Y H++   +
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRR--FFQQIICAIEYCHRH---K 128
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           I+HRDLK  N+LLD ++N KI+DFG++ I   GN L+ +     G+  Y +PE     ++
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKLY 184
Query: 273 S-IKSDVFSFGVLLLEIVSGK 292
           +  + DV+S G++L  ++ G+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 151
           LG+G FG V+    KK ++  A+K L  +    L +   E +++ K       +H  L  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           +      K+    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG- 138
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 270
             I++RDLK  NILLDKD + KI+DFGM   C  N L  A T+   GT  Y++PE  L  
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            ++   D +SFGVLL E++ G+
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 32/279 (11%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 152 LLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G       + L  + EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 130
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 264
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 186
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID- 323
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +R LEL++ 
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEE 246
Query: 324 ----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMN 358
               P      +  H L++      LC   S  DRP+ +
Sbjct: 247 GQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFS 279

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           K+GEG  G V     K  G ++AVK++  R  Q    + NE  ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +  DE  ++ E++   +L   +     RM  + +  V +   + + L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCL--SVLRALSYLHNQG---VIH 164
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 275
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 276 SDVFSFGVLLLEIVSGK 292
            D++S G++++E++ G+
Sbjct: 222 VDIWSLGIMVIEMIDGE 238

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   +   L   +K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDY 177
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 122 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 171
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 176
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASV 140
           S   A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  +
Sbjct: 5   SRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 200
            + ++H N++RL G   D     LI EY P   L     +  K    D       I  +A
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELA 121
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVG 257
             L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + G
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCG 171
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 49/290 (16%)
Query: 93  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           F +   +G GGFG V+K   +  G    +KR+   + +  RE+K     +AK+ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK----ALAKLDHVNIVH 68
Query: 152 LLGCC--IDKDEK--------------ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
             GC    D D +               +  E+    +L+ ++ +  +   LD V  +++
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
            E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      +       R 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRS 181
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS 315
            GT  YMSPE      +  + D+++ G++L E+              L++   A++  TS
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL--------------LHVCDTAFE--TS 225
Query: 316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
               +L D I+ D +  K   L         + +  +DRP  ++++  LT
Sbjct: 226 KFFTDLRDGIISDIFDKKEKTL-----LQKLLSKKPEDRPNTSEILRTLT 270

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAV-KRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRLLGC 155
           +G G +G   K   K   +I V K L  G   +  ++M  +E +++ +++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 156 CIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSR- 211
            ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 212 -VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
              ++HRDLK +N+ LD   N K+ DFG+ARI   N   +     VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRM 191
Query: 271 IFSIKSDVFSFGVLLLEIVS 290
            ++ KSD++S G LL E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 175
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           Y H     R+IHRD+K  N+LL      KI+DFG +  C     +  T  + GT  Y+ P
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT--LSGTLDYLPP 176
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 80  LFSFSSVSTATNKFSDANKLGEGGFGPVY---KGVLKKGDEIAVKRLSGRSGQGLREMKN 136
           +F  S     +  +    KLG G +G V      V      I + R +  S     ++  
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 137 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQI 195
           E +V+  + H N+++L     DK    L+ E      L    FD    RM  + V    I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVI 141
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANT 252
           I+ +  G+ YLH+++   I+HRDLK  N+LL   +KD   KI DFG++ +    E Q   
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKM 195
Query: 253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
              +GT  Y++PE  L   +  K DV+S GV+L  +++G
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 90  TNKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIA 142
           + KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           K+QH N+VRL     ++    L+++ +    L     D   R           I+ I + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILES 117
Query: 203 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----I 255
           + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S      
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGF 167
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE         K D++S GVL  E + GK
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 131/285 (45%), Gaps = 32/285 (11%)
Query: 97  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 152 LLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G       + L  + EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 264
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 187
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID- 323
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+    R LEL++ 
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEE 247
Query: 324 ----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
               P      +  H L++      LC   S  DRP+ + +   L
Sbjct: 248 GQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFSALGPQL 286

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 102 GGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC-----C 156
           G FG V+K  L   + +AVK    +  Q  +  + E   +  ++H+N+++ +G       
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-------Y 209
           +D D   LI  +    SL  FL    K  ++ W     I E +A+GL YLH+        
Sbjct: 93  VDVD-LWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            +  I HRD+K+ N+LL  ++   I+DFG+A      +   +T   VGT  YM+PE  LE
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLE 206
Query: 270 GIFSIKSDVF------SFGVLLLEIVS 290
           G  + + D F      + G++L E+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 120 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 169
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 90  TNKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIA 142
           + KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           K+QH N+VRL     ++    L+++ +    L     D   R           I+ I + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILES 117
Query: 203 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----I 255
           + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S      
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGF 167
Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 91  NKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAK 143
            KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA +  K
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           +QH N+VRL     ++    L+++ +    L     D   R           I+ I + +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 117
Query: 204 LYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----IV 256
            Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S       
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGFA 167
Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQH 146
           T  ++ +    +G+G +G V++G  + G+ +AVK  S R  +   RE +   +V+  ++H
Sbjct: 5   TVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRH 61
Query: 147 KNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           +N++  +   +       +  LI  Y    SL    +D  +   LD V+ ++I+  IA G
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASG 117
Query: 203 LLYLH-----QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRI 255
           L +LH        +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 256 VGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 297
           VGT  YM+PE   E I         + D+++FG++L E+     + G+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 84  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIA 142
           SS     + F     LG+G FG V    +K+ GD  AVK L  +    L++   E ++  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTE 73
Query: 143 KV------QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           K        H  L +L  C    D    + E++    L F +     R   +   R    
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAA 131
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSR 254
           E I   L++LH      II+RDLK  N+LLD + + K++DFGM +  IC G      T+ 
Sbjct: 132 E-IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTTAT 183
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             GT  Y++PE   E ++    D ++ GVLL E++ G 
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 111/215 (51%), Gaps = 23/215 (10%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS---------GRSGQGLREMK 135
           V +   ++   + LGEG F  VYK   K  ++I A+K++          G +   LRE+K
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 136 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
               ++ ++ H N++ LL     K    L++++M    L+  + D +  +    +    +
Sbjct: 65  ----LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYML 119
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
           +    QGL YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+  G    +A   ++
Sbjct: 120 M--TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYXHQV 173
Query: 256 VGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIV 289
           V T  Y +PE      ++ +  D+++ G +L E++
Sbjct: 174 V-TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G +G V++G  + G+ +AVK  S R  +   RE +   +V+  ++H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 158 ----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-----Q 208
                  +  LI  Y    SL    +D  +   LD V+ ++I+  IA GL +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 266
             +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 267 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 297
             E I         + D+++FG++L E+     + G+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 133 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-----DFFLFDPTKRMLL 187
           + KNE  +I  ++++  +   G   + DE  +IYEYM N S+      FF+ D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  II+ +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 248 LQANTSRIVGTYGYMSPE-YALEGIFS-IKSDVFSFGVLL 285
           ++   SR  GTY +M PE ++ E  ++  K D++S G+ L
Sbjct: 207 IKG--SR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G +G V++G  + G+ +AVK  S R  +   RE +   +V+  ++H+N++  +   +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 101
Query: 158 ----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-----Q 208
                  +  LI  Y    SL    +D  +   LD V+ ++I+  IA GL +LH      
Sbjct: 102 TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 266
             +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  VGT  YM+PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 267 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 297
             E I         + D+++FG++L E+     + G+
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR   + GT  Y
Sbjct: 125 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDY 174
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 203
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 262
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 203
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 262
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 112/220 (50%), Gaps = 34/220 (15%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 142
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 193
            ++H+N+V L+  C  K        Y   K+  + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 194 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 249
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 250 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 288
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 203
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 262
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 203
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 262
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 111/220 (50%), Gaps = 34/220 (15%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 142
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 193
            ++H+N+V L+  C  K        Y   K   + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKASP-----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 194 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 249
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 250 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 288
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG  G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 277 -DVFSFGVLLLEIVSGK 292
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 99  LGEGGFGPVYKGVL--KKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHKNLVRLL 153
           LGEG FG VY+GV    KG++I V   + +    L    +  +EA ++  + H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I+++   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLY 298
           +  SDV+ F V + EI+S  K    +
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 99  LGEGGFGPVYKGVL--KKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHKNLVRLL 153
           LGEG FG VY+GV    KG++I V   + +    L    +  +EA ++  + H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I+++   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLY 298
           +  SDV+ F V + EI+S  K    +
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 111/220 (50%), Gaps = 34/220 (15%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 142
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 71
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 193
            ++H+N+V L+  C  K        Y   K   + +FD  +  L   ++ V         
Sbjct: 72  LLKHENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 194 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 249
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 250 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 288
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 184 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 144
           A   F     LG+G FG VY    K    I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 261
           Y H     ++IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDY 172
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS---GQGL-REMKNEASVIAKVQHKN 148
           F     LG+G FG VY    KK   I   ++  +S    +G+  +++ E  + A + H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++RL     D+    LI EY P   L   L    K    D      I+E +A  L+Y H 
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYCHG 141
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               ++IHRD+K  N+LL      KI+DFG +       L+  T  + GT  Y+ PE   
Sbjct: 142 ---KKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT--MCGTLDYLPPEMIE 194
Query: 269 EGIFSIKSDVFSFGVLLLEIVSG 291
             + + K D++  GVL  E++ G
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 111/220 (50%), Gaps = 34/220 (15%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 142
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 193
            ++H+N+V L+  C  K        Y   K   + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 194 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 249
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 250 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 288
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 99  LGEGGFGPVYKGVL--KKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHKNLVRLL 153
           LGEG FG VY+GV    KG++I V   + +    L    +  +EA ++  + H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I+++   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLY 298
           +  SDV+ F V + EI+S  K    +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 148
           F     LG+G FG VY    ++   I A+K L  +     G+  +++ E  + + ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++RL G   D     LI EY P   L     +  K    D       I  +A  L Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 265
               R+IHRD+K  N+LL  +   KI+DFG +       + A +SR   + GT  Y+ PE
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPE 180
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSG 291
                +   K D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 148
           F     LG+G FG VY    ++   I A+K L  +     G+  +++ E  + + ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++RL G   D     LI EY P   L     +  K    D       I  +A  L Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 265
               R+IHRD+K  N+LL  +   KI+DFG +       + A +SR   + GT  Y+ PE
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPE 180
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSG 291
                +   K D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPA 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 87  STATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASV----- 140
           S AT+++    ++G G +G VYK      G  +A+K +   +G G       ++V     
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 141 ---IAKVQHKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTR 192
              +   +H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 252
             ++    +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMAL 176
Query: 253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           + +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 98  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN-EASVIAKVQHKNLVRL--- 152
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 153 ---LGCCIDKDEKILIYEYMPNKSLDFFL--FD--------PTKRMLLDWVTRVQIIEGI 199
              L      D  +L  EY     L  +L  F+        P + +L D          I
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD----------I 131
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIV 256
           +  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     EL    +  V
Sbjct: 132 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFV 185
Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           GT  Y++PE   +  +++  D +SFG L  E ++G
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 98  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN-EASVIAKVQHKNLVRL--- 152
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 153 ---LGCCIDKDEKILIYEYMPNKSLDFFL--FD--------PTKRMLLDWVTRVQIIEGI 199
              L      D  +L  EY     L  +L  F+        P + +L D          I
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD----------I 130
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIV 256
           +  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     EL    +  V
Sbjct: 131 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFV 184
Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           GT  Y++PE   +  +++  D +SFG L  E ++G
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 194
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 195 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 248 LQANTSRIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 123
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 180
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 234
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQH 146
           N F     LG+GGFG V    ++   ++     +++   +  +G     NE  ++ KV  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           + +V L      KD   L+   M    L F ++   +    +    V     I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFYAAEICCGLEDL 302
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 265
           H   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT GYM+PE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 355
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 ++   D ++ G LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 194
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 195 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GG 245
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           N +    +R+     +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 223 NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 194
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 195 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 210
Query: 248 LQANTSRIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 194
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 195 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 212
Query: 248 LQANTSRIVG-----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQH 146
           N F     LG+GGFG V    ++   ++     +++   +  +G     NE  ++ KV  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           + +V L      KD   L+   M    L F ++   +    +    V     I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFYAAEICCGLEDL 302
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 265
           H   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT GYM+PE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 355
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 ++   D ++ G LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 80
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 137
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 191
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG 296
           E      +S++SD++S G+ L+E+  G+   G
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 181
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 116/245 (47%), Gaps = 34/245 (13%)
Query: 59  ELPANNKQAKR-----SKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK 113
           EL  + +Q KR     ++K++V +L            + F   ++LG G  G V+K   K
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGEL----------KDDDFEKISELGAGNGGVVFKVSHK 55
Query: 114 KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 167
               +  ++L           Q +RE++    V+ +     +V   G      E  +  E
Sbjct: 56  PSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD 227
           +M   SLD  L     R+    + +V I   + +GL YL +  + +I+HRD+K SNIL++
Sbjct: 112 HMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVN 166
Query: 228 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 287
                K+ DFG++    G  + +  +  VGT  YMSPE      +S++SD++S G+ L+E
Sbjct: 167 SRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 288 IVSGK 292
           +  G+
Sbjct: 223 MAVGR 227

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 194
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 195 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 217
Query: 248 LQANTSRIVG-----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 181
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++   + +G G +G V     +K G +IAVK+LS R  Q +   K    E  +
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRL 103
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P  SL    D +L        L+ + + Q  
Sbjct: 104 LKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKL 151
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 152 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 203
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 306
                +  V T  Y +PE  L  + +++  D++S G ++ E+++G+  T    TD +N L
Sbjct: 204 TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR--TLFPGTDHINQL 261

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V K   +    I  ++L           Q +RE++    V+ + 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 71
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L +  KR+  + + +V I   + +GL 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI--AVLRGLA 128
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YM+P
Sbjct: 129 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAP 182
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 144
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 64
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 121
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  +    +  VGT  YMSP
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSP 175
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           E      +S++SD++S G+ L+E+  G+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +++   +G G FG V++  L + DE+A+K++     Q  R    E  ++  V+H N+V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVDL 97
Query: 153 LGCCI---DKDEKI---LIYEYMPN----KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
                   DK +++   L+ EY+P      S  +     T  MLL  +   Q++  +A  
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA-- 155
Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGY 261
             Y+H    + I HRD+K  N+LLD      K+ DFG A+I    E   N S I   Y Y
Sbjct: 156 --YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSRY-Y 207
Query: 262 MSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            +PE       ++   D++S G ++ E++ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 250
           +++I    Q L + HQ     IIHRD+K +NIL+      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX- 174
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRML 186
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            +   T  +V  Y Y +PE  L   +    D++S GV++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQH 146
           T   +     ++G+G +G V+ G  + G+++AVK   +       RE +   +V+  ++H
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRH 90
Query: 147 KNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           +N++  +   I       +  LI +Y  N SL    +D  K   LD  + +++      G
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 203 LLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRI 255
           L +LH        +  I HRDLK+ NIL+ K+    I+D G+A   I   NE+    +  
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 256 VGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIV 289
           VGT  YM PE   E +        I +D++SFG++L E+ 
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRML 186
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            +   T  +V  Y Y +PE  L   +    D++S GV++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 145
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 206 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 260
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 65/118 (55%), Gaps = 9/118 (7%)
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 250
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-T 174
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 308
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+     +  DS + + Y
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPDSVAY 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 17/215 (7%)
Query: 93  FSDANKLGEGGFGPVYK-GVLKKGDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHKN 148
           F     LG G FG V+       G   A+K L       L+++++   E  +++ V H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++R+ G   D  +  +I +Y+    L F L   ++R   + V +    E +   L YLH 
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQR-FPNPVAKFYAAE-VCLALEYLHS 124
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
                II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE   
Sbjct: 125 KD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVS 176
Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
              ++   D +SFG+L+ E+++G   T  Y ++++
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTM 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--------------- 135
           ++F     LG+G FG V+           VK++SG   + L  MK               
Sbjct: 24  SQFELLKVLGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRT 73
Query: 136 -NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
             E  ++ +V H  +V+L      + +  LI +++  +  D F     + M  +   +  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 131
Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           + E +A  L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +  
Sbjct: 132 LAE-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 185
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             GT  YM+PE       +  +D +SFGVL+ E+++G
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 250
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT- 174
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 94
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 250
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT- 174
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 99  LGEGGFGPVY--KGVLK--KGDEIAVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVR 151
           LG+G FG V+  + V +   G   A+K L  ++   +R+    K E  ++A V H  +V+
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLK-KATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L      + +  LI +++  +  D F     + M  +   +  + E +A GL +LH    
Sbjct: 95  LHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLDHLHS--- 148
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
           + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQG 206
Query: 272 FSIKSDVFSFGVLLLEIVSG 291
            S  +D +S+GVL+ E+++G
Sbjct: 207 HSHSADWWSYGVLMFEMLTG 226

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVI 141
           + T+++     +G+G F  V + V L  G E A K     +LS R  Q L   + EA + 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKL---EREARIC 57
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
             ++H N+VRL     ++    L+++ +    L     D   R           I+ I +
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 114
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGT 258
            +L+ HQ     ++HRDLK  N+LL    K    K++DFG+A    G+  Q       GT
Sbjct: 115 AVLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD--QQAWFGFAGT 169
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 250
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT- 174
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 83  FSSVSTATNKFSD----ANKLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLR 132
           F  ++T T +F+D      +LG+G F  V + V K   +      I  K+LS R  Q L 
Sbjct: 20  FQXMATCT-RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL- 77
Query: 133 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR 192
             + EA +   ++H N+VRL     ++    L+++ +    L     D   R        
Sbjct: 78  --EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADA 132
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQ 249
              I  I + + ++HQ+    I+HRDLK  N+LL    K    K++DFG+A    G   Q
Sbjct: 133 SHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE--Q 187
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
                  GT GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 188 QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 96  ANKLGEGGFGPVYKGVLK-KGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            + LG G FG V  G  +  G ++AVK   R   RS   + +++ E   +   +H ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L        +  ++ EY+    L  ++    K   LD     ++ + I  G+ Y H++  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
             ++HRDLK  N+LLD  MN KI+DFG++ +    E    +    G+  Y +PE     +
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRL 191
Query: 272 FS-IKSDVFSFGVLLLEIVSG 291
           ++  + D++S GV+L  ++ G
Sbjct: 192 YAGPEVDIWSSGVILYALLCG 212

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 183 --TPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--------------- 135
           ++F     LG+G FG V+           VK++SG   + L  MK               
Sbjct: 24  SQFELLKVLGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRT 73
Query: 136 -NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
             E  ++ +V H  +V+L      + +  LI +++  +  D F     + M  +   +  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 131
Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           + E +A  L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +  
Sbjct: 132 LAE-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 185
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             GT  YM+PE       +  +D +SFGVL+ E+++G
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--------------- 135
           ++F     LG+G FG V+           VK++SG   + L  MK               
Sbjct: 25  SQFELLKVLGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRT 74
Query: 136 -NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
             E  ++ +V H  +V+L      + +  LI +++  +  D F     + M  +   +  
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 132
Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           + E +A  L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +  
Sbjct: 133 LAE-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 186
Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             GT  YM+PE       +  +D +SFGVL+ E+++G
Sbjct: 187 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRDLKA N+LLD DMN KI+DFG +     GN+L A            +P YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---------APPYAAPELFQ 185
Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 93
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--LFDPTKRMLLDWVTRVQ---- 194
           +  ++H+N++ LL              + P +SL+ F  ++  T  M  D    V+    
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 267
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 268 LEGIFSIKSDVFSFGVLLLEIVS 290
               FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 111/272 (40%), Gaps = 36/272 (13%)
Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYA 267
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 324
               FS  SD + FGV L E+ +                 Y  + W     ++ L  ID 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKIDK 239
Query: 325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPT 356
             E     +       N+ + C     +DRPT
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 250
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-T 191
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYA 267
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 268 LEGIFSIKSDVFSFGVLLLEIVS 290
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 89  ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKR-LSGRSGQGLREMK-NEASVIAKVQ 145
           +  K+ +   +GEG +G V K   K  G  +A+K+ L     + ++++   E  ++ +++
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H+NLV LL  C  K    L++E++ +  LD     P     LD+    + +  I  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGF 139
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSP 264
            H ++   IIHRD+K  NIL+ +    K+ DFG AR +    E+  +    V T  Y +P
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAP 193
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E  +  + +    DV++ G L+ E+  G+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ +   +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 84
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 85  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 133 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 184
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 267
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 268 LEGIFSIKSDVFSFGVLLLEIVS 290
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 15  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLHQYSR 211
               +    L+ EY     +  +L      +   W+   +       I   + Y HQ   
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYCHQKF- 126
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEG 270
             I+HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPE 175
Query: 271 IFSIKS------DVFSFGVLLLEIVSG 291
           +F  K       DV+S GV+L  +VSG
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 36/273 (13%)
Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 267
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 324
               FS  SD + FGV L E+ +                 Y  + W     ++ L  ID 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKIDK 239
Query: 325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTM 357
             E     +       N+ + C     +DRPT 
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 99  LGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI----IEGIAQGLLYLHQ 208
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 209 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            +   IIHRD+K  N+LL    N    K+ DFG+A   G + L A     VGT  +M+PE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSG 291
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRML 186
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 94
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT-DDE 198
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           +       V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 199 MXGX----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 31/269 (11%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 142
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS-SK 333
           + DV+S G ++  ++ GK     + T  L                E    I ++EYS  K
Sbjct: 201 EVDVWSIGCIMYTLLVGKPP---FETSCLK---------------ETYLRIKKNEYSIPK 242
Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVS 362
           H+     ++    +Q     RPT+N++++
Sbjct: 243 HINPVAASLIQKMLQTDPTARPTINELLN 271

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 267
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 268 LEGIFSIKSDVFSFGVLLLEIVS 290
               FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 31/269 (11%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS-SK 333
           + DV+S G ++  ++ GK     + T  L                E    I ++EYS  K
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLK---------------ETYLRIKKNEYSIPK 238
Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVS 362
           H+     ++    +Q     RPT+N++++
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 97  NKLGEGGFGPVYKGVLKKGDE-IAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +KLGEG +  VYKG  K  D  +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 66
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                +    L++EY+ +K L  +L D     +++       +  + +GL Y H   R +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGI- 271
           ++HRDLK  N+L+++    K++DFG+AR      +   T    V T  Y  P+  L    
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +S + D++  G +  E+ +G+
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 31/269 (11%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS-SK 333
           + DV+S G ++  ++ GK     + T  L                E    I ++EYS  K
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLK---------------ETYLRIKKNEYSIPK 238
Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVS 362
           H+     ++    +Q     RPT+N++++
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 267
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 268 LEGIFSIKSDVFSFGVLLLEIVS 290
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 71
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 84  SSVSTATNK------FSDANKLGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLRE 133
           +S+++AT++      +     +G+G F  V   + VL  G E+AVK +  +  +   L++
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQK 60
Query: 134 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 193
           +  E  ++  + H N+V+L      +    L+ EY     +  +L    +  + +   R 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARA 118
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANT 252
           +  + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN+L    
Sbjct: 119 KFRQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC 174
Query: 253 SRIVGTYGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSG 291
                     SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 G---------SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 72
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 121 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 172
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 173 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIAKVQHKNL 149
           +     +G G +G V   + K+ G+++A+K+LS   +S    +    E  ++  +QH+N+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           + LL              + P  SL    DF+L  P  +  L  +  ++  E   Q L+Y
Sbjct: 86  IGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY 133
Query: 206 -----LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
                L       ++HRDLK  N+ +++D   KI DFG+AR        A  +  V T  
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 188
Query: 261 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 71
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 73
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 74  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 122 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 173
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 174 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 59
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 60  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 118
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 119 ERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 175
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 176 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+A+K +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    LI EY     +  +L    +    +  ++ + I    Q   Y HQ    RI
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RI 135
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRDLKA N+LLD DMN KI+DFG +     G +L A            +P YA   +F 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG---------APPYAAPELFQ 186
Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       DV+S GV+L  +VSG
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 102 GGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL-----GCC 156
           G FG V+K  L   D +AVK    +  Q  +  + E      ++H+NL++ +     G  
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-------- 208
           ++  E  LI  +    SL  +L    K  ++ W     + E +++GL YLH+        
Sbjct: 84  LEV-ELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
             +  I HRD K+ N+LL  D+   ++DFG+A      +   +T   VGT  YM+PE  L
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VL 197
Query: 269 EGIFSIKSDVF------SFGVLLLEIVS 290
           EG  + + D F      + G++L E+VS
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 37/272 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 160
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 215
Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 331
            S + DV+S G ++  ++ GK     + T  L                E    I ++EYS
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPP---FETSCLK---------------ETYLRIKKNEYS 257
Query: 332 -SKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
             KH+     ++    +Q     RPT+N++++
Sbjct: 258 IPKHINPVAASLIQKMLQTDPTARPTINELLN 289

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 67
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 68  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 126
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 184 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRML 186
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 97  NKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLV 150
            +LG+G F  V + V +  G E A K     +LS R  Q   +++ EA +   ++H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIV 84
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           RL     ++    LI++ +    L     D   R           I+ I + +L+ HQ  
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 211 RVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
              ++HRDLK  N+LL    K    K++DFG+A    G   Q       GT GY+SPE  
Sbjct: 142 ---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVL 196
Query: 268 LEGIFSIKSDVFSFGVLLLEIVSG 291
            +  +    D+++ GV+L  ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 32/214 (14%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHKN 148
           +     +G G +G V   + K+ G+++A+K+LS R  Q     +    E  ++  +QH+N
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           ++ LL              + P  SL    DF+L  P  +  L  +  ++  E   Q L+
Sbjct: 103 VIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 205 Y-----LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
           Y     L       ++HRDLK  N+ +++D   KI DFG+AR        A  +  V T 
Sbjct: 151 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTR 205
Query: 260 GYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 86
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 86
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 94
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 85
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 185
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 85
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 185
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 93
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 97
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 197
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 198 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRML 186
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 90  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAV-----KRLSGRSGQGLREMKNEASVIAK 143
           T ++    +LG+G F  V + V +  G E A      K+LS R  Q L   + EA +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRL 66
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           ++H N+VRL     ++    LI++ +    L     D   R           I+ I + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 204 LYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G   Q       GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPG 178
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           Y+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 37/272 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 331
            S + DV+S G ++  ++ GK     + T  L                E    I ++EYS
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPP---FETSCLK---------------ETYLRIKKNEYS 259
Query: 332 -SKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
             KH+     ++    +Q     RPT+N++++
Sbjct: 260 IPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 37/272 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 331
            S + DV+S G ++  ++ GK     + T  L                E    I ++EYS
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPP---FETSCLK---------------ETYLRIKKNEYS 233
Query: 332 -SKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
             KH+     ++    +Q     RPT+N++++
Sbjct: 234 IPKHINPVAASLIQKMLQTDPTARPTINELLN 265

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++     +G G  G V   +  VL  G  +AVK+LS       R  +N+    
Sbjct: 18  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV LL C   K+   L+  + P K+L+ F        L D        M LD 
Sbjct: 67  AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   ++   D++S G ++ E+V G
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRML 186
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----H 176
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----H 180
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 138
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRML 186
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 84  SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEAS 139
           +S S     F     +G G +  V    LKK D I   R+  +      + +  ++ E  
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 140 VIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
           V  +   H  LV L  C   +     + EY+    L F +    +R L +   R    E 
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE- 161
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           I+  L YLH+     II+RDLK  N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 97
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E
Sbjct: 146 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE 201
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           +       V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 202 MXG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 84  SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEAS 139
           +S S     F     +G G +  V    LKK D I     VK+      + +  ++ E  
Sbjct: 13  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 140 VIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
           V  +   H  LV L  C   +     + EY+    L F +    +R L +   R    E 
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE- 129
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           I+  L YLH+     II+RDLK  N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+AV+ +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 38/282 (13%)
Query: 95  DANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKN---EASVIAKVQH-KNL 149
           D  ++G G +G V K V K   +I AVKR+  RS    +E K    +  V+ +      +
Sbjct: 26  DLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--H 207
           V+  G    + +  +  E M   S  F  F      +LD V   +I+  I    +    H
Sbjct: 84  VQFYGALFREGDCWICMELM---STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY- 266
               ++IIHRD+K SNILLD+  N K+ DFG   I G        +R  G   YM+PE  
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERI 197
Query: 267 ---ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS--NRTLEL 321
              A    + ++SDV+S G+ L E+ +G+               + +  W S  ++  ++
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGR---------------FPYPKWNSVFDQLTQV 242
Query: 322 I--DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
           +  DP        +     ++N   LC+ +    RP   +++
Sbjct: 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+A+K +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 20  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    LI EY     +  +L    +    +  ++ + I    Q   Y HQ    RI
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RI 132
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRDLKA N+LLD DMN KI+DFG +     G +L              SP YA   +F 
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCG---------SPPYAAPELFQ 183
Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       DV+S GV+L  +VSG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 109/211 (51%), Gaps = 20/211 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAK 143
            K+    K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKE 57
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           ++HKN+VRL        +  L++E+  ++ L  + FD     L   + +  + + + +GL
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGL 114
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            + H  +   ++HRDLK  N+L++++   K++DFG+AR   G  ++  ++ +V T  Y  
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWYRP 169
Query: 264 PEYALEG-IFSIKSDVFSFGVLLLEIVSGKK 293
           P+      ++S   D++S G +  E+ +  +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 98  KLGEGGFGPVYKGVLKKGD-EIAVKRLS------GRSGQGLR-------EMKNEASVIAK 143
           KLG G +G V     K G  E A+K +       GR     +       E+ NE S++  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQG 202
           + H N+++L     DK    L+ E+     L    F+    R   D      I++ I  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILSG 158
Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMARICGGNELQANTSRIVGTY 259
           + YLH+++   I+HRD+K  NILL+     +N KI DFG++     +         +GT 
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTA 212
Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            Y++PE  L+  ++ K DV+S GV++  ++ G
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 94/168 (55%), Gaps = 16/168 (9%)
Query: 131 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLD 188
           + ++  E +++ K+ H N+V+L+    D +E  L  ++E +    +   +  PT + L +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136
Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNE 247
              R    + + +G+ YLH     +IIHRD+K SN+L+ +D + KI+DFG++    G + 
Sbjct: 137 DQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 248 LQANTSRIVGTYGYMSPEYALEG--IFSIKS-DVFSFGVLLLEIVSGK 292
           L +NT   VGT  +M+PE   E   IFS K+ DV++ GV L   V G+
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 104
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 105 AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 164 ERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 221 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G +G V++G L  G+ +AVK  S R  Q   RE +   +V+  ++H N++  +   +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVL--LRHDNILGFIASDM 72
Query: 158 ----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-----Q 208
                  +  LI  Y  + SL  FL    +R  L+    +++    A GL +LH      
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 266
             +  I HRD K+ N+L+  ++   I+D G+A +   G + L    +  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 267 ALEGIFS------IKSDVFSFGVLLLEI 288
             E I +        +D+++FG++L EI
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 60
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 61  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 119
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 120 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 176
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 177 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 60
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 61  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 119
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 120 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 176
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 177 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 17  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 65
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 66  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 124
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 125 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 181
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 182 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 67
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 68  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 126
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 184 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+AV+ +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---------SPPYAAPELFQ 185
Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 59
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 60  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 118
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 176 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 23  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 71
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 72  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 130
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 131 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 187
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 188 --TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 67
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 68  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 126
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 184 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 60
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 61  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 119
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 120 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 176
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 177 --TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------RPFQNQTH-- 104
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D       +M LD 
Sbjct: 105 AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 164 ERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 221 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D+G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++     +G G  G V   +  VL  G  +AVK+LS       R  +N+    
Sbjct: 16  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-------RPFQNQTH-- 64
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV LL C   K+   L+  + P K+L+ F        L D        M LD 
Sbjct: 65  AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH 123
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N + 
Sbjct: 124 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM 180
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             T  +V  Y Y +PE  L   +    D++S G ++ E+V G
Sbjct: 181 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 34/227 (14%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQ-HK 147
           K+    KLG+G +G V+K + ++ G+ +AVK++  + ++    +    E  ++ ++  H+
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 148 NLVRLLGCC-IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           N+V LL     D D  + L+++YM        L    +  +L+ V +  ++  + + + Y
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-------RICGGNELQANT------ 252
           LH      ++HRD+K SNILL+ + + K++DFG++       R+     L  N       
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 253 ------SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
                 +  V T  Y +PE  L      K  D++S G +L EI+ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 307
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 20  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 68
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 69  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 127
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 128 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 184
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
                 V T  Y +PE  L   +    D++S G ++ E++ G
Sbjct: 185 VP---FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
            S + D++S G +L  ++ GK
Sbjct: 203 HSFEVDIWSLGCILYTLLVGK 223

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 307
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 307
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 146
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 268
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 269 EGIFSIKSDVFSFGVLLLEIVS-GKK 293
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 146
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 268
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 269 EGIFSIKSDVFSFGVLLLEIVS-GKK 293
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 307
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS +  Q +   K    E  +
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-KPFQSIIHAKRTYRELRL 86
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 85
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 141
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 142 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 246

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 99  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLL 153
           +G G +  V    LKK D I     VK+      + +  ++ E  V  +   H  LV L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            C   +     + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 126
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 274 IKSDVFSFGVLLLEIVSGK 292
              D ++ GVL+ E+++G+
Sbjct: 185 FSVDWWALGVLMFEMMAGR 203

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 81/340 (23%), Positives = 135/340 (39%), Gaps = 92/340 (27%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 150
           F     +G GGFG V++   K  D   A+KR+   + +  RE +  E   +AK++H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 151 RLLGCCIDKDEKILIYE----YMPNKSLDFFLFDPT---------KRM------------ 185
           R     ++   +    E    ++ ++S D+ L  P+         +RM            
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 186 --------------------LLDWVTR------------VQIIEGIAQGLLYLHQYSRVR 213
                               L DW+ R            + I   IA+ + +LH      
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVGTYGYMS 263
           ++HRDLK SNI    D   K+ DFG+      +E +          A     VGT  YMS
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE      +S K D+FS G++L E++    +T + R   +          T  R L+   
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYS-FSTQMERVRII----------TDVRNLKF-- 291
Query: 324 PIL-EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
           P+L   +Y  +HM+++ +      +  S  +RP   D++ 
Sbjct: 292 PLLFTQKYPQEHMMVQDM------LSPSPTERPEATDIIE 325

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 79
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 135
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 144
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 268
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 201
Query: 269 EGIFSIKSDVFSFGVLLLEIVS-GKK 293
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 126
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 268
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 183
Query: 269 EGIFSIKSDVFSFGVLLLEIVS-GKK 293
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 99  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLL 153
           +G G +  V    LKK D I     VK+      + +  ++ E  V  +   H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            C   +     + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 130
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 188
Query: 274 IKSDVFSFGVLLLEIVSGK 292
              D ++ GVL+ E+++G+
Sbjct: 189 FSVDWWALGVLMFEMMAGR 207

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A+G+ +L   S  + IHRDL A NILL ++   KI DFG+AR    N            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M+PE   + I+S KSDV+S+GVLL EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
                +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 183 --EPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 97
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + +  ++     D +    T+ +  D +     +  I
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYLVTHL--MGADLYKLLKTQHLSNDHI--CYFLYQI 153
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 154 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 97
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 153
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 154 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEG 270
             +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE     
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NXYKAQTHGKWPVKWYAPECINYY 189
Query: 271 IFSIKSDVFSFGVLLLEIVS 290
            FS KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DF +AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 130
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 268
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 187
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
              FS KSDV+SFGVL+ E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 137
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 268
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 193
Query: 269 EGIFSIKSDVFSFGVLLLEIVS-GKK 293
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 98  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 124
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 268
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 181
Query: 269 EGIFSIKSDVFSFGVLLLEIVS 290
              FS KSDV+SFGVL+ E  S
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 99  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  +   + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               +    L+ EY     +  +L    +    +   + + I    Q   Y HQ     I
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-YALEGIF 272
           +HRDLKA N+LLD D N KI+DFG +     GN+L A      G   Y +PE +  +   
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYD 190
Query: 273 SIKSDVFSFGVLLLEIVSG 291
             + DV+S GV+L  +VSG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+ R      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLA 79
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 135
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 39/212 (18%)
Query: 98  KLGEGGFGPVYKG--------------VLK-KGDEIAVKRLSGRSGQGLREMKNEASVIA 142
           +LG G FG V KG              +LK + ++ A+K           E+  EA+V+ 
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQ 425
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           ++ +  +VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G
Sbjct: 426 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMG 481
Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGT 258
           + YL + +    +HRDL A N+LL      KISDFG+++    +E     Q +    V  
Sbjct: 482 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 538
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           Y   +PE      FS KSDV+SFGVL+ E  S
Sbjct: 539 Y---APECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS       R  +N+    
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------RPFQNQTH-- 66
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 189
           AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D       +M LD 
Sbjct: 67  AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
                +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 183 --EPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNL 149
           + D   +G G +G V   V  + G ++A+K+L    +S    +    E  ++  ++H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 150 VRLLGCCIDK---DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ-IIEGIAQGLLY 205
           + LL         D+    Y  MP    D       +++  D   R+Q ++  + +GL Y
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED---RIQFLVYQMLKGLRY 143
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           +H      IIHRDLK  N+ +++D   KI DFG+AR     +  +     V T  Y +PE
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPE 195
Query: 266 YALEGI-FSIKSDVFSFGVLLLEIVSGK 292
             L  + ++   D++S G ++ E+++GK
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPESINFRRF 189
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKR-LSGRSGQGLREMK-NEASVIAKVQHK 147
            K+    K+GEG +G V+K   +  G  +A+K+ L       ++++   E  ++ +++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           NLV LL     K    L++EY  +  L     D  +R + + + +  I     Q + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
           +++    IHRD+K  NIL+ K    K+ DFG AR+  G     +    V T  Y SPE  
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELL 174
Query: 268 L-EGIFSIKSDVFSFGVLLLEIVSG 291
           + +  +    DV++ G +  E++SG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI  FG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 98  KLGEGGFGPVYKG--------------VLK-KGDEIAVKRLSGRSGQGLREMKNEASVIA 142
           +LG G FG V KG              +LK + ++ A+K           E+  EA+V+ 
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQ 426
Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           ++ +  +VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G
Sbjct: 427 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMG 482
Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGT 258
           + YL +      +HRDL A N+LL      KISDFG+++    +E     Q +    V  
Sbjct: 483 MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 539
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           Y   +PE      FS KSDV+SFGVL+ E  S
Sbjct: 540 Y---APECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 96
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 157 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 210
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 89
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYXQRTLREIK----ILLR 81
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLA 79
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 135
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 75
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 131
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 111
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 225
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 109/211 (51%), Gaps = 20/211 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAK 143
            K+    K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKE 57
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           ++HKN+VRL        +  L++E+  ++ L  + FD     L   + +  + + + +GL
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGL 114
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            + H  +   ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T  Y  
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV-TLWYRP 169
Query: 264 PEYALEG-IFSIKSDVFSFGVLLLEIVSGKK 293
           P+      ++S   D++S G +  E+ +  +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 75
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 131
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 85
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 146 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 199
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 99  LGEGGFGPVYKGVL----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLL 153
           +G+G FG VY G      +   + A+K LS  +  Q +     E  ++  + H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 154 GCCIDKDE-KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           G  +  +    ++  YM +  L  F+  P +   +  +    +   +A+G+ YL   +  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYL---AEQ 143
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL----QANTSRIVGTYGYMSPEYAL 268
           + +HRDL A N +LD+    K++DFG+AR     E     Q   +R+   +       AL
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------AL 197
Query: 269 EGI----FSIKSDVFSFGVLLLEIVS 290
           E +    F+ KSDV+SFGVLL E+++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 78
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 139 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 192
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 82
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 138
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 83
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 139
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 140 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 244

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 74
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 130
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 131 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 235

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 82
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 143 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 196
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 89
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 112/233 (48%), Gaps = 29/233 (12%)
Query: 76  DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK-------RLSGRS 127
           D+LP   +++      K+   + +G G    V + V +  G E AVK       RLS   
Sbjct: 81  DELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 128 GQGLRE-MKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM 185
            + +RE  + E  ++ +V  H +++ L+          L+++ M    L  +L   T+++
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKV 195
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICG 244
            L       I+  + + + +LH  +   I+HRDLK  NILLD +M  ++SDFG +  +  
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 245 GNELQANTSRIVGTYGYMSPEY------ALEGIFSIKSDVFSFGVLLLEIVSG 291
           G +L+     + GT GY++PE            +  + D+++ GV+L  +++G
Sbjct: 253 GEKLR----ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVR 77
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 111
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 225
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 105
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 166 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 219
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 90
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 151 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 204
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 113
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 174 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 227
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 96  ANKLGEGGFGPVYKGVLK-KGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            + LG G FG V  G  +  G ++AVK   R   RS   + ++K E   +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L        +  ++ EY+    L  ++    K   ++ +   ++ + I   + Y H++  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
             ++HRDLK  N+LLD  MN KI+DFG++ +    E   ++    G+  Y +PE     +
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVISGRL 186
Query: 272 FS-IKSDVFSFGVLLLEIVSG 291
           ++  + D++S GV+L  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 115
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 176 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 229
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVR 77
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     +G G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EYMP   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 150
           F     LG G F  V     K  G   AVK +  ++ +G    ++NE +V+ K++H+N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
            L       +   L+ + +    L    FD   ++          +I  +   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLH-- 137
Query: 210 SRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
            R+ I+HRDLK  N+L    D++    ISDFG++++ G  ++    S   GT GY++PE 
Sbjct: 138 -RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPGYVAPEV 193
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
             +  +S   D +S GV+   ++ G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 158
           +G+G FG VY G       I +  +   +   L+  K E     + +H+N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 159 KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD 218
                +I      ++L   + D   +++LD     QI + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 219 LKASNILLDKDMNPK--ISDFGMARICGGNELQANTSRIVGTYGY-----------MSPE 265
           LK+ N+  D   N K  I+DFG+  I G  +      ++    G+           +SP+
Sbjct: 156 LKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 266 YALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP 324
              + + FS  SDVF+ G +  E+ +       ++T     +   W + T          
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHA---REWPFKTQPAEAI--IWQMGTG--------- 258
Query: 325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            ++   S   M     +I L C     ++RPT   ++ ML
Sbjct: 259 -MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     +G G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EYMP   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVR 77
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 81
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 142 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 195
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RLSGRSGQGLREMKNEASVIAK 143
           ++++    KLG G +G V     K  G E A+K      ++  S  G   + +E +V+ +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQ 77
Query: 144 VQHKNLVRLLGCCIDKDEKILIYE-YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           + H N+++L     DK    L+ E Y   +  D  +     R     V    I++ +  G
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSG 133
Query: 203 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 259
             YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+       +GT 
Sbjct: 134 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTA 187
Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 156
Query: 152 LLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 270
Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R        +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R        +A+  ++     +M+PE      F
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 217
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 148
           F     LG+G FG VY    K+   I A+K L  S    +G+  +++ E  + + ++H N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++R+     D+    L+ E+ P   L   L    K    D       +E +A  L Y H+
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHE 133
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 265
               ++IHRD+K  N+L+      KI+DFG +       + A + R   + GT  Y+ PE
Sbjct: 134 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 183
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSG 291
                    K D++  GVL  E + G
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 96  ANKLGEGGFGPVYKGVLK-KGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            + LG G FG V  G  +  G ++AVK   R   RS   + ++K E   +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L        +  ++ EY+    L  ++    K   ++ +   ++ + I   + Y H++  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
             ++HRDLK  N+LLD  MN KI+DFG++ +    E    +    G+  Y +PE     +
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 186
Query: 272 FS-IKSDVFSFGVLLLEIVSG 291
           ++  + D++S GV+L  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L+E++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+++D+    K++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R        +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 148
           F     LG+G FG VY    K+   I A+K L  S    +G+  +++ E  + + ++H N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++R+     D+    L+ E+ P   L   L    K    D       +E +A  L Y H+
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHE 132
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 265
               ++IHRD+K  N+L+      KI+DFG +       + A + R   + GT  Y+ PE
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 182
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSG 291
                    K D++  GVL  E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 191
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 194
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 140
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 194
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 195 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR-----H 174
Query: 248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 186
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A++++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIRKISPFEHQTYCQRTLREIK----ILLR 81
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 192
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 82
Query: 144 VQHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 138
Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 258
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V T
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 259 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 138/308 (44%), Gaps = 33/308 (10%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEA 138
           ++    N FS    +G GGFG VY       G +     +  KR+  + G+ L    NE 
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNER 239
Query: 139 SVIAKVQHKN--LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
            +++ V   +   +  +       +K+  I + M    L + L   ++  +         
Sbjct: 240 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFY 296
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 349
Query: 256 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 405
Query: 315 SNRTLELIDPILEDEYS-SKHMLLRYVNIALLCVQESAD---DRP---TMNDVVSMLTNE 367
               +EL D    +  S  + +L R VN  L C+   A    + P   +++  +  L   
Sbjct: 406 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 465
Query: 368 AAALLPPK 375
              L+PP+
Sbjct: 466 PPPLIPPR 473

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 138/308 (44%), Gaps = 33/308 (10%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEA 138
           ++    N FS    +G GGFG VY       G +     +  KR+  + G+ L    NE 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNER 240
Query: 139 SVIAKVQHKN--LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
            +++ V   +   +  +       +K+  I + M    L + L   ++  +         
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFY 297
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 350
Query: 256 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 406
Query: 315 SNRTLELIDPILEDEYS-SKHMLLRYVNIALLCVQESAD---DRP---TMNDVVSMLTNE 367
               +EL D    +  S  + +L R VN  L C+   A    + P   +++  +  L   
Sbjct: 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 466
Query: 368 AAALLPPK 375
              L+PP+
Sbjct: 467 PPPLIPPR 474

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 96  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLR-EMKNEASVIAKVQH-KNLVR 151
           + +LG G F  V + + K  G E A K L  R  GQ  R E+ +E +V+   +    ++ 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L     +  E ILI EY     + F L  P    ++     +++I+ I +G+ YLHQ + 
Sbjct: 94  LHEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 212 VRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
             I+H DLK  NILL   + P    KI DFGM+R  G          I+GT  Y++PE  
Sbjct: 152 --IVHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEIL 205
Query: 268 LEGIFSIKSDVFSFGVL 284
                +  +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGII 222

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 56/242 (23%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 143
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 144 VQHKNLV------------RLLGCCIDKD------EKILIYEYMPNKSLDFFLFDPTKRM 185
            +H+N++            ++    I +D       K+L  +++ N  + +FL+      
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ----- 136
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                        I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   
Sbjct: 137 -------------ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 246 NELQAN-TSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDS 302
           +       +  V T  Y +PE  L      KS D++S G +L E++S +    G +  D 
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240
Query: 303 LN 304
           LN
Sbjct: 241 LN 242

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 139/309 (44%), Gaps = 35/309 (11%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEA 138
           ++    N FS    +G GGFG VY       G +     +  KR+  + G+ L    NE 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNER 240
Query: 139 SVIAKVQHKN--LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
            +++ V   +   +  +       +K+  I + M    L + L   ++  +         
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFY 297
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 350
Query: 256 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 406
Query: 315 SNRTLELIDPILEDEYS-SKHMLLRYVNIALLC-------VQESADDRPTMNDVVSMLTN 366
               +EL D    +  S  + +L R VN  L C       V+ES   R +++  +  L  
Sbjct: 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR-SLDWQMVFLQK 465
Query: 367 EAAALLPPK 375
               L+PP+
Sbjct: 466 YPPPLIPPR 474

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 139/309 (44%), Gaps = 35/309 (11%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEA 138
           ++    N FS    +G GGFG VY       G +     +  KR+  + G+ L    NE 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNER 240
Query: 139 SVIAKVQHKN--LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
            +++ V   +   +  +       +K+  I + M    L + L   ++  +         
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFY 297
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
              I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 350
Query: 256 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 406
Query: 315 SNRTLELIDPILEDEYS-SKHMLLRYVNIALLC-------VQESADDRPTMNDVVSMLTN 366
               +EL D    +  S  + +L R VN  L C       V+ES   R +++  +  L  
Sbjct: 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR-SLDWQMVFLQK 465
Query: 367 EAAALLPPK 375
               L+PP+
Sbjct: 466 YPPPLIPPR 474

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RLSGRSGQGLREMKNEASVIAK 143
           ++++    KLG G +G V     K  G E A+K      ++  S  G   + +E +V+ +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQ 60
Query: 144 VQHKNLVRLLGCCIDKDEKILIYE-YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
           + H N+++L     DK    L+ E Y   +  D  +     R     V    I++ +  G
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSG 116
Query: 203 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 259
             YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+       +GT 
Sbjct: 117 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTA 170
Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+      K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRL 152
           +G+G FG V      K +E+  AVK L  ++    +E K+   E +V+ K V+H  LV L
Sbjct: 46  IGKGSFGKVLLA-RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                  D+   + +Y+    L + L    +R  L+   R    E IA  L YLH    +
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 158
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 271
            I++RDLK  NILLD   +  ++DFG+   C  N E  + TS   GT  Y++PE   +  
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 272 FSIKSDVFSFGVLLLEIVSG 291
           +    D +  G +L E++ G
Sbjct: 216 YDRTVDWWCLGAVLYEMLYG 235

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 67
Query: 158 DKD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 208
           +KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 209 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 265
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 266 YALEGIFSIK-------SDVFSFGVLLLEIV 289
             L+   ++K       +D+++ G++  EI 
Sbjct: 184 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 12/220 (5%)
Query: 92  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGL-REMKNEASVIAKVQHK 147
           +++    +GEG +G V   Y  V K    +A+K++S    Q   +    E  ++ + +H+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKT--RVAIKKISPFEHQTYCQRTLREIQILLRFRHE 101
Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           N++ +         + +   Y+    ++  L+   K   L        +  I +GL Y+H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEY 266
                 ++HRDLK SN+L++   + KI DFG+ARI           +  V T  Y +PE 
Sbjct: 162 S---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 267 ALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 304
            L      KS D++S G +L E++S +    G +  D LN
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 105
Query: 158 DKD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 208
           +KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 209 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 265
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 266 YALEGIFSIK-------SDVFSFGVLLLEIV 289
             L+   ++K       +D+++ G++  EI 
Sbjct: 222 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 148
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++ L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 209 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 263
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 66
Query: 158 DKD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 208
           +KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 209 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 265
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 266 YALEGIFSIK-------SDVFSFGVLLLEIV 289
             L+   ++K       +D+++ G++  EI 
Sbjct: 183 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 92
Query: 158 DKD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 208
           +KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 209 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 265
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 266 YALEGIFSIK-------SDVFSFGVLLLEIV 289
             L+   ++K       +D+++ G++  EI 
Sbjct: 209 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 99  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 153
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            +HRD+ A N+L+      K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 273 SIKSDVFSFGVLLLEIV 289
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 69
Query: 158 DKD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 208
           +KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 209 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 265
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 266 YALEGIFSIK-------SDVFSFGVLLLEIV 289
             L+   ++K       +D+++ G++  EI 
Sbjct: 186 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 72
Query: 158 DKD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 208
           +KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 209 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 265
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 266 YALEGIFSIK-------SDVFSFGVLLLEIV 289
             L+   ++K       +D+++ G++  EI 
Sbjct: 189 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 81  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKNEA 138
           F  S+       ++  N +G G +G V K  ++KG  I  A K++     + +   K E 
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR----VQ 194
            ++  + H N++RL     D  +  L+ E      L        +R++   V R     +
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL-------FERVVHKRVFRESDAAR 127
Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNP-KISDFGM-ARICGGNELQA 250
           I++ +   + Y H   ++ + HRDLK  N L   D   +P K+ DFG+ AR   G  ++ 
Sbjct: 128 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 184
Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
                VGT  Y+SP+  LEG++  + D +S GV++  ++ G
Sbjct: 185 K----VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           +++ D   LG GG G V+  V    D+ +A+K++     Q ++    E  +I ++ H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 150 VRL--------------LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
           V++              +G   + +   ++ EYM     +     P    LL+   R+ +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----LLEEHARLFM 126
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGN-ELQANTS 253
            + + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +   + + S
Sbjct: 127 YQ-LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 254 RIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 292
             + T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 148
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++ L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 209 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 263
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 204
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 148
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 200
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSG 291
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 204
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSG 291
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L+E++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+++D+    +++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 204
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 156
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSG 291
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 148
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++ L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 209 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 263
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 204
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSG 291
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 148
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++ L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 209 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 263
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 204
             LV+L     D     ++ EY P   +    F   +R+    +   R    + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSG 291
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 148
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++ L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 209 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 263
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 140
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 195
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 147
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 202
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     +G G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           ++  N +G G +G V K  ++KG  I  A K++     + +   K E  ++  + H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR----VQIIEGIAQGLLYL 206
           RL     D  +  L+ E      L        +R++   V R     +I++ +   + Y 
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGEL-------FERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 207 HQYSRVRIIHRDLKASNILL--DKDMNP-KISDFGM-ARICGGNELQANTSRIVGTYGYM 262
           H   ++ + HRDLK  N L   D   +P K+ DFG+ AR   G  ++      VGT  Y+
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK----VGTPYYV 175
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           SP+  LEG++  + D +S GV++  ++ G
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 96  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 148
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++ L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 209 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 263
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 90  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAK 143
           T+++    +LG+G F  V + + +  G E A K     +LS R  Q L   + EA +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL---EREARICRL 59
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
           ++H N+VRL     ++    L+++ +    L     D   R           I+ I + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESV 116
Query: 204 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
            + H      I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGTPG 171
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           Y+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 32/212 (15%)
Query: 99  LGEGGFGPVYKGVLKK-GD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           LG+G F  ++KGV ++ GD       E+ +K L              AS+++K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
              G C+  DE IL+ E++   SLD +L      + + W  ++++ + +A  + +L + +
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 211 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMA-RICGGNELQANTSRIVGTYGY 261
              +IH ++ A NILL      K  NP   K+SD G++  +   + LQ    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERI----PW 183
Query: 262 MSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 291
           + PE  +E     ++ +D +SFG  L EI SG
Sbjct: 184 VPPE-CIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 88  TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVI 141
           + T+++    +LG+G F  V + + +  G E A K     +LS R  Q L   + EA + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL---EREARIC 57
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
             ++H N+VRL     ++    L+++ +    L     D   R           I+ I +
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 114
Query: 202 GLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT 258
            + + H      I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT
Sbjct: 115 SVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGT 169
Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 99  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG G F  V     K+  +      IA K L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 153 LGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 206 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG G FG V++ V K  G     K ++         +KNE S++ ++ H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 157 IDKDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
            DK E +LI E++        LFD    +   +     +  +    +GL ++H++S   I
Sbjct: 118 EDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 215 IHRDLKASNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           +H D+K  NI+ +  K  + KI DFG+A     +E+   T+    T  + +PE       
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPV 227
Query: 273 SIKSDVFSFGVLLLEIVSG 291
              +D+++ GVL   ++SG
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 43/228 (18%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGL---REMKNEA 138
           +V     +      +G G +G V   Y   L++  ++AVK+LS R  Q L   R    E 
Sbjct: 14  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYREL 70
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--LFDPTKRMLLDW--VTRVQ 194
            ++  ++H+N++ LL              + P  S++ F  ++  T  M  D   + + Q
Sbjct: 71  RLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQ 118
Query: 195 ---------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                    ++  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR    
Sbjct: 119 ALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR---- 171
Query: 246 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            +     +  V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 172 -QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 175
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + GT  Y++PE 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 230
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 147
           N   +  ++G G  G V+K   +K G  IAVK  R SG   +  R + +   V+      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLY 205
            +V+  G  I   +  +  E M   +         KRM      R+  ++   I + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKL-----KKRMQGPIPERILGKMTVAIVKALYY 139
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           L +  +  +IHRD+K SNILLD+    K+ DFG   I G         R  G   YM+PE
Sbjct: 140 LKE--KHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 266 Y-----ALEGIFSIKSDVFSFGVLLLEIVSGK 292
                   +  + I++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 133/281 (47%), Gaps = 46/281 (16%)
Query: 98  KLGEGGFGPVYK-GVLKKGDEIAVKRLSG--RSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +LG G +G V K   +  G  +AVKR+     S +  R + +    +  V     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 155 CCIDKDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
               + +  +  E M + SLD F   + D  + +  D + ++ +   I + L +LH  S+
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 172
Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYALEG 270
           + +IHRD+K SN+L++     K+ DFG++    G  + +    I  G   YM+PE     
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDSVAKTIDAGCKPYMAPERINPE 228
Query: 271 I----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-----NRTLEL 321
           +    +S+KSD++S G+ ++E               L +L + +D W +      + +E 
Sbjct: 229 LNQKGYSVKSDIWSLGITMIE---------------LAILRFPYDSWGTPFQQLKQVVEE 273
Query: 322 IDPILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
             P L  D++S++     +V+    C+++++ +RPT  +++
Sbjct: 274 PSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELM 309

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           K+  A  LG G FG V++ V     +  + +     G     +K E S++   +H+N++ 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L       +E ++I+E++    LD F    T    L+    V  +  + + L +LH ++ 
Sbjct: 66  LHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 212 VRIIHRDLKASNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
             I H D++  NI+    +    KI +FG AR     +   N   +     Y +PE    
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH 177
Query: 270 GIFSIKSDVFSFGVLLLEIVSG 291
            + S  +D++S G L+  ++SG
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSG 199

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 99  LGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI----IEGIAQGLLYLHQ 208
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 209 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            +   IIHRD+K   +LL    N    K+  FG+A   G + L A     VGT  +M+PE
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSG 291
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 43/228 (18%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGL---REMKNEA 138
           +V     +      +G G +G V   Y   L++  ++AVK+LS R  Q L   R    E 
Sbjct: 22  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYREL 78
Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--LFDPTKRMLLDW--VTRVQ 194
            ++  ++H+N++ LL              + P  S++ F  ++  T  M  D   + + Q
Sbjct: 79  RLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQ 126
Query: 195 ---------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                    ++  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR    
Sbjct: 127 ALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR---- 179
Query: 246 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            +     +  V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 180 -QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 99  LGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI----IEGIAQGLLYLHQ 208
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 209 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            +   IIHRD+K   +LL    N    K+  FG+A   G + L A     VGT  +M+PE
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 205
Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSG 291
                 +    DV+  GV+L  ++SG
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 99  LGEGGFGPVYKGVLK-----KGDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNL 149
           LG+GG+G V++ V K      G   A+K L      R+ +     K E +++ +V+H  +
Sbjct: 25  LGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           V L+       +  LI EY+    L F   +     + D  T    +  I+  L +LHQ 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMED--TACFYLAEISMALGHLHQK 140
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYA 267
               II+RDLK  NI+L+   + K++DFG+ +  I  G      T    GT  YM+PE  
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHXFCGTIEYMAPEIL 193
Query: 268 LEGIFSIKSDVFSFGVLLLEIVSG 291
           +    +   D +S G L+ ++++G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 85  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGL---REMKNEA 138
           +V     +      +G G +G V   Y   L++  ++AVK+LS R  Q L   R    E 
Sbjct: 22  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYREL 78
Query: 139 SVIAKVQHKNLVRLL-----GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 193
            ++  ++H+N++ LL        I+   ++ +   +    L+  +     + L D    V
Sbjct: 79  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KSQALSD--EHV 133
Query: 194 Q-IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 252
           Q ++  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     
Sbjct: 134 QFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEM 185
Query: 253 SRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           +  V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 99  LGEGGFGPVYKGVLK-----KGDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNL 149
           LG+GG+G V++ V K      G   A+K L      R+ +     K E +++ +V+H  +
Sbjct: 25  LGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           V L+       +  LI EY+    L F   +     + D  T    +  I+  L +LHQ 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMED--TACFYLAEISMALGHLHQK 140
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYA 267
               II+RDLK  NI+L+   + K++DFG+ +  I  G      T    GT  YM+PE  
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHTFCGTIEYMAPEIL 193
Query: 268 LEGIFSIKSDVFSFGVLLLEIVSG 291
           +    +   D +S G L+ ++++G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 32/212 (15%)
Query: 99  LGEGGFGPVYKGVLKK-GD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           LG+G F  ++KGV ++ GD       E+ +K L              AS+++K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
              G C   DE IL+ E++   SLD +L      + + W  ++++ + +A  + +L + +
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 211 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMA-RICGGNELQANTSRIVGTYGY 261
              +IH ++ A NILL      K  NP   K+SD G++  +   + LQ    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERI----PW 183
Query: 262 MSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 291
           + PE  +E     ++ +D +SFG  L EI SG
Sbjct: 184 VPPE-CIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 204
             L +L     D     ++ EY P   +    F   +R+    +   R    + I     
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 156
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSG 291
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG G FG V++   +  G+  A K +          ++ E   ++ ++H  LV L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            D +E ++IYE+M    L   + D   +M  D    V+ +  + +GL ++H+ + V   H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENNYV---H 278
Query: 217 RDLKASNILL--DKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
            DLK  NI+    +    K+ DFG+ A +     ++  T    GT  + +PE A      
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVG 334
Query: 274 IKSDVFSFGVLLLEIVSG 291
             +D++S GVL   ++SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG G FG V++   +  G+  A K +          ++ E   ++ ++H  LV L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            D +E ++IYE+M    L   + D   +M  D    V+ +  + +GL ++H+ +    +H
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN---YVH 172
Query: 217 RDLKASNILL--DKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
            DLK  NI+    +    K+ DFG+ A +     ++  T    GT  + +PE A      
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVG 228
Query: 274 IKSDVFSFGVLLLEIVSG 291
             +D++S GVL   ++SG
Sbjct: 229 YYTDMWSVGVLSYILLSG 246

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 257
           I+ GL +LH+     II+RDLK  N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMMDGVTTREFCG 182
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y++PE      +    D +++GVLL E+++G+
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+++D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  +   V  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 19/178 (10%)
Query: 123 LSGRSGQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 180
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 241 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 291
            ++  G +L++    + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 172 CQLDPGEKLRS----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 99  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG G F  V     K+  +      IA + L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 153 LGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 206 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L +L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L +L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 99  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG G F  V     K+  +      IA + L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 153 LGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 206 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 99  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 152
           LG G F  V     K+  +      IA + L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 153 LGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 206 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 110/247 (44%), Gaps = 46/247 (18%)
Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           F +   LG+G FG V K          A+K++   + + L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 152 LLGCCID-------------KDEKILIYEYMPNKSLDFFLFDPTKRMLLD--WVTRVQII 196
                ++             K    +  EY  N++L   +         D  W    QI+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 241
           E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 242 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYR 299
           + G ++   N +  +GT  Y++ E  L+G   ++ K D++S G++  E++    +TG+ R
Sbjct: 180 LPGSSD---NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY-PFSTGMER 234
Query: 300 TDSLNLL 306
            + L  L
Sbjct: 235 VNILKKL 241

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 123 LSGRSGQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 180
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 241 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 291
            ++  G +L+     + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 172 CQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           KLG G FG V+    +  G E  +K ++  RS   + +++ E  V+  + H N++++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKR-MLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
             D     ++ E      L   +     R   L      ++++ +   L Y H      +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 215 IHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
           +H+DLK  NIL  +D +P    KI DFG+A +   +E   N +   GT  YM+PE     
Sbjct: 146 VHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVFKRD 201
Query: 271 IFSIKSDVFSFGVLLLEIVSG 291
           + + K D++S GV++  +++G
Sbjct: 202 V-TFKCDIWSAGVVMYFLLTG 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 123 LSGRSGQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 180
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 102
Query: 181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 103 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158
Query: 241 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 291
            ++  G +L+     + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 159 CQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 69  RSKKKEVDQLPLFSFSSV-STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR 126
           R +  E  Q P +  S   S     F   ++LG G +G V+K   K+ G   AVKR    
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR---- 89
Query: 127 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML 186
           S    R  K+ A  +A+V     V    CC+  ++    +E      L   L  P+ +  
Sbjct: 90  SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA---WEEGGILYLQTELCGPSLQQH 146
Query: 187 LD-W---VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM--- 239
            + W   +   Q+   +   LL L       ++H D+K +NI L      K+ DFG+   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 289
               G  E+Q    R      YM+PE  L+G +   +DVFS G+ +LE+ 
Sbjct: 207 LGTAGAGEVQEGDPR------YMAPEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 15  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 73
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 74  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 129
Query: 185 M--LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           +    +   R    + I     YLH    + +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 130 IGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 185
Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 186 VKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDE---IAVKRLSGRSGQGLREMKN---EASVIAKV 144
           + F     +G+G FG V   +++K D     A+K ++ +      E++N   E  ++  +
Sbjct: 15  DHFEILRAIGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
           +H  LV L     D+++  ++ + +    L + L    + +     T    I  +   L 
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALD 129
Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           YL      RIIHRD+K  NILLD+  +  I+DF +A +    E Q  T  + GT  YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAP 183
Query: 265 EY--ALEGI-FSIKSDVFSFGVLLLEIVSGKK 293
           E   + +G  +S   D +S GV   E++ G++
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 M--LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           +    +   R    + I     YLH    + +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 135 IGRFAEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 191 VKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 M--LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           +    +   R    + I     YLH    + +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 135 IGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 191 VKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 M--LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           +    +   R    + I     YLH    + +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 135 IGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 191 VKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 M--LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           +    +   R    + I     YLH    + +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 135 IGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
             G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 191 VKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 7   AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 65
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 66  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 121
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 122 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK 179
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 180 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 154
           ++G G F  VYKG+  +   E+A   L  R  +    +  K EA  +  +QH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 155 C---------CIDKDEKILIYEYMPNKSLDFFL--FDPTK-RMLLDWVTRVQIIEGIAQG 202
                     CI     +L+ E   + +L  +L  F   K ++L  W  +      I +G
Sbjct: 93  SWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKG 141
Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGY 261
           L +LH  +   IIHRDLK  NI +       KI D G+A +   +  +A    ++GT  +
Sbjct: 142 LQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEF 196
Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            +PE   E  +    DV++FG   LE  + +
Sbjct: 197 XAPE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 41  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 99
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 100 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 155
Query: 185 M--LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
           +    +   R    + I     YLH    + +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 156 IGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK- 210
Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
                ++  T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 21  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 79
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 80  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 135
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 136 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 194 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 143
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 8   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 121
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 122 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 177
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE   +  +    D +  GV++ E++ G+
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 143
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 10  NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 123
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 124 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 179
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE   +  +    D +  GV++ E++ G+
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 143
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 261
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 317
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE   +  +    D +  GV++ E++ G+
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 143
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 9   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 122
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 123 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 178
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE   +  +    D +  GV++ E++ G+
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 257
           IA GL +L       II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 504
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 137/295 (46%), Gaps = 48/295 (16%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYK-GVLKKGDEIAVKRLSG--RSGQGLREMKNEASVI 141
           S+    +      +LG G +G V K   +  G  +AVKR+     S +  R + +    +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEG 198
             V     V   G    + +  +  E M + SLD F   + D  + +  D + ++ +   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--S 117
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV-- 256
           I + L +LH  S++ +IHRD+K SN+L++     K+ DFG++       L  + ++ +  
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDA 170
Query: 257 GTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL 312
           G   YM+PE     +    +S+KSD++S G+ ++E               L +L + +D 
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE---------------LAILRFPYDS 215
Query: 313 WTS-----NRTLELIDPILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
           W +      + +E   P L  D++S++     +V+    C+++++ +RPT  +++
Sbjct: 216 WGTPFQQLKQVVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELM 265

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 143
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 151 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 264
Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 265 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 320
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE   +  +    D +  GV++ E++ G+
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 35/231 (15%)
Query: 83  FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASV 140
           F S+S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 141 IAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
           + K+Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKN 135
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI--- 255
           + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +   
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKD 186
Query: 256 --VGTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
             VGT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 187 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 32/230 (13%)
Query: 85  SVSTATNKFSDANKL-----GEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           S  + + +F D  +L     GEG    V   + L    E AVK +  + G     +  E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 139 SVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
            ++ + Q H+N++ L+    ++D   L++E M   S+   L    KR   + +    +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ 118
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNP-KISDFGMARICGGNELQANTSR 254
            +A  L +LH      I HRDLK  NIL +    ++P KI DFG+     G +L  + S 
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLG---SGIKLNGDCSP 172
Query: 255 I--------VGTYGYMSPE----YALEG-IFSIKSDVFSFGVLLLEIVSG 291
           I         G+  YM+PE    ++ E  I+  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 91  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 146
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             LV+L     D     ++ EY+    +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 257
           IA GL +L       II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 183
Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 53/225 (23%)
Query: 93  FSDANKLGEGGFGP-VYKGVLKKGDEIAVKRL-------SGRSGQGLREMKNEASVIAKV 144
           F   + LG G  G  VY+G+    D +AVKR+       + R  Q LRE           
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESD--------- 75
Query: 145 QHKNLVRLLGCCIDKDEKI----------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
           +H N++R    C +KD +            + EY+  K       +P           + 
Sbjct: 76  EHPNVIRYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------IT 122
Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMA-RICGGNEL 248
           +++    GL +LH    + I+HRDLK  NIL+        +   ISDFG+  ++  G   
Sbjct: 123 LLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 249 QANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVS 290
            +  S + GT G+++PE   E      +   D+FS G +   ++S
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 46/247 (18%)
Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           F +   LG+G FG V K          A+K++   + + L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 152 LLGCCID-------------KDEKILIYEYMPNKSLDFFLFDPTKRMLLD--WVTRVQII 196
                ++             K    +  EY  N +L   +         D  W    QI+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 241
           E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 242 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYR 299
           + G ++   N +  +GT  Y++ E  L+G   ++ K D++S G++  E++    +TG+ R
Sbjct: 180 LPGSSD---NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY-PFSTGMER 234
Query: 300 TDSLNLL 306
            + L  L
Sbjct: 235 VNILKKL 241

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 41  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 99
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 100 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 155
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 156 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--- 210
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
              ++  T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 211 --RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 99  LGEGGFGPVYKGVLKK---GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           LG G F  V+  ++K+   G   A+K +          ++NE +V+ K++H+N+V L   
Sbjct: 17  LGSGAFSEVF--LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ----IIEGIAQGLLYLHQYSR 211
                   L+ + +    L    FD   R+L   V   +    +I+ +   + YLH+   
Sbjct: 75  YESTTHYYLVMQLVSGGEL----FD---RILERGVYTEKDASLVIQQVLSAVKYLHENG- 126
Query: 212 VRIIHRDLKASNIL-LDKDMNPKI--SDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
             I+HRDLK  N+L L  + N KI  +DFG++++    E     S   GT GY++PE   
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLA 180
Query: 269 EGIFSIKSDVFSFGVLLLEIVSG 291
           +  +S   D +S GV+   ++ G
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCG 203

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ ++ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 124
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 125 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 179
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 32/230 (13%)
Query: 85  SVSTATNKFSDANKL-----GEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           S  +   KF D  KL     GEG +  V   V L+ G E AVK +  ++G     +  E 
Sbjct: 2   STDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREV 61
Query: 139 SVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
             + + Q +KN++ L+    D     L++E +   S+   L    K+   +     +++ 
Sbjct: 62  ETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVR 118
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNP-KISDFGMARICGGNELQANTSR 254
            +A  L +LH      I HRDLK  NIL +  + ++P KI DF +     G +L  + + 
Sbjct: 119 DVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLG---SGMKLNNSCTP 172
Query: 255 I--------VGTYGYMSPE----YALEGIFSIK-SDVFSFGVLLLEIVSG 291
           I         G+  YM+PE    +  +  F  K  D++S GV+L  ++SG
Sbjct: 173 ITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIA 142
           V   ++ F   + LGEG +G V     K  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 143 KVQHKNLVRLLGC----CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
             +H+N++ +         +   ++ I + +    L   +   + +ML D    +Q    
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSD--DHIQYF-- 117
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL--------QA 250
           I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q+
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 251 NTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 288
             +  V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 126
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 127 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 181
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIA 142
           V   ++ F   + LGEG +G V     K  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 143 KVQHKNLVRLLGC----CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
             +H+N++ +         +   ++ I + +    L   +   + +ML D    +Q    
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSD--DHIQYF-- 117
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL--------QA 250
           I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q+
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 251 NTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 288
             +  V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 97  NKLGEGGFGPV--YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
            KLGEGGF  V   +G L  G   A+KR+     Q   E + EA +     H N++RL+ 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 155 CCI----DKDEKILIYEYMPNKSLDFFLFDPTKRML--LDWVTRVQIIE---GIAQGLLY 205
            C+     K E  L+  +    +L    ++  +R+    +++T  QI+    GI +GL  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFG-MARICGGNE--LQANTSRIVG----T 258
           +H        HRDLK +NILL  +  P + D G M + C   E   QA T +       T
Sbjct: 150 IHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 259 YGYMSPEYALEGIFSIKS--------DVFSFGVLLLEIVSGK 292
             Y +PE     +FS++S        DV+S G +L  ++ G+
Sbjct: 207 ISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 34/230 (14%)
Query: 84  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 139
            S ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S   LR +     E  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59
Query: 140 VIAKVQHKNLVRLLGCCIDKD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 195
           V+ K+ HKN+V+L    I+++     K+LI E+ P  SL   L +P+    L     + +
Sbjct: 60  VLKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQAN 251
           +  +  G+ +L +     I+HR++K  NI+     D     K++DFG AR     EL+ +
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-----ELEDD 169
Query: 252 TS--RIVGTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 291
                + GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 170 EQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 93  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           F +   LG+G FG V K          A+K++   + + L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 152 LLGCCID-------------KDEKILIYEYMPNKSLDFFLFDPTKRMLLD--WVTRVQII 196
                ++             K    +  EY  N++L   +         D  W    QI+
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 241
           E ++    Y+H      IIHR+LK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 242 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIV 289
           + G ++   N +  +GT  Y++ E  L+G   ++ K D +S G++  E +
Sbjct: 180 LPGSSD---NLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSG------RSGQGLREM 134
           SF       +++     +G G +G V     +  G ++A+K++         + + LRE+
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 135 KNEASVIAKVQHKNLVRL---LGCCIDKDEKILIYEYMPNKSLDFF-LFDPTKRMLLDWV 190
           K    ++   +H N++ +   L   +   E   +Y  +     D   +   ++ + L+ V
Sbjct: 105 K----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 160
Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-IC-GGNEL 248
                +  + +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E 
Sbjct: 161 R--YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 249 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 293
           Q   +  V T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASV 140
           S ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S   LR +     E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEV 60
Query: 141 IAKVQHKNLVRLLGCCIDKD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           + K+ HKN+V+L    I+++     K+LI E+ P  SL   L +P+    L     + ++
Sbjct: 61  LKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANT 252
             +  G+ +L +     I+HR++K  NI+     D     K++DFG AR    +E     
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QF 172
Query: 253 SRIVGTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 291
             + GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+++D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSG------RSGQGLREM 134
           SF       +++     +G G +G V     +  G ++A+K++         + + LRE+
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 135 KNEASVIAKVQHKNLVRL---LGCCIDKDEKILIYEYMPNKSLDFF-LFDPTKRMLLDWV 190
           K    ++   +H N++ +   L   +   E   +Y  +     D   +   ++ + L+ V
Sbjct: 106 K----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 161
Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-IC-GGNEL 248
                +  + +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E 
Sbjct: 162 R--YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 249 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 293
           Q   +  V T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIA 142
           V   ++ F   + LGEG +G V     K  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 143 KVQHKNLVRLLGC----CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
             +H+N++ +         +   ++ I + +    L   +   + +ML D    +Q    
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSD--DHIQYF-- 117
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL--------QA 250
           I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q+
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 251 NTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 288
                V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT  Y++P   L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--------SGQGLREMKNEASV 140
           + K+S  + LG G FG V+  V K K  E+ VK +               L ++  E ++
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRM---LLDWVTRVQII 196
           +++V+H N++++L    ++    L+ E      LD F F D   R+   L  ++ R Q++
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRLDEPLASYIFR-QLV 140
Query: 197 EGIAQGLLYLHQYSRVR-IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
             +         Y R++ IIHRD+K  NI++ +D   K+ DFG A      +L       
Sbjct: 141 SAVG--------YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTF 189
Query: 256 VGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIV 289
            GT  Y +PE  +   +   + +++S GV L  +V
Sbjct: 190 CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 85  SVSTATNKFSDANKL-----GEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 138
           S  + + +F D  +L     GEG    V   + L    E AVK +  + G     +  E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 139 SVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
            ++ + Q H+N++ L+    ++D   L++E M   S+   L    KR   + +    +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ 118
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNP-KISDFGMARICGGNELQANTSR 254
            +A  L +LH      I HRDLK  NIL +    ++P KI DF +     G +L  + S 
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLG---SGIKLNGDCSP 172
Query: 255 I--------VGTYGYMSPE----YALEG-IFSIKSDVFSFGVLLLEIVSG 291
           I         G+  YM+PE    ++ E  I+  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 70  SKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS 127
           +K KE D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 128 GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             +   +        AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 --IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           G      T  + GT   ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           KL E   G ++KG  + G++I VK L  R  S +  R+   E   +    H N++ +LG 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 156 C--IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           C         LI  +MP  SL   L + T   ++D    V+    +A+G+ +LH    + 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL----E 269
           I    L + ++++D+DM  +IS   MA +    +    +   +    +++PE AL    E
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS---MADV----KFSFQSPGRMYAPAWVAPE-ALQKKPE 185
Query: 270 GIFSIKSDVFSFGVLLLEIVS 290
                 +D++SF VLL E+V+
Sbjct: 186 DTNRRSADMWSFAVLLWELVT 206

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 35/231 (15%)
Query: 83  FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASV 140
           F S+S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 141 IAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 198
           + K+Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKN 135
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI--- 255
           + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +   +   
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDXXXVVKD 186
Query: 256 --VGTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
             VGT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 187 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 93  FSDANKLGEGGFGPVYKGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           F   ++LG G    VY+   +KG +   A+K L     + +  ++ E  V+ ++ H N++
Sbjct: 55  FEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNII 111
Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-------TKRMLLDWVTRVQIIEGIAQGL 203
           +L        E  L+ E +    L    FD        ++R   D V   QI+E +A   
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVK--QILEAVA--- 162
Query: 204 LYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
            YLH+     I+HRDLK  N+L      D   KI+DFG+++I    E Q     + GT G
Sbjct: 163 -YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPG 215
Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           Y +PE      +  + D++S G++   ++ G
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 128/312 (41%), Gaps = 63/312 (20%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC 156
           L EGGF  VY+   +  G E A+KRL     +  R +  E   + K+  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 157 -IDKDE------KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
            I K+E      + L+   +    L  FL     R  L   T ++I     + + ++H+ 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154
Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMA---------------RICGGNELQANTSR 254
            +  IIHRDLK  N+LL      K+ DFG A               R     E+  NT+ 
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 255 IVGTYGYMSPEYA-LEGIFSI--KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD 311
           +     Y +PE   L   F I  K D+++ G +L                   LL +   
Sbjct: 215 M-----YRTPEIIDLYSNFPIGEKQDIWALGCILY------------------LLCFRQH 251
Query: 312 LWTSNRTLELID-----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
            +     L +++     P  + +Y+  H L+R +      +Q + ++R ++ +VV  L  
Sbjct: 252 PFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAM------LQVNPEERLSIAEVVHQLQE 305
Query: 367 EAAAL-LPPKQP 377
            AAA  + PK P
Sbjct: 306 IAAARNVNPKSP 317

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 143
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 66
Query: 144 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 67  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 122
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 256
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 123 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 173
Query: 257 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 174 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 143
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 144 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 256
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 257 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNI 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 207
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 132
Query: 208 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
               +++ HRDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPE 186
Query: 266 YALEGIFSIK-SDVFSFGVLLLEIVSG 291
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 143
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 144 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 64  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 119
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 256
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 120 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 170
Query: 257 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 171 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 143
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 62
Query: 144 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 63  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 118
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 256
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 119 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 169
Query: 257 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 170 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 143
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 144 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 256
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 257 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 207
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YAH 132
Query: 208 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
               +++ HRDLK  N LLD    P  KI+DFG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPE 186
Query: 266 YALEGIFSIK-SDVFSFGVLLLEIVSG 291
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 76
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 207
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 77  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 131
Query: 208 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
               +++ HRDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE
Sbjct: 132 A---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPE 185
Query: 266 YALEGIFSIK-SDVFSFGVLLLEIVSG 291
             L+  +  K +DV+S GV L  ++ G
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC 156
           LGEG F    K V KK ++  AVK +S R     ++   E + +   + H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ-IIEGIAQGLLYLHQYSRVRII 215
            D+    L+ E +    L    F+  K+      T    I+  +   + ++H    V ++
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 216 HRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           HRDLK  N+L    + ++  KI DFG AR+   +     T     T  Y +PE   +  +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGY 186
Query: 273 SIKSDVFSFGVLLLEIVSGK 292
               D++S GV+L  ++SG+
Sbjct: 187 DESCDLWSLGVILYTMLSGQ 206

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 140
Query: 153 LGCCIDKDEKIL--IYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
              C  +D+K L  + EYMP   L   +  +D  ++    W          A+ +L L  
Sbjct: 141 F--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDA 189
Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY- 266
              + +IHRD+K  N+LLDK  + K++DFG   ++     +  +T+  VGT  Y+SPE  
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPDYISPEVL 247
Query: 267 ---ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
                +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 284

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 40/276 (14%)
Query: 79  PLFSFSSVSTAT--NKFSDANKLGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRS 127
           PL S  SV      +++  +  LG G  G V     +K   ++A+K +S         R 
Sbjct: 2   PLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 128 GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRM 185
                 ++ E  ++ K+ H  ++++     D ++  ++ E M    L    FD     + 
Sbjct: 62  ADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKR 116
Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARI 242
           L +   ++   + +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I
Sbjct: 117 LKEATCKLYFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 172
Query: 243 CGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 299
            G   L      + GT  Y++PE  +      ++   D +S GV+L   +SG      +R
Sbjct: 173 LGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229
Query: 300 T-----DSLNLLGYAW--DLWT--SNRTLELIDPIL 326
           T     D +    Y +  ++W   S + L+L+  +L
Sbjct: 230 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 265

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 99  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 149
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 207
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 131
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 185
Query: 265 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 314
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 315 --SNRTLELIDPIL 326
             S + L+L+  +L
Sbjct: 246 EVSEKALDLVKKLL 259

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 127/283 (44%), Gaps = 52/283 (18%)
Query: 98  KLGEGGFGPVYKG-VLKKGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +LG G +G V K   +  G   AVKR+    + Q  + +  +  +  +            
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 156 CIDKDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            + ++  + I   + + SLD F   + D  + +  D + ++ +   I + L +LH  S++
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SKL 156
Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMA---------RICGGNELQANTSRIVGTYGYMS 263
            +IHRD+K SN+L++     K  DFG++          I  G +      RI       +
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI-------N 209
Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-----NRT 318
           PE   +G +S+KSD++S G+  +E               L +L + +D W +      + 
Sbjct: 210 PELNQKG-YSVKSDIWSLGITXIE---------------LAILRFPYDSWGTPFQQLKQV 253
Query: 319 LELIDPILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
           +E   P L  D++S++     +V+    C+++++ +RPT  ++
Sbjct: 254 VEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPEL 291

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 99  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 149
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 207
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 131
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 185
Query: 265 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 314
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 315 --SNRTLELIDPIL 326
             S + L+L+  +L
Sbjct: 246 EVSEKALDLVKKLL 259

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 99  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 149
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 207
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 131
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 185
Query: 265 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 314
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 315 --SNRTLELIDPIL 326
             S + L+L+  +L
Sbjct: 246 EVSEKALDLVKKLL 259

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 99  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 149
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 207
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 130
Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 131 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 184
Query: 265 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 314
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 315 --SNRTLELIDPIL 326
             S + L+L+  +L
Sbjct: 245 EVSEKALDLVKKLL 258

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 108/242 (44%), Gaps = 31/242 (12%)
Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGCC 156
           K+G G +G VYK   K G +     L    G G+      E +++ +++H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 157 IDK-DEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY-----LHQY 209
           +   D K+ L+++Y  +       F    +        VQ+  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 210 SRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSP 264
               ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ Y +P
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSL----NLLGYA 309
           E  L      K+ D+++ G +  E+++ +          K +  Y  D L    N++G+ 
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 310 WD 311
            D
Sbjct: 265 AD 266

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 143
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 144 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 256
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 257 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 292
           G   YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GAVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 124 SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT- 182
           S R       ++ E  ++ K+ H  ++++     D ++  ++ E M    L    FD   
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVV 231
Query: 183 -KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFG 238
             + L +   ++   + +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG
Sbjct: 232 GNKRLKEATCKLYFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 239 MARICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNT 295
            ++I G   L      + GT  Y++PE  +      ++   D +S GV+L   +SG    
Sbjct: 288 HSKILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344
Query: 296 GLYRT 300
             +RT
Sbjct: 345 SEHRT 349

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 124 SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT- 182
           S R       ++ E  ++ K+ H  ++++     D ++  ++ E M    L    FD   
Sbjct: 191 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVV 245
Query: 183 -KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFG 238
             + L +   ++   + +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG
Sbjct: 246 GNKRLKEATCKLYFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 301
Query: 239 MARICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNT 295
            ++I G   L      + GT  Y++PE  +      ++   D +S GV+L   +SG    
Sbjct: 302 HSKILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358
Query: 296 GLYRT 300
             +RT
Sbjct: 359 SEHRT 363

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 134
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG-----IAQGLLYLH 207
                D     ++ EYMP   L            ++ ++   + E       A+ +L L 
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVLALD 182
Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY- 266
               +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE  
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 267 ---ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
                +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 139
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
                D     ++ EYMP   L   +  +D  ++    W          A+ +L L    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIH 190
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---- 266
            +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
             +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 283

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 152
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 139
Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
                D     ++ EYMP   L   +  +D  ++    W          A+ +L L    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIH 190
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---- 266
            +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
             +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 283

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 207
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 132
Query: 208 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
               +++ HRDLK  N LLD    P  KI  FG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPE 186
Query: 266 YALEGIFSIK-SDVFSFGVLLLEIVSG 291
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 207
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 132
Query: 208 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
               +++ HRDLK  N LLD    P  KI  FG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPE 186
Query: 266 YALEGIFSIK-SDVFSFGVLLLEIVSG 291
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 91  NKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLREMKNEASVIAKV 144
            K+   + LGEG +G V K VL      ++  +I  K+   R   G   +K E  ++ ++
Sbjct: 5   GKYLMGDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 145 QHKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--VQIIEGIA 200
           +HKN+++L+    +++++   ++ EY      +     P KR  +        Q+I+G  
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG-- 121
Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
             L YLH      I+H+D+K  N+LL      KIS  G+A                G+  
Sbjct: 122 --LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 261 YMSPEYA--LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL 305
           +  PE A  L+     K D++S GV L  I      TGLY  +  N+
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNI-----TTGLYPFEGDNI 218

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 12/205 (5%)
Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           ++++     +G G FG       K   E+   +   R       ++ E      ++H N+
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           VR     +      +I EY     L   + +   R   D        + +  G+ Y H  
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARF--FFQQLLSGVSYCHS- 134
Query: 210 SRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
             ++I HRDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE  
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVL 189
Query: 268 LEGIFSIK-SDVFSFGVLLLEIVSG 291
           L   +  K +DV+S GV L  ++ G
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 107/258 (41%), Gaps = 49/258 (18%)
Query: 76  DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK 135
           D++  FS+       N F    K+G+G FG V         +    ++     +  R  K
Sbjct: 20  DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK 79
Query: 136 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--- 192
            EA ++ K+Q+ ++       +    K + Y++M        +F+P    L + +TR   
Sbjct: 80  IEADILKKIQNDDINNNNI--VKYHGKFMYYDHMC------LIFEPLGPSLYEIITRNNY 131
Query: 193 ---------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 243
                    +  IE I + L YL + S   + H DLK  NILLD     K S   + R+ 
Sbjct: 132 NGFHIEDIKLYCIE-ILKALNYLRKMS---LTHTDLKPENILLDDPYFEK-SLITVRRVT 186
Query: 244 GGNELQANTSR---------------------IVGTYGYMSPEYALEGIFSIKSDVFSFG 282
            G ++Q   ++                     I+ T  Y +PE  L   + + SD++SFG
Sbjct: 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 283 VLLLEIVSGKKNTGLYRT 300
            +L E+ +G   + L+RT
Sbjct: 247 CVLAELYTG---SLLFRT 261

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 120/286 (41%), Gaps = 57/286 (19%)
Query: 72  KKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV--LKKGDE--IAVKRLSGRS 127
           KK++++L    + +V   +N F   +K+GEG F  VY     L+ G E  IA+K L   S
Sbjct: 6   KKDIEKL----YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS 61
Query: 128 GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS----LDFFLFDPTK 183
              +R       +       N++ +  C    D  ++   Y+ ++S    L+   F   +
Sbjct: 62  -HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVR 120
Query: 184 RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMAR- 241
             +L+          + + L  +HQ+    I+HRD+K SN L ++ +    + DFG+A+ 
Sbjct: 121 EYMLN----------LFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167
Query: 242 -------------------ICGGNELQANTSR------IVGTYGYMSPEYALEGIFSIKS 276
                               C  N+     SR        GT G+ +PE   +      +
Sbjct: 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA 227
Query: 277 -DVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYAWDLWTSNRTLE 320
            D++S GV+ L ++SG+     Y+ +D L  L     +  S  T++
Sbjct: 228 IDMWSAGVIFLSLLSGR--YPFYKASDDLTALAQIMTIRGSRETIQ 271

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE----MKNEASVIAKVQHKNLVRLLG 154
           +G G FG V    LK  D++   ++  +     R      + E  V+     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D +   L+ +Y     L   L    +  L + + R  +    A+ ++ +    ++  
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAIDSVHQLHY 196
Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE--YALE-- 269
           +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VGT  Y+SPE   A+E  
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGG 254
Query: 270 -GIFSIKSDVFSFGVLLLEIVSGK 292
            G +  + D +S GV + E++ G+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 35/234 (14%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLLGC 155
           +G G +G V +   K    +   +   R  + L + K    E +++ ++ H ++V++L  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 156 CIDKD-EKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            I KD EK   +Y  +     DF     T   L +   +  ++  +  G+ Y+H      
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVHSAG--- 176
Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARIC----GGNE---------------------L 248
           I+HRDLK +N L+++D + K+ DFG+AR       GN                      L
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236
Query: 249 QANTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD 301
           +   +  V T  Y +PE   L+  ++   DV+S G +  E+++  K    Y  D
Sbjct: 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRL-----SGRSGQGL------REMKNEASVIAKVQHK 147
           +  G +G V  GV  +G  +A+KR+      GR+   L      + +  E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           N++ L    +  +E  +   Y+  + +  D       +R++   ++   I   +   LL 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV---ISPQHIQYFMYHILLG 146
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           LH      ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y +PE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGK 292
             ++   F+   D++S G ++ E+ + K
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRL-----SGRSGQGL------REMKNEASVIAKVQHK 147
           +  G +G V  GV  +G  +A+KR+      GR+   L      + +  E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           N++ L    +  +E  +   Y+  + +  D       +R++   ++   I   +   LL 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV---ISPQHIQYFMYHILLG 146
Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           LH      ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y +PE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 266 YALE-GIFSIKSDVFSFGVLLLEIVSGK 292
             ++   F+   D++S G ++ E+ + K
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ----HK 147
           LG+GGFG V+ G  L    ++A+K +      G   + +      E +++ KV     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV---QIIEGIAQGLL 204
            ++RLL     ++  +L+ E  P  + D F +   K  L +  +R    Q++  I     
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153
Query: 205 YLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
             H +SR  ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  
Sbjct: 154 --HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSP 206
Query: 264 PEY-ALEGIFSIKSDVFSFGVLLLEIVSG 291
           PE+ +     ++ + V+S G+LL ++V G
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 99  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--NEASVIAKV---QHKNLVRLL 153
           LG G +G V+           V+++SG     L  MK   +A+++ K    +H    R +
Sbjct: 62  LGTGAYGKVF----------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG----------- 202
              I +   ++   Y        F  +    ++LD++   ++   ++Q            
Sbjct: 112 LEHIRQSPFLVTLHYA-------FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 203 ----LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
               +L L    ++ II+RD+K  NILLD + +  ++DFG+++    +E +       GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
Query: 259 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 291
             YM+P+    G        D +S GVL+ E+++G
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 173
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 174 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 225
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 145
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 146 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 197
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNE 247
           QI + +  GL Y+H+  R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
              N+   + T  Y SPE  L   +   +D++S   L+ E+++G
Sbjct: 191 HYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNE 247
           QI + +  GL Y+H+  R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
              N+   + T  Y SPE  L   +   +D++S   L+ E+++G
Sbjct: 191 HYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 173
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE
Sbjct: 174 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 226
Query: 266 YALEGIFSIKS-DVFSFGVLLLEIVSG 291
           +     +  +S  V+S G+LL ++V G
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 145
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 146 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 197
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 146
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 147 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 198
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 99  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLLG 154
           +G G +G VY    K  ++ +A+K+++ R  + L + K    E +++ +++   ++RL  
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 155 CCIDKD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
             I  D    +++ I   + +  L      P   + L       I+  +  G  ++H+  
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG 149
Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------NELQAN------------ 251
              IIHRDLK +N LL++D + K+ DFG+AR           N+L+ N            
Sbjct: 150 ---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 252 --TSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVS 290
             TS +V T  Y +PE   L+  ++   D++S G +  E+++
Sbjct: 207 QLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 131
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 132 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 183
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RLL      D  +LI E  P    D F F   +  L + + R      + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNX 129
Query: 210 SRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 182
Query: 269 EGIFSIKS-DVFSFGVLLLEIVSG 291
              +  +S  V+S G+LL ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 239
Query: 259 YGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 292
             Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 178
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 179 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 230
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 146
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 147 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 198
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 146
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 147 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 198
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RLL      D  +LI E  P    D F F   +  L + + R      + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 210 SRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 187
Query: 269 EGIFSIKS-DVFSFGVLLLEIVSG 291
              +  +S  V+S G+LL ++V G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RLL      D  +LI E  P    D F F   +  L + + R      + + + + H  
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 132
Query: 210 SRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSPEYA 267
               ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  PE+ 
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWI 184
Query: 268 LEGIFSIKS-DVFSFGVLLLEIVSG 291
               +  +S  V+S G+LL ++V G
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 255
Query: 259 YGYMSPE--YALE---GIFSIKSDVFSFGVLLLEIVSGK 292
             Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RLL      D  +LI E  P    D F F   +  L + + R      + + + + H  
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 133
Query: 210 SRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+  
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 186
Query: 269 EGIFSIKS-DVFSFGVLLLEIVSG 291
              +  +S  V+S G+LL ++V G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RLL      D  +LI E  P    D F F   +  L + + R      + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 129
Query: 210 SRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSPEYA 267
               ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  PE+ 
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 268 LEGIFSIKS-DVFSFGVLLLEIVSG 291
               +  +S  V+S G+LL ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 131
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE
Sbjct: 132 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 184
Query: 266 YALEGIFSIKS-DVFSFGVLLLEIVSG 291
           +     +  +S  V+S G+LL ++V G
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 165
Query: 207 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 264
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 217
Query: 265 EYALEGIFSIKS-DVFSFGVLLLEIVSG 291
           E+     +  +S  V+S G+LL ++V G
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 46/221 (20%)
Query: 93  FSDA----NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKV-QH 146
           FSD       +G G +    + V K  + E AVK +     +  R+   E  ++ +  QH
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID----KSKRDPSEEIEILLRYGQH 80
Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIE 197
            N++ L     D     L+ E M    L            LD + R +         ++ 
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGEL------------LDKILRQKFFSEREASFVLH 128
Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNIL-LDKDMNP---KISDFGMARICGGNELQANTS 253
            I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     +L+A   
Sbjct: 129 TIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRAENG 180
Query: 254 RIVG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
            ++    T  +++PE      +    D++S G+LL  +++G
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RLL      D  +LI E  P    D F F   +  L + + R      + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 129
Query: 210 SRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 182
Query: 269 EGIFSIKS-DVFSFGVLLLEIVSG 291
              +  +S  V+S G+LL ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           ++F      G+G FG V  G  K  G  +A+K++        RE++     +A + H N+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-LAVLHHPNI 81
Query: 150 VRL------LGCCIDKDEKIL----IYEYMPNK----SLDFFLFDPTKRMLLDWVTRVQI 195
           V+L      LG   ++D + +    + EY+P+       +++        +L  V   Q+
Sbjct: 82  VQLQSYFYTLG---ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSR 254
           I  I  G L+L     V + HRD+K  N+L+++ D   K+ DFG A+    +E   N + 
Sbjct: 139 IRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAY 191
Query: 255 IVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
           I   Y Y +PE       ++   D++S G +  E++ G+    ++R D+
Sbjct: 192 ICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP---IFRGDN 236
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	411
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-147
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-145
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-127
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-81
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-63
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-63
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-53
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-51
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-51
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-51
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-49
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-49
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-49
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-48
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-48
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-47
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-47
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-47
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-47
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-47
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-47
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-47
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-47
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-46
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-46
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-46
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-46
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-46
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-46
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-46
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-46
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-46
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-45
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-45
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-45
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-45
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-45
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-45
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-45
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-45
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-45
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-45
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-44
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-44
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-44
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-44
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-44
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-44
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-43
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-43
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-43
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-43
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-42
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-42
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-42
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-33
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  418 bits (1077), Expect = e-147
 Identities = 114/305 (37%), Positives = 161/305 (52%), Gaps = 19/305 (6%)

Query: 77  QLPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR---- 126
           +   FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDIT 69

Query: 127 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML 186
           + +  ++   E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
           L W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 306
                TSRIVGT  YM+PE  L G  + KSD++SFGV+LLEI++G      +R     LL
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244

Query: 307 GYAWDLWTSNRTLE-LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
               ++    +T+E  ID  + D   S  +     ++A  C+ E  + RP +  V  +L 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMND-ADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 366 NEAAA 370
              A+
Sbjct: 303 EMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  415 bits (1070), Expect = e-145
 Identities = 115/299 (38%), Positives = 173/299 (57%), Gaps = 7/299 (2%)

Query: 77  QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGL-REMK 135
           QL  FS   +  A++ FS+ N LG GGFG VYKG L  G  +AVKRL     QG   + +
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 136 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQ 194
            E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L +  + +  LDW  R +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
           I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++    +    T  
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT---DSLNLLGYAWD 311
           + GT G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D + LL +   
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 370
           L    +   L+D  L+  Y  + +  + + +ALLC Q S  +RP M++VV ML  +  A
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  368 bits (948), Expect = e-127
 Identities = 102/286 (35%), Positives = 169/286 (59%), Gaps = 6/286 (2%)

Query: 81  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 140
                +  ATN F     +G G FG VYKGVL+ G ++A+KR +  S QG+ E + E   
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGI 199
           ++  +H +LV L+G C +++E ILIY+YM N +L   L+      M + W  R++I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
           A+GL YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++     +    ++ + GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYAWDLWTSNRT 318
           GY+ PEY ++G  + KSDV+SFGV+L E++  +         + +NL  +A +   + + 
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265

Query: 319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            +++DP L D+   + +  ++ + A+ C+  S++DRP+M DV+  L
Sbjct: 266 EQIVDPNLADKIRPESL-RKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  284 bits (729), Expect = 5e-94
 Identities = 68/311 (21%), Positives = 124/311 (39%), Gaps = 34/311 (10%)

Query: 81  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 140
               ++   +           G FG V+K  L   + +AVK    +  Q   + + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 141 IAKVQHKNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           +  ++H+N+++ +G          +  LI  +    SL  FL    K  ++ W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 197 EGIAQGLLYLHQ-------YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
           E +A+GL YLH+         +  I HRD+K+ N+LL  ++   I+DFG+A      +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 250 ANTSRIVGTYGYMSPEYALEGI-----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 304
            +T   VGT  YM+PE     I       ++ D+++ G++L E+ S          +   
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--Y 245

Query: 305 LLGYAWDLWTSNRTLE---------LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP 355
           +L +  ++   + +LE            P+L D +     +         C    A+ R 
Sbjct: 246 MLPFEEEIG-QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 356 TMNDVVSMLTN 366
           +   V   +T 
Sbjct: 305 SAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  251 bits (642), Expect = 7e-81
 Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 45/334 (13%)

Query: 81  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 140
            + S  S   +       +G G +G VYKG L     +AVK  S  + Q      NE ++
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58

Query: 141 --IAKVQHKNLVRLLGCCI-----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 193
             +  ++H N+ R +          + E +L+ EY PN SL  +L   T     DWV+  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 194 QIIEGIAQGLLYLHQ------YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN- 246
           ++   + +GL YLH       + +  I HRDL + N+L+  D    ISDFG++    GN 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 247 -----ELQANTSRIVGTYGYMSPEYALEGIFSI--------KSDVFSFGVLLLEIVSGKK 293
                E        VGT  YM+PE  LEG  ++        + D+++ G++  EI     
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 294 NTGLYRTDSLNLLGYAWDLWTSNRTLELID--------PILEDEYSSKHMLLR-YVNIAL 344
           +     +     + +  ++       ++          P   + +    + +R       
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 345 LCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
            C  + A+ R T       +          K  +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  211 bits (538), Expect = 1e-65
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 21/282 (7%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 154
            K+G G FG V++     G ++AVK L  +    + + E   E +++ +++H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
                    ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           +HR+LK+ N+L+DK    K+ DFG++R+     L + ++   GT  +M+PE   +   + 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNE 218

Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
           KSDV+SFGV+L E+ + ++    +   +LN       +    + LE+   +         
Sbjct: 219 KSDVYSFGVILWELATLQQ---PW--GNLNPAQVVAAVGFKCKRLEIPRNLNPQ------ 267

Query: 335 MLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 376
                  I   C       RP+   ++ +L     + +PP  
Sbjct: 268 ----VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  205 bits (524), Expect = 1e-63
 Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 25/301 (8%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
            +      +G G FG V K   +   ++A+K++   S    +    E   +++V H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           +L G C++     L+ EY    SL   L              +      +QG+ YLH   
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 211 RVRIIHRDLKASNILLDKDMN-PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
              +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 270 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
             +S K DVFS+G++L E+++ +K    +           W +    R   LI  + +  
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR-PPLIKNLPKP- 232

Query: 330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVRNTVTST 389
                      ++   C  +    RP+M ++V ++T+         +P     ++++   
Sbjct: 233 ---------IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283

Query: 390 S 390
            
Sbjct: 284 E 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  205 bits (523), Expect = 2e-63
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 36/283 (12%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
             LG+G FG   K   ++ G+ + +K L     +  R    E  V+  ++H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
                    I EY+   +L   +     +    W  RV   + IA G+ YLH  +   II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMN---II 130

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR------------IVGTYGYMS 263
           HRDL + N L+ ++ N  ++DFG+AR+    + Q    R            +VG   +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE      +  K DVFSFG++L EI+                   A   +   RT++   
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLP-RTMDFGL 234

Query: 324 PILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            +      Y   +    +  I + C     + RP+   +   L
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (502), Expect = 9e-61
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 36/282 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRL----SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
             +G GGFG VY+     GDE+AVK           Q +  ++ EA + A ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            G C+ +    L+ E+     L+  L        +     V     IA+G+ YLH  + V
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 213 RIIHRDLKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGYMSP 264
            IIHRDLK+SNIL+ + +          KI+DFG+AR       +       G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP 324
           E     +FS  SDV+S+GVLL E+++G+     +    ++ L  A+ +  +   L +   
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLALPIPST 238

Query: 325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
             E           +  +   C       RP+  +++  LT 
Sbjct: 239 CPEP----------FAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (499), Expect = 4e-60
 Identities = 67/291 (23%), Positives = 131/291 (45%), Gaps = 38/291 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG-------LREMKNEASVIA 142
           N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E  +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 143 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
            + H N+V+L G   +     ++ E++P   L   L D      + W  +++++  IA G
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMARICGGNELQANTSRIVG 257
           + Y+       I+HRDL++ NI L        +  K++DFG+++     +   + S ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 258 TYGYMSPE--YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS 315
            + +M+PE   A E  ++ K+D +SF ++L  I++G+     +   S   + +   +   
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREE 245

Query: 316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
                + +              R  N+  LC       RP  + +V  L+ 
Sbjct: 246 GLRPTIPEDCPP----------RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (494), Expect = 2e-59
 Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 34/276 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 154
            KL E   G ++KG  + G++I VK L  R  S +  R+   E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 155 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            C          I  +MP  SL   L + T   ++D    V+    +A+G+ +LH    +
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-- 270
            I    L + ++++D+DM  +IS   +            +   +    +++PE AL+   
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-ALQKKP 184

Query: 271 --IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
                  +D++SF VLL E+V+ +     +    L+ +     +        +   I   
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREV---PF--ADLSNMEIGMKVALEGLRPTIPPGISP- 238

Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                        +  +C+ E    RP  + +V +L
Sbjct: 239 ---------HVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (488), Expect = 2e-58
 Identities = 71/273 (26%), Positives = 128/273 (46%), Gaps = 24/273 (8%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
            ++G G FG VYKG      ++AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
                 +  ++ ++    SL   L     +   +    + I    A+G+ YLH      I
Sbjct: 88  YST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YALEGI 271
           IHRDLK++NI L +D   KI DFG+A             ++ G+  +M+PE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 331
           +S +SDV++FG++L E+++G+     Y     N+      +    R    + P L    S
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQL---PYS----NINNRDQIIEMVGR--GSLSPDLSKVRS 252

Query: 332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           +    ++   +   C+++  D+RP+   +++ +
Sbjct: 253 NCPKRMK--RLMAECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  185 bits (472), Expect = 9e-56
 Identities = 64/295 (21%), Positives = 117/295 (39%), Gaps = 37/295 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
             +G+G FG VY G      E+A++ +     +   L+  K E     + +H+N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
            C+      +I      ++L   + D      LD     QI + I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA---KGI 151

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI---VGTYGYMSPE------ 265
           +H+DLK+ N+  D +    I+DFG+  I G  +      ++    G   +++PE      
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 266 ---YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 322
                 +  FS  SDVF+ G +  E+ + +     ++  +       W + T  +     
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW---PFK--TQPAEAIIWQMGTGMKP---- 261

Query: 323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 377
             + +     +       +I L C     ++RPT   ++ ML            P
Sbjct: 262 -NLSQIGMGKE-----ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (461), Expect = 3e-54
 Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 44/300 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 154
             +G+G +G V++G  + G+ +AVK  S R     +    E  +     ++H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69

Query: 155 CCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--- 207
             +          LI  Y    SL  +L    +   LD V+ ++I+  IA GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 208 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYM 262
                +  I HRDLK+ NIL+ K+    I+D G+A +           N  R VGT  YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184

Query: 263 SPE------YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-DLWTS 315
           +PE               + D+++FG++L E+     + G+            + D+  +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPN 239

Query: 316 NRTLELID---------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
           + + E +          P + + + S   L     +   C  ++   R T   +   LT 
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  179 bits (456), Expect = 3e-53
 Identities = 70/295 (23%), Positives = 124/295 (42%), Gaps = 34/295 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 154
            ++G+G +G V+ G  + G+++AVK               E  +     ++H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 155 CCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--- 207
             I          LI +Y  N SL  +L    K   LD  + +++      GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 208 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMS 263
                +  I HRDLK+ NIL+ K+    I+D G+A       NE+    +  VGT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 264 PEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGL---YRTDSLNLLGY--AWD 311
           PE  L+           I +D++SFG++L E+     + G+   Y+    +L+    +++
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
                  ++ + P   + +SS   L +   +   C   +   R T   V   L  
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  175 bits (446), Expect = 3e-51
 Identities = 72/277 (25%), Positives = 112/277 (40%), Gaps = 34/277 (12%)

Query: 98  KLGEGGFGPVYKGVLKKGD-EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           ++G G FG V+ G L+  +  +AVK            +   EA ++ +  H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  K    ++ E +       FL   T+   L   T +Q++   A G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG---YAWDLWTSNRTLELIDPILEDEY-- 330
           SDV+SFG+LL E  S               LG   Y     ++ +T E +    E     
Sbjct: 296 SDVWSFGILLWETFS---------------LGASPYPN--LSNQQTREFV----EKGGRL 334

Query: 331 -SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              +        +   C       RP+ + +   L +
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  172 bits (437), Expect = 7e-51
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 43/293 (14%)

Query: 97  NKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V            G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L     +  +D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMS 263
              R IHRDL   NIL++ +   KI DFG+ ++     L  +               + +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGESPIFWYA 185

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELI 322
           PE   E  FS+ SDV+SFGV+L E+ +  + +     + + ++G            +EL 
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL- 244

Query: 323 DPILEDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              L++              +M++        C   + + RP+  D+   +  
Sbjct: 245 ---LKNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 288

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  173 bits (440), Expect = 8e-51
 Identities = 70/300 (23%), Positives = 123/300 (41%), Gaps = 44/300 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 154
             +G+G FG V++G  + G+E+AVK  S    +  R    EA +     ++H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 155 CCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-- 208
                +       L+ +Y  + SL  +L     R  +     +++    A GL +LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 209 ---YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYM 262
                +  I HRDLK+ NIL+ K+    I+D G+A            A   R VGT  YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218

Query: 263 SPEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS 315
           +PE  L+            ++D+++ G++  EI       G++    L      +DL  S
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY----YDLVPS 273

Query: 316 NRTLELID---------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
           + ++E +          P + + + S   L     I   C   +   R T   +   L+ 
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  172 bits (439), Expect = 8e-51
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 43/293 (14%)

Query: 97  NKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +LG+G FG V            G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G C     +   LI EY+P  SL  +L     +  +D +  +Q    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMS 263
              R IHRDL   NIL++ +   KI DFG+ ++     L  +               + +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGESPIFWYA 216

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELI 322
           PE   E  FS+ SDV+SFGV+L E+ +  + +     + + ++G            +EL 
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL- 275

Query: 323 DPILEDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              L++              +M++        C   + + RP+  D+   +  
Sbjct: 276 ---LKNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  169 bits (430), Expect = 1e-49
 Identities = 82/294 (27%), Positives = 123/294 (41%), Gaps = 47/294 (15%)

Query: 97  NKLGEGGFGPVYKGVLK-----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 150
             LGEG FG V            G+ +AVK L +    Q     K E  ++  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 151 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +  GCC D       L+ EY+P  SL  +L     R  +     +   + I +G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMS 263
                 IHRDL A N+LLD D   KI DFG+A+              V   G     + +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE   E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 324 -----------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
                      P   + Y          ++   C +  A  RPT  +++ +L  
Sbjct: 266 RGERLPRPDKCP--AEVY----------HLMKNCWETEASFRPTFENLIPILKT 307

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  169 bits (429), Expect = 1e-49
 Identities = 62/292 (21%), Positives = 123/292 (42%), Gaps = 45/292 (15%)

Query: 97  NKLGEGGFGPVYKGVLK-----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 150
             LGEG FG V            G+++AVK L     G  + ++K E  ++  + H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 151 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +  G C +       LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YM 262
               + +HRDL A N+L++ +   KI DFG+ +      ++ +               + 
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFWY 196

Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 321
           +PE  ++  F I SDV+SFGV L E+++    ++         +      +  +     L
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM--TVT--RL 252

Query: 322 IDPILEDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           ++  L++              + L+        C +    +R +  +++   
Sbjct: 253 VN-TLKEGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGF 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  169 bits (430), Expect = 2e-49
 Identities = 82/319 (25%), Positives = 135/319 (42%), Gaps = 44/319 (13%)

Query: 97  NKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++LG+G FG V            G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 152 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
             G       +   L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMS 263
              R +HRDL A NIL++ + + KI+DFG+A++     L  +    V          + +
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPIFWYA 198

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 322
           PE   + IFS +SDV+SFGV+L E+ +   K+      + L ++G   D+   +R LEL 
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS-AEFLRMMGCERDVPALSRLLEL- 256

Query: 323 DPILEDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 373
              LE+           +  H L+       LC   S  DRP+ + +   L    +    
Sbjct: 257 ---LEEGQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307

Query: 374 PKQPAFSFVRNTVTSTSST 392
            +  AF+        + S 
Sbjct: 308 CETHAFTAHPEGKHHSLSF 326

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  166 bits (423), Expect = 2e-48
 Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 31/213 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 150
             LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLYL 206
           RLLG C+      LI + MP   L  ++ +       + LL+W         IA+G+ YL
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 261
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +        G     +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 293
           M+ E  L  I++ +SDV+S+GV + E+++ G K
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  165 bits (421), Expect = 4e-48
 Identities = 88/320 (27%), Positives = 147/320 (45%), Gaps = 61/320 (19%)

Query: 98  KLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +G G FG VYKG+LK         +A+K L +G + +   +   EA ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L G        ++I EYM N +LD FL +         +  V ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPE 265
           +  +HRDL A NIL++ ++  K+SDFG++R+   +     T+      G      + +PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG---YAWDLWTSNRTLELI 322
                 F+  SDV+SFG+++ E+++                G   Y W+L  SN   E++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT---------------YGERPY-WEL--SNH--EVM 260

Query: 323 DPILEDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 373
             I  D +         S+ + L+      + C Q+    RP   D+VS+L     A   
Sbjct: 261 KAI-NDGFRLPTPMDCPSAIYQLM------MQCWQQERARRPKFADIVSILDKLIRAPDS 313

Query: 374 PKQPAFSFVRNTVTSTSSTG 393
            K  A    R ++   S++G
Sbjct: 314 LKTLADFDPRVSIRLPSTSG 333

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (426), Expect = 1e-47
 Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 17/197 (8%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
             +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 157 IDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           +++   + ++ EYM   SL  +L    + +L      ++    + + + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 273
           HRDL A N+L+ +D   K+SDFG+ +       +A++++  G       +PE   E  FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 274 IKSDVFSFGVLLLEIVS 290
            KSDV+SFG+LL EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  164 bits (417), Expect = 1e-47
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 21/205 (10%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
             +G G  G V  G L+   +    +A+K L +G + +  R+  +EAS++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L G        +++ EYM N SLD FL     +     +  V ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPE 265
           +  +HRDL A N+L+D ++  K+SDFG++R+   +   A T+      G      + +PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPE 224

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS 290
                 FS  SDV+SFGV++ E+++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  162 bits (413), Expect = 1e-47
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
            ++G G FG V+ G     D++A+K +  G   +   +   EA V+ K+ H  LV+L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C+++    L+ E+M +  L  +L   T+R L    T + +   + +G+ YL       +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 272
           HRDL A N L+ ++   K+SDFGM R    ++  ++T    GT     + SPE      +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182

Query: 273 SIKSDVFSFGVLLLEIVS 290
           S KSDV+SFGVL+ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  162 bits (412), Expect = 2e-47
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 17/197 (8%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
             +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 157 IDKDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           +++   + I  EYM   SL  +L     R +L     ++    + + + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 273
           HRDL A N+L+ +D   K+SDFG+ +       +A++++  G       +PE   E  FS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 274 IKSDVFSFGVLLLEIVS 290
            KSDV+SFG+LL EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  162 bits (412), Expect = 3e-47
 Identities = 82/305 (26%), Positives = 125/305 (40%), Gaps = 68/305 (22%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 149
            +LGE  FG VYKG L           +A+K L     G    E ++EA + A++QH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQII 196
           V LLG         +I+ Y  +  L  FL              D T +  L+    V ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
             IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R     E+ A     +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKL 186

Query: 257 GTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-- 309
                    +M+PE  + G FSI SD++S+GV+L E+ S                G    
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------------YGLQPY 231

Query: 310 WDLWTSNRTLELIDPILEDEYSSKHMLLR--------YVNIALLCVQESADDRPTMNDVV 361
                SN+  ++++ I         +L          Y  + + C  E    RP   D+ 
Sbjct: 232 CGY--SNQ--DVVEMIRNR-----QVLPCPDDCPAWVY-ALMIECWNEFPSRRPRFKDIH 281

Query: 362 SMLTN 366
           S L  
Sbjct: 282 SRLRA 286

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  162 bits (411), Expect = 5e-47
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 52/288 (18%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
             +G G FG VY G L   D      AVK L        + +   E  ++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 152 LLGCCIDKDEKIL-IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           LLG C+  +   L +  YM +  L  F+ +            +     +A+G+ YL   +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---A 145

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSP 264
             + +HRDL A N +LD+    K++DFG+AR    +        +    G      +M+ 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201

Query: 265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA--WDLWTSNRTLELI 322
           E      F+ KSDV+SFGVLL E+++                G     D+  +    ++ 
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT---------------RGAPPYPDV--NTF--DIT 242

Query: 323 DPILED------EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             +L+       EY    +   Y  + L C    A+ RP+ +++VS +
Sbjct: 243 VYLLQGRRLLQPEYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRI 286

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  164 bits (416), Expect = 6e-47
 Identities = 84/326 (25%), Positives = 146/326 (44%), Gaps = 52/326 (15%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
             +G G FG V  G LK   +    +A+K L  G + +  R+   EAS++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           L G        +++ EYM N SLD FL     +     +  V ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL---SD 165

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAL 268
           +  +HRDL A NIL++ ++  K+SDFG+ R+   +   A T+R  G      + SPE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIA 223

Query: 269 EGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE 327
              F+  SDV+S+G++L E++S G++                +   ++   ++ +    +
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQDVIKAV----D 264

Query: 328 DEY---------SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN--EAAALLPPKQ 376
           + Y         ++ + L+      L C Q+  ++RP    +VS+L         L    
Sbjct: 265 EGYRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318

Query: 377 PAFSFVRNTVTSTSSTGKTEDCSVNQ 402
            A +   N +   S+   T   +   
Sbjct: 319 SAAARPSNLLLDQSNVDITTFRTTGD 344

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  161 bits (409), Expect = 8e-47
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 15/198 (7%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
            +LG G FG V  G  +   ++A+K +  G   +   E   EA V+  + H+ LV+L G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I EYM N  L  +L     R        +++ + + + + YL      + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 272
           HRDL A N L++     K+SDFG++R    +E  ++     G+     +  PE  +   F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198

Query: 273 SIKSDVFSFGVLLLEIVS 290
           S KSD+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  165 bits (420), Expect = 1e-46
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 40/277 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            KLG G FG V+     K  ++AVK +       +     EA+V+  +QH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             K+   +I E+M   SL  FL    +         +     IA+G+ ++    +   IH
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 273
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A      G      + +PE    G F+
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFT 363

Query: 274 IKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILE 327
           IKSDV+SFG+LL+EIV+ G+               Y     ++   +  ++     P  E
Sbjct: 364 IKSDVWSFGILLMEIVTYGRI-------------PYPG--MSNPEVIRALERGYRMPRPE 408

Query: 328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
           +     + ++      + C +   ++RPT   + S+L
Sbjct: 409 NCPEELYNIM------MRCWKNRPEERPTFEYIQSVL 439

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  160 bits (408), Expect = 1e-46
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 32/218 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
            +LGEG FG V+               +AVK L   +    ++ + EA ++  +QH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQIIE 197
           +  G C D D  I+++EYM +  L+ FL                  +  L     + I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     ++ +     VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVG 192

Query: 258 TYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +      +M PE  +   F+ +SDV+SFGV+L EI +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  160 bits (407), Expect = 2e-46
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 98  KLGEGGFGPVYKGVLKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +LG G FG V +GV +   +   +A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 154 GCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           G C  + E +++  E      L  FL    +   +      +++  ++ G+ YL      
Sbjct: 77  GVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEK 129

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEY 266
             +HRDL A N+LL      KISDFG+++  G ++                   + +PE 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPEC 184

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
                FS +SDV+S+GV + E +S
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  159 bits (405), Expect = 2e-46
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 15/197 (7%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           +LG G FG V  G  K   ++AVK +  + G    +    EA  + K+ H  LV+  G C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             +    ++ EY+ N  L  +L   +    L+    +++   + +G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 273
           RDL A N L+D+D+  K+SDFGM R    ++  ++     GT     + +PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYS 183

Query: 274 IKSDVFSFGVLLLEIVS 290
            KSDV++FG+L+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  161 bits (409), Expect = 2e-46
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
            +LGEG FG V+               +AVK L   S    ++ + EA ++  +QH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFL------------FDPTKRMLLDWVTRVQIIEG 198
           R  G C +    ++++EYM +  L+ FL             +      L     + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           +A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     ++ +     VG 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGG 218

Query: 259 YG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                  +M PE  L   F+ +SDV+SFGV+L EI +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  159 bits (405), Expect = 2e-46
 Identities = 71/197 (36%), Positives = 108/197 (54%), Gaps = 13/197 (6%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            +LG G FG V+ G      ++AVK L  + G    +    EA+++ ++QH+ LVRL   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
              ++   +I EYM N SL  FL  P   + L     + +   IA+G+ ++        I
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 273
           HRDL+A+NIL+   ++ KI+DFG+AR+   NE    T+R    +     +PE    G F+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFT 188

Query: 274 IKSDVFSFGVLLLEIVS 290
           IKSDV+SFG+LL EIV+
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  160 bits (406), Expect = 2e-46
 Identities = 69/199 (34%), Positives = 106/199 (53%), Gaps = 15/199 (7%)

Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           +KLG G +G VY+GV KK    +AVK L          E   EA+V+ +++H NLV+LLG
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 76

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
            C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGI 271
           IHRDL A N L+ ++   K++DFG++R+  G+   A+     G      + +PE      
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNK 188

Query: 272 FSIKSDVFSFGVLLLEIVS 290
           FSIKSDV++FGVLL EI +
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  165 bits (419), Expect = 2e-46
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)

Query: 97  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 276 SDVFSFGVLLLEIVS 290
           SDV++FGVLL EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  160 bits (408), Expect = 3e-46
 Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLVR 151
           + +GEG FG V K  +KK       A+KR+    S    R+   E  V+ K+  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQIIEG 198
           LLG C  +    L  EY P+ +L  FL                +    L     +     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS----- 253
           +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R  G       T      
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 205

Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           R      +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 206 R------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  160 bits (406), Expect = 3e-46
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
             +G+G FG VY G      +     A+K L      Q +     E  ++  + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 152 LLGCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           L+G  +  +    +   YM +  L  F+  P  +        +     +A+G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL---A 141

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 265
             + +HRDL A N +LD+    K++DFG+AR     E     S     +      + + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWTALE 198

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS 290
                 F+ KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  159 bits (404), Expect = 1e-45
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 30/209 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 150
             LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLYL 206
           RLLG C+      LI + MP   L  ++ +       + LL+W         IA+G+ YL
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 261
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +        G     +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  160 bits (406), Expect = 1e-45
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 151
             +G G FG VY G L   D      AVK L        + +   E  ++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 152 LLGCCIDKDEKIL-IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           LLG C+  +   L +  YM +  L  F+ +            +     +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 265
             + +HRDL A N +LD+    K++DFG+AR     E  +  ++   T       +M+ E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALE 266

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVS 290
                 F+ KSDV+SFGVLL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  159 bits (403), Expect = 2e-45
 Identities = 70/213 (32%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGD------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 149
             LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           VR +G  +    + ++ E M    L  FL      P++   L  +  + +   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 206 LHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY- 261
           L        IHRD+ A N LL         KI DFGMAR     ++   +    G     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAML 207

Query: 262 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  158 bits (402), Expect = 2e-45
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 149
            +LG+G FG VY+GV K   +      +A+K +    S +   E  NEASV+ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRMLLDWVTRVQIIEGIAQG 202
           VRLLG        ++I E M    L  +L        +            +Q+   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY- 261
           + YL   +  + +HRDL A N ++ +D   KI DFGM R     ++        G  G  
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLL 202

Query: 262 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  157 bits (400), Expect = 3e-45
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE----IAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLV 150
             LGEG FG V +G LK+ D     +AVK +     S + + E  +EA+ +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 151 RLLGCCIDKD-----EKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQG 202
           RLLG CI+       + ++I  +M    L  +L      T    +   T ++ +  IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-- 260
           + YL   S    +HRDL A N +L  DM   ++DFG+++     ++ +      G     
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKM 211

Query: 261 ---YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
              +++ E   + +++ KSDV++FGV + EI +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  159 bits (403), Expect = 4e-45
 Identities = 70/213 (32%), Positives = 96/213 (45%), Gaps = 27/213 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGD------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 149
             LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           VR +G  +    + ++ E M    L  FL      P++   L  +  + +   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 206 LHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY- 261
           L        IHRD+ A N LL         KI DFGMAR     ++        G     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAML 248

Query: 262 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  156 bits (397), Expect = 4e-45
 Identities = 62/300 (20%), Positives = 116/300 (38%), Gaps = 73/300 (24%)

Query: 98  KLGEGGFGPVYKGVLKKGD--------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
            LG+G F  ++KGV ++          E+ +K L              AS+++K+ HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           V   G C+  DE IL+ E++   SLD +L     +  ++ + ++++ + +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 210 SRVRIIHRDLKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGY 261
               +IH ++ A NILL ++ +         K+SD G++              ++     
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177

Query: 262 ------MSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLW 313
                 + PE        ++ +D +SFG  L EI S                G       
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS---------------GGDKPLSAL 222

Query: 314 TSNRTLELID-------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
            S R L+  +       P   +            N+   C+    D RP+   ++  L +
Sbjct: 223 DSQRKLQFYEDRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIRDLNS 272

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  157 bits (399), Expect = 6e-45
 Identities = 71/323 (21%), Positives = 124/323 (38%), Gaps = 57/323 (17%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE----IAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLV 150
             LG+G FG V +  LK+ D     +AVK L     +   + E   EA+ + +  H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 151 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQ 201
           +L+G  +    K       +I  +M +  L  FL           L   T V+ +  IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG- 260
           G+ YL   S    IHRDL A N +L +DM   ++DFG++R     ++ +      G    
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASK 200

Query: 261 ----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTDSLNLLGYA 309
               +++ E   + ++++ SDV++FGV + EI++       G +N  +Y           
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY----------- 249

Query: 310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 369
            +       L+     +E+ Y          ++   C       RP+   +   L N   
Sbjct: 250 -NYLIGGNRLKQPPECMEEVY----------DLMYQCWSADPKQRPSFTCLRMELENILG 298

Query: 370 ALLPPKQPAFSFVRNTVTSTSST 392
            L            N   +    
Sbjct: 299 HLSVLSTSQDPLYINIERAHHHH 321

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  157 bits (399), Expect = 6e-45
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 30/209 (14%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE-----IAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLV 150
             LG G FG V+KGV     E     + +K +  +SG Q  + + +    I  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLYL 206
           RLLG C       L+ +Y+P  SL   +         ++LL+W         IA+G+ YL
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYYL 131

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 261
                  ++HR+L A N+LL      +++DFG+A +   ++ Q   S            +
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKW 183

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           M+ E    G ++ +SDV+S+GV + E+++
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  156 bits (396), Expect = 7e-45
 Identities = 58/207 (28%), Positives = 85/207 (41%), Gaps = 26/207 (12%)

Query: 98  KLGEGGFGPVYKGVLKKGD----EIAVKRL---SGRSGQGLREMKNEASVIAKVQHKNLV 150
           KLG+G FG V +G           +AVK L        + + +   E + +  + H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR----MLLDWVTRVQIIEGIAQGLLYL 206
           RL G  +    K+ + E  P  SL   L           L  +         +A+G+ YL
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYL 137

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMS 263
                 R IHRDL A N+LL      KI DFG+ R    N+              + + +
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVS 290
           PE      FS  SD + FGV L E+ +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  159 bits (405), Expect = 1e-44
 Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 34/274 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            KLG+G FG V+ G       +A+K L  + G    E    EA V+ K++H+ LV+L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
             ++   I + EYM   SL  FL        L     V +   IA G+ Y+    R+  +
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILEDEY 330
           SDV+SFG+LL E+             +   + Y      +   L+ ++     P   +  
Sbjct: 362 SDVWSFGILLTELT------------TKGRVPYPG--MVNREVLDQVERGYRMPCPPECP 407

Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            S H L+        C ++  ++RPT   + + L
Sbjct: 408 ESLHDLM------CQCWRKEPEERPTFEYLQAFL 435

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  161 bits (408), Expect = 1e-44
 Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 34/274 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 155
            KLG+G FG V+ G       +A+K L  + G    E    EA V+ K++H+ LV+L   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
             ++   I + EYM   SL  FL        L     V +   IA G+ Y+    R+  +
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 275
           HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444

Query: 276 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILEDEY 330
           SDV+SFG+LL E+             +   + Y      +   L+ ++     P   +  
Sbjct: 445 SDVWSFGILLTELT------------TKGRVPYPG--MVNREVLDQVERGYRMPCPPECP 490

Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            S H L+        C ++  ++RPT   + + L
Sbjct: 491 ESLHDLM------CQCWRKEPEERPTFEYLQAFL 518

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  155 bits (393), Expect = 1e-44
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 38/211 (18%)

Query: 98  KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
            +GEG FG V++G+    +     +A+K   +  S     +   EA  + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 153 LGCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           +G   +    + I  E      L  FL    ++  LD  + +     ++  L YL     
Sbjct: 82  IGVITE--NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ES 134

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY---------- 261
            R +HRD+ A N+L+  +   K+ DFG++R    +              Y          
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------------YYKASKGKLPI 181

Query: 262 --MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
             M+PE      F+  SDV+ FGV + EI+ 
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  154 bits (392), Expect = 2e-44
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 44/214 (20%)

Query: 98  KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
            LGEG FG VY+GV          +AVK      +     +  +EA ++  + H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +G   +++   +I E  P   L  +L           L+ +         I + + YL  
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL-- 129

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY------- 261
              +  +HRD+   NIL+      K+ DFG++R     +             Y       
Sbjct: 130 -ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-------------YYKASVTR 175

Query: 262 -----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                MSPE      F+  SDV+ F V + EI+S
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  161 bits (408), Expect = 3e-44
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 98  KLGEGGFGPVYKGVLKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +LG G FG V +GV +   +   +A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C   +  +L+ E      L  FL    KR  +      +++  ++ G+ YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEG 270
            +HR+L A N+LL      KISDFG+++  G ++                + +PE     
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 514

Query: 271 IFSIKSDVFSFGVLLLEIVS 290
            FS +SDV+S+GV + E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  153 bits (389), Expect = 7e-44
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 98  KLGEGGFGPVYKGVLKKGD---EIAVKRL-SGRSGQGLR-EMKNEASVIAKVQHKNLVRL 152
           +LG G FG V KG  +       +AVK L +  +   L+ E+  EA+V+ ++ +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G C + +  +L+ E      L+ +L    +   +     ++++  ++ G+ YL      
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEY 266
             +HRDL A N+LL      KISDFG+++    +E                   + +PE 
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVS 290
                FS KSDV+SFGVL+ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  154 bits (391), Expect = 8e-44
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
             LG G FG V +      D+      +AVK L  G +    R + +E  ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 149 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQ 194
           +V LLG C      + +I E+    +L  +L              +   +  L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 254
               +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR     ++  +   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204

Query: 255 IVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +          +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (390), Expect = 2e-43
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 24/214 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
             LG G FG V +       +      +AVK L S         + +E  +++ + QH+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRMLLDWVTRVQIIE--- 197
           +V LLG C      ++I EY     L  FL         DP   +     +   ++    
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIV 256
            +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR I   +      +  +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 229 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  153 bits (388), Expect = 2e-43
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 43/228 (18%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 149
             LGEG FG V K              +AVK L    S   LR++ +E +V+ +V H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDPTKRMLLD 188
           ++L G C      +LI EY    SL  FL                      D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNE 247
               +     I+QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R +   + 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 248 LQANTS-----RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               +      +      +M+ E   + I++ +SDV+SFGVLL EIV+
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  153 bits (388), Expect = 3e-43
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE--------IAVKRL-SGRSGQGLREMKNEASVIAKV-QH 146
             LGEG FG V        D+        +AVK L    + + L ++ +E  ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRV 193
           KN++ LLG C       +I EY    +L  +L              +      + +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
                +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     ++     
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212

Query: 254 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               T G     +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  153 bits (388), Expect = 3e-43
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 149
             +GEG FG V++              +AVK L    S     + + EA+++A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDPTKRMLLD 188
           V+LLG C       L++EYM    L+ FL                             L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
              ++ I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R      +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 224

Query: 249 QANTSRIVGTYGY-----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
            +                M PE      ++ +SDV+++GV+L EI S
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  151 bits (384), Expect = 6e-43
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 28/218 (12%)

Query: 97  NKLGEGGFGPVYKGV---LKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
             LG G FG V +     L K D    +AVK L           + +E  V++ +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------FDPTKRMLLDWVTRV 193
           +V LLG C      ++I EY     L  FL                     + LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANT 252
                +A+G+ +L   +    IHRDL A NILL      KI DFG+AR I   +      
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
           +  +    +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 206 NARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  152 bits (386), Expect = 1e-42
 Identities = 71/305 (23%), Positives = 119/305 (39%), Gaps = 65/305 (21%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE--------IAVKRL-SGRSGQGLREMKNEASVIAKV-QH 146
             LGEG FG V        D+        +AVK L    + + L ++ +E  ++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRV 193
           KN++ LLG C       +I EY    +L  +L              +      + +   V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
                +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     ++     
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 258

Query: 254 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTD 301
               T G     +M+PE   + +++ +SDV+SFGVL+ EI +       G     L+   
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 315

Query: 302 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV 361
                     L      ++       + Y           +   C       RPT   +V
Sbjct: 316 ---------KLLKEGHRMDKPANCTNELY----------MMMRDCWHAVPSQRPTFKQLV 356

Query: 362 SMLTN 366
             L  
Sbjct: 357 EDLDR 361

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  152 bits (385), Expect = 2e-42
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 36/222 (16%)

Query: 97  NKLGEGGFGPVYKGVLKKGD--------EIAVKRL-SGRSGQGLREMKNEASVIAKV-QH 146
             LGEG FG V        D        ++AVK L S  + + L ++ +E  ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRV 193
           KN++ LLG C       +I EY    +L  +L                     L     V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
                +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     ++     
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246

Query: 254 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
               T G     +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  155 bits (393), Expect = 8e-42
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 98  KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 152
            +GEG FG V++G+    +     +A+K   +  S     +   EA  + +  H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G    ++   +I E      L  FL    ++  LD  + +     ++  L YL      
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           R +HRD+ A N+L+  +   K+ DFG++R    +     +   +    +M+PE      F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRF 569

Query: 273 SIKSDVFSFGVLLLEIVS 290
           +  SDV+ FGV + EI+ 
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  148 bits (375), Expect = 3e-41
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 43/228 (18%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
             LG G FG V         +      +AVK L           + +E  ++ ++  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---------- 198
           +V LLG C       LI+EY     L  +L    ++   D +                  
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 199 ----------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNE 247
                     +A+G+ +L        +HRDL A N+L+      KI DFG+AR I   + 
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 248 LQANTS-----RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 290
                +     +      +M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  144 bits (366), Expect = 6e-40
 Identities = 73/314 (23%), Positives = 129/314 (41%), Gaps = 43/314 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 147
            K+    K+GEG FG        + G +  +K   +S  S +   E + E +V+A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-----LDWVTRVQIIEGIAQG 202
           N+V+      +     ++ +Y     L   +      +      LDW   VQI       
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF--VQI----CLA 137

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           L ++H     +I+HRD+K+ NI L KD   ++ DFG+AR+       A     +GT  Y+
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYL 192

Query: 263 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 321
           SPE   E   ++ KSD+++ G +L E+ + K     +   S+                 L
Sbjct: 193 SPE-ICENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSM---------------KNL 233

Query: 322 IDPILEDEYS--SKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALLPPKQP 377
           +  I+   +   S H      ++     + +  DRP++N ++    +       L P+  
Sbjct: 234 VLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLI 293

Query: 378 AFSFVRNTVTSTSS 391
           A  F   T +   S
Sbjct: 294 AEEFCLKTFSKFGS 307

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (362), Expect = 8e-40
 Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 35/281 (12%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREM-KNEASVIAKVQH 146
             F    K+G G F  VY+      G  +A+K  ++        R     E  ++ ++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------MLLDWVTRVQIIEGI 199
            N+++     I+ +E  ++ E      L   +    K+        +  +   VQ+    
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQL---- 145

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 259
              L ++H     R++HRD+K +N+ +      K+ D G+ R        A++  +VGT 
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 200

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL 319
            YMSPE   E  ++ KSD++S G LL E+ + +     +  D +NL      +   +   
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCD--- 254

Query: 320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
               P+  D YS +   LR   +  +C+    + RP +  V
Sbjct: 255 --YPPLPSDHYSEE---LR--QLVNMCINPDPEKRPDVTYV 288

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (355), Expect = 8e-39
 Identities = 65/294 (22%), Positives = 117/294 (39%), Gaps = 45/294 (15%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKN 148
             F     LG GGFG V++   K  D   A+KR+          ++  E   +AK++H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 149 LVRLLGCCIDKDE---------KILIY---EYMPNKSLDFFLFDPTKRMLLDWVTRVQII 196
           +VR     ++K+          K+ +Y   +    ++L  ++         +    + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT---- 252
             IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +       
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 253 ------SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 306
                 +  VGT  YMSPE      +S K D+FS G++L E+        LY   +    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--------LYPFSTQMER 233

Query: 307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
                   + +      P+   +Y  ++++++        +  S  +RP   ++
Sbjct: 234 VRTLTDVRNLK----FPPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (346), Expect = 1e-37
 Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 21/237 (8%)

Query: 66  QAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK--R 122
           Q +R+++++  +        +S          ++G G F  VYKG+  +   E+A    +
Sbjct: 1   QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60

Query: 123 LSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK----ILIYEYMPNKSLDFFL 178
               +    +  K EA ++  +QH N+VR         +     +L+ E M + +L  +L
Sbjct: 61  DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120

Query: 179 --FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKIS 235
             F   K  +L    R QI+    +GL +LH      IIHRDLK  NI +     + KI 
Sbjct: 121 KRFKVMKIKVLRSWCR-QIL----KGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIG 174

Query: 236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           D G+A +   +        ++GT  +M+PE   E  +    DV++FG+ +LE+ + +
Sbjct: 175 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (343), Expect = 3e-37
 Identities = 66/282 (23%), Positives = 109/282 (38%), Gaps = 42/282 (14%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
            +G G +G   K   K   +I   K       +    + + +E +++ +++H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 155 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR-------MLLDWVTRVQIIEGIAQGLLY 205
             ID+    L  + EY     L   +   TK         +L  +   Q+       L  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQL----TLALKE 126

Query: 206 LHQ--YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            H+       ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   VGT  YMS
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMS 184

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE      ++ KSD++S G LL E+ +       +   S                 EL  
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQK---------------ELAG 226

Query: 324 PILEDEYS--SKHMLLRYVNIALLCVQESADDRPTMNDVVSM 363
            I E ++             I    +      RP++ +++  
Sbjct: 227 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  136 bits (344), Expect = 4e-37
 Identities = 59/259 (22%), Positives = 96/259 (37%), Gaps = 26/259 (10%)

Query: 47  LDLNLKADNVIIE---LPANNKQAKRSKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEG 102
             ++L  +N+  +        + + R +  E  Q P +  S   +     F   ++LG G
Sbjct: 9   SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHG 68

Query: 103 GFGPVYKGVLKKGDEI-AVK--RLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID 158
            +G V+K   K+   + AVK      R  +       E     KV QH   VRL     +
Sbjct: 69  SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128

Query: 159 KDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
                L  E     SL          +    +  ++            L +LH      +
Sbjct: 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYL--RDT----LLALAHLHSQ---GL 178

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           +H D+K +NI L      K+ DFG+    G            G   YM+PE  L+G +  
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGDPRYMAPE-LLQGSYGT 234

Query: 275 KSDVFSFGVLLLEIVSGKK 293
            +DVFS G+ +LE+    +
Sbjct: 235 AADVFSLGLTILEVACNME 253

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (339), Expect = 1e-36
 Identities = 69/292 (23%), Positives = 121/292 (41%), Gaps = 51/292 (17%)

Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ 145
                 F +   +G GGFG V+K   +  G    +KR+         + + E   +AK+ 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLD 62

Query: 146 HKNLVRLLGCCIDKDEKI----------------LIYEYMPNKSLDFFLFDPTKRMLLDW 189
           H N+V   GC    D                   +  E+    +L+ ++ +  +   LD 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDK 121

Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
           V  +++ E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      N+ +
Sbjct: 122 VLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGK 177

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA 309
                  GT  YMSPE      +  + D+++ G++L E++                   A
Sbjct: 178 RTR--SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--------------A 221

Query: 310 WDLWTSNRTLELIDPILEDEYSSK-HMLLRYVNIALLCVQESADDRPTMNDV 360
           ++  TS    +L D I+ D +  K   LL+        + +  +DRP  +++
Sbjct: 222 FE--TSKFFTDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (338), Expect = 3e-36
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 25/227 (11%)

Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEAS 139
            F S+S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE +
Sbjct: 19  YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78

Query: 140 VIAKVQHKNL--VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 197
            + K+Q  +   +RL    I      ++ E   N  L+ +L    K+  +D   R    +
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWK 134

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            + + +  +HQ+    I+H DLK +N L+      K+ DFG+A     +         VG
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 258 TYGYMSPEYALEGI------------FSIKSDVFSFGVLLLEIVSGK 292
           T  YM PE A++ +             S KSDV+S G +L  +  GK
Sbjct: 191 TVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  132 bits (334), Expect = 1e-35
 Identities = 64/289 (22%), Positives = 110/289 (38%), Gaps = 45/289 (15%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           KLGEGGF  V        G   A+KR+     Q   E + EA +     H N++RL+  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 157 IDKDEK----ILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           + +        L+  +    +L +       K   L     + ++ GI +GL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV-------GTYGYMSP 264
               HRDLK +NILL  +  P + D G       +   +  +  +        T  Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 265 E-YALEGIFSI--KSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLL---GYAWDLWTSN 316
           E ++++    I  ++DV+S G +L  ++ G+   +    + DS+ L      +       
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS--- 269

Query: 317 RTLELIDPILEDEYSSK-HMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                        +SS    LL         +      RP +  ++S L
Sbjct: 270 -----------PRHSSALWQLLNS------MMTVDPHQRPHIPLLLSQL 301

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (332), Expect = 1e-35
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 158 DKDEKILIY-EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           + +  I I+ E +P  SL   L      +  +  T     + I +GL YLH     +I+H
Sbjct: 90  E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 217 RDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI--FS 273
           RD+K  N+L++      KISDFG ++   G      T    GT  YM+PE   +G   + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203

Query: 274 IKSDVFSFGVLLLEIVSGK 292
             +D++S G  ++E+ +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (335), Expect = 2e-35
 Identities = 74/333 (22%), Positives = 129/333 (38%), Gaps = 40/333 (12%)

Query: 59  ELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI 118
           EL  + +Q KR +     +  +          + F   ++LG G  G V+K   K    +
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 119 -AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 176
            A K +          ++  E  V+ +     +V   G      E  +  E+M   SLD 
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 177 FLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD 236
            L     R+    + +  +   + +GL YL    + +I+HRD+K SNIL++     K+ D
Sbjct: 121 VL-KKAGRIPEQILGK--VSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 237 FGMARICGGNEL---QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 293
           FG++      +L    AN+   VGT  YMSPE      +S++SD++S G+ L+E+  G+ 
Sbjct: 176 FGVSG-----QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR- 227

Query: 294 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADD 353
                         Y      +     +    +E + +      R     L      +  
Sbjct: 228 --------------YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273

Query: 354 RPTMNDVVSMLTNEAAALLPPKQ--PAF-SFVR 383
              + +++  + NE    LP       F  FV 
Sbjct: 274 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 306

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  132 bits (333), Expect = 3e-35
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL--VRL 152
            ++G GG   V++ + +K    A+K   L     Q L   +NE + + K+Q  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
               I      ++ E   N  L+ +L    K+  +D   R    + + + +  +HQ+   
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 271
            I+H DLK +N L+      K+ DFG+A     +         VGT  YM PE A++ + 
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMS 185

Query: 272 -----------FSIKSDVFSFGVLLLEIVSGK 292
                       S KSDV+S G +L  +  GK
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (333), Expect = 6e-35
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL--VRL 152
            ++G GG   V++ + +K    A+K   L     Q L   +NE + + K+Q  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
               I      ++ E   N  L+ +L    K+  +D   R    + + + +  +HQ+   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 271
            I+H DLK +N L+  D   K+ DFG+A     +         VG   YM PE A++ + 
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMS 232

Query: 272 -----------FSIKSDVFSFGVLLLEIVSGK 292
                       S KSDV+S G +L  +  GK
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (328), Expect = 6e-35
 Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 37/231 (16%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
            + F +   LG+G FG V K          A+K++     + L  + +E  ++A + H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFF---------LFD--PTKRMLLD----WVTRV 193
           +VR     +++   +     +  KS  F          L+D   ++ +       W    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC---------- 243
           QI+E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+            
Sbjct: 124 QILEALS----YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 244 --GGNELQANTSRIVGTYGYMSPE-YALEGIFSIKSDVFSFGVLLLEIVSG 291
                    N +  +GT  Y++ E     G ++ K D++S G++  E++  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (320), Expect = 1e-33
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 22/217 (10%)

Query: 84  SSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIA 142
                  +  +   ++G G FG V++    + G + AVK++     +       E    A
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105

Query: 143 KVQHKNLVRLLGCCIDKDEKILIY-EYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGI 199
            +    +V L G    +   + I+ E +   SL   +            +    Q +EG 
Sbjct: 106 GLSSPRIVPLYGAVR-EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QALEG- 162

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSR---I 255
              L YLH     RI+H D+KA N+LL  D +   + DFG A     + L  +      I
Sbjct: 163 ---LEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 256 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            GT  +M+PE  +      K D++S   ++L +++G 
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 4e-33
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKV 144
           ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S     +    E  V+ K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 145 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
            HKN+V+L           K+LI E+ P  SL   L +P+    L     + ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 203 LLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           + +L +     I+HR++K  NI+     D     K++DFG AR    +E    +  + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGT 178

Query: 259 YGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 292
             Y+ P+           +  +    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  125 bits (316), Expect = 4e-33
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 29/245 (11%)

Query: 60  LPANNKQAKRSKKKEVDQLPLFSFSSVSTATN---KFSDANKLGEGGFGPVYKGVLKK-G 115
           +    +           +    +   V    +         K+GEG  G V     K  G
Sbjct: 11  VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70

Query: 116 DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD 175
            ++AVK +  R  Q    + NE  ++   QH N+V +    +  +E  ++ E++   +L 
Sbjct: 71  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL- 129

Query: 176 FFLFDPTKRMLLDWVTRVQIIEG-IA-------QGLLYLHQYSRVRIIHRDLKASNILLD 227
                       D V++V++ E  IA       Q L YLH      +IHRD+K+ +ILL 
Sbjct: 130 -----------TDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175

Query: 228 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 287
            D   K+SDFG       +  +  +  +VGT  +M+PE     +++ + D++S G++++E
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233

Query: 288 IVSGK 292
           +V G+
Sbjct: 234 MVDGE 238

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  125 bits (316), Expect = 5e-33
 Identities = 70/339 (20%), Positives = 115/339 (33%), Gaps = 90/339 (26%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKN 148
             F     +G GGFG V++   K      A+KR+          ++  E   +AK++H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 149 LVRLLGC------------------------CIDKDEKILIYEYMPNKSLDFFLFDPTKR 184
           +VR                                    +    +  + +D F    T  
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 185 M---------------------LLDWVTR------------VQIIEGIAQGLLYLHQYSR 211
                                 L DW+ R            + I   IA+ + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS----------RIVGTYGY 261
             ++HRDLK SNI    D   K+ DFG+      +E +                VGT  Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 321
           MSPE      +S K D+FS G++L E++     T + R   +  +          R L+ 
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS-TQMERVRIITDV----------RNLK- 290

Query: 322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
              +   +Y  +HM+++        +  S  +RP   D+
Sbjct: 291 FPLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDI 323

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  123 bits (312), Expect = 8e-33
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)

Query: 85  SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSG-QGLREMKNEASVIA 142
           S+    +      +LG G +G V K       +I AVKR+      Q  + +  +  +  
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 143 K-VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEG 198
           + V     V   G    + +  +  E M + SLD F     D  + +  D + +  I   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVS 117

Query: 199 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIV 256
           I + L +LH  S++ +IHRD+K SN+L++     K+ DFG   I G   +++  +     
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDID--A 170

Query: 257 GTYGYMSPE----YALEGIFSIKSDVFSFGVLLLEIVSGK 292
           G   YM+PE       +  +S+KSD++S G+ ++E+   +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (317), Expect = 1e-32
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKV 144
           ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S     +    E  V+ K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 145 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 202
            HKN+V+L           K+LI E+ P  SL   L +P+    L     + ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 203 LLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGT 258
           + +L +     I+HR++K  NI+     D     K++DFG AR    +E    +  + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGT 178

Query: 259 YGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 292
             Y+ P+           +  +    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  123 bits (312), Expect = 1e-32
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
             K++   K+G+G  G VY  +    G E+A+++++ +       + NE  V+ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG-IA------- 200
           +V  L   +  DE  ++ EY+   SL             D VT   + EG IA       
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL------------TDVVTETCMDEGQIAAVCRECL 126

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG        + + +T  +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 181

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           +M+PE      +  K D++S G++ +E++ G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (310), Expect = 4e-32
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       +  A K +          RE M  E S+   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLLYLHQYSRV 212
              D D   ++ E    +SL     +  KR   L +   R   +  I  G  YLH+    
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN--- 160

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 269
           R+IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSK 215

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
              S + DV+S G ++  ++ GK
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (307), Expect = 4e-32
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 154
           LG+G F  VY+   +  G E+A+K +  ++    G+ + ++NE  +  +++H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D +   L+ E   N  +         +   +   R   +  I  G+LYLH +    I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---GI 133

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 271
           +HRDL  SN+LL ++MN KI+DFG+A      +L+    +   + GT  Y+SPE A    
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
             ++SDV+S G +   ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (306), Expect = 7e-32
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 154
           LG+GGF   ++       +  A K +          RE M  E S+   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLLYLHQYSRV 212
              D D   ++ E    +SL     +  KR   L +   R   +  I  G  YLH+    
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN--- 134

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 269
           R+IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSK 189

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
              S + DV+S G ++  ++ GK
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGK 212

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (305), Expect = 1e-31
 Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 12/231 (5%)

Query: 63  NNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK 121
              Q +   ++++ +L     S        F    KLGEG +G VYK + K+ G  +A+K
Sbjct: 3   ETVQLRNPPRRQLKKLD--EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 122 RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP 181
           ++       L+E+  E S++ +    ++V+  G      +  ++ EY    S+   +   
Sbjct: 61  QVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118

Query: 182 TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR 241
            K +  D +    I++   +GL YLH     R IHRD+KA NILL+ + + K++DFG+A 
Sbjct: 119 NKTLTEDEIAT--ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173

Query: 242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
                  + NT  ++GT  +M+PE   E  ++  +D++S G+  +E+  GK
Sbjct: 174 QLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 2e-31
 Identities = 75/321 (23%), Positives = 124/321 (38%), Gaps = 49/321 (15%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 155
            L EGGF  VY+      G E A+KRL     +  R +  E   + K+  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 156 CIDKDEK-------ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
                E+        L+   +    L  FL     R  L   T ++I     + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI----------VGT 258
             +  IIHRDLK  N+LL      K+ DFG A         + +++             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 259 YGYMSPE-YALEGIFSI--KSDVFSFGVLLLEIVSGK---KNTGLYRTDSLNLLGYAWDL 312
             Y +PE   L   F I  K D+++ G +L  +   +   ++    R  +     Y+   
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---YSI-- 268

Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL- 371
                      P  + +Y+  H L+R        +Q + ++R ++ +VV  L   AAA  
Sbjct: 269 -----------PPHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIAAARN 311

Query: 372 LPPKQPAFSFVRNTVTSTSST 392
           + PK P    +       S+T
Sbjct: 312 VNPKSPITELLEQNGGYGSAT 332

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  120 bits (303), Expect = 3e-31
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSG-QGLREMKNEASVIAK-VQHKNLVRLLG 154
           ++G G +G V K V K   +I AVKR+      +  +++  +  V+ +      +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---IIEGIAQGLLYLHQYSR 211
               + +  +  E M + S D F       +L D +       I     + L +L     
Sbjct: 89  ALFREGDCWICMELM-STSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALNHLK--EN 144

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPE---- 265
           ++IIHRD+K SNILLD+  N K+ DFG   I G  +L  + ++    G   YM+PE    
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFG---ISG--QLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
            A    + ++SDV+S G+ L E+ +G+
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  123 bits (310), Expect = 9e-31
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 17/206 (8%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL-- 153
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 154 ----GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
                     D  +L  EY     L  +L        L       ++  I+  L YLH+ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 210 SRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
              RIIHRDLK  NI+L    + +  KI D G A+     EL       VGT  Y++PE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF--VGTLQYLAPEL 194

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +++  D +SFG L  E ++G 
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (299), Expect = 2e-30
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 31/219 (14%)

Query: 98  KLGEGGFGPVY---------------KGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVI 141
            L +G F  +                K +L+K  +         S +   +  KNE  +I
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-----DFFLFDPTKRMLLDWVTRVQII 196
             ++++  +   G   + DE  +IYEYM N S+      FF+ D      +       II
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
           + +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +++   S   
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS--R 211

Query: 257 GTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGK 292
           GTY +M PE       S    K D++S G+ L  +    
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (296), Expect = 2e-30
 Identities = 52/209 (24%), Positives = 103/209 (49%), Gaps = 13/209 (6%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
              +    +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +V+LLG      +  ++ E+ P  ++D  + +  + +    +    +   + + L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHS 135

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE--- 265
               RIIHRDLKA N+L+  + + +++DFG++        + ++   +GT  +M+PE   
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190

Query: 266 --YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                +  +  K+D++S G+ L+E+   +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (295), Expect = 3e-30
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 150
           F+   K+G+G FG V+KG+  +    +A+K +     +  + +++ E +V+++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           +  G  +   +  +I EY+   S      D  +   LD      I+  I +GL YLH   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
             + IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   + 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +  K+D++S G+  +E+  G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (296), Expect = 3e-30
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL-SGRSGQGLREMKNEASVIAK-VQHK 147
           N   +  ++G G  G V+K   +K   + AVK++    + +  + +  +  V+ K     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            +V+  G  I   +  +  E M     +         +    + +  +   I + L YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPE 265
              +  +IHRD+K SNILLD+    K+ DFG   I G   ++   + S   G   YM+PE
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRS--AGCAAYMAPE 194

Query: 266 -----YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                   +  + I++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (291), Expect = 8e-30
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           KLG GG   VY         ++A+K +        + L+  + E    +++ H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
               + D   L+ EY+   +L  ++        L   T +     I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           I+HRD+K  NIL+D +   KI DFG+A+      L   T+ ++GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190

Query: 274 IKSDVFSFGVLLLEIVSGK 292
             +D++S G++L E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (290), Expect = 1e-29
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 16/207 (7%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS----GRSGQGLREMKNEASVIAKVQ 145
             F     LG+G FG VY    K+    +A+K L      ++G    +++ E  + + ++
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N++RL G   D     LI EY P  ++ +       +   +  T    I  +A  L Y
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSK-FDEQRTA-TYITELANALSY 124

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
            H     R+IHRD+K  N+LL      KI+DFG +     +        + GT  Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                +   K D++S GVL  E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (289), Expect = 2e-29
 Identities = 51/240 (21%), Positives = 89/240 (37%), Gaps = 46/240 (19%)

Query: 84  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKR--LSGRSGQGLREMKNEASV 140
              S  T +F +  K+G G FG V+K V +  G   A+KR           +    E   
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 141 IAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM-------LLDWVTR 192
            A + QH ++VR      + D  ++  EY    SL   + +  + M       L D +  
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-- 121

Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------K 233
           +Q+     +GL Y+H    + ++H D+K SNI + +   P                   K
Sbjct: 122 LQV----GRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 234 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           I D G            +     G   +++ E   E      K+D+F+  + ++     +
Sbjct: 175 IGDLGHVTRIS------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  116 bits (293), Expect = 4e-29
 Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 21/211 (9%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLV 150
            F   + LG G  G +    +    ++AVKR+             E  ++ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           R      D+  + +  E       ++      K      +  + +++    GL +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHSL- 137

Query: 211 RVRIIHRDLKASNILL-----DKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSP 264
              I+HRDLK  NIL+        +   ISDFG+ +    G    +  S + GT G+++P
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 265 EYALEGIF----SIKSDVFSFGVLLLEIVSG 291
           E  L        +   D+FS G +   ++S 
Sbjct: 196 EM-LSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  116 bits (292), Expect = 1e-28
 Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 36/246 (14%)

Query: 65  KQAKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIA 119
             + R        L       +++     S+      KLG G +G V     K    E A
Sbjct: 7   HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66

Query: 120 VKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF 177
           +K +     S     ++  E +V+  + H N+++L     DK    L+ E      L   
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL--- 123

Query: 178 LFDPTKRMLLDWVTR--------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 226
            FD    +    + R          II+ +  G+ YLH+++   I+HRDLK  N+LL   
Sbjct: 124 -FD---EI----IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESK 172

Query: 227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 286
           +KD   KI DFG++ +    +        +GT  Y++PE  L   +  K DV+S GV+L 
Sbjct: 173 EKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228

Query: 287 EIVSGK 292
            +++G 
Sbjct: 229 ILLAGY 234

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  113 bits (285), Expect = 1e-28
 Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 25/255 (9%)

Query: 48  DLNLKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPV 107
           D ++     +    A +      +   +    +            FSD  ++G G FG V
Sbjct: 11  DYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAV 70

Query: 108 YKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 163
           Y     +  + +A+K++S    +S +  +++  E   + K++H N ++  GC + +    
Sbjct: 71  YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130

Query: 164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLHQYSRVRIIHRDLK 220
           L+ EY    + D  L +  K+ L      V+I     G  QGL YLH +    +IHRD+K
Sbjct: 131 LVMEYCLGSASD--LLEVHKKPL----QEVEIAAVTHGALQGLAYLHSH---NMIHRDVK 181

Query: 221 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YALEGIFSIKSD 277
           A NILL +    K+ DFG A         AN+   VGT  +M+PE      EG +  K D
Sbjct: 182 AGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVD 235

Query: 278 VFSFGVLLLEIVSGK 292
           V+S G+  +E+   K
Sbjct: 236 VWSLGITCIELAERK 250

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  113 bits (285), Expect = 2e-28
 Identities = 24/249 (9%), Positives = 54/249 (21%), Gaps = 43/249 (17%)

Query: 79  PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREM 134
                S +S    K      L  G    V+     +  ++ A+K  +     S   L  +
Sbjct: 50  ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109

Query: 135 KNEASVIAKVQHKNLVRLLGCC--------------------------IDKDEKILIYEY 168
                  A++  ++                                        +L+   
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 169 MP---NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 225
                        F    R     +    +   + +    L       ++H      N+ 
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226

Query: 226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGV 283
           +  D    + D       G                Y   E+       F+   + +  G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 284 LLLEIVSGK 292
            +  +    
Sbjct: 282 SIYRVWCLF 290

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  116 bits (292), Expect = 2e-28
 Identities = 43/203 (21%), Positives = 79/203 (38%), Gaps = 24/203 (11%)

Query: 98  KLGEGGFGPVYKGV--LKKGDEIAVKRLSGRSGQGLREM-KNEASVIAKVQHKNLVRLL- 153
            +  GG G +Y  +     G  + +K L        + M   E   +A+V H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 154 -GCCIDKDEKILIY---EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
                D+    + Y   EY+  +SL            L     +  +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
             + +++ DLK  NI+L ++   K+ D G                + GT G+ +PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
           G  ++ +D+++ G  L  +    
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  112 bits (283), Expect = 5e-28
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 21/236 (8%)

Query: 61  PANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKK 114
           P  +K+              F    V+      +          LG G FG V+K     
Sbjct: 53  PVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112

Query: 115 -GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 173
            G ++A K +  R  +   E+KNE SV+ ++ H NL++L      K++ +L+ EY+    
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172

Query: 174 LDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDM 230
           L    FD    +   L  +  +  ++ I +G+ ++HQ     I+H DLK  NIL  ++D 
Sbjct: 173 L----FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDA 225

Query: 231 NP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
              KI DFG+AR     E         GT  +++PE       S  +D++S GV+ 
Sbjct: 226 KQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (277), Expect = 1e-27
 Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 11/199 (5%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLRE-MKNEASVIAKVQHKNLVRLL 153
            +G GG G VY+     +   +A+K +S    S    R  M+ EA    ++Q  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                  +  +    +    L   L    ++  L     V I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
             HRD+K  NIL+  D    + DFG+A      +L       VGT  YM+PE   E   +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHAT 213

Query: 274 IKSDVFSFGVLLLEIVSGK 292
            ++D+++   +L E ++G 
Sbjct: 214 YRADIYALTCVLYECLTGS 232

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  113 bits (285), Expect = 1e-27
 Identities = 51/234 (21%), Positives = 92/234 (39%), Gaps = 19/234 (8%)

Query: 61  PANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLKK-G 115
                 +        D    +    V    +   D      +LG G FG V++   +  G
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182

Query: 116 DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD 175
           +  A K +          ++ E   ++ ++H  LV L     D +E ++IYE+M      
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE-- 240

Query: 176 FFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNP 232
             LF+    +   +     V+ +  + +GL ++H+ +    +H DLK  NI+   K  N 
Sbjct: 241 --LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE 295

Query: 233 -KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
            K+ DFG+       +   +     GT  + +PE A        +D++S GVL 
Sbjct: 296 LKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (276), Expect = 1e-27
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 15/204 (7%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
            LG GG   V+    L+   ++AVK L     R        + EA   A + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 154 GCCIDKDEKILIY----EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
                +     +     EY+   +L   +        +     +++I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAL 268
            +  IIHRD+K +NI++      K+ DFG+AR I         T+ ++GT  Y+SPE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGK 292
                 +SDV+S G +L E+++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  109 bits (275), Expect = 2e-27
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 16/199 (8%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           LG+G FG VY    K+    +A+K L      + G    +++ E  + + ++H N++R+ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMY 80

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
               D+    L+ E+ P   L +       R   +  +    +E +A  L Y H+    +
Sbjct: 81  NYFHDRKRIYLMLEFAPRGEL-YKELQKHGR-FDEQRSA-TFMEELADALHYCHER---K 134

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +IHRD+K  N+L+      KI+DFG +           T    GT  Y+ PE        
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTM--CGTLDYLPPEMIEGKTHD 190

Query: 274 IKSDVFSFGVLLLEIVSGK 292
            K D++  GVL  E + G 
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  111 bits (279), Expect = 2e-27
 Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 19/237 (8%)

Query: 58  IELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLK 113
           +    +  +     K   D    +    V        D      +LG G FG V++ V K
Sbjct: 14  VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73

Query: 114 K-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 172
             G     K ++         +KNE S++ ++ H  L+ L     DK E +LI E++   
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133

Query: 173 SLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKD 229
            L    FD    +   +     +  +    +GL ++H++    I+H D+K  NI+   K 
Sbjct: 134 EL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKK 186

Query: 230 MNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
            +  KI DFG+A     +E+         T  + +PE          +D+++ GVL 
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (274), Expect = 2e-27
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 27/217 (12%)

Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREM-KNEAS 139
           +     T  + F    KLG G FG V+    +  G E  +K ++    Q   E  + E  
Sbjct: 13  NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------- 192
           V+  + H N++++     D     ++ E      L     +   R++             
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LE---RIVSAQARGKALSEGY 125

Query: 193 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNEL 248
             ++++ +   L Y H      ++H+DLK  NIL          KI DFG+A +   +E 
Sbjct: 126 VAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
             N     GT  YM+PE   +   + K D++S GV++
Sbjct: 183 STN---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (282), Expect = 2e-27
 Identities = 60/258 (23%), Positives = 109/258 (42%), Gaps = 47/258 (18%)

Query: 63  NNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDE 117
           ++  +   +      + +     V     K  ++     KLG G +G V     K    E
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 118 IAVKRLS-------------GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 164
            A+K +                  +   E+ NE S++  + H N+++L     DK    L
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123

Query: 165 IYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLLYLHQYSRVRIIH 216
           + E+     L    F+   ++    + R          I++ I  G+ YLH+++   I+H
Sbjct: 124 VTEFYEGGEL----FE---QI----INRHKFDECDAANIMKQILSGICYLHKHN---IVH 169

Query: 217 RDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           RD+K  NILL   +  +N KI DFG++     +         +GT  Y++PE  L+  ++
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPE-VLKKKYN 225

Query: 274 IKSDVFSFGVLLLEIVSG 291
            K DV+S GV++  ++ G
Sbjct: 226 EKCDVWSCGVIMYILLCG 243

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (281), Expect = 3e-27
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 33/210 (15%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRL 152
             LG+G FG V     K  G E AVK +S R          +  E  ++ ++ H N+++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLL 204
                DK    L+ E      L    FD    +    ++R         +II  +  G+ 
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL----FD---EI----ISRKRFSEVDAARIIRQVLSGIT 140

Query: 205 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
           Y+H+     I+HRDLK  N+LL    KD N +I DFG++     ++        +GT  Y
Sbjct: 141 YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYY 194

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           ++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (276), Expect = 4e-27
 Identities = 47/222 (21%), Positives = 87/222 (39%), Gaps = 18/222 (8%)

Query: 84  SSVSTATNKFSDANKLGEG--GFGPVYKGVLKK-GDEIAVKR--LSGRSGQGLREMKNEA 138
           SS       +     +G+G      V     K  G+ + V+R  L   S + +  ++ E 
Sbjct: 18  SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIE 197
            V     H N+V      I  +E  ++  +M   S  D  L        ++ +    I++
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQ 135

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT----- 252
           G+ + L Y+H       +HR +KAS+IL+  D    +S          +  +        
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 253 SRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 292
              V    ++SPE   + +  +  KSD++S G+   E+ +G 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  111 bits (279), Expect = 5e-27
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLL 153
             LG+G FG V K   +    E AVK ++      +    +  E  ++ K+ H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLLY 205
               D     ++ E          LFD    +    + R         +II+ +  G+ Y
Sbjct: 88  EILEDSSSFYIVGELYTGGE----LFD---EI----IKRKRFSEHDAARIIKQVFSGITY 136

Query: 206 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           +H++    I+HRDLK  NILL   +KD + KI DFG++     N         +GT  Y+
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYI 190

Query: 263 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 291
           +PE  L G +  K DV+S GV+L  ++SG
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (270), Expect = 7e-27
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 32/202 (15%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 154
            LG+G FG V K   +    E AVK ++      +    +  E  ++ K+ H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLLYL 206
              D     ++ E          LFD    +    + R         +II+ +  G+ Y+
Sbjct: 89  ILEDSSSFYIVGELYTGGE----LFD---EI----IKRKRFSEHDAARIIKQVFSGITYM 137

Query: 207 HQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
           H+++   I+HRDLK  NILL   +KD + KI DFG++     N         +GT  Y++
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIA 191

Query: 264 PEYALEGIFSIKSDVFSFGVLL 285
           PE  L G +  K DV+S GV+L
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVIL 212

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (271), Expect = 7e-27
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 22/221 (9%)

Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ-GLREMKNEASVIAKV 144
           S   + +     +G G    V         E  A+KR++    Q  + E+  E   +++ 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE--GIA-- 200
            H N+V      + KDE  L+ + +   S+     D  K ++     +  +++   IA  
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 201 -----QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR 254
                +GL YLH   +   IHRD+KA NILL +D + +I+DFG+ A +  G ++  N  R
Sbjct: 127 LREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 255 --IVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
              VGT  +M+PE   +   +  K+D++SFG+  +E+ +G 
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 8e-27
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 22/237 (9%)

Query: 70  SKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG 128
           +       L     S++      F     +G G +G VYKG   K G   A+K +   +G
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTG 61

Query: 129 QGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI------LIYEYMPNKSL-DFFLFD 180
               E+K E +++ K   H+N+    G  I K+         L+ E+    S+ D     
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
               +  +W+    I   I +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++
Sbjct: 122 KGNTLKEEWIA--YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 241 RICGGNELQANTSRIVGTYGYMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                   + NT   +GT  +M+PE        +  +  KSD++S G+  +E+  G 
Sbjct: 177 AQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (272), Expect = 1e-26
 Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
            +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVT-RV--QIIEGIAQGLLYL 206
           LL          +++E+M    L          +       +  V    +  I + L Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 207 HQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
           H      IIHRD+K   +LL   +     K+  FG+A   G + L A     VGT  +M+
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201

Query: 264 PEYALEGIFSIKSDVFSFGVLL 285
           PE      +    DV+  GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  107 bits (270), Expect = 1e-26
 Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 10/198 (5%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           LGEG F  V            A+K L  R      +   +  E  V++++ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D ++      Y  N  L                TR    E I   L YLH      I
Sbjct: 98  TFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDET-CTRFYTAE-IVSALEYLHGKG---I 151

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           IHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E     
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211

Query: 275 KSDVFSFGVLLLEIVSGK 292
            SD+++ G ++ ++V+G 
Sbjct: 212 SSDLWALGCIIYQLVAGL 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  107 bits (270), Expect = 1e-26
 Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 23/211 (10%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS------GRSGQGLREMKNEASVIAKV 144
            K+    K+GEG +G VYK    +G  +A+KR+       G     +RE+    S++ ++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQG 202
            H N+V L+     +    L++E+M  K L   L +    +    +     Q++ G+A  
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA-- 133

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
             + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y 
Sbjct: 134 --HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186

Query: 263 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           +P+  +    +S   D++S G +  E+++GK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (267), Expect = 2e-26
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 16/193 (8%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +G G +G V   V K      A K++     + +   K E  ++  + H N++RL    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
            D  +  L+ E          LF+    + +       +I++ +   + Y H+     + 
Sbjct: 76  EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128

Query: 216 HRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           HRDLK  N L      D   K+ DFG+A      ++       VGT  Y+SP+  LEG++
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-VLEGLY 184

Query: 273 SIKSDVFSFGVLL 285
             + D +S GV++
Sbjct: 185 GPECDEWSAGVMM 197

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (269), Expect = 3e-26
 Identities = 29/216 (13%), Positives = 66/216 (30%), Gaps = 24/216 (11%)

Query: 97  NKLGEGGFGPVYKGV------LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
           + LGEG F  VY+         K   +  +K     +             +        +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           +     + ++  +L+ E     +L   +    +  ++++   +     +  +   +  +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-MLYMIEQVH 189

Query: 208 QYSRVRIIHRDLKASNILL-----------DKDMNPKISDFGMARICGGNELQANTSRIV 256
                 IIH D+K  N +L           D      + D G +            +   
Sbjct: 190 D---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            T G+   E      ++ + D F     +  ++ G 
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (268), Expect = 7e-26
 Identities = 31/233 (13%), Positives = 67/233 (28%), Gaps = 43/233 (18%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQH-------- 146
           LG+       +    + G+   V             +++MK E   +  ++         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 147 --------KNLVRLLGCCIDKDEK-----------ILIYEYMPNKSLDFF--LFD-PTKR 184
                    +LV+          +             +Y  M +    F   L    +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             L    R+Q+   + + L  LH Y    ++H  L+  +I+LD+     ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261

Query: 245 GNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGK 292
           G    +   R        +            + +   D ++ G+ +  I    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (263), Expect = 7e-26
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 41/217 (18%)

Query: 90  TNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEAS 139
           + KFSD      +LG+G F  V + V K  G E A K     +LS R  Q L     EA 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REAR 57

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV------ 193
           +  K+QH N+VRL     ++    L+++ +        LF+       D V R       
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-------DIVAREFYSEAD 106

Query: 194 --QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNEL 248
               I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A     +E 
Sbjct: 107 ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163

Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
                   GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 164 ---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (263), Expect = 9e-26
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS------GRSGQGLREMKNEASVIAKV 144
            K+    K+GEG +G VYK     G+  A+K++       G     +RE+    S++ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI----SILKEL 57

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQG 202
           +H N+V+L      K   +L++E++  + L   L      +          Q++ GIA  
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-- 114

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
             Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  IV T  Y 
Sbjct: 115 --YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167

Query: 263 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           +P+  +    +S   D++S G +  E+V+G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (262), Expect = 1e-25
 Identities = 51/207 (24%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEASVIAKVQHKNL 149
            K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ +++HKN+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKELKHKNI 63

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 207
           VRL        +  L++E+   + L  +       +  + V     Q+++G+     + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG----FCH 118

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
                 ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T  Y  P+  
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173

Query: 268 L-EGIFSIKSDVFSFGVLLLEIVSGKK 293
               ++S   D++S G +  E+ +  +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  104 bits (263), Expect = 1e-25
 Identities = 64/218 (29%), Positives = 118/218 (54%), Gaps = 26/218 (11%)

Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-----LREMKNEASVI 141
           +++++F    KLG G +  VYKG+ K      A+K +   S +G     +RE+    S++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI----SLM 57

Query: 142 AKVQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLDFFLFDPTKRMLLDWVTR---VQI 195
            +++H+N+VRL      +++  L++E+M N   K +D      T R L   + +    Q+
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 196 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 255
           ++G+A    + H+    +I+HRDLK  N+L++K    K+ DFG+AR   G  +   +S +
Sbjct: 118 LQGLA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEV 169

Query: 256 VGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           V T  Y +P+  +    +S   D++S G +L E+++GK
Sbjct: 170 V-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (267), Expect = 1e-25
 Identities = 51/227 (22%), Positives = 81/227 (35%), Gaps = 32/227 (14%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNL 149
           N       LG G  G V      +G  +AVKR+             E  ++ +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           +R            +  E       D             L      + ++  IA G+ +L
Sbjct: 72  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 207 HQYSRVRIIHRDLKASNILLD-------------KDMNPKISDFGMARICGGNE--LQAN 251
           H    ++IIHRDLK  NIL+              +++   ISDFG+ +     +   + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 252 TSRIVGTYGYMSPEYALEGIFSI-------KSDVFSFGVLLLEIVSG 291
            +   GT G+ +PE   E              D+FS G +   I+S 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (264), Expect = 2e-25
 Identities = 58/254 (22%), Positives = 101/254 (39%), Gaps = 47/254 (18%)

Query: 61  PANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-G 115
             N+ Q K ++      +          A  +F       + +G G    V + V +  G
Sbjct: 60  KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119

Query: 116 DEIAVK-------RLSGRSGQGLREM-KNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 166
            E AVK       RLS    + +RE  + E  ++ +V  H +++ L+          L++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179

Query: 167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIEGIAQGLLYLHQYSRVRIIHR 217
           + M                L D++T            I+  + + + +LH      I+HR
Sbjct: 180 DLMRKGE------------LFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHR 224

Query: 218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE------YALEGI 271
           DLK  NILLD +M  ++SDFG +      E       + GT GY++PE            
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPG 281

Query: 272 FSIKSDVFSFGVLL 285
           +  + D+++ GV+L
Sbjct: 282 YGKEVDLWACGVIL 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (263), Expect = 2e-25
 Identities = 34/239 (14%), Positives = 72/239 (30%), Gaps = 54/239 (22%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ--------- 145
           LG+       +   ++ G+   V             +++MK E   +  ++         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 146 ----------------HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFF--LFD-PTKR 184
                            K ++R+     D        +Y  M +    F   L    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 185 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
             L    R+Q+   + + L  LH Y    ++H  L+  +I+LD+     ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 245 GNELQANTSRIVGTYGYMSPEYAL-----------EGIFSIKSDVFSFGVLLLEIVSGK 292
                        + G+  PE                + +   D ++ G+++  I    
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (261), Expect = 2e-25
 Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 32/201 (15%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            LG G F  V+    +  G   A+K +          ++NE +V+ K++H+N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---------VQIIEGIAQGLLYLH 207
                  L+ + +            +   L D +             +I+ +   + YLH
Sbjct: 76  ESTTHYYLVMQLV------------SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123

Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +     I+HRDLK  N+L    +++    I+DFG++++     +        GT GY++P
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAP 176

Query: 265 EYALEGIFSIKSDVFSFGVLL 285
           E   +  +S   D +S GV+ 
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (259), Expect = 3e-25
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 44/214 (20%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK--------RLSGRSGQGLREM-KNEASVIAKV-QH 146
            LG G    V + + K    E AVK          S    Q LRE    E  ++ KV  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIE 197
            N+++L           L+++ M    L             D++T            I+ 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGEL------------FDYLTEKVTLSEKETRKIMR 131

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            + + +  LH+     I+HRDLK  NILLD DMN K++DFG +      E       + G
Sbjct: 132 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 185

Query: 258 TYGYMSPE------YALEGIFSIKSDVFSFGVLL 285
           T  Y++PE            +  + D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (258), Expect = 3e-25
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 38/208 (18%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREM-KNEASVIAKVQHKNLV 150
           +LG G F  V K   K  G E A K     RLS       RE  + E +++ +++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD---------WVTRVQIIEGIAQ 201
            L     +K + +LI E +    L    FD    +               + QI++G+  
Sbjct: 72  TLHDIFENKTDVVLILELVSGGEL----FD---FLAEKESLTEDEATQFLK-QILDGVH- 122

Query: 202 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 257
              YLH     RI H DLK  NI+L      +   K+ DFG+A              I G
Sbjct: 123 ---YLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           T  +++PE        +++D++S GV+ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (261), Expect = 4e-25
 Identities = 60/233 (25%), Positives = 109/233 (46%), Gaps = 31/233 (13%)

Query: 67  AKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG 125
           A  +  +++ +   F  ++ +  ++ +    +LG+G F  V + V K  G E A K ++ 
Sbjct: 5   ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64

Query: 126 R--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK 183
           +  S +  ++++ EA +  K+QH N+VRL     ++    L+++ +    L    F+   
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FE--- 117

Query: 184 RMLLDWVTRV--------QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNP 232
               D V R           I+ I + + Y H      I+HR+LK  N+LL    K    
Sbjct: 118 ----DIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170

Query: 233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           K++DFG+A     +E         GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 171 KLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (260), Expect = 4e-25
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 150
           +LG G F  V K   K  G E A K     +         RE ++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
            L     ++ + +LI E +        LFD   ++  L        I+ I  G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 210 SRVRIIHRDLKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
               I H DLK  NI+L DK++     K+ DFG+A              I GT  +++PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188

Query: 266 YALEGIFSIKSDVFSFGVLL 285
                   +++D++S GV+ 
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (261), Expect = 4e-25
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 22/200 (11%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 150
           +LG G F  V K   K  G E A K     +         RE ++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
            L     ++ + +LI E +        LFD   ++  L        I+ I  G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 210 SRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
               I H DLK  NI+L        + K+ DFG+A              I GT  +++PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188

Query: 266 YALEGIFSIKSDVFSFGVLL 285
                   +++D++S GV+ 
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  103 bits (259), Expect = 5e-25
 Identities = 52/280 (18%), Positives = 94/280 (33%), Gaps = 58/280 (20%)

Query: 63  NNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK 121
           ++     S ++ +     F   S+     K+     +G+G +G V   +  +     A+K
Sbjct: 2   HHHHHHSSGRENLY----FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57

Query: 122 -----RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM------- 169
                ++   + + +  +K E  ++ K+ H N+ RL     D+    L+ E         
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117

Query: 170 ------------------PNKSLDFFLFDPTKRMLLDWVTRV------------QIIEGI 199
                               +       +           R              I+  I
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNPKISDFGMARICGGNELQANT--SRI 255
              L YLH      I HRD+K  N L   +K    K+ DFG+++             +  
Sbjct: 178 FSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234

Query: 256 VGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGK 292
            GT  +++PE  L      +  K D +S GVLL  ++ G 
Sbjct: 235 AGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (258), Expect = 6e-25
 Identities = 44/193 (22%), Positives = 83/193 (43%), Gaps = 16/193 (8%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            LG G FG V++ V          K +  + G     +K E S++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 157 IDKDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              +E ++I+E++    +    F+   T    L+    V  +  + + L +LH ++   I
Sbjct: 71  ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---I 123

Query: 215 IHRDLKASNILL--DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            H D++  NI+    +    KI +FG AR     +       +     Y +PE     + 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVV 180

Query: 273 SIKSDVFSFGVLL 285
           S  +D++S G L+
Sbjct: 181 STATDMWSLGTLV 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 1e-24
 Identities = 56/208 (26%), Positives = 84/208 (40%), Gaps = 38/208 (18%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 150
           +LG G F  V K   K  G + A K     R         RE ++ E S++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD---------WVTRVQIIEGIAQ 201
            L     +K + ILI E +    L    FD    +               + QI+ G+  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FD---FLAEKESLTEEEATEFLK-QILNGVY- 128

Query: 202 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 257
              YLH      I H DLK  NI+L          KI DFG+A              I G
Sbjct: 129 ---YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           T  +++PE        +++D++S GV+ 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (255), Expect = 1e-24
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-----LREMKNEASVIAKV 144
             +   +KLGEG +  VYKG  K  D + A+K +     +G     +RE+    S++  +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV----SLLKDL 57

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQG 202
           +H N+V L      +    L++EY+ +K L  +L D    + +  V     Q++ G+A  
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA-- 114

Query: 203 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
             Y H+    +++HRDLK  N+L+++    K++DFG+AR       +   + +V T  Y 
Sbjct: 115 --YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167

Query: 263 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
            P+  L    +S + D++  G +  E+ +G+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  101 bits (255), Expect = 2e-24
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAK 143
            K+ +   +GEG +G V K   K    I A+K+              +RE+K    ++ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLKQ 80

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQ 201
           ++H+NLV LL  C  K    L++E++ + ++   L      +    V +   QII GI  
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIG- 138

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
              + H +    IIHRD+K  NIL+ +    K+ DFG AR       +     +  T  Y
Sbjct: 139 ---FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWY 190

Query: 262 MSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
            +PE  + +  +    DV++ G L+ E+  G+
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (253), Expect = 2e-24
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           LGEG +G V + +  +     AVK L      R   G   +K E  ++ +++HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 154 GCCIDKDEKILIY---EYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYLH 207
              +  +EK  +Y   EY      +     P KR            Q+I+G+     YLH
Sbjct: 73  DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLE----YLH 126

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI----CGGNELQANTSRIVGTYGYMS 263
                 I+H+D+K  N+LL      KIS  G+A         +  +  TS+  G+  +  
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR--TSQ--GSPAFQP 179

Query: 264 PEYA--LEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE A  L+     K D++S GV L  I +G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  103 bits (259), Expect = 3e-24
 Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 11/198 (5%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG+GGFG V    ++   ++ A K+L  +     +G     NE  ++ KV  + +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
               KD   L+   M    L F ++   +    +        E I  GL  LH+    RI
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHRE---RI 307

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           ++RDLK  NILLD   + +ISD G+A      +        VGT GYM+PE      ++ 
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTF 364

Query: 275 KSDVFSFGVLLLEIVSGK 292
             D ++ G LL E+++G+
Sbjct: 365 SPDWWALGCLLYEMIAGQ 382

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  101 bits (254), Expect = 3e-24
 Identities = 57/192 (29%), Positives = 100/192 (52%), Gaps = 26/192 (13%)

Query: 86  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVK--RLSGRSGQ-------GLREMK 135
           V +   ++   + LGEG F  VYK   K  ++I A+K  +L  RS          LRE+K
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 136 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--V 193
               ++ ++ H N++ LL     K    L++++M    L+  + D +  +    +    +
Sbjct: 65  ----LLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYML 119

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 253
             ++G+     YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+   G+  +A T 
Sbjct: 120 MTLQGLE----YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171

Query: 254 RIVGTYGYMSPE 265
           ++V T  Y +PE
Sbjct: 172 QVV-TRWYRAPE 182

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (255), Expect = 4e-24
 Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 43/212 (20%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE---MKNEASVIAKVQHKN 148
            LG G  G V     +K   ++A++     + +  S +       ++ E  ++ K+ H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIEGI 199
           ++++     D ++  ++ E M    L             D V   +             +
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL------------FDKVVGNKRLKEATCKLYFYQM 248

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIV 256
              + YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + 
Sbjct: 249 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302

Query: 257 GTYGYMSPE---YALEGIFSIKSDVFSFGVLL 285
           GT  Y++PE         ++   D +S GV+L
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (257), Expect = 6e-24
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 12/200 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG GGFG V+   +K   ++ A K+L+ +     +G +    E  ++AKV  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKR--MLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
               K +  L+   M    + + +++  +      +        + I  GL +LHQ    
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR--- 308

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            II+RDLK  N+LLD D N +ISD G+A      + +       GT G+M+PE  L   +
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEY 366

Query: 273 SIKSDVFSFGVLLLEIVSGK 292
               D F+ GV L E+++ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  100 bits (252), Expect = 7e-24
 Identities = 59/239 (24%), Positives = 113/239 (47%), Gaps = 39/239 (16%)

Query: 77  QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL---SGRSG---Q 129
           Q             +K+    K+G+G FG V+K   +K  +  A+K++   + + G    
Sbjct: 4   QYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62

Query: 130 GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI--------LIYEYMPN--KSLDFFLF 179
            LRE+K    ++  ++H+N+V L+  C  K            L++++  +    L   L 
Sbjct: 63  ALREIK----ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LS 115

Query: 180 DPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF 237
           +   +  L  + RV   ++ G+     Y+H+    +I+HRD+KA+N+L+ +D   K++DF
Sbjct: 116 NVLVKFTLSEIKRVMQMLLNGLY----YIHRN---KILHRDMKAANVLITRDGVLKLADF 168

Query: 238 GMARICG---GNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           G+AR       ++    T+R+V T  Y  PE  L E  +    D++  G ++ E+ +  
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  100 bits (250), Expect = 7e-24
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 26/201 (12%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQH-KNLVRLL 153
           +LG G F  V + + K  G E A K L  R        E+ +E +V+   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLYLH 207
               +  E ILI EY         +F      L +          +++I+ I +G+ YLH
Sbjct: 96  EVYENTSEIILILEYAAGGE----IFS---LCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           Q     I+H DLK  NILL       + KI DFGM+R  G          I+GT  Y++P
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAP 202

Query: 265 EYALEGIFSIKSDVFSFGVLL 285
           E       +  +D+++ G++ 
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (254), Expect = 8e-24
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 36/219 (16%)

Query: 86  VSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREM--KNEA 138
            +    +F++      +LG+G F  V + V    G E A   ++ +          + EA
Sbjct: 2   ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61

Query: 139 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------ 192
            +   ++H N+VRL     ++    LI++ +            T   L + +        
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLV------------TGGELFEDIVAREYYSE 109

Query: 193 ---VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGN 246
                 I+ I + +L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G 
Sbjct: 110 ADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 285
           +         GT GY+SPE   +  +    D+++ GV+L
Sbjct: 167 QQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 27/204 (13%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE---MKNEASVIAKVQHKN 148
            LG G  G V     +K   ++A+K     + +  S +       ++ E  ++ K+ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLH 207
           ++++     D ++  ++ E M        LFD       L   T       +   + YLH
Sbjct: 77  IIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAP 185

Query: 265 E---YALEGIFSIKSDVFSFGVLL 285
           E         ++   D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 53/232 (22%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLS----------------------GRSGQGLREM- 134
           +G+G +G V            A+K LS                             R   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 135 ---KNEASVIAKVQHKNLVRLLGCCIDKDEKILIY---EYMPNKSLDFFLFD-PTKRMLL 187
                E +++ K+ H N+V+L+   +D   +  +Y   E +    +     + PT + L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 188 DWVTRV---QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 244
           +   R     +I+GI     YLH     +IIHRD+K SN+L+ +D + KI+DFG++    
Sbjct: 136 EDQARFYFQDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 245 GNELQANTSRIVGTYGYMSPEYALEGIFSI----KSDVFSFGVLLLEIVSGK 292
           G++   + +  VGT  +M+PE +L     I      DV++ GV L   V G+
Sbjct: 189 GSDALLSNT--VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 44/224 (19%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
              +++   +G G FG V++  L + DE+A+K++        RE++    ++  V+H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94

Query: 150 VRLLGC----CIDKDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG----- 198
           V L          KDE    L+ EY+P +++         R    +    Q +       
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRHYAKLKQTMPMLLIKL 145

Query: 199 ----IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTS 253
               + + L Y+H    + I HRD+K  N+LLD      K+ DFG A+I      + N S
Sbjct: 146 YMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200

Query: 254 RIVGTYGYMSPEYALEGIF-----SIKSDVFSFGVLLLEIVSGK 292
            I   Y Y +PE     IF     +   D++S G ++ E++ G+
Sbjct: 201 YICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 30/221 (13%)

Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEAS 139
           +T+ +++    KLGEG +G VYK +    +E  A+KR+       G  G  +RE+    S
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV----S 85

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIE 197
           ++ ++QH+N++ L           LI+EY     L  ++ D    + +  +     Q+I 
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSFLYQLIN 143

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-----KISDFGMARICGGNELQANT 252
           G+     + H     R +HRDLK  N+LL           KI DFG+AR   G  ++  T
Sbjct: 144 GVN----FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFT 195

Query: 253 SRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
             I+ T  Y  PE  L    +S   D++S   +  E++   
Sbjct: 196 HEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAK 143
            K+    K+GEG +G V+K   +   +I A+K+              LRE++    ++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQ 58

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQ 201
           ++H NLV LL     K    L++EY  + ++   L    + +    V  +  Q ++ +  
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVN- 116

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
              + H++     IHRD+K  NIL+ K    K+ DFG AR+  G         +  T  Y
Sbjct: 117 ---FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWY 168

Query: 262 MSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
            SPE  + +  +    DV++ G +  E++SG 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.1 bits (247), Expect = 4e-23
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 35/218 (16%)

Query: 98  KLGEGGFGPVYKGVLKK---GDEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKNLVRL 152
           K+G G +G VYK   K      + A+K++   G S    RE+     ++ +++H N++ L
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA----LLRELKHPNVISL 83

Query: 153 LGCCIDK-DEKI-LIYEYMPN---KSLDFFLFDPTKRMLLDWVTRV------QIIEGIAQ 201
               +   D K+ L+++Y  +     + F       +  +     +      QI++GI  
Sbjct: 84  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH- 142

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICG--GNELQANTSRI 255
              YLH      ++HRDLK +NIL+  +       KI+D G AR+       L      +
Sbjct: 143 ---YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 256 VGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           V T+ Y +PE  L    ++   D+++ G +  E+++ +
Sbjct: 197 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.9 bits (242), Expect = 7e-23
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 46/232 (19%)

Query: 87  STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSG---QGLRE--- 133
           S AT+++    ++G G +G VYK          A+K +       G  G     +RE   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 134 MKNEASVIAKVQHKNLVRLL----GCCIDKDEKI-LIYEYMP--------NKSLDFFLFD 180
           ++     +   +H N+VRL+        D++ K+ L++E++                  +
Sbjct: 65  LRR----LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120

Query: 181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
             K ++       Q + G+     +LH      I+HRDLK  NIL+      K++DFG+A
Sbjct: 121 TIKDLMR------QFLRGLD----FLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167

Query: 241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           RI       A T  +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 168 RIYSYQ--MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASV---IA-------KVQHK 147
           LG+GGFG V+ G  L    ++A+K +      G   + +  +    +A          H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLL 204
            ++RLL     ++  +L+ E  P  + D F +   K  L +  +R    Q++  I     
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 263
           + H      ++HRD+K  NIL+D      K+ DFG   +              GT  Y  
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DF--DGTRVYSP 206

Query: 264 PEYALEGI--FSIKSDVFSFGVLLLEIVSG 291
           PE+ +      ++ + V+S G+LL ++V G
Sbjct: 207 PEW-ISRHQYHALPATVWSLGILLYDMVCG 235

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 36/213 (16%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQHK--NL 149
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 206
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 165

Query: 207 HQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           H      ++HRD+K  NIL+D +    K+ DFG   +              GT  Y  PE
Sbjct: 166 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF--DGTRVYSPPE 218

Query: 266 YALEGIFSIK------SDVFSFGVLLLEIVSGK 292
                           + V+S G+LL ++V G 
Sbjct: 219 -----WIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 44/226 (19%)

Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEI-AVKRL---SGRSG---QGLRE---MKNEAS 139
            ++    ++GEG +G V+K   LK G    A+KR+   +G  G     +RE   +++   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67

Query: 140 VIAKVQHKNLVRLL----GCCIDKDEKI-LIYEYMP--------NKSLDFFLFDPTKRML 186
            +   +H N+VRL         D++ K+ L++E++                  +  K M+
Sbjct: 68  -LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126

Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
                  Q++ G+     +LH +   R++HRDLK  NIL+      K++DFG+ARI    
Sbjct: 127 F------QLLRGLD----FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

Query: 247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
              A TS +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 --MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V     + +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 157 IDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSR 211
            + + + L  EY     L    FD   P   M      R   Q++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYALE 269
             I HRD+K  N+LLD+  N KISDFG+A +      E   N     GT  Y++PE    
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE---- 177

Query: 270 GIFSIK------SDVFSFGVLLLEIVSG 291
            +   +       DV+S G++L  +++G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 37/210 (17%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC 156
           LGEG    V   +      E AVK +  + G     +  E  ++ + Q H+N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------QIIEGIAQGLLYLHQ 208
            ++D   L++E M   S+          +      R          +++ +A  L +LH 
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LS---HI----HKRRHFNELEASVVVQDVASALDFLHN 129

Query: 209 YSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSR-----IVGTYG 260
                I HRDLK  NIL    ++    KI DF +      N   +  S        G+  
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 261 YMSPE-----YALEGIFSIKSDVFSFGVLL 285
           YM+PE          I+  + D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 53/249 (21%), Positives = 100/249 (40%), Gaps = 33/249 (13%)

Query: 50  NLKADNVIIELPANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYK 109
           +L  +N+  +  ++   +       +        S+    ++ F   ++LG G    VY+
Sbjct: 12  DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71

Query: 110 GVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 168
              K      A+K L     +  + ++ E  V+ ++ H N+++L        E  L+ E 
Sbjct: 72  CKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129

Query: 169 MPNKSLDFFLFDPTKRMLLDWVTR---------VQIIEGIAQGLLYLHQYSRVRIIHRDL 219
           +            T   L D +              ++ I + + YLH+     I+HRDL
Sbjct: 130 V------------TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDL 174

Query: 220 KASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           K  N+L      D   KI+DFG+++I     L      + GT GY +PE      +  + 
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEV 231

Query: 277 DVFSFGVLL 285
           D++S G++ 
Sbjct: 232 DMWSVGIIT 240

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 156
           LGEG +G V   V     + +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 157 IDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSR 211
            + + + L  EY     L    FD   P   M      R   Q++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYALE 269
             I HRD+K  N+LLD+  N KISDFG+A +      E   N     GT  Y++PE    
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE---- 177

Query: 270 GIFSIK------SDVFSFGVLLLEIVSG 291
            +   +       DV+S G++L  +++G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 33/208 (15%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGC 155
           +G+G F  V     +  G E+A+K +     +   L+++  E  ++  + H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRV---QIIEGIAQGLLYLHQYS 210
              +    LI EY     +    FD       + +   R    QI+  +     Y HQ  
Sbjct: 83  IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQK- 133

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
             RI+HRDLKA N+LLD DMN KI+DFG +          +     G   Y +PE     
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAF--CGAPPYAAPE----- 183

Query: 271 IFS------IKSDVFSFGVLLLEIVSGK 292
           +F        + DV+S GV+L  +VSG 
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)

Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK------RLSGRSGQGLREM 134
           +        ++F      G+G FG V  G  K  G  +A+K      R   R    L+ M
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70

Query: 135 KNEASVIAKVQHKNLVRLLGCCIDKDEK-------ILIYEYMPNKSLDFFLFDPTKRMLL 187
           +     +A + H N+V+L        E+        ++ EY+P  +L         R   
Sbjct: 71  Q----DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTL--------HRCCR 117

Query: 188 DWVTRVQIIEG---------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDF 237
           ++  R               + + +  LH  S   + HRD+K  N+L+++     K+ DF
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDF 176

Query: 238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 292
           G A+    +E   N + I   Y Y +PE     IF  +      D++S G +  E++ G+
Sbjct: 177 GSAKKLSPSE--PNVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.6 bits (243), Expect = 4e-22
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKN---LVR 151
           +G GGFG VY        ++ A+K L  +     QG     NE  +++ V   +   +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           +       D+   I + M    L + L      +  +   R    E I  GL ++H    
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILGLEHMHNR-- 311

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
             +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE   +G+
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEVLQKGV 366

Query: 272 FSIKS-DVFSFGVLLLEIVSGK 292
               S D FS G +L +++ G 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGH 388

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.9 bits (239), Expect = 6e-22
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 45/225 (20%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 148
              ++D   +G G FG VY+  L   G+ +A+K++        RE++    ++ K+ H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108

Query: 149 LVRLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---- 198
           +VRL        EK       L+ +Y+P +++         R+   +    Q +      
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETV--------YRVARHYSRAKQTLPVIYVK 159

Query: 199 -----IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT 252
                + + L Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   N 
Sbjct: 160 LYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 214

Query: 253 SRIVGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 292
           S I   Y Y +PE     IF         DV+S G +L E++ G+
Sbjct: 215 SYICSRY-YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.8 bits (236), Expect = 6e-22
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 36/212 (16%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVK--------RLSGRSGQGLREMKNEASVIAKVQHKNL 149
           LG G FG V+  V  +K  E+ VK                 L ++  E +++++V+H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV---QIIEGIAQGLLYL 206
           +++L    ++    L+ E   +  LD F F      L + +      Q++  +     YL
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----YL 146

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPE 265
                  IIHRD+K  NI++ +D   K+ DFG  A +  G      T    GT  Y +PE
Sbjct: 147 RLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTF--CGTIEYCAPE 199

Query: 266 YALEGIFSIKS------DVFSFGVLLLEIVSG 291
                +           +++S GV L  +V  
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVTLYTLVFE 226

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 50/203 (24%), Positives = 77/203 (37%), Gaps = 34/203 (16%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
             +G G +    + + K    E AVK +         E      ++   QH N++ L   
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDV 84

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---------VQIIEGIAQGLLYL 206
             D     ++ E M    L            LD + R           ++  I + + YL
Sbjct: 85  YDDGKYVYVVTELMKGGEL------------LDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 207 HQYSRVRIIHRDLKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 262
           H      ++HRDLK SNIL  D+  NP   +I DFG A+          T     T  ++
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFV 187

Query: 263 SPEYALEGIFSIKSDVFSFGVLL 285
           +PE      +    D++S GVLL
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 155
            LGEG F    K V KK     AVK +S R        + E + +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------QIIEGIAQGLLYLH 207
             D+    L+ E +    L    F+   R+      +          I+  +   + ++H
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FE---RI----KKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 208 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
               V ++HRDLK  N+L    + ++  KI DFG AR+   +     T     T  Y +P
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178

Query: 265 EYALEGIFSIKSDVFSFGVLL 285
           E   +  +    D++S GV+L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 47/203 (23%), Positives = 78/203 (38%), Gaps = 34/203 (16%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 155
            LG G  G V +   ++ G + A+K L         + + E     +     ++V +L  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90

Query: 156 CIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLY 205
             +         +I E M    L    F    R+              +I+  I   + +
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL----FS---RIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 206 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
           LH      I HRD+K  N+L    +KD   K++DFG A+    N LQ        T  Y+
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYV 196

Query: 263 SPEYALEGIFSIKSDVFSFGVLL 285
           +PE      +    D++S GV++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIM 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 154
           LG G FG V  G     G ++AVK L+ +      +   +K E   +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRV---QIIEGIAQGLLYLHQY 209
                 +  ++ EY+    L    FD       + +   R    QI+  +     Y H++
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCHRH 130

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
               ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS   G+  Y +PE    
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE---- 180

Query: 270 GIFS------IKSDVFSFGVLLLEIVSGK 292
            + S       + D++S GV+L  ++ G 
Sbjct: 181 -VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.8 bits (220), Expect = 9e-20
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 11/132 (8%)

Query: 160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL 219
           +EK L          D +    T   L+ +  +      +A+G+ +L   +  + IHRDL
Sbjct: 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKCIHRDL 219

Query: 220 KASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDV 278
            A NILL +    KI DFG+AR I    +        +    +M+PE   + +++I+SDV
Sbjct: 220 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDV 278

Query: 279 FSFGVLLLEIVS 290
           +SFGVLL EI S
Sbjct: 279 WSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 34/160 (21%), Positives = 55/160 (34%), Gaps = 19/160 (11%)

Query: 97  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 148
             LG G FG V +      D+      +AVK L  G +    R + +E  ++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 149 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           +V LLG C      + +I E+    +L  +L       +       +  +G         
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK-------- 139

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
               V  I  DLK     +    +   S F   +     E
Sbjct: 140 --DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 51/217 (23%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLRE-MKNEASVIAKVQHKNLVRLLG 154
           LGEG FG V      K   ++A+K +S +      +   ++ E S +  ++H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 155 CCIDKDEKILIYEYMPNKSLDFF--------LFD--PTKRMLLDWVTRV---QIIEGIAQ 201
                      Y+ +   +            LFD    K+ + +   R    QII  I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
              Y H++   +I+HRDLK  N+LLD ++N KI+DFG++ I         TS   G+  Y
Sbjct: 123 ---YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNY 173

Query: 262 MSPEYALEGIFS------IKSDVFSFGVLLLEIVSGK 292
            +PE     + +       + DV+S G++L  ++ G+
Sbjct: 174 AAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           +G G FG V    LK  D++ A+K L+        E    + E  V+     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D +   L+ +Y     L   L    +  L + + R  + E +   +  +HQ      
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQLH---Y 196

Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +HRD+K  NIL+D + + +++DFG   ++     +Q++    VGT  Y+SPE  L+ +  
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPE-ILQAMEG 253

Query: 274 IKS------DVFSFGVLLLEIVSG 291
            K       D +S GV + E++ G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYG 277

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 34/209 (16%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
           LG G FG V  G     G ++AVK   R   RS   + +++ E   +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRV---QIIEGIAQGLLYLHQY 209
                 +  ++ EY+    L    FD       L +  +R    QI+ G+     Y H++
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCHRH 135

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
               ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS   G+  Y +PE    
Sbjct: 136 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE---- 185

Query: 270 GIFS------IKSDVFSFGVLLLEIVSGK 292
            + S       + D++S GV+L  ++ G 
Sbjct: 186 -VISGRLYAGPEVDIWSSGVILYALLCGT 213

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 15/197 (7%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           LG G FG V     K+     A+K L  +    L++     NE  ++  V    LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D     ++ EY+    +   L         +   R    + I     YLH      +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQ-IVLTFEYLHSLD---L 162

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           I+RDLK  N+L+D+    +++DFG A+   G      T  + GT   ++PE  L   ++ 
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNK 217

Query: 275 KSDVFSFGVLLLEIVSG 291
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 51/247 (20%), Positives = 91/247 (36%), Gaps = 41/247 (16%)

Query: 61  PANNKQAKRSKKKEVDQLPLFSF-SSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKK 114
           PA      +       Q P F   S +    N   D     +  LG G  G V +   K+
Sbjct: 26  PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR 85

Query: 115 -GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKI----LIYEY 168
             ++ A+K L         + + E  +  +     ++VR++    +         ++ E 
Sbjct: 86  TQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140

Query: 169 MPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 222
           +    L    F    R+              +I++ I + + YLH  +   I HRD+K  
Sbjct: 141 LDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 190

Query: 223 NILL---DKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDV 278
           N+L      +   K++DFG A+     N L         T  Y++PE      +    D+
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDM 246

Query: 279 FSFGVLL 285
           +S GV++
Sbjct: 247 WSLGVIM 253

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 153
           +G+G FG V         ++ A+K ++        + +R +  E  ++  ++H  LV L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHPFLVNLW 81

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
               D+++  ++ + +    L  +          +   ++ I E +   L YL      R
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEE-TVKLFICE-LVMALDYLQNQ---R 135

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           IIHRD+K  NILLD+  +  I+DF +A +          + + GT  YM+PE     +FS
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE-----MFS 187

Query: 274 IKS--------DVFSFGVLLLEIVSGK 292
            +         D +S GV   E++ G+
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGR 214

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           LG G FG V+    +      A+K L       L++     +E  +++ V H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D  +  +I +Y+    L F L   ++R     V +    E +   L YLH      I
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNP-VAKFYAAE-VCLALEYLHSKD---I 127

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           I+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE      ++ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 182

Query: 275 KSDVFSFGVLLLEIVSG 291
             D +SFG+L+ E+++G
Sbjct: 183 SIDWWSFGILIYEMLAG 199

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 19/205 (9%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           +G G F  V    +K+  ++ A+K ++        E    + E  V+     + + +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D++   L+ EY     L   L    +R+  +   R  + E I   +  +H+      
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVHRLG---Y 183

Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-------Y 266
           +HRD+K  NILLD+  + +++DFG   ++     +++     VGT  Y+SPE        
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGG 241

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSG 291
              G +  + D ++ GV   E+  G
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYG 266

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 38/226 (16%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK------ 143
            + ++    +  G +G V  GV  +G  +A+KR+      G        S + K      
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 144 -----VQHKNLVRLLGCCI----DKDEKI-LIYEYMPN------KSLDFFLFDPTKRMLL 187
                  H N++ L    +        K+ L+ E M              +     +  +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                  I+     GL  LH+     ++HRDL   NILL  + +  I DF +AR    + 
Sbjct: 141 -----YHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 248 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
              N +  V    Y +PE  ++   F+   D++S G ++ E+ + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           +G G FG V     K   ++ A+K LS        +      E  ++A      +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              D     ++ EYMP   L   L       + +   R    E +   L  +H       
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL-VNLMS--NYDVPEKWARFYTAE-VVLALDAIHSMG---F 189

Query: 215 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE----YALE 269
           IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT  Y+SPE       +
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGD 247

Query: 270 GIFSIKSDVFSFGVLLLEIVSG 291
           G +  + D +S GV L E++ G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG 269

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 34/207 (16%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
           +G G FG           + +AVK +  R       ++ E      ++H N+VR     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 158 DKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRV 212
                 +I EY     L    ++      R   D       Q++ G++    Y H    +
Sbjct: 87  TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---SM 135

Query: 213 RIIHRDLKASNILLDKD--MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
           +I HRDLK  N LLD       KI DFG ++    +     ++  VGT  Y++PE     
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST--VGTPAYIAPE----- 187

Query: 271 IFSIK------SDVFSFGVLLLEIVSG 291
           +   +      +DV+S GV L  ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 56/198 (28%), Positives = 84/198 (42%), Gaps = 11/198 (5%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           LG+G FG V     K      A+K L         E      E  V+   +H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
                D    + EY     L F L    +R+  +   R    E I   L YLH  S   +
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKNV 270

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
           ++RDLK  N++LDKD + KI+DFG+ +    +     T    GT  Y++PE   +  +  
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGR 328

Query: 275 KSDVFSFGVLLLEIVSGK 292
             D +  GV++ E++ G+
Sbjct: 329 AVDWWGLGVVMYEMMCGR 346

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.4 bits (196), Expect = 8e-17
 Identities = 19/199 (9%), Positives = 57/199 (28%), Gaps = 41/199 (20%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             G       ++ +      ++A+  +          L+E  +    ++++    + R+L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                +   +++ E++   SL               V  ++ ++ +A      H   R  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +       S + +  D +  ++                          M          +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-------N 180

Query: 274 IKSDVFSFGVLLLEIVSGK 292
            + D+   G  L  ++  +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 51/289 (17%)

Query: 24  LGLIFYCVRRKPRSRGEDLMMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQLPLFS- 82
           L  ++YC       +      FD  +++             K    SK K  +Q      
Sbjct: 3   LHFLYYCSEPTLDVKIAFCQGFDKQVDV---------SYIAKHYNMSKSKVDNQFYSVEV 53

Query: 83  FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLR 132
             S  T   ++ +   +G G  G V           +A+K+LS          R+    R
Sbjct: 54  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YR 110

Query: 133 EMKNEASVIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP---NKSLDFFLFDPTK 183
           E+     ++  V HKN++ LL        +++ + + L+ E M     + +   L     
Sbjct: 111 ELV----LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166

Query: 184 RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 243
             LL      Q++     G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  
Sbjct: 167 SYLL-----YQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214

Query: 244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           G + +    +  V T  Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 215 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 99  LGEGGFGPVY---KGVLKKGDEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKNLV 150
           LG+GG+G V+   K       +I A+K L      R+ +     K E +++ +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 151 RLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
            L+        K+ LI EY+    L F   +  + + ++      + E I+  L +LHQ 
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGEL-FMQLE-REGIFMEDTACFYLAE-ISMALGHLHQK 140

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
               II+RDLK  NI+L+   + K++DFG+ +    +    +T    GT  YM+PE  + 
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMR 195

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK 292
              +   D +S G L+ ++++G 
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGA 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)

Query: 99  LGEGGFGPVY---KGVLKKGDEI-AVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRL 152
           LG+G FG V+   K       ++ A+K L   +   +     K E  ++ +V H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 153 LGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
                  + K+ LI +++    L F           + V +  + E +A  L +LH    
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHSLG- 146

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
             II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE      
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRG 202

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
            +  +D +SFGVL+ E+++G 
Sbjct: 203 HTQSADWWSFGVLMFEMLTGT 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 50/255 (19%), Positives = 100/255 (39%), Gaps = 69/255 (27%)

Query: 88  TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 146
           T++ K+S    LG G FG V +    + G   A+K++        RE+     ++  + H
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59

Query: 147 KNLVRLLGCCIDKDEKI--------------------------------------LIYEY 168
            N+++L+       ++                                       +I EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---------IAQGLLYLHQYSRVRIIHRDL 219
           +P  +L         ++L  ++   + I           + + + ++H    + I HRD+
Sbjct: 120 VP-DTL--------HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDI 167

Query: 220 KASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSD 277
           K  N+L++ KD   K+ DFG A+       + + + I   + Y +PE  L    ++   D
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSID 224

Query: 278 VFSFGVLLLEIVSGK 292
           ++S G +  E++ GK
Sbjct: 225 LWSIGCVFGELILGK 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 41/222 (18%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 139
             ++ +   +G G  G V           +A+K+LS          R+    RE+     
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELV---- 76

Query: 140 VIAKVQHKNLVRLL------GCCIDKDEKILIYEYMP---NKSLDFFLFDPTKRMLLDWV 190
           ++  V HKN++ LL          +  +  ++ E M     + +   L       LL   
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--- 133

Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
              Q++     G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +  
Sbjct: 134 --YQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

Query: 251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
                V T  Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 185 PY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 41/220 (18%)

Query: 90  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG-LREMKNEASVIAK--VQ 145
            + +    KLG G +  V++ + +   +++ VK L     +   RE+K     I +    
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-----ILENLRG 89

Query: 146 HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
             N++ L     D   +   L++E++ N   DF     T   L D+  R  + E I + L
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQT---LTDYDIRFYMYE-ILKAL 143

Query: 204 LYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 262
            Y H  S   I+HRD+K  N+++D +    ++ D+G+A     +  Q    R+   Y + 
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FK 197

Query: 263 SPE---------YALEGIFSIKSDVFSFGVLLLEIVSGKK 293
            PE         Y+L        D++S G +L  ++  K+
Sbjct: 198 GPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 14/199 (7%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 154
           LG+G FG V     K      A+K L         E      E+ V+   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 155 CCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                 +++  + EY     L FF     +    +   R    E I   L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEER-ARFYGAE-IVSALEYLHSRD--- 125

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           +++RD+K  N++LDKD + KI+DFG+ +    +     T    GT  Y++PE   +  + 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYG 183

Query: 274 IKSDVFSFGVLLLEIVSGK 292
              D +  GV++ E++ G+
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 61/201 (30%), Positives = 87/201 (43%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLL 153
           LG+G FG V     K  DE+ AVK L          +     E  V+A   +   L +L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            C    D    + EY+    L  +      R            E IA GL +L       
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEP-HAVFYAAE-IAIGLFFLQSKG--- 462

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEGI 271
           II+RDLK  N++LD + + KI+DFGM +  I  G      T    GT  Y++PE      
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQP 518

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +    D ++FGVLL E+++G+
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQ 539

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 44/223 (19%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 139
              +     +G G +G V   + K+ G+++A+K+LS          R+    RE+     
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELL---- 75

Query: 140 VIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP---NKSLDFFLFDPTKRMLLDWV 190
           ++  +QH+N++ LL        +       L+  +M     K +     +   + L+   
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV--- 132

Query: 191 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 250
              Q++    +GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR        A
Sbjct: 133 --YQML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADA 178

Query: 251 NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
             +  V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 42/237 (17%), Positives = 88/237 (37%), Gaps = 59/237 (24%)

Query: 62  ANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAV 120
              ++ +    K    +P     S     +++   + +G G +G V +     +   +A+
Sbjct: 26  EGQQRKQHHSSKPTASMPRPH--SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 121 KRLSG---------RSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----DKDEKI-LIY 166
           K++           R    LRE+     ++ ++ H ++V++L   I    +K +++ ++ 
Sbjct: 84  KKILRVFEDLIDCKRI---LREIA----ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 167 EYMP---------NKSLD-----FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           E               L        L+               ++     G+ Y+H     
Sbjct: 137 EIADSDFKKLFRTPVYLTELHIKTLLY--------------NLL----VGVKYVHS---A 175

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            I+HRDLK +N L+++D + K+ DFG+AR     E   +   I      M+      
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 57/232 (24%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--------RSGQGLREMKNEASV 140
             ++++ + +GEG +G V           +A+K++S         R+   LRE+K    +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIK----I 78

Query: 141 IAKVQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDPT 182
           + + +H+N++ +        I++ + + ++ + M          + L      +FL+   
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY--- 135

Query: 183 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
                      QI+    +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 136 -----------QIL----RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177

Query: 243 CGGNELQANT-SRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
              +       +  V T  Y +PE  L    ++   D++S G +L E++S +
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 65/239 (27%), Positives = 106/239 (44%), Gaps = 28/239 (11%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKV-QHKNLVRLL 153
           +G G +  V    LKK D I A+K +         +   ++ E  V  +   H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 154 GCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
             C   + ++  + EY+    L F +    +R L +   R    E I+  L YLH+    
Sbjct: 77  -SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAE-ISLALNYLHERG-- 130

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEG 270
            II+RDLK  N+LLD + + K++D+GM +  +  G+     TS   GT  Y++PE     
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGE 185

Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
            +    D ++ GVL+ E+++G+         S   +  + D    N    L   ILE +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGR---------SPFDIVGSSDNPDQNTEDYLFQVILEKQ 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.1 bits (181), Expect = 8e-15
 Identities = 39/212 (18%), Positives = 64/212 (30%), Gaps = 47/212 (22%)

Query: 73  KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL--------S 124
            E  Q     FS     T K     K+GEG FG V++ +      +A+K +        +
Sbjct: 3   GECSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVN 60

Query: 125 GRSGQGLREMKNEASV---------IAKVQHKNLVRLLG--CCIDKDEKILIYEYM---- 169
           G   +   E+  E  +             + +  + L    C       +L+  +     
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 170 ----PNKSLDFF----------------LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
                N   DFF                  +  +  L    T   I+  +   L      
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA- 179

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR 241
             +R  HRDL   N+LL K    K+      +
Sbjct: 180 -SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 28/239 (11%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKV-QHKNLVRLL 153
           +G G +  V    LKK D I A++ +         +   ++ E  V  +   H  LV L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 154 GCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
             C   + ++  + EY+    L F +    +R L +   R    E I+  L YLH+    
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAE-ISLALNYLHERG-- 173

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEG 270
            II+RDLK  N+LLD + + K++D+GM +  +  G+     TS   GT  Y++PE     
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGE 228

Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
            +    D ++ GVL+ E+++G+         S   +  + D    N    L   ILE +
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGR---------SPFDIVGSSDNPDQNTEDYLFQVILEKQ 278

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKV-QHKNLVRLL 153
           LG+G FG V    +K+  ++ AVK L         +      E  +++    H  L +L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
            C    D    + E++    L  F    ++R       R    E I   L++LH      
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEAR-ARFYAAE-IISALMFLHDKG--- 144

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPEYALEGI 271
           II+RDLK  N+LLD + + K++DFGM    IC G      T+   GT  Y++PE   E +
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYIAPEILQEML 200

Query: 272 FSIKSDVFSFGVLLLEIVSGK 292
           +    D ++ GVLL E++ G 
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 19/202 (9%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLL 153
           LG+G FG V     K  DE+ AVK L          +     E  V+A   +   L +L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 154 GCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
             C    +++  + EY+    L  +      R            E IA GL +L      
Sbjct: 88  -SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPH-AVFYAAE-IAIGLFFLQSK--- 140

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEG 270
            II+RDLK  N++LD + + KI+DFGM +  I  G      T    GT  Y++PE     
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQ 196

Query: 271 IFSIKSDVFSFGVLLLEIVSGK 292
            +    D ++FGVLL E+++G+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQ 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 24/220 (10%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG----LREMKNEASVIAKV 144
            +++ D   LG GG G V+  V       +A+K++     Q     LRE+K    +I ++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRL 65

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG------ 198
            H N+V++         ++        +    ++        L  V     +        
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125

Query: 199 ---IAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANT-S 253
              + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +       S
Sbjct: 126 MYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 254 RIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
             + T  Y SP   L    ++   D+++ G +  E+++GK
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAK-VQHKNLVRLL 153
           +G+G FG V     K  +   AVK L  ++    +E   + +E +V+ K V+H  LV L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                 D+   + +Y+    L F+     +  L     R    E IA  L YLH  +   
Sbjct: 106 FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPR-ARFYAAE-IASALGYLHSLN--- 159

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           I++RDLK  NILLD   +  ++DFG+ +    +    +T    GT  Y++PE   +  + 
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPYD 217

Query: 274 IKSDVFSFGVLLLEIVSGK 292
              D +  G +L E++ G 
Sbjct: 218 RTVDWWCLGAVLYEMLYGL 236

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 99  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREM---KNEASVIAKV-QHKNLVRLL 153
           LG+G FG V+    KK ++  A+K L         ++     E  V++   +H  L  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
                K+    + EY+    L  +      +  L         E I  GL +LH      
Sbjct: 85  CTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLS-RATFYAAE-IILGLQFLHSKG--- 138

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 273
           I++RDLK  NILLDKD + KI+DFGM +     + + NT    GT  Y++PE  L   ++
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYN 196

Query: 274 IKSDVFSFGVLLLEIVSG 291
              D +SFGVLL E++ G
Sbjct: 197 HSVDWWSFGVLLYEMLIG 214

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 70/242 (28%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--------RSGQGLREMKNEASV 140
           ++ F   + LGEG +G V     K  G+ +A+K++          R+   LRE+K    +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIK----I 62

Query: 141 IAKVQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDPT 182
           +   +H+N++ +         +   ++ +I E M          + L      +F++   
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY--- 119

Query: 183 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
                      Q +    + +  LH      +IHRDLK SN+L++ + + K+ DFG+ARI
Sbjct: 120 -----------QTL----RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 243 CGGNELQANTSRIVGTYGYMSPEY-------ALEGIFSIKS-----DVFSFGVLLLEIVS 290
              +E  A+ S   G    M  E+       A E + +        DV+S G +L E+  
Sbjct: 162 I--DESAADNSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

Query: 291 GK 292
            +
Sbjct: 219 RR 220

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)

Query: 99  LGEGGFGPVY---KGVLKKGDEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKN-L 149
           LG G +G V+   K       ++ A+K L      +  +     + E  V+  ++    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           V L      + +  LI +Y+    L F      +R     V ++ + E I   L +LH+ 
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEV-QIYVGE-IVLALEHLHKL 178

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYA 267
               II+RD+K  NILLD + +  ++DFG+++  +    E         GT  YM+P+  
Sbjct: 179 G---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFCGTIEYMAPDIV 232

Query: 268 LEGIFSIKSDV--FSFGVLLLEIVSGK 292
             G       V  +S GVL+ E+++G 
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 39/210 (18%), Positives = 75/210 (35%), Gaps = 57/210 (27%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 139
            + +   + +G G +G VY    K     +A+K+++          R    LRE+     
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREIT---- 77

Query: 140 VIAKVQHKNLVRLLGCCIDKDEKI-----LIYEYMP---------NKSLD-----FFLFD 180
           ++ +++   ++RL    I  D        ++ E               L        L+ 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136

Query: 181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
                         ++     G  ++H+     IIHRDLK +N LL++D + K+ DFG+A
Sbjct: 137 -------------NLL----LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 241 RICGGNELQANTSRIVGTYGYMSPEYALEG 270
           R     +     + +            L+ 
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 49/226 (21%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 139
             ++ + + +G G +G V      K G  +AVK+LS          R+    RE++    
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELR---- 80

Query: 140 VIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMPN------KSLDFFLFDPTKRMLL 187
           ++  ++H+N++ LL        +++   + L+   M        K     L D   + L+
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLI 138

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                 QI+    +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 139 -----YQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181

Query: 248 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
                +  V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 55/233 (23%), Positives = 101/233 (43%), Gaps = 63/233 (27%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 139
              + D   +G G +G V   V  + G ++A+K+L           R+    RE++    
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELR---- 76

Query: 140 VIAKVQHKNLVRLL------GCCIDKDEKILIYEYMP--------NKSLD-----FFLFD 180
           ++  ++H+N++ LL          D  +  L+  +M         ++ L      F ++ 
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY- 135

Query: 181 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 240
                        Q++    +GL Y+H      IIHRDLK  N+ +++D   KI DFG+A
Sbjct: 136 -------------QML----KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175

Query: 241 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
           R        +  +  V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 176 RQ-----ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 48/225 (21%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSG-----QGLREMK-----NEASVIAKVQ- 145
           KLG G F  V+    +     +A+K +  R           E+K     N+A    +   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 146 -HKNLVRLLGC-----------CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 193
              ++++LL              +       ++E +    L        + + L +V + 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVM-------VFEVLGENLLALIKKYEHRGIPLIYVKQ- 135

Query: 194 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNE 247
            I + +  GL Y+H   R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 136 -ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190

Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
              + +  + T  Y SPE  L   +   +D++S   L+ E+++G 
Sbjct: 191 ---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 34/158 (21%), Positives = 63/158 (39%), Gaps = 30/158 (18%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGC 155
            LG G  G V +   K+  ++ A+K L         + + E  +  +  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79

Query: 156 CIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLY 205
             +         ++ E +    L    F    R+              +I++ I + + Y
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 206 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMA 240
           LH    + I HRD+K  N+L      +   K++DFG A
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 58/250 (23%), Positives = 102/250 (40%), Gaps = 76/250 (30%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 139
             K+    KLG+G +G V+K + ++ G+ +AVK++           R+    RE+     
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIM---- 60

Query: 140 VIAK--VQHKNLVRLLGCCI-DKDEKI-LIYEYMP--------NKSLD-----FFLFDPT 182
            I      H+N+V LL     D D  + L+++YM            L+     + ++   
Sbjct: 61  -ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY--- 116

Query: 183 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
                      Q+I    + + YLH      ++HRD+K SNILL+ + + K++DFG++R 
Sbjct: 117 -----------QLI----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158

Query: 243 CGGNELQANTSRIVGTYGYMSP--------EY-------ALEGIFSIKS-----DVFSFG 282
                   N   +       +         +Y       A E +          D++S G
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

Query: 283 VLLLEIVSGK 292
            +L EI+ GK
Sbjct: 219 CILGEILCGK 228

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 47/218 (21%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 90  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQH- 146
            +++   + +G+G FG V K     + + +A+K +  ++ +      + E  ++  +   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKH 110

Query: 147 -----KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRVQII 196
                  +V L    + ++   L++E      L + L+D  +      + L+   +    
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRK--FA 163

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSR 254
           + +   LL+L     + IIH DLK  NILL        KI DFG +  C   +      +
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQ---RIYQ 217

Query: 255 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            + +  Y SPE  L   + +  D++S G +L+E+ +G+
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 33/151 (21%), Positives = 71/151 (47%), Gaps = 17/151 (11%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGC 155
           K+G G FG +Y G  ++  +E+A+K  + ++     ++  E+ +   +Q    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVR 213
            ++ D  +L+ + +   SL+      ++++ L  V  +  Q+I  +     ++H  S   
Sbjct: 72  GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE----FVHSKS--- 123

Query: 214 IIHRDLKASNILLDKDMNPK---ISDFGMAR 241
            +HRD+K  N L+          I DFG+A+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 38/158 (24%), Positives = 72/158 (45%), Gaps = 17/158 (10%)

Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           N++    K+G G FG +Y G  +  G+E+A+K    ++     ++  E+ +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66

Query: 150 V-RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYL 206
           +  +  C  + D  +++ E +   SL+      +++  L  V  +  Q+I  I     Y+
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE----YI 121

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPK---ISDFGMAR 241
           H  +    IHRD+K  N L+          I DFG+A+
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 32/160 (20%), Positives = 62/160 (38%), Gaps = 19/160 (11%)

Query: 91  NKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KN 148
             F    K+G G FG +  G  L   + +A+K    +S     ++  E     ++     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYL 206
           + ++           ++ E +   SL+       +   L  V  +  Q+I  +     Y+
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME----YV 121

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPK-----ISDFGMAR 241
           H  +   +I+RD+K  N L+ +  N       I DF +A+
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 51/262 (19%), Positives = 101/262 (38%), Gaps = 41/262 (15%)

Query: 62  ANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI--- 118
           A   +   +K+   +Q  +    +   A   +     +G+GGFG +Y   +   + +   
Sbjct: 7   AQAGRQSSAKRHLAEQFAVGEIITDMAA-AAWKVGLPIGQGGFGCIYLADMNSSESVGSD 65

Query: 119 ---AVKRLSGRSGQGLREMK-----NEASVIAKVQHKNLVRLLG----------CCIDKD 160
               VK     +G    E+K      +   I K      ++ LG              K 
Sbjct: 66  APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS 125

Query: 161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIHRD 218
            + +I +      L        KR     V ++  +I++ +     Y+H++     +H D
Sbjct: 126 YRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILE----YIHEHE---YVHGD 177

Query: 219 LKASNILLDKDMNPKI--SDFGMA-RICGGNELQANTSR----IVGTYGYMSPEYALEGI 271
           +KASN+LL+     ++   D+G+A R C     +A  +       GT  + S + A  G+
Sbjct: 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID-AHNGV 236

Query: 272 F-SIKSDVFSFGVLLLEIVSGK 292
             S + D+   G  +++ ++G 
Sbjct: 237 APSRRGDLEILGYCMIQWLTGH 258

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 39/210 (18%), Positives = 85/210 (40%), Gaps = 26/210 (12%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGC 155
           ++GEG FG +++G  L    ++A+K    RS     ++++E      +     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVR 213
             +    +L+ + +   SL+  L    ++  +  V     Q++  +      +H+ S   
Sbjct: 75  GQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ----SIHEKS--- 126

Query: 214 IIHRDLKASNILLDKDMNPK-----ISDFGMARI-----CGGNELQANTSRIVGTYGYMS 263
           +++RD+K  N L+ +  +       + DFGM +         +        + GT  YMS
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186

Query: 264 PEYALEGIF-SIKSDVFSFGVLLLEIVSGK 292
                 G   S + D+ + G + +  + G 
Sbjct: 187 I-NTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 24/177 (13%), Positives = 59/177 (33%), Gaps = 35/177 (19%)

Query: 91  NKFSDANKLGEGGFGPVYKGV---------LKKGDEIAVKRLSGRSGQGLREMKNEASVI 141
            ++   +       G +Y+             +  + ++K L  + G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 142 AKVQHKNLVRLLGC---CI---------DKDEKILIYEYMPNKSL-DFFLFDPTKRMLLD 188
             +Q     +L       I             + L+   +  +SL       P   +   
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159

Query: 189 WVTRV--QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI--SDFGMAR 241
            V +V  ++++ +     +LH+      +H ++ A NI +D +   ++  + +G A 
Sbjct: 160 SVLQVACRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 34/203 (16%), Positives = 73/203 (35%), Gaps = 33/203 (16%)

Query: 62  ANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIA- 119
           +       +   +    P           N++    K+G GGFG +Y      K ++ A 
Sbjct: 9   SGVDLGTENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPTNKPEKDAR 67

Query: 120 --VKRLSGRSGQGLREMK-----NEASVIAKVQHKNLVRLLG----------CCIDKDEK 162
             VK     +G    E+K      +   I K   +  +  LG              +  +
Sbjct: 68  HVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYR 127

Query: 163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIHRDLK 220
            ++ E +    L   +           V ++  ++++ +     Y+H+      +H D+K
Sbjct: 128 FMVMERL-GIDLQK-ISGQNGTFKKSTVLQLGIRMLDVLE----YIHENE---YVHGDIK 178

Query: 221 ASNILLDKDMNPKI--SDFGMAR 241
           A+N+LL      ++  +D+G++ 
Sbjct: 179 AANLLLGYKNPDQVYLADYGLSY 201

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 32/209 (15%)

Query: 99  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK------NLV 150
           +G+G FG V K    K    +A+K +  R+ +        E  ++  ++ +      N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRVQIIEGIAQGLLY 205
            +L     ++   + +E      L   L++  K+       L  V +      I Q L  
Sbjct: 163 HMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDA 215

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMS 263
           LH+    RIIH DLK  NILL +      K+ DFG +  C  ++        + +  Y +
Sbjct: 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQ---RVYTYIQSRFYRA 267

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
           PE  L   + +  D++S G +L E+++G 
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 59/329 (17%), Positives = 112/329 (34%), Gaps = 112/329 (34%)

Query: 90  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREM-KNEASVIAKVQ-- 145
             ++    KLG G F  V+    ++    +A+K +  +S +   E   +E  ++  V+  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALDEIRLLKSVRNS 93

Query: 146 ------HKNLVRLLGC-----------CIDKDEKILIYEYMPNKSLDFFLFD-PTKRMLL 187
                  + +V+LL             C       +++E +    L  ++     + + L
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPL 145

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--------------------- 226
             V   +II+ + QGL YLH  ++ RIIH D+K  NILL                     
Sbjct: 146 PCVK--KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 227 ----------------------------DKDMNPKISDFGMARICGGNELQANTSRIVGT 258
                                        + +  KI+D G A       +  + +  + T
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQT 256

Query: 259 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK------KNTGLYRTDSL-----NLLG 307
             Y S E  +   ++  +D++S   +  E+ +G             R +        LLG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316

Query: 308 -----------YAWDLWTSNRTLELIDPI 325
                      Y+ + +T    L+ I  +
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKL 345

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.3 bits (127), Expect = 1e-07
 Identities = 58/414 (14%), Positives = 124/414 (29%), Gaps = 91/414 (21%)

Query: 16  IVPAAVAILGLIFYCVRRKPRSRGEDLMMFDLDLN-------LKADNVIIELPANNKQAK 68
           +   AV+    +F+ +  K     +  +   L +N       +K +     +       +
Sbjct: 56  MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115

Query: 69  RSKKKEVDQLPLFSFSSVS---------TATNKFSDANKL---GEGGFGPVYKGVLKKGD 116
           R +    +Q+  F+  +VS          A  +   A  +   G  G G   K  +    
Sbjct: 116 RDRLYNDNQV--FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV---- 166

Query: 117 EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 176
             A+      S +   +M  +   +           L  C +  E +L       + L  
Sbjct: 167 --ALDVC--LSYKVQCKMDFKIFWLN----------LKNC-NSPETVLE----MLQKL-L 206

Query: 177 FLFDPTKRMLLDWVTRVQI-IEGIAQGLLYL---HQYSRVRIIHRDLKASNILLDKDMNP 232
           +  DP      D  + +++ I  I   L  L     Y    ++  +++ +      +++ 
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266

Query: 233 KI----SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS---------IKSDVF 279
           KI        +               +      ++P+     +           +  +V 
Sbjct: 267 KILLTTRFKQVTDFLSAATTTH--ISLDHHSMTLTPDEVKS-LLLKYLDCRPQDLPREVL 323

Query: 280 SFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDPILE--DEYSSKH 334
           +     L I++     GL            WD W     ++   +I+  L   +    + 
Sbjct: 324 TTNPRRLSIIAESIRDGLAT----------WDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373

Query: 335 MLLRY------VNI--ALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS 380
           M  R        +I   LL +      +  +  VV+ L   +     PK+   S
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 58/234 (24%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQH-----KNLV 150
           K+G+G FG V     +      AVK +  R+ +      K EA ++ K+Q+      N+V
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRV--QIIEGIAQGL 203
           +  G  +  D   LI+E      L   L++   R       ++ +     +I++ +    
Sbjct: 100 KYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN--- 151

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------------KISDFG 238
            YL    ++ + H DLK  NILLD                              K+ DFG
Sbjct: 152 -YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            A     ++       I+ T  Y +PE  L   + + SD++SFG +L E+ +G 
Sbjct: 208 CA--TFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 54/230 (23%), Positives = 86/230 (37%), Gaps = 54/230 (23%)

Query: 98  KLGEGGFGPVYKGV--LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK------N 148
            LGEG FG V + +   +   ++A+K +  R+    RE  + E +V+ K++ K       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRV--QIIEGIAQ 201
            V +           + +E      L    F+  K        L  V  +  Q+      
Sbjct: 84  CVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA--- 135

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------KISDFGMARI 242
            L +LH     ++ H DLK  NIL                          +++DFG A  
Sbjct: 136 -LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189

Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
              +E   + + IV T  Y  PE  LE  ++   DV+S G +L E   G 
Sbjct: 190 TFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 54/230 (23%)

Query: 98  KLGEGGFGPVYKGV-LKKGDEI-AVKRLSGRSGQGLRE-MKNEASVIAKVQHK------N 148
            LGEG FG V + +  K G    AVK +  ++     E  ++E  V+  +          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRV--QIIEGIAQ 201
            V++L          +++E      L    +D  K        LD + ++  QI + +  
Sbjct: 79  CVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN- 132

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------KISDFGMARI 242
              +LH     ++ H DLK  NIL  +                       K+ DFG A  
Sbjct: 133 ---FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184

Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
              +E   + S +V T  Y +PE  L   +S   DV+S G +L+E   G 
Sbjct: 185 TYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	411
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.78
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.76
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.5
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.28
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.26
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.71
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.71
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.68
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.57
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.32
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.25
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.0
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.98
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.48
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.45
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.02
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	96.01
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.92
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.94
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	88.94
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.3
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.19
1afo_A	40	Glycophorin A; integral membrane protein, transmem	80.65
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	80.42

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-59  Score=434.90  Aligned_cols=261  Identities=28%  Similarity=0.431  Sum_probs=215.8

Q ss_pred             cCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++++|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888899999999999999864      367899999987776677889999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCC----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          165 IYEYMPNKSLDFFLFDPT----------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                      |||||++|+|.++|+...          ....++|..+..++.|+++||+|||+++   |+||||||+|||++.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          2346899999999999999999999998   999999999999999999999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHh
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....     .+..... 
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~~i-  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIECI-  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHH-
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH-
Confidence            99999987654443333444579999999999999999999999999999999999 8999864331     1111111 


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ..+....          .+..++.++.+|+.+||+.||++|||+.||++.|+++...
T Consensus       244 ~~~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 TQGRVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1111111          1122356789999999999999999999999999987664

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.1e-59  Score=435.50  Aligned_cols=261  Identities=28%  Similarity=0.395  Sum_probs=208.6

Q ss_pred             cCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ++|.+.+.||+|+||.||+|++.      +++.||||+++..+....++|.+|+++|++++|||||+++++|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56777889999999999999864      377899999987777777889999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCC------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          165 IYEYMPNKSLDFFLFDPTK------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                      |||||++|+|.++++....            ..+++|..+..|+.|+++||+|||+++   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999865422            246899999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  311 (411)
                      ||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....     ......
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEAIDC  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----HHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence            9999999987655444444455689999999999999999999999999999999999 8999864321     111111


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                       +..+...     ..     +..++.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       273 -i~~g~~~-----~~-----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 -ITQGREL-----ER-----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -HHHTCCC-----CC-----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -HHcCCCC-----CC-----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence             1111110     11     112356789999999999999999999999999988764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-58  Score=428.85  Aligned_cols=258  Identities=29%  Similarity=0.429  Sum_probs=211.3

Q ss_pred             cCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++++.+.||+|+||+||+|.+.      +++.||||++.... ....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566789999999999999863      36789999997543 344678999999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          164 LIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                      +|||||++|+|.++|.....             ...+++..+..|+.||++||+|||+++   |+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999964321             245899999999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHH
Q 040952          231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  309 (411)
                      .+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |..||.....     .+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~~~~  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVV  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence            999999999987654443444455689999999999999999999999999999999999 8999864332     1111


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      . .+..+....          .+..++..+.+|+.+||+.||++|||+.||++.|+..
T Consensus       258 ~-~i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 E-MIRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H-HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H-HHHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1 122211111          1123356789999999999999999999999999754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-58  Score=426.00  Aligned_cols=263  Identities=26%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||+||+|++++  .||||+++..  +....+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4677888999999999999998753  6999998754  33456789999999999999999999998865 56899999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      ||++|+|.++|+...  ..+++..+..|+.|+++||+|||+++   |+||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            999999999996543  34899999999999999999999988   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ........+||+.|||||++.+   +.|+.++|||||||++|||+||+.||......     .........+..    .+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-----~~~~~~~~~~~~----~p  257 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-----DQIIFMVGRGYA----SP  257 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHTTCC----CC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcCCC----CC
Confidence            3334455689999999999864   46899999999999999999999998643221     111111111111    11


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      .+..  .+..++..+.+|+.+||+.||++|||+.||++.|+.+...+
T Consensus       258 ~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          258 DLSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CSTT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             Cccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            1111  11123567899999999999999999999999998776544

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.4e-58  Score=432.72  Aligned_cols=250  Identities=23%  Similarity=0.346  Sum_probs=202.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...  .....+.+.+|+.+|++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999975 5999999999754  33446678999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      ||+||+|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+......
T Consensus       104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999986432 345788899999999999999999998   9999999999999999999999999998764211


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                        ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....     ........... ..     .+ 
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~~-~~-----~~-  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----KNLVLKIISGS-FP-----PV-  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTC-CC-----CC-
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcCC-CC-----CC-
Confidence              122346899999999999999999999999999999999999999964321     11222222111 10     01 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                          +...+.++.+|+.+||+.||++|||+.|+++
T Consensus       246 ----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 ----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1122567899999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-57  Score=421.91  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=208.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ...|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            356999999999999999999976 5999999999766555566789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      |+||+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+++.+.... 
T Consensus       153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            999999999854    34899999999999999999999998   9999999999999999999999999998765332 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|++||.....     ....... ...     ..+.+. 
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i-~~~-----~~~~~~-  291 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMI-RDN-----LPPRLK-  291 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHH-HHS-----SCCCCS-
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHH-HcC-----CCCCCC-
Confidence             223456899999999999999999999999999999999999999864321     1111111 111     011111 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        .....+.++.+|+.+||+.||++|||+.|+++.
T Consensus       292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              111235678999999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.1e-58  Score=422.31  Aligned_cols=248  Identities=25%  Similarity=0.303  Sum_probs=208.4

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999975 5999999999753   2344678999999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |||+||+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999543   34899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.     .......... ..      .+
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~-~~------~~  253 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKIIKL-EY------DF  253 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHT-CC------CC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC-CC------CC
Confidence            444445567999999999999999999999999999999999999999964321     1111111111 10      01


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  361 (411)
                      .     ...+.++.+|+.+||+.||++|||+.|++
T Consensus       254 p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 P-----EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C-----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            1     11245689999999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-57  Score=420.20  Aligned_cols=270  Identities=23%  Similarity=0.300  Sum_probs=205.5

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCC----ceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  166 (411)
                      ++|.+.+.||+|+||+||+|+++ |+.||||++...... ...+..|+..+.+++|||||+++++|.+.+    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45778899999999999999985 899999999754322 122334666667889999999999998754    579999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-----SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      |||++|+|.++++.    ..+++..+.+++.|+++||+|||++     +.++|+||||||+|||++.++.+||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999954    3489999999999999999999986     12359999999999999999999999999998


Q ss_pred             ccCCCCcc--cccccccccccccChhhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchh-------
Q 040952          242 ICGGNELQ--ANTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL-------  306 (411)
Q Consensus       242 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-------  306 (411)
                      ........  ......+||+.|||||++.+.      .++.++|||||||++|||+||++|++..........       
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543322  122345899999999998764      367899999999999999999988754332221111       


Q ss_pred             --HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          307 --GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       307 --~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                        ........    ....++.++......+.+..+.+|+.+||+.||++|||+.||++.|+++..+
T Consensus       237 ~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence              11111111    1223334444444445577899999999999999999999999999887653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.5e-57  Score=421.64  Aligned_cols=257  Identities=20%  Similarity=0.224  Sum_probs=206.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .+.|++.+.||+|+||.||+|++. +|+.||||++.....     ..+|+.++++++|||||++++++.+.+..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356788889999999999999976 499999999975432     24799999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCccccCCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  247 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~  247 (411)
                      |+||+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+| .+||+|||+|+......
T Consensus       132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999643   35899999999999999999999998   99999999999999987 59999999998765432


Q ss_pred             ccc---ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          248 LQA---NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       248 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...   .....+||+.|||||++.+..|+.++|||||||++|||++|++||........  .   ............   
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~---~~i~~~~~~~~~---  277 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--C---LKIASEPPPIRE---  277 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--H---HHHHHSCCGGGG---
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--H---HHHHcCCCCchh---
Confidence            211   22346899999999999999999999999999999999999999964332211  1   111111110000   


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                       +     +...+..+.+++.+||+.||++|||+.|+++.|.......
T Consensus       278 -~-----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          278 -I-----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             -S-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -c-----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence             0     1123567899999999999999999999999998776543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-55  Score=423.38  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=209.2

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .+.|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999976 5999999999876656667789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      |+||+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+++.+.... 
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999999853    23899999999999999999999998   9999999999999999999999999998765332 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....     ......... .     ..+.+..
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~-~-----~~~~~~~  369 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRD-N-----LPPRLKN  369 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH-S-----CCCCCSC
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHc-C-----CCCCCcc
Confidence             223456899999999999999999999999999999999999999853221     111111111 1     0111111


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       370 ---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          370 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             ---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               11225678999999999999999999999873

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-56  Score=421.02  Aligned_cols=267  Identities=27%  Similarity=0.362  Sum_probs=215.9

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCC-cccceeeeeee
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQH-KNLVRLLGCCI  157 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~  157 (411)
                      .+...++|++.+.||+|+||.||+|.+..      ++.||||.+.... ....+.|.+|+.+|.+++| ||||+++|+|.
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            34446789999999999999999998642      3579999997653 3345679999999999965 89999999987


Q ss_pred             cC-CceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 040952          158 DK-DEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  223 (411)
Q Consensus       158 ~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N  223 (411)
                      +. +..++|||||++|+|.++|+....             ...+++..+..++.||++||+|||+++   |+||||||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~N  215 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN  215 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccc
Confidence            64 568999999999999999965322             345899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 040952          224 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  302 (411)
Q Consensus       224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  302 (411)
                      ||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.......
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987765444444455689999999999999999999999999999999998 899986433211


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                           ........+....     .     +..++.++.+++.+||+.||++|||+.||++.|+++...
T Consensus       296 -----~~~~~i~~g~~~~-----~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          296 -----EFCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             -----HHHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHcCCCCC-----C-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence                 1111121111111     1     112256789999999999999999999999999987653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-55  Score=405.30  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=196.1

Q ss_pred             CccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeec----CCceEEEE
Q 040952           94 SDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIY  166 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  166 (411)
                      ++.+.||+|+||+||+|.+. ++..||+|++...  .....+.|.+|+.+|++++|||||+++++|.+    .+..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999976 4889999998654  33445679999999999999999999999875    34579999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~  245 (411)
                      |||++|+|.+++...   ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999643   45899999999999999999999875 35999999999999984 79999999999986432


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||......    . ........+...    ..
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~-~~~~~i~~~~~~----~~  250 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----A-QIYRRVTSGVKP----AS  250 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----H-HHHHHHTTTCCC----GG
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----H-HHHHHHHcCCCC----CC
Confidence            2    2345689999999998865 6999999999999999999999998532211    1 111111111100    01


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ...     ..+.++.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~-----~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          251 FDK-----VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGG-----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCc-----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111     11346889999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.9e-56  Score=403.90  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=189.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||+||+|... +|+.||||++...   .......+.+|+.++++++|||||++++++.+.+..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999965 5999999999754   233456789999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+ +|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 67888888543   34899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ..   .....+||+.|+|||++.+..| +.++|||||||++|||++|+.||.....     ........ ....      
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~~~i~-~~~~------  229 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLFKNIS-NGVY------  229 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH-HTCC------
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHH-cCCC------
Confidence            22   2234689999999999998876 5799999999999999999999864221     11111111 1110      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .+.     ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~p-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 TLP-----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            011     112456889999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.1e-56  Score=409.70  Aligned_cols=247  Identities=22%  Similarity=0.281  Sum_probs=195.9

Q ss_pred             cCCCccCcccccCcccEEEEEec----CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ++|++.+.||+|+||+||+|+..    .++.||||++....  ......+.+|+.+|++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    37899999997542  2233467889999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      |||||+||+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999543   35899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.     .......... ..      
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~-~~------  243 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMTMILKA-KL------  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC-CC------
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHHHHHcC-CC------
Confidence            322  223446899999999999999999999999999999999999999964321     1111111111 10      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTM-----NDVVS  362 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  362 (411)
                      .+     +...+.++.+|+.+||+.||++|||+     .|+++
T Consensus       244 ~~-----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 GM-----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CC-----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CC-----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            01     11225678999999999999999984     67764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.5e-54  Score=400.19  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=189.8

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC--------
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--------  160 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  160 (411)
                      ++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999975 58999999987543 334567899999999999999999999987644        


Q ss_pred             ----ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEee
Q 040952          161 ----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  236 (411)
Q Consensus       161 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D  236 (411)
                          ..|+|||||++|+|.+++.........++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976555445667778899999999999999998   99999999999999999999999


Q ss_pred             cCCccccCCCCcc----------cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 040952          237 FGMARICGGNELQ----------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  306 (411)
Q Consensus       237 fgl~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  306 (411)
                      ||+|+........          ......+||+.|||||++.+..|+.++|||||||++|||++   ||....    +..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence            9999876543221          11234579999999999999999999999999999999996   653211    111


Q ss_pred             HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ...... .....    .+      ..........+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~-~~~~~----p~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTDV-RNLKF----PP------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHH-HTTCC----CH------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHH-hcCCC----CC------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111 11000    00      11122345678999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-51  Score=389.47  Aligned_cols=203  Identities=25%  Similarity=0.383  Sum_probs=172.6

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec----CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCC
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  160 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  160 (411)
                      +....++|++.+.||+|+||+||+|+.+    .++.||+|.+....  ....+.+|+++|+.+ +||||+++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            4455688999999999999999999853    36789999987543  345678999999998 6999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGM  239 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl  239 (411)
                      ..|+||||+++|+|.+++.      .+++..+..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            9999999999999999982      2788899999999999999999998   9999999999999877 7999999999


Q ss_pred             ccccCCCCcc--------------------------cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCC
Q 040952          240 ARICGGNELQ--------------------------ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK  292 (411)
Q Consensus       240 ~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~  292 (411)
                      |+........                          ......+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            9865432211                          112335799999999999875 5899999999999999999999


Q ss_pred             CCCCCCc
Q 040952          293 KNTGLYR  299 (411)
Q Consensus       293 ~p~~~~~  299 (411)
                      .||....
T Consensus       245 ~Pf~~~~  251 (361)
T 4f9c_A          245 YPFYKAS  251 (361)
T ss_dssp             SSSSCCS
T ss_pred             CCCCCCC
Confidence            9986443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-51  Score=394.63  Aligned_cols=265  Identities=18%  Similarity=0.252  Sum_probs=200.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeec------CC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID------KD  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  160 (411)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....  ....+.+.+|+.+|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            467999999999999999999975 59999999997543  2345678899999999999999999998764      35


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..|+|||||+ |+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 6788888543   45899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCC--cccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          241 RICGGNE--LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       241 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      +.+....  ........+||+.|+|||++.+. .|+.++||||+||++|||++|++||...+..  +.............
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~--~~l~~I~~~~g~p~  283 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV--HQLQLIMMVLGTPS  283 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCC
Confidence            8764322  12233456899999999998875 4699999999999999999999999643311  11111111100000


Q ss_pred             c-----------ccccccccccccch-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 T-----------LELIDPILEDEYSS-----KHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ~-----------~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .           ...+.........+     ...+.++.+|+.+||+.||++|||+.|+++.
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0           00000000000000     0124578899999999999999999999974

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.9e-50  Score=377.30  Aligned_cols=287  Identities=36%  Similarity=0.631  Sum_probs=238.5

Q ss_pred             cchhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      +++.++...+++|++.+.||+|+||.||+|.+++|+.||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34455566789999999999999999999998889999999998776666788999999999999999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC-CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999865432 235899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-cccchhHHHHHHhhcCcc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-DSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~  318 (411)
                      +................||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+.......+..
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            9875433333333445689999999999999999999999999999999999999875443 223344444444445555


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      ...+++.+.... ....+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       266 ~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          266 EQIVDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CSSSSSSCTTCS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhcChhhcccc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            555555444333 3445788999999999999999999999999999887643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-49  Score=373.40  Aligned_cols=293  Identities=38%  Similarity=0.657  Sum_probs=239.1

Q ss_pred             cCCCCCcchhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceee
Q 040952           75 VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLL  153 (411)
Q Consensus        75 ~~~l~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~  153 (411)
                      ...+..+++.++....++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+|+.+++.++||||++++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            344556888899999999999999999999999999988899999999976432 2233688999999999999999999


Q ss_pred             eeeecCCceEEEEeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          154 GCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                      +++...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            99999999999999999999999987643 33458999999999999999999999922239999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC---cccccchhHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY---RTDSLNLLGYA  309 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~---~~~~~~~~~~~  309 (411)
                      ||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...   .........+.
T Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999987653322 2233456999999999999889999999999999999999999998632   22333444555


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      .............+..+..... ...+..+.+++.+||+.||++|||+.||++.|++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYK-DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCC-HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHhhchhhhhhcChhhccccC-HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            5555555555555555544443 4447899999999999999999999999999987533

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.7e-50  Score=401.84  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=208.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999976 5999999999876666667889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC--CCeEEeecCCccccCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD--MNPKISDFGMARICGGN  246 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfgl~~~~~~~  246 (411)
                      |+||+|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999885432  34889999999999999999999998   9999999999999854  89999999999887543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .   .....+||+.|+|||++.+..|+.++|||||||++|||++|++||......     ......... .. ...... 
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-----~~~~~i~~~-~~-~~~~~~-  379 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNVKSC-DW-NMDDSA-  379 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTT-CC-CCCSGG-
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHHhC-CC-CCCccc-
Confidence            2   233458999999999999999999999999999999999999998643321     111111111 00 000000 


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       380 -----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          380 -----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 11125678899999999999999999999873

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-49  Score=395.81  Aligned_cols=250  Identities=24%  Similarity=0.278  Sum_probs=199.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHH---HHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.+..   ......+.   .++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999976 49999999986431   12222333   446666778999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      |+||||++||+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            9999999999999999643   34899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      .....    ....+||+.|||||++.+ ..|+.++|+|||||++|||++|++||.......  ........... .    
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~-~----  410 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTM-A----  410 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHC-C----
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCC-C----
Confidence            65332    234689999999999974 579999999999999999999999996432211  11111111111 0    


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                        ..+     +...+.++.+|+.+||+.||++|++     +.|+++.
T Consensus       411 --~~~-----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          411 --VEL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --CCC-----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --CCC-----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence              001     1122567899999999999999998     6787753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.9e-48  Score=363.12  Aligned_cols=271  Identities=25%  Similarity=0.420  Sum_probs=206.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ...++|++.+.||+|+||.||+|... |+.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            34578999999999999999999875 8899999987653  33456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999999976554455899999999999999999999875 2499999999999999999999999999976543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ............     .
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~-----~  259 (309)
T 3p86_A          192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGFKCKRL-----E  259 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHHSCCCC-----C
T ss_pred             cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCCC-----C
Confidence            22  12234578999999999999999999999999999999999999986433211     111110010000     1


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCC
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP  377 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  377 (411)
                      +     +...+..+.+++.+||+.||++|||+.++++.|+.+.....||..+
T Consensus       260 ~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~  306 (309)
T 3p86_A          260 I-----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR  306 (309)
T ss_dssp             C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred             C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence            1     1112456899999999999999999999999999998876665543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.4e-47  Score=354.70  Aligned_cols=284  Identities=38%  Similarity=0.583  Sum_probs=227.0

Q ss_pred             CCCcchhhhhHHhcCCCcc------CcccccCcccEEEEEecCCCEEEEEEccCC----CcccHHHHHHHHHHHHhcCCc
Q 040952           78 LPLFSFSSVSTATNKFSDA------NKLGEGGFGPVYKGVLKKGDEIAVKRLSGR----SGQGLREMKNEASVIAKVQHK  147 (411)
Q Consensus        78 l~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~  147 (411)
                      ...+++.++..++++|...      +.||+|+||.||+|..+ ++.||||++...    .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4557788888888888766      88999999999999974 889999998653    233456789999999999999


Q ss_pred             ccceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       148 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                      ||+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||.|||+++   ++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999876555566899999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhH
Q 040952          228 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  307 (411)
Q Consensus       228 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  307 (411)
                      .++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||....... ....
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHH
Confidence            999999999999987654333333344578999999998765 58999999999999999999999987544322 1111


Q ss_pred             HHHHHhhc-CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          308 YAWDLWTS-NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       308 ~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      +....... ......++..+..  .....+..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            22111111 1122222322221  234457889999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.1e-48  Score=361.15  Aligned_cols=265  Identities=25%  Similarity=0.402  Sum_probs=215.6

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            467889999999999999999976 4899999999776666778899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999996532  34899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cc------------ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC
Q 040952          249 QA------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       249 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      ..            ......||+.|+|||.+.+..++.++|||||||++|||++|..|+...................  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--  241 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--  241 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence            11            1114579999999999999999999999999999999999999986544322211111111100  


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCC
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP  373 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  373 (411)
                             ...     +..++..+.+++.+||+.||++|||+.++++.|+.+...+..
T Consensus       242 -------~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          242 -------RYC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             -------HTC-----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             -------ccC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                   000     111234688999999999999999999999999988766443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.8e-48  Score=364.55  Aligned_cols=267  Identities=23%  Similarity=0.322  Sum_probs=211.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc----eEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----KILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv  165 (411)
                      .++|++.+.||+|+||.||+|++. ++.||||++..... .......|+.++++++||||+++++++.....    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            478999999999999999999987 89999999975433 23445678999999999999999999987543    6999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY----------SRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                      |||+++|+|.+++..    ..+++..+..++.|++.||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999954    2389999999999999999999998          7   9999999999999999999999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchh----
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL----  306 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~----  306 (411)
                      |||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||...........    
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999877654433334446799999999998863     466789999999999999999999865432211110    


Q ss_pred             ------HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          307 ------GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       307 ------~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                            .........    ....+.+.........+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       254 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          254 GQHPSLEDMQEVVVH----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CSSCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhc----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  000111111    11122222222333446779999999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-47  Score=353.07  Aligned_cols=252  Identities=23%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            4578999999999999999999964 589999999976655566788999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|.+++...    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999998543    4789999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ............ ..      
T Consensus       171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~-~~------  236 (297)
T 3fxz_A          171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTP-EL------  236 (297)
T ss_dssp             C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSC-CC------
T ss_pred             c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCC-CC------
Confidence            2  233457999999999999999999999999999999999999998643211     111111111100 00      


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              0112235668999999999999999999999874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.4e-47  Score=364.69  Aligned_cols=263  Identities=26%  Similarity=0.397  Sum_probs=213.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEec--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeec
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  158 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (411)
                      ..++|++.+.||+|+||.||+|.+.        ++..||||++.... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3578999999999999999999853        24579999997653 33456789999999999 89999999999999


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  225 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil  225 (411)
                      .+..++||||+++|+|.+++.....             ...+++..+..++.||+.||+|||+++   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            9999999999999999999865331             234788999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 040952          226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  304 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  304 (411)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence            99999999999999987665443333444567889999999999999999999999999999999 99998643221  1


Q ss_pred             hhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          305 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ..    .........     ..     +..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       314 ~~----~~~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 LF----KLLKEGHRM-----DK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             HH----HHHHTTCCC-----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH----HHHhcCCCC-----CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11    111111100     01     112255789999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=361.84  Aligned_cols=277  Identities=26%  Similarity=0.371  Sum_probs=219.6

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeee
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCC  156 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (411)
                      ....++|.+.+.||+|+||.||+|.+.        .+..||||++.... ......+.+|+.+++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            344678999999999999999999853        23579999997653 34457789999999999 999999999999


Q ss_pred             ecCCceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 040952          157 IDKDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  223 (411)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N  223 (411)
                      ...+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999865431             235899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 040952          224 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  302 (411)
Q Consensus       224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  302 (411)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999987665443334444567899999999999999999999999999999999 99998643211 


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeee
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFV  382 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~  382 (411)
                          .. ...........     ..     ...+..+.+++.+||+.||++|||+.|+++.|+.+.........+.....
T Consensus       301 ----~~-~~~~~~~~~~~-----~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  365 (382)
T 3tt0_A          301 ----EL-FKLLKEGHRMD-----KP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH  365 (382)
T ss_dssp             ----HH-HHHHHTTCCCC-----CC-----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-------
T ss_pred             ----HH-HHHHHcCCCCC-----CC-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCcc
Confidence                11 11111111111     01     11245789999999999999999999999999999887666655555433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-47  Score=358.73  Aligned_cols=249  Identities=24%  Similarity=0.308  Sum_probs=205.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            357899999999999999999997 46999999998654  334466788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999998543   34889999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ..   .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.....     .......... ..      
T Consensus       167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~-~~------  231 (328)
T 3fe3_A          167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERVLRG-KY------  231 (328)
T ss_dssp             SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC-CC------
T ss_pred             CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC-CC------
Confidence            32   23446899999999999888765 799999999999999999999864321     1111111111 00      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+     +...+..+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 RI-----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CC-----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CC-----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00     11124568899999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.3e-47  Score=355.13  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=204.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999976 589999999865432 234568899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            99999999998543   34899999999999999999999998   9999999999999999999999999998764333


Q ss_pred             cccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+.    .....   ..   
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~---~~---  229 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTY---LN---  229 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTCTT---ST---
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----ccccc---CC---
Confidence            3333345689999999999987775 7889999999999999999999865443222211111    10000   00   


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                011124567899999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-46  Score=352.78  Aligned_cols=275  Identities=16%  Similarity=0.164  Sum_probs=216.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....  .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            478999999999999999999964 589999999875432  23578999999999 99999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC-----eEEeecCCccc
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKISDFGMARI  242 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfgl~~~  242 (411)
                      |+ +++|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998653  235899999999999999999999998   999999999999998887     99999999987


Q ss_pred             cCCCCccc-----ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          243 CGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       243 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      ........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ........... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~~~-  236 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKIGDTK-  236 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHHHHHH-
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHHHhhh-
Confidence            64332211     12356799999999999999999999999999999999999999875432211  11111100000 


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeee
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFV  382 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~  382 (411)
                      . ......+.     ...+ .+.+++.+||+.+|.+||++.++++.|+++...........++|.
T Consensus       237 ~-~~~~~~~~-----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          237 R-ATPIEVLC-----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             H-HSCHHHHT-----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             c-cCCHHHHh-----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            0 00000000     0113 799999999999999999999999999988777666555556664

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=354.26  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec----CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467999999999999999999974    2456999999765 33445678999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999986542  34899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          245 GNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       245 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......     ...... .....    
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~-~~~~~----  272 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVISSV-EEGYR----  272 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHH-HTTCC----
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHH-HcCCC----
Confidence            43221 12223356788999999999999999999999999999999 99998543221     111111 11100    


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                       ..     .+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       273 -~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          273 -LP-----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -CC-----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence             00     011225678999999999999999999999999999876533

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=356.87  Aligned_cols=268  Identities=25%  Similarity=0.397  Sum_probs=214.3

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeec
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCID  158 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (411)
                      .....++|++.+.||+|+||.||+|.+.      +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445688999999999999999999975      24789999998653 3345678999999999999999999999999


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCCC---------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPTK---------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR  217 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  217 (411)
                      .+..++||||+++|+|.+++.....                     ...+++..++.++.|++.||.|||+++   |+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9999999999999999999865321                     146899999999999999999999998   9999


Q ss_pred             CCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 040952          218 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTG  296 (411)
Q Consensus       218 dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~  296 (411)
                      ||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999987653332233344568899999999999999999999999999999999 999986


Q ss_pred             CCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          297 LYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                      .....     ..... ........     .     +...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       279 ~~~~~-----~~~~~-~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          279 GMAHE-----EVIYY-VRDGNILA-----C-----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TSCHH-----HHHHH-HHTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCChH-----HHHHH-HhCCCcCC-----C-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            43211     11111 11111111     0     11224578999999999999999999999999999876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-46  Score=348.92  Aligned_cols=267  Identities=25%  Similarity=0.397  Sum_probs=207.4

Q ss_pred             hcCCCccCcccccCcccEEEEEe-----cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec--CCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  162 (411)
                      .++|++.+.||+|+||.||+|++     .+|+.||||++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            47799999999999999999984     2488999999987766667789999999999999999999999865  3568


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            99999999999999986543  34889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc----------hhHHHHH
Q 040952          243 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN----------LLGYAWD  311 (411)
Q Consensus       243 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~----------~~~~~~~  311 (411)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.........          .......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6533221 1222345778899999999999999999999999999999999987543211000          0000001


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      .......     .     ..+...+..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus       244 ~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          244 LLKNNGR-----L-----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHTTCC-----C-----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHhccCc-----C-----CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            1111000     0     011223567999999999999999999999999999887654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=346.72  Aligned_cols=273  Identities=21%  Similarity=0.295  Sum_probs=215.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC--ceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  164 (411)
                      ..++|.+.+.||+|+||.||+|.+.. |+.||||++.... ....+.+.+|+.++++++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            35789999999999999999999764 8999999997543 334567889999999999999999999988765  7799


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCCeEEeecCCc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMA  240 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfgl~  240 (411)
                      ||||+++++|.+++........+++..++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999977655555899999999999999999999998   9999999999999    78888999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYAL--------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      +.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||......... .......
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~  239 (319)
T 4euu_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKI  239 (319)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-HHHHHHH
T ss_pred             eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-HHHHHHH
Confidence            87654322   23357899999999886        567899999999999999999999998654332211 1111111


Q ss_pred             hhcCc---ccc---ccc-------cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          313 WTSNR---TLE---LID-------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       313 ~~~~~---~~~---~~~-------~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      .....   ...   ...       ...............+.+++.+||+.||++|||+.|+++...+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            11110   000   000       000111223556788999999999999999999999999987654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.9e-47  Score=360.77  Aligned_cols=269  Identities=27%  Similarity=0.365  Sum_probs=213.9

Q ss_pred             hhhhHHhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeee
Q 040952           84 SSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGC  155 (411)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~  155 (411)
                      .......++|++.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|+.++.++ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            344455688999999999999999999842      35789999997643 33456789999999999 78999999999


Q ss_pred             eecCCc-eEEEEeeCCCCCchhhhcCCCC---------------------------------------------------
Q 040952          156 CIDKDE-KILIYEYMPNKSLDFFLFDPTK---------------------------------------------------  183 (411)
Q Consensus       156 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------  183 (411)
                      +.+.+. .++||||+++|+|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            987654 8999999999999999875432                                                   


Q ss_pred             ------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          184 ------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       184 ------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                                  +..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...........
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence                        122888999999999999999999998   99999999999999999999999999987654433333


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  330 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  330 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.......     .............     ..   
T Consensus       252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~~~~~~~-----~~---  318 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRMR-----AP---  318 (359)
T ss_dssp             C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----HHHHHHHHTCCCC-----CC---
T ss_pred             ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----HHHHHHHcCCCCC-----CC---
Confidence            445578999999999999999999999999999999998 999986433221     1111111111111     01   


Q ss_pred             chHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                        ...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       319 --~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          319 --DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence              11245689999999999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.7e-47  Score=363.30  Aligned_cols=261  Identities=26%  Similarity=0.351  Sum_probs=210.6

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34567889999999999999999986 58999999987543 23345688999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++....  ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999986432  34788999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...........++..|+|||.+.++.++.++|||||||++|||++ |..||.......      ............    
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~----  335 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGRLP----  335 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH------HHHHHHTTCCCC----
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCC----
Confidence            322222222345778999999999999999999999999999998 999986433111      111111111000    


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                            .+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       336 ------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          336 ------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                  011124578899999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-45  Score=346.84  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=205.3

Q ss_pred             CCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           93 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            666778999999999999976 5999999999877666677899999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      ++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........  .
T Consensus       127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  197 (321)
T 2c30_A          127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  197 (321)
T ss_dssp             CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence            999999853    34899999999999999999999998   99999999999999999999999999987653221  2


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccc
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  331 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  331 (411)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..........      .+.+..   
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~------~~~~~~---  263 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-----QAMKRLRDSP------PPKLKN---  263 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSS------CCCCTT---
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC------CCCcCc---
Confidence            23457999999999999999999999999999999999999998643211     1111111110      111110   


Q ss_pred             hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          332 SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       332 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11124568899999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.6e-46  Score=345.04  Aligned_cols=276  Identities=16%  Similarity=0.204  Sum_probs=220.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++.....  .+.+.+|+.++..+ +|+|++++++++......++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            357899999999999999999996 4589999999865432  24578899999999 8999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC-----eEEeecCCcc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKISDFGMAR  241 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfgl~~  241 (411)
                      ||+ +++|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.     +||+|||++.
T Consensus        86 e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 999999986532  34899999999999999999999998   999999999999987776     9999999998


Q ss_pred             ccCCCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-chhHHHHHHhhc
Q 040952          242 ICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYAWDLWTS  315 (411)
Q Consensus       242 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~  315 (411)
                      ........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            76543221     123445799999999999999999999999999999999999999875432211 111111100000


Q ss_pred             CccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeee
Q 040952          316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFV  382 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~  382 (411)
                      ......     .     ...+..+.+++.+||+.||++|||+.+|++.|+++..........+++|.
T Consensus       240 ~~~~~~-----~-----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          240 TPLREL-----C-----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             SCHHHH-----T-----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             ccHHHH-----H-----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence            000000     0     01246789999999999999999999999999999998888888777774

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=346.33  Aligned_cols=267  Identities=25%  Similarity=0.402  Sum_probs=208.1

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.+. ++.||+|.+...  ...+.+.+|+.++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            367888999999999999999986 789999999743  345678999999999999999999998874  589999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC-eEEeecCCccccCCCCc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-PKISDFGMARICGGNEL  248 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfgl~~~~~~~~~  248 (411)
                      ++++|.+++........+++...+.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976555455788899999999999999999943234999999999999998887 799999998765321  


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...+..... ..     +....
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~-~~-----~~~~~  227 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWAVHNG-TR-----PPLIK  227 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHHHHTT-CC-----CCCBT
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHHHhcC-CC-----CCccc
Confidence               2234689999999999999999999999999999999999999864332211   111111111 10     11111


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCcee
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS  380 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~  380 (411)
                           ..+..+.+++.+||+.||++|||+.++++.|+.+....+....|...
T Consensus       228 -----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~  274 (307)
T 2eva_A          228 -----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY  274 (307)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred             -----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence                 12456889999999999999999999999999998877665555443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-46  Score=351.47  Aligned_cols=264  Identities=30%  Similarity=0.432  Sum_probs=214.3

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      ...++|.+.+.||+|+||.||+|.+.      +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            34578999999999999999999862      35789999997643 344577899999999999999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC---------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK---------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL  219 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  219 (411)
                      ..++||||+++++|.+++.....                     ...+++..++.++.|++.||.|||+++   |+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            99999999999999999865432                     234788999999999999999999998   999999


Q ss_pred             CCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 040952          220 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLY  298 (411)
Q Consensus       220 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~  298 (411)
                      ||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654443333344567889999999999999999999999999999999 99998643


Q ss_pred             cccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          299 RTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ....  .    ...........     .     +...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       257 ~~~~--~----~~~~~~~~~~~-----~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PPER--L----FNLLKTGHRME-----R-----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CGGG--H----HHHHHTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHHH--H----HHHhhcCCcCC-----C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            3211  1    11111111110     0     111256789999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.4e-46  Score=341.34  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=211.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            46789999999999999999998888899999998653 33467899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            9999999986533  34889999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......     .........      .....  
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~~~------~~~~~--  228 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTG------FRLYK--  228 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTT------CCCCC--
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHhcC------ccCCC--
Confidence            12233456788999999999999999999999999999999 99998643221     111111111      00111  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                         +...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       229 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          229 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence               11124568999999999999999999999999998765

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-46  Score=341.67  Aligned_cols=258  Identities=27%  Similarity=0.392  Sum_probs=211.3

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.++++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            47799999999999999999999888899999997643 23467899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999999986532  34889999999999999999999998   999999999999999999999999999876543322


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      . .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......     .........   ....     
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~---~~~~-----  226 (268)
T 3sxs_A          161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQGH---RLYR-----  226 (268)
T ss_dssp             E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHTTC---CCCC-----
T ss_pred             c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHHHcCC---CCCC-----
Confidence            2 223456778999999999899999999999999999999 999986433211     111111110   0000     


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                         +...+..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       227 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          227 ---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence               011145688999999999999999999999999988764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-46  Score=353.90  Aligned_cols=265  Identities=24%  Similarity=0.403  Sum_probs=196.3

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecC-C---CEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKK-G---DEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ...++|++.+.||+|+||.||+|.+.. +   ..||||++...  .....+.+.+|+.++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345789999999999999999999664 3   27999999754  34456789999999999999999999999988765


Q ss_pred             e------EEEEeeCCCCCchhhhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          162 K------ILIYEYMPNKSLDFFLFDPT---KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       162 ~------~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                      .      ++||||+++|+|.+++....   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence            5      99999999999999985422   2225889999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  311 (411)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......  .   ...
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~---~~~  251 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--I---YNY  251 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H---HHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--H---HHH
Confidence            9999999987654433333334457889999999999999999999999999999999 899986433211  1   111


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                       ........          .+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       252 -~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          252 -LIGGNRLK----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             -HHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             -HhcCCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence             11111000          01112457899999999999999999999999999887753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.2e-46  Score=345.30  Aligned_cols=263  Identities=25%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHh--cCCcccceeeeeeecC----Cce
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDK----DEK  162 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~  162 (411)
                      ..++|++.+.||+|+||.||+|.++ |+.||||++...   ....+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            3578999999999999999999984 899999998753   33456667777777  7999999999986653    457


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--------QYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                      ++||||+++|+|.+++..    ..+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            899999999999999943    34899999999999999999999        666   999999999999999999999


Q ss_pred             eecCCccccCCCCccc--ccccccccccccChhhhccC------CCCcchhhHHHHHHHHHHHhC----------CCCCC
Q 040952          235 SDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG----------KKNTG  296 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p~~  296 (411)
                      +|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999997654332211  12334799999999999876      456799999999999999999          67765


Q ss_pred             CCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          297 LYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      ...................     ...+.+.........+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            4333222222111111111     11122222222334578899999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-46  Score=361.26  Aligned_cols=260  Identities=28%  Similarity=0.423  Sum_probs=198.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec----CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|++.    ++..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            468999999999999999999865    4778999999764 33445679999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999996532  34889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          245 GNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       245 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......     .... .......    
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~~~~-~i~~~~~----  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----DVIK-AVDEGYR----  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----HHHH-HHHTTEE----
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-HHHcCCC----
Confidence            33211 11222345778999999999999999999999999999998 99998543211     1111 1111100    


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                       .     ..+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       269 -~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 -L-----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -C-----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -C-----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence             0     00112256789999999999999999999999999887653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.6e-46  Score=351.23  Aligned_cols=254  Identities=23%  Similarity=0.319  Sum_probs=201.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC------
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (411)
                      ..++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3567999999999999999999976 69999999997543 334577899999999999999999999986543      


Q ss_pred             ---------------------------------------------------ceEEEEeeCCCCCchhhhcCCCCCcCCCH
Q 040952          161 ---------------------------------------------------EKILIYEYMPNKSLDFFLFDPTKRMLLDW  189 (411)
Q Consensus       161 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  189 (411)
                                                                         ..++||||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27899999999999999987666566777


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc----------cccccccccc
Q 040952          190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVGTY  259 (411)
Q Consensus       190 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~gt~  259 (411)
                      ..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            788999999999999999998   999999999999999999999999999876543211          1223357999


Q ss_pred             cccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHH
Q 040952          260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY  339 (411)
Q Consensus       260 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l  339 (411)
                      .|+|||++.+..++.++|||||||++|||++|..|+.       ......... ...     ..     ..........+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~~~~~-~~~-----~~-----~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRIITDV-RNL-----KF-----PLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHHHHHH-HTT-----CC-----CHHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHHHHHh-hcc-----CC-----CcccccCChhH
Confidence            9999999999999999999999999999999876631       000000000 000     00     01112234667


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHH
Q 040952          340 VNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       340 ~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+++.+||+.||++|||+.|+++.
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhc
Confidence            899999999999999999999863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.3e-46  Score=353.29  Aligned_cols=252  Identities=23%  Similarity=0.274  Sum_probs=205.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc------ccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4578999999999999999999976 489999999875432      235778999999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----CeEEeec
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDF  237 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Df  237 (411)
                      .++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999998543   35899999999999999999999998   99999999999998877    7999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      |++.......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......     ....... ...
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~~~~~i~-~~~  234 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANIT-AVS  234 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHH-TTC
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH-hcC
Confidence            9998765432   223457999999999999999999999999999999999999998643211     1111111 100


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .  .+++..     ....+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~--~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 Y--DFDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C--CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--CCCchh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  000000     0112467899999999999999999999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=357.65  Aligned_cols=262  Identities=30%  Similarity=0.392  Sum_probs=209.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467999999999999999999943      3668999999754 334456788999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCC----CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---CeEEe
Q 040952          163 ILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKIS  235 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~  235 (411)
                      ++||||+++|+|.+++....    ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999986532    2245889999999999999999999998   99999999999999555   59999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhh
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......     ..... ..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-----~~~~~-i~  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLEF-VT  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHH-HH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH-HH
Confidence            9999976533222233344568999999999999999999999999999999998 99998643211     11111 11


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ......          .+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       301 ~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          301 SGGRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             TTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCC----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            111000          0111245688999999999999999999999999877553

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.8e-47  Score=361.29  Aligned_cols=286  Identities=16%  Similarity=0.155  Sum_probs=216.0

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCCcccH-----------HHHHHHHHHHHhcCCcccce
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQGL-----------REMKNEASVIAKVQHKNLVR  151 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~  151 (411)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999999764      47899999876542111           12334555667778999999


Q ss_pred             eeeeeecC----CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          152 LLGCCIDK----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       152 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                      +++++...    ...++||||+ +++|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998765    4579999999 999999986532  45899999999999999999999998   99999999999999


Q ss_pred             --CCCCeEEeecCCccccCCCCccc-----ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 040952          228 --KDMNPKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  300 (411)
Q Consensus       228 --~~~~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  300 (411)
                        .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999997764322111     11334699999999999999999999999999999999999999864222


Q ss_pred             cccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCcee
Q 040952          301 DSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS  380 (411)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~  380 (411)
                      ... ........ ........+++.+...    ..+..+.+++..||+.+|++||++.++++.|+++......+....++
T Consensus       267 ~~~-~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  340 (364)
T 3op5_A          267 DPK-YVRDSKIR-YRENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD  340 (364)
T ss_dssp             CHH-HHHHHHHH-HHHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred             CHH-HHHHHHHH-hhhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence            111 11111111 1111222222222111    12457899999999999999999999999999999999999888998


Q ss_pred             eecccc
Q 040952          381 FVRNTV  386 (411)
Q Consensus       381 ~~~~~~  386 (411)
                      |.....
T Consensus       341 w~~~~~  346 (364)
T 3op5_A          341 LSVVEN  346 (364)
T ss_dssp             C-----
T ss_pred             eEeccC
Confidence            865444

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.5e-46  Score=351.16  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=201.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.+.. |+    +||+|.+... .....+.+.+|+.++++++||||+++++++... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            4679999999999999999999643 44    3688888643 334567899999999999999999999999875 478


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +|+||+.+|+|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999986543  34889999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  ..    ..........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~----~~~~~~~~~~--  239 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKGERLP--  239 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH----HHHHTTCCCC--
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HH----HHHHcCCCCC--
Confidence            65444333444567889999999999999999999999999999999 999986433221  11    1111111000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                              .+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    011124568899999999999999999999999987754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6e-46  Score=345.06  Aligned_cols=263  Identities=24%  Similarity=0.353  Sum_probs=207.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            578999999999999999999965 58999999985432   33456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++++|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999998543   34899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......     ......... .... ...
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~-~~~~-~~~  235 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKHIQDS-VPNV-TTD  235 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHHHSSC-CCCH-HHH
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhhcc-CCCc-chh
Confidence            221 22334579999999999999999999999999999999999999986433111     111111110 0000 000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhccccc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRP-TMNDVVSMLTNEAAAL  371 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~~  371 (411)
                      .     ....+..+.+++.+||+.||++|| ++.++.+.|.......
T Consensus       236 ~-----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          236 V-----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             S-----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             c-----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            0     111256789999999999999998 9999999998876643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.6e-46  Score=352.64  Aligned_cols=249  Identities=22%  Similarity=0.277  Sum_probs=204.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367999999999999999999976 5899999999653   233456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999888543   34889999999999999999999998   99999999999999999999999999976432


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......     ........ ...      .
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~~-~~~------~  223 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILM-EEI------R  223 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH-CCC------C
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-----HHHHHHHc-CCC------C
Confidence            22  2234468999999999999999999999999999999999999998643211     11111111 110      0


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      +.     ...+..+.+++.+||+.||++||     ++.|+++.
T Consensus       224 ~p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 FP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            11     11245789999999999999999     89999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-46  Score=345.74  Aligned_cols=260  Identities=27%  Similarity=0.385  Sum_probs=209.6

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ...++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            34578999999999999999999998888999999986533 34678999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          100 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999986532  34899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      . .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......     ...... ..     .....
T Consensus       175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~-~~-----~~~~~  242 (283)
T 3gen_A          175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIA-QG-----LRLYR  242 (283)
T ss_dssp             H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHH-TT-----CCCCC
T ss_pred             c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----HHHHHh-cc-----cCCCC
Confidence            1 12223456788999999998999999999999999999998 999986433211     111111 11     00111


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .     ...+..+.+++.+||+.+|++|||+.++++.|.++...
T Consensus       243 ~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          243 P-----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             C-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            1     11145688999999999999999999999999887653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-46  Score=351.72  Aligned_cols=265  Identities=27%  Similarity=0.366  Sum_probs=210.1

Q ss_pred             HhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  160 (411)
                      ..++|++.+.||+|+||.||+|.+.      ++..||||.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999999962      3568999999754 233456789999999999 8999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCC--------------------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKR--------------------MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  220 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  220 (411)
                      ..++||||+++|+|.+++......                    ..+++..++.++.|++.||+|||+++   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999654321                    34788999999999999999999998   9999999


Q ss_pred             CCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 040952          221 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYR  299 (411)
Q Consensus       221 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~  299 (411)
                      |+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654333333344567889999999999999999999999999999998 999986443


Q ss_pred             ccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          300 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      ...     ..........     ....     +...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       280 ~~~-----~~~~~~~~~~-----~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDA-----NFYKLIQNGF-----KMDQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSH-----HHHHHHHTTC-----CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHH-----HHHHHHhcCC-----CCCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            211     1111111110     0000     1112457899999999999999999999999999887654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.9e-45  Score=347.87  Aligned_cols=266  Identities=25%  Similarity=0.363  Sum_probs=213.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEec--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeec
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  158 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (411)
                      ..++|++.+.||+|+||.||+|.+.        ++..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999863        46789999997653 34456789999999999 99999999999999


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  225 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil  225 (411)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999865432             234788999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 040952          226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  304 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  304 (411)
                      ++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  266 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  266 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence            99999999999999987665443333344567889999999998899999999999999999999 99998643211   


Q ss_pred             hhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCC
Q 040952          305 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP  373 (411)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  373 (411)
                        ..... .......     ...     ...+..+.+++.+||+.+|++|||+.++++.|+++......
T Consensus       267 --~~~~~-~~~~~~~-----~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          267 --ELFKL-LKEGHRM-----DKP-----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             --HHHHH-HHHTCCC-----CCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             --HHHHH-HhcCCCC-----CCC-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence              11111 1111100     011     11245689999999999999999999999999988765443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=351.50  Aligned_cols=259  Identities=28%  Similarity=0.438  Sum_probs=200.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.+.. ++    +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            4679999999999999999999653 44    3578877543 3445678999999999999999999999998754 78


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +|++|+.+|+|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            9999999999999986543  34889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  ..    ..........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~----~~~~~~~~~~--  239 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKGERLP--  239 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH----HHHHTTCCCC--
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCCCC--
Confidence            54433333344567889999999999999999999999999999999 999986443221  11    1111111000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                              .+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                    0111245688999999999999999999999999988754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-46  Score=349.25  Aligned_cols=252  Identities=20%  Similarity=0.283  Sum_probs=205.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            478999999999999999999976 48899999987543 3446688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--CCCeEEeecCCccccCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGGN  246 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~  246 (411)
                      +++|+|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.  ++.+||+|||++......
T Consensus        83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999999985432  34889999999999999999999998   999999999999987  789999999999876533


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     ............   .... 
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~---~~~~-  225 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEYT---FDEE-  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCC---CCHH-
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHcCCCC---CChh-
Confidence            2   223457899999999999888999999999999999999999998643211     111111111000   0000 


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       226 ----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          226 ----AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                001125678999999999999999999999974

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-45  Score=336.17  Aligned_cols=254  Identities=30%  Similarity=0.454  Sum_probs=196.5

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC----cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|.+. |+.||||++....    ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467899999999999999999986 8899999987542    23356789999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--------CCCeEEeec
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--------DMNPKISDF  237 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--------~~~~kl~Df  237 (411)
                      |||+++++|.+++..    ..+++.....++.|++.||.|||+++..+++||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999843    34889999999999999999999987555899999999999986        778999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      |++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......     ..........
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~  231 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMNKL  231 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHTSCC
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHhhhcCCC
Confidence            9997654322    223478999999999999999999999999999999999999986433211     1111111110


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                           .....     ...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       232 -----~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 -----ALPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -----CCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -----CCCCC-----cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                 00111     11245789999999999999999999999999763

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-46  Score=352.99  Aligned_cols=278  Identities=28%  Similarity=0.380  Sum_probs=209.8

Q ss_pred             cCC-CccCcccccCcccEEEEEec-----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecC--Cc
Q 040952           91 NKF-SDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE  161 (411)
Q Consensus        91 ~~y-~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  161 (411)
                      ++| ++.+.||+|+||.||++.+.     +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            444 89999999999999988643     47889999998653 34456789999999999999999999999874  57


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+++++|.+++...    .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence            79999999999999998543    3889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          242 ICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       242 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||............+...........+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            76543221 22233467888999999999999999999999999999999999975432111100000000000000001


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCC
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ  376 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~  376 (411)
                      .+...... ..+...+..+.+++.+||+.||++|||+.|+++.|+.+.....++.+
T Consensus       263 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          263 LLERGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             HHhcccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            11100000 01112256799999999999999999999999999988776654443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8e-46  Score=346.94  Aligned_cols=264  Identities=27%  Similarity=0.402  Sum_probs=213.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEe------cCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhc-CCcccceeeeeeecCC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  160 (411)
                      ..++|++.+.||+|+||.||+|.+      .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            357899999999999999999985      2367899999976533 3456789999999999 9999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC---------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  225 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil  225 (411)
                      ..++||||+++|+|.+++.....               ...+++..++.++.|++.||.|||+++   ++||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999865432               224899999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 040952          226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  304 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  304 (411)
                      ++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            99999999999999987654433333344567889999999999999999999999999999999 9999864332211 


Q ss_pred             hhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          305 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                          ........     .....     +...+..+.+++.+||+.||++|||+.|+++.|++....
T Consensus       257 ----~~~~~~~~-----~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 ----FYKMIKEG-----FRMLS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ----HHHHHHHT-----CCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHhccC-----CCCCC-----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                11111111     00100     111245789999999999999999999999999987764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-45  Score=343.79  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=201.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..++|++.+.||+|+||.||+|.+.+|+.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357899999999999999999999889999999987542  223467889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++ +|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 6766665432  34889999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc--cc-
Q 040952          247 ELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE--LI-  322 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-  322 (411)
                      .  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  ...............  .. 
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGT
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhh
Confidence            2  12233578999999999876 5689999999999999999999999965432221  111111111100000  00 


Q ss_pred             ---------cccccccc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          323 ---------DPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       323 ---------~~~l~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                               ........   .....+.++.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                     00000000   00112457889999999999999999999997

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-45  Score=344.08  Aligned_cols=278  Identities=23%  Similarity=0.327  Sum_probs=209.7

Q ss_pred             cchhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc--CCcccceeeeeeec
Q 040952           81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV--QHKNLVRLLGCCID  158 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~  158 (411)
                      .+........++|++.+.||+|+||.||+|.++ |+.||||++....   ...+..|.+++...  +||||+++++++..
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            334445566789999999999999999999987 8999999986432   23445566666554  89999999999988


Q ss_pred             C----CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCEEEcCC
Q 040952          159 K----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-----RVRIIHRDLKASNILLDKD  229 (411)
Q Consensus       159 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlkp~Nill~~~  229 (411)
                      .    ...++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.+
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence            7    678999999999999999953    24889999999999999999999880     1129999999999999999


Q ss_pred             CCeEEeecCCccccCCCCccc--ccccccccccccChhhhccCCCCcc------hhhHHHHHHHHHHHhC----------
Q 040952          230 MNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEGIFSIK------SDVFSFGVLLLEIVSG----------  291 (411)
Q Consensus       230 ~~~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------  291 (411)
                      +.+||+|||++..........  ......||+.|+|||++.+..++.+      +|||||||++|||++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999997664332211  1224579999999999987766655      9999999999999999          


Q ss_pred             CCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          292 KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       292 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      ..||............. .....    .....+.+........++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       259 ~~p~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDM-REIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCTTTTTSCSSCCHHHH-HHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccHhhhcCCCCchhhh-HHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            44443322222111111 11111    11222223333334466888999999999999999999999999999887654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-45  Score=347.10  Aligned_cols=269  Identities=27%  Similarity=0.400  Sum_probs=214.9

Q ss_pred             chhhhhHHhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeee
Q 040952           82 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLG  154 (411)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~  154 (411)
                      ...+.....++|++.+.||+|+||.||+|.+.      +++.||+|.+.... ......+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33445566788999999999999999999864      36789999997543 234556889999999999999999999


Q ss_pred             eeecCCceEEEEeeCCCCCchhhhcCCC-------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          155 CCIDKDEKILIYEYMPNKSLDFFLFDPT-------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                      ++.+.+..++||||+++|+|.+++....       ....+++..++.++.|++.||.|||+++   |+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence            9999999999999999999999986422       1134688899999999999999999998   99999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchh
Q 040952          228 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLL  306 (411)
Q Consensus       228 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  306 (411)
                      .++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......     
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  247 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----  247 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----
Confidence            999999999999986543332223334467889999999999999999999999999999999 88887543211     


Q ss_pred             HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ... ...........          +...+..+.+++.+||+.||++|||+.|+++.|++...
T Consensus       248 ~~~-~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 QVL-RFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHH-HHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH-HHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111 11111111110          11124568999999999999999999999999988755

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.6e-46  Score=349.31  Aligned_cols=259  Identities=26%  Similarity=0.387  Sum_probs=204.1

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCE----EEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDE----IAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.+.. |+.    ||+|.+.... ......+.+|+.++++++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            3678999999999999999999653 443    8888875432 333456788999999999999999999986 46789


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+.+|+|.+++...  +..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999998654  235788889999999999999999998   999999999999999999999999999887


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .............||..|+|||.+.+..++.++|||||||++|||++ |+.||.......  .    ............ 
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~-  238 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--V----PDLLEKGERLAQ-  238 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--H----HHHHHTTCBCCC-
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--H----HHHHHcCCCCCC-
Confidence            65444444445578889999999999999999999999999999999 999986433211  1    111111110000 


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                          .     ...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       239 ----~-----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          239 ----P-----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----C-----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----C-----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                0     01134578899999999999999999999999887653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-46  Score=355.14  Aligned_cols=268  Identities=25%  Similarity=0.339  Sum_probs=210.0

Q ss_pred             hcCCCccCcccccCcccEEEEEe-----cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeee--cCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI--DKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|.+     .+++.||||++........+.+.+|+.++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36789999999999999999984     348899999998776666778999999999999999999999887  45568


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            89999999999999986432  34899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc---------chhHHHHHH
Q 040952          243 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---------NLLGYAWDL  312 (411)
Q Consensus       243 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---------~~~~~~~~~  312 (411)
                      ....... .......||..|+|||.+.+..++.++|||||||++|+|++|+.||........         .........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543221 122334678889999999999999999999999999999999998753221100         000000111


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                      ......     .     ..+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       257 ~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          257 LEEGQR-----L-----PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHTTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             hhcccC-----C-----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            111100     0     0111235678999999999999999999999999998866543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=345.44  Aligned_cols=253  Identities=24%  Similarity=0.305  Sum_probs=205.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc------ccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3567999999999999999999976 489999999875422      245778999999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----CeEEeec
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDF  237 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Df  237 (411)
                      .++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999998543   45899999999999999999999998   99999999999999887    7999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     .......... 
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~-  233 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANVSAVN-  233 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHHTC-
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHHHhcC-
Confidence            9998765322   223457999999999999899999999999999999999999998543211     1111111000 


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       ... ....     ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       234 -~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 -YEF-EDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -CCC-CHHH-----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CCc-Cccc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             000 0000     01124568899999999999999999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.6e-46  Score=350.55  Aligned_cols=247  Identities=20%  Similarity=0.312  Sum_probs=200.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            478999999999999999999974 5899999998643   122345788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+ +|+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 67887777543   34899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ..   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......               ....+..
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~~  222 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVNS  222 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCCS
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHc
Confidence            32   2234579999999999988776 789999999999999999999985432111               0011110


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...  ..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus       223 ~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          223 CVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            000  0111225568899999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.4e-46  Score=346.59  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-C-------CEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-G-------DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      .++|.+.+.||+|+||.||+|.+.. +       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4678999999999999999998653 3       4799999987666667889999999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC--------eE
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------PK  233 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~k  233 (411)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999996532  33888999999999999999999998   999999999999998887        99


Q ss_pred             EeecCCccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCC-CCCCcccccchhHHHHH
Q 040952          234 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~  311 (411)
                      |+|||++.....      .....||+.|+|||++.+ ..++.++|||||||++|||++|..| +......     .. ..
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~-~~  229 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RK-LQ  229 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HH-HH
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HH-HH
Confidence            999999865432      223467899999999987 6799999999999999999996554 3322111     00 01


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCC
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP  377 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  377 (411)
                      ......       .+....     +..+.+++.+||+.||++|||+.++++.|+.+..+..++...
T Consensus       230 ~~~~~~-------~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~  283 (289)
T 4fvq_A          230 FYEDRH-------QLPAPK-----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS  283 (289)
T ss_dssp             HHHTTC-------CCCCCS-----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred             HhhccC-------CCCCCC-----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence            111100       000011     335788999999999999999999999999987765555443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.1e-45  Score=337.66  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=195.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--------------------------ccHHHHHHHHHHHH
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--------------------------QGLREMKNEASVIA  142 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  142 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999975 488999999865421                          12356889999999


Q ss_pred             hcCCcccceeeeeeec--CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 040952          143 KVQHKNLVRLLGCCID--KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  220 (411)
Q Consensus       143 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  220 (411)
                      +++||||+++++++.+  .+..++||||+++++|.+++.    ...+++..+..++.|++.||+|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  567899999999999988753    245899999999999999999999998   9999999


Q ss_pred             CCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCC
Q 040952          221 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGL  297 (411)
Q Consensus       221 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~  297 (411)
                      |+|||++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++|||||||++|+|++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987653321  223457999999999987655   47889999999999999999999864


Q ss_pred             CcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          298 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ...     ...... ...... ..  +      .....+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~-----~~~~~~-~~~~~~-~~--~------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERI-----MCLHSK-IKSQAL-EF--P------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSH-----HHHHHH-HHHCCC-CC--C------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccH-----HHHHHH-HhcccC-CC--C------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321     111111 111110 00  0      00112456899999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.4e-45  Score=339.06  Aligned_cols=262  Identities=26%  Similarity=0.440  Sum_probs=197.0

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..++|++.+.||+|+||.||+|.+.  ..||+|++....  ....+.+.+|+.++++++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3578999999999999999999865  359999987543  34456789999999999999999999965 456789999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999985433  44889999999999999999999998   999999999999999999999999999765433


Q ss_pred             CcccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ..........||+.|+|||++.   +..++.++||||||+++|+|++|+.||.......     ..............+.
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-----HHHHHHHHTSCCCCTT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcccccCcchh
Confidence            3233334457899999999986   5678999999999999999999999986433211     1111111111111111


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ..      ....+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       249 ~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 KV------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SS------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hc------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            10      11124678999999999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-45  Score=353.67  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=201.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|+.+. ++.||+|++...   .....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4679999999999999999999764 788999999754   223345678899999887 89999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999988543   34899999999999999999999998   9999999999999999999999999997533


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc---cchhHHHHHHhhcCccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ................   
T Consensus       205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  279 (396)
T 4dc2_A          205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  279 (396)
T ss_dssp             CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred             cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence            221  22345689999999999999999999999999999999999999996432111   1111111221111111   


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTM------NDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~~  363 (411)
                         .+     +...+..+.+++.+||+.||++||++      .|+++.
T Consensus       280 ---~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 ---RI-----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ---CC-----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ---CC-----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence               01     11125578899999999999999995      566653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=355.21  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=199.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++...   .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            578999999999999999999976 4899999999753   233456788999999988 79999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999998543   34899999999999999999999998   9999999999999999999999999997543


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......     .......... .      
T Consensus       176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~~-~------  241 (353)
T 3txo_A          176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE-V------  241 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCC-C------
T ss_pred             cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCC-C------
Confidence            222  2234468999999999999989999999999999999999999998643321     1111111111 0      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTM------NDVVS  362 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~  362 (411)
                      ..     +...+..+.+++.+||+.||++||++      .|+++
T Consensus       242 ~~-----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VY-----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CC-----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CC-----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            00     11124568899999999999999998      77775

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-45  Score=362.47  Aligned_cols=263  Identities=30%  Similarity=0.414  Sum_probs=212.7

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .....++|++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.++++++||||+++++++. .+..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344567889999999999999999999888899999998644 45678999999999999999999999986 5678999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999996432 234788889999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      .... ......++..|+|||++....++.++|||||||++|||++ |+.||......     ...........      .
T Consensus       337 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~~------~  404 (454)
T 1qcf_A          337 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALERGYR------M  404 (454)
T ss_dssp             HHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHHTCC------C
T ss_pred             Ccee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCC------C
Confidence            2211 1223356788999999999999999999999999999999 99998643211     11111111100      0


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      .     .+..++..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       405 ~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          405 P-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             C-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            0     11123567899999999999999999999999999886543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=349.94  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=203.1

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|.... |+.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            4679999999999999999999764 889999998643   234457788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+.+|+|..++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999998653   34899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ..   .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||........  ....... ....     
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~-~~~~-----  236 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTF-ETTV-----  236 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHH-HHCC-----
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHH-hhcc-----
Confidence            22   2344689999999999874   4589999999999999999999999864432221  1111111 1100     


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPT-MNDVVS  362 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  362 (411)
                       ...     +...+..+.+++.+||+.||++||+ +.++++
T Consensus       237 -~~~-----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 -VTY-----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -CCC-----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -cCC-----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             000     1112567899999999999999998 677664

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.5e-45  Score=359.83  Aligned_cols=268  Identities=28%  Similarity=0.413  Sum_probs=210.3

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ....++|++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            34457788999999999999999999877889999998654 345678999999999999999999999876 6789999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       258 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999995421 234788999999999999999999998   999999999999999999999999999876533


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......     ..... ...+.     ...
T Consensus       334 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~-i~~~~-----~~~  401 (452)
T 1fmk_A          334 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ-VERGY-----RMP  401 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH-HHTTC-----CCC
T ss_pred             cee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHH-HHcCC-----CCC
Confidence            221 1223456789999999999999999999999999999999 89998543211     11111 11110     000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCC
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP  377 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  377 (411)
                           .+..++..+.+++.+||+.||++|||+.++++.|+.+.....+...|
T Consensus       402 -----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~  448 (452)
T 1fmk_A          402 -----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  448 (452)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence                 01123567899999999999999999999999999988766555444

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=359.95  Aligned_cols=255  Identities=21%  Similarity=0.296  Sum_probs=204.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ...++|++.+.||+|+||.||+|... +|+.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999865 58899999987653  2345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCCeEEeecCCcc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMAR  241 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfgl~~  241 (411)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999998888543   34899999999999999999999998   99999999999998   56889999999997


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|.+||......  .   .... ...+.. ..
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~---~~~~-i~~~~~-~~  232 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--R---LYQQ-IKAGAY-DF  232 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHH-HHHTCC-CC
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--H---HHHH-HHhCCC-CC
Confidence            765332  1223457999999999999999999999999999999999999998543211  1   1111 111110 00


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+.      ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSPE------WDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Cccc------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0000      01124578999999999999999999999974

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-45  Score=365.48  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=212.7

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ....+|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.+|++++||||++++++|...+..++||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            345678889999999999999999875 8899999997643 34678999999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       296 E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          296 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             ECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999996533 245889999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ... ......++..|+|||++.+..++.++|||||||++|||++ |..||......  ..    ........     ...
T Consensus       372 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~----~~~~~~~~-----~~~  439 (495)
T 1opk_A          372 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV----YELLEKDY-----RME  439 (495)
T ss_dssp             CEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH----HHHHHTTC-----CCC
T ss_pred             cee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCC-----CCC
Confidence            222 2223456788999999999999999999999999999999 89898643321  11    11111110     000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                           .+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       440 -----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          440 -----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                 111225678999999999999999999999999988754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-45  Score=351.57  Aligned_cols=254  Identities=22%  Similarity=0.321  Sum_probs=205.1

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            44678999999999999999999976 48999999997543  3345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CCeEEeecCCcc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMAR  241 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfgl~~  241 (411)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999888543   34899999999999999999999998   9999999999999865   459999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     ..... +..... ..
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~-i~~~~~-~~  249 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQ-IKAGAY-DY  249 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH-HHHTCC-CC
T ss_pred             EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH-HHhCCC-CC
Confidence            765332   123457999999999999989999999999999999999999998643211     11111 111110 00


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+.      ....+..+.+++.+||+.||++|||+.++++.
T Consensus       250 ~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 PSPE------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CTTG------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             Cccc------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000      01124568999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-44  Score=334.68  Aligned_cols=255  Identities=25%  Similarity=0.494  Sum_probs=202.6

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc-------cHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            478999999999999999999975 5899999998654321       1267889999999999999999999987654 


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC-----eEEee
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKISD  236 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~D  236 (411)
                       ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             79999999999988876533  35899999999999999999999875 24999999999999988776     99999


Q ss_pred             cCCccccCCCCcccccccccccccccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh
Q 040952          237 FGMARICGGNELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       237 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      ||+++....     ......||+.|+|||.+.  ...++.++|||||||++|||++|+.||.............   ...
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~  244 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM---IRE  244 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH---HHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH---Hhc
Confidence            999975432     233457899999999983  5567899999999999999999999986544332211111   111


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                       ...    .+.+..     ..+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       245 -~~~----~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 -EGL----RPTIPE-----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -SCC----CCCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -cCC----CCCCCc-----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence             111    111111     1245789999999999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.4e-45  Score=338.20  Aligned_cols=264  Identities=20%  Similarity=0.266  Sum_probs=199.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999976 48999999997543  2334678899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |++++.+..+...   +..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9987555444422   234899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc------cc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT------LE  320 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~  320 (411)
                        .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ ..............      ..
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhcc
Confidence              2223457899999999998765 89999999999999999999888543222111 11111111110000      00


Q ss_pred             cccc----cc----ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 LIDP----IL----EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~----~l----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+.    ..    .........+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000    00    0000011235678899999999999999999999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.1e-45  Score=340.47  Aligned_cols=264  Identities=22%  Similarity=0.350  Sum_probs=205.6

Q ss_pred             hcCCCccCcccccCcccEEEEEe-----cCCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecC--Cc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  161 (411)
                      .++|++.+.||+|+||.||+|.+     .+++.||+|++... .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35688999999999999999983     35889999999754 334567889999999999999999999999876  67


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            899999999999999985432  34889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc---------ccchhHHHHH
Q 040952          242 ICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD---------SLNLLGYAWD  311 (411)
Q Consensus       242 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---------~~~~~~~~~~  311 (411)
                      ........ .......||..|+|||.+.+..++.++||||||+++|+|++|+.|+......         ..........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76543321 2233456888899999999999999999999999999999999885322100         0000000001


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                      .......     ..     .+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       255 ~~~~~~~-----~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEGKR-----LP-----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTTCC-----CC-----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCC-----CC-----CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111000     00     11122567899999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.3e-45  Score=336.86  Aligned_cols=276  Identities=20%  Similarity=0.257  Sum_probs=211.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeee-ecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  166 (411)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++......  ..+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 45889999987654322  3578899999999998877776665 5667789999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCCeEEeecCCcccc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  243 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfgl~~~~  243 (411)
                      ||+ +++|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 999999986432  34899999999999999999999998   9999999999999   78999999999999876


Q ss_pred             CCCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-chhHHHHHHhhcCc
Q 040952          244 GGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYAWDLWTSNR  317 (411)
Q Consensus       244 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~  317 (411)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            543221     122345789999999999999999999999999999999999999875432211 11111110000000


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeee
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFV  382 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~  382 (411)
                           .+.+.     ...+..+.+++.+||+.||++|||+.++++.|+++.........-+++|.
T Consensus       239 -----~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          239 -----IEVLC-----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             -----HHHHT-----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             -----hhhhh-----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence                 00000     11145789999999999999999999999999999888777766666664

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-45  Score=344.84  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=203.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367899999999999999999976 58999999987531   23456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999998643   34889999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ........... .      .
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~-~------~  221 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNAE-L------R  221 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHCC-C------C
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC-C------C
Confidence            2     2345899999999999999999999999999999999999999864321     11111111111 0      0


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      +.     ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       222 ~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          222 FP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            01     11245689999999999999999     89999853

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-44  Score=335.81  Aligned_cols=276  Identities=20%  Similarity=0.256  Sum_probs=217.1

Q ss_pred             hcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeee-ecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++......  ..+.+|+.+++.++|++++..+..+ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999996 45899999998754332  4678999999999998877766665 55667799999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCCeEEeecCCccccC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICG  244 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~  244 (411)
                      |+ +++|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 999999986432  34899999999999999999999998   9999999999999   488999999999998765


Q ss_pred             CCCccc-----ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-cchhHHHHHHhhcCcc
Q 040952          245 GNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDLWTSNRT  318 (411)
Q Consensus       245 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~  318 (411)
                      ......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ............... 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence            433211     1234579999999999999999999999999999999999999987543221 111111111000000 


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeeec
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVR  383 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~  383 (411)
                          .+.+.     ...+..+.+++.+||+.||++|||+.++++.|+++......+...+++|..
T Consensus       239 ----~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 3uzp_A          239 ----IEVLC-----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             ----HHHHT-----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred             ----hHHHH-----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence                00000     112457899999999999999999999999999999888887777777753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=347.60  Aligned_cols=253  Identities=24%  Similarity=0.333  Sum_probs=196.5

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCC--cccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++...+..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            35679999999999999999999888999999998754  33445678999999999976  999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||| +.+++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||+++...
T Consensus        87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 5788999998653   34889999999999999999999998   99999999999997 6789999999998765


Q ss_pred             CCCcccccccccccccccChhhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      ............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......    ........
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~  234 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAII  234 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHHHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----HHHHHHHh
Confidence            4333333345679999999999865           67899999999999999999999998632211    11111111


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .......     ....     .+..+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~-----~~~~-----~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNHEIE-----FPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTSCCC-----CCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccC-----Cccc-----CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1111000     0011     13468899999999999999999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.3e-45  Score=343.17  Aligned_cols=268  Identities=26%  Similarity=0.367  Sum_probs=213.4

Q ss_pred             hhhHHhcCCCccCcccccCcccEEEEEe------cCCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeee
Q 040952           85 SVSTATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCC  156 (411)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (411)
                      ......++|++.+.||+|+||.||+|.+      .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            3344567899999999999999999984      236789999997653 23456788999999999 799999999998


Q ss_pred             ecCC-ceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 040952          157 IDKD-EKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  222 (411)
Q Consensus       157 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~  222 (411)
                      ...+ ..++||||+++++|.+++.....             +..+++..++.++.|++.||.|||+++   |+||||||+
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~  177 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR  177 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc
Confidence            8755 58999999999999999965433             123788899999999999999999998   999999999


Q ss_pred             CEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 040952          223 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  301 (411)
Q Consensus       223 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~  301 (411)
                      ||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999987654433333344568899999999999999999999999999999998 99998643322


Q ss_pred             ccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          302 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ..     ............     ..     ...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       258 ~~-----~~~~~~~~~~~~-----~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          258 EE-----FCRRLKEGTRMR-----AP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             HH-----HHHHHHHTCCCC-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH-----HHHHhccCccCC-----CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11     111111111100     01     11245689999999999999999999999999988754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.5e-45  Score=357.28  Aligned_cols=254  Identities=27%  Similarity=0.379  Sum_probs=206.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-ceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  167 (411)
                      ..++|++.+.||+|+||.||+|.++ |+.||||++....  ..+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999987 8899999997643  4568899999999999999999999987765 7899999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            999999999996532 234788899999999999999999998   999999999999999999999999999854321 


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                          .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......  ..   .. ...+.     ... 
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~---~~-i~~~~-----~~~-  406 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV---PR-VEKGY-----KMD-  406 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HH---HH-HHTTC-----CCC-
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---HH-HHcCC-----CCC-
Confidence                122356889999999999999999999999999999998 999986433211  11   11 11110     000 


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                          .+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       407 ----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          407 ----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                1112356789999999999999999999999999887653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.6e-45  Score=349.24  Aligned_cols=254  Identities=22%  Similarity=0.335  Sum_probs=203.2

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|... +|+.||||++...     .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999975 5899999998532     1224677899999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC---eEEeecCC
Q 040952          164 LIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGM  239 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfgl  239 (411)
                      +||||+++++|.+++.... ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987775432 2335789999999999999999999998   999999999999987655   99999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      +........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ........ ....
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~i~~-~~~~  250 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFEGIIK-GKYK  250 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HHHHHHHH-TCCC
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HHHHHHHc-CCCC
Confidence            987654322  22345799999999999999999999999999999999999999864221      11111111 1000


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                        ..+.     .....+..+.+++.+||+.||++|||+.|+++
T Consensus       251 --~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 --MNPR-----QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --CCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCcc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              0000     00112467899999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.3e-46  Score=347.24  Aligned_cols=263  Identities=22%  Similarity=0.301  Sum_probs=198.4

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce--
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK--  162 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--  162 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++....   ......+.+|+.++++++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999999964 58899999997642   23356788999999999999999999998876544  


Q ss_pred             --EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          163 --ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       163 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                        ++||||+++++|.+++...   ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence              9999999999999998543   34899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          241 RICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       241 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ......... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     .............
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~  238 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIP  238 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCCCCC
Confidence            876433211 2233457899999999999999999999999999999999999998643321     1111111111100


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHhhcccc
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV-SMLTNEAAA  370 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl-~~L~~~~~~  370 (411)
                          +    .......+..+.+++.+||+.||++||++.+++ +.|......
T Consensus       239 ----~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          239 ----P----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ----H----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ----c----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                0    000011256789999999999999999766655 555555443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.6e-45  Score=341.41  Aligned_cols=268  Identities=26%  Similarity=0.383  Sum_probs=201.3

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  159 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (411)
                      +....++|.+.+.||+|+||.||+|.+..    +..||+|.+...  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34456789999999999999999998642    458999998754  233456789999999999999999999999875


Q ss_pred             C-----ceEEEEeeCCCCCchhhhcCC---CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC
Q 040952          160 D-----EKILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  231 (411)
Q Consensus       160 ~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  231 (411)
                      +     ..++||||+++++|.+++...   .....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence            5     349999999999999988432   23355899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHH
Q 040952          232 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       232 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  310 (411)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......  .   ..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~---~~  260 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--M---YD  260 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H---HH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--H---HH
Confidence            99999999987654333233334467889999999999999999999999999999999 888876433211  1   11


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                      ... ....     ...     +...+..+.+++.+||+.||++|||+.++++.|+.+...++
T Consensus       261 ~~~-~~~~-----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          261 YLL-HGHR-----LKQ-----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHH-TTCC-----CCC-----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHH-cCCC-----CCC-----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            111 1110     000     11124578999999999999999999999999999877654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=349.23  Aligned_cols=278  Identities=13%  Similarity=0.130  Sum_probs=217.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC---------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccce---------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK---------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR---------  151 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  151 (411)
                      .++|++.+.||+|+||.||+|.+..         ++.||+|.+...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999763         789999998754     35789999999999999998         


Q ss_pred             ------eeeeeec-CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 040952          152 ------LLGCCID-KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  224 (411)
Q Consensus       152 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni  224 (411)
                            +++++.. .+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5666665 67889999999 999999996542 245899999999999999999999998   99999999999


Q ss_pred             EEcCCC--CeEEeecCCccccCCCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 040952          225 LLDKDM--NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  297 (411)
Q Consensus       225 ll~~~~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~  297 (411)
                      |++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999766432211     112334789999999999999999999999999999999999999865


Q ss_pred             CcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCC
Q 040952          298 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP  377 (411)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  377 (411)
                      ..................  ...........    ...+..+.+++.+||+.||++|||+.++++.|+++..........
T Consensus       271 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  344 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDK--PGPFVGPCGHW----IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD  344 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHS--CCCEECTTSCE----ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             CCcCHHHHHHHHHhccCC--hhhhhhhcccc----CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence            432222222221111111  11111111110    011456899999999999999999999999999999888877777


Q ss_pred             ceeeec
Q 040952          378 AFSFVR  383 (411)
Q Consensus       378 ~~~~~~  383 (411)
                      +.+|..
T Consensus       345 ~~dw~~  350 (352)
T 2jii_A          345 PIGLPM  350 (352)
T ss_dssp             CCCCCC
T ss_pred             cccCcC
Confidence            777754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3e-45  Score=352.50  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=207.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            3578999999999999999999976 588999999987655556678999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--CCCeEEeecCCccccCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGG  245 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~  245 (411)
                      |+++|+|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.  ++.+||+|||++.....
T Consensus       129 ~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          129 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999886432  34889999999999999999999998   999999999999974  57899999999987654


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|..||......     ...........  . .+..
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~i~~~~~--~-~~~~  272 (387)
T 1kob_A          204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ETLQNVKRCDW--E-FDED  272 (387)
T ss_dssp             TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHHCCC--C-CCSS
T ss_pred             Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCC--C-CCcc
Confidence            322   23347899999999999999999999999999999999999998643211     11111111100  0 0000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       273 -----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 -----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                 001124578999999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.1e-45  Score=339.21  Aligned_cols=263  Identities=23%  Similarity=0.335  Sum_probs=199.0

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||+|+||.||+|...+|+.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5789999999999999999999889999999986543  22346788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++ +|.+++....  ..+++.....++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            986 8888775432  34788899999999999999999998   9999999999999999999999999998764322 


Q ss_pred             ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc------cc--
Q 040952          249 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR------TL--  319 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~--  319 (411)
                       .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......  .............      ..  
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCChhhchhhhcc
Confidence             122334789999999998764 58999999999999999999999986533211  1111111100000      00  


Q ss_pred             ccccccccc------ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          320 ELIDPILED------EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       320 ~~~~~~l~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...++....      .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000000      00011124678899999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.3e-45  Score=332.59  Aligned_cols=257  Identities=28%  Similarity=0.401  Sum_probs=210.4

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.+.+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            467889999999999999999988888999999986543 3467899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........ 
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            9999999986532  34789999999999999999999998   99999999999999999999999999987543211 


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......     ........ ..     ..... 
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~i~~-~~-----~~~~~-  227 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDIST-GF-----RLYKP-  227 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHT-TC-----CCCCC-
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHHHHHhc-CC-----cCCCC-
Confidence            12223457788999999998999999999999999999999 89998643211     11111111 10     00001 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                          ...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          228 ----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                1124568899999999999999999999999998765

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.8e-45  Score=337.35  Aligned_cols=259  Identities=22%  Similarity=0.325  Sum_probs=197.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            35789999999999999999998643    4579999987643 334567899999999999999999999984 56789


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999999986432  34889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......  ..   .... .......  
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~---~~~i-~~~~~~~--  237 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DV---IGRI-ENGERLP--  237 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GH---HHHH-HTTCCCC--
T ss_pred             Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HH---HHHH-HcCCCCC--
Confidence            533221 1223456789999999999999999999999999999997 89998643321  11   1111 1111000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                         +     +...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       238 ---~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          238 ---M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ---C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               1     112246788999999999999999999999999887653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=348.34  Aligned_cols=267  Identities=18%  Similarity=0.199  Sum_probs=200.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec----CCCEEEEEEccCCCcc-----------cHHHHHHHHHHHHhcCCcccceeee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRSGQ-----------GLREMKNEASVIAKVQHKNLVRLLG  154 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  154 (411)
                      .++|.+.+.||+|+||.||+|.+.    .+..+|+|++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999975    4788999998765321           1223567888999999999999999


Q ss_pred             eeec----CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          155 CCID----KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       155 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                      ++..    ....++||||+ +++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    67889999999 999999986433   5899999999999999999999998   99999999999999887


Q ss_pred             --CeEEeecCCccccCCCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 040952          231 --NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL  303 (411)
Q Consensus       231 --~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  303 (411)
                        .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432111     112345799999999999999999999999999999999999999853222111


Q ss_pred             chhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          304 NLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ......... .     ..+...+.........+..+.+++.+||+.||++|||+.++++.|++...
T Consensus       269 ~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AVQTAKTNL-L-----DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHH-H-----HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHHhh-c-----ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            111111111 0     00111110000011225579999999999999999999999999998765

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-44  Score=332.43  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3467999999999999999999976 58999999986543 334567899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++...   ..+++.....++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999998543   34889999999999999999999998   999999999999999999999999999765433


Q ss_pred             CcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..........||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||............+.    .....   ..  
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~---~~--  229 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTY---LN--  229 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----TTCTT---ST--
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----hcccc---cC--
Confidence            32223344578999999999987665 7889999999999999999999865443222211111    10000   00  


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                 011124568899999999999999999999863

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.7e-44  Score=344.83  Aligned_cols=253  Identities=21%  Similarity=0.255  Sum_probs=194.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+++.. +|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            578999999999999999999976 589999999976433 235688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC--eEEeecCCccccCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFGMARICGGN  246 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfgl~~~~~~~  246 (411)
                      +++|+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999988543   34899999999999999999999998   999999999999987765  999999998753322


Q ss_pred             CcccccccccccccccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIK-SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                         .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ..............       .
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~-------~  240 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKY-------S  240 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCC-------C
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCC-------C
Confidence               12234579999999999988887665 899999999999999999986443221 11111111111100       0


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +..   ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       241 ~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 IPD---DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            000   00124568899999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-45  Score=354.33  Aligned_cols=270  Identities=17%  Similarity=0.232  Sum_probs=204.5

Q ss_pred             HhcCCCccCccccc--CcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           89 ATNKFSDANKLGEG--GFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ..++|++.+.||+|  +||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35789999999999  99999999976 59999999997542  334567888999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||.+...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999865422 34889999999999999999999998   999999999999999999999999988654


Q ss_pred             CCCC-----cccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh--
Q 040952          244 GGNE-----LQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT--  314 (411)
Q Consensus       244 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  314 (411)
                      ....     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........... .......  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~  257 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCL  257 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C--------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCcc
Confidence            2211     1111223478999999999987  5799999999999999999999999865332211100 0000000  


Q ss_pred             -------cCc-------------ccccccc--------ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          315 -------SNR-------------TLELIDP--------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       315 -------~~~-------------~~~~~~~--------~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                             ...             ..+....        ...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                   000             0000000        000000112235678999999999999999999999965

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.7e-45  Score=344.51  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=203.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++...   .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367899999999999999999976 4889999999754   233456688999999988 89999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999988543   34899999999999999999999998   9999999999999999999999999997643


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc---cchhHHHHHHhhcCccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ................   
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  236 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  236 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence            221  22344689999999999999999999999999999999999999996432111   0111111111111111   


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTM------NDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~~  363 (411)
                         .+.     ...+..+.+++.+||+.||++||++      .|+++.
T Consensus       237 ---~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          237 ---RIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ---CCC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ---CCC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence               011     1125578999999999999999995      666643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.9e-45  Score=336.59  Aligned_cols=261  Identities=28%  Similarity=0.421  Sum_probs=213.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ...++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            446789999999999999999999775 8889999997543 34577899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++.... ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999986533 345899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......  ..    .......     ...
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~----~~~~~~~-----~~~  232 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY----ELLEKDY-----RME  232 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH----HHHHTTC-----CCC
T ss_pred             cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHhccC-----CCC
Confidence            32 22233467889999999999999999999999999999999 999986433211  11    1111110     000


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .     +...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       233 ~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          233 R-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            0     111245789999999999999999999999999877553

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-45  Score=348.71  Aligned_cols=246  Identities=23%  Similarity=0.289  Sum_probs=204.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999976 58999999986432   23456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999998643   34889999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......... ...      .
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~-~~~------~  256 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKIVS-GKV------R  256 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH-CCC------C
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHHHHHc-CCC------C
Confidence            2     2345799999999999999999999999999999999999999864321     111111111 110      0


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                      +.     ...+..+.+++.+||+.||++||+     +.++++.
T Consensus       257 ~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          257 FP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC-----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            11     112456899999999999999998     8888764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-44  Score=341.61  Aligned_cols=274  Identities=23%  Similarity=0.299  Sum_probs=214.4

Q ss_pred             cchhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHh--cCCcccceeeeeeec
Q 040952           81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCID  158 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~  158 (411)
                      .+........++|++.+.||+|+||.||+|.++ |+.||||++...   ....+.+|.+++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            444445566789999999999999999999985 899999999643   34567889999988  799999999999988


Q ss_pred             CC----ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCEEE
Q 040952          159 KD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--------QYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       159 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlkp~Nill  226 (411)
                      ..    ..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||        +.+   |+||||||+|||+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            76    78999999999999999854    24889999999999999999999        666   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCccc--ccccccccccccChhhhccC------CCCcchhhHHHHHHHHHHHhC-------
Q 040952          227 DKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG-------  291 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg-------  291 (411)
                      +.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999997765432211  22345789999999998765      234789999999999999999       


Q ss_pred             ---CCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          292 ---KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       292 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                         ..||............+... ...    ....+.+.........+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKV-VCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHH-HTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCccccCcCcccHHHHHHH-HHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence               55664433222222211111 111    1122222222333455778999999999999999999999999999886


Q ss_pred             cc
Q 040952          369 AA  370 (411)
Q Consensus       369 ~~  370 (411)
                      ..
T Consensus       336 ~~  337 (342)
T 1b6c_B          336 QQ  337 (342)
T ss_dssp             HT
T ss_pred             HH
Confidence            64

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.8e-46  Score=350.62  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=202.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCce
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (411)
                      ...++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999976 48899999997532   23456778899999887 999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      |+||||+++|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999998543   34889999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......     ........ ..     
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~~-~~-----  234 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----ELFHSIRM-DN-----  234 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH-CC-----
T ss_pred             cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHh-CC-----
Confidence            43222  2234568999999999999999999999999999999999999998643211     11111111 11     


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMN-DVVS  362 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  362 (411)
                       ..+.     ...+..+.+++.+||+.||++||++. ++++
T Consensus       235 -~~~p-----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 -PFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -CCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCCC-----cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence             0111     11245788999999999999999997 6653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.9e-45  Score=339.95  Aligned_cols=272  Identities=21%  Similarity=0.328  Sum_probs=203.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3467999999999999999999964 5899999998753   23345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          165 IYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999988542 12345889999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      .....  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......   ........ .......   
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~---  257 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-EQCDYPP---  257 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHH-HTTCSCC---
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHh-hcccCCC---
Confidence            43221  123346899999999999999999999999999999999999998543221   11111111 1111110   


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA  378 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~  378 (411)
                        ..    ....+..+.+++.+||+.||++|||+.++++.|+++.+...+|.+..
T Consensus       258 --~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~~  306 (310)
T 2wqm_A          258 --LP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHH  306 (310)
T ss_dssp             --CC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred             --Cc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhhh
Confidence              00    11124568999999999999999999999999999999888776643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-45  Score=345.69  Aligned_cols=265  Identities=26%  Similarity=0.369  Sum_probs=211.2

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeec
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  158 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (411)
                      ....++|++.+.||+|+||.||+|.+..      +..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999999653      2479999997653 33456789999999999 89999999999999


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCCC-----------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPTK-----------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                      .+..++||||+++|+|.+++.....           ...+++..++.++.|++.||.|||+++   |+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence            9999999999999999999864221           235788999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchh
Q 040952          228 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLL  306 (411)
Q Consensus       228 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  306 (411)
                      .++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||++ |..||.......    
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  274 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----  274 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH----
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH----
Confidence            999999999999986543332222334567889999999999999999999999999999999 888886433211    


Q ss_pred             HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                       ..........     .....     ...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       275 -~~~~~~~~~~-----~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          275 -KFYKLVKDGY-----QMAQP-----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             -HHHHHHHHTC-----CCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHhcCC-----CCCCC-----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence             1111111110     00000     1114568899999999999999999999999987754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.2e-45  Score=358.06  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=207.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999976 59999999986532   23356789999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999998543   34899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ..   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......     ...... ..+.. .    
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~~i-~~~~~-~----  234 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFKKI-CDGIF-Y----  234 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHHHH-HTTCC-C----
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHHHH-hcCCc-C----
Confidence            32   2234579999999999988765 78999999999999999999998643211     111111 11110 0    


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhhccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS--MLTNEAA  369 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~  369 (411)
                            .+...+..+.+++.+||+.||++|||+.|+++  .+....+
T Consensus       235 ------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          235 ------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             ------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence                  01112456889999999999999999999997  3554433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-44  Score=340.10  Aligned_cols=266  Identities=24%  Similarity=0.357  Sum_probs=189.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999965 48999999987543 2334678899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCC---CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          168 YMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       168 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      |++ |+|.+++...   .....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5888877532   12234888999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--ccc--
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--RTL--  319 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~--  319 (411)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  ............  ...  
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCTTTCGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHhhh
Confidence            322  12234578999999999876 468999999999999999999999986543211  111111110000  000  


Q ss_pred             ----ccccccccc-----------ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          320 ----ELIDPILED-----------EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       320 ----~~~~~~l~~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ....+.+..           .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                000000000           00001124578999999999999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.1e-45  Score=355.60  Aligned_cols=261  Identities=20%  Similarity=0.232  Sum_probs=205.6

Q ss_pred             hhhHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           85 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      ......++|++.+.||+|+||+||+|++.. ++.||+|++....   ......+.+|..++..++||||++++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            344456889999999999999999999775 7889999986421   122334789999999999999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..++||||+++|+|..++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999996532  34899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                      +....... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||......     .........
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~~~  296 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNH  296 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTH
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----HHHHhhhhc
Confidence            77643322 2223458999999999987     567899999999999999999999998643211     111111110


Q ss_pred             CccccccccccccccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040952          316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNDVVSM  363 (411)
Q Consensus       316 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  363 (411)
                      ......  +   ..  ....+..+.+|+.+||+.+|++  ||++.|+++.
T Consensus       297 ~~~~~~--p---~~--~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          297 KERFQF--P---TQ--VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHCCC--C---SS--CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cccccC--C---cc--cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            000000  0   00  0012456889999999888888  9999999974

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-44  Score=332.91  Aligned_cols=263  Identities=31%  Similarity=0.448  Sum_probs=210.4

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..++|++.+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            357899999999999999999998888899999997543 345788999999999999999999999864 568999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            99999999985432 125889999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......     ...... ....     .... 
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~-~~~~-----~~~~-  231 (279)
T 1qpc_A          165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNL-ERGY-----RMVR-  231 (279)
T ss_dssp             E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHH-HTTC-----CCCC-
T ss_pred             c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHHHH-hccc-----CCCC-
Confidence            1 2223456789999999998899999999999999999999 89888643211     111111 1110     0011 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCC
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP  374 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  374 (411)
                          +...+..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus       232 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  274 (279)
T 1qpc_A          232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ  274 (279)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred             ----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence                1112457899999999999999999999999999887654433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=349.57  Aligned_cols=274  Identities=21%  Similarity=0.304  Sum_probs=215.1

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC--ceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  164 (411)
                      ..++|.+.+.||+|+||.||+|.+.. |+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            35789999999999999999999764 8999999997543 334567889999999999999999999998765  6799


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCCeEEeecCCc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMA  240 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfgl~  240 (411)
                      ||||+++|+|.+++........+++..++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999976555555899999999999999999999998   9999999999999    77888999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhcc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALE--------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      +......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......... .......
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~  239 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKI  239 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHH
Confidence            8765322   2234579999999998865        56788999999999999999999998654432211 1122222


Q ss_pred             hhcCcc--cccc----------ccccc-cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          313 WTSNRT--LELI----------DPILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       313 ~~~~~~--~~~~----------~~~l~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ......  ....          ...+. ...........+.+++.+||+.||++|||+.++++.+..+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            211110  0000          00000 111234567889999999999999999999999999987755

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=343.50  Aligned_cols=269  Identities=22%  Similarity=0.247  Sum_probs=208.1

Q ss_pred             HhcCCCccCcccccCcccEEEEEe-cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec----CCceE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  163 (411)
                      ..++|++.+.||+|+||.||++.. .+|+.||||++........+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            357899999999999999999997 4589999999876666667789999999999999999999999873    34778


Q ss_pred             EEEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          164 LIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      +||||+++|+|.+++... .....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999988642 12345899999999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCccc-------ccccccccccccChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          243 CGGNELQA-------NTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       243 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      ........       ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||.............    
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----  259 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA----  259 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----
Confidence            43211100       012245799999999987554   6899999999999999999999974321111111100    


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCC
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP  374 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  374 (411)
                      ....     ..  .   ......+..+.+++.+||+.||++|||+.++++.|+.+.+..+++
T Consensus       260 ~~~~-----~~--~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          260 VQNQ-----LS--I---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             HHCC---------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             hhcc-----CC--C---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence            0000     00  0   001112457899999999999999999999999999887654443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=334.58  Aligned_cols=267  Identities=25%  Similarity=0.368  Sum_probs=212.5

Q ss_pred             hcCCCccC-cccccCcccEEEEEec---CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||||++.... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35566666 8999999999999854   47789999998653 34567789999999999999999999999 5567899


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++...  +..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            99999999999998643  344899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          245 GNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       245 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  .   .. ........    
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~---~~-~~i~~~~~----  231 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--E---VM-AFIEQGKR----  231 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--H---HH-HHHHTTCC----
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--H---HH-HHHhcCCc----
Confidence            33221 12233456889999999998899999999999999999998 99998643321  1   11 11111110    


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA  378 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~  378 (411)
                       ....     ...+..+.+++.+||+.+|++|||+.++++.|..+......+..++
T Consensus       232 -~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~  281 (287)
T 1u59_A          232 -MECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH  281 (287)
T ss_dssp             -CCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             -CCCC-----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence             0111     1225678999999999999999999999999999877665555443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-44  Score=348.36  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=197.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcC--CcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|+.++++++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4569999999999999999999888999999998654  3344577899999999996  59999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      || +.+++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++....
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 67889999986533   4788889999999999999999998   99999999999995 58999999999987654


Q ss_pred             CCcccccccccccccccChhhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh
Q 040952          246 NELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      ..........+||+.|+|||++.+           ..++.++|||||||++|||++|+.||......    .........
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~~~~~  282 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAIID  282 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHHC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----HHHHHHHhC
Confidence            332222344579999999999865           46899999999999999999999998643211    111111111


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ......     .....     +..+.+++.+||+.||++|||+.|+++.
T Consensus       283 ~~~~~~-----~~~~~-----~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PNHEIE-----FPDIP-----EKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TTSCCC-----CCCCS-----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCC-----CCccc-----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111000     01111     3468899999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=340.37  Aligned_cols=260  Identities=28%  Similarity=0.424  Sum_probs=202.3

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.+..     +..||||.+.... ......+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4678888999999999999998653     2359999997543 334557889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus       123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999986532  34889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          244 GGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       244 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......     ..... .......  
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~~-~~~~~~~--  269 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKA-INDGFRL--  269 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH-HHTTCCC--
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----HHHHH-HHCCCcC--
Confidence            533211 11222356788999999999999999999999999999999 99998543211     11111 1111000  


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                         ..     +...+..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus       270 ---~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          270 ---PT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             ---CC-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---CC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               00     111245689999999999999999999999999887654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=344.92  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=190.9

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ....++|++.+.||+|+||.||+|.+.. ++.||||++....  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3456789999999999999999999764 8899999997543  335678999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCCccc
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARI  242 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl~~~  242 (411)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++.
T Consensus       127 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999998543   34889999999999999999999998   999999999999975   88999999999986


Q ss_pred             cCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........     ....+..... ...
T Consensus       201 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~-~~~  271 (349)
T 2w4o_A          201 VEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEY-YFI  271 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCC-CCC
T ss_pred             cCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCC-ccC
Confidence            54322   12345789999999999999999999999999999999999999864332211     1111111110 000


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+.      ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       272 ~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          272 SPW------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTT------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Cch------hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            110      01124578899999999999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-44  Score=342.10  Aligned_cols=264  Identities=20%  Similarity=0.223  Sum_probs=202.7

Q ss_pred             hhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCcccceeeeeee
Q 040952           84 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCI  157 (411)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  157 (411)
                      .++....++|++.+.||+|+||.||+|... +++.||+|++...     .....+.+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            345667789999999999999999999975 4889999998643     3345678999999999999999999999999


Q ss_pred             cCCceEEEEeeCCCCCchhhhcCCC-------------------------------------CCcCCCHHHHHHHHHHHH
Q 040952          158 DKDEKILIYEYMPNKSLDFFLFDPT-------------------------------------KRMLLDWVTRVQIIEGIA  200 (411)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~  200 (411)
                      +.+..++||||+++|+|.+++....                                     ....+++..+..++.|++
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            9999999999999999999884210                                     012235667788999999


Q ss_pred             HHHHHHhhcCCCCeeecCCCCCCEEEcCCC--CeEEeecCCccccCCCC--cccccccccccccccChhhhcc--CCCCc
Q 040952          201 QGLLYLHQYSRVRIIHRDLKASNILLDKDM--NPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEYALE--GIFSI  274 (411)
Q Consensus       201 ~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfgl~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~  274 (411)
                      .||+|||+.+   |+||||||+|||++.++  .+||+|||++.......  .........||+.|+|||++.+  ..++.
T Consensus       179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999998   99999999999998776  89999999998653221  1112334579999999999875  67899


Q ss_pred             chhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCC
Q 040952          275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR  354 (411)
Q Consensus       275 ~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~R  354 (411)
                      ++|||||||++|||++|+.||......     ............  ...+      .....+..+.+++.+||+.||++|
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~--~~~~------~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDA-----DTISQVLNKKLC--FENP------NYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCC--TTSG------GGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcccc--cCCc------ccccCCHHHHHHHHHHcCCChhHC
Confidence            999999999999999999998643321     111111111110  0000      011124578999999999999999


Q ss_pred             CCHHHHHHH
Q 040952          355 PTMNDVVSM  363 (411)
Q Consensus       355 Pt~~evl~~  363 (411)
                      ||+.++++.
T Consensus       323 ps~~~~l~h  331 (345)
T 3hko_A          323 FDAMRALQH  331 (345)
T ss_dssp             CCHHHHHHS
T ss_pred             CCHHHHhcC
Confidence            999999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-44  Score=333.50  Aligned_cols=252  Identities=19%  Similarity=0.257  Sum_probs=204.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ...++|++.+.||+|+||.||+|.+.. +..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            346789999999999999999999764 7799999998765566788999999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCCeEEeecCCcccc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  243 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfgl~~~~  243 (411)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+++   ++||||||+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999998888543   34889999999999999999999998   9999999999999   78899999999999876


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....   ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......     ........ ... ....
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~-~~~~  228 (277)
T 3f3z_A          160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVMLKIRE-GTF-TFPE  228 (277)
T ss_dssp             CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH-CCC-CCCH
T ss_pred             cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHh-CCC-CCCc
Confidence            5332   22335789999999988654 899999999999999999999998643321     11111111 100 0000


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .      .....+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 K------DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             H------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             h------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0      00012467899999999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-44  Score=330.29  Aligned_cols=255  Identities=22%  Similarity=0.349  Sum_probs=205.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC--CceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|+++ |+.||||++....  ....+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            467999999999999999999986 8899999997653  34456789999999999999999999999887  788999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ .+++||||||+||+++.++.++|+|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            99999999999997543 235899999999999999999999865 349999999999999999999999998865432 


Q ss_pred             CCcccccccccccccccChhhhccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                            .....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||......     ...........     
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-----  228 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIGMKVALEGL-----  228 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----HHHHHHHHSCC-----
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----HHHHHHHhcCC-----
Confidence                  12346899999999998765544   799999999999999999998643211     11111111111     


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      .+.+..     ..+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       229 ~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 RPTIPP-----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111111     124568999999999999999999999999988753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=347.52  Aligned_cols=274  Identities=23%  Similarity=0.239  Sum_probs=197.9

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-Ccccceeeeeee------
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCI------  157 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~------  157 (411)
                      +.....+|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.++.++. ||||+++++++.      
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3444578999999999999999999975 58999999987666666678899999999996 999999999984      


Q ss_pred             --cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          158 --DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       158 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                        .....++||||+. |+|.+++........+++..++.++.|++.||.|||+++ ++|+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence              3345789999996 688888765334456899999999999999999999875 249999999999999999999999


Q ss_pred             ecCCccccCCCCccc----------ccccccccccccChhhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 040952          236 DFGMARICGGNELQA----------NTSRIVGTYGYMSPEYA---LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  302 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  302 (411)
                      |||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            999998765322111          11134689999999998   56678999999999999999999999985322110


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCcee
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS  380 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~  380 (411)
                           .    ...     ........     ..+..+.+++.+||+.||++|||+.|+++.|..+.........++..
T Consensus       261 -----~----~~~-----~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~  319 (337)
T 3ll6_A          261 -----I----VNG-----KYSIPPHD-----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT  319 (337)
T ss_dssp             -------------------CCCCTTC-----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCH
T ss_pred             -----h----hcC-----cccCCccc-----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHH
Confidence                 0    000     00000000     11234788999999999999999999999999987765544444433

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.1e-45  Score=343.37  Aligned_cols=249  Identities=23%  Similarity=0.289  Sum_probs=193.9

Q ss_pred             hcCCCccCcccccCcccEEEEEe----cCCCEEEEEEccCCC----cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL----KKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      .++|++.+.||+|+||.||+++.    .+|+.||+|++....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999996    468999999997542    2334567889999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+++++|.+++...   ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999998543   34788899999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     .......... .   
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~-~---  238 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----KTIDKILKCK-L---  238 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHTC-C---
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhCC-C---
Confidence            543221  1223457999999999999999999999999999999999999998643211     1111111110 0   


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                         .+.     ...+..+.+++.+||+.||++||     ++.|+++.
T Consensus       239 ---~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 ---NLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ---CCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ---CCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence               011     11245789999999999999999     77888764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=348.73  Aligned_cols=246  Identities=25%  Similarity=0.313  Sum_probs=196.1

Q ss_pred             cCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           96 ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      .+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999965 5899999999876656667899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE--cCCCCeEEeecCCccccCCCCccccc
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNPKISDFGMARICGGNELQANT  252 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~~~  252 (411)
                      .+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.......   .
T Consensus       174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~  245 (373)
T 2x4f_A          174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L  245 (373)
T ss_dssp             HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence            88885432  34889999999999999999999998   9999999999999  5678899999999987653322   2


Q ss_pred             ccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccch
Q 040952          253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS  332 (411)
Q Consensus       253 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  332 (411)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...........  ......      .
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~~~~--~~~~~~------~  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-----ETLNNILACRW--DLEDEE------F  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCC--CSCSGG------G
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhccC--CCChhh------h
Confidence            3347999999999999999999999999999999999999998643311     11111111110  000000      0


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          333 KHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       333 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            112467899999999999999999999997

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.1e-45  Score=340.40  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=199.1

Q ss_pred             hcCCCcc-CcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .+.|.+. +.||+|+||.||+|... +|+.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678874 78999999999999965 5899999999876656677899999999995 7999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC---eEEeecCCcccc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARIC  243 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfgl~~~~  243 (411)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999998543   34889999999999999999999998   999999999999998776   999999998765


Q ss_pred             CCCCc-----ccccccccccccccChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch--------
Q 040952          244 GGNEL-----QANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL--------  305 (411)
Q Consensus       244 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------  305 (411)
                      .....     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||..........        
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211     111223468999999999875     558899999999999999999999987543221100        


Q ss_pred             -hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          306 -LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       306 -~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       ............. .....      .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~~~i~~~~~-~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGKY-EFPDK------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCCC-CCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccCc-ccCch------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             0001111111100 00000      001124678999999999999999999999984

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=341.00  Aligned_cols=247  Identities=23%  Similarity=0.260  Sum_probs=192.4

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (411)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||++....  .........|+..+.++ +||||+++++++.+.+..+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            34578999999999999999999976 59999999986542  22333455566666555 9999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+ +++|..++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       134 lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            999999 668877775432  34899999999999999999999998   999999999999999999999999998776


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....         .+.......    ..
T Consensus       208 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~----~~  270 (311)
T 3p1a_A          208 GTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGY----LP  270 (311)
T ss_dssp             C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTC----CC
T ss_pred             ccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccC----CC
Confidence            4322   2233568999999998876 79999999999999999999976643211         011111110    00


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +.+     ....+..+.+++.+||+.||++|||+.|+++
T Consensus       271 ~~~-----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 PEF-----TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            111     1112567899999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=335.61  Aligned_cols=266  Identities=24%  Similarity=0.328  Sum_probs=197.9

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-----cccHHHHHHHHHHHHhc---CCcccceeeeeeec
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQGLREMKNEASVIAKV---QHKNLVRLLGCCID  158 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~  158 (411)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++....     ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34689999999999999999999964 58999999986432     11234566777777766   49999999999987


Q ss_pred             CC-----ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeE
Q 040952          159 KD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  233 (411)
Q Consensus       159 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  233 (411)
                      ..     ..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     4789999997 599888865432 34899999999999999999999998   99999999999999999999


Q ss_pred             EeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          234 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .........
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~  235 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLI  235 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHH
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence            99999998764322   2234578999999999999999999999999999999999999986433211  111111111


Q ss_pred             hcC---ccc---cccccccccc--c----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          314 TSN---RTL---ELIDPILEDE--Y----SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       314 ~~~---~~~---~~~~~~l~~~--~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...   ...   ..........  .    .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000   000   0000000000  0    001124678999999999999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.6e-45  Score=350.85  Aligned_cols=266  Identities=24%  Similarity=0.336  Sum_probs=192.3

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcC-CcccceeeeeeecCC--c
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD--E  161 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  161 (411)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            44678999999999999999999965 5899999998643  3344567889999999997 999999999997544  6


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .|+||||++ ++|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 588888753    34888899999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCC-------------------cccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccc
Q 040952          242 ICGGNE-------------------LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  301 (411)
Q Consensus       242 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~  301 (411)
                      ......                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            653211                   0111234579999999999886 67899999999999999999999999654321


Q ss_pred             ccchhHHHHHHhhcCccc-----------c--------------ccccccc-------cccchHHHHHHHHHHHHHcccc
Q 040952          302 SLNLLGYAWDLWTSNRTL-----------E--------------LIDPILE-------DEYSSKHMLLRYVNIALLCVQE  349 (411)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~-----------~--------------~~~~~l~-------~~~~~~~~~~~l~~li~~cl~~  349 (411)
                      .  ...........+...           .              .......       ........+..+.+|+.+||+.
T Consensus       238 ~--~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          238 N--QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             H--HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             H--HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            1  111111110000000           0              0000000       0000002245789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 040952          350 SADDRPTMNDVVSM  363 (411)
Q Consensus       350 ~p~~RPt~~evl~~  363 (411)
                      ||++|||+.|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=345.43  Aligned_cols=268  Identities=25%  Similarity=0.365  Sum_probs=198.5

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHH--HHhcCCcccceeeeeeec-----CCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLGCCID-----KDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~  162 (411)
                      .++|++.+.||+|+||.||+|+.. ++.||||++.....   ..+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            478999999999999999999874 89999999975432   334444444  445899999999985432     3356


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeeecCCCCCCEEEcCCCCeE
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY---------SRVRIIHRDLKASNILLDKDMNPK  233 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------~~~~ivH~dlkp~Nill~~~~~~k  233 (411)
                      ++||||+++|+|.+++...    ..++.....++.|++.||.|||+.         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            8999999999999998543    248888999999999999999998         6   99999999999999999999


Q ss_pred             EeecCCccccCCCCc------ccccccccccccccChhhhcc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 040952          234 ISDFGMARICGGNEL------QANTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  300 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~p~~~~~~  300 (411)
                      |+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653221      112223579999999999886       4567889999999999999999877643322


Q ss_pred             cccchhHH------------HHHHhhcCccccccccccccc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          301 DSLNLLGY------------AWDLWTSNRTLELIDPILEDE-YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       301 ~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                      .......+            .........    ..+.+... ......+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            11100000            000111111    11111111 11223467899999999999999999999999999998


Q ss_pred             ccccC
Q 040952          368 AAALL  372 (411)
Q Consensus       368 ~~~~~  372 (411)
                      ...+.
T Consensus       317 l~~~~  321 (336)
T 3g2f_A          317 MMIWE  321 (336)
T ss_dssp             HHCCC
T ss_pred             HHHHH
Confidence            87544

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=347.57  Aligned_cols=259  Identities=13%  Similarity=0.111  Sum_probs=207.9

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEE------ecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---Ccccceeeeee
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGV------LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCC  156 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~  156 (411)
                      .....++|.+.+.||+|+||.||+|.      ..+++.||||++....   ...+..|+.++..++   |+||+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            34456789999999999999999994      3458899999997643   346778888888886   99999999999


Q ss_pred             ecCCceEEEEeeCCCCCchhhhcCC--CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC------
Q 040952          157 IDKDEKILIYEYMPNKSLDFFLFDP--TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK------  228 (411)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~------  228 (411)
                      ...+..++||||+++|+|.+++...  .....+++..++.++.|++.||+|||+++   |+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence            9999999999999999999998642  12345899999999999999999999988   999999999999998      


Q ss_pred             -----CCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 040952          229 -----DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL  303 (411)
Q Consensus       229 -----~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  303 (411)
                           ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                 89999999999976543222333445679999999999999999999999999999999999999974221110 


Q ss_pred             chhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhhccccc
Q 040952          304 NLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR-PTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~~~~~~  371 (411)
                                      ..+...+....    ....+.+++..|++.+|.+| |++.++.+.|++.....
T Consensus       293 ----------------~~~~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 ----------------CKPEGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------------EEECSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------eeechhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                            00111111111    14567889999999999999 67888888888776653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6e-45  Score=352.48  Aligned_cols=257  Identities=21%  Similarity=0.249  Sum_probs=204.9

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      +....++|++.+.||+|+||.||+|+... |+.||+|++...   .....+.+.+|..+++.++||||+++++++.+.+.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            44456789999999999999999999764 889999998642   11223457899999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .|+||||+++|+|.+++...    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            99999999999999998542    3788899999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      ....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......     ...........
T Consensus       217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~~~~  290 (410)
T 3v8s_A          217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMNHKN  290 (410)
T ss_dssp             ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTHHH
T ss_pred             eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-----hHHHHHHhccc
Confidence            7654322 1233568999999999998665    889999999999999999999998643211     11111111000


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNDVVSM  363 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  363 (411)
                      .....     .   ....+..+.+|+.+||+.+|.+  ||++.|+++.
T Consensus       291 ~~~~p-----~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          291 SLTFP-----D---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HCCCC-----T---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cccCC-----C---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00000     0   0012467899999999999988  9999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.5e-45  Score=347.15  Aligned_cols=249  Identities=26%  Similarity=0.304  Sum_probs=203.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|+... |+.||+|++...   .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4789999999999999999999765 789999998753   223456788999999987 89999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999998543   34889999999999999999999998   9999999999999999999999999997643


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......... ..      
T Consensus       173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~-~~------  238 (353)
T 2i0e_A          173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSIMEH-NV------  238 (353)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHC-CC------
T ss_pred             cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-----HHHHHHHhC-CC------
Confidence            221  2234468999999999999999999999999999999999999998643211     111111111 10      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                      .+     +...+..+.+++.+||+.||++||+     +.++++.
T Consensus       239 ~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 AY-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CC-----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CC-----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            00     1122567899999999999999995     5777754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-44  Score=333.67  Aligned_cols=263  Identities=26%  Similarity=0.369  Sum_probs=204.8

Q ss_pred             hcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeee-cCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCI-DKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~  163 (411)
                      ..+|++.+.||+|+||.||+|.+.+    +..+|+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4678889999999999999998643    2358999987543 344567899999999999999999999865 456789


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus       104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999999999996533  34788899999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc--cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          244 GGNELQ--ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       244 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......  ..   ........   
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~---~~~~~~~~---  250 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--IT---VYLLQGRR---  250 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HH---HHHHTTCC---
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HH---HHHhcCCC---
Confidence            533221  12233467889999999999999999999999999999999 555554322211  11   11111100   


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCC
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP  373 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  373 (411)
                         ...     +...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus       251 ---~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          251 ---LLQ-----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             ---CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             ---CCC-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence               000     111245689999999999999999999999999998776544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=344.31  Aligned_cols=244  Identities=24%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--------ccHHHHHHHHHHHHhcCCcccceeeeeeec
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCID  158 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (411)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++.....        .....+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            45678999999999999999999965 588999999875421        123356789999999999999999999999


Q ss_pred             CCceEEEEeeCCCC-CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          159 KDEKILIYEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       159 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                      .+..++||||+.+| +|..++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999777 999988543   34899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  316 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  316 (411)
                      |++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......               
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------  236 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------  236 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence            99987654322   234579999999999988776 88999999999999999999998532110               


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           .......   +...+..+.+++.+||+.||++|||+.++++.
T Consensus       237 -----~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----VEAAIHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----HhhccCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000000   00124568999999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-44  Score=332.23  Aligned_cols=265  Identities=25%  Similarity=0.321  Sum_probs=206.9

Q ss_pred             cCCCccCcccccCcccEEEEEecC-C---CEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce-EE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-G---DEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK-IL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l  164 (411)
                      ..|...+.||+|+||.||+|.+.+ +   ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            346667899999999999998543 2   379999987543 34457789999999999999999999999876665 99


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+.+++|.+++....  ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus       101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999986533  34788899999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCc--ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          245 GNEL--QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       245 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ....  ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ......    .........  
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~----~~~~~~~~~--  248 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTH----FLAQGRRLP--  248 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHH----HHHTTCCCC--
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHH----HhhcCCCCC--
Confidence            3221  1122335678999999999999999999999999999999996655322111 111111    111111000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCC
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPK  375 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~  375 (411)
                              .+...+..+.+++.+||+.||++|||+.++++.|+++...+....
T Consensus       249 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          249 --------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             --------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence                    011124568999999999999999999999999999887765443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-44  Score=344.78  Aligned_cols=213  Identities=29%  Similarity=0.350  Sum_probs=183.4

Q ss_pred             CCCCCcchhhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----Cccc
Q 040952           76 DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----HKNL  149 (411)
Q Consensus        76 ~~l~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni  149 (411)
                      +....+++.......++|.+.+.||+|+||.||+|.+. +++.||||++... ......+..|+.+++.++     ||||
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            33445666667777899999999999999999999975 5889999999743 334456788999999996     9999


Q ss_pred             ceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-
Q 040952          150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-  228 (411)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-  228 (411)
                      +++++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++   |+||||||+|||++. 
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP  173 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence            99999999999999999999 8999999865432 34888999999999999999999998   999999999999975 


Q ss_pred             ------------------------CCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHH
Q 040952          229 ------------------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVL  284 (411)
Q Consensus       229 ------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i  284 (411)
                                              ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    789999999999864422     234578999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCc
Q 040952          285 LLEIVSGKKNTGLYR  299 (411)
Q Consensus       285 l~elltg~~p~~~~~  299 (411)
                      +|+|++|+.||....
T Consensus       249 l~ell~g~~pf~~~~  263 (360)
T 3llt_A          249 LAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHSSCSCCCSS
T ss_pred             HHHHHHCCCCCCCCc
Confidence            999999999996543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=339.10  Aligned_cols=266  Identities=26%  Similarity=0.393  Sum_probs=209.4

Q ss_pred             hcCCCccCcccccCcccEEEEEe-----cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCC--ce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  162 (411)
                      .++|++.+.||+|+||.||+|.+     .+|+.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46789999999999999999984     358899999998776666778999999999999999999999987654  78


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999999986543  34889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc---------c-hhHHHHH
Q 040952          243 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---------N-LLGYAWD  311 (411)
Q Consensus       243 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---------~-~~~~~~~  311 (411)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+........         . .......
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            6543221 112234567889999999998899999999999999999999988653210000         0 0000001


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .......     .     ..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       275 ~~~~~~~-----~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          275 LLKNNGR-----L-----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHTTCC-----C-----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhhcCCC-----C-----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1111000     0     01112356789999999999999999999999999987654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.9e-44  Score=337.87  Aligned_cols=262  Identities=30%  Similarity=0.407  Sum_probs=205.2

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|.+.      +++.||||.+... .......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            578999999999999999999842      3778999999754 334456788999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCC----CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEe
Q 040952          163 ILIYEYMPNKSLDFFLFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKIS  235 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~  235 (411)
                      ++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+++   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999865432    244888999999999999999999998   999999999999984   4569999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhh
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      |||++................||+.|+|||.+.+..++.++|||||||++|+|++ |..||......     ... ....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~-~~~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVL-EFVT  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHH-HHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----HHH-HHHh
Confidence            9999976543333333344567899999999999999999999999999999998 88888643211     111 1111


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ......     .     +...+..+.+++.+||+.||++|||+.++++.|......
T Consensus       260 ~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          260 SGGRMD-----P-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             TTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCC-----C-----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            111000     0     111245688999999999999999999999999877553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.4e-44  Score=335.98  Aligned_cols=263  Identities=24%  Similarity=0.317  Sum_probs=207.4

Q ss_pred             cchhhhhHHhcCCCcc-CcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCcccceeeee
Q 040952           81 FSFSSVSTATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGC  155 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  155 (411)
                      ..+.......++|.+. +.||+|+||.||+|... +|+.||+|++...  .......+.+|+.++..+ .||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4456667778888887 89999999999999976 4899999998754  233467889999999999 56999999999


Q ss_pred             eecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCe
Q 040952          156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNP  232 (411)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~  232 (411)
                      +.+.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999999985432 245899999999999999999999998   999999999999988   7899


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      ||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     .....
T Consensus       174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i  245 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TYLNI  245 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH
T ss_pred             EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHH
Confidence            999999998764322   1233579999999999999999999999999999999999999986433211     11111


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....  .......      ....+..+.+++.+||+.||++|||+.++++.
T Consensus       246 ~~~~--~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQVN--VDYSEET------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHTC--CCCCTTT------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hhcc--cccCchh------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            1000  0000000      01124568899999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=336.11  Aligned_cols=266  Identities=22%  Similarity=0.275  Sum_probs=198.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .++|++.+.||+|+||.||+|.+.. |+.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3679999999999999999999764 89999999865432  23466789999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|..++...   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999999887543   34889999999999999999999998   999999999999999999999999999876532


Q ss_pred             CcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchh---------HHHHHHhhcC
Q 040952          247 ELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWTSN  316 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---------~~~~~~~~~~  316 (411)
                      ..  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........         ......+...
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            21  2234578999999999876 5689999999999999999999999865432111000         0000001111


Q ss_pred             ccccccccccccccc-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 RTLELIDPILEDEYS-----SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ...............     ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000000000000     01224568899999999999999999999964

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=349.51  Aligned_cols=261  Identities=20%  Similarity=0.229  Sum_probs=204.8

Q ss_pred             hhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecC
Q 040952           84 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  159 (411)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (411)
                      .......++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            334445688999999999999999999975 59999999986431   22334578999999999999999999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      +..|+||||+++|+|..++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999996432  24889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYAL-------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      ++....... ......+||+.|+|||++.       +..++.++|||||||++|||++|+.||......     ......
T Consensus       209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i  282 (412)
T 2vd5_A          209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-----ETYGKI  282 (412)
T ss_dssp             CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH
T ss_pred             heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence            987653322 1223458999999999987       356899999999999999999999998643211     111111


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR---PTMNDVVSM  363 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~~  363 (411)
                      ......  ...+..     ....+..+.+++.+||+ +|++|   |++.|+++.
T Consensus       283 ~~~~~~--~~~p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          283 VHYKEH--LSLPLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HTHHHH--CCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HhcccC--cCCCcc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            110000  000100     11125678999999999 99998   689999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.1e-44  Score=339.37  Aligned_cols=249  Identities=21%  Similarity=0.254  Sum_probs=179.5

Q ss_pred             cCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEeeCCCCC
Q 040952           96 ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKS  173 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (411)
                      .+.||+|+||.||+|.+. +|+.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999976 4899999999653   3456789999999997 9999999999999999999999999999


Q ss_pred             chhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---CeEEeecCCccccCCCCccc
Q 040952          174 LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMARICGGNELQA  250 (411)
Q Consensus       174 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      |.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++......  .
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            99998653   34899999999999999999999998   99999999999997765   79999999998654322  1


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc--cchhHHHHHHhhcCcccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ....... ..+..+...      ...
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~------~~~  237 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFS------FEG  237 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCC------CCS
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCC------CCc
Confidence            2234578999999999999999999999999999999999999987543211  1111111 111111100      000


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       238 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          238 -EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence             0011235678999999999999999999999854

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-44  Score=334.23  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=204.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec--------
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--------  158 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  158 (411)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|.+....    ..+.+|+.++++++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34577999999999999999999976 69999999997653    245789999999999999999998864        


Q ss_pred             --------CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 040952          159 --------KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  230 (411)
Q Consensus       159 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  230 (411)
                              ....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                    345789999999999999986532 245889999999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH
Q 040952          231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  310 (411)
                      .+||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|..|+...       ... .
T Consensus       160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~-~  228 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKF-F  228 (284)
T ss_dssp             EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHH-H
T ss_pred             CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHH-H
Confidence            999999999987654321   23346899999999999999999999999999999999999874210       000 1


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCC
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP  373 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  373 (411)
                      ......        .+...     .+..+.+++.+||+.||++|||+.|+++.|..+......
T Consensus       229 ~~~~~~--------~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          229 TDLRDG--------IISDI-----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHHHTT--------CCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             HHhhcc--------ccccc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            111111        11111     134688999999999999999999999999988765443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.2e-44  Score=337.61  Aligned_cols=253  Identities=24%  Similarity=0.281  Sum_probs=205.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc------ccHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            4577999999999999999999976 489999999875422      236778999999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----CeEEeec
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDF  237 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Df  237 (411)
                      .++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999998643   34789999999999999999999998   99999999999999888    7999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ......... .
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~-~  234 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITSV-S  234 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTT-C
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhc-c
Confidence            9998765332   223457899999999999999999999999999999999999998643211     111111110 0


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        ...++...     ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       235 --~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          235 --YDFDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --CCCCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --cccChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              00000000     1124568999999999999999999999873

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-44  Score=334.95  Aligned_cols=266  Identities=20%  Similarity=0.220  Sum_probs=200.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34578999999999999999999976 58899999997542   223467889999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus       111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999998543   34889999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......      ...........    .
T Consensus       185 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~----~  253 (309)
T 2h34_A          185 TDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIP----R  253 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCC----C
T ss_pred             ccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCC----C
Confidence            43221 1223457899999999999999999999999999999999999998643211      11111111100    0


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhcccccCCC
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRP-TMNDVVSMLTNEAAALLPP  374 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~~~~~  374 (411)
                      +    .......+..+.+++.+||+.||++|| ++.++++.|+.........
T Consensus       254 ~----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          254 P----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD  301 (309)
T ss_dssp             G----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred             c----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence            0    000111245688999999999999999 9999999999887765443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.5e-44  Score=330.78  Aligned_cols=258  Identities=26%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ..++|.+.+.||+|+||.||+|.+..    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35789999999999999999998643    235999999765 33446778999999999999999999999865 4568


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++++|.+++....  ..+++.....++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            9999999999999986432  34789999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....    ........  
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~----~~~~~~~~--  234 (281)
T 3cc6_A          164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGV----LEKGDRLP--  234 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHH----HHHTCCCC--
T ss_pred             cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHH----HhcCCCCC--
Confidence            533221 1233457889999999998999999999999999999998 999986433221  1111    11111000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                         .     +...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       235 ---~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          235 ---K-----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ---C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---C-----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence               0     11124568999999999999999999999999987754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-44  Score=340.38  Aligned_cols=253  Identities=20%  Similarity=0.235  Sum_probs=199.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..++|++.+.||+|+||.||+|..+ +|+.||||++......    ..+|++++.++ +||||+++++++.+.+..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4578999999999999999999976 4889999999765432    35688888887 7999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC----CCeEEeecCCccc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKISDFGMARI  242 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfgl~~~  242 (411)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||+..+    +.+||+|||++..
T Consensus        96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999988543   34899999999999999999999998   9999999999998543    3599999999987


Q ss_pred             cCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......  ..... ..+..+... . 
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~-~~i~~~~~~-~-  242 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEIL-ARIGSGKFS-L-  242 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHH-HHHHHCCCC-C-
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHH-HHHccCCcc-c-
Confidence            64332  12234578999999999988889999999999999999999999986432211  11111 111111110 0 


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          ... .....+..+.+++.+||+.||++|||+.++++.
T Consensus       243 ----~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          243 ----SGG-YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             ----CST-TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----Ccc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                000 011225678999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.7e-44  Score=330.23  Aligned_cols=254  Identities=21%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ...++|.+.+.||+|+||.||+|... +|..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            34578999999999999999999975 48899999987543 34567889999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCCeEEeecCCcc
Q 040952          166 YEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMAR  241 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfgl~~  241 (411)
                      |||+++|+|.+++... .....+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999998887543 22345899999999999999999999998   9999999999999   456889999999997


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......   ......||+.|+|||++. ..++.++||||||+++|||++|+.||.......     ............. 
T Consensus       176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~-  245 (285)
T 3is5_A          176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-----VQQKATYKEPNYA-  245 (285)
T ss_dssp             C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCCCC-
T ss_pred             ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-----HHhhhccCCcccc-
Confidence            654322   223457899999999875 568999999999999999999999986433111     1111111100000 


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                          ....    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       246 ----~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 ----VECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----C--C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----cccC----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000    01456889999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=344.83  Aligned_cols=261  Identities=27%  Similarity=0.407  Sum_probs=196.7

Q ss_pred             cCCCccCcccccCcccEEEEEecC--C--CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeec-CCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK--G--DEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l  164 (411)
                      ..|.+.+.||+|+||.||+|.+.+  +  ..||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            457778899999999999998642  2  36899998754 33456789999999999999999999998754 457899


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|.+++....  ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999996533  34788889999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCccc--ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          245 GNELQA--NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       245 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......  ......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||.......  ....   ......   .
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~---~~~~~~---~  315 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY---LLQGRR---L  315 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHH---HHTTCC---C
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHH---HHcCCC---C
Confidence            332211  1233457889999999999999999999999999999999 667765433211  1111   111110   0


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                      .        .+...+..+.+++.+||+.||++|||+.|+++.|+.+...+.
T Consensus       316 ~--------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 L--------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             C--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             C--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            0        011124568999999999999999999999999999877654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=361.29  Aligned_cols=266  Identities=27%  Similarity=0.405  Sum_probs=213.4

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ....++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..++||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            34456788899999999999999999877889999998654 345679999999999999999999999876 6789999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             ehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999995421 234788999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .. .......++..|+|||++.+..++.++|||||||++|||++ |+.||......     ..... ......     ..
T Consensus       417 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~~-i~~~~~-----~~  484 (535)
T 2h8h_A          417 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ-VERGYR-----MP  484 (535)
T ss_dssp             HH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHHH-HHTTCC-----CC
T ss_pred             ce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH-HHcCCC-----CC
Confidence            21 11223356788999999999999999999999999999999 89998543211     11111 111100     00


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCC
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPK  375 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~  375 (411)
                           .+..++..+.+++.+||+.||++|||+.+|++.|+.+.....+.-
T Consensus       485 -----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~  529 (535)
T 2h8h_A          485 -----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  529 (535)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence                 011235678999999999999999999999999999876655443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-44  Score=355.77  Aligned_cols=261  Identities=23%  Similarity=0.260  Sum_probs=194.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC-----
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  160 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++....     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999965 4889999999754  3344667889999999999999999999997653     


Q ss_pred             -ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          161 -EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                       ..|+||||++++ |...+..     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence             569999999876 4444421     2788899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH---------
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW---------  310 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---------  310 (411)
                      ++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+...  ......         
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPE  285 (464)
T ss_dssp             C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred             eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence            98765322   2334589999999999999999999999999999999999999996543111  000000         


Q ss_pred             ----------HHhhcCcc------cccccccc-ccc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          311 ----------DLWTSNRT------LELIDPIL-EDE-YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       311 ----------~~~~~~~~------~~~~~~~l-~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                                ........      ...+...+ ... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                      00000000      00000000 000 0112235678999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.9e-44  Score=336.64  Aligned_cols=264  Identities=27%  Similarity=0.358  Sum_probs=207.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCE--EEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDE--IAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.+. +|..  +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            367999999999999999999965 4554  499988753 233456788999999999 99999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC
Q 040952          165 IYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  231 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  231 (411)
                      ||||+++++|.+++....             ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999986542             2346899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHH
Q 040952          232 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       232 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  310 (411)
                      +||+|||+++....   ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||......     ... 
T Consensus       181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~-  251 (327)
T 1fvr_A          181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELY-  251 (327)
T ss_dssp             EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-
T ss_pred             EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHH-
Confidence            99999999874321   111223456889999999998889999999999999999998 99998543211     111 


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCC
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPK  375 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~  375 (411)
                      .......     ....     +...+..+.+++.+||+.||++|||+.++++.|..+........
T Consensus       252 ~~~~~~~-----~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          252 EKLPQGY-----RLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             HHGGGTC-----CCCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             HHhhcCC-----CCCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence            1111110     0001     11124568999999999999999999999999999887654433

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=330.04  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=200.3

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      ++|.....||+|+||.||+|.+. +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555668999999999999965 58899999998766666678999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecCCccccCCCCc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      ++++|.+++........+++..+..++.|++.||.|||+++   ++||||||+||+++. ++.+||+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999976544455778888999999999999999998   999999999999987 8999999999998764322 


Q ss_pred             ccccccccccccccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                       .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...........  .....       ...+.+
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~-------~~~~~~  247 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMF-------KVHPEI  247 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHH-------CCCCCC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhccc-------cccccc
Confidence             1223457899999999987653  88999999999999999999999853221111000  00000       001111


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..     ..+..+.+++.+||+.||++|||+.++++.
T Consensus       248 ~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          248 PE-----SMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CT-----TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             cc-----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11     124568899999999999999999999863

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.2e-44  Score=332.02  Aligned_cols=258  Identities=26%  Similarity=0.359  Sum_probs=204.4

Q ss_pred             hcCCCccC-cccccCcccEEEEEec---CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .++|.+.+ .||+|+||.||+|.+.   .++.||||++....  ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            46788877 9999999999999643   36789999997553  23356789999999999999999999999 567789


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++++|.+++...   ..+++...+.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999998653   34889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          244 GGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       244 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.......     . ..........  
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~-~~~~~~~~~~--  239 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----V-TAMLEKGERM--  239 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----H-HHHHHTTCCC--
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----H-HHHHHcCCCC--
Confidence            543221 11222346788999999998889999999999999999999 999986433211     1 1111111110  


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                         ...     ...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       240 ---~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          240 ---GCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             ---CCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---CCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence               011     11256789999999999999999999999999887654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=332.13  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=183.5

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            3467999999999999999999974 58999999986432   2235678999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999986532  35889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........     ..... .      .+.
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~-~------~~~  229 (278)
T 3cok_A          164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVV-L------ADY  229 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC-S------SCC
T ss_pred             CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHh-h------ccc
Confidence            3221  12235789999999999988899999999999999999999999864332110     00000 0      000


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..     +...+..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 EM-----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CC-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CC-----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            01     1112456889999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-44  Score=331.67  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=203.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++...  .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999976 4899999998654  333456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC---eEEeecCCccc
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARI  242 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfgl~~~  242 (411)
                      |||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999998887543   34889999999999999999999998   999999999999986655   99999999977


Q ss_pred             cCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......     ..... ...... ...
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~-~~~~~~-~~~  227 (284)
T 3kk8_A          158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQ-IKAGAY-DYP  227 (284)
T ss_dssp             CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH-HHHTCC-CCC
T ss_pred             cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHHHH-HHhccc-cCC
Confidence            653222   23357899999999999999999999999999999999999998543211     11111 111110 000


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+.      ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       228 ~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          228 SPE------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             chh------hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000      01124568899999999999999999999873

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.5e-45  Score=348.97  Aligned_cols=248  Identities=23%  Similarity=0.268  Sum_probs=192.1

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHH-HHhcCCcccceeeeeeecCCceE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ..++|++.+.||+|+||.||+|+.+. ++.||+|++....   ......+..|..+ ++.++||||+++++++.+.+..|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            35789999999999999999999764 8899999997542   2233455667666 46689999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++|+|..++...   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999999998543   34788889999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....     .......... .. .   
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~-~~-~---  257 (373)
T 2r5t_A          190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNK-PL-Q---  257 (373)
T ss_dssp             BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHHHHHS-CC-C---
T ss_pred             ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhc-cc-C---
Confidence            3222  223456899999999999999999999999999999999999999864321     1111111111 10 0   


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  361 (411)
                        +..     ..+..+.+++.+||+.||++||++.+.+
T Consensus       258 --~~~-----~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          258 --LKP-----NITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             --CCS-----SSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             --CCC-----CCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence              011     1245688999999999999999985433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-43  Score=349.74  Aligned_cols=196  Identities=24%  Similarity=0.421  Sum_probs=154.6

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC-----Cc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999966 5899999998654  333456788999999999999999999998543     57


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .|+||||+ +++|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999997 46888888543   34899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-------------------------cccccccccccccChhhh-ccCCCCcchhhHHHHHHHHHHHhCC
Q 040952          242 ICGGNELQ-------------------------ANTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGK  292 (411)
Q Consensus       242 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~  292 (411)
                      ........                         ......+||+.|+|||++ .+..++.++|||||||++|||++|.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            76432110                         122345789999999976 4667999999999999999999943

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-43  Score=343.14  Aligned_cols=253  Identities=18%  Similarity=0.233  Sum_probs=191.5

Q ss_pred             hcCCCcc-CcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHh-cCCcccceeeeeeec----CCce
Q 040952           90 TNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAK-VQHKNLVRLLGCCID----KDEK  162 (411)
Q Consensus        90 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~  162 (411)
                      .++|.+. +.||+|+||.||+|.+. +|+.||||++...     ..+.+|+.++.+ .+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567766 68999999999999976 4889999998642     356788888754 589999999999875    5678


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCC
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGM  239 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl  239 (411)
                      |+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999996543 245899999999999999999999998   999999999999997   78999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ++......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... . ...+..... 
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~-~~~i~~~~~-  284 (400)
T 1nxk_A          211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-M-KTRIRMGQY-  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-H-HHHHHHTCC-
T ss_pred             ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-H-HHHHHcCcc-
Confidence            98654322   22345789999999999999999999999999999999999999865432211100 0 000111100 


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....+      .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       285 ~~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 EFPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000      001225678999999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.9e-44  Score=339.30  Aligned_cols=247  Identities=30%  Similarity=0.462  Sum_probs=198.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .+.|+..+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            456899999999999999999964 58899999997543   23346788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+. |+|.+++...  +..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 5676666432  245889999999999999999999998   99999999999999999999999999976532


Q ss_pred             CCcccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                            .....||+.|+|||++.   +..++.++|||||||++|||++|+.||.....     ............     
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~-----  270 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES-----  270 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC-----
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCC-----
Confidence                  22357899999999984   56789999999999999999999999854321     111111111111     


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       +...    ....+..+.+++.+||+.||++|||+.++++.
T Consensus       271 -~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 -PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -CCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             1111    11124568899999999999999999999865

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.8e-45  Score=358.53  Aligned_cols=249  Identities=22%  Similarity=0.266  Sum_probs=194.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|... +|+.||||++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999965 4899999998743   233445678899999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      |||+++|+|..++...   ..+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999988543   348999999999999999999998 77   9999999999999999999999999997643


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......... ..      
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~~~-~~------  366 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME-EI------  366 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHC-CC------
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHHhC-CC------
Confidence            222  2233468999999999999999999999999999999999999998643221     111111111 10      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      .+.     ...+..+.+++.+||+.||++||     ++.|+++.
T Consensus       367 ~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 RFP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCC-----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            001     11245689999999999999999     99999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.5e-44  Score=355.10  Aligned_cols=255  Identities=25%  Similarity=0.335  Sum_probs=206.9

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999976 5999999998643   22345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|..++.... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999986543 234899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... .........      .
T Consensus       338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~-i~~~i~~~~------~  406 (576)
T 2acx_A          338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE-VERLVKEVP------E  406 (576)
T ss_dssp             TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHH-HHHHHHHCC------C
T ss_pred             cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHH-HHHHhhccc------c
Confidence            332   12335899999999999999999999999999999999999999865432111 111 111111100      0


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                      .+.     ...+..+.+++.+||+.||++||     ++.|+++.
T Consensus       407 ~~p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          407 EYS-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             cCC-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            011     11256789999999999999999     78888864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-43  Score=352.41  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=206.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999976 59999999996532   23456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          166 YEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      |||+++|+|..++.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999986543 2345899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............. .      
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~-~------  410 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQA-V------  410 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCC-C------
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcc-c------
Confidence            3321  2234589999999999999999999999999999999999999996543211 1111111111110 0      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTM-----NDVVS  362 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  362 (411)
                      ..     +...+..+.+++.+||+.||++||++     .++++
T Consensus       411 ~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          411 TY-----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CC-----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             CC-----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            00     11225678899999999999999975     66664

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=360.44  Aligned_cols=259  Identities=26%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             CCCccC-cccccCcccEEEEEec---CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           92 KFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        92 ~y~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||++.... ....+.+.+|+.+|++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333334 7999999999999864   35679999997653 3456789999999999999999999999976 5689999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...  +..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999998643  345899999999999999999999998   999999999999999999999999999876433


Q ss_pred             Ccc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          247 ELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       247 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......  ..   . ..+..+....    
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~---~-~~i~~~~~~~----  559 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV---M-AFIEQGKRME----  559 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HH---H-HHHHTTCCCC----
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HH---H-HHHHcCCCCC----
Confidence            211 11222345689999999999999999999999999999998 99998643321  11   1 1111111100    


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                            .+..++..+.+++.+||+.+|++||++.++++.|+.+.....
T Consensus       560 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          560 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             ------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             ------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                  011235678999999999999999999999999998765443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-44  Score=332.06  Aligned_cols=247  Identities=25%  Similarity=0.342  Sum_probs=199.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|.+.. +..||+|++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4679999999999999999999764 7799999986432   22356788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999988543   34889999999999999999999988   99999999999999999999999999865432


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .    ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ...... ....      ..
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~------~~  225 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRI-SRVE------FT  225 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH-HHTC------CC
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----HHHHHH-HhCC------CC
Confidence            2    123457899999999999999999999999999999999999998643211     111111 1100      00


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..     ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       226 ~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CC-----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CC-----CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11     1124568899999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.4e-43  Score=347.83  Aligned_cols=263  Identities=19%  Similarity=0.278  Sum_probs=205.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc-ccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++......  ..+..|+++++.++|+ ++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            578999999999999999999964 5899999988754332  3478899999999874 55556666677788899999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCCeEEeecCCccccC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICG  244 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~  244 (411)
                      |+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++...
T Consensus        84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 999999986432  34899999999999999999999998   9999999999999   688999999999998765


Q ss_pred             CCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-chhHHHHHHhhcCcc
Q 040952          245 GNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYAWDLWTSNRT  318 (411)
Q Consensus       245 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  318 (411)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........    ..
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cc
Confidence            43321     112356799999999999999999999999999999999999999875433211 111111100    00


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ...+... .     ...+.++.+++.+||+.+|++||++.+|++.|+.+...
T Consensus       234 ~~~~~~l-~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          234 ATSIEAL-C-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HSCHHHH-H-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccHHHH-h-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            0000000 0     11245789999999999999999999999999887553

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-43  Score=345.18  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=192.6

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--------cccHHHHHHHHHHHHhcCCcccceeeeeee
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCI  157 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  157 (411)
                      ....++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345688999999999999999999976 48999999986431        112234789999999999999999999975


Q ss_pred             cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CCeEE
Q 040952          158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKI  234 (411)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl  234 (411)
                      . +..++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.+   +.+||
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             c-CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence            4 5679999999999999988543   34899999999999999999999998   9999999999999754   45999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  311 (411)
                      +|||+++......   ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........ ..    .
T Consensus       284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~----~  355 (419)
T 3i6u_A          284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LK----D  355 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HH----H
T ss_pred             eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HH----H
Confidence            9999998765322   2234579999999999853   5688999999999999999999999864332211 11    1


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....... ......      ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       356 ~i~~~~~-~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          356 QITSGKY-NFIPEV------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHTTCC-CCCHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhcCCC-CCCchh------hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1111110 000000      01125678999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.5e-44  Score=329.59  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=199.2

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecC-CceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+|..+ |+.||||++....  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            478999999999999999999886 8899999997543  456789999999999999999999997654 478999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            99999999985432 233788889999999999999999998   999999999999999999999999998765422  


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.......     .... .....     .....
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~~~~-~~~~~-----~~~~~  236 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPR-VEKGY-----KMDAP  236 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHHH-HTTTC-----CCCCC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH-HhcCC-----CCCCc
Confidence               122357889999999999999999999999999999998 999986433211     1111 11110     01111


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                           ...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       237 -----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          237 -----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                 11245789999999999999999999999999987654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-44  Score=337.88  Aligned_cols=265  Identities=25%  Similarity=0.368  Sum_probs=199.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .++|++.+.||+|+||.||+|.+.. |+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4679999999999999999999764 89999999865432  23456789999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|..++....   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988864433   3899999999999999999999998   999999999999999999999999999765432


Q ss_pred             CcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH----------HHHhhc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA----------WDLWTS  315 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~  315 (411)
                      .  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ .....          ...+..
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHH
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhh
Confidence            2  122335789999999998875 789999999999999999999999865432111 00000          000111


Q ss_pred             Ccc-ccccccccccccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 NRT-LELIDPILEDEYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 ~~~-~~~~~~~l~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ... .....+.+.....    ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000 0000011111000    01235679999999999999999999999863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.6e-44  Score=329.95  Aligned_cols=259  Identities=22%  Similarity=0.301  Sum_probs=208.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999976 47789999986431   22346789999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++++|.+++...   ..+++.....++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999988543   34889999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..    .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......     ........ ..      ..
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~------~~  230 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIVN-VD------LK  230 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHT-TC------CC
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHhc-cc------cC
Confidence            21    23357899999999999999999999999999999999999998643311     11111111 10      00


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhhcccccCCCC
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAALLPPK  375 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~~~~  375 (411)
                      +..     ..+..+.+++.+||+.||++|||+.++++  .+........||.
T Consensus       231 ~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~  277 (284)
T 2vgo_A          231 FPP-----FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV  277 (284)
T ss_dssp             CCT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCC
T ss_pred             CCC-----cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCc
Confidence            111     12456889999999999999999999996  4555544444443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-43  Score=328.34  Aligned_cols=249  Identities=25%  Similarity=0.418  Sum_probs=205.6

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .+.|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467899999999999999999865 58999999997553 3456789999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999843    34899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      .  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ..... .....     .+.+.
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~-----~~~~~  240 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KVLFL-IPKNN-----PPTLE  240 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH-HHHSC-----CCCCC
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HHHHH-hhcCC-----CCCCc
Confidence            1  223457899999999999999999999999999999999999998643211     11111 11111     11111


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..     .+..+.+++.+||+.||++|||+.++++.
T Consensus       241 ~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 GN-----YSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SS-----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             cc-----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11     14568899999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.4e-44  Score=348.13  Aligned_cols=200  Identities=24%  Similarity=0.398  Sum_probs=167.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC-----Cc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            578999999999999999999976 4889999999754  333456789999999999999999999999776     57


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .|+||||++ ++|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 5898888543   34899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc--------------------cccccccccccccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 040952          242 ICGGNELQ--------------------ANTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  296 (411)
Q Consensus       242 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~  296 (411)
                      ........                    ......+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76533211                    112456899999999986 45679999999999999999998766553

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-43  Score=330.21  Aligned_cols=253  Identities=22%  Similarity=0.393  Sum_probs=199.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4578999999999999999999976 489999999987766677889999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|..++....  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...... 
T Consensus        97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            999999999885422  34889999999999999999999998   999999999999999999999999987543211 


Q ss_pred             cccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                       ........||+.|+|||++.     +..++.++||||||+++|+|++|+.||......     ............ .. 
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~~-  242 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSDPP-TL-  242 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCC-CC-
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHHhccCCc-cc-
Confidence             11122347899999999883     567899999999999999999999998643321     111111111110 00 


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                             ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       243 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                   011122456899999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.1e-44  Score=340.20  Aligned_cols=264  Identities=25%  Similarity=0.353  Sum_probs=203.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999976 5899999999765 33445678999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |+++++|.+++...   ..+++.....++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++..... 
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            99999999998543   3488999999999999999999985 7   99999999999999999999999999875431 


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhH-------------------
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG-------------------  307 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------------------  307 (411)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............                   
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               1223457899999999999999999999999999999999999998654321110000                   


Q ss_pred             -----HHHHHhhcCccccccccccc---cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          308 -----YAWDLWTSNRTLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       308 -----~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                           +...........+.++....   ........+..+.+++.+||+.||++|||+.|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                 00000000000000000000   001111124578999999999999999999999964

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-44  Score=340.39  Aligned_cols=262  Identities=23%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            578999999999999999999975 5999999999653  2334567889999999999999999999998753      


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..|+||||+ +++|..++..    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899998854    34788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC---
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN---  316 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  316 (411)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+...  ............   
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~  248 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAE  248 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence            875422     234578999999999887 679999999999999999999999986443211  110000000000   


Q ss_pred             --------c-------cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhcc
Q 040952          317 --------R-------TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEA  368 (411)
Q Consensus       317 --------~-------~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~  368 (411)
                              .       ........+...  ....+..+.+|+.+||+.||++|||+.|+++.  ++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          249 FVQRLQSDEAKNYMKGLPELEKKDFASI--LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGT--CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhhHHHHHHHHhCCCCCCCCHHHH--CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                    0       000000000000  01124578999999999999999999999984  45443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=340.57  Aligned_cols=276  Identities=24%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             hhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           85 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      ......++|++.+.||+|+||.||+|.++.  .+|+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            334446889999999999999999999763  49999987542  23345677899999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+++   ++||||||+||+++ ++.+||+|||++..
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             EEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            99999999999999996532  35888999999999999999999998   99999999999998 68999999999876


Q ss_pred             cCCCC---cccccccccccccccChhhhcc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH
Q 040952          243 CGGNE---LQANTSRIVGTYGYMSPEYALE---------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       243 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  310 (411)
                      .....   .........||+.|+|||++.+         ..++.++|||||||++|||++|+.||......     ....
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~  253 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIW  253 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHH
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence            53211   1122233468999999999874         45789999999999999999999998643221     1111


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeeec
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVR  383 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~  383 (411)
                      .... ..     .+....    ...+..+.+++.+||+.||++|||+.++++.|+.+.........|...|..
T Consensus       254 ~~~~-~~-----~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~  316 (319)
T 2y4i_B          254 QMGT-GM-----KPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS  316 (319)
T ss_dssp             HHHT-TC-----CCCCCC----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred             Hhcc-CC-----CCCCCc----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence            1111 11     111110    011345889999999999999999999999999999887777777666643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-44  Score=348.17  Aligned_cols=243  Identities=15%  Similarity=0.190  Sum_probs=188.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHH---HHHHhcCCcccceee-------e
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEA---SVIAKVQHKNLVRLL-------G  154 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~  154 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...   .....+.+.+|+   ..+++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3578999999999999999999964 5999999998743   334567788999   555566899999998       5


Q ss_pred             eeecCC-----------------ceEEEEeeCCCCCchhhhcCCCC----CcCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 040952          155 CCIDKD-----------------EKILIYEYMPNKSLDFFLFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVR  213 (411)
Q Consensus       155 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  213 (411)
                      ++.+.+                 ..++||||+ +|+|.+++.....    ...+++..++.++.|++.||+|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            555443                 278999999 6899999864311    122345788899999999999999998   


Q ss_pred             eeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccC-----------CCCcchhhHHHH
Q 040952          214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----------IFSIKSDVFSFG  282 (411)
Q Consensus       214 ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG  282 (411)
                      |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999986432     2234567 999999999887           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          283 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       283 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      |++|||++|+.||........                  ........   ...+..+.+++.+||+.||++|||+.|+++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~------------------~~~~~~~~---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGG------------------SEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHSSCCC------CC------------------SGGGGSSC---CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHCCCCCcccccccc------------------hhhhhhhc---cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999999853321110                  00000000   011456889999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.3e-43  Score=332.85  Aligned_cols=266  Identities=21%  Similarity=0.315  Sum_probs=199.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC-------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-------  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  159 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++....  ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999974 58999999986543  22345678999999999999999999998874       


Q ss_pred             -CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          160 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                       +..++||||+++ +|...+....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             467999999986 5655554432  33889999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCc--ccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc
Q 040952          239 MARICGGNEL--QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       239 l~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                      ++........  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  ...........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~  247 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGS  247 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCC
Confidence            9987643221  122234578999999998876 458999999999999999999999987543211  11111110000


Q ss_pred             -----------CccccccccccccccchHH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 -----------NRTLELIDPILEDEYSSKH------MLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 -----------~~~~~~~~~~l~~~~~~~~------~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                                 ....+.+............      .+..+.+|+.+||+.||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence                       0000000000000000111      13468899999999999999999999974

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=336.39  Aligned_cols=267  Identities=23%  Similarity=0.303  Sum_probs=196.1

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc-----cHHHHHHHHHHHHhcCCcccceeeeeeecCCc
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (411)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++......     ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 4899999999753221     12467899999999999999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+++ +|..++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 7877775432  34778888999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc--
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT--  318 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  318 (411)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|||++|.+||......  ...............  
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChhh
Confidence            764322  122345789999999998764 5899999999999999999999988643321  111111111100000  


Q ss_pred             ----cccccccccc---ccch----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040952          319 ----LELIDPILED---EYSS----KHMLLRYVNIALLCVQESADDRPTMNDVVSML  364 (411)
Q Consensus       319 ----~~~~~~~l~~---~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  364 (411)
                          ....+.....   ..+.    ...+..+.+++.+||+.||++|||+.|+++.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence                0000000000   0000    11246799999999999999999999999753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.6e-43  Score=348.18  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=202.5

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ...++|++.+.||+|+||.||+|... +|+.||||++...  .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            45678999999999999999999976 5899999998643  23346778999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCCeEEeecCCcc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMAR  241 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfgl~~  241 (411)
                      ||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999998887543   34899999999999999999999998   99999999999995   45679999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......     .............. 
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~-  242 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DILKRVETGKYAFD-  242 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHTCCCSC-
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCCCC-
Confidence            764332   2234579999999998875 5999999999999999999999998643211     11111111110000 


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       .+      .....+..+.+++.+||+.||++|||+.++++.
T Consensus       243 -~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 -LP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -SG------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -Cc------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00      011225678999999999999999999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-43  Score=326.16  Aligned_cols=256  Identities=23%  Similarity=0.300  Sum_probs=203.2

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC------cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+....      ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999976 58999999986542      12367889999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----CeEEeecC
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDFG  238 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg  238 (411)
                      ++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999998542   34899999999999999999999998   99999999999998877    89999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      ++.......   ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......     ...... .....
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~  228 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----ETLTNI-SAVNY  228 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH-HTTCC
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----HHHHHh-Hhccc
Confidence            998764322   123346899999999999999999999999999999999999998643211     111111 10000


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhhc
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS--MLTNE  367 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~  367 (411)
                        ......     ....+..+.+++.+||+.||++|||+.++++  .++..
T Consensus       229 --~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          229 --DFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             --CCCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             --CCcchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence              000000     0112456899999999999999999999997  34444

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4e-44  Score=338.10  Aligned_cols=264  Identities=20%  Similarity=0.268  Sum_probs=192.6

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999999965 588999999975432  234567899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-----CCCCeEEeecCC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-----KDMNPKISDFGM  239 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-----~~~~~kl~Dfgl  239 (411)
                      ||||+++ +|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999985 8888885433   4889999999999999999999998   99999999999994     455699999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--  316 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  316 (411)
                      +.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......  ............  
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDD  259 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCT
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCch
Confidence            98764322  122334789999999999874 48999999999999999999999986433211  110010000000  


Q ss_pred             ----------ccccccccccccc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 ----------RTLELIDPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ----------~~~~~~~~~l~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                                .............   ......+..+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                      0000000000000   001112467899999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=336.42  Aligned_cols=268  Identities=22%  Similarity=0.338  Sum_probs=196.0

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999976 5899999998754322 112345799999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      ++ |+|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            98 47877775432  34888999999999999999999998   9999999999999999999999999997654322 


Q ss_pred             ccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ............. .........
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~-~~~~~~~~~  230 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPT-EETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCC-TTTSTTGGG
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC-hHhchhhhc
Confidence             22233578999999999876 568999999999999999999999986543211  1111111111100 000000000


Q ss_pred             -------------cc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhccc
Q 040952          328 -------------DE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA  369 (411)
Q Consensus       328 -------------~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~  369 (411)
                                   ..   ......+..+.+++.+||+.||++|||+.|+++.  +.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                         00   0001124578899999999999999999999973  444433

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.5e-44  Score=327.72  Aligned_cols=261  Identities=24%  Similarity=0.309  Sum_probs=204.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeec--CCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+....  ....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999976 58999999997543  3345678999999999999999999998754  567899


Q ss_pred             EEeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          165 IYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ||||+++++|.+++.... .+..+++..++.++.|++.||+|||+.+  ..+++||||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986432 2345899999999999999999999976  2339999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      .......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ..... .......  
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-i~~~~~~--  234 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGK-IREGKFR--  234 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH-HHHTCCC--
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-----HHHHH-Hhhcccc--
Confidence            7643221  122346899999999999989999999999999999999999998654311     11111 1111111  


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  368 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  368 (411)
                         .+..     ..+..+.+++.+||+.||++|||+.|+++.+....
T Consensus       235 ---~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          235 ---RIPY-----RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             ---CCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ---cCCc-----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence               1111     12457899999999999999999999998765443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-43  Score=326.99  Aligned_cols=260  Identities=25%  Similarity=0.342  Sum_probs=197.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec--CCC--EEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK--KGD--EIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|.+.  +++  .||||++...   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999854  233  6899998754   2344677899999999999999999999998764 8


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++|+||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999986432  34889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          243 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       243 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ....... .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||......     ............. 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~-  244 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGERL-  244 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCCC-
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCCCC-
Confidence            6543221 12233457888999999998889999999999999999999 99998643211     1111111111100 


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                          .     .+...+..+.+++.+||+.||++|||+.++++.|++..+.
T Consensus       245 ----~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          245 ----P-----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             ----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             ----C-----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                0     0112256789999999999999999999999999887653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.5e-44  Score=332.43  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=201.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4578999999999999999999976 589999999986554445678899999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCCeEEeecCCccccC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICG  244 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~  244 (411)
                      |+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999888543   34889999999999999999999998   9999999999999   788999999999987643


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ..    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ..... ...... ....+
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~-i~~~~~-~~~~~  229 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-----KLFEK-IKEGYY-EFESP  229 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH-HHHCCC-CCCTT
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH-HHcCCC-CCCcc
Confidence            21    223346899999999999999999999999999999999999998643211     11111 111100 00000


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                            .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       230 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          230 ------FWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  011124678999999999999999999999963

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-43  Score=325.62  Aligned_cols=247  Identities=21%  Similarity=0.337  Sum_probs=198.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999976 5999999998754  233456788999999999 99999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCC-CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC--------------
Q 040952          165 IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD--------------  229 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--------------  229 (411)
                      ||||+++++|.+++..... ...+++..+..++.|++.||.|||+++   |+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999865321 245899999999999999999999998   9999999999999844              


Q ss_pred             -----CCeEEeecCCccccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 040952          230 -----MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL  303 (411)
Q Consensus       230 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  303 (411)
                           ..+||+|||++.......      ...||+.|+|||.+.+. .++.++|||||||++|+|++|.+++....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                 479999999998764322      23589999999999866 67789999999999999999987753211    


Q ss_pred             chhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          304 NLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       .    .........     +.+..     ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 -~----~~~~~~~~~-----~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 -Q----WHEIRQGRL-----PRIPQ-----VLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -H----HHHHHTTCC-----CCCSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -H----HHHHHcCCC-----CCCCc-----ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             0    111111111     11111     124568999999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-43  Score=335.96  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=205.0

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|.+.+.||+|+||.||++.+.. ++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            45789999999999999999999764 789999998654   23345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999999988542   34889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......     ........ ...      
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~------  258 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKK-NEY------  258 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHH-TCC------
T ss_pred             cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHHhc-CCC------
Confidence            3221  223457899999999999989999999999999999999999998643211     11111111 100      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+..     ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       259 ~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 SIPK-----HINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CCCT-----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCc-----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0111     124568899999999999999999999973

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.1e-43  Score=331.99  Aligned_cols=258  Identities=17%  Similarity=0.271  Sum_probs=199.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-Ccccceeeeeeec--CCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID--KDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   .+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            477999999999999999999864 58999999997533   467889999999997 9999999999988  5678999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCccccC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICG  244 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~  244 (411)
                      |||+++++|..++.      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998873      2788889999999999999999998   99999999999999776 89999999998765


Q ss_pred             CCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH--------HHhhc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW--------DLWTS  315 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  315 (411)
                      ....   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+.....        .....
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            3322   233478999999999877 67899999999999999999999998543322111111100        00000


Q ss_pred             Cc--------------cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 NR--------------TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 ~~--------------~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..              ........... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhhhhhccccchhhhccc-cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00              00000000000 0111135678999999999999999999999973

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=328.60  Aligned_cols=252  Identities=21%  Similarity=0.239  Sum_probs=197.6

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC----cccHHHHHHHHHHHHhcCCcccceeeeeee--cCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCI--DKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  162 (411)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....    ......+.+|+.++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999975 58899999987542    234567899999999999999999999984  45688


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ++||||++++ |.+++.... ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 555554332 345889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ..............||+.|+|||++.+..  ++.++||||||+++|||++|+.||.....     ...... ......  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~-i~~~~~--  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFEN-IGKGSY--  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH-HHHCCC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHH-HhcCCC--
Confidence            65433333334457899999999987644  47899999999999999999999864321     111111 111110  


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          .+..     ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       231 ----~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 ----AIPG-----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----CCCS-----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCCC-----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                0111     124568899999999999999999999964

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=338.08  Aligned_cols=255  Identities=22%  Similarity=0.286  Sum_probs=201.9

Q ss_pred             hcCCCccCcccccCcccEEEEEe----cCCCEEEEEEccCCC----cccHHHHHHHHHHHHhc-CCcccceeeeeeecCC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVL----KKGDEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  160 (411)
                      .++|++.+.||+|+||.||+|+.    .+|+.||||++....    ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            47899999999999999999997    358999999986532    22345567899999999 6999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999998643   34889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      +....... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... .............  
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~--  282 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE--  282 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCC--
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhccC--
Confidence            86542221 22334579999999999985  347899999999999999999999986433221 1111111111110  


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSML  364 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L  364 (411)
                           +..     +...+..+.+++.+||+.||++||     |+.|+++..
T Consensus       283 -----~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 -----PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -----CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -----CCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                 001     112245688999999999999999     999999765

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-43  Score=329.71  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|.+.+.||+|+||.||+|.+.. ++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            34789999999999999999999764 889999998654   23345678899999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++...   ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999987542   34889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ...... .....      
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~------  232 (294)
T 2rku_A          167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRI-KKNEY------  232 (294)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH-HTTCC------
T ss_pred             cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-hhccC------
Confidence            3221  223357899999999999888999999999999999999999998643311     111111 11100      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+..     ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 SIPK-----HINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCCT-----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCcc-----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0111     124568899999999999999999999974

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.1e-43  Score=335.83  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=203.6

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc--------ccHHHHHHHHHHHHhc-CCcccceeeee
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--------QGLREMKNEASVIAKV-QHKNLVRLLGC  155 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~  155 (411)
                      .....++|++.+.||+|+||.||+|.+. +|+.||||++.....        ...+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3455678999999999999999999986 699999999865431        1145678899999999 89999999999


Q ss_pred             eecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                      +...+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999998543   34899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  309 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  309 (411)
                      |||++.......   ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||......     ...
T Consensus       243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----~~~  314 (365)
T 2y7j_A          243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-----LML  314 (365)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred             ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-----HHH
Confidence            999998765332   2234579999999998863      35889999999999999999999998543211     111


Q ss_pred             HHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .. ...... ....+.      ....+..+.+++.+||+.||++|||+.++++
T Consensus       315 ~~-i~~~~~-~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 RM-IMEGQY-QFSSPE------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH-HHHTCC-CCCHHH------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH-HHhCCC-CCCCcc------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11 111100 000000      0012456899999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-44  Score=333.67  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=186.4

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3578999999999999999999964 58999999987543 334567889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcC-----CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          167 EYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       167 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ||+++++|.+++..     ......+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999998853     112345899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCc---ccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          242 ICGGNEL---QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       242 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      .......   ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........     ........ 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~-  243 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-----LMLTLQND-  243 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-----HHHHHTSS-
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-----HHHHhccC-
Confidence            6543211   111233578999999999875 5689999999999999999999999865432211     11111110 


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .... .............+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSL-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCT-TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCcc-ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000 0000000000112456889999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.5e-43  Score=328.00  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=197.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeec----CCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  162 (411)
                      ...|.+.+.||+|+||.||+|.+. ++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            355788889999999999999975 4889999998754  33446678999999999999999999998875    3567


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeEEeecCCcc
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMAR  241 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfgl~~  241 (411)
                      ++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+ .+++||||||+||+++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999999998543   34889999999999999999999875 3499999999999998 78999999999997


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......    .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.......    ... .........  
T Consensus       181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~-~~~~~~~~~--  248 (290)
T 1t4h_A          181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIY-RRVTSGVKP--  248 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHH-HHHTTTCCC--
T ss_pred             cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHH-HHHhccCCc--
Confidence            654322    23357899999999876 458999999999999999999999986432211    111 111111000  


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        .....     ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       249 --~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 --ASFDK-----VAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --GGGGG-----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --cccCC-----CCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              00111     113568999999999999999999999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.4e-43  Score=349.04  Aligned_cols=253  Identities=25%  Similarity=0.316  Sum_probs=205.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ...++|++.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34578999999999999999999976 58999999986542   345678899999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCCeEEeecCCc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMA  240 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfgl~  240 (411)
                      +||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++
T Consensus       103 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            999999999999888543   34889999999999999999999998   9999999999999   56789999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|+|++|++||......     ........ .... 
T Consensus       177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~-~~~~-  245 (484)
T 3nyv_A          177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-----DILKKVEK-GKYT-  245 (484)
T ss_dssp             HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH-CCCC-
T ss_pred             EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc-CCCC-
Confidence            8765332   2234579999999998866 6999999999999999999999998643321     11111111 1100 


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         ....   .....+..+.+++.+||+.+|++|||+.|+++.
T Consensus       246 ---~~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          246 ---FELP---QWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ---CCSG---GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CCCc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence               0000   011225678999999999999999999999964

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=324.71  Aligned_cols=251  Identities=26%  Similarity=0.415  Sum_probs=199.3

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ..++|++.+.||+|+||.||+|.+.. |+.||+|.+....  ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45789999999999999999999764 8999999997643  34678999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999998532  234889999999999999999999998   9999999999999999999999999997764322


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                        .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ...........      +...
T Consensus       180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~------~~~~  246 (314)
T 3com_A          180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIPTNPP------PTFR  246 (314)
T ss_dssp             --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCC------CCCS
T ss_pred             --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCCC------cccC
Confidence              1223457899999999999989999999999999999999999998643211     11111111100      0000


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                         .+...+..+.+++.+||+.||++|||+.++++
T Consensus       247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               01112456899999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.8e-43  Score=336.04  Aligned_cols=259  Identities=23%  Similarity=0.333  Sum_probs=203.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcc-----------------cHHHHHHHHHHHHhcCCccccee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ-----------------GLREMKNEASVIAKVQHKNLVRL  152 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~l  152 (411)
                      .++|++.+.||+|+||.||+|.. +|+.||||.+......                 ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999999999 7999999998643211                 11788999999999999999999


Q ss_pred             eeeeecCCceEEEEeeCCCCCchhh------hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEE
Q 040952          153 LGCCIDKDEKILIYEYMPNKSLDFF------LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNIL  225 (411)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nil  225 (411)
                      ++++.+.+..++||||+++++|.++      +... ....+++..+..++.|++.||.|||+ .+   ++||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      5332 24568999999999999999999999 87   999999999999


Q ss_pred             EcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCccccc
Q 040952          226 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSI-KSDVFSFGVLLLEIVSGKKNTGLYRTDSL  303 (411)
Q Consensus       226 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~  303 (411)
                      ++.++.+||+|||++......    ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||....... 
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-  259 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-  259 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence            999999999999999876433    23345789999999999877 6766 9999999999999999999987543211 


Q ss_pred             chhHHHHHHhhcCccc-c-----cccccccc--ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          304 NLLGYAWDLWTSNRTL-E-----LIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       304 ~~~~~~~~~~~~~~~~-~-----~~~~~l~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .   .... ....... .     ...+....  .......+..+.+++.+||+.||++|||+.|+++
T Consensus       260 ~---~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 E---LFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             H---HHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H---HHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1   1111 1111100 0     00000000  0001223567899999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.7e-43  Score=358.18  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=198.0

Q ss_pred             CcccccCcccEEEEEec---CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      +.||+|+||.||+|.+.   .++.||||++....  ....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   36789999997543  3346789999999999999999999999864 568899999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc-c
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-A  250 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~  250 (411)
                      |+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........ .
T Consensus       454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999999543   34889999999999999999999998   999999999999999999999999999876543221 1


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......      ............     .   
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~-----~---  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMG-----C---  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCC-----C---
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCC-----C---
Confidence            2223456789999999999999999999999999999998 999986433211      111111111111     0   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                        +..++..+.+++.+||+.||++|||+.+|++.|+++..+
T Consensus       594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              112256789999999999999999999999999887543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-43  Score=325.87  Aligned_cols=248  Identities=21%  Similarity=0.349  Sum_probs=195.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||.+....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999976 59999999986432   23456788999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++++|.+++...   ..+++.....++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998543   34789999999999999999999998   99999999999999999999999999977643


Q ss_pred             CCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      ...   .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......     ... ........      
T Consensus       164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~------  228 (276)
T 2h6d_A          164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-----TLF-KKIRGGVF------  228 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH-HHHHHCCC------
T ss_pred             Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHH-HHhhcCcc------
Confidence            221   223468999999999987765 68999999999999999999998643211     111 11111100      


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .+.     ...+..+.+++.+||+.||++|||+.++++.
T Consensus       229 ~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 YIP-----EYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            011     1124568899999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-43  Score=351.08  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-------------ccHHHHHHHHHHHHhcCCcccceee
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-------------QGLREMKNEASVIAKVQHKNLVRLL  153 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~  153 (411)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++.....             ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            45688999999999999999999976 488999999875421             2356788999999999999999999


Q ss_pred             eeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---
Q 040952          154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---  230 (411)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---  230 (411)
                      +++.+....++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++   
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999998888543   34899999999999999999999998   99999999999998776   


Q ss_pred             CeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH
Q 040952          231 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  310 (411)
Q Consensus       231 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  310 (411)
                      .+||+|||++.......   ......||+.|+|||++. +.++.++|||||||++|+|++|..||......     ....
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~  257 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-----DIIK  257 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence            69999999998765332   223457999999999876 46999999999999999999999998643321     1111


Q ss_pred             HHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          311 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .... ....  .+  ..   .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       258 ~i~~-~~~~--~~--~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          258 KVEK-GKYY--FD--FN---DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHH-CCCC--CC--HH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHc-CCCC--CC--cc---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1111 1100  00  00   001124678999999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.2e-44  Score=329.97  Aligned_cols=253  Identities=24%  Similarity=0.333  Sum_probs=186.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc-c-cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-Q-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++..... . ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999974 588999999975422 2 223344555567788999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          166 YEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      |||+++ +|.+++... .....+++..+..++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 776666431 2234589999999999999999999998 7   999999999999999999999999999776


Q ss_pred             CCCCcccccccccccccccChhhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ....   ......||+.|+|||.+    .+..++.++|||||||++|+|++|+.||..........    ......... 
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~-  232 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL----KQVVEEPSP-  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH----HHHHHSCCC-
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH----HHHhccCCC-
Confidence            4322   12334689999999996    45678999999999999999999999986433221111    111111110 


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                           ..    .....+..+.+++.+||+.||++|||+.|+++
T Consensus       233 -----~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 -----QL----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CC----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----Cc----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 00    11112456899999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.5e-43  Score=328.52  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=199.5

Q ss_pred             cchhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcC--Ccccceeeeee
Q 040952           81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQ--HKNLVRLLGCC  156 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~  156 (411)
                      +.+.++....++|++.+.||+|+||.||++.+.+|+.||||++...  .....+.+.+|+.++.+++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3445556667889999999999999999999888999999998754  3344577899999999997  59999999999


Q ss_pred             ecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEee
Q 040952          157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  236 (411)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D  236 (411)
                      ...+..++||| +.+++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||+++ +.+||+|
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence            99999999999 6788999998643   34888999999999999999999998   999999999999964 8999999


Q ss_pred             cCCccccCCCCcccccccccccccccChhhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 040952          237 FGMARICGGNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  305 (411)
Q Consensus       237 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  305 (411)
                      ||++................||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......   
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---  246 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---  246 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---
Confidence            999987654332222334578999999999875           468899999999999999999999986432211   


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       .............     .....     .+..+.+++.+||+.||++|||+.|+++.
T Consensus       247 -~~~~~~~~~~~~~-----~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 -SKLHAIIDPNHEI-----EFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -HHHHHHHCTTSCC-----CCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHHhccccc-----CCccc-----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             1111111111000     00111     13568899999999999999999999964

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.3e-43  Score=351.00  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ...++|++.+.||+|+||.||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567999999999999999999976 58899999987542  3345678999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CCeEEeecCCcc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMAR  241 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfgl~~  241 (411)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.+   +.+||+|||++.
T Consensus       114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999998887543   34889999999999999999999998   9999999999999764   559999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||......     ......... .. ..
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~-~~-~~  256 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-----EILRKVEKG-KY-TF  256 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHT-CC-CC
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhC-CC-CC
Confidence            765332   223457999999999876 56999999999999999999999998643321     111111111 10 00


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..+.      ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       257 ~~~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 DSPE------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CSGG------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             Cchh------cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0000      01124568899999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.7e-43  Score=328.33  Aligned_cols=260  Identities=23%  Similarity=0.377  Sum_probs=199.1

Q ss_pred             cchhhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeec
Q 040952           81 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID  158 (411)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (411)
                      +.+..+....++|++.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344445566789999999999999999999974 58999999987543 3346788999999999 89999999999987


Q ss_pred             ------CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          159 ------KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       159 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                            .+..++||||+++++|.+++.... ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  457899999999999999986542 345888999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  307 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  307 (411)
                      ||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|+.||......     .
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~  241 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----R  241 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----H
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----H
Confidence            999999987654321  1223357899999999987     567899999999999999999999998543211     1


Q ss_pred             HHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          308 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ......... .....    .     ...+..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~-~~~~~----~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          242 ALFLIPRNP-APRLK----S-----KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHSC-CCCCS----C-----SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhhcCc-cccCC----c-----cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111111 00000    1     111456899999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-43  Score=337.68  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=183.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecC------
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  159 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3578999999999999999999965 5889999999754  233456788999999999999999999998754      


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ...++|+|++ +++|..++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999998 6899888743    34899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc-
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR-  317 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  317 (411)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..  +............. 
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGA  251 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCH
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCH
Confidence            9765422     234578999999999887 67899999999999999999999998654321  11111111100000 


Q ss_pred             ----------cccccccccc-cccch----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 ----------TLELIDPILE-DEYSS----KHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ----------~~~~~~~~l~-~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                                ....+..... .....    ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                      0000000000 00000    0114568999999999999999999999974

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-43  Score=361.84  Aligned_cols=249  Identities=26%  Similarity=0.310  Sum_probs=203.5

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (411)
                      ..++|++.+.||+|+||.||+|... +++.||||++...   .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3467999999999999999999976 4889999998743   233456778899999987 7999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++|+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999998653   34899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..     ........ ...     
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~-~~~-----  559 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSIME-HNV-----  559 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHS-SCC-----
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HHHHHHHh-CCC-----
Confidence            3222  2234568999999999999999999999999999999999999998643211     11111111 110     


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTM-----NDVVS  362 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  362 (411)
                       .+     +...+.++.+|+.+||+.||++||++     .||++
T Consensus       560 -~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 -AY-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -CC-----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -CC-----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             00     11235678999999999999999998     77765

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.9e-43  Score=338.25  Aligned_cols=264  Identities=20%  Similarity=0.259  Sum_probs=200.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC--------Ccccceeeeeee-
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ--------HKNLVRLLGCCI-  157 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~-  157 (411)
                      ...++|++.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++        |+||+++++++. 
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            34578999999999999999999865 4889999999753 334567889999999985        788999999988 


Q ss_pred             ---cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCC---
Q 040952          158 ---DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDM---  230 (411)
Q Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~---  230 (411)
                         .....++||||+.++.+..++...  ...+++..+..++.||+.||.|||++ +   |+||||||+|||++.++   
T Consensus       113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          113 SGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EETTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred             cCCCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence               556789999999555444444322  23488999999999999999999998 7   99999999999999775   


Q ss_pred             ----------------------------------------------CeEEeecCCccccCCCCcccccccccccccccCh
Q 040952          231 ----------------------------------------------NPKISDFGMARICGGNELQANTSRIVGTYGYMSP  264 (411)
Q Consensus       231 ----------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aP  264 (411)
                                                                    .+||+|||++......     .....||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                          8999999999875422     2334789999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc----hhHHHHHHhhc--------Cc-ccccc---------
Q 040952          265 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN----LLGYAWDLWTS--------NR-TLELI---------  322 (411)
Q Consensus       265 E~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~----~~~~~~~~~~~--------~~-~~~~~---------  322 (411)
                      |++.+..++.++|||||||++|||++|+.||.........    ...........        .. ....+         
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            9999999999999999999999999999999754432211    01111110000        00 00000         


Q ss_pred             cc---------ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          323 DP---------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       323 ~~---------~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..         .......+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00         00001123445778999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-43  Score=336.18  Aligned_cols=270  Identities=19%  Similarity=0.258  Sum_probs=196.9

Q ss_pred             hhhhhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCc-----------ccHHHHHHHHHHHHhcCCcccce
Q 040952           83 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-----------QGLREMKNEASVIAKVQHKNLVR  151 (411)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~  151 (411)
                      ..++....++|++.+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4456677899999999999999999999988899999999864321           12367899999999999999999


Q ss_pred             eeeeeec-----CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          152 LLGCCID-----KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       152 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                      +++++..     ....++||||++ |+|.+++...  +..+++..+..++.|++.||.|||+++   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999854     335799999998 5776766543  335899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 040952          227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  305 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  305 (411)
                      +.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~  242 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--Q  242 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--H
Confidence            999999999999997543222   2233578999999999876 678999999999999999999999986533111  1


Q ss_pred             hHHHHHHhhcCc-----------cccccccccccc------cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          306 LGYAWDLWTSNR-----------TLELIDPILEDE------YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       306 ~~~~~~~~~~~~-----------~~~~~~~~l~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ............           ..+.+...+...      ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            101100000000           000000000000      0011124568999999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.1e-43  Score=327.80  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=195.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--------cccHHHHHHHHHHHHhcCCcccceeeeeeecC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  159 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (411)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||.+....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999976 48899999986532        12234578999999999999999999998765


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC---eEEee
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISD  236 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~D  236 (411)
                      + .++||||+++++|.+++...   ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 89999999999999988543   34889999999999999999999998   999999999999987654   99999


Q ss_pred             cCCccccCCCCcccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          237 FGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       237 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      ||++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||....... .+...    .
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~----~  232 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQ----I  232 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHH----H
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHH----H
Confidence            99998764322   123356899999999874   4678999999999999999999999986433221 11111    1


Q ss_pred             hcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          314 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       314 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..... ... +..     ....+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~-~~~-~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 TSGKY-NFI-PEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHTCC-CCC-HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCcc-ccC-chh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11100 000 000     0112467899999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.8e-43  Score=339.41  Aligned_cols=262  Identities=20%  Similarity=0.289  Sum_probs=195.2

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc------eE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE------KI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  163 (411)
                      ..+|++.+.||+|+||.||+|++..+..||+|++......    ..+|+.+++.++||||+++++++...+.      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4679999999999999999999877777999988654322    2469999999999999999999865433      78


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeEEeecCCccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARI  242 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfgl~~~  242 (411)
                      +||||++++.+............+++..+..++.|+++||+|||+++   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999998765544432223345889999999999999999999998   99999999999999 799999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhh-------
Q 040952          243 CGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT-------  314 (411)
Q Consensus       243 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------  314 (411)
                      ......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.... ....       
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~-~~~g~p~~~~~  266 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEII-KVLGTPSREQI  266 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HHHCCCCHHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HHhCCCCHHHH
Confidence            643322   2335789999999998765 58999999999999999999999986543211 011000 0000       


Q ss_pred             ---cCccccccccccccc----cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          315 ---SNRTLELIDPILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       315 ---~~~~~~~~~~~l~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         .........+.....    ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence               000000000000000    0011124678999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-43  Score=340.40  Aligned_cols=254  Identities=10%  Similarity=0.040  Sum_probs=180.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc---ccHHHHHHHHHHHHhc--CCcccceee-------eee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVIAKV--QHKNLVRLL-------GCC  156 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~  156 (411)
                      ..+|.+.+.||+|+||.||+|.+. +|+.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456899999999999999999975 589999999987542   3345677885544444  699988755       343


Q ss_pred             ecC-----------------CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 040952          157 IDK-----------------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLYLHQYSRVR  213 (411)
Q Consensus       157 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~  213 (411)
                      ...                 ...++||||++ |+|.+++.....  .+++..+      ..++.|++.||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            332                 23799999999 899999865322  2344455      678899999999999998   


Q ss_pred             eeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhC
Q 040952          214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSG  291 (411)
Q Consensus       214 ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg  291 (411)
                      |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999876421     113456799999999987  6799999999999999999999


Q ss_pred             CCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          292 KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       292 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +.||...........       ............... ......+..+.+++.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSW-------KRPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCC-------CBCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccch-------hhhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999875432211100       000000000000000 000122567899999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.4e-43  Score=334.14  Aligned_cols=261  Identities=23%  Similarity=0.261  Sum_probs=191.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (411)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999965 4889999998753  2334567889999999999999999999997765      


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..++||||+++ +|.+++.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6766663     23788899999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHH------------
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY------------  308 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~------------  308 (411)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ....            
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHH
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence            8654321   12335789999999999999999999999999999999999999865432110 0000            


Q ss_pred             ------HHHHhhcCc------ccccccccccc--ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          309 ------AWDLWTSNR------TLELIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       309 ------~~~~~~~~~------~~~~~~~~l~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                            .........      ....+......  .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                  000000000      00000000000  00122336789999999999999999999999974

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.4e-43  Score=334.08  Aligned_cols=265  Identities=19%  Similarity=0.273  Sum_probs=200.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecC-----Cc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (411)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3578999999999999999999976 58889999997543 33446788999999999999999999998765     36


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+. ++|.+++..    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            799999997 488888743    34889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccc-ccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          242 ICGGNELQA-NTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       242 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ......... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.......  ...............
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQE  254 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHHHCSCCHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHHhCCCCHH
Confidence            764322111 123457999999999865 4558999999999999999999999986543211  111111100000000


Q ss_pred             -----------cccccccc-cccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          320 -----------ELIDPILE-DEYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       320 -----------~~~~~~l~-~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                                 ........ ....    ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       00000000 0000    01124578999999999999999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.2e-43  Score=334.43  Aligned_cols=269  Identities=18%  Similarity=0.227  Sum_probs=187.8

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCc---
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE---  161 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  161 (411)
                      .....++|++.+.||+|+||.||+|.+. +|+.||||++..... ......+++..+..++||||+++++++...+.   
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            4456789999999999999999999975 589999999865432 23456778888999999999999999876443   


Q ss_pred             ----eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeecCCCCCCEEEcC-CCCeEE
Q 040952          162 ----KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--QYSRVRIIHRDLKASNILLDK-DMNPKI  234 (411)
Q Consensus       162 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~dlkp~Nill~~-~~~~kl  234 (411)
                          .++||||++++.+..+.........+++.....++.|++.||.|||  +.+   |+||||||+|||++. ++.+||
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence                7899999987644333322233455788899999999999999999  777   999999999999997 899999


Q ss_pred             eecCCccccCCCCcccccccccccccccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHh
Q 040952          235 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  313 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  313 (411)
                      +|||++........   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......  .........
T Consensus       174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~  248 (360)
T 3e3p_A          174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRVL  248 (360)
T ss_dssp             CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHH
T ss_pred             eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHHc
Confidence            99999987653322   23357899999999987654 8999999999999999999999986543211  110010000


Q ss_pred             hc------------Cccccccccc-c--ccc--cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          314 TS------------NRTLELIDPI-L--EDE--YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       314 ~~------------~~~~~~~~~~-l--~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ..            .......... .  ...  ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00            0000000000 0  000  0001125679999999999999999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.2e-43  Score=323.93  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=202.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---------cccHHHHHHHHHHHHhcC-Ccccceeeeeee
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---------GQGLREMKNEASVIAKVQ-HKNLVRLLGCCI  157 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  157 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999976 48899999987543         122456789999999995 999999999999


Q ss_pred             cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          158 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                      ..+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999998543   34889999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  311 (411)
                      |++.......   ......|++.|+|||++.      ...++.++||||||+++|+|++|+.||......     .....
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~  240 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-----LMLRM  240 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-----HHHHH
Confidence            9998765322   223357899999999885      456889999999999999999999998543211     11111


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      . ...... ...+      .....+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~-~~~~~~-~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 I-MSGNYQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H-HHTCCC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H-hcCCcc-cCcc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1 111100 0000      01122567899999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-42  Score=339.37  Aligned_cols=201  Identities=22%  Similarity=0.292  Sum_probs=171.8

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc------CCcccceeeeeeecCC
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV------QHKNLVRLLGCCIDKD  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~  160 (411)
                      ....+|++.+.||+|+||.||+|.+.. ++.||||++... ......+.+|+.+++.+      .|+||+++++++...+
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            345679999999999999999998764 889999999754 23345677888888887      5779999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC--eEEeecC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFG  238 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg  238 (411)
                      ..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.  +||+|||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             eEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence            9999999996 588887755332 34889999999999999999999998   999999999999999887  9999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  299 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  299 (411)
                      ++......     .....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus       248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99765422     233578999999999999999999999999999999999999986543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=335.83  Aligned_cols=268  Identities=22%  Similarity=0.312  Sum_probs=181.9

Q ss_pred             hcCCCc-cCcccccCcccEEEEEec---CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec--CCceE
Q 040952           90 TNKFSD-ANKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI  163 (411)
Q Consensus        90 ~~~y~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  163 (411)
                      .+.|++ .++||+|+||.||+|...   +++.||||++.....  ...+.+|+.++++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            345665 458999999999999965   478899999975432  3467899999999999999999999954  66889


Q ss_pred             EEEeeCCCCCchhhhcCC------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCCeE
Q 040952          164 LIYEYMPNKSLDFFLFDP------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPK  233 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~k  233 (411)
                      +||||+.+ +|.+++...      .....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999975 666665321      12234889999999999999999999998   9999999999999    6789999


Q ss_pred             EeecCCccccCCCCc-ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-------c
Q 040952          234 ISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-------N  304 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-------~  304 (411)
                      |+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|++||.....+..       +
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987653221 1223346789999999999874 589999999999999999999999965432110       1


Q ss_pred             hhHHHHHHhhcCc--cccccc----------ccccccc---chH--------HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040952          305 LLGYAWDLWTSNR--TLELID----------PILEDEY---SSK--------HMLLRYVNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       305 ~~~~~~~~~~~~~--~~~~~~----------~~l~~~~---~~~--------~~~~~l~~li~~cl~~~p~~RPt~~evl  361 (411)
                      .............  ....+.          ......+   ...        ..+..+.+|+.+||+.||++|||+.|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            1111111100000  000000          0000000   000        0034678999999999999999999999


Q ss_pred             HH
Q 040952          362 SM  363 (411)
Q Consensus       362 ~~  363 (411)
                      +.
T Consensus       333 ~h  334 (405)
T 3rgf_A          333 QD  334 (405)
T ss_dssp             TS
T ss_pred             cC
Confidence            75

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.8e-43  Score=326.72  Aligned_cols=264  Identities=23%  Similarity=0.314  Sum_probs=193.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeee-----------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI-----------  157 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  157 (411)
                      .++|++.+.||+|+||.||+|.+.. |+.||+|++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            5789999999999999999999775 8999999998776666788999999999999999999998874           


Q ss_pred             ---cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeE
Q 040952          158 ---DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPK  233 (411)
Q Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~k  233 (411)
                         +....++||||++ |+|.+++..    ..+++..+..++.|++.||+|||+++   |+||||||+||+++ .++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467799999998 689988843    34788999999999999999999998   99999999999997 567999


Q ss_pred             EeecCCccccCCCCc-ccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHH
Q 040952          234 ISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  311 (411)
                      |+|||++........ ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  .......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~  239 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILE  239 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            999999987643211 112233467899999998865 678999999999999999999999986543211  0000000


Q ss_pred             Hhhc------Cccccccc----cccc-cccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          312 LWTS------NRTLELID----PILE-DEYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       312 ~~~~------~~~~~~~~----~~l~-~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....      ......+.    .... ....    ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            0000      00000000    0000 0000    01125678999999999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-42  Score=332.60  Aligned_cols=259  Identities=21%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce---
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK---  162 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  162 (411)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3578999999999999999999976 48899999997642  33356788999999999999999999999887655   


Q ss_pred             ---EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          163 ---ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       163 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                         ++||||+. ++|..++.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999998 57877762     22889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC--
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--  316 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  316 (411)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ............  
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~  263 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT  263 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCH
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcH
Confidence            9765422     234578999999999887 678999999999999999999999986433111  000000000000  


Q ss_pred             ccccc------------ccccccccc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 RTLEL------------IDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 ~~~~~------------~~~~l~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .....            +........  .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00000            000000000  001125678999999999999999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-42  Score=334.52  Aligned_cols=263  Identities=21%  Similarity=0.265  Sum_probs=193.0

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecC------
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  159 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (411)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999964 5899999998754322    24799999999999999999998543      


Q ss_pred             --------------------------------CceEEEEeeCCCCCchhhhcCC-CCCcCCCHHHHHHHHHHHHHHHHHH
Q 040952          160 --------------------------------DEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYL  206 (411)
Q Consensus       160 --------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~L  206 (411)
                                                      ...++||||+++ +|.+.+... .....+++..+..++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            347899999984 776665431 2234589999999999999999999


Q ss_pred             hhcCCCCeeecCCCCCCEEEc-CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHH
Q 040952          207 HQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVL  284 (411)
Q Consensus       207 H~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~i  284 (411)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9998   99999999999998 688999999999987643322   2334789999999998865 48999999999999


Q ss_pred             HHHHHhCCCCCCCCcccccchhHHHHHHhhc----------Cccccccccccccc----cchHHHHHHHHHHHHHccccC
Q 040952          285 LLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS----------NRTLELIDPILEDE----YSSKHMLLRYVNIALLCVQES  350 (411)
Q Consensus       285 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~~----~~~~~~~~~l~~li~~cl~~~  350 (411)
                      +|||++|+.||.......  ...........          ....+..-+.+...    ..+...+..+.+|+.+||+.|
T Consensus       232 l~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            999999999986533211  11000000000          00000000000000    001112456899999999999


Q ss_pred             CCCCCCHHHHHH
Q 040952          351 ADDRPTMNDVVS  362 (411)
Q Consensus       351 p~~RPt~~evl~  362 (411)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-42  Score=328.86  Aligned_cols=263  Identities=22%  Similarity=0.284  Sum_probs=203.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEe-c-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc------cceeeeeeecC
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVL-K-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN------LVRLLGCCIDK  159 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~  159 (411)
                      ...++|++.+.||+|+||.||+|.+ . +|+.||||++... ....+.+.+|+.+++.++|++      ++++++++...
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            3457899999999999999999986 3 5889999999754 234567889999999987665      99999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----------
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----------  228 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----------  228 (411)
                      +..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.           
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            9999999999 888988886543 235788999999999999999999998   999999999999987           


Q ss_pred             --------CCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 040952          229 --------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  300 (411)
Q Consensus       229 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  300 (411)
                              ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                    678999999999764422     2345789999999999999999999999999999999999999875432


Q ss_pred             cccchhHHHHHHhhc--------Cccc---------------------cccccccccccchHHHHHHHHHHHHHccccCC
Q 040952          301 DSLNLLGYAWDLWTS--------NRTL---------------------ELIDPILEDEYSSKHMLLRYVNIALLCVQESA  351 (411)
Q Consensus       301 ~~~~~~~~~~~~~~~--------~~~~---------------------~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p  351 (411)
                      ..  ...........        ....                     ....+...........+..+.+++.+||+.||
T Consensus       240 ~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          240 KE--HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             HH--HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HH--HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            11  11011000000        0000                     00000000011122346789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 040952          352 DDRPTMNDVVSM  363 (411)
Q Consensus       352 ~~RPt~~evl~~  363 (411)
                      ++|||+.|+++.
T Consensus       318 ~~Rpt~~ell~h  329 (339)
T 1z57_A          318 AKRITLREALKH  329 (339)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             ccccCHHHHhcC
Confidence            999999999854

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-42  Score=352.01  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=205.2

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      .....++|++.+.||+|+||.||+|.+..    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            33445779999999999999999998642    4579999987543 334567899999999999999999999985 46


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            7899999999999999986432  34889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      +........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......     ......... ...
T Consensus       539 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~~~i~~~-~~~  611 (656)
T 2j0j_A          539 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENG-ERL  611 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHHT-CCC
T ss_pred             eecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHcC-CCC
Confidence            876543221 2223457789999999999999999999999999999997 99998643211     111111111 100


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      .     +     +...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       612 ~-----~-----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          612 P-----M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             C-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-----C-----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            0     1     11224678999999999999999999999999988754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.2e-43  Score=341.19  Aligned_cols=262  Identities=22%  Similarity=0.282  Sum_probs=191.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecC------Cce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  162 (411)
                      ..+|++.+.||+|+||.||+|++. +|+.||||++.....    ...+|+++++.++||||+++++++...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346999999999999999999986 489999999865432    234799999999999999999998542      136


Q ss_pred             EEEEeeCCCCCchhhhcC-CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CCeEEeecCCc
Q 040952          163 ILIYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMA  240 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfgl~  240 (411)
                      ++||||+++ ++..++.. ......+++..+..++.||++||.|||+++   |+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999986 44444322 122345899999999999999999999998   9999999999999965 56899999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH-------
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL-------  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  312 (411)
                      +.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......       
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence            87643221   2335789999999998765 79999999999999999999999986533211 111111100       


Q ss_pred             h--hcCcccccccccccccc----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 W--TSNRTLELIDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ~--~~~~~~~~~~~~l~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      +  ......+...+.+....    .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0  00000111001110000    011124678999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8e-42  Score=316.06  Aligned_cols=253  Identities=23%  Similarity=0.282  Sum_probs=202.2

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ....++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            455678999999999999999999976 5899999998654  2345678899999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CCeEEeecCCc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMA  240 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfgl~  240 (411)
                      +|+||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999998887543   34889999999999999999999998   9999999999999754   46999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......     ........ .....
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~  241 (287)
T 2wei_A          172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DILKRVET-GKYAF  241 (287)
T ss_dssp             GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH-CCCCC
T ss_pred             eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHc-CCCCC
Confidence            87643321   223468999999998865 4899999999999999999999998643211     11111111 11000


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                          ...   .....+..+.+++.+||+.||++|||+.|+++
T Consensus       242 ----~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 ----DLP---QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----CSG---GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----Cch---hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                000   00112456899999999999999999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.6e-42  Score=328.71  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=198.7

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecC-----Cc
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  161 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+.... ......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999976 58899999997543 33456788999999999999999999987754     67


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .++||||+. ++|..++..    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 588888754    34889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccc--------ccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          242 ICGGNELQA--------NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       242 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      .........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~  238 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIFGI  238 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHH
Confidence            765322111        1223478999999998764 678999999999999999999999986543211  00011111


Q ss_pred             hhcCccc------------ccccccc--ccc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 WTSNRTL------------ELIDPIL--EDE---YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ~~~~~~~------------~~~~~~l--~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .......            +.+....  ...   ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1000000            0000000  000   0001225678899999999999999999999973

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4e-42  Score=323.76  Aligned_cols=265  Identities=24%  Similarity=0.324  Sum_probs=198.0

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec--CCCEEEEEEccCCC--cccHHHHHHHHHHHHhc---CCcccceeeeeee---
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCI---  157 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---  157 (411)
                      ...++|++.+.||+|+||.||+|.+.  +|+.||+|++....  ......+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34578999999999999999999973  58899999986432  11223456777777666   8999999999987   


Q ss_pred             --cCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          158 --DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       158 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                        .....++||||++ |+|.+++..... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999998 589888865432 34789999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                      |||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ...........
T Consensus       163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~  237 (326)
T 1blx_A          163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGL  237 (326)
T ss_dssp             SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred             cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCC
Confidence            99999765422   12334578999999999999999999999999999999999999986543211  11111110000


Q ss_pred             Cc---cc---cccccccc----c--ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          316 NR---TL---ELIDPILE----D--EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       316 ~~---~~---~~~~~~l~----~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..   ..   ........    .  .......+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00   00   00000000    0  0001112567889999999999999999999995

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.1e-42  Score=319.87  Aligned_cols=254  Identities=23%  Similarity=0.343  Sum_probs=191.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec---------
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID---------  158 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  158 (411)
                      ..++|++.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3567999999999999999999975 5899999999643 3445678899999999999999999998865         


Q ss_pred             ----CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEE
Q 040952          159 ----KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  234 (411)
Q Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  234 (411)
                          .+..++||||+++++|.+++....  ..+++...+.++.|++.||+|||+++   ++||||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                346789999999999999996432  34678888999999999999999998   999999999999999999999


Q ss_pred             eecCCccccCCCCc------------ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccc
Q 040952          235 SDFGMARICGGNEL------------QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  301 (411)
Q Consensus       235 ~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~  301 (411)
                      +|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||....  
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence            99999976542210            1122345689999999998764 68999999999999999998   432111  


Q ss_pred             ccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          302 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        ........ .....  ..+.+..     ....+..+.+++.+||+.||++|||+.++++.
T Consensus       233 --~~~~~~~~-~~~~~--~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 --ERVNILKK-LRSVS--IEFPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HHHHHHHH-HHSTT--CCCCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --hHHHHHHh-ccccc--cccCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence              00111111 11100  0011111     11124568899999999999999999999873

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=321.57  Aligned_cols=256  Identities=21%  Similarity=0.284  Sum_probs=194.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc-----
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-----  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  161 (411)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999975 58999999997542  2335678899999999999999999999987654     


Q ss_pred             -eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          162 -KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       162 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                       .++||||+. ++|..++..     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 588777632     3889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC---
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN---  316 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  316 (411)
                      ......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ............   
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTE  246 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence            765322     233578999999999886 678999999999999999999999986433111  110000000000   


Q ss_pred             ---------------ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          317 ---------------RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       317 ---------------~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                                     .........+..  .....+..+.+++.+||+.||++|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQ--LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTT--TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHH--hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                           000000000000  011225678999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.1e-42  Score=334.57  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=186.6

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      +.|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            445667889999999998776667999999998653   235678899999886 8999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCc----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-------------CCe
Q 040952          170 PNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-------------MNP  232 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-------------~~~  232 (411)
                      . |+|.+++.......    ...+..++.++.|++.||+|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999986543211    1123345689999999999999998   9999999999999754             489


Q ss_pred             EEeecCCccccCCCCcc--cccccccccccccChhhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 040952          233 KISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  302 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  302 (411)
                      ||+|||++.........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543221  12234579999999999875       568999999999999999999 999986432111


Q ss_pred             cchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          303 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                         .    ............     ........+..+.+++.+||+.||++|||+.++++
T Consensus       248 ---~----~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---S----NIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---H----HHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---H----HHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               0    111110000000     11123345678999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-41  Score=326.48  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----------Ccccceeeeeee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCI  157 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  157 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999999964 5889999999753 234466788999999886           899999999988


Q ss_pred             cCC----ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEc-----
Q 040952          158 DKD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLD-----  227 (411)
Q Consensus       158 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~-----  227 (411)
                      ..+    ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 8899998865332 3488999999999999999999998 7   99999999999994     


Q ss_pred             -CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc--
Q 040952          228 -KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN--  304 (411)
Q Consensus       228 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--  304 (411)
                       ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4457999999999875422     23347899999999999999999999999999999999999999754322110  


Q ss_pred             --hhHHHHHH------------------hhcCcccccccc--------ccc-cccchHHHHHHHHHHHHHccccCCCCCC
Q 040952          305 --LLGYAWDL------------------WTSNRTLELIDP--------ILE-DEYSSKHMLLRYVNIALLCVQESADDRP  355 (411)
Q Consensus       305 --~~~~~~~~------------------~~~~~~~~~~~~--------~l~-~~~~~~~~~~~l~~li~~cl~~~p~~RP  355 (411)
                        ........                  +........+..        .+. ....+...+..+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence              00000000                  000000000000        000 0012344578899999999999999999


Q ss_pred             CHHHHHHH
Q 040952          356 TMNDVVSM  363 (411)
Q Consensus       356 t~~evl~~  363 (411)
                      |+.|+++.
T Consensus       327 t~~ell~h  334 (373)
T 1q8y_A          327 DAGGLVNH  334 (373)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhhC
Confidence            99999973

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-41  Score=328.09  Aligned_cols=208  Identities=23%  Similarity=0.316  Sum_probs=173.1

Q ss_pred             chhhhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-Cc-----ccceeee
Q 040952           82 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HK-----NLVRLLG  154 (411)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~  154 (411)
                      .........++|++.+.||+|+||.||+|.+. +|+.||||++... ......+..|+.+++.++ |+     +|+++++
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            33444556789999999999999999999976 4789999999753 233566778888888884 44     4999999


Q ss_pred             eeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCCCe
Q 040952          155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNP  232 (411)
Q Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~  232 (411)
                      ++...+..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||++. .+|+||||||+|||++  .++.+
T Consensus       124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEETTEEEEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeccCCceEEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcE
Confidence            99999999999999965 88888865432 34889999999999999999999531 2399999999999994  57889


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY  298 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  298 (411)
                      ||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876432     23357899999999999999999999999999999999999998754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-41  Score=322.05  Aligned_cols=254  Identities=19%  Similarity=0.214  Sum_probs=173.9

Q ss_pred             HhcCCCccC-cccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec----CCce
Q 040952           89 ATNKFSDAN-KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEK  162 (411)
Q Consensus        89 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  162 (411)
                      ..++|.+.+ .||+|+||.||+|.+. +|+.||||++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            457888855 6999999999999976 58999999986532    222333344667799999999999876    4457


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCC
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGM  239 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl  239 (411)
                      ++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            999999999999999975432 45899999999999999999999998   999999999999976   45599999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      +.......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........  ......... .
T Consensus       178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~-~  250 (336)
T 3fhr_A          178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLGQ-Y  250 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhccc-c
Confidence            98654322    2335789999999999888899999999999999999999999864332211000  000000000 0


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ....      ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       251 ~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          251 GFPN------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             CCCT------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccCc------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000      0001225678999999999999999999999973

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.3e-42  Score=321.56  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=176.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHH-HHHhcCCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999975 58899999997653 233344555665 666789999999999999999999999


Q ss_pred             eeCCCCCchhhhcC--CCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          167 EYMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       167 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 77666542  11234588999999999999999999998 8   999999999999999999999999999766


Q ss_pred             CCCCcccccccccccccccChhhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ....   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||..........          ....
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~  243 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----------TQVV  243 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----------HHHh
Confidence            4322   12234689999999998    45678999999999999999999999986432111000          0000


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ....+.+... .....+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          244 KGDPPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CSCCCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000111110 00112457899999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-41  Score=322.33  Aligned_cols=262  Identities=21%  Similarity=0.265  Sum_probs=198.1

Q ss_pred             HHhcCCCccCcccccCcccEEEEEecC-C-CEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc------cceeeeeeecC
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLKK-G-DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN------LVRLLGCCIDK  159 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~  159 (411)
                      ...++|++.+.||+|+||.||+|.... + +.||+|++... ....+.+.+|+.+++.++|++      ++.+.+++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            345789999999999999999999753 4 68999999753 234567888999999998766      89999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-------------
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-------------  226 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-------------  226 (411)
                      +..++||||+. +++.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||+             
T Consensus        95 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           95 GHMCIAFELLG-KNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CeEEEEEeccC-CChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            99999999995 45555554322 234889999999999999999999998   9999999999999             


Q ss_pred             ------cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 040952          227 ------DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  300 (411)
Q Consensus       227 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  300 (411)
                            +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                  66889999999999764322     2335789999999999999999999999999999999999999875432


Q ss_pred             cccchhHHHHHHhhc--------Ccccc---------------------ccccccccccchHHHHHHHHHHHHHccccCC
Q 040952          301 DSLNLLGYAWDLWTS--------NRTLE---------------------LIDPILEDEYSSKHMLLRYVNIALLCVQESA  351 (411)
Q Consensus       301 ~~~~~~~~~~~~~~~--------~~~~~---------------------~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p  351 (411)
                      ..  ...........        .....                     ...+...........+..+.+++.+||+.||
T Consensus       245 ~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          245 RE--HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             HH--HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HH--HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            11  01011110000        00000                     0000000001112235689999999999999


Q ss_pred             CCCCCHHHHHH
Q 040952          352 DDRPTMNDVVS  362 (411)
Q Consensus       352 ~~RPt~~evl~  362 (411)
                      ++|||+.|+++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-42  Score=323.51  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=198.0

Q ss_pred             hhhHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc------cHHHHHHHHHHHHhcC--Ccccceeeee
Q 040952           85 SVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ------GLREMKNEASVIAKVQ--HKNLVRLLGC  155 (411)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~  155 (411)
                      ......++|++.+.||+|+||.||+|.+. +|+.||||.+......      ....+.+|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            33445688999999999999999999864 5889999998654211      1234678999999996  5999999999


Q ss_pred             eecCCceEEEEeeCCC-CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeE
Q 040952          156 CIDKDEKILIYEYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPK  233 (411)
Q Consensus       156 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~k  233 (411)
                      +...+..++|+|++.+ ++|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ +++.+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence            9999999999999986 8999988542   34889999999999999999999998   99999999999999 789999


Q ss_pred             EeecCCccccCCCCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          234 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      |+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....           ..
T Consensus       191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~  255 (320)
T 3a99_A          191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EI  255 (320)
T ss_dssp             ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HH
T ss_pred             EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------hh
Confidence            99999998765322    233568999999999887665 788999999999999999999985321           00


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .....   .    ...     ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       256 ~~~~~---~----~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          256 IRGQV---F----FRQ-----RVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             HHCCC---C----CSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hcccc---c----ccc-----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11100   0    011     124568899999999999999999999873

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.7e-42  Score=319.57  Aligned_cols=244  Identities=21%  Similarity=0.350  Sum_probs=190.4

Q ss_pred             hHHhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc------cHHHHHHHHHHHHhc----CCcccceeeee
Q 040952           87 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ------GLREMKNEASVIAKV----QHKNLVRLLGC  155 (411)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~~  155 (411)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            445688999999999999999999864 5889999999754321      223356799999998    89999999999


Q ss_pred             eecCCceEEEEee-CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeE
Q 040952          156 CIDKDEKILIYEY-MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPK  233 (411)
Q Consensus       156 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~k  233 (411)
                      +...+..++|+|+ +.+++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 7899999998643   34899999999999999999999998   99999999999999 889999


Q ss_pred             EeecCCccccCCCCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          234 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       234 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      |+|||++.......    .....||..|+|||++.+..+ +.++|||||||++|||++|+.||....           ..
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~  245 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------EI  245 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HH
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------HH
Confidence            99999998765332    234568999999999887766 458999999999999999999985321           00


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ... ..      .+.     ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~-~~------~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 LEA-EL------HFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHT-CC------CCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hhh-cc------CCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000 00      001     1124568899999999999999999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=319.27  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=179.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc--cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++......  ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467899999999999999999976 5899999999765322  2233445556788889999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+ ++.+..+....  ...+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 45555544321  23488999999999999999999985 7   99999999999999999999999999976543


Q ss_pred             CCcccccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ..   ......||+.|+|||++.     +..++.++|||||||++|||++|+.||.......    ...........   
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~---  247 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF----EVLTKVLQEEP---  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHHSCC---
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH----HHHHHHhccCC---
Confidence            22   123346899999999984     4568899999999999999999999986432211    11111111110   


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         +.+...   ...+..+.+++.+||+.||.+|||+.++++.
T Consensus       248 ---~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 ---PLLPGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ---CCCCSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---CCCCcc---CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               111110   0124568899999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=330.25  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=185.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..+|...+.||+|+||+||.....+|+.||||++......   .+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4568889999999999976555556999999999754332   346899999999 899999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----CCCeEEeecCCcccc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMARIC  243 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfgl~~~~  243 (411)
                      +. |+|.+++.....  .........++.|++.||.|||+++   |+||||||+|||++.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 589888865432  2344456789999999999999998   999999999999953     346889999999876


Q ss_pred             CCCCc-ccccccccccccccChhhhc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          244 GGNEL-QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       244 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||+......      ... ......
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------~~~-~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANI-LLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------HHH-HTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------HHH-HhccCC
Confidence            53221 12233457999999999987   4567889999999999999999 899985322111      000 111100


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ....       .........+.+++.+||+.||++|||+.++++
T Consensus       247 ~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 LDCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CTTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0110       111223556889999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.9e-41  Score=341.98  Aligned_cols=261  Identities=24%  Similarity=0.307  Sum_probs=197.4

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeec------CC
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID------KD  160 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  160 (411)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.++++++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            3478999999999999999999975 5899999998754 33445678999999999999999999998765      66


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC---eEEeec
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDF  237 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Df  237 (411)
                      ..++||||+++|+|.+++........+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            78999999999999999977655556888899999999999999999998   999999999999997765   999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH-----
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL-----  312 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----  312 (411)
                      |++........   .....||+.|+|||.+.+..++.++|||||||++|+|++|..||......    ..|....     
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC----
T ss_pred             ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccc
Confidence            99987653322   23457899999999999999999999999999999999999998643110    0000000     


Q ss_pred             ---hhcCcccc--ccccccc-cccchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 040952          313 ---WTSNRTLE--LIDPILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMND  359 (411)
Q Consensus       313 ---~~~~~~~~--~~~~~l~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  359 (411)
                         ........  .....+. ........+..+.+++.+||+.||++|||+.+
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence               00000000  0000000 01112224678999999999999999999977

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-40  Score=343.82  Aligned_cols=242  Identities=20%  Similarity=0.310  Sum_probs=194.5

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec--CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCc---
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE---  161 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  161 (411)
                      ...++|++.+.||+|+||.||+|.+.  +|+.||||++.... ......+.+|+.++++++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            34588999999999999999999975  58899999987543 3445678899999999999999999999987665   


Q ss_pred             --eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          162 --KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       162 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                        .|+||||+++++|.+++..     .+++..++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence              6999999999999887633     4899999999999999999999998   9999999999999885 999999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ++.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|.+|+.......                 
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------  283 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------  283 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred             chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence            9876432      3457999999999887654 899999999999999999988764211100                 


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhhcc
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT-MNDVVSMLTNEA  368 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L~~~~  368 (411)
                            +.........+..+.+++.+||+.||++||+ +.++.+.|....
T Consensus       284 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 ------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                  0011111223467899999999999999995 556666665543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.6e-40  Score=304.71  Aligned_cols=233  Identities=11%  Similarity=0.065  Sum_probs=184.2

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      ..++|++.+.||+|+||.||+|.+.. |+.||||++.....   ...+.+.+|+..+.+++||||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            34789999999999999999999764 89999999976532   334678999999999999999999999999999999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++++|.+++...     ........++.|++.||+|||+++   |+||||||+|||++.++.+||+++|      
T Consensus       109 v~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            99999999999998432     244567889999999999999998   9999999999999999999998544      


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                                      |++|       ++.++|||||||++|||++|+.||...........           .......
T Consensus       175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------~~~~~~~  220 (286)
T 3uqc_A          175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTAG  220 (286)
T ss_dssp             ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------CCBCTTS
T ss_pred             ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------HHHHhcc
Confidence                            3333       68899999999999999999999875432210000           0000000


Q ss_pred             ccc-cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          325 ILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       325 ~l~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      ... ........+..+.+++.+||+.||++| |+.|+++.|+.....
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            000 000011225678999999999999999 999999999887654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.7e-39  Score=298.25  Aligned_cols=235  Identities=18%  Similarity=0.246  Sum_probs=180.8

Q ss_pred             HhcCCCcc-CcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHH-HhcCCcccceeeeeeec----CCc
Q 040952           89 ATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVI-AKVQHKNLVRLLGCCID----KDE  161 (411)
Q Consensus        89 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~  161 (411)
                      ..++|.+. +.||+|+||.||+|... +|+.||+|++...     ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            34667776 78999999999999975 5899999998642     3567888888 55699999999999876    667


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecC
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  238 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg  238 (411)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++   |+||||||+||+++.   ++.+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            899999999999999986543 235899999999999999999999998   999999999999998   7899999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      ++....                        +..++.++|||||||++|||++|+.||.........           ...
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~  210 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGM  210 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCS
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHH
Confidence            986532                        234678999999999999999999998643221100           000


Q ss_pred             ccccccccccccch---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhcc
Q 040952          319 LELIDPILEDEYSS---KHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEA  368 (411)
Q Consensus       319 ~~~~~~~l~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~  368 (411)
                      ...+.... ...+.   ...+..+.+++.+||+.||++|||+.|+++.  +.+..
T Consensus       211 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          211 KTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CCSSCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HHHHhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            00000000 00010   1235679999999999999999999999973  44443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-39  Score=316.73  Aligned_cols=241  Identities=15%  Similarity=0.168  Sum_probs=178.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCC-ccccee---------eee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQH-KNLVRL---------LGC  155 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l---------~~~  155 (411)
                      ..+|...+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+.+++.++| .|....         .+.
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            455778899999999999999965 59999999987432   2336778999999999977 222111         111


Q ss_pred             ------------eec-----CCceEEEEeeCCCCCchhhhcC----CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 040952          156 ------------CID-----KDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI  214 (411)
Q Consensus       156 ------------~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  214 (411)
                                  +..     ....+++|++ .+++|.+++..    ......+++..++.++.|+++||+|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                        111     1234566665 46889888731    122345788889999999999999999998   9


Q ss_pred             eecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhh----------ccCCCCcchhhHHHHHH
Q 040952          215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA----------LEGIFSIKSDVFSFGVL  284 (411)
Q Consensus       215 vH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~i  284 (411)
                      +||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998765422     334577 999999999          55568899999999999


Q ss_pred             HHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040952          285 LLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       285 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  361 (411)
                      +|||++|+.||.......                  .....+....   ..+..+.+++.+||+.||++|||+.+++
T Consensus       307 l~elltg~~Pf~~~~~~~------------------~~~~~~~~~~---~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALG------------------GSEWIFRSCK---NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGS------------------CSGGGGSSCC---CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhh------------------hHHHHHhhcc---cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999986432111                  0111111100   1145689999999999999999976664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.9e-39  Score=305.77  Aligned_cols=241  Identities=16%  Similarity=0.148  Sum_probs=182.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--------cccHHHHHHHHHHHHhcC----------------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--------GQGLREMKNEASVIAKVQ----------------  145 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~----------------  145 (411)
                      .++|++.+.||+|+||.||+|++ +|+.||||++....        ....+.+.+|+.+++.++                
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 58999999997542        233477899999999986                


Q ss_pred             ----------Ccccceeeeeeec-------------CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHH
Q 040952          146 ----------HKNLVRLLGCCID-------------KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG  202 (411)
Q Consensus       146 ----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~  202 (411)
                                ||||+++++++.+             .+..++||||+++|++.+.+..    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence                      5555555555554             6789999999999976666532    347899999999999999


Q ss_pred             HHHHh-hcCCCCeeecCCCCCCEEEcCCC--------------------CeEEeecCCccccCCCCcccccccccccccc
Q 040952          203 LLYLH-QYSRVRIIHRDLKASNILLDKDM--------------------NPKISDFGMARICGGNELQANTSRIVGTYGY  261 (411)
Q Consensus       203 l~~LH-~~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y  261 (411)
                      |+||| +++   |+||||||+|||++.++                    .+||+|||+++....       ....||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 888   99999999999999887                    899999999987542       234799999


Q ss_pred             cChhhhccCCCCcchhhHHHHHH-HHHHHhCCCCCCCCcccccchhHHHH-HHhhcCccccccccccccccchHHHHHHH
Q 040952          262 MSPEYALEGIFSIKSDVFSFGVL-LLEIVSGKKNTGLYRTDSLNLLGYAW-DLWTSNRTLELIDPILEDEYSSKHMLLRY  339 (411)
Q Consensus       262 ~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~l  339 (411)
                      +|||++.+.. +.++||||||++ .+++++|..||...     ....... .........     ...........+..+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFK-----TKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCS-----SCCCSHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccC-----cccchhhhhhcCHHH
Confidence            9999998766 899999998777 78888899886310     0000000 101000000     000111233467889


Q ss_pred             HHHHHHccccCCCCCCCHHHHH
Q 040952          340 VNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       340 ~~li~~cl~~~p~~RPt~~evl  361 (411)
                      .+|+.+||+.|     |+.|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            99999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.4e-32  Score=274.62  Aligned_cols=185  Identities=16%  Similarity=0.129  Sum_probs=129.6

Q ss_pred             cccccCcccEEEEE-ecCCCEEEEEEccCCC----------cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEE
Q 040952           98 KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRS----------GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        98 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ..+.|++|.+..++ .-.|+.+++|.+....          ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777666554 2238889999986531          22346799999999999 799999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||++|++|.+++....   +++..   +|+.||+.||+|+|++|   |+||||||+|||++.+|.+||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999996543   35543   58999999999999999   99999999999999999999999999987653


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  294 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  294 (411)
                      ..  ......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  22344689999999998875 467789999999998887666443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=3e-29  Score=250.72  Aligned_cols=184  Identities=20%  Similarity=0.206  Sum_probs=146.0

Q ss_pred             ccCcccccCcccEEEEEecCCCEEEEEEccCCCc--------ccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           95 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..+.||+|+||.||+|... ++.+++|+......        ...+.+.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            4568999999999999654 88899998654321        11345789999999999999997777777788889999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++++|.+++..           ...++.|+++||.|||+++   |+||||||+|||++.  .+||+|||+++.....
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999999854           3589999999999999998   999999999999998  9999999999887543


Q ss_pred             Cccc-----ccccccccccccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 040952          247 ELQA-----NTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNT  295 (411)
Q Consensus       247 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~  295 (411)
                      ....     ......||+.|+|||++.+  ..|+..+|+||..+-..+-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2111     1234689999999999986  56888899999999988888877664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.4e-25  Score=206.04  Aligned_cols=147  Identities=18%  Similarity=0.128  Sum_probs=118.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCc------------------ccHHHHHHHHHHHHhcCCcccce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG------------------QGLREMKNEASVIAKVQHKNLVR  151 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~  151 (411)
                      ...|.+.+.||+|+||.||+|.+.+|+.||+|.+.....                  .....+.+|+.++++++  | ++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            445666799999999999999997799999999864321                  12456889999999999  5 66


Q ss_pred             eeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCC
Q 040952          152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  231 (411)
Q Consensus       152 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  231 (411)
                      +.+++.. +..++||||+++++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||++ ++.
T Consensus       166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          166 VPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             SCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTE
T ss_pred             cCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCc
Confidence            6665543 56799999999999988 421         123479999999999999998   99999999999999 999


Q ss_pred             eEEeecCCccccCCCCcccccccccccccccChhhhcc
Q 040952          232 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE  269 (411)
Q Consensus       232 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  269 (411)
                      +||+|||+++.               +..+.|||++..
T Consensus       231 vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          231 IWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             EEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99999999853               345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.9e-21  Score=174.28  Aligned_cols=136  Identities=15%  Similarity=0.160  Sum_probs=104.5

Q ss_pred             CCccCcccccCcccEEEEEe-cCCCE--EEEEEccCCCcc------------------------cHHHHHHHHHHHHhcC
Q 040952           93 FSDANKLGEGGFGPVYKGVL-KKGDE--IAVKRLSGRSGQ------------------------GLREMKNEASVIAKVQ  145 (411)
Q Consensus        93 y~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  145 (411)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||++......                        ....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            66788999999999999998 67888  999987543111                        1135788999999998


Q ss_pred             Cccc--ceeeeeeecCCceEEEEeeCCC-C----CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeec
Q 040952          146 HKNL--VRLLGCCIDKDEKILIYEYMPN-K----SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-QYSRVRIIHR  217 (411)
Q Consensus       146 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~  217 (411)
                      |+++  ..++++    +..++||||+.+ |    +|.++...      .++.....++.|++.||.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8764  333332    367899999942 4    55544321      123356789999999999999 887   9999


Q ss_pred             CCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          218 DLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       218 dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999988  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=5.5e-19  Score=166.75  Aligned_cols=138  Identities=13%  Similarity=0.133  Sum_probs=97.6

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCc--------------ccHHHH--------HHHHHHHHhcCCcc
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG--------------QGLREM--------KNEASVIAKVQHKN  148 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~~~--------~~e~~~l~~l~h~n  148 (411)
                      .-|++.+.||+|+||.||+|...+|+.||||+++....              ......        ..|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34899999999999999999998899999998753210              011112        23455555553333


Q ss_pred             cceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 040952          149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  228 (411)
Q Consensus       149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~  228 (411)
                      +.-.. .+. ....++||||++|++|..+...       +  ....++.|++.+|.+||+.|   ||||||||.|||+++
T Consensus       175 v~vp~-p~~-~~~~~LVME~i~G~~L~~l~~~-------~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPE-PIA-QSRHTIVMSLVDALPMRQVSSV-------P--DPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCC-EEE-EETTEEEEECCSCEEGGGCCCC-------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred             CCCCe-eee-ccCceEEEEecCCccHhhhccc-------H--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence            21111 111 1234799999999988765421       1  23468899999999999998   999999999999987


Q ss_pred             CCC----------eEEeecCCccc
Q 040952          229 DMN----------PKISDFGMARI  242 (411)
Q Consensus       229 ~~~----------~kl~Dfgl~~~  242 (411)
                      ++.          +.|+||+-+..
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcccccccccceEEEEeCCccc
Confidence            763          89999997643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=1.8e-13  Score=123.98  Aligned_cols=144  Identities=17%  Similarity=0.120  Sum_probs=112.6

Q ss_pred             HhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ....|++...++.|+++.||++... |+.+++|............+.+|+.+++.+. +..+.++++++...+..|+|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3457888888999999999999865 7899999987532122345789999999984 6778889999988889999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-------------------------------------  210 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------  210 (411)
                      |++|.+|...+..        ......++.++++++..||+..                                     
T Consensus        91 ~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999776311        1123467889999999999811                                     


Q ss_pred             -------------------CCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          211 -------------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       211 -------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                                         ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               1348999999999999876666799998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=2e-12  Score=116.55  Aligned_cols=137  Identities=16%  Similarity=0.167  Sum_probs=100.9

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc--cceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~  168 (411)
                      ..|.+....+.|..+.||++...+|+.+++|.....   ....+..|+.+++.+.+.+  +.+++++....+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            344543333456669999998777888999997654   2245678999999885444  45688888877888999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS--------------------------------------  210 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  210 (411)
                      ++|.+|.  ...      .+   ...++.++++.+..||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999884  211      11   1356778888888888743                                      


Q ss_pred             -----------------CCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          211 -----------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       211 -----------------~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                                       ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             1239999999999999887667799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=7.4e-11  Score=111.76  Aligned_cols=142  Identities=14%  Similarity=0.256  Sum_probs=106.2

Q ss_pred             ccCcccccCcccEEEEEecCCCEEEEEEcc--CCC-cccHHHHHHHHHHHHhcC--CcccceeeeeeecC---CceEEEE
Q 040952           95 DANKLGEGGFGPVYKGVLKKGDEIAVKRLS--GRS-GQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDK---DEKILIY  166 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  166 (411)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998876 5688999876  322 122346788999999997  45578888888776   4579999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS------------------------------------  210 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  210 (411)
                      ||++|..+.+...     ..++...+..++.++++.|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999988854221     12567777889999999999999731                                    


Q ss_pred             -------------------CCCeeecCCCCCCEEEcCCCC--eEEeecCCccc
Q 040952          211 -------------------RVRIIHRDLKASNILLDKDMN--PKISDFGMARI  242 (411)
Q Consensus       211 -------------------~~~ivH~dlkp~Nill~~~~~--~kl~Dfgl~~~  242 (411)
                                         ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997754  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=8.5e-11  Score=108.69  Aligned_cols=186  Identities=19%  Similarity=0.230  Sum_probs=119.4

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-Ccc--cceeeeeeecCC---ceEEEEeeC
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKN--LVRLLGCCIDKD---EKILIYEYM  169 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  169 (411)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..+++.+. +..  +.+++......+   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999863    56889986532  33567889999999883 333  334444433333   348899999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS---------------------------------------  210 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  210 (411)
                      +|.++.....     ..++...+..++.++++.++.||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998865321     12456666778888888888888511                                       


Q ss_pred             ----------------CCCeeecCCCCCCEEEcC--CCCeEEeecCCccccCCCCcccccc------------ccccccc
Q 040952          211 ----------------RVRIIHRDLKASNILLDK--DMNPKISDFGMARICGGNELQANTS------------RIVGTYG  260 (411)
Q Consensus       211 ----------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~------------~~~gt~~  260 (411)
                                      ...++|+|++|.||++++  +..+.|+||+.+..-..........            .......
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            235899999999999998  5568899999886532110000000            0000011


Q ss_pred             ccC-hhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 040952          261 YMS-PEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  294 (411)
Q Consensus       261 y~a-PE~~~~~~~~~~~DvwslG~il~elltg~~p  294 (411)
                      ... |+....  .....+.|++|.++|.+.+|..+
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence            112 222111  12236899999999999999876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=3.1e-07  Score=84.71  Aligned_cols=135  Identities=20%  Similarity=0.187  Sum_probs=92.0

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc---ccceeeeeee-cCCceEEEEeeCCCC
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCI-DKDEKILIYEYMPNK  172 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g  172 (411)
                      +.++.|....||+.    |..+++|+..  .......+..|..+|+.+.+.   .+.+.+.++. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45788888899987    5678888853  223456788999999999653   2455666654 345678999999998


Q ss_pred             CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 040952          173 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-------------------------------------------  209 (411)
Q Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  209 (411)
                      .+......     .++......++.++++.|+.||+.                                           
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88653211     123334445555555555555532                                           


Q ss_pred             --------------CCCCeeecCCCCCCEEEcC---CCC-eEEeecCCccc
Q 040952          210 --------------SRVRIIHRDLKASNILLDK---DMN-PKISDFGMARI  242 (411)
Q Consensus       210 --------------~~~~ivH~dlkp~Nill~~---~~~-~kl~Dfgl~~~  242 (411)
                                    ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2234799999999999987   455 48999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.58  E-value=4e-07  Score=82.19  Aligned_cols=134  Identities=19%  Similarity=0.184  Sum_probs=96.1

Q ss_pred             cccccCcc-cEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEeeCCCCCc
Q 040952           98 KLGEGGFG-PVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSL  174 (411)
Q Consensus        98 ~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (411)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34455555 58987755 3667999986643   3456788999998884 33366788888888899999999999887


Q ss_pred             hhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 040952          175 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS--------------------------------------------  210 (411)
Q Consensus       175 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------  210 (411)
                      .+.....       ......+..+++..|..||...                                            
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            6654211       1123356667777777777421                                            


Q ss_pred             -----------CCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          211 -----------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       211 -----------~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                                 ...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1237999999999999988777899999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.50  E-value=3e-07  Score=86.70  Aligned_cols=81  Identities=7%  Similarity=-0.004  Sum_probs=55.8

Q ss_pred             cCcc-cccCcccEEEEEec-------CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCC---cccceeeeeeecC--
Q 040952           96 ANKL-GEGGFGPVYKGVLK-------KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQH---KNLVRLLGCCIDK--  159 (411)
Q Consensus        96 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--  159 (411)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+..   ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988754       26678999875432   1012356788888888742   3466777777655  


Q ss_pred             -CceEEEEeeCCCCCchh
Q 040952          160 -DEKILIYEYMPNKSLDF  176 (411)
Q Consensus       160 -~~~~lv~e~~~~g~L~~  176 (411)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999987754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=1.8e-06  Score=82.53  Aligned_cols=75  Identities=15%  Similarity=0.272  Sum_probs=50.1

Q ss_pred             cCcccccCcccEEEEEec-CCCEEEEEEccCCCc-------ccHHHHHHHHHHHHhcCC--cccc-eeeeeeecCCceEE
Q 040952           96 ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-------QGLREMKNEASVIAKVQH--KNLV-RLLGCCIDKDEKIL  164 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~l  164 (411)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.++++.+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 478899998653211       123456788999988742  4444 44443  3456789


Q ss_pred             EEeeCCCC
Q 040952          165 IYEYMPNK  172 (411)
Q Consensus       165 v~e~~~~g  172 (411)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.28  E-value=4.2e-06  Score=76.26  Aligned_cols=79  Identities=16%  Similarity=0.206  Sum_probs=58.2

Q ss_pred             CCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc---ccceeeeeeecCCceEEEEee
Q 040952           92 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .....+.+|.|..+.||+....+|+.|.+|+...........+..|+..|+.+...   -+.+++++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            34446779999999999999999999999988765444445678899999988432   23444443    234789999


Q ss_pred             CCCCCc
Q 040952          169 MPNKSL  174 (411)
Q Consensus       169 ~~~g~L  174 (411)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.26  E-value=3.3e-06  Score=78.81  Aligned_cols=140  Identities=14%  Similarity=0.170  Sum_probs=79.1

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC--cccceeee------eeecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLG------CCIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  168 (411)
                      +.|+.|..+.||+....+| .+++|+....    ...+..|..+++.+..  -.+.+++.      +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999887644 5899998752    1333445555555531  12333332      12345677899999


Q ss_pred             CCCCCchh--------------hhcC----C--CC-----CcCCCHHHH-------------------------------
Q 040952          169 MPNKSLDF--------------FLFD----P--TK-----RMLLDWVTR-------------------------------  192 (411)
Q Consensus       169 ~~~g~L~~--------------~l~~----~--~~-----~~~~~~~~~-------------------------------  192 (411)
                      ++|..+..              .++.    .  ..     .....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99876531              0111    0  00     001122211                               


Q ss_pred             HHHHHHHHHHHHHHhh----------cCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          193 VQIIEGIAQGLLYLHQ----------YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       193 ~~i~~~i~~~l~~LH~----------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ..+..++..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345666653          123459999999999999888899999999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.03  E-value=4e-05  Score=70.45  Aligned_cols=138  Identities=16%  Similarity=0.087  Sum_probs=91.5

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CcccceeeeeeecCCceEEEEeeCCCC
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK  172 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (411)
                      .+.|+.|....+|+.... +..+++|+....   ....+..|...|+.+.   ...+.+++.++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467899999999998864 778999987643   3456788999888883   356788888888778899999999998


Q ss_pred             Cchh-----------hhcCCCC--C-----------------cCCCHHHHH---HHHH----------------HHH-HH
Q 040952          173 SLDF-----------FLFDPTK--R-----------------MLLDWVTRV---QIIE----------------GIA-QG  202 (411)
Q Consensus       173 ~L~~-----------~l~~~~~--~-----------------~~~~~~~~~---~i~~----------------~i~-~~  202 (411)
                      .+..           -|+....  .                 ..-+|....   ++..                .+. ..
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            7531           1121111  0                 012343221   1111                111 11


Q ss_pred             HHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          203 LLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       203 l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                      ...|.. ...+.++|+|+.+.|++++.++ +.|.||+
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223321 2245699999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=4e-05  Score=73.80  Aligned_cols=78  Identities=10%  Similarity=0.113  Sum_probs=48.2

Q ss_pred             CCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccccccccc--cccccChhhhccC---CCCcchhhHHHHHHH
Q 040952          211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG--TYGYMSPEYALEG---IFSIKSDVFSFGVLL  285 (411)
Q Consensus       211 ~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il  285 (411)
                      ...++|+|++|.|||++.++ +.|+||+.+..-.... .  .....+  ...|++|+.....   .-....++.+....+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            34599999999999998876 9999999876532100 0  000111  1345666544311   112335666888888


Q ss_pred             HHHHhCC
Q 040952          286 LEIVSGK  292 (411)
Q Consensus       286 ~elltg~  292 (411)
                      |+.+++.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8887764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.78  E-value=7.8e-05  Score=68.83  Aligned_cols=142  Identities=15%  Similarity=0.110  Sum_probs=78.1

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc--cceeeee------eecCCceEEEEee
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGC------CIDKDEKILIYEY  168 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~  168 (411)
                      +.|+.|....+|+....+| .+++|......  ....+..|..++..+...+  +.+++..      ....+..+++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4567788889999887655 68899887531  1224556777777663212  2333321      1223556899999


Q ss_pred             CCCCCchhh--------------hcCC----CCC--cCC---CHHHHHH------------HHHHHHHHHHHHhhc----
Q 040952          169 MPNKSLDFF--------------LFDP----TKR--MLL---DWVTRVQ------------IIEGIAQGLLYLHQY----  209 (411)
Q Consensus       169 ~~~g~L~~~--------------l~~~----~~~--~~~---~~~~~~~------------i~~~i~~~l~~LH~~----  209 (411)
                      ++|..+...              ++..    ...  ...   .|.....            +...+...++.++..    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            998765320              1110    000  001   1211100            001134445555532    


Q ss_pred             CCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       210 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            23459999999999999987666899998763

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.71  E-value=0.00028  Score=65.44  Aligned_cols=141  Identities=13%  Similarity=0.115  Sum_probs=71.5

Q ss_pred             CcccccCccc-EEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC--cccceeeeeeecCCceEEEEeeCCCCC
Q 040952           97 NKLGEGGFGP-VYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILIYEYMPNKS  173 (411)
Q Consensus        97 ~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (411)
                      +.|+.|.... +|+....+|+.+++|........   .+..|+.+++.+..  -.+.+++.+..+.  -+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~---~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG---DTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTTC---CSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc---cccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            4566555444 66766544777888876543212   23456666666632  2345566553332  378999997766


Q ss_pred             chhhhc---------------------CCCC--CcCCCHHHHH-------HH-------------HHHHHHHHHHHh---
Q 040952          174 LDFFLF---------------------DPTK--RMLLDWVTRV-------QI-------------IEGIAQGLLYLH---  207 (411)
Q Consensus       174 L~~~l~---------------------~~~~--~~~~~~~~~~-------~i-------------~~~i~~~l~~LH---  207 (411)
                      +.+++.                     ....  ...++.....       .+             ...+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            543321                     1000  0011111000       00             001112222221   


Q ss_pred             hcCCCCeeecCCCCCCEEEcCC----CCeEEeecCCccc
Q 040952          208 QYSRVRIIHRDLKASNILLDKD----MNPKISDFGMARI  242 (411)
Q Consensus       208 ~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfgl~~~  242 (411)
                      ......++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123469999999999999875    6799999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.71  E-value=0.00025  Score=65.59  Aligned_cols=142  Identities=13%  Similarity=0.127  Sum_probs=81.0

Q ss_pred             CcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc--ccceeeee-----eecCCceEEEEeeC
Q 040952           97 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLGC-----CIDKDEKILIYEYM  169 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~  169 (411)
                      ..++ |....||+....+|+.+++|...... .....+..|..++..+...  .+.+++..     ....+..+++|+|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 77889998877667789999986432 1334667788888877422  23444432     12234567899999


Q ss_pred             CCCCchh-----h---------hcC----C--CCCcCCCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 040952          170 PNKSLDF-----F---------LFD----P--TKRMLLDWVTR----VQI---------------IEGIAQGLLYLHQY-  209 (411)
Q Consensus       170 ~~g~L~~-----~---------l~~----~--~~~~~~~~~~~----~~i---------------~~~i~~~l~~LH~~-  209 (411)
                      +|..+..     +         ++.    .  ..+...++...    ..+               ...+...++.+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            9865431     0         111    0  01111222110    000               11111223333221 


Q ss_pred             ---CCCCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          210 ---SRVRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       210 ---~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                         ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234589999999999998 4 899999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.69  E-value=0.00013  Score=66.62  Aligned_cols=72  Identities=11%  Similarity=0.181  Sum_probs=45.3

Q ss_pred             cCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccc-ceeeeeeecCCceEEEEeeC-CCCC
Q 040952           96 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYM-PNKS  173 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  173 (411)
                      .+.|+.|....+|+.     +.+++|+........ .....|+.+++.+...++ .++++.  +.+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577888999999998     468889886542221 123567777777643333 345544  334457899999 6655


Q ss_pred             ch
Q 040952          174 LD  175 (411)
Q Consensus       174 L~  175 (411)
                      +.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.68  E-value=0.00023  Score=67.18  Aligned_cols=141  Identities=18%  Similarity=0.195  Sum_probs=82.3

Q ss_pred             CcccccCcccEEEEEec--------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEe
Q 040952           97 NKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      +.|..|-...+|+....        +++.+++|+.... ........+|..+++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            46777888899998864        2578999986432 234456678999998884 3223556666543    29999


Q ss_pred             eCCCCCchhh-----------------hcCC--CCCcCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 040952          168 YMPNKSLDFF-----------------LFDP--TKRMLLD--WVTRVQIIEGIAQ-------------------GLLYLH  207 (411)
Q Consensus       168 ~~~~g~L~~~-----------------l~~~--~~~~~~~--~~~~~~i~~~i~~-------------------~l~~LH  207 (411)
                      |++|..|..-                 ++..  .-.....  +....++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998766421                 1111  0011112  2333344433321                   223332


Q ss_pred             ----hc-CCCCeeecCCCCCCEEEcCC----CCeEEeecCCccc
Q 040952          208 ----QY-SRVRIIHRDLKASNILLDKD----MNPKISDFGMARI  242 (411)
Q Consensus       208 ----~~-~~~~ivH~dlkp~Nill~~~----~~~kl~Dfgl~~~  242 (411)
                          .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 23459999999999999876    7899999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.57  E-value=0.00021  Score=68.88  Aligned_cols=73  Identities=14%  Similarity=0.256  Sum_probs=49.8

Q ss_pred             cCcccccCcccEEEEEecC--------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccc-ceeeeeeecCCceEEEE
Q 040952           96 ANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIY  166 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  166 (411)
                      .+.|+.|....+|+....+        ++.+++|+.....  ....+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567888889999998653        5789999885421  11455678888888843333 566665542    3899


Q ss_pred             eeCCCCCc
Q 040952          167 EYMPNKSL  174 (411)
Q Consensus       167 e~~~~g~L  174 (411)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987555

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.42  E-value=0.00077  Score=65.33  Aligned_cols=75  Identities=12%  Similarity=0.096  Sum_probs=48.7

Q ss_pred             cCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccc-ceeeeeeecCCceEEEEeeCCCCC
Q 040952           96 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPNKS  173 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  173 (411)
                      .+.|+.|-...+|+....+ +..+++|+......... ....|..+++.+...++ .++++.+.  +  .+|+||++|..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3567778888999998764 47888998754322211 12578889998865444 45666663  2  35999999866


Q ss_pred             ch
Q 040952          174 LD  175 (411)
Q Consensus       174 L~  175 (411)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.32  E-value=0.00048  Score=64.89  Aligned_cols=73  Identities=15%  Similarity=0.150  Sum_probs=44.2

Q ss_pred             CcccccCcccEEEEEecC---------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc-cceeeeeeecCCceEEEE
Q 040952           97 NKLGEGGFGPVYKGVLKK---------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  166 (411)
                      +.|+.|....+|+....+         ++.+++|+....... ......|..+++.+...+ ..++++..    .-++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            467788888999988653         268889987643222 112357788888774333 34555543    137899


Q ss_pred             eeCCCCCc
Q 040952          167 EYMPNKSL  174 (411)
Q Consensus       167 e~~~~g~L  174 (411)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.25  E-value=0.0017  Score=60.31  Aligned_cols=31  Identities=23%  Similarity=0.386  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          212 VRIIHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       212 ~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.00  E-value=0.0027  Score=54.20  Aligned_cols=103  Identities=12%  Similarity=0.005  Sum_probs=65.6

Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcccc
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  251 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  251 (411)
                      -+|.+.|...  ..++++.++|.++.|.+.+|.-+-....  -..+=+.|..|++..+|.+.+.+ +.+.          
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence            3677777543  3569999999999999988776622110  11334457899999999988874 2110          


Q ss_pred             cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 040952          252 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  294 (411)
Q Consensus       252 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  294 (411)
                          .....+.|||... ...+.+.-|||||+++|..+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1123466888653 3456789999999999999975443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.48  E-value=0.02  Score=54.75  Aligned_cols=74  Identities=14%  Similarity=0.126  Sum_probs=48.4

Q ss_pred             cCcccccCcccEEEEEecC--------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcc-cceeeeeeecCCceEEEE
Q 040952           96 ANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  166 (411)
                      .+.+..|-...+|+....+        ++.+++++......... ...+|..+++.+...+ ..++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567778788899988653        57899998755432222 2357888888774323 345554332    37899


Q ss_pred             eeCCCCCc
Q 040952          167 EYMPNKSL  174 (411)
Q Consensus       167 e~~~~g~L  174 (411)
                      +|++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99999765

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.45  E-value=0.0026  Score=39.03  Aligned_cols=16  Identities=19%  Similarity=0.011  Sum_probs=7.0

Q ss_pred             HHHHHHHHHHhhccCC
Q 040952           22 AILGLIFYCVRRKPRS   37 (411)
Q Consensus        22 ~i~~~~~~~~~r~~~~   37 (411)
                      +++++++++.|||+++
T Consensus        26 ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           26 VVALGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHhhhhHhh
Confidence            3334444444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.02  E-value=0.0031  Score=38.54  Aligned_cols=15  Identities=27%  Similarity=0.095  Sum_probs=6.5

Q ss_pred             HHHHHHHHHhhccCC
Q 040952           23 ILGLIFYCVRRKPRS   37 (411)
Q Consensus        23 i~~~~~~~~~r~~~~   37 (411)
                      ++++++++.|||+++
T Consensus        26 i~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           26 VGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHhhhhhhh
Confidence            334444444444443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=96.01  E-value=0.0025  Score=38.92  Aligned_cols=8  Identities=13%  Similarity=0.235  Sum_probs=3.1

Q ss_pred             HHHHhhcc
Q 040952           28 FYCVRRKP   35 (411)
Q Consensus        28 ~~~~~r~~   35 (411)
                      +++.|||+
T Consensus        32 ~~~~RRR~   39 (44)
T 2jwa_A           32 GILIKRRQ   39 (44)
T ss_dssp             HHHHHHHC
T ss_pred             Hhheehhh
Confidence            33334433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.92  E-value=0.075  Score=50.37  Aligned_cols=30  Identities=27%  Similarity=0.393  Sum_probs=25.3

Q ss_pred             CeeecCCCCCCEEE------cCCCCeEEeecCCccc
Q 040952          213 RIIHRDLKASNILL------DKDMNPKISDFGMARI  242 (411)
Q Consensus       213 ~ivH~dlkp~Nill------~~~~~~kl~Dfgl~~~  242 (411)
                      .++|+|+.+.|||+      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      4567799999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.94  E-value=0.41  Score=40.67  Aligned_cols=116  Identities=11%  Similarity=0.091  Sum_probs=76.7

Q ss_pred             cCCcccceeeeeeecCCceEEEEeeCCCC-CchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 040952          144 VQHKNLVRLLGCCIDKDEKILIYEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  222 (411)
Q Consensus       144 l~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~  222 (411)
                      -.||++++. .+-.+.+.+.+-++.-+++ ++.. +      ...+...+++++.+|+....+++.     -+|--|+|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~  108 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD  108 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence            368888876 4555566655555554322 2222 2      226778889999999887765554     478899999


Q ss_pred             CEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 040952          223 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  296 (411)
Q Consensus       223 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~  296 (411)
                      |++++.++.+++.-.|+-..                   ++|.     .++...=.-.+=|++..+++++..|.
T Consensus       109 NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999987775322                   2222     11112223367889999999988764

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=88.94  E-value=0.041  Score=32.57  Aligned_cols=8  Identities=25%  Similarity=0.708  Sum_probs=3.2

Q ss_pred             HHHHHHhh
Q 040952           26 LIFYCVRR   33 (411)
Q Consensus        26 ~~~~~~~r   33 (411)
                      +++|++||
T Consensus        30 l~~~~~rr   37 (38)
T 2k1k_A           30 ILVFRSRR   37 (38)
T ss_dssp             HHHHHHCC
T ss_pred             HHHHHeec
Confidence            33444433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.30  E-value=1.2  Score=37.84  Aligned_cols=114  Identities=8%  Similarity=0.103  Sum_probs=73.4

Q ss_pred             CCcccceeeeeeecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeeecCCCCCC
Q 040952          145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL-YLHQYSRVRIIHRDLKASN  223 (411)
Q Consensus       145 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlkp~N  223 (411)
                      .||++  -...-.+.+.+.+.++.-+++.=...+      ...+...+++++.+|+.... +++.     -+|--|+|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            67887  333335566666666655333222222      12577788888888877666 4443     5788999999


Q ss_pred             EEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhH-HHHHHHHHHHhCCCCCC
Q 040952          224 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVF-SFGVLLLEIVSGKKNTG  296 (411)
Q Consensus       224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-slG~il~elltg~~p~~  296 (411)
                      ++++.++.+++.-.|+-.                   -++|.-+     + ..|.| ++=|++..++.++..|.
T Consensus       115 L~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKE-------------------SLPPDEW-----D-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETT-------------------TBSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999777532                   2233211     1 12333 57788888998887653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.19  E-value=0.087  Score=50.94  Aligned_cols=60  Identities=10%  Similarity=0.082  Sum_probs=17.6

Q ss_pred             ccCcccccCcccEEEEEecC-CCEEEE------EEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeee
Q 040952           95 DANKLGEGGFGPVYKGVLKK-GDEIAV------KRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCI  157 (411)
Q Consensus        95 ~~~~lg~G~~g~Vy~~~~~~-g~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  157 (411)
                      +.+.||   ||.||+|.+.. ..+||+      |.....  ..+....+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            446676   99999999864 357888      665532  2233456788899999999999999988754

>1afo_A Glycophorin A; integral membrane protein, transmembrane helix interactions, membrane protein folding; NMR {Homo sapiens} SCOP: j.35.1.1 PDB: 2kpf_A

Probab=80.65  E-value=0.89  Score=26.43  Aligned_cols=32  Identities=25%  Similarity=0.484  Sum_probs=20.8

Q ss_pred             CCCCeEEeehHHHHHHHHHHHHHHHHHHhhcc
Q 040952            4 SATPIISLLLLSIVPAAVAILGLIFYCVRRKP   35 (411)
Q Consensus         4 ~~~~i~~~~~~~~~~~~~~i~~~~~~~~~r~~   35 (411)
                      .+.+.+++++.++.+.++..++++.||.+|-.
T Consensus         7 fs~p~i~lII~~vmaGiIG~IllI~y~I~rl~   38 (40)
T 1afo_A            7 FSEPEITLIIFGVMAGVIGTILLISYGIRRLI   38 (40)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             CCCchhHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence            34555666666666666777777777777643

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=80.42  E-value=1.8  Score=28.57  Aligned_cols=21  Identities=24%  Similarity=0.219  Sum_probs=9.5

Q ss_pred             eehHHHHHHHHHHHHHHHHHH
Q 040952           11 LLLLSIVPAAVAILGLIFYCV   31 (411)
Q Consensus        11 ~~~~~~~~~~~~i~~~~~~~~   31 (411)
                      +++++++.+++.+.+.+|+|.
T Consensus        12 ivlGg~~~lll~~glcI~ccv   32 (70)
T 2klu_A           12 IVLGGVAGLLLFIGLGIFFSV   32 (70)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhHHHHHHHHHHHHHHHhh
Confidence            344444444444444444344

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	411
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-73
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 9e-73
 Identities = 68/288 (23%), Positives = 131/288 (45%), Gaps = 22/288 (7%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
            + +   ++G G FG VYKG       + +  ++  + Q L+  KNE  V+ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
             +G      +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-- 268
              IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 269 -EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE 327
            +  +S +SDV++FG++L E+++G+         ++N       +         +  +  
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRGYLSPDLSKV-- 234

Query: 328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPK 375
                 +       +   C+++  D+RP    +++ +   A +L  PK
Sbjct: 235 ----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 4e-68
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 22/288 (7%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
                  KLG+G FG V+ G       +A+K L             EA V+ K++H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           +L      ++   ++ EYM   SL  FL   T + L      V +   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
               +HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
            F+IKSDV+SFG+LL E+ +  +                +    +   L+ ++       
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC 235

Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 378
                     ++   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 6e-68
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 22/274 (8%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
                  +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           RL       +   +I EYM N SL  FL  P   + L     + +   IA+G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 270
               IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
            F+IKSDV+SFG+LL EIV+  +                +   T+   ++ ++       
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--------------PYPGMTNPEVIQNLERGYRMVR 231

Query: 331 SSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
              +       +  LC +E  +DRPT + + S+L
Sbjct: 232 PD-NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-66
 Identities = 71/268 (26%), Positives = 124/268 (46%), Gaps = 22/268 (8%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            ++G G FG V+ G     D++A+K +         +   EA V+ K+ H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
           +++    L++E+M +  L  +L    +R L    T + +   + +G+ YL +     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 124

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL A N L+ ++   K+SDFGM R    ++   +++       + SPE      +S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 277 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 336
           DV+SFGVL+ E+ S  K                ++  +++  +E I       Y  +   
Sbjct: 184 DVWSFGVLMWEVFSEGK--------------IPYENRSNSEVVEDISTGFR-LYKPRLAS 228

Query: 337 LRYVNIALLCVQESADDRPTMNDVVSML 364
                I   C +E  +DRP  + ++  L
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 37/301 (12%)

Query: 81  FSFSSVSTATNKFSDA---------NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGR 126
           F+F   + A  +F+             +G G FG V  G LK   +    +A+K L SG 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 127 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML 186
           + +  R+  +EAS++ +  H N++ L G        ++I E+M N SLD FL     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 187 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 246
              +  V ++ GIA G+ YL        +HRDL A NIL++ ++  K+SDFG++R    +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 247 ELQANTSRIVG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 303
                 +  +G      + +PE      F+  SDV+S+G+++ E++S  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 304 NLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM 363
                 +   T+   +  I+                  + L C Q+  + RP    +V+ 
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPP-PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 364 L 364
           L
Sbjct: 287 L 287

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 63/291 (21%), Positives = 118/291 (40%), Gaps = 28/291 (9%)

Query: 98  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 157
            +G+G FG V++G  + G+E+AVK  S R  +     + E      ++H+N++  +    
Sbjct: 10  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 158 DKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ----- 208
             +       L+ +Y  + SL  +L     R  +     +++    A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 266
             +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 267 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-----LNLLGYAWDLWTS 315
             + I         ++D+++ G++  EI       G++         L     + +    
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 316 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
               + + P + + + S   L     I   C   +   R T   +   L+ 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-64
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 22/270 (8%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            +LG G FG V  G  +   ++A+K +         E   EA V+  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
             +    +I EYM N  L  +L +   R        +++ + + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 123

Query: 217 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 276
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKS 182

Query: 277 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 336
           D+++FGVL+ EI S  K                ++ +T++ T E I   L          
Sbjct: 183 DIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRPH-LAS 227

Query: 337 LRYVNIALLCVQESADDRPTMNDVVSMLTN 366
            +   I   C  E AD+RPT   ++S + +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (518), Expect = 1e-63
 Identities = 76/275 (27%), Positives = 128/275 (46%), Gaps = 22/275 (8%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
              +  +KLG G +G VY+GV KK    +AVK L       + E   EA+V+ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           V+LLG C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL + 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
                IHRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE    
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 270 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
             FSIKSDV++FGVLL EI +   +               +     ++  EL++     E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRME 236

Query: 330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
              +    +   +   C Q +  DRP+  ++    
Sbjct: 237 R-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 9e-63
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 38/301 (12%)

Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQH 146
             + F   ++LG G  G V+K   K  G  +A K +       +R  +  E  V+ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             +V   G      E  +  E+M   SLD  L    K   +      ++   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
               + +I+HRD+K SNIL++     K+ DFG++     +      +  VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK------------------------KNTGLYRTDS 302
                +S++SD++S G+ L+E+  G+                        +     RT  
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 303 LNLLGYAWDLWTSNRTLELIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMND 359
             L  Y  D        EL+D I+ +      S    L + +    C+ ++  +R  +  
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 360 V 360
           +
Sbjct: 295 L 295

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 2e-62
 Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 28/275 (10%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 150
            +      +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63

Query: 151 RLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +LLG  +++   + ++ EYM   SL  +L     R +L     ++    + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
                +HRDL A N+L+ +D   K+SDFG+ +     E  +          + +PE   E
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174

Query: 270 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
             FS KSDV+SFG+LL EI S  +    Y    L  +            ++  D      
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV---VPRVEKGYKMDAPDGCPPA- 228

Query: 330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                       +   C    A  RP+   +   L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 4e-62
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 50/304 (16%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQGLR-EMKNEASVIAK 143
           N       +GEG FG V++              +AVK L   +   ++ + + EA+++A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML----------------- 186
             + N+V+LLG C       L++EYM    L+ FL   +   +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 187 ----LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 242
               L    ++ I   +A G+ YL +    + +HRDL   N L+ ++M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 243 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 302
               +             +M PE      ++ +SDV+++GV+L EI S            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP------- 242

Query: 303 LNLLGYAWDLWTSNRTLELIDPILEDEYSS--KHMLLRYVNIALLCVQESADDRPTMNDV 360
                     +      E+I  + +    +  ++  L   N+  LC  +   DRP+   +
Sbjct: 243 ----------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

Query: 361 VSML 364
             +L
Sbjct: 293 HRIL 296

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 5e-61
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 28/277 (10%)

Query: 97  NKLGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVR 151
             +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 152 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
           LLG C+  +    ++  YM +  L  F+ + T    +  +    +          +   +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL 268
             + +HRDL A N +LD+    K++DFG+AR     E  +  ++        +M+ E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
              F+ KSDV+SFGVLL E+++            +N       L    R       +L+ 
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRR-------LLQP 256

Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
           EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 257 EYCPDPL----YEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-61
 Identities = 66/272 (24%), Positives = 114/272 (41%), Gaps = 26/272 (9%)

Query: 98  KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 153
           +LG G FG V +GV +   K  ++A+K L   + +    EM  EA ++ ++ +  +VRL+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 154 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 213
           G C   +  +L+ E      L  FL    KR  +      +++  ++ G+ YL + +   
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 129

Query: 214 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYALEGIF 272
            +HRDL A N+LL      KISDFG+++  G ++      S       + +PE      F
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 332
           S +SDV+S+GV + E +S  +                +        +  I+     E   
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIEQGKRMECPP 235

Query: 333 KHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                    +   C     +DRP    V   +
Sbjct: 236 -ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 7e-61
 Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 27/281 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDE-----IAVKRLS-GRSGQGLREMKNEASVIAKV 144
           +  +    +G G FG VYKG+LK         +A+K L  G + +   +   EA ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 145 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 204
            H N++RL G        ++I EYM N +LD FL +  K      +  V ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 205 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMS 263
           YL     +  +HRDL A NIL++ ++  K+SDFG++R+   +     T S       + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 264 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
           PE      F+  SDV+SFG+++ E+++  +                +   +++  ++ I+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKAIN 227

Query: 324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                             + + C Q+    RP   D+VS+L
Sbjct: 228 DGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (502), Expect = 8e-61
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 34/280 (12%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG---LREMKNEASVIAKVQ 145
              FSD  ++G G FG VY     +  + +A+K++S    Q     +++  E   + K++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           H N ++  GC + +    L+ EY    + D        +  L  V    +  G  QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           LH +    +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 266 YAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 322
             L   EG +  K DV+S G+  +E+   K    L+  ++++ L             +  
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---------YHIAQNE 230

Query: 323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
            P L+  + S++      N    C+Q+   DRPT   ++ 
Sbjct: 231 SPALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-60
 Identities = 64/278 (23%), Positives = 114/278 (41%), Gaps = 28/278 (10%)

Query: 95  DANKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNL 149
           +  +LG G FG V KG  +       +AVK L   +       E+  EA+V+ ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           VR++G C + +  +L+ E      L+ +L        +     ++++  ++ G+ YL + 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS-RIVGTYGYMSPEYAL 268
                +HRDL A N+LL      KISDFG+++    +E              + +PE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
              FS KSDV+SFGVL+ E  S  +                +     +    +++     
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERM 229

Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              +        ++  LC     ++RP    V   L N
Sbjct: 230 GCPA-GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 6e-60
 Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 31/274 (11%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLL 153
            ++G G F  VYKG+  +   E+A   L  R  +    +  K EA ++  +QH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 154 GCCID----KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
                    K   +L+ E M + +L  +L    +  ++           I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 210 SRVRIIHRDLKASNILL-DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
           +   IIHRDLK  NI +     + KI D G+A +   +        ++GT  +M+PE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
           E  +    DV++FG+ +LE+ + +                        R    + P   D
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSE----------YPYSECQNAAQIYRRVTSGVKPASFD 235

Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
           + +   +      I   C++++ D+R ++ D+++
Sbjct: 236 KVAIPEV----KEIIEGCIRQNKDERYSIKDLLN 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-59
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 27/278 (9%)

Query: 93  FSDANKLGEGGFGPVYKGVLKKGDE-----IAVKRLS-GRSGQGLREMKNEASVIAKVQH 146
           F     LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
            ++ RLLG C+    + LI + MP   L  ++ +    +       +     IA+G+ YL
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M+ E 
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
            L  I++ +SDV+S+GV + E+++                   +D   ++    +++   
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230

Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
                     +    I + C    AD RP   +++   
Sbjct: 231 RLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 3e-59
 Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 45/298 (15%)

Query: 98  KLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLRE-MKNEASVIAKV-QHKNL 149
            LG G FG V         +      +AVK L  ++    RE + +E  ++ ++  H+N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM--------------------LLDW 189
           V LLG C       LI+EY     L  +L    ++                     +L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 190 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 249
              +     +A+G+ +L        +HRDL A N+L+      KI DFG+AR    +   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA 309
                      +M+PE   EGI++IKSDV+S+G+LL EI S   N   Y    ++     
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIPVDAN--F 276

Query: 310 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 367
           + L  +   ++      E+ Y           I   C    +  RP+  ++ S L  +
Sbjct: 277 YKLIQNGFKMDQPFYATEEIY----------IIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 7e-59
 Identities = 70/300 (23%), Positives = 112/300 (37%), Gaps = 40/300 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQGLRE-MKNEASVIAK 143
           N+ S    LG G FG V +              +AVK L   +    RE + +E  V++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 144 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---------------PTKRMLL 187
           +  H N+V LLG C      ++I EY     L  FL                     + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
           D    +     +A+G+ +L        IHRDL A NILL      KI DFG+AR    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 307
                        +M+PE     +++ +SDV+S+G+ L E+ S   +             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 308 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 367
               +   ++  ++I          +H      +I   C       RPT   +V ++  +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-58
 Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 30/275 (10%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 153
             +G G +G   K   K  G  +  K L     +    + + +E +++ +++H N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 154 GCCIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYS 210
              ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 211 RV--RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
                ++HRDLK +N+ LD   N K+ DFG+ARI   +   A     VGT  YMSPE   
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
              ++ KSD++S G LL E+ +                      +T+    EL   I E 
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMP------------------PFTAFSQKELAGKIREG 229

Query: 329 EYSS--KHMLLRYVNIALLCVQESADDRPTMNDVV 361
           ++             I    +      RP++ +++
Sbjct: 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 6e-58
 Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 34/305 (11%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLS-GRSGQGLREMKNEASVIAK 143
            K + + +LG+G FG VY+GV K          +A+K ++   S +   E  NEASV+ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 144 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-------LDWVTRVQII 196
               ++VRLLG        ++I E M    L  +L      M              +Q+ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 197 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 256
             IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 257 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN 316
               +MSPE   +G+F+  SDV+SFGV+L EI +  +      ++               
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLRFVMEG 251

Query: 317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 376
             L+  D   +              +  +C Q +   RP+  +++S +  E       ++
Sbjct: 252 GLLDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEP--GFRE 299

Query: 377 PAFSF 381
            +F +
Sbjct: 300 VSFYY 304

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 7e-58
 Identities = 62/274 (22%), Positives = 119/274 (43%), Gaps = 35/274 (12%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 155
            +LG+G FG VYK   K+     A K +  +S + L +   E  ++A   H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 215
              ++   ++ E+    ++D  + +  +   L       + +     L YLH     +II
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 216 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 270
           HRDLKA NIL   D + K++DFG++        + ++   +GT  +M+PE  +     + 
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190

Query: 271 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 330
            +  K+DV+S G+ L+E+   +                          + ++  I + E 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP------------------PHHELNPMRVLLKIAKSEP 232

Query: 331 SSKHMLLRY----VNIALLCVQESADDRPTMNDV 360
            +     R+     +    C++++ D R T + +
Sbjct: 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-57
 Identities = 72/277 (25%), Positives = 110/277 (39%), Gaps = 28/277 (10%)

Query: 97  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNL 149
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +RL G  +    K+ + E  P  SL   L       LL  ++R      +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESK 130

Query: 210 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAL 268
              R IHRDL A N+LL      KI DFG+ R +   ++           + + +PE   
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 328
              FS  SD + FGV L E+ +  +                W     ++ L  ID   E 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQ--------------EPWIGLNGSQILHKIDKEGER 233

Query: 329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT 365
               +       N+ + C     +DRPT   +   L 
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 3e-57
 Identities = 74/292 (25%), Positives = 118/292 (40%), Gaps = 39/292 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLS-GRSGQGLREMKNEASVIAKV-Q 145
           N     + +GEG FG V K  +KK     + A+KR+    S    R+   E  V+ K+  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 146 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTR 192
           H N++ LLG C  +    L  EY P+ +L  FL                +    L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 193 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 252
           +     +A+G+ YL Q    + IHRDL A NIL+ ++   KI+DFG++R           
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 253 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL 312
           +       +M+ E     +++  SDV+S+GVLL EIVS                   +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--------------PYCG 229

Query: 313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
            T     E +      E    +      ++   C +E   +RP+   ++  L
Sbjct: 230 MTCAELYEKLPQGYRLEKPL-NCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 5e-57
 Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 23/269 (8%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 154
             LGEG +G V   V +   + +AVK +   R+      +K E  +   + H+N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 155 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 214
              + + + L  EY     L   +      + +      +    +  G++YLH      I
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 124

Query: 215 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-S 273
            HRD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 274 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK 333
              DV+S G++L  +++G+        D  +     +  W   +T       ++      
Sbjct: 185 EPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA--PL 237

Query: 334 HMLLRYVNIALLCVQESADDRPTMNDVVS 362
            +L +        + E+   R T+ D+  
Sbjct: 238 ALLHK-------ILVENPSARITIPDIKK 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 67/271 (24%), Positives = 109/271 (40%), Gaps = 33/271 (12%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRL 152
             LG+G FG VY    K+   I A+K L            +++ E  + + ++H N++RL
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            G   D     LI EY P  ++   L   +K    D       I  +A  L Y H     
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK--- 125

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           R+IHRD+K  N+LL      KI+DFG +     +      + + GT  Y+ PE     + 
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMH 181

Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS- 331
             K D++S GVL  E + GK                    + +N   E    I   E++ 
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYKRISRVEFTF 223

Query: 332 SKHMLLRYVNIALLCVQESADDRPTMNDVVS 362
              +     ++    ++ +   RP + +V+ 
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 5e-55
 Identities = 66/281 (23%), Positives = 122/281 (43%), Gaps = 26/281 (9%)

Query: 82  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASV 140
           S  SV     K++   K+G+G  G VY  +    G E+A+++++ +       + NE  V
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 200
           + + ++ N+V  L   +  DE  ++ EY+   S    L D      +D      +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG          Q+  S +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE 320
           +M+PE      +  K D++S G++ +E++ G+                 +      R L 
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---------------PPYLNENPLRALY 226

Query: 321 LIDPILEDEYSS-KHMLLRYVNIALLCVQESADDRPTMNDV 360
           LI      E  + + +   + +    C+    + R +  ++
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 31/276 (11%)

Query: 98  KLGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRL 152
            +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
           +G   + +   +I E      L  FL        LD  + +     ++  L YL      
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK--- 127

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
           R +HRD+ A N+L+  +   K+ DFG++R    +      S+      +M+PE      F
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 186

Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 332
           +  SDV+ FGV + EI+                       +   +  ++I  I   E   
Sbjct: 187 TSASDVWMFGVCMWEILMHGV-----------------KPFQGVKNNDVIGRIENGERLP 229

Query: 333 --KHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
              +      ++   C       RP   ++ + L+ 
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 6e-53
 Identities = 69/298 (23%), Positives = 112/298 (37%), Gaps = 39/298 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQG-LREMKNEASVIAK 143
           ++      LG G FG V +              +AVK L   +     R + +E  ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 144 -VQHKNLVRLLGCCIDKDEKILI-YEYMPNKSLDFFLF-------------DPTKRMLLD 188
              H N+V LLG C      +++  E+    +L  +L              +   +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 189 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 248
               +     +A+G+ +L      + IHRDL A NILL +    KI DFG+AR    +  
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 308
                       +M+PE   + +++I+SDV+SFGVLL EI S   +        + +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEE 245

Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
                     +   D    + Y             L C       RPT +++V  L N
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 7e-52
 Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 41/297 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRL-SGRSGQGLREMKNEASVI 141
           ++      LGEG FG V              +  ++AVK L S  + + L ++ +E  ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 142 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-------------L 187
             + +HKN++ LLG C       +I EY    +L  +L       L             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 188 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 247
                V     +A+G+ YL      + IHRDL A N+L+ +D   KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 307
               T+       +M+PE   + I++ +SDV+SFGVLL EI +   +   Y    +  L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246

Query: 308 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSML 364
             + L      ++       +             +   C       RPT   +V  L
Sbjct: 247 --FKLLKEGHRMDKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 60/269 (22%), Positives = 103/269 (38%), Gaps = 29/269 (10%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRL 152
             LGEG F  V          E A+K L  R       +  +  E  V++++ H   V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
                D ++      Y  N  L  ++                     A+ +  L      
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGK 127

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E   
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 273 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS- 331
              SD+++ G ++ ++V+G                     + +     +   I++ EY  
Sbjct: 188 CKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQKIIKLEYDF 229

Query: 332 SKHMLLRYVNIALLCVQESADDRPTMNDV 360
            +    +  ++    +   A  R    ++
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  169 bits (428), Expect = 2e-49
 Identities = 51/271 (18%), Positives = 102/271 (37%), Gaps = 34/271 (12%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG G FG V++   +  G+  A K +          ++ E   ++ ++H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            D +E ++IYE+M    L   + D   +  +     V+ +  + +GL ++H       +H
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYVH 147

Query: 217 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
            DLK  NI+     +   K+ DFG+       +   +     GT  + +PE A       
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
            +D++S GVL   ++SG                     +      E +  +   +++   
Sbjct: 205 YTDMWSVGVLSYILLSGLS------------------PFGGENDDETLRNVKSCDWNMDD 246

Query: 335 MLLRYV-----NIALLCVQESADDRPTMNDV 360
                +     +     +    + R T++  
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (424), Expect = 7e-49
 Identities = 56/271 (20%), Positives = 103/271 (38%), Gaps = 34/271 (12%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
           +LG G FG V++ V K  G     K ++         +KNE S++ ++ H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
            DK E +LI E++    L   +     +  +     +  +    +GL ++H      I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH---EHSIVH 150

Query: 217 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
            D+K  NI+ +       KI DFG+A     +E+         T  + +PE         
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207

Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
            +D+++ GVL   ++SG                     +     LE +  +   ++    
Sbjct: 208 YTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKRCDWEFDE 249

Query: 335 MLLRYVNIALL-----CVQESADDRPTMNDV 360
                V+          +Q+    R T++D 
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-46
 Identities = 59/289 (20%), Positives = 114/289 (39%), Gaps = 21/289 (7%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK 147
             ++++ + +GEG +G V           +A+K++S    Q   +    E  ++ + +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           N++ +         + +   Y+    +   L+   K   L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEY 266
                 ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  Y +PE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 267 ALEGIFSIKS-DVFSFGVLLLEIVSGK------KNTGLYRTDSLNLLGYAWDLWTSNRTL 319
            L      KS D++S G +L E++S +                  L   + +       L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 320 ELIDPILEDEYSSKHMLLRYVN------IALL--CVQESADDRPTMNDV 360
           +  + +L   + +K    R         + LL   +  +   R  +   
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-45
 Identities = 53/271 (19%), Positives = 108/271 (39%), Gaps = 35/271 (12%)

Query: 98  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 156
            LG G FG V++ V     +    K +    G     +K E S++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 157 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 216
              +E ++I+E++    +   +   T    L+    V  +  + + L +LH +    I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125

Query: 217 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 274
            D++  NI+     +   KI +FG AR     +   N   +     Y +PE     + S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182

Query: 275 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKH 334
            +D++S G L+  ++SG                     + +    ++I+ I+  EY+   
Sbjct: 183 ATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMNAEYTFDE 224

Query: 335 MLLRYVNIALL-----CVQESADDRPTMNDV 360
              + ++I  +      + +    R T ++ 
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (393), Expect = 8e-45
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRL 152
             LG G FG V+    +  G   A+K L        + +    +E  +++ V H  ++R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 153 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            G   D  +  +I +Y+    L   L    +                A+  L L      
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLALEYLHSK 123

Query: 213 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 272
            II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE      +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 273 SIKSDVFSFGVLLLEIVSGKK 293
           +   D +SFG+L+ E+++G  
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 54/278 (19%), Positives = 105/278 (37%), Gaps = 31/278 (11%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK 147
            + +   + LG G F  V     K+    +A+K ++ ++ +G    M+NE +V+ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           N+V L           LI + +    L   +    ++         ++I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
               V    +        LD+D    ISDFG++++     +    S   GT GY++PE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181

Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE 327
            +  +S   D +S GV+   ++ G                     +      +L + IL+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFEQILK 223

Query: 328 DEYSSKHMLLRYV-----NIALLCVQESADDRPTMNDV 360
            EY         +     +     +++  + R T    
Sbjct: 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 3e-44
 Identities = 51/285 (17%), Positives = 102/285 (35%), Gaps = 25/285 (8%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
           N++    K+G G FG +Y G     G+E+A+K    ++     ++  E+ +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  +  C  + +  ++   +   SL+      +++      T + + + +   + Y+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120

Query: 210 SRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQAN-----TSRIVGTYGY 261
                IHRD+K  N L     K     I DFG+A+         +        + GT  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 321
            S    L    S + D+ S G +L+    G       +  +             +  +E+
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTN 366
           +      E         +      C     DD+P  + +  +  N
Sbjct: 240 LCKGYPSE---------FATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (385), Expect = 5e-44
 Identities = 59/290 (20%), Positives = 116/290 (40%), Gaps = 39/290 (13%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQ 145
           ++++     LG GG   V+     +   ++AVK L     R        + EA   A + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 146 HKNLVRLLGCCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           H  +V +      +        ++ EY+   +L   +        +     +++I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYG 260
            L + HQ     IIHRD+K +NI++      K+ DFG+AR I         T+ ++GT  
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 261 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE 320
           Y+SPE A       +SDV+S G +L E+++G+                    +T +  + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP------------------PFTGDSPVS 221

Query: 321 LIDPILEDEYSSKHMLLRYV-----NIALLCVQESADDRP-TMNDVVSML 364
           +    + ++          +      + L  + ++ ++R  T  ++ + L
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 49/291 (16%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--------SGRSGQGLRE-MKNEASVI 141
            +     LG G    V + + K    E AVK +        S    Q LRE    E  ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 142 AKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 200
            KV  H N+++L           L+++ M    L  +L   T+++ L      +I+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 201 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 260
           + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +      E       + GT  
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 261 YMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 314
           Y++PE     +      +  + D++S GV++  +++G                     + 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PFW 216

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYV-----NIALLCVQESADDRPTMNDV 360
             + + ++  I+   Y               ++    +      R T  + 
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 18/210 (8%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQ- 145
           N FS    +G GGFG VY       G   A+K L     +  QG     NE  +++ V  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 146 --HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 203
                +V +       D+   I + M    L + L    +  +            I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 204 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 263
            ++H      +++RDLK +NILLD+  + +ISD G+A      +        VGT+GYM+
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 264 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           PE   +G+ +   +D FS G +L +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 66/269 (24%), Positives = 103/269 (38%), Gaps = 32/269 (11%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKV-QHKNLVR 151
             LG+G FG V+    KK     A+K L          +     E  V++   +H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 152 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 211
           +      K+    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK-- 122

Query: 212 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 271
             I++RDLK  NILLDKD + KI+DFGM +     + + NT    GT  Y++PE  L   
Sbjct: 123 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 179

Query: 272 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 331
           ++   D +SFGVLL E++ G+                    +      EL   I  D   
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHSIRMDNPF 221

Query: 332 -SKHMLLRYVNIALLCVQESADDRPTMND 359
             + +     ++ +       + R  +  
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-42
 Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 28/301 (9%)

Query: 97  NKLGEGGFGPVYKGVLKK-GDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLV 150
           + LGEG F  VYK   K     +A+K++     S       R    E  ++ ++ H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
            LL     K    L++++M               ++L        +    QGL YLHQ+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 211 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE- 269
              I+HRDLK +N+LLD++   K++DFG+A+  G        +  V T  Y +PE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175

Query: 270 GIFSIKSDVFSFGVLLLEIVSGK------KNTGLYRTDSLNLLGYAWDLWTSNRTLELID 323
            ++ +  D+++ G +L E++          +          L     + W    +L    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 324 PILEDEYSSKHMLLRYVNIALL-----CVQESADDRPTMNDVVSM--LTNEAAALLPPKQ 376
                     H +       LL         +   R T    + M   +N        + 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295

Query: 377 P 377
           P
Sbjct: 296 P 296

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 9e-42
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 93  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 151
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 152 LLGCCIDKDEK------ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 206 LHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 264
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   +    + +  Y +P
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 191

Query: 265 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 2e-41
 Identities = 61/286 (21%), Positives = 119/286 (41%), Gaps = 25/286 (8%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKN 148
            K+    K+GEG +G VYK     G+  A+K  RL             E S++ +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +V+L      K   +L++E++                 L+ VT    +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               R++HRDLK  N+L++++   KI+DFG+AR  G    +      + T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 269 -EGIFSIKSDVFSFGVLLLEIVSGK-------------KNTGLYRTDSLNLLGYAWDLWT 314
               +S   D++S G +  E+V+G              +   +  T +        +L  
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
            +    + +P+  + +  K +    +++    ++   + R T    
Sbjct: 234 YDPNFTVYEPLPWESF-LKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-41
 Identities = 59/293 (20%), Positives = 113/293 (38%), Gaps = 28/293 (9%)

Query: 89  ATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRSGQG------LREMKNEASV 140
           A  ++    ++GEG +G V+K    K  G  +A+KR+  ++G+       +RE+      
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRH 63

Query: 141 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD---FFLFDPTKRMLLDWVTRVQIIE 197
           +   +H N+VRL   C            +  + +D       D      +   T   ++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 198 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 257
            + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI          + +V 
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVV 177

Query: 258 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK------KNTGLYRTDSLNLLGYAWD 311
           T  Y +PE  L+  ++   D++S G +  E+   K       +          +     +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIAL----LCVQESADDRPTMNDV 360
            W  +  L       +     +  +     +       C+  +   R +    
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (367), Expect = 3e-41
 Identities = 42/293 (14%), Positives = 99/293 (33%), Gaps = 39/293 (13%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
             +    ++GEG FG +++G       ++A+K    RS     ++++E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 150 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 209
           +  +     +    ++   +   SL+  L    ++      T     + +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK 120

Query: 210 SRVRIIHRDLKASNILLDKDMNP-----KISDFGMARICGGNELQAN-----TSRIVGTY 259
               +++RD+K  N L+ +  +       + DFGM +       + +        + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 260 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL 319
            YMS    L    S + D+ + G + +  + G                  W    +    
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS---------------LPWQGLKAATNK 222

Query: 320 ELIDPILEDEYSSKHMLLR------YVNIALLCVQESADDRPTMNDVVSMLTN 366
           +  + I E + S+    L       +          + D  P  + +  + + 
Sbjct: 223 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 9/204 (4%)

Query: 92  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKN 148
            F    K+GEG +G VYK   K  G+ +A+K  RL   +         E S++ ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           +V+LL     +++  L++E++      F        + L  +        + Q L  L  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLAF 117

Query: 209 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 268
               R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V  +         
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLG 176

Query: 269 EGIFSIKSDVFSFGVLLLEIVSGK 292
              +S   D++S G +  E+V+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 43/279 (15%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 150
           +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 151 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 210
            L     +K + ILI E +    L  F     ++  L      + ++ I  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQILNGVYYLHSL- 132

Query: 211 RVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
             +I H DLK  NI+L     P    KI DFG+A              I GT  +++PE 
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 187

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                  +++D++S GV+   ++SG                     +  +   E +  + 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQETLANVS 229

Query: 327 EDEYSSKHMLLRYVNIALL-----CVQESADDRPTMNDV 360
              Y  +       +          + +    R T+ D 
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 1e-39
 Identities = 59/274 (21%), Positives = 97/274 (35%), Gaps = 43/274 (15%)

Query: 98  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKN 148
            LG GGFG VY G+       +A+K +         E+ N      E  ++ KV      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 149 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 208
           ++RLL      D  +LI E        F     T+R  L           + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 209 YSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
                ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+ 
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181

Query: 268 L-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 326
                    + V+S G+LL ++V G                     +  +  +       
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEEIIRGQVFF 223

Query: 327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
               SS+       ++   C+     DRPT  ++
Sbjct: 224 RQRVSSE-----CQHLIRWCLALRPSDRPTFEEI 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-38
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 20/216 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHK 147
           +K+    K+G+G FG V+K   +K G ++A+K++               E  ++  ++H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 148 NLVRLLGCCIDKDEKI--------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 199
           N+V L+  C  K            L++++  +        +   +  L  + RV     +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRV-----M 123

Query: 200 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVG 257
              L  L+   R +I+HRD+KA+N+L+ +D   K++DFG+AR      N      +  V 
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 258 TYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 292
           T  Y  PE  L E  +    D++  G ++ E+ +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-37
 Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 12/206 (5%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQH 146
           N F     LG+G FG V     K  G   A+K L      +   +     E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
             L  L       D    + EY     L F L   ++  +             A+ +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 266
                  +++RD+K  N++LDKD + KI+DFG+ +    +   A      GT  Y++PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176

Query: 267 ALEGIFSIKSDVFSFGVLLLEIVSGK 292
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 3e-37
 Identities = 44/206 (21%), Positives = 92/206 (44%), Gaps = 10/206 (4%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 147
            K+    K+GEG +G V+K   ++  + +A+K  RL             E  ++ +++HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
           N+VRL        +  L++E+       +F            +    +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
                 ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V  +        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174

Query: 268 LEGIFSIKSDVFSFGVLLLEIVSGKK 293
              ++S   D++S G +  E+ +  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 9e-37
 Identities = 49/271 (18%), Positives = 101/271 (37%), Gaps = 30/271 (11%)

Query: 99  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCC 156
           LG G  G V +   K+  ++ A+K L         + + E  +  +  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 157 IDKDEK----ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 212
            +        +++ E +    L   + D   +         +I++ I + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130

Query: 213 RIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 269
            I HRD+K  N+L          K++DFG A+    +           T  Y++PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 270 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 329
             +    D++S GV++  ++ G      + ++    +             E  +P   + 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 330 YSSKHMLLRYVNIALLCVQESADDRPTMNDV 360
                ML+R        ++     R T+ + 
Sbjct: 245 SEEVKMLIR------NLLKTEPTQRMTITEF 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (335), Expect = 4e-36
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 16/227 (7%)

Query: 71  KKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG 128
            K + D L  +   S +TA  ++F     LG G FG V     K+ G+  A+K L  +  
Sbjct: 20  AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79

Query: 129 QGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM 185
             L++++   NE  ++  V    LV+L     D     ++ EY+    +   L    +  
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIG 136

Query: 186 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 245
                        I     YLH      +I+RDLK  N+L+D+    +++DFG A+   G
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

Query: 246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 T  + GT   ++PE  L   ++   D ++ GVL+ E+ +G 
Sbjct: 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-34
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHK 147
             + D   +G G +G V   V  + G ++A+K+L    +S    +    E  ++  ++H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 148 NLVRLLGCCIDKD------EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           N++ LL      +      +  L+  +M             K   L       ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
           GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     +  +  +  V T  Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 262 MSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 292
            +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-31
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS--GRSGQGLREMKNEASVIAKVQHK 147
            ++ +   +G G  G V           +A+K+LS   ++    +    E  ++  V HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 148 NLVRLLGCCIDKD------EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 201
           N++ LL     +       +  L+ E M              +M LD      ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130

Query: 202 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 261
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +    +  V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 262 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 292
            +PE  L   +    D++S G ++ E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (300), Expect = 2e-31
 Identities = 43/237 (18%), Positives = 98/237 (41%), Gaps = 28/237 (11%)

Query: 62  ANNKQAKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAV 120
            N  + +     E   +   +        + +    KLG G +  V++ +     +++ V
Sbjct: 13  VNTHRPREYWDYESHVVEWGNQ-------DDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65

Query: 121 KRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFF 177
           K L        +++K E  ++  ++   N++ L     D   +   L++E++ N      
Sbjct: 66  KILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122

Query: 178 LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISD 236
                 + L D+  R   +  I + L Y H    + I+HRD+K  N+++D +    ++ D
Sbjct: 123 Y-----QTLTDYDIR-FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLID 173

Query: 237 FGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 292
           +G+A      +     +  V +  +  PE  ++  ++    D++S G +L  ++  K
Sbjct: 174 WGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-31
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 18/207 (8%)

Query: 97  NKLGEGGFGPVYKGVLKK----GDEIAVKRLS----GRSGQGLREMKNEASVIAKVQHK- 147
             LG G +G V+          G   A+K L      +  +     + E  V+  ++   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 148 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 207
            LV L      + +  LI +Y+    L   L    +       T  ++   + + +L L 
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALE 143

Query: 208 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 267
              ++ II+RD+K  NILLD + +  ++DFG+++    +E +       GT  YM+P+  
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 202

Query: 268 LEGI--FSIKSDVFSFGVLLLEIVSGK 292
             G        D +S GVL+ E+++G 
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 7e-30
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 11/207 (5%)

Query: 90  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS--GRSGQGLREMKNEASVIAKVQH 146
             ++ + + +G G +G V      K G  +AVK+LS   +S    +    E  ++  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 147 KNLVRLLGCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 205
           +N++ LL               Y+    +   L +  K   L       +I  I +GL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 206 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 265
           +H      IIHRDLK SN+ +++D   KI DFG+AR          T  +   +      
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 189

Query: 266 YALEGIFSIKSDVFSFGVLLLEIVSGK 292
                 ++   D++S G ++ E+++G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (277), Expect = 5e-28
 Identities = 52/304 (17%), Positives = 109/304 (35%), Gaps = 30/304 (9%)

Query: 91  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 149
            ++    KLG G F  V+          +A+K + G         ++E  ++ +V   + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71

Query: 150 VRLLGCCIDKDEKILIY---------------EYMPNKSLDFFLFDPTKRMLLDWVTRVQ 194
            +      +   K+L +               E +    L        + + L +V   Q
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV--KQ 129

Query: 195 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTS 253
           I + +  GL Y+H+  R  IIH D+K  N+L++  D    +    +A +        + +
Sbjct: 130 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 254 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-----KNTGLYRTDSLNLLGY 308
             + T  Y SPE  L   +   +D++S   L+ E+++G           Y  D  ++   
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 309 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 368
              L      L          ++S+ +L     +    +++   ++   +   +    E 
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA---KEI 304

Query: 369 AALL 372
           +  L
Sbjct: 305 SDFL 308

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 97.2 bits (241), Expect = 2e-24
 Identities = 37/202 (18%), Positives = 69/202 (34%), Gaps = 27/202 (13%)

Query: 97  NKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQ--------GLREMKNEASVIAKVQH 146
             +GEG    V+    +K  E  VK  ++   S +        G       A   A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 147 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 206
           + L +L G  + K      Y +  N  L   +       +       ++++ I + +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 207 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPE 265
           +      I+H DL   N+L+  +    I DF  +   G    +    R +     Y S  
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 266 YALEGIFSIKSDVFSFGVLLLE 287
           Y        + D+ S    +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	411
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.87
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.39
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.02
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.65
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.21
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.98

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=408.19  Aligned_cols=253  Identities=24%  Similarity=0.327  Sum_probs=204.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            367999999999999999999975 58999999987543 2334568999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999998543   35899999999999999999999998   9999999999999999999999999998765444


Q ss_pred             cccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      ........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||............    ........       
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~----~~~~~~~~-------  226 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYL-------  226 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----HHTTCTTS-------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCC-------
Confidence            3344455789999999999988776 67899999999999999999998644322211111    11111000       


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                         ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               001112456889999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=407.44  Aligned_cols=263  Identities=27%  Similarity=0.442  Sum_probs=204.8

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||+||+|+++  ..||||++...  +....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999875  36999998754  34556789999999999999999999998754 56899999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|.+++....  ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            999999999986533  34899999999999999999999998   9999999999999999999999999998765444


Q ss_pred             cccccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      .........||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.......     ........+..    .+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-----~~~~~~~~~~~----~p  229 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIFMVGRGYL----SP  229 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHHHTSC----CC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-----HHHHHHhcCCC----CC
Confidence            3334455689999999999864   358999999999999999999999986432211     11111111111    11


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccccc
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  371 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  371 (411)
                      .+..  .+..++..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus       230 ~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         230 DLSK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CGGG--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             cchh--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            1100  11122567899999999999999999999999999887643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=404.26  Aligned_cols=256  Identities=28%  Similarity=0.417  Sum_probs=200.1

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      ++|++.+.||+|+||+||+|.+.+++.||||++.... ...+++.+|+.++++++||||++++|+|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788899999999999999999888899999997643 345789999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +|+|.+++....  ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            999999886543  44889999999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCC-CCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......||+.|+|||++.+..|+.++|||||||++|||+|+.. |+....     .............   ...      
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~~~~~i~~~~~---~~~------  223 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTGFR---LYK------  223 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHHHHHHHHHTCC---CCC------
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHhcCC---CCC------
Confidence            2233578999999999999999999999999999999999644 443211     1111111111100   001      


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                        +..++.++.+++.+||+.||++|||+.||++.|+++..
T Consensus       224 --p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         224 --PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence              11124578999999999999999999999999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=401.60  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=208.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            357999999999999999999965 5999999999866555667899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +++|+|..++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            999999988743    34899999999999999999999998   9999999999999999999999999998765332 


Q ss_pred             ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                       ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......     ............ .     +  
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~~~-~-----~--  236 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTP-E-----L--  236 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSC-C-----C--
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HHHHHHHhCCCC-C-----C--
Confidence             2234458999999999999999999999999999999999999998643211     111111111110 0     0  


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                       ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011223567899999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-55  Score=401.74  Aligned_cols=260  Identities=28%  Similarity=0.400  Sum_probs=211.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEecC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ..++|++.+.||+|+||+||+|.+.. |+.||||+++... ...+++.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            35678889999999999999999764 8899999997543 446789999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+++|+|..++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        94 ~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             cccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999986533 345899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      .. ......|++.|+|||++.+..|+.++|||||||++|||++|..|+......    . ........+..     +.. 
T Consensus       170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~-~~~~~i~~~~~-----~~~-  237 (287)
T d1opja_         170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----S-QVYELLEKDYR-----MER-  237 (287)
T ss_dssp             SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----H-HHHHHHHTTCC-----CCC-
T ss_pred             ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----H-HHHHHHhcCCC-----CCC-
Confidence            22 223346889999999999999999999999999999999977665322111    1 11111111110     111 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                          +...+..+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus       238 ----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         238 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                11225678999999999999999999999999987644

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=399.95  Aligned_cols=245  Identities=25%  Similarity=0.345  Sum_probs=204.6

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56899999999999999999976 5889999998643   2334567899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999998543   34899999999999999999999998   999999999999999999999999999775432


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....... .....      .+
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i-~~~~~------~~  223 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRI-SRVEF------TF  223 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH-HTTCC------CC
T ss_pred             c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHH-HcCCC------CC
Confidence            2    2345799999999999999999999999999999999999999864321     1111111 11110      01


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +     ...+..+.+++.+||+.||++|||+.|+++
T Consensus       224 p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 P-----DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1     112567899999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=400.08  Aligned_cols=256  Identities=31%  Similarity=0.448  Sum_probs=206.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.+++++.||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46788899999999999999999888899999997543 345789999999999999999999998754 5679999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|.+++.... ...+++..+..++.||++||.|||+++   |+||||||+||||++++.+||+|||+++........
T Consensus        90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999998875432 234899999999999999999999998   999999999999999999999999999887543322


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                       ......||+.|+|||++.++.++.++|||||||++|||+||..|+......    ...... ...+     ..+...  
T Consensus       166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----~~~~~~-i~~~-----~~~~~p--  232 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQN-LERG-----YRMVRP--  232 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHH-HHTT-----CCCCCC--
T ss_pred             -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----HHHHHH-HHhc-----CCCCCc--
Confidence             233457899999999999999999999999999999999976554322111    111111 1111     111111  


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                         ...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus       233 ---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         233 ---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence               12245789999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-54  Score=388.42  Aligned_cols=254  Identities=28%  Similarity=0.411  Sum_probs=211.3

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  170 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (411)
                      ++|++.++||+|+||+||+|++++++.||||.++... ...+.+.+|+.++++++||||++++++|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6789999999999999999999888899999998654 345689999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCccc
Q 040952          171 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  250 (411)
Q Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  250 (411)
                      +|+|..++....  ..+++..+++++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++........ 
T Consensus        83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            999999875533  34788999999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.......     ..... ..+.  ....      
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----~~~~i-~~~~--~~~~------  222 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHI-AQGL--RLYR------  222 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHH-HTTC--CCCC------
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----HHHHH-HhCC--CCCC------
Confidence            2334578999999999999999999999999999999998 898986543221     11111 1111  0011      


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        +...+..+.+++.+||+.||++|||+.++++.|.++
T Consensus       223 --p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         223 --PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             --cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence              112245789999999999999999999999998653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=403.10  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      +.|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999975 58999999998776667778999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|..++.+..  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  .
T Consensus        92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~  164 (288)
T d2jfla1          92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I  164 (288)
T ss_dssp             TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence            9999999875432  34899999999999999999999998   999999999999999999999999999764321  1


Q ss_pred             cccccccccccccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  324 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (411)
                      .......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.......     .......... .     
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~~~~i~~~~~-~-----  233 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VLLKIAKSEP-P-----  233 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHHHHHHSCC-C-----
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCC-C-----
Confidence            1233468999999999984     4568999999999999999999999986433211     1111111111 0     


Q ss_pred             ccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          325 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       325 ~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .+   ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 TL---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CC---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   011223567899999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-55  Score=403.70  Aligned_cols=258  Identities=27%  Similarity=0.407  Sum_probs=198.9

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CC---EEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ++|++.+.||+|+||+||+|.++. |+   .||||.+... .....+.|.+|+.+|++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            568888999999999999999753 32   5899998754 344566799999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++....  ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999886533  34899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccc---cccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          246 NELQAN---TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       246 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......   .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......     ...........    
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~~~i~~~~~----  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVINAIEQDYR----  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTCC----
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCC----
Confidence            322211   222457899999999999999999999999999999998 89998643221     11111111110    


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                        .     ..+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       252 --~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         252 --L-----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             --C-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --C-----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence              0     0112235678999999999999999999999999988765

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=403.38  Aligned_cols=248  Identities=25%  Similarity=0.306  Sum_probs=202.1

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...   .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999975 5899999998643   2344577899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999988543   34899999999999999999999998   999999999999999999999999999887644


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..     ........ ...      .+
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~-~~~------~~  229 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKIIK-LEY------DF  229 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHT-TCC------CC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-----HHHHHHHc-CCC------CC
Confidence            4444445568999999999999999999999999999999999999998643211     11111111 110      01


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVV  361 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  361 (411)
                      .     ...+..+.+|+.+||+.||++|||+.|++
T Consensus       230 p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         230 P-----EKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             C-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             C-----ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            1     11245689999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-55  Score=396.33  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=194.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeec--CCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|+.. +|+.||||.+....  ....+.+.+|++++++++||||+++++++.+  .+..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999975 58999999987653  3445678899999999999999999999865  456899


Q ss_pred             EEeeCCCCCchhhhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          165 IYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ||||+++|+|.+++.... .+..+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999985432 2346899999999999999999999865  2349999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ......  .......||+.|+|||++.+..|+.++|||||||++|||+||+.||......     +.... +....... 
T Consensus       163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-----~~~~~-i~~~~~~~-  233 (269)
T d2java1         163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGK-IREGKFRR-  233 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHH-HHHTCCCC-
T ss_pred             ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-----HHHHH-HHcCCCCC-
Confidence            765332  2233468999999999999999999999999999999999999998643211     11111 11111111 


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                          +.     ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       234 ----~~-----~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 ----IP-----YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CC-----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                11     112457899999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=401.87  Aligned_cols=258  Identities=27%  Similarity=0.370  Sum_probs=206.9

Q ss_pred             hcCCCccCcccccCcccEEEEEecC-C-----CEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK-G-----DEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      .++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4678999999999999999998653 2     26999998654 334456789999999998 89999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCC--------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 040952          162 KILIYEYMPNKSLDFFLFDPTK--------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKA  221 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp  221 (411)
                      .++||||+++|+|.+++.....                    ...+++..++.++.|+++||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965432                    235889999999999999999999998   99999999


Q ss_pred             CCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcc
Q 040952          222 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRT  300 (411)
Q Consensus       222 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  300 (411)
                      +|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443333445678999999999999999999999999999999998 8999864332


Q ss_pred             cccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 040952          301 DSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLT  365 (411)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  365 (411)
                      ..     ........+..     ...     +..++..+.+|+.+||+.||++|||+.||++.|.
T Consensus       273 ~~-----~~~~~~~~~~~-----~~~-----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA-----NFYKLIQNGFK-----MDQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH-----HHHHHHHTTCC-----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH-----HHHHHHhcCCC-----CCC-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            21     11111211110     001     1123567899999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=392.78  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=207.0

Q ss_pred             cCCCccCc-ccccCcccEEEEEec---CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANK-LGEGGFGPVYKGVLK---KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ++|.+.+. ||+|+||.||+|.++   ++..||||.++... ....+.|.+|+++|++++|||||++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999864   24579999997543 3456789999999999999999999999865 568999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|.+++....  ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999875432  35899999999999999999999998   99999999999999999999999999988764


Q ss_pred             CCcc-cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          246 NELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       246 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      .... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......  .   .. ..+..+....   
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~---~~-~~i~~~~~~~---  232 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--E---VM-AFIEQGKRME---  232 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--H---HH-HHHHTTCCCC---
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--H---HH-HHHHcCCCCC---
Confidence            3322 22334568999999999999999999999999999999998 89998643321  1   11 1121111111   


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                        .     +..++.++.+|+.+||+.||++|||+.+|++.|+..-..
T Consensus       233 --~-----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         233 --C-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             --C-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --C-----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              1     112356789999999999999999999999999866443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=394.58  Aligned_cols=266  Identities=28%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             hcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      .++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46799999999999999999999888899999997543 345789999999999999999999999854 5689999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|..++.... ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....... 
T Consensus        94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            9999998886532 234899999999999999999999998   99999999999999999999999999987653332 


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      .......||+.|+|||++.++.++.++|||||||++|||++|+.|+.......    ..... +..+.     ....   
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~----~~~~~-i~~~~-----~~~~---  235 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQ-VERGY-----RMPC---  235 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH-HHTTC-----CCCC---
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH----HHHHH-HHhcC-----CCCC---
Confidence            22334578999999999999999999999999999999999776654322111    11111 11111     0111   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCC
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP  377 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  377 (411)
                        +..++.++.+++.+||+.||++|||+.+|++.|+.......|+-.|
T Consensus       236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             --CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence              1123567899999999999999999999999999877665544443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=404.30  Aligned_cols=267  Identities=24%  Similarity=0.334  Sum_probs=205.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+.+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999975 58999999997543 3345678999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |+++|+|.+++.+.   ..+++..+..++.|++.||.|||+ ++   |+||||||+|||++.++.+||+|||+|+.... 
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            99999999998643   348999999999999999999997 47   99999999999999999999999999986532 


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHH----------HHh---
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW----------DLW---  313 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~---  313 (411)
                         ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+...........          ...   
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               1223468999999999999999999999999999999999999999654322110000000          000   


Q ss_pred             -----------hcCccccccccccc---cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhh
Q 040952          314 -----------TSNRTLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS--MLTN  366 (411)
Q Consensus       314 -----------~~~~~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~  366 (411)
                                 ......+..+....   ...+....+.++.+++.+||+.||++|||+.|+++  .+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                       00000000000000   00001112457899999999999999999999997  3544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=389.83  Aligned_cols=261  Identities=27%  Similarity=0.404  Sum_probs=201.2

Q ss_pred             hcCCCccCcccccCcccEEEEEecCC-----CEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKKG-----DEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      .+.|+..+.||+|+||.||+|.++.+     ..||||++.... ......|.+|+.++++++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35688889999999999999997642     369999997543 334557899999999999999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+.++++.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999988875433  34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCc-ccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ..... ........||+.|+|||++.++.++.++|||||||++|||++|..|+......    .... ..+..+.     
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~-~~i~~~~-----  230 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVM-KAINDGF-----  230 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH-HHHHTTC-----
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHH-HHHhccC-----
Confidence            54322 22233456899999999999999999999999999999999976664322111    1111 1111111     


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                      .+..     +...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       231 ~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 RLPT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCC-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCC-----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            1111     112356789999999999999999999999999887653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=389.75  Aligned_cols=248  Identities=27%  Similarity=0.378  Sum_probs=197.9

Q ss_pred             CcccccCcccEEEEEecC---CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeCCC
Q 040952           97 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  171 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (411)
                      ++||+|+||+||+|.+++   ++.||||+++..  +....+.+.+|+.+|++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998653   468999999654  23345679999999999999999999999865 567899999999


Q ss_pred             CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc-c
Q 040952          172 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-A  250 (411)
Q Consensus       172 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~  250 (411)
                      |+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........ .
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            9999998643   34899999999999999999999998   999999999999999999999999999876543222 2


Q ss_pred             ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccccccccc
Q 040952          251 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  329 (411)
Q Consensus       251 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  329 (411)
                      ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......     +. ...+..+....     .   
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----~~-~~~i~~~~~~~-----~---  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EV-TAMLEKGERMG-----C---  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HH-HHHHHTTCCCC-----C---
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----HH-HHHHHcCCCCC-----C---
Confidence            2334578999999999999999999999999999999998 89998643211     11 11122111111     1   


Q ss_pred             cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          330 YSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                        +..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence              112356789999999999999999999999988764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=390.55  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=195.0

Q ss_pred             CccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeec----CCceEEEE
Q 040952           94 SDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIY  166 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  166 (411)
                      +..+.||+|+||+||+|.+. +++.||+|.+...  .....+.+.+|+++|++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999976 4889999998654  33445678999999999999999999999865    34679999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCCeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~  245 (411)
                      ||+++|+|.+++...   ..+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999998543   34899999999999999999999875 3499999999999996 578999999999986443


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      .    .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||......    .. .......+...    ..
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~-~~~~i~~~~~~----~~  233 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQ-IYRRVTSGVKP----AS  233 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HH-HHHHHTTTCCC----GG
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HH-HHHHHHcCCCC----cc
Confidence            2    2334689999999998865 5999999999999999999999998533211    11 11111111100    01


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +.     ...+.++.+++.+||+.||++|||+.|+++
T Consensus       234 ~~-----~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 FD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GG-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11     111446889999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-54  Score=397.81  Aligned_cols=253  Identities=22%  Similarity=0.270  Sum_probs=190.8

Q ss_pred             HhcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           89 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ..+.|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567999999999999999999976 58999999997543 223456789999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCCeEEeecCCcccc
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARIC  243 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfgl~~~~  243 (411)
                      ||++||+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999998643   35899999999999999999999998   99999999999994   5789999999999876


Q ss_pred             CCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ....   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......     .......... . .. .
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~~~-~-~~-~  229 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-----KLFEQILKAE-Y-EF-D  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHTTC-C-CC-C
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHhccC-C-CC-C
Confidence            4332   223457999999999999999999999999999999999999998643211     1111111111 0 00 0


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .     ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       230 ~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 S-----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             T-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C-----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            0     0111225678999999999999999999999984

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-53  Score=395.20  Aligned_cols=263  Identities=25%  Similarity=0.395  Sum_probs=211.6

Q ss_pred             HHhcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCcccceeeeeeecCC
Q 040952           88 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  160 (411)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (411)
                      ...++|++.+.||+|+||+||+|+++      +++.||||++..... ...+.+.+|+.++++++||||++++++|...+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34578999999999999999999864      357899999976533 34567999999999999999999999999999


Q ss_pred             ceEEEEeeCCCCCchhhhcCCC---------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 040952          161 EKILIYEYMPNKSLDFFLFDPT---------------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL  219 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  219 (411)
                      ..+++|||+++|+|.+++....                     ....+++..++.++.|++.||+|||+++   ++||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEE
Confidence            9999999999999999985322                     1234888999999999999999999998   999999


Q ss_pred             CCCCEEEcCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCC
Q 040952          220 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLY  298 (411)
Q Consensus       220 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~  298 (411)
                      ||+|||++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++|. +||...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999998765444444444567899999999999999999999999999999999986 465433


Q ss_pred             cccccchhHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          299 RTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      ...     ..... +..+.....          +..++.++.+|+.+||+.+|++||||.||+++|+++++
T Consensus       247 ~~~-----e~~~~-v~~~~~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         247 AHE-----EVIYY-VRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             CHH-----HHHHH-HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CHH-----HHHHH-HHcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            211     11111 122211111          11224578999999999999999999999999998763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-53  Score=399.79  Aligned_cols=253  Identities=21%  Similarity=0.303  Sum_probs=208.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999975 5899999999877666677899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCCCeEEeecCCccccCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNPKISDFGMARICGGN  246 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |++|+|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++.....
T Consensus       105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999885432  34899999999999999999999998   99999999999996  4688999999999876543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...........  . +... 
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~~~~--~-~~~~-  247 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNVKSCDW--N-MDDS-  247 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHTCC--C-SCCG-
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCC--C-CCcc-
Confidence            2   223458999999999999999999999999999999999999998643211     11111111110  0 0000 


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       248 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 ----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                011124578999999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-53  Score=391.40  Aligned_cols=245  Identities=30%  Similarity=0.475  Sum_probs=200.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      +.|+..+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45899999999999999999965 58899999987543   233467889999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |||.+|+|..++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..... 
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            999999998776432   45899999999999999999999998   99999999999999999999999999976532 


Q ss_pred             CcccccccccccccccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                           .....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||.....     ............      
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~~~i~~~~~------  231 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES------  231 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC------
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCCC------
Confidence                 234579999999999864   4689999999999999999999999864321     111111111111      


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      +.+.    +...+..+.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1111    1112457899999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.6e-53  Score=398.45  Aligned_cols=253  Identities=23%  Similarity=0.266  Sum_probs=208.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||.||+|... +|+.||||++..........+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999999999975 5999999999876655567788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCCCeEEeecCCccccCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNPKISDFGMARICGGN  246 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfgl~~~~~~~  246 (411)
                      |++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||++......
T Consensus       108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999998877443  234899999999999999999999998   99999999999998  6789999999999887543


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     .......... . . +... 
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~-~-~-~~~~-  250 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ETLQNVKRCD-W-E-FDED-  250 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHHCC-C-C-CCSS-
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC-C-C-CCcc-
Confidence            2   233457899999999999999999999999999999999999998643211     1111111111 0 0 0000 


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                          .....+.++.+|+.+||+.||++|||+.|+++.
T Consensus       251 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         251 ----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                011125678999999999999999999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=386.34  Aligned_cols=252  Identities=24%  Similarity=0.306  Sum_probs=205.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC------cccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....      ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            478999999999999999999975 58999999986432      22467899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----CeEEeecC
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDFG  238 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg  238 (411)
                      |+|||||++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999998543   35899999999999999999999998   99999999999998776    49999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  318 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  318 (411)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......... ..
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~~-~~  233 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANVSAV-NY  233 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHTT-CC
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----HHHHHHHhc-CC
Confidence            998765332   223457899999999999999999999999999999999999998643211     111111111 00


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       . ....     .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       234 -~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         234 -E-FEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -C-CCHH-----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -C-CCch-----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0 0000     011125678899999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=387.40  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=202.2

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .+|++.+.||+|+||+||+|.+.. |+    +||+|.+... .....+.+.+|+.++++++|||||+++++|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999998653 44    5899988654 344567899999999999999999999999864 5678


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ++||+.+|+|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999998887553  345899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      ............||+.|+|||++.++.|+.++|||||||++|||+| |.+||.......  ..    .....+...    
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~----~~i~~~~~~----  232 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKGERL----  232 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HH----HHHHHTCCC----
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCCC----
Confidence            5444444445578999999999999999999999999999999999 788876433211  11    111111100    


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                       .     .+..++..+.+++.+||+.||++|||+.|+++.|..+..
T Consensus       233 -~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         233 -P-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -C-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -C-----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence             0     011225678999999999999999999999999877643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=385.35  Aligned_cols=262  Identities=26%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             hcCCCccCcccccCcccEEEEEecC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC-C
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK-D  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  160 (411)
                      .++|++.+.||+|+||.||+|.+..      ++.||||++.... ....+.+.+|...+.++ +|+||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4679999999999999999998542      4689999997543 33456678888888877 688999999998765 4


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  227 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~  227 (411)
                      ..++||||+++|+|.+++.....             ...+++..+..++.||++||.|||+++   |+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            68999999999999999864321             345889999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcccccchh
Q 040952          228 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLL  306 (411)
Q Consensus       228 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~  306 (411)
                      +++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+||. +||.......    
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----  244 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence            99999999999998766544444445568999999999999999999999999999999999975 5664332211    


Q ss_pred             HHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          307 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                       ........+.....     .     ...+.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       245 -~~~~~~~~~~~~~~-----~-----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         245 -EFCRRLKEGTRMRA-----P-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             -HHHHHHHHTCCCCC-----C-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHhcCCCCCC-----C-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             11111111111111     1     1124568999999999999999999999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=383.00  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             hcCCCccCcccccCcccEEEEEecC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (411)
                      .++|++.+.||+|+||.||+|.+..    +..||||.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3678999999999999999998643    3468999987543 334567999999999999999999999986 467899


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  244 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  244 (411)
                      ||||+++|+|..++....  ..+++..+..++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999998875432  35899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 040952          245 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  323 (411)
Q Consensus       245 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (411)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||......  ...   .. +..+....   
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~---~~-i~~~~~~~---  229 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVI---GR-IENGERLP---  229 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH---HH-HHTTCCCC---
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHH---HH-HHcCCCCC---
Confidence            3322 22334578999999999999999999999999999999998 88887643321  111   11 11111111   


Q ss_pred             cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          324 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       324 ~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                        .     +..++..+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus       230 --~-----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 --M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             --C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --C-----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              1     112356789999999999999999999999999877543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=378.57  Aligned_cols=251  Identities=27%  Similarity=0.379  Sum_probs=197.5

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeec-CCceEEEEeeC
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYM  169 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  169 (411)
                      ++|++.+.||+|+||.||+|.++ |+.||||+++..  ...+.+.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            56788899999999999999986 889999999754  345779999999999999999999999865 45689999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|.+++.... ...+++..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            9999999986432 235899999999999999999999988   999999999999999999999999999865422   


Q ss_pred             cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCcccccccccccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  328 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (411)
                        .....+|..|+|||++.++.++.++|||||||++|||+| |++||......  +..   .. +..+     ..+.+. 
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~---~~-i~~~-----~~~~~~-  222 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV---PR-VEKG-----YKMDAP-  222 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHH---HH-HTTT-----CCCCCC-
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHH---HH-HHcC-----CCCCCC-
Confidence              233467899999999999999999999999999999998 67776533221  111   11 1111     111111 


Q ss_pred             ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          329 EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       329 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                          ...+..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus       223 ----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         223 ----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                1124578999999999999999999999999987753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=390.74  Aligned_cols=249  Identities=22%  Similarity=0.274  Sum_probs=205.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            357999999999999999999975 5999999998753   233467789999999999999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999998543   34888899999999999999999998   99999999999999999999999999987543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+...     .... ...... .     
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~-i~~~~~-~-----  223 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFEL-ILMEEI-R-----  223 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH-HHHCCC-C-----
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-----HHHH-HhcCCC-C-----
Confidence            22  22344689999999999999999999999999999999999999986543211     1111 111110 0     


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                      +     +...+.++.+|+.+||+.||++||+     +.|+++.
T Consensus       224 ~-----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         224 F-----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C-----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            1     1122556889999999999999995     8888863

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.9e-52  Score=386.79  Aligned_cols=245  Identities=24%  Similarity=0.317  Sum_probs=203.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56999999999999999999975 5999999998643   2344677899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||++||+|..++....   .+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999998885433   3788888899999999999999998   999999999999999999999999999876532


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                           ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....     ........... .      .+
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~~-~------~~  220 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNAE-L------RF  220 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHCC-C------CC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHHHcCC-C------CC
Confidence                 2346899999999999999999999999999999999999999864321     11111111111 0      00


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVSM  363 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  363 (411)
                           +...+.++.+++.+||+.||++||     |+.++++.
T Consensus       221 -----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 -----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                 111245688999999999999996     89999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=380.18  Aligned_cols=261  Identities=28%  Similarity=0.394  Sum_probs=208.7

Q ss_pred             hcCCCccCcccccCcccEEEEEecC--------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  159 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (411)
                      .++|++.+.||+|+||.||+|+...        +..||||+++... ......+.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4688999999999999999998542        2479999997653 34457788899999888 899999999999999


Q ss_pred             CceEEEEeeCCCCCchhhhcCCCC-------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          160 DEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                      +..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+++   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965431             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 040952          227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  305 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  305 (411)
                      +.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||......    
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence            9999999999999987765444444555678999999999999999999999999999999998 67787533321    


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                        .....+..+.....     ..     ..+..+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       245 --~~~~~i~~~~~~~~-----p~-----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 --ELFKLLKEGHRMDK-----PS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHHHHHHTTCCCCC-----CS-----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHcCCCCCC-----Cc-----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              11222222211111     11     124578999999999999999999999999988754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=377.16  Aligned_cols=256  Identities=26%  Similarity=0.337  Sum_probs=196.4

Q ss_pred             cCCCccCcccccCcccEEEEEecC--C--CEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK--G--DEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|+++.  +  ..||||++...   .....+.|.+|+.+|++++||||++++++|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568999999999999999998642  3  36899998654   33445789999999999999999999999976 4678


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++|++.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999998877543  234899999999999999999999988   999999999999999999999999999987


Q ss_pred             CCCCccc-ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccchhHHHHHHhhcCccccc
Q 040952          244 GGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  321 (411)
Q Consensus       244 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (411)
                      ....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.....     ..........+.... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----~~~~~~i~~~~~~~~-  235 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGERLP-  235 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCCCCC-
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----HHHHHHHHhCCCCCC-
Confidence            5443222 2334467889999999999999999999999999999998 8999863321     111222222211111 


Q ss_pred             cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 040952          322 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  367 (411)
Q Consensus       322 ~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  367 (411)
                          .     +...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus       236 ----~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 ----R-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                0     112245789999999999999999999999999764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.1e-52  Score=389.49  Aligned_cols=244  Identities=23%  Similarity=0.296  Sum_probs=204.2

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (411)
                      ++|++++.||+|+||.||+|+++ +|+.||||++...   .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999975 5999999998643   2344567899999999999999999999999999999999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  246 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  246 (411)
                      ||+.+|+|..++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999988543   34899999999999999999999998   999999999999999999999999999876532


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                           .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....     .......... ..      ..
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~-~~------~~  257 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKIVSG-KV------RF  257 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC-CC------CC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----HHHHHHHhcC-CC------CC
Confidence                 2346899999999999999999999999999999999999999864321     1111111111 10      00


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  362 (411)
                           +...+.++.+++.+||+.||++|+     |+.++++
T Consensus       258 -----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 -----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 112255789999999999999994     8999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=383.81  Aligned_cols=268  Identities=24%  Similarity=0.322  Sum_probs=203.7

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHH--HHHHHHHhcCCcccceeeeeeecCC----ceEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--NEASVIAKVQHKNLVRLLGCCIDKD----EKIL  164 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~~~----~~~l  164 (411)
                      ..|.+.+.||+|+||.||+|+++ |+.||||++.....   +.+.  .|+..+.+++||||+++++++.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            45777889999999999999975 89999999975432   3333  4555556789999999999998654    5789


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCCEEEcCCCCeEEeecCC
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-----SRVRIIHRDLKASNILLDKDMNPKISDFGM  239 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl  239 (411)
                      ||||+++|+|.+++.+    ..++|..++.++.|++.||+|||+.     +.++|+||||||+||||+.++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            9999999999999954    2489999999999999999999974     123599999999999999999999999999


Q ss_pred             ccccCCCCcc--cccccccccccccChhhhccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCcccccch------
Q 040952          240 ARICGGNELQ--ANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL------  305 (411)
Q Consensus       240 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~------  305 (411)
                      ++........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..|++.........      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9876543222  2234467999999999987543      6788999999999999999998875433221111      


Q ss_pred             ---hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          306 ---LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       306 ---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                         .........    ....++.+............+.+++.+||+.||++|||+.||++.|+++...
T Consensus       235 ~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         235 DPSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCCHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence               111111111    1222333333444445577899999999999999999999999999887654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=381.52  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=204.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      .++|++.+.||+|+||+||+|.+. +|+.||||.++.... ....+.+|+.+|+.++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999976 588999999986543 345688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--CCCeEEeecCCccccCCC
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGGN  246 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~  246 (411)
                      |+||+|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.  .+.+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999999985432  34899999999999999999999998   999999999999985  458999999999876433


Q ss_pred             CcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 040952          247 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  326 (411)
Q Consensus       247 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (411)
                      .   ......||+.|+|||.+.+..|+.++|||||||++|+|++|+.||......     ............   ++.. 
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~i~~~~~~---~~~~-  225 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEYT---FDEE-  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCC---CCHH-
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCC---CChh-
Confidence            2   223457899999999999999999999999999999999999998643321     111111111100   0000 


Q ss_pred             ccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          327 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       327 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                          .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       226 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 ----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00112456899999999999999999999997

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=382.46  Aligned_cols=263  Identities=25%  Similarity=0.369  Sum_probs=212.0

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCcccceeeeeeecCCc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (411)
                      .++|++.+.||+|+||.||+|++.      +++.||||++.... ......+.+|+.+++++ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            468888999999999999999852      35689999997643 33456788999999999 69999999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCC---------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 040952          162 KILIYEYMPNKSLDFFLFDPT---------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  226 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill  226 (411)
                      .++||||+++|+|.+++....               ....+++..+..++.||++||+|||+++   ++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986432               2235889999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcccccch
Q 040952          227 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNL  305 (411)
Q Consensus       227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~  305 (411)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|+ .+|+..... ... 
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-~~~-  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSK-  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SHH-
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-HHH-
Confidence            99999999999999887654444444556899999999999999999999999999999999995 444433221 111 


Q ss_pred             hHHHHHHhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          306 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                         .......+.     .+..     +...+..+.+|+.+||+.||++|||+.+|++.|++...+
T Consensus       257 ---~~~~i~~~~-----~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 ---FYKMIKEGF-----RMLS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ---HHHHHHHTC-----CCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHhcCC-----CCCC-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence               111111111     1111     111256789999999999999999999999999876553

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=384.84  Aligned_cols=260  Identities=28%  Similarity=0.359  Sum_probs=205.2

Q ss_pred             cCCCccCcccccCcccEEEEEecC-CC--EEEEEEccCC-CcccHHHHHHHHHHHHhc-CCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ++|++.+.||+|+||.||+|.+++ |.  .||||++... .....+.+.+|+++|+++ +||||++++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999999764 43  4788887643 334556799999999998 799999999999999999999


Q ss_pred             EeeCCCCCchhhhcCC-------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCe
Q 040952          166 YEYMPNKSLDFFLFDP-------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  232 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  232 (411)
                      |||+++|+|.++++..             .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998653             23356899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCC-CCCCCcccccchhHHHHH
Q 040952          233 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLGYAWD  311 (411)
Q Consensus       233 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~  311 (411)
                      ||+|||+++.....   .......||..|+|||.+.++.++.++|||||||++|||++|.. ||....     .......
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK  238 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence            99999999765321   12233468999999999999999999999999999999999765 553221     1111111


Q ss_pred             HhhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccC
Q 040952          312 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL  372 (411)
Q Consensus       312 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  372 (411)
                       +..+.     .+..     +...+..+.+|+.+||+.||++|||+.||++.|+++.....
T Consensus       239 -i~~~~-----~~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         239 -LPQGY-----RLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             -GGGTC-----CCCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             -HHhcC-----CCCC-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence             11111     1111     11225679999999999999999999999999999876543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.9e-51  Score=374.22  Aligned_cols=259  Identities=22%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCcccceeeeeeecCC----c
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----E  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  161 (411)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            477999999999999999999965 58999999997542   233567899999999999999999999988654    3


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .|+||||++|++|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            78999999999999888543   34899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCC-cccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 040952          242 ICGGNE-LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  320 (411)
Q Consensus       242 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (411)
                      ...... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ...............
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIPP  234 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCG
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCCCC
Confidence            654322 22233446799999999999999999999999999999999999999864321     111222222111100


Q ss_pred             ccccccccccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhc
Q 040952          321 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-TMNDVVSMLTNE  367 (411)
Q Consensus       321 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~  367 (411)
                         ..     .....+..+.+++.+||+.||++|| |+.++++.|.++
T Consensus       235 ---~~-----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         235 ---SA-----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ---GG-----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---ch-----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence               00     0111246789999999999999999 899999988765

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-51  Score=377.07  Aligned_cols=261  Identities=28%  Similarity=0.394  Sum_probs=211.4

Q ss_pred             hcCCCccCcccccCcccEEEEEec------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeecCCce
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  162 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (411)
                      .++|++.+.||+|+||+||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            478889999999999999999864      2578999999754 334445689999999999999999999999999999


Q ss_pred             EEEEeeCCCCCchhhhcCC-------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          163 ILIYEYMPNKSLDFFLFDP-------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                      ++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||+++   |+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999987532       22234788899999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcccccchhHHHHHHhh
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYAWDLWT  314 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~  314 (411)
                      |||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||.....     ...... ..
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~~~~-i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRF-VM  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHHHH-HH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HH
Confidence            999998765444444445557899999999999999999999999999999999985 56543221     111111 11


Q ss_pred             cCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccc
Q 040952          315 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  369 (411)
Q Consensus       315 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  369 (411)
                      .+.....          +..++..+.+++.+||+.+|++|||+.+|++.|++...
T Consensus       250 ~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 EGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             hCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1111111          11224679999999999999999999999999987754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=377.95  Aligned_cols=255  Identities=26%  Similarity=0.387  Sum_probs=202.3

Q ss_pred             cCcccccCcccEEEEEecCC----CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCcccceeeeeeec-CCceEEEEeeC
Q 040952           96 ANKLGEGGFGPVYKGVLKKG----DEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYM  169 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  169 (411)
                      .++||+|+||+||+|.+.++    ..||||+++.. +....++|.+|+++|++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999997542    25899999753 44556789999999999999999999999875 45789999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      ++|+|.+++....  ...++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999886543  34678888999999999999999998   999999999999999999999999999876543222


Q ss_pred             c--ccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 040952          250 A--NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  327 (411)
Q Consensus       250 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (411)
                      .  ......||+.|+|||.+.++.++.++||||||+++|||+||+.||...... .+..   .........      .. 
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~---~~i~~g~~~------~~-  255 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDIT---VYLLQGRRL------LQ-  255 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CH---HHHHTTCCC------CC-
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHH---HHHHcCCCC------CC-
Confidence            1  223356899999999999999999999999999999999988876533211 1111   111111110      01 


Q ss_pred             cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccc
Q 040952          328 DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  370 (411)
Q Consensus       328 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  370 (411)
                          +...+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus       256 ----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         256 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                111245789999999999999999999999999988764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-50  Score=383.93  Aligned_cols=249  Identities=24%  Similarity=0.284  Sum_probs=197.5

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC---cccHHHHH---HHHHHHHhcCCcccceeeeeeecCCceE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKI  163 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....   ......+.   .++.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999976 59999999986431   12223333   4466777778999999999999999999


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      +||||+++|+|..++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999998543   34788899999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  322 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (411)
                      ....    .....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||........  .... ......      
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~-~~~~~~------  224 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEID-RMTLTM------  224 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHH-HHSSSC------
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HhcccC------
Confidence            5332    234579999999999875 5689999999999999999999999865432211  1111 000000      


Q ss_pred             ccccccccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040952          323 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPT-----MNDVVSM  363 (411)
Q Consensus       323 ~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  363 (411)
                      ...+     +...+..+.+|+.+||+.||++|||     +.|+++.
T Consensus       225 ~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 AVEL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             CCCC-----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCC-----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            0001     1112456899999999999999999     6888753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.2e-51  Score=371.62  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=203.5

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcc---------cHHHHHHHHHHHHhcC-Ccccceeeeeeec
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ---------GLREMKNEASVIAKVQ-HKNLVRLLGCCID  158 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  158 (411)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++......         ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999974 5899999998754211         2345789999999997 9999999999999


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                      .+..|+||||+++|+|.+++...   ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999999643   35899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHH
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  312 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  312 (411)
                      +++......   ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.......     .....
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-----~~~~i  227 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----MLRMI  227 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-----HHHHH
Confidence            998875432   2234579999999998863      347889999999999999999999986433111     11111


Q ss_pred             hhcCccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          313 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .. +... ...+      .....+.++.+++.+||++||++|||+.|+++.
T Consensus       228 ~~-~~~~-~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MS-GNYQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HH-TCCC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             Hh-CCCC-CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11 1110 0000      111235678999999999999999999999763

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=374.13  Aligned_cols=258  Identities=23%  Similarity=0.278  Sum_probs=193.9

Q ss_pred             cCcccccCcccEEEEEec-CCCEEEEEEccCCCcc-----cHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEeeC
Q 040952           96 ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  169 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (411)
                      ++.||+|+||+||+|++. +|+.||||++......     ..+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999975 5899999998654221     1346889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCcc
Q 040952          170 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  249 (411)
Q Consensus       170 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  249 (411)
                      .++++..+...   +..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            99888776632   344788888999999999999999998   99999999999999999999999999987654322 


Q ss_pred             cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc------ccc
Q 040952          250 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL------ELI  322 (411)
Q Consensus       250 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  322 (411)
                       .....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||......  +...............      ...
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchhccc
Confidence             22345799999999988754 5899999999999999999999998643321  1111111111000000      000


Q ss_pred             ccc-cc--cccch----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          323 DPI-LE--DEYSS----KHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       323 ~~~-l~--~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      ... ..  .....    ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000 00  00000    1124678999999999999999999999973

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=381.55  Aligned_cols=247  Identities=26%  Similarity=0.369  Sum_probs=201.2

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC---CcccHHHHHHHHHHHH-hcCCcccceeeeeeecCCceEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIA-KVQHKNLVRLLGCCIDKDEKILI  165 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  165 (411)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...   .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999976 5899999999643   2334556677777765 68999999999999999999999


Q ss_pred             EeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCC
Q 040952          166 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  245 (411)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  245 (411)
                      |||+++|+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999998643   34788999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  325 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (411)
                      ..  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......     . .........      +.
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----~-~~~~i~~~~------~~  221 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----E-LFHSIRMDN------PF  221 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHCC------CC
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----H-HHHHHHcCC------CC
Confidence            32  2234468999999999999999999999999999999999999998643211     1 111111111      11


Q ss_pred             cccccchHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040952          326 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMN-DVVS  362 (411)
Q Consensus       326 l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  362 (411)
                      +.     ...+..+.+|+.+||+.||++|||+. ++++
T Consensus       222 ~p-----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 YP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CC-----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11     11245689999999999999999995 7764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=376.87  Aligned_cols=253  Identities=17%  Similarity=0.204  Sum_probs=197.7

Q ss_pred             hcCCCccC-cccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCcccceeeeeeec----CCce
Q 040952           90 TNKFSDAN-KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID----KDEK  162 (411)
Q Consensus        90 ~~~y~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  162 (411)
                      .++|.+.. .||+|+||+||+|++. +|+.||||++...     ..+.+|+.++.++ +||||++++++|.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788875 5999999999999974 5899999998643     4567899987655 89999999999875    4568


Q ss_pred             EEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCC
Q 040952          163 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGM  239 (411)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl  239 (411)
                      |+|||||+||+|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            99999999999999996542 245899999999999999999999998   999999999999985   56799999999


Q ss_pred             ccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          240 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      ++.......   .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||........  ...........   
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~---  232 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMG---  232 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC---
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcC---
Confidence            987654332   2345899999999999999999999999999999999999999853221110  00000000000   


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                         ...+. .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       233 ---~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         233 ---QYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ---SSSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---CCCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               00000 01122346789999999999999999999999873

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=371.01  Aligned_cols=270  Identities=20%  Similarity=0.291  Sum_probs=202.1

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999975 59999999996542  2345778999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      |+.++.+......  ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9987655544332  2344899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccccccccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc--C--------
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS--N--------  316 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~--------  316 (411)
                        .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+...  ...........  .        
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccc
Confidence              2233457999999999887665 5889999999999999999999986432111  00000000000  0        


Q ss_pred             --cccccccccccccc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhccc
Q 040952          317 --RTLELIDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA  369 (411)
Q Consensus       317 --~~~~~~~~~l~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~  369 (411)
                        ..............  .....+..+.+|+.+||+.||++|||+.|+++.  ++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence              00000000000000  001124678999999999999999999999985  655533

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-49  Score=364.83  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=200.4

Q ss_pred             cCCCccCcccccCcccEEEEEecCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEee
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  168 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (411)
                      ++|++.+.||+|+||+||+|++++|+.||||++....  ....+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999999989999999997543  33357889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCCc
Q 040952          169 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  248 (411)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  248 (411)
                      +.++++..+....   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9988887776433   45899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             ccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc------cccc
Q 040952          249 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR------TLEL  321 (411)
Q Consensus       249 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~  321 (411)
                        ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......  +.............      ....
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhh
Confidence              22334689999999998754 5799999999999999999999998643211  11111111000000      0000


Q ss_pred             c--ccc------cccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          322 I--DPI------LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       322 ~--~~~------l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      .  ...      ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  000      0000011122457889999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=364.66  Aligned_cols=241  Identities=23%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCc------ccHHHHHHHHHHHHhcC--CcccceeeeeeecCC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG------QGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKD  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  160 (411)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....      .....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999975 589999999864321      11234678999999986  899999999999999


Q ss_pred             ceEEEEeeCCC-CCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCCeEEeecC
Q 040952          161 EKILIYEYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFG  238 (411)
Q Consensus       161 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg  238 (411)
                      ..++||||+.+ +++.+++..   +..+++..+..++.|+++||+|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 567777643   344899999999999999999999998   999999999999985 4799999999


Q ss_pred             CccccCCCCcccccccccccccccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          239 MARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       239 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      +++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....           ...... 
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~-  220 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQ-  220 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCC-
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------HHhhcc-
Confidence            99875432    2234689999999999987765 677999999999999999999985321           001110 


Q ss_pred             cccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        ..    +..     ..+.++.+++.+||+.||++|||+.|+++.
T Consensus       221 --~~----~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         221 --VF----FRQ-----RVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --CC----CSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --cC----CCC-----CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              00    111     124568999999999999999999999873

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=362.95  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=195.1

Q ss_pred             hcCCCccCcccccCcccEEEEEec-C-CCEEEEEEccCCC--cccHHHHHHHHHHHHhc---CCcccceeeeeeec----
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-K-GDEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCID----  158 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  158 (411)
                      .++|++.+.||+|+||+||+|++. + ++.||||++....  ......+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999974 4 5679999986432  22223456677776665   89999999999853    


Q ss_pred             -CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeec
Q 040952          159 -KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  237 (411)
Q Consensus       159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  237 (411)
                       ....+++|||+.++++.......  ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             34678999999998876554332  344788899999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc
Q 040952          238 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  317 (411)
Q Consensus       238 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  317 (411)
                      |+++.....   .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......  +.............
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~  235 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPG  235 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCc
Confidence            998765322   2334568999999999999999999999999999999999999999643321  11111111000000


Q ss_pred             c------c----cccccccc--cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          318 T------L----ELIDPILE--DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       318 ~------~----~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .      .    ........  ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0      0    00000000  000011124568899999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-48  Score=357.83  Aligned_cols=276  Identities=20%  Similarity=0.231  Sum_probs=204.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccccee-eeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL-LGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......  ..+..|+++++.++|+|++.. .+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            467999999999999999999975 5889999998764332  357889999999987775554 555677788899999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCCeEEeecCCccccC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICG  244 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfgl~~~~~  244 (411)
                      |+.+ ++...+...  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++...
T Consensus        84 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLGP-SLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCCC-BHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcCC-chhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9955 444444332  234899999999999999999999998   999999999999863   5679999999998765


Q ss_pred             CCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH-HHHhhcCcc
Q 040952          245 GNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRT  318 (411)
Q Consensus       245 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~  318 (411)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. .........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            43221     223446799999999999999999999999999999999999999975543222111000 000000000


Q ss_pred             ccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeeec
Q 040952          319 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFVR  383 (411)
Q Consensus       319 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~  383 (411)
                           +.+     ....+.++.+++.+||+.+|++||++.++.+.|+...........-+++|..
T Consensus       238 -----~~~-----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~  292 (299)
T d1ckia_         238 -----EVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  292 (299)
T ss_dssp             -----HHH-----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred             -----hHh-----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence                 000     0112467899999999999999999999999998876555545555566643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-47  Score=353.02  Aligned_cols=275  Identities=16%  Similarity=0.203  Sum_probs=214.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC-cccceeeeeeecCCceEEEEe
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  167 (411)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            478999999999999999999965 588999999865432  2346788999999965 899999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----CCCeEEeecCCccc
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMARI  242 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfgl~~~  242 (411)
                      |+ +++|.+++....  ..++......++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 678888875433  34889999999999999999999998   999999999999974     57899999999987


Q ss_pred             cCCCCcc-----cccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccch-hHHHHHHhhcC
Q 040952          243 CGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-LGYAWDLWTSN  316 (411)
Q Consensus       243 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~  316 (411)
                      .......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ...........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6532211     12344679999999999999999999999999999999999999996443222111 11111110000


Q ss_pred             ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcccccCCCCCCceeee
Q 040952          317 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSFV  382 (411)
Q Consensus       317 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~  382 (411)
                      ...++     .     ..++.++.+++..|+..+|++||+++.+.+.|+++.........-+++|.
T Consensus       236 ~~~~l-----~-----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~  291 (293)
T d1csna_         236 PLREL-----C-----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  291 (293)
T ss_dssp             CHHHH-----T-----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             ChHHh-----c-----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence            00010     0     11245689999999999999999999999999888777666666666663

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=357.87  Aligned_cols=266  Identities=20%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeec--------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--------  158 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  158 (411)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  .......+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999975 6999999998644  33345678899999999999999999998865        


Q ss_pred             CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecC
Q 040952          159 KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  238 (411)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  238 (411)
                      .+..++||||+.++++..+...   ...++......++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            3467999999998887766533   234788889999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcc--cccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc
Q 040952          239 MARICGGNELQ--ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  315 (411)
Q Consensus       239 l~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  315 (411)
                      +++........  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||......  ............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~  240 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGS  240 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCC
Confidence            99776533221  122335799999999998765 6899999999999999999999998643211  111111111100


Q ss_pred             --Ccc---------ccccccccccccc------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          316 --NRT---------LELIDPILEDEYS------SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       316 --~~~---------~~~~~~~l~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                        ...         ...+.........      .......+.+|+.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence              000         0000000000011      11123567889999999999999999999965

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=359.44  Aligned_cols=263  Identities=23%  Similarity=0.299  Sum_probs=194.9

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeecCC------
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (411)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++...  +....+.+.+|+.+|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            478999999999999999999975 5999999999754  3334567889999999999999999999998654      


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..|+||||+ +.+|..+..    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            569999999 566776653    234899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhc----
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS----  315 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  315 (411)
                      +.....     .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.......  ...........    
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~  241 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAE  241 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcHH
Confidence            876432     2345789999999998764 57899999999999999999999986543211  00000000000    


Q ss_pred             ----C----------ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhccc
Q 040952          316 ----N----------RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA  369 (411)
Q Consensus       316 ----~----------~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~  369 (411)
                          .          ...+.....+..  .....+..+.+|+.+||+.||++|||+.|+++.  ++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         242 FVQRLQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhhhcchhhhhhhccCCcccccchHH--hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                0          000000000000  011124567899999999999999999999985  555443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-48  Score=363.71  Aligned_cols=265  Identities=22%  Similarity=0.273  Sum_probs=195.7

Q ss_pred             CCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCcccceeeeeeecC------CceEE
Q 040952           92 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DEKIL  164 (411)
Q Consensus        92 ~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  164 (411)
                      +|+..++||+|+||+||+|++. +|+.||||++......    ..+|+.+|++++||||++++++|...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999976 5999999999764322    24799999999999999999998543      34689


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCcccc
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARIC  243 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~~~  243 (411)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999988765555433334456899999999999999999999988   99999999999999775 8999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHH----------HHH
Q 040952          244 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA----------WDL  312 (411)
Q Consensus       244 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~----------~~~  312 (411)
                      .....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+....          +..
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence            54332   233579999999998875 568999999999999999999999986543211 000000          000


Q ss_pred             hhcCccccccccccc---cccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhc
Q 040952          313 WTSNRTLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM--LTNE  367 (411)
Q Consensus       313 ~~~~~~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~  367 (411)
                      .........+.....   ........+..+.+|+.+||+.||++|||+.|+++.  ++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            000000000000000   001111225578999999999999999999999963  4444

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-47  Score=356.42  Aligned_cols=265  Identities=19%  Similarity=0.264  Sum_probs=196.3

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCcccceeeeeeecCC----ceE
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKI  163 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  163 (411)
                      +.+|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            467999999999999999999964 69999999997543 334567889999999999999999999987653    335


Q ss_pred             EEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcccc
Q 040952          164 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  243 (411)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~  243 (411)
                      ++++|+.+|+|.+++..    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            56677789999999853    24899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc--
Q 040952          244 GGNELQ-ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL--  319 (411)
Q Consensus       244 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  319 (411)
                      ...... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||........  ..............  
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDL  237 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhhccCCChhhh
Confidence            433221 2234467999999999985 55678999999999999999999999865432110  00000000000000  


Q ss_pred             ---------cccccccc-cccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          320 ---------ELIDPILE-DEYS----SKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       320 ---------~~~~~~l~-~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                               ........ ....    ....+.++.+|+.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     00000000 0000    00113568899999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=349.15  Aligned_cols=264  Identities=20%  Similarity=0.257  Sum_probs=202.9

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecCCceEEEEe
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...  ......+.+|+.+++.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 58899999986542  3346788999999999999999999999999999999999


Q ss_pred             eCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCccccCCCC
Q 040952          168 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  247 (411)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  247 (411)
                      ++.+++|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999998887543   34788999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccccccccccccccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCc------ccc
Q 040952          248 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR------TLE  320 (411)
Q Consensus       248 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~  320 (411)
                      .  ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||........ .............      ...
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHHHHhhcCCCChhhhhhhhh
Confidence            2  222345788899999987665 68999999999999999999999743322111 1111111111000      000


Q ss_pred             c--------cccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          321 L--------IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       321 ~--------~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                      .        ..............+..+.+|+.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0        000000000111224578899999999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.5e-46  Score=350.68  Aligned_cols=257  Identities=17%  Similarity=0.283  Sum_probs=196.7

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-Ccccceeeeeeec--CCceEEEE
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID--KDEKILIY  166 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  166 (411)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...   .+.+.+|+.+|+.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            67999999999999999999975 58999999997543   457889999999995 9999999999874  45689999


Q ss_pred             eeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-CeEEeecCCccccCC
Q 040952          167 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGG  245 (411)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~  245 (411)
                      ||+.+++|..+.      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      23788999999999999999999998   99999999999998655 599999999987653


Q ss_pred             CCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHH--------HHHHhhcC
Q 040952          246 NELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY--------AWDLWTSN  316 (411)
Q Consensus       246 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~  316 (411)
                      ..   ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.............        ........
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            32   23345789999999998765 47999999999999999999999986544321111000        00000000


Q ss_pred             cc------ccccc-------cccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040952          317 RT------LELID-------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS  362 (411)
Q Consensus       317 ~~------~~~~~-------~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  362 (411)
                      ..      .....       ............+.++.+|+.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      00000       000011111223467899999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-47  Score=352.54  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=199.1

Q ss_pred             cCCCccCcccccCcccEEEEEec----CCCEEEEEEccCCC----cccHHHHHHHHHHHHhcCC-cccceeeeeeecCCc
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDE  161 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  161 (411)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++....    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    37899999986432    2334567899999999976 899999999999999


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .+++|||+.+|+|..++....   .++......++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999985443   3677888899999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcCccc
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  319 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  319 (411)
                      .+...... ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||........... ........ .  
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~~~~~~~-~--  252 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRILKS-E--  252 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHHHC-C--
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcccC-C--
Confidence            76533322 23345799999999998754  478899999999999999999999865432221111 11111110 0  


Q ss_pred             cccccccccccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 040952          320 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNDVVS  362 (411)
Q Consensus       320 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  362 (411)
                          +.+     +...+..+.+++.+||++||++||     |+.|+++
T Consensus       253 ----~~~-----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ----PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----CCC-----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                000     112356789999999999999999     4788886

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=354.27  Aligned_cols=263  Identities=22%  Similarity=0.271  Sum_probs=196.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCcccceeeeeeecC-----Cc
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  161 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (411)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999965 59999999997543  33456788999999999999999999998643     34


Q ss_pred             eEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          162 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      .+++++|+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5677888899999999843    24899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccccccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccchhHHHHHHhhcC----
Q 040952          242 ICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN----  316 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  316 (411)
                      ...     .......||+.|+|||...+. .++.++|||||||++|+|++|+.||...+....  ...........    
T Consensus       170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAEL  242 (348)
T ss_dssp             CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred             ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHH
Confidence            643     223345789999999987765 468999999999999999999999864331110  00000000000    


Q ss_pred             --------------ccccccccccccccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhhcc
Q 040952          317 --------------RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNDVVS--MLTNEA  368 (411)
Q Consensus       317 --------------~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~  368 (411)
                                    .........+...  ....+..+.+|+.+||+.||++|||+.|+++  .+.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANV--FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHH--STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhccchhhhhhhhhcccCCCcchhhh--cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                          0000000000000  0112456889999999999999999999997  455443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=351.79  Aligned_cols=262  Identities=23%  Similarity=0.250  Sum_probs=191.7

Q ss_pred             hcCCCccCcccccCcccEEEEEec-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCcccceeeeeeec------CC
Q 040952           90 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID------KD  160 (411)
Q Consensus        90 ~~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  160 (411)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++...  +......+.+|+.++++++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            378999999999999999999976 5999999999754  33445678899999999999999999999864      35


Q ss_pred             ceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEeecCCc
Q 040952          161 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  240 (411)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~  240 (411)
                      ..|+||||+.++.+..+.      ..+++.....++.|++.||.|||++|   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            789999999877665542      23788999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc----------------
Q 040952          241 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN----------------  304 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~----------------  304 (411)
                      +......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....                
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            7654322   234457899999999999999999999999999999999999998643311100                


Q ss_pred             -hhHHHHHHhhcCcc------cccccccccc--ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040952          305 -LLGYAWDLWTSNRT------LELIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNDVVSM  363 (411)
Q Consensus       305 -~~~~~~~~~~~~~~------~~~~~~~l~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  363 (411)
                       ..............      ..........  .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             00000001111000      0001111100  11133356789999999999999999999999965

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-40  Score=316.42  Aligned_cols=268  Identities=20%  Similarity=0.231  Sum_probs=192.2

Q ss_pred             cCCCccCcccccCcccEEEEEec-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----------Ccccceeeeeeec
Q 040952           91 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCID  158 (411)
Q Consensus        91 ~~y~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  158 (411)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999975 59999999997543 23456788999888875           5789999988764


Q ss_pred             --CCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCC----
Q 040952          159 --KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMN----  231 (411)
Q Consensus       159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~----  231 (411)
                        ....+++++++..+..............+++..+..++.|++.|++|||+ .+   |+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence              34566777776665544333333344557888899999999999999998 66   999999999999986653    


Q ss_pred             --eEEeecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-cchhHH
Q 040952          232 --PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGY  308 (411)
Q Consensus       232 --~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~  308 (411)
                        ++++|||.+.....     ......||+.|+|||++.+..++.++|+||+||++++|++|+.||....... ......
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              99999999876432     2234579999999999999999999999999999999999999986543211 000000


Q ss_pred             HH---H------------------HhhcCcccccccccc--------c-cccchHHHHHHHHHHHHHccccCCCCCCCHH
Q 040952          309 AW---D------------------LWTSNRTLELIDPIL--------E-DEYSSKHMLLRYVNIALLCVQESADDRPTMN  358 (411)
Q Consensus       309 ~~---~------------------~~~~~~~~~~~~~~l--------~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  358 (411)
                      ..   .                  .+........+....        . ........+..+.+|+.+||+.||++|||+.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            00   0                  000000000000000        0 0011344577899999999999999999999


Q ss_pred             HHHHH--Hhhc
Q 040952          359 DVVSM--LTNE  367 (411)
Q Consensus       359 evl~~--L~~~  367 (411)
                      |+++.  +++.
T Consensus       324 e~L~Hp~f~~~  334 (362)
T d1q8ya_         324 GLVNHPWLKDT  334 (362)
T ss_dssp             HHHTCGGGTTC
T ss_pred             HHhcCcccCCC
Confidence            99874  5533

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=9.5e-26  Score=193.20  Aligned_cols=168  Identities=18%  Similarity=0.157  Sum_probs=119.4

Q ss_pred             CccCcccccCcccEEEEEecCCCEEEEEEccCCCc------------------ccHHHHHHHHHHHHhcCCcccceeeee
Q 040952           94 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG------------------QGLREMKNEASVIAKVQHKNLVRLLGC  155 (411)
Q Consensus        94 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~  155 (411)
                      .+.++||+|+||+||+|.+.+|+.||||++.....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45688999999999999988899999998753210                  011234568889999999999988765


Q ss_pred             eecCCceEEEEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCCeEEe
Q 040952          156 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  235 (411)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  235 (411)
                      .    ..+++|||+++..+..+          +......++.|++++++|||+++   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    24799999998766432          22334578999999999999998   99999999999998654 8999


Q ss_pred             ecCCccccCCCCcccccccccccccccChhhhccCCCCcchhhHHHHHH
Q 040952          236 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVL  284 (411)
Q Consensus       236 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i  284 (411)
                      |||++.............+.+.    .-.+ +....|+.++|+||..--
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~----~~~~-~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVR----NIIT-YFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHH----HHHH-HHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHH----HHHH-HHcCCCCCcccHHHHHHH
Confidence            9999876542211110000000    0011 124567889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.87  E-value=5.3e-09  Score=92.08  Aligned_cols=147  Identities=16%  Similarity=0.134  Sum_probs=102.1

Q ss_pred             hhHHhcCCCccCcccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEE
Q 040952           86 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKIL  164 (411)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  164 (411)
                      +......|+..+..+.++.+.||+...+ ++.+.+|+...........+.+|...+..+. +--+.+++.++.+.+..++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            4444566776666555556789988654 6778899887554444445678888888774 3335677888888888999


Q ss_pred             EEeeCCCCCchhhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 040952          165 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS----------------------------------  210 (411)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  210 (411)
                      ||++++|.++........        ....++.++++.+..||+..                                  
T Consensus        88 v~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            999999988865432111        12345566666777777421                                  


Q ss_pred             ----------------------CCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          211 ----------------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       211 ----------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                                            ...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1237999999999999987777799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.39  E-value=1.7e-06  Score=74.97  Aligned_cols=129  Identities=16%  Similarity=0.164  Sum_probs=86.7

Q ss_pred             ccccCc-ccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC--cccceeeeeeecCCceEEEEeeCCCCCch
Q 040952           99 LGEGGF-GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILIYEYMPNKSLD  175 (411)
Q Consensus        99 lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~  175 (411)
                      +..|.. +.||+...+++..+++|........   .+..|...++.+..  -.+.+++.+..+.+..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444543 5789998887888999987654332   45677777777633  33566788878888899999999987764


Q ss_pred             hhhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 040952          176 FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS---------------------------------------------  210 (411)
Q Consensus       176 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  210 (411)
                      ...        ..   ....+.++++.|.-||+..                                             
T Consensus        95 ~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          95 SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            321        11   1122334444444444211                                             


Q ss_pred             ----------CCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          211 ----------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       211 ----------~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                                ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                      2237999999999999987777899998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.02  E-value=1.5e-05  Score=73.79  Aligned_cols=77  Identities=13%  Similarity=0.263  Sum_probs=49.3

Q ss_pred             cCcccccCcccEEEEEecC-CCEEEEEEccCC-------CcccHHHHHHHHHHHHhc-CC-cc-cceeeeeeecCCceEE
Q 040952           96 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR-------SGQGLREMKNEASVIAKV-QH-KN-LVRLLGCCIDKDEKIL  164 (411)
Q Consensus        96 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l-~h-~n-iv~l~~~~~~~~~~~l  164 (411)
                      .+.||.|....||+....+ |+.++||.-...       ......+...|...|+.+ .+ |. +.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999998654 678999965321       112334556788888766 22 33 4445443  4556789


Q ss_pred             EEeeCCCCCc
Q 040952          165 IYEYMPNKSL  174 (411)
Q Consensus       165 v~e~~~~g~L  174 (411)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.65  E-value=7.7e-05  Score=66.88  Aligned_cols=135  Identities=13%  Similarity=0.110  Sum_probs=78.0

Q ss_pred             ccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCccc--ceee-----eeeecCCceEEEEeeCCCCCchhh
Q 040952          105 GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL--VRLL-----GCCIDKDEKILIYEYMPNKSLDFF  177 (411)
Q Consensus       105 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L~~~  177 (411)
                      -.||++..++|+.+++|+..... ...+++..|...+..+....+  +..+     ..+...+..+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            57999999889999999986542 344667889888888743222  1111     122345567889999987554211


Q ss_pred             -----------h---c----C--CCCCcCCCHH-------------------HHHHHHHHHHHHHHHHhh----cCCCCe
Q 040952          178 -----------L---F----D--PTKRMLLDWV-------------------TRVQIIEGIAQGLLYLHQ----YSRVRI  214 (411)
Q Consensus       178 -----------l---~----~--~~~~~~~~~~-------------------~~~~i~~~i~~~l~~LH~----~~~~~i  214 (411)
                                 +   +    .  ...+...+..                   ....+...+...++.+..    .....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                       0   0    0  0111111111                   111122222233333322    223458


Q ss_pred             eecCCCCCCEEEcCCCCeEEeecCCccc
Q 040952          215 IHRDLKASNILLDKDMNPKISDFGMARI  242 (411)
Q Consensus       215 vH~dlkp~Nill~~~~~~kl~Dfgl~~~  242 (411)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899997653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.21  E-value=0.00068  Score=62.21  Aligned_cols=73  Identities=12%  Similarity=0.197  Sum_probs=49.2

Q ss_pred             CcccccCcccEEEEEecC--------CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CcccceeeeeeecCCceEEEEe
Q 040952           97 NKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE  167 (411)
Q Consensus        97 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  167 (411)
                      +.|+.|-.-.+|+....+        .+.|.+++... .. ......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            567778888899988653        34677777653 22 2335568888888884 4334467777643    68999


Q ss_pred             eCCCCCch
Q 040952          168 YMPNKSLD  175 (411)
Q Consensus       168 ~~~~g~L~  175 (411)
                      |++|..+.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99886553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.98  E-value=0.005  Score=54.14  Aligned_cols=156  Identities=12%  Similarity=-0.010  Sum_probs=77.9

Q ss_pred             hhhhhHHhcCCCccCc-----ccccCcccEEEEEecCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCc-----cccee
Q 040952           83 FSSVSTATNKFSDANK-----LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK-----NLVRL  152 (411)
Q Consensus        83 ~~~~~~~~~~y~~~~~-----lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-----niv~l  152 (411)
                      ..++.....+|.+.+.     |..|---+.|....++| .+++|++.....  .+.+..|+.++..+...     ..+..
T Consensus         5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccccee
Confidence            3445555666765433     44565577899887755 489999865321  23445566677766322     22211


Q ss_pred             ee---eeecCCceEEEEeeCCCCCchhhh--------------c----C--CCCCcCC------------------CHHH
Q 040952          153 LG---CCIDKDEKILIYEYMPNKSLDFFL--------------F----D--PTKRMLL------------------DWVT  191 (411)
Q Consensus       153 ~~---~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~--~~~~~~~------------------~~~~  191 (411)
                      .+   +.........++.+..+.......              +    .  .......                  ....
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence            10   112234456677776664432110              0    0  0000000                  0001


Q ss_pred             HHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCCeEEeecCCcc
Q 040952          192 RVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  241 (411)
Q Consensus       192 ~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfgl~~  241 (411)
                      ....+......+.-.+. .-+.++||+|+.++||+++++...-|.||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11111112222222221 113459999999999999988878899999764